PT J
AU Grady, JP
   Campbell, G
   Ratnaike, T
   Blakely, EL
   Falkous, G
   Nesbitt, V
   Schaefer, AM
   McNally, RJ
   Gorman, GS
   Taylor, RW
   Turnbull, DM
   McFarland, R
AF Grady, John P.
   Campbell, Georgia
   Ratnaike, Thiloka
   Blakely, Emma L.
   Falkous, Gavin
   Nesbitt, Victoria
   Schaefer, Andrew M.
   McNally, Richard J.
   Gorman, Grainne S.
   Taylor, Robert W.
   Turnbull, Doug M.
   McFarland, Robert
TI Disease progression in patients with single, large-scale mitochondrial DNA deletions
SO BRAIN
LA English
DT Article
DE mitochondrial diseases; mitochondrial DNA deletion; disease progression
ID real-time pcr; parkinsons-disease; external ophthalmoplegia; mtdna; heteroplasmy; features; mutations; threshold; cognition; dementia
AB Single, large-scale deletions of mitochondrial DNA are an important cause of mitochondrial disease, with a broad phenotypic spectrum. Grady et al. report that disease severity and progression are correlated with the size of the deletion, its location within the genome, and the deletion heteroplasmy level in skeletal muscle.Single, large-scale deletions of mitochondrial DNA are a common cause of mitochondrial disease and cause a broad phenotypic spectrum ranging from mild myopathy to devastating multi-system syndromes such as Kearns-Sayre syndrome. Studies to date have been inconsistent on the value of putative predictors of clinical phenotype and disease progression such as mutation load and the size or location of the deletion. Using a cohort of 87 patients with single, large-scale mitochondrial DNA deletions we demonstrate that a variety of outcome measures such as COX-deficient fibre density, age-at-onset of symptoms and progression of disease burden, as measured by the Newcastle Mitochondrial Disease Adult Scale, are significantly (P < 0.05) correlated with the size of the deletion, the deletion heteroplasmy level in skeletal muscle, and the location of the deletion within the genome. We validate these findings with re-analysis of 256 cases from published data and clarify the previously conflicting information of the value of these predictors, identifying that multiple regression analysis is necessary to understand the effect of these interrelated predictors. Furthermore, we have used mixed modelling techniques to model the progression of disease according to these predictors, allowing a better understanding of the progression over time of this strikingly variable disease. In this way we have developed a new paradigm in clinical mitochondrial disease assessment and management that sidesteps the perennial difficulty of ascribing a discrete clinical phenotype to a broad multi-dimensional and progressive spectrum of disease, establishing a framework to allow better understanding of disease progression.
C1 [Grady, John P.; Campbell, Georgia; Ratnaike, Thiloka; Blakely, Emma L.; Falkous, Gavin; Nesbitt, Victoria; Schaefer, Andrew M.; Gorman, Grainne S.; Taylor, Robert W.; Turnbull, Doug M.; McFarland, Robert] Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [McNally, Richard J.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Turnbull, DM (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk; robert.mcfarland@newcastle.ac.uk
FU Wellcome Trust Centre for Mitochondrial Research [G906919]; Newcastle University Centre for Brain Ageing and Vitality; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council [G0700718]; MRC Centre for Neuromuscular Disease [G000608-1]; MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre in Age and Age Related Diseases award; UK NHS Specialist Commissioners 'Rare Mitochondrial Disorders of Adults and Children' Service; Wellcome Trust [090194/Z/09/Z]; Wellcome Trust [090194/Z/09/Z] Funding Source: Wellcome Trust; MRC [G0700718, MR/K000608/1, G0800674] Funding Source: UKRI
CR AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Apabhai S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022294
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Bates MGD, 2013, EUR HEART J-CARD IMG, V14, P650, DOI 10.1093/ehjci/jes226
   Blackwood JK, 2010, BIOCHEM BIOPH RES CO, V393, P740, DOI 10.1016/j.bbrc.2010.02.072
   BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   den Heijer T, 2010, BRAIN, V133, P1163, DOI 10.1093/brain/awq048
   Diggle P, 2002, ANAL LONGITUDINAL DA, V2nd ed., P0
   Dobkin RD, 2011, AM J PSYCHIAT, V168, P1066, DOI 10.1176/appi.ajp.2011.10111669
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009
   Galvin JE, 2005, ARCH NEUROL-CHICAGO, V62, P758, DOI 10.1001/archneur.62.5.758
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Hassing LB, 2004, J INT NEUROPSYCH SOC, V10, P599, DOI 10.1017/S1355617704104165
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Ishikawa Y, 2000, J CHILD NEUROL, V15, P750, DOI 10.1177/088307380001501107
   Jacobs LJAM, 2004, J INHERIT METAB DIS, V27, P47, DOI 10.1023/B:BOLI.0000016601.49372.18
   JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059
   Johnson DK, 2011, DEMENT GERIATR COGN, V31, P98, DOI 10.1159/000323570
   Johnson DK, 2009, ARCH NEUROL-CHICAGO, V66, P1254, DOI 10.1001/archneurol.2009.158
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Knopman DS, 2009, ALZHEIMERS DEMENT, V5, P207, DOI 10.1016/j.jalz.2009.01.027
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065
   LARSSON NG, 1992, BIOCHIM BIOPHYS ACTA, V1139, P311, DOI 10.1016/0925-4439(92)90106-W
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Mancuso M, 2013, NEUROL SCI, V34, P71, DOI 10.1007/s10072-011-0901-0
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Meier DS, 2007, NEUROTHERAPEUTICS, V4, P485, DOI 10.1016/j.nurt.2007.05.008
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moser EB, 2004, P 29 SAS US GROUP IN, V0, P0
   Nandhagopal R, 2009, BRAIN, V132, P2970, DOI 10.1093/brain/awp209
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   Orsucci D, 2012, NEUROEPIDEMIOLOGY, V38, P195, DOI 10.1159/000337161
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Sadikovic B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015687
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Singer JD, 1998, J EDUC BEHAV STAT, V23, P323
   Tornatore JB, 2002, GERONTOLOGIST, V42, P497, DOI 10.1093/geront/42.4.497
   Vu TC, 2012, BRIT J CLIN PHARMACO, V74, P267, DOI 10.1111/j.1365-2125.2012.04192.x
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 58
TC 83
Z9 88
U1 1
U2 22
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD FEB 15
PY 2014
VL 137
IS 
BP 323
EP 334
DI 10.1093/brain/awt321
PG 12
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AA7QB
UT WOS:000331290900006
PM 24277717
DA 2024-11-01
ER

PT J
AU Piekutowska-Abramczuk, D
   Pronicki, M
   Strawa, K
   Karkucinska-Wieckowska, A
   Szymanska-Debinska, T
   Fidzianska, A
   Wieckowski, MR
   Jurkiewicz, D
   Ciara, E
   Jankowska, I
   Sykut-Cegielska, J
   Krajewska-Walasek, M
   Ploski, R
   Pronicka, E
AF Piekutowska-Abramczuk, D.
   Pronicki, M.
   Strawa, K.
   Karkucinska-Wieckowska, A.
   Szymanska-Debinska, T.
   Fidzianska, A.
   Wieckowski, M. R.
   Jurkiewicz, D.
   Ciara, E.
   Jankowska, I.
   Sykut-Cegielska, J.
   Krajewska-Walasek, M.
   Ploski, R.
   Pronicka, E.
TI Novel c.191C&gt;G (p.Pro64Arg) <i>MPV17</i> mutation identified in two pairs of unrelated Polish siblings with mitochondrial hepatoencephalopathy
SO CLINICAL GENETICS
LA English
DT Article
DE hepatocerebral depletion syndrome; novel mutation; MPV17 gene; MDS-related pathology
ID dna depletion syndrome; protein
AB This study reports clinical, biochemical and histopathological findings associated with a novel homozygous MPV17 mutation in four patients with mitochondrial depletion syndrome. The severe course of the disease, which started in the first weeks of life, was dominated by a failure to thrive, hypotonia and liver dysfunction, with relatively mild neurological involvement. All affected infants died by 1 year of age. Laboratory findings included progressive liver failure (hypertransaminasaemia, icterus, and coagulopathy), recurrent hypoglycaemia, lactic acidaemia, hyperferritinaemia, and increased transferrin saturation. Histological and ultrastructural analyses uncovered significant lipid accumulation in hepatocytes and myocytes. A severe decrease in the mitochondrial/nuclear DNA (mtDNA/nDNA) ratio was found post-mortem in the livers (and in one muscle specimen) of both examined patients. Oxidative phosphorylation system (OXPHOS) Western blotting revealed low levels of complexes I, III and IV subunits. The highlights of our findings are as follows: (i) The novel p.Pro64Arg mutation is the second recurrent MPV17 mutation reported. The phenotype associated with the p.Pro64Arg mutation differs from the phenotype of the relatively common p.Arg50Gln mutation, suggesting the existence of a genotype-phenotype correlation. (ii) Tissues collected from patients during autopsy may be useful for both mtDNA/nDNA ratio assessment and OXPHOS Western blotting.
C1 [Piekutowska-Abramczuk, D.; Jurkiewicz, D.; Ciara, E.; Krajewska-Walasek, M.; Pronicka, E.] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland.
   [Pronicki, M.; Karkucinska-Wieckowska, A.; Szymanska-Debinska, T.] Childrens Mem Hlth Inst, Dept Pathol, PL-04730 Warsaw, Poland.
   [Strawa, K.; Ploski, R.] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.
   [Fidzianska, A.] Polish Acad Sci, Neuromuscular Unit, Mossakowski Res Med Ctr, Warsaw, Poland.
   [Wieckowski, M. R.] Nencki Inst Expt Biol, Dept Biochememistry, Lab Bioenerget Biomembranes & Metab Regulat, Warsaw, Poland.
   [Jankowska, I.] Childrens Mem Hlth Inst, Dept Liver Dis & Transplantat, PL-04730 Warsaw, Poland.
   [Sykut-Cegielska, J.; Pronicka, E.] Childrens Mem Hlth Inst, Dept Metab Dis, PL-04730 Warsaw, Poland.
C3 Children's Memorial Health Institute; Children's Memorial Health Institute; Medical University of Warsaw; Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Children's Memorial Health Institute; Children's Memorial Health Institute
RP Piekutowska-Abramczuk, D (corresponding author), Childrens Mem Hlth Inst, Dept Med Genet, Al Dzieci Polskich 20, PL-04730 Warsaw, Poland.
EM d.abramczuk@czd.pl
FU National Science Centre [2857/B/P01/2010/39]; Ministry of Science and Higher Education [0751/B/P01/2009/37]; EU Structural Funds [POIG.02.01.00-14-059/09]
CR Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   El-Hattab AW, 1993, GENEREVIEWS, V0, P0
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Mudd SH, 2012, MOL GENET METAB, V105, P228, DOI 10.1016/j.ymgme.2011.11.006
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Walker JA, 2005, ANAL BIOCHEM, V337, P89, DOI 10.1016/j.ab.2004.09.036
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
NR 11
TC 6
Z9 6
U1 0
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9163
EI 1399-0004
J9 CLIN GENET
JI Clin. Genet.
PD JUN 15
PY 2014
VL 85
IS 6
BP 573
EP 577
DI 10.1111/cge.12228
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA AF7PW
UT WOS:000334908000013
PM 23829229
DA 2024-11-01
ER

PT J
AU Li, BM
   Iglesias-Pedraz, JM
   Chen, LY
   Yin, F
   Cadenas, E
   Reddy, S
   Comai, L
AF Li, Baomin
   Iglesias-Pedraz, Juan Manuel
   Chen, Leng-Ying
   Yin, Fei
   Cadenas, Enrique
   Reddy, Sita
   Comai, Lucio
TI Downregulation of the Werner syndrome protein induces a metabolic shift that compromises redox homeostasis and limits proliferation of cancer cells
SO AGING CELL
LA English
DT Article
DE aging; DNA methylation; molecular biology of aging; muscle; epigenetic
ID extrachromosomal telomeric circles; wrn; gene; helicase; exonuclease; insulin; mice; mitochondria; stimulation; sensitivity
AB The Werner syndrome protein (WRN) is a nuclear protein required for cell growth and proliferation. Loss-of-function mutations in the Werner syndrome gene are associated with the premature onset of age-related diseases. How loss of WRN limits cell proliferation and induces replicative senescence is poorly understood. Here, we show that WRN depletion leads to a striking metabolic shift that coordinately weakens the pathways that generate reducing equivalents for detoxification of reactive oxygen species and increases mitochondrial respiration. In cancer cells, this metabolic shift counteracts the Warburg effect, a defining characteristic of many malignant cells, resulting in altered redox balance and accumulation of oxidative DNA damage that inhibits cell proliferation and induces a senescence-like phenotype. Consistent with these findings, supplementation with antioxidant rescues at least in part cell proliferation and decreases senescence in WRN-knockdown cancer cells. These results demonstrate that WRN plays a critical role in cancer cell proliferation by contributing to the Warburg effect and preventing metabolic stress.
C1 [Li, Baomin; Iglesias-Pedraz, Juan Manuel; Chen, Leng-Ying; Comai, Lucio] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA.
   [Li, Baomin; Iglesias-Pedraz, Juan Manuel; Chen, Leng-Ying; Reddy, Sita; Comai, Lucio] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90089 USA.
   [Yin, Fei; Cadenas, Enrique] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.
   [Cadenas, Enrique; Reddy, Sita] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.
C3 University of Southern California; University of Southern California; University of Southern California; University of Southern California
RP Comai, L (corresponding author), Univ So Calif, Keck Sch Med, 2250 Alcazar St,CSC 264, Los Angeles, CA 90033 USA.
EM comai@med.usc.edu
FU NIH [R01AG034156]; National Center for Research Resources, National Institutes of Health [C06 RR014514-01, C06 RR10600-01, C06 CA62528]
CR Arai A, 2011, CANCER RES, V71, P4598, DOI 10.1158/0008-5472.CAN-11-0320
   Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619
   Dickinson BC, 2008, J AM CHEM SOC, V130, P9638, DOI 10.1021/ja802355u
   Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497
   Düvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022
   EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001
   Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999
   FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893
   Futami K, 2008, CANCER SCI, V99, P843, DOI 10.1111/j.1349-7006.2008.00778.x
   Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239
   Hewitt G, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms1708
   Kirito K, 2009, CELL CYCLE, V8, P2844, DOI 10.4161/cc.8.17.9544
   Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002
   Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001
   Li BM, 2008, MOL CELL BIOL, V28, P1892, DOI 10.1128/MCB.01364-07
   Li BM, 2011, AGING-US, V3, P395, DOI 10.18632/aging.100308
   Li BM, 2009, AGING-US, V1, P289, DOI 10.18632/aging.100032
   Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000
   Machwe A, 2004, ONCOGENE, V23, P149, DOI 10.1038/sj.onc.1206906
   Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3
   Massip L, 2006, EXP GERONTOL, V41, P157, DOI 10.1016/j.exger.2005.10.011
   Moore G, 2008, MECH AGEING DEV, V129, P201, DOI 10.1016/j.mad.2007.12.009
   Moser R, 2012, MOL CANCER RES, V10, P535, DOI 10.1158/1541-7786.MCR-11-0508
   Opresko PL, 2007, MECH AGEING DEV, V128, P423, DOI 10.1016/j.mad.2007.05.009
   Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023
   Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200
   Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200
   Pagano G, 2005, FREE RADICAL RES, V39, P529, DOI 10.1080/10715760500092683
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0
   Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011
   SALK D, 1985, ADV EXP MED BIOL, V190, P541
   Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Slupianek A, 2011, CANCER RES, V71, P842, DOI 10.1158/0008-5472.CAN-10-1066
   Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337
   Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083
   Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803
   Vercesi AE, 1997, BIOSCIENCE REP, V17, P43, DOI 10.1023/A:1027335217774
   Wang ZL, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1000951
   Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258
NR 45
TC 25
Z9 26
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD APR 15
PY 2014
VL 13
IS 2
BP 367
EP 378
DI 10.1111/acel.12181
PG 12
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA AC4VG
UT WOS:000332518600019
PM 24757718
DA 2024-11-01
ER

PT J
AU Gang, Q
   Bettencourt, C
   Machado, P
   Hanna, MG
   Houlden, H
AF Gang, Qiang
   Bettencourt, Conceicao
   Machado, Pedro
   Hanna, Michael G.
   Houlden, Henry
TI Sporadic inclusion body myositis: the genetic contributions to the pathogenesis
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Review
DE Inclusion body myositis; Inclusion body myopathy; IBM; Genes; Genetics; Exome sequencing
ID amyloid precursor protein; mitochondrial-dna deletions; idiopathic inflammatory myopathy; cytosolic 5'-nucleotidase 1a; endoplasmic-reticulum stress; hla class-i; apolipoprotein-e; muscle-fibers; messenger-rna; hexanucleotide repeat
AB Sporadic inclusion body myositis (sIBM) is the commonest idiopathic inflammatory muscle disease in people over 50 years old. It is characterized by slowly progressive muscle weakness and atrophy, with typical pathological changes of inflammation, degeneration and mitochondrial abnormality in affected muscle fibres. The cause(s) of sIBM are still unknown, but are considered complex, with the contribution of multiple factors such as environmental triggers, ageing and genetic susceptibility. This review summarizes the current understanding of the genetic contributions to sIBM and provides some insights for future research in this mysterious disease with the advantage of the rapid development of advanced genetic technology. An international sIBM genetic study is ongoing and whole-exome sequencing will be applied in a large cohort of sIBM patients with the aim of unravelling important genetic risk factors for sIBM.
C1 [Gang, Qiang; Bettencourt, Conceicao; Hanna, Michael G.; Houlden, Henry] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.
   [Gang, Qiang; Machado, Pedro; Hanna, Michael G.; Houlden, Henry] UCL, Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
C3 University of London; University College London; University of London; University College London
RP Gang, Q (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.
EM q.gang@ucl.ac.uk
FU UCL Impact Studentship; Chinese Scholarship Council; MRC Centre [MR/K000608/01]; MRC [MR/J004758/1]; MRC [G0802760, MR/J004758/1, G108/638, G1001253] Funding Source: UKRI
CR Abdo WF, 2009, ACTA NEUROPATHOL, V118, P429, DOI 10.1007/s00401-009-0554-8
   Amato AA, 1998, NEUROLOGY, V51, P598, DOI 10.1212/WNL.51.2.598
   ASKANAS V, 1994, LANCET, V343, P364, DOI 10.1016/S0140-6736(94)91208-4
   Askanas V, 2005, MICROSC RES TECHNIQ, V67, P114, DOI 10.1002/jemt.20186
   ASKANAS V, 1993, NEUROREPORT, V5, P25, DOI 10.1097/00001756-199310000-00006
   ASKANAS V, 1992, LANCET, V339, P560, DOI 10.1016/0140-6736(92)90388-J
   Askanas V, 2002, CURR OPIN NEUROL, V15, P525, DOI 10.1097/00019052-200210000-00002
   Askanas V, 2001, J NEUROPATH EXP NEUR, V60, P1
   Askanas V, 1998, AM J PATHOL, V152, P889
   ASKANAS V, 1993, ANN NEUROL, V34, P551, DOI 10.1002/ana.410340408
   Askanas V, 1996, ANN NEUROL, V40, P264, DOI 10.1002/ana.410400223
   Askanas V, 2009, BRAIN PATHOL, V19, P493, DOI 10.1111/j.1750-3639.2009.00290.x
   Badrising UA, 2000, NEUROLOGY, V55, P1385, DOI 10.1212/WNL.55.9.1385
   Badrising UA, 2004, NEUROLOGY, V63, P2396, DOI 10.1212/01.WNL.0000148588.15052.4C
   Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711
   Barthélémy F, 2011, MOL MED, V17, P875, DOI 10.2119/molmed.2011.00084
   Benveniste Olivier, 2010, NEUROMUSCUL DISORD, V20, P414, DOI 10.1016/j.nmd.2010.03.014
   Bieniek KF, 2013, ACTA NEUROPATHOL, V125, P289, DOI 10.1007/s00401-012-1048-7
   BILAK M, 1993, ACTA NEUROPATHOL, V85, P378, DOI 10.1007/BF00334447
   Cacciottolo M, 2013, ACTA NEUROPATHOL, V126, P781, DOI 10.1007/s00401-013-1186-6
   Cai HY, 2012, J NEUROL, V259, P1913, DOI 10.1007/s00415-012-6439-0
   Cortese A, 2013, NEUROMUSCULAR DISORD, V23, P404, DOI 10.1016/j.nmd.2013.02.010
   Cox FM, 2011, BRAIN, V134, P3167, DOI 10.1093/brain/awr217
   Dalakas MC, 2008, ANN NEUROL, V64, P1, DOI 10.1002/ana.21452
   Dalakas MC, 2006, NEUROLOGY, V66, PS33, DOI 10.1212/01.wnl.0000192129.65677.87
   DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
   Di Blasi C, 2000, ANN NEUROL, V47, P811, DOI 10.1002/1531-8249(200006)47:6<811::AID-ANA16>3.3.CO;2-0
   Felice KJ, 2001, MEDICINE, V80, P320, DOI 10.1097/00005792-200109000-00006
   Ferrer I, 2004, J NEUROPATH EXP NEUR, V63, P484, DOI 10.1093/jnen/63.5.484
   Fratta P, 2004, NEUROLOGY, V63, P1114, DOI 10.1212/01.WNL.0000138574.56908.5D
   GARLEPP MJ, 1994, CLIN EXP IMMUNOL, V98, P40
   Garlepp MJ, 1995, ANN NEUROL, V38, P957, DOI 10.1002/ana.410380619
   Gossrau G, 2004, EUR NEUROL, V51, P215, DOI 10.1159/000078488
   Greenberg SA, 2012, CURR OPIN NEUROL, V25, P630, DOI 10.1097/WCO.0b013e328357f211
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   Guerreiro R, 2014, HUM MOL GENET, V23, PR47, DOI 10.1093/hmg/ddu203
   Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851
   Guerreiro RJ, 2012, ARCH NEUROL-CHICAGO, V69, P1243, DOI 10.1001/archneurol.2012.1935
   HARRINGTON CR, 1995, NEUROSCI LETT, V183, P35, DOI 10.1016/0304-3940(94)11108-U
   Lain AH, 2011, J NEUROL NEUROSUR PS, V82, P1414, DOI 10.1136/jnnp.2010.208868
   Hilton-Jones D, 2010, NEUROMUSCULAR DISORD, V20, P622, DOI 10.1016/j.nmd.2010.07.087
   Ipata PL, 2013, CURR MED CHEM, V20, P4205
   Jaworska-Wilczynska M, 2002, NEUROLOGY, V58, P438, DOI 10.1212/WNL.58.3.438
   Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132
   KaipiainenSeppanen O, 1996, J INTERN MED, V240, P81, DOI 10.1046/j.1365-2796.1996.14843000.x
   KAMBOH MI, 1995, NAT GENET, V10, P486, DOI 10.1038/ng0895-486
   Karpati G, 2009, ANN NEUROL, V65, P7, DOI 10.1002/ana.21622
   Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922
   Koffman BM, 1998, J NEUROIMMUNOL, V84, P139, DOI 10.1016/S0165-5728(97)00245-2
   Kok CC, 1999, IMMUNOGENETICS, V49, P508, DOI 10.1007/s002510050528
   Kok CC, 2000, NEUROMUSCULAR DISORD, V10, P604, DOI 10.1016/S0960-8966(00)00144-9
   Lampe J, 2001, NEUROLOGY, V57, P368
   Lampe J, 1999, LANCET, V353, P465, DOI 10.1016/S0140-6736(98)05208-8
   Lampe JB, 2003, J NEUROL, V250, P1313, DOI 10.1007/s00415-003-0204-3
   Larman HB, 2013, ANN NEUROL, V73, P408, DOI 10.1002/ana.23840
   LINDBERG C, 1994, ACTA NEUROL SCAND, V89, P123
   Love S, 1996, MUSCLE NERVE, V19, P1605, DOI 10.1002/(SICI)1097-4598(199612)19:12<1605::AID-MUS11>3.0.CO;2-Q
   Machado P, 2013, CURR OPIN RHEUMATOL, V25, P763, DOI 10.1097/01.bor.0000434671.77891.9a
   Mastaglia FL, 2013, NEUROMUSCULAR DISORD, V23, P969, DOI 10.1016/j.nmd.2013.09.008
   Mastaglia FL, 2009, NEUROMUSCULAR DISORD, V19, P763, DOI 10.1016/j.nmd.2009.07.015
   Masuda Y, 2009, CHEMBIOCHEM, V10, P287, DOI 10.1002/cbic.200800411
   Maurage CA, 2004, NEUROPATH APPL NEURO, V30, P624, DOI 10.1111/j.1365-2990.2004.00577.x
   Mirabella M, 1996, ANN NEUROL, V40, P864, DOI 10.1002/ana.410400608
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Müntzing K, 2003, SCAND J IMMUNOL, V58, P195, DOI 10.1046/j.1365-3083.2003.01251.x
   Needham M, 2008, J NEUROL NEUROSUR PS, V79, P1056, DOI 10.1136/jnnp.2007.138891
   Needham M, 2007, MUSCLE NERVE, V35, P549, DOI 10.1002/mus.20766
   Needham M, 2008, NEUROMUSCULAR DISORD, V18, P150, DOI 10.1016/j.nmd.2007.09.005
   Needham M, 2008, J CLIN NEUROSCI, V15, P1350, DOI 10.1016/j.jocn.2008.01.011
   Nogalska A, 2010, ACTA NEUROPATHOL, V120, P661, DOI 10.1007/s00401-010-0737-3
   Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050
   OHanlon TP, 2005, MEDICINE, V84, P338, DOI 10.1097/01.md.0000189818.63141.8c
   Oflazer P Serdaroglu, 2011, ACTA MYOL, V30, P34
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Olivé M, 2009, J NEUROPATH EXP NEUR, V68, P262, DOI 10.1097/NEN.0b013e3181996d8f
   Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105
   Phillips BA, 2000, MUSCLE NERVE, V23, P970, DOI 10.1002/(SICI)1097-4598(200006)23:6<970::AID-MUS20>3.0.CO;2-I
   Pinkus JL, 2014, NEUROMUSCULAR DISORD, V24, P611, DOI 10.1016/j.nmd.2014.04.012
   Pluk H, 2013, ANN NEUROL, V73, P397, DOI 10.1002/ana.23822
   Price P, 2004, TISSUE ANTIGENS, V64, P575, DOI 10.1111/j.1399-0039.2004.00310.x
   Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038
   Ranque-Francois B, 2005, ANN RHEUM DIS, V64, P634, DOI 10.1136/ard.2004.025494
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Rojana-udomsart A, 2013, J NEUROIMMUNOL, V254, P174, DOI 10.1016/j.jneuroim.2012.09.003
   Rojana-Udomsart A, 2012, J NEUROIMMUNOL, V250, P77, DOI 10.1016/j.jneuroim.2012.05.003
   Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007
   Roses AD, 2013, ALZHEIMERS DEMENT, V9, P132, DOI 10.1016/j.jalz.2012.10.009
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Salajegheh M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0020266
   Salajegheh M, 2009, MUSCLE NERVE, V40, P19, DOI 10.1002/mus.21386
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   SARKOZI E, 1994, AM J PATHOL, V145, P1280
   SARKOZI E, 1993, NEUROREPORT, V4, P815, DOI 10.1097/00001756-199306000-00055
   Scott AP, 2012, J NEUROIMMUNOL, V250, P66, DOI 10.1016/j.jneuroim.2012.04.021
   Scott AP, 2011, J NEUROIMMUNOL, V235, P77, DOI 10.1016/j.jneuroim.2011.02.011
   Scott AP, 2006, NEUROMUSCULAR DISORD, V16, P311, DOI 10.1016/j.nmd.2006.02.002
   Sivakumar K, 1997, BRAIN, V120, P653, DOI 10.1093/brain/120.4.653
   SIVAKUMAR K, 1995, ANN NEUROL, V38, P267, DOI 10.1002/ana.410380222
   Suzuki N, 2012, J NEUROL, V259, P554, DOI 10.1007/s00415-011-6185-8
   Tan JA, 2013, INT J RHEUM DIS, V16, P331, DOI 10.1111/j.1756-185X.2011.01669.x
   Tateyama M, 2003, INTERNAL MED, V42, P1035, DOI 10.2169/internalmedicine.42.1035
   Tawil R, 2002, CURR OPIN RHEUMATOL, V14, P653, DOI 10.1097/00002281-200211000-00004
   van Slegtenhorst M, 2000, EXP GERONTOL, V35, P461, DOI 10.1016/S0531-5565(00)00114-5
   Verschuuren JJ, 1997, DIAGNOSTIC CRITERIA, V0, P81
   Vetrivel KS, 2006, NEUROLOGY, V66, PS69, DOI 10.1212/01.wnl.0000192107.17175.39
   Weggen S, 2012, ALZHEIMERS RES THER, V4, P0, DOI 10.1186/alzrt107
   Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334
   Wilson FC, 2008, J RHEUMATOL, V35, P445
   Yang CC, 1996, NEUROREPORT, V8, P153, DOI 10.1097/00001756-199612200-00031
NR 110
TC 25
Z9 26
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD JUN 19
PY 2014
VL 9
IS 
BP 
EP 
DI 10.1186/1750-1172-9-88
PG 11
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA AK3DS
UT WOS:000338303800002
PM 24948216
DA 2024-11-01
ER

PT J
AU Miguel, R
   Gago, MF
   Martins, J
   Barros, P
   Vale, J
   Rosas, MJ
AF Miguel, Rita
   Gago, Miguel Fernandes
   Martins, Joao
   Barros, Pedro
   Vale, Jose
   Rosas, Maria Jose
TI POLG1-related levodopa-responsive parkinsonism
SO CLINICAL NEUROLOGY AND NEUROSURGERY
LA English
DT Article
DE Parkinsonism; PEO; SANDO; DNA polymerase gamma gene; Mitochondria
ID progressive external ophthalmoplegia; dna polymerase-gamma; polg1 gene; alpha-synuclein; mutations; deletions; disease; encephalomyopathy; inheritance; spectrum
AB Parkinsonian features have been described in patients with POLG1 mutations. Notwithstanding, the clinical expression has been revealed heterogeneous and the response to dopaminergic treatment has been document in few cases. We aim to describe the longitudinal clinical features and the treatment response of three unrelated patients with neurodegenerative parkinsonism, preceded by PEO and SANDO syndromes, who harbor POLG1 mutations, including two novel mutations. It was documented a sustained response to levodopa, at 3 and 8 years of follow-up of parkinsonian syndrome, and reduced striatal dopamine uptake. We review the genotypic and phenotypic spectrum of POLG1-related parkinsonism. Our observations stimulate the debate around the role of mitochondrial DNA defects in the pathogenesis of neurodegenerative parkinsonism. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Miguel, Rita] Ctr Hosp Lisboa Ocidental, Dept Neurol, Hosp Egas Moniz, P-1349019 Lisbon, Portugal.
   [Gago, Miguel Fernandes] Ctr Hosp Alto Ave, Dept Neurol, Guimaraes, Portugal.
   [Gago, Miguel Fernandes] Univ Minho, Escola Ciencias Saude, Braga, Portugal.
   [Martins, Joao] Hosp Pedro Hispano, Dept Neurol, Matosinhos, Portugal.
   [Barros, Pedro] Ctr Hosp Vila Nova de Gaia Espinho, Dept Neurol, Vila Nova De Gala, Portugal.
   [Vale, Jose] Hosp Beatriz Angelo, Dept Neurol, Loures, Portugal.
   [Rosas, Maria Jose] Ctr Hosp Sao Joao, Dept Neurol, Oporto, Portugal.
C3 Universidade de Lisboa; Centro Hospitalar de Lisboa Ocidental, EPE; Egas Moniz Hospital; Universidade do Minho; Sao Joao Hospital
RP Miguel, R (corresponding author), Ctr Hosp Lisboa Ocidental, Dept Neurol, Hosp Egas Moniz, Rua Junqueira 126, P-1349019 Lisbon, Portugal.
EM rita.migue185@gmail.com
CR Albanese A, 2001, MOVEMENT DISORD, V16, P197, DOI 10.1002/mds.1069
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   di Poggio MB, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-105
   Dolhun R, 2013, BMC NEUROL, V13, P0, DOI 10.1186/1471-2377-13-92
   Ferreira M, 2011, NEUROMUSCULAR DISORD, V21, P483, DOI 10.1016/j.nmd.2011.03.011
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Gurgel-Giannetti J, 2012, MUSCLE NERVE, V45, P453, DOI 10.1002/mus.22330
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mehta AR, 2011, MOVEMENT DISORD, V26, P753, DOI 10.1002/mds.23510
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Sato K, 2011, J NEUROL, V258, P1327, DOI 10.1007/s00415-011-5936-x
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Takeda A, 2006, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/JBB/2006/19365
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Vekrellis K, 2011, LANCET NEUROL, V10, P1015, DOI 10.1016/S1474-4422(11)70213-7
NR 27
TC 27
Z9 27
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0303-8467
EI 1872-6968
J9 CLIN NEUROL NEUROSUR
JI Clin. Neurol. Neurosurg.
PD NOV 15
PY 2014
VL 126
IS 
BP 47
EP 54
DI 10.1016/j.clineuro.2014.08.020
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA AT3GN
UT WOS:000344824000010
PM 25203713
DA 2024-11-01
ER

PT J
AU Sonam, K
   Khan, NA
   Bindu, PS
   Taly, AB
   Gayathri, N
   Srinivas Bharath, MM
   Govindaraju, C
   Arvinda, HR
   Nagappa, M
   Sinha, S
   Thangaraj, K
AF Sonam, Kothari
   Khan, Nahid Akthar
   Bindu, Parayil Sankaran
   Taly, Arun B.
   Gayathri, N.
   Srinivas Bharath, M. M.
   Govindaraju, C.
   Arvinda, H. R.
   Nagappa, Madhu
   Sinha, Sanjib
   Thangaraj, K.
TI Clinical and magnetic resonance imaging findings in patients with Leigh syndrome and <i>SURF1</i> mutations
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE Leigh syndrome; COX deficiency; SURF1 mutation; Dentate nucleus; Inferior olivary nucleus
ID cytochrome-c-oxidase; mitochondrial disease; gene-mutations; cox deficiency; tissue; muscle; dna
AB Background: Mutation in the SURF1 is one of the most common nuclear mutations associated with Leigh syndrome and cytochrome c oxidase deficiency. This study aims to describe the phenotypic and imaging features in four patients with Leigh syndrome and novel SURF1 mutation. Methods: The study included four patients with Leigh syndrome and SURFI mutations identified from a cohort of 25 children with Leigh syndrome seen over a period of six years (2006-2012). All the patients underwent a detailed neurological assessment, muscle biopsy, and sequencing of the complete mitochondrial genome and SURF1. Results: Three patients had classical presentation of Leigh syndrome. The fourth patient had a later age of onset with ataxia as the presenting manifestation and a stable course. Hypertrichosis, facial dysmorphism and hypopigmentation were the additional phenotypic features noted. On magnetic resonance imaging all patients had brainstem and cerebellar involvement and two had basal ganglia involvement in addition. The bilateral symmetrical hypertrophic olivary degeneration in these patients was striking. The SURF1 analysis identified previously unreported mutations in all the patients. On follow-up three patients expired and one had a stable course. Conclusions: Patients with Leigh syndrome and SURF1 mutation often have skin and hair abnormalities. Bilateral symmetrical hypertrophic olivary degeneration was a consistent finding on magnetic resonance imaging in these patients. (C) 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Sonam, Kothari; Bindu, Parayil Sankaran; Taly, Arun B.; Govindaraju, C.; Nagappa, Madhu; Sinha, Sanjib] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurol, Bangalore, Karnataka, India.
   [Gayathri, N.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuropathol, Bangalore, Karnataka, India.
   [Srinivas Bharath, M. M.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurochem, Bangalore, Karnataka, India.
   [Arvinda, H. R.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuroimaging & Intervent Radiol, Bangalore, Karnataka, India.
   [Khan, Nahid Akthar; Thangaraj, K.] CCMB, Dept Evolutionary & Med Genet, Hyderabad, Andhra Pradesh, India.
C3 National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)
RP Sonam, K (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurol, Bangalore, Karnataka, India.
EM sonamkothari86@yahoo.com; nahid.ibu@gmail.com; drpsbindu@yahoo.co.in; abtaly@yahoo.com; gayathrin12@rediffmail.com; bharath.nimhans@nic.in; drgobiraj_76@yahoo.com; aravind.radiology@gmail.com; madhu_nagappa@yahoo.co.in; sanjib_sinha2004@yahoo.co.in; thangs@cemb.res.in
FU Dpt. of Biotechnology, Govt of India [BT/PR7470/MED/14/1011/2006]
CR Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   Bodemer C, 1999, PEDIATRICS, V103, P428, DOI 10.1542/peds.103.2.428
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   Coenen MJH, 2006, J INHERIT METAB DIS, V29, P212, DOI 10.1007/s10545-006-0185-3
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Hat-ney JP, 1998, J INHERIT METAB DIS, V21, P748
   Kinghorn KJ, 2013, J NEUROL, V260, P3, DOI 10.1007/s00415-012-6564-9
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Lee IC, 2012, HUM MUTAT, V33, P1192, DOI 10.1002/humu.22095
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Ostergaard E, 2005, AM J MED GENET A, V138A, P384, DOI 10.1002/ajmg.a.30972
   Pronicki M, 2008, J CLIN PATHOL, V61, P460, DOI 10.1136/jcp.2007.051060
   Rahman S, 2001, ANN NEUROL, V49, P797, DOI 10.1002/ana.1060
   Savoiardo M, 1991, NEURORADIOLOGY S, V0, PP507, DOI 10.1007/978-3-642-49329-4_187
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4
   Tanigawa J, 2012, BRAIN DEV-JPN, V34, P861, DOI 10.1016/j.braindev.2012.02.007
   Tay SKH, 2005, J CHILD NEUROL, V20, P670, DOI 10.1177/08830738050200080701
   Tenney JR, 2012, J CHILD NEUROL, V0, P0
   Timothy J, 2009, J CHILD NEUROL, V24, P1296, DOI 10.1177/0883073809333543
   Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   van der Knaap MS, 1993, GENEREVIEWS, V0, P0
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-96
   WILLEMS JL, 1977, PEDIATRICS, V60, P850
   Xie S, 2009, CLIN IMAG, V33, P1, DOI 10.1016/j.clinimag.2008.08.001
   Yasaki E, 2001, NEUROPEDIATRICS, V32, P299
   Yüksel A, 2006, PEDIATR NEUROL, V34, P486, DOI 10.1016/j.pediatrneurol.2005.10.020
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 31
TC 21
Z9 23
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 1872-7131
J9 BRAIN DEV-JPN
JI Brain Dev.
PD OCT 15
PY 2014
VL 36
IS 9
BP 807
EP 812
DI 10.1016/j.braindev.2013.10.012
PG 6
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA CB2AQ
UT WOS:000349429500010
PM 24262866
DA 2024-11-01
ER

PT J
AU Steriade, C
   Andrade, DM
   Faghfoury, H
   Tarnopolsky, MA
   Tai, P
AF Steriade, Claude
   Andrade, Danielle M.
   Faghfoury, Hanna
   Tarnopolsky, Mark A.
   Tai, Peter
TI Mitochondrial Encephalopathy With Lactic Acidosis and Stroke-like Episodes (MELAS) May Respond to Adjunctive Ketogenic Diet
SO PEDIATRIC NEUROLOGY
LA English
DT Article
DE MELAS; status epilepticus; ketogenic diet; magnesium; refractory seizures; respiratory chain complexes
ID complex-i deficiency; mutation; epilepsy; myopathy; dna
AB BACKGROUND: Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome can present management challenges. Refractory seizures and stroke-like episodes leading to disability are common. PATIENT: We analyzed the clinical, electrophysiologic, and radiologic data of a 22-year-old woman with multiple episodes of generalized and focal status epilepticus and migratory cortical stroke-like lesions who underwent muscle biopsy for mitochondrial genome sequencing. RESULTS: Although initial mitochondrial genetic testing was negative, muscle biopsy demonstrated a mitochondrial DNA disease-causing mutation (m.3260A > G). New antiepileptic medications were added with each episode of focal status epilepticus with only temporary improvement, until a modified ketogenic diet and magnesium were introduced, leading to seizure freedom despite development of a new stroke-like lesion, and subsequent decrease in frequency of stroke-like episodes. We propose a metabolic model in which the ketogenic diet may lead to improvement of the function of respiratory chain complexes. CONCLUSIONS: The ketogenic diet may lead to improvement of mitochondrial dysfunction in MELAS, which in turn may promote better seizure control and less frequent stroke-like episodes.
C1 [Steriade, Claude; Andrade, Danielle M.; Tai, Peter] Univ Toronto, Toronto Western Hosp, Dept Med, Div Neurol, Toronto, ON M5T 2S8, Canada.
   [Faghfoury, Hanna] Univ Toronto, Univ Hlth Network, Dept Med, Div Clin & Metab Genet, Toronto, ON, Canada.
   [Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Dept Neuromuscular & Neurometab Dis, Hamilton, ON, Canada.
C3 University of Toronto; University Health Network Toronto; University of Toronto; University Health Network Toronto; McMaster University
RP Steriade, C (corresponding author), Toronto Western Hosp, Dept Med, Div Neurol, 399 Bathurst St,5th Floor,West Wing,Room 446, Toronto, ON M5T 2S8, Canada.
EM claude.steriade@mail.mcgill.ca
CR Connolly BS, 2010, BIOCHEM BIOPH RES CO, V402, P443, DOI 10.1016/j.bbrc.2010.10.060
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hirano M, 1997, EPILEPSY COMPREHENSI, V0, P0
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Kossoff EH, 2008, EPILEPSIA, V49, P316, DOI 10.1111/j.1528-1167.2007.01256.x
   Levy RG, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD001903.pub2
   Majamaa K, 1997, MOL CELL BIOCHEM, V174, P291, DOI 10.1023/A:1006833200371
   Martikainen MH, 2012, EPILEPTIC DISORD, V14, P438, DOI 10.1684/epd.2012.0543
   Nishino I, 1996, MUSCLE NERVE, V19, P1603, DOI 10.1002/(SICI)1097-4598(199612)19:12<1603::AID-MUS10>3.0.CO;2-S
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Roef MJ, 2002, AM J CLIN NUTR, V75, P228, DOI 10.1093/ajcn/75.2.228
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   ZEVIANI M, 1995, MUSCLE NERVE, V0, PS170
NR 16
TC 59
Z9 64
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD MAY 15
PY 2014
VL 50
IS 5
BP 498
EP 502
DI 10.1016/j.pediatrneurol.2014.01.009
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA AG9CZ
UT WOS:000335717600012
PM 24656211
DA 2024-11-01
ER

PT J
AU Gershoni, M
   Levin, L
   Ovadia, O
   Toiw, Y
   Shani, N
   Dadon, S
   Barzilai, N
   Bergman, A
   Atzmon, G
   Wainstein, J
   Tsur, A
   Nijtmans, L
   Glaser, B
   Mishmar, D
AF Gershoni, Moran
   Levin, Liron
   Ovadia, Ofer
   Toiw, Yasmin
   Shani, Naama
   Dadon, Sara
   Barzilai, Nir
   Bergman, Aviv
   Atzmon, Gil
   Wainstein, Julio
   Tsur, Anat
   Nijtmans, Leo
   Glaser, Benjamin
   Mishmar, Dan
TI Disrupting Mitochondrial-Nuclear Coevolution Affects OXPHOS Complex I Integrity and Impacts Human Health
SO GENOME BIOLOGY AND EVOLUTION
LA English
DT Article
DE coevolution; complex I; mitonuclear interaction; mitochondria; mtDNA; NDUFC2
ID electron-transport chain; human skeletal-muscle; mtdna haplogroup distribution; false discovery rates; insulin-secretion; oxidative-phosphorylation; disease; polymorphisms; evolution; obesity
AB The mutation rate of the mitochondrial DNA (mtDNA), which is higher by an order of magnitude as compared with the nuclear genome, enforces tight mitonuclear coevolution to maintain mitochondrial activities. Interruption of such coevolution plays a role in interpopulation hybrid breakdown, speciation events, and disease susceptibility. Previously, we found an elevated amino acid replacement rate and positive selection in the nuclear DNA-encoded oxidative phosphorylation (OXPHOS) complex I subunit NDUFC2, a phenomenon important for the direct interaction of NDUFC2 with the mtDNA-encoded complex I subunit ND4. This finding underlines the importance of mitonuclear coevolution to physical interactions between mtDNA and nuclear DNA-encoded factors. Nevertheless, it remains unclear whether this interaction is important for the stability and activity of complex I. Here, we show that siRNA silencing of NDUFC2 reduced growth of human D-407 retinal pigment epithelial cells, significantly diminished mitochondrial membrane potential, and interfered with complex I integrity. Moreover, site-directed mutagenesis of a positively selected amino acid in NDUFC2 significantly interfered with the interaction of NDUFC2 with its mtDNA-encoded partner ND4. Finally, we show that a genotype combination involving this amino acid (NDUFC2 residue 46) and the mtDNA haplogroup HV likely altered susceptibility to type 2 diabetes mellitus in Ashkenazi Jews. Therefore, mitonuclear coevolution is important for maintaining mitonuclear factor interactions, OXPHOS, and for human health.
C1 [Gershoni, Moran; Levin, Liron; Ovadia, Ofer; Toiw, Yasmin; Shani, Naama; Dadon, Sara; Mishmar, Dan] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.
   [Barzilai, Nir; Atzmon, Gil] Albert Einstein Coll Med, Inst Aging, Div Endocrinol, Dept Med, New York, NY USA.
   [Barzilai, Nir; Atzmon, Gil] Albert Einstein Coll Med, Dept Genet, New York, NY USA.
   [Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, New York, NY USA.
   [Wainstein, Julio] E Wolfson Med Ctr, Diabet Unit, Holon, Israel.
   [Tsur, Anat] Clalit Hlth Serv, Endocrine Clin, Jerusalem, Israel.
   [Nijtmans, Leo] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, NL-6525 ED Nijmegen, Netherlands.
   [Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Endocrinol & Metab Serv, Jerusalem, Israel.
C3 Ben Gurion University; Yeshiva University; Yeshiva University; Yeshiva University; Clalit Health Services; Radboud University Nijmegen; Hebrew University of Jerusalem; Hadassah University Medical Center
RP Mishmar, D (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.
EM dmishmar@bgu.ac.il
FU National Institutes of Health [AG028872, AG042188, AG021654-01, AG-18728-02A1]; Israeli Science Foundation [ISF 387/08, 610/12]; Ori foundation
CR Achilli A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021029
   Amar S, 2007, SCHIZOPHR RES, V94, P354, DOI 10.1016/j.schres.2007.04.020
   Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015
   Bar-Yaacov D, 2012, BBA-GENE REGUL MECH, V1819, P1107, DOI 10.1016/j.bbagrm.2011.10.008
   Barreto FS, 2013, MOL BIOL EVOL, V30, P310, DOI 10.1093/molbev/mss228
   Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210
   Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052
   Burton RS, 2006, AM NAT, V168, PS14, DOI 10.1086/509046
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955
   Dowling DK, 2014, BBA-GEN SUBJECTS, V1840, P1393, DOI 10.1016/j.bbagen.2013.11.013
   Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330
   EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8
   Feder J, 2007, EUR J HUM GENET, V15, P498, DOI 10.1038/sj.ejhg.5201764
   Feder J, 2009, BMC MED GENET, V10, P0, DOI 10.1186/1471-2350-10-60
   Feder J, 2008, BMC GENOMICS, V9, P0, DOI 10.1186/1471-2164-9-198
   Fridman Y, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000507
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   Gabaldón T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067
   Gaweda-Walerych K, 2010, NEUROSCI LETT, V469, P24, DOI 10.1016/j.neulet.2009.11.037
   Gershoni M, 2010, J MOL BIOL, V404, P158, DOI 10.1016/j.jmb.2010.09.029
   Gershoni M, 2009, BIOESSAYS, V31, P642, DOI 10.1002/bies.200800139
   Gray MW, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011403
   Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002
   Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001
   Guzmán-Fulgencio M, 2013, JAIDS-J ACQ IMM DEF, V63, P178, DOI 10.1097/QAI.0b013e3182893f74
   Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577
   Hoekstra LA, 2013, GENETICS, V195, P1129, DOI 10.1534/genetics.113.154914
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046
   Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831
   Kloss-Brandstätter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382
   Krempler F, 2002, DIABETES, V51, P3331, DOI 10.2337/diabetes.51.11.3331
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047
   Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174
   Lemasters JJ, 2007, METHOD CELL BIOL, V80, P283, DOI 10.1016/S0091-679X(06)80014-2
   Lindholm E, 2004, J DIABETES COMPLICAT, V18, P103, DOI 10.1016/S1056-8727(03)00019-9
   Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JCI30938
   Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429
   Meiklejohn CD, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003238
   Mimaki M, 2011, BIOCHIM BIOPHYS ACTA, V1817, P851
   Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015
   Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4
   Muller YL, 2003, DIABETES, V52, P895, DOI 10.2337/diabetes.52.3.895
   Nishigaki Y, 2007, HUM GENET, V120, P827, DOI 10.1007/s00439-006-0269-z
   Olsson AH, 2011, EUR J ENDOCRINOL, V164, P765, DOI 10.1530/EJE-10-0995
   Bayona-Bafaluy MP, 2011, MITOCHONDRION, V11, P467, DOI 10.1016/j.mito.2011.01.007
   Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Rai E, 2007, HUM GENET, V122, P535, DOI 10.1007/s00439-007-0421-4
   REITZER LJ, 1979, J BIOL CHEM, V254, P2669
   Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, PE49, DOI 10.1152/ajpendo.00317.2009
   Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Stern A, 2007, NUCLEIC ACIDS RES, V35, PW506, DOI 10.1093/nar/gkm382
   Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x
   Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Ueki M, 2012, PLOS GENET, V8, P141, DOI 10.1371/journal.pgen.1002625
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008
   Wang H, 2004, AM J PHYSIOL-ENDOC M, V286, PE1, DOI 10.1152/ajpendo.00231.2003
   Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhu CT, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004354
   Zimmermann Franz A, 2011, FRONT BIOSCI (ELITE ED), V3, P315
NR 69
TC 59
Z9 61
U1 0
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1759-6653
EI 
J9 GENOME BIOL EVOL
JI Genome Biol. Evol.
PD OCT 15
PY 2014
VL 6
IS 10
BP 2665
EP 2680
DI 10.1093/gbe/evu208
PG 16
WC Evolutionary Biology; Genetics & Heredity
SC Evolutionary Biology; Genetics & Heredity
GA AX2LQ
UT WOS:000346775800008
PM 25245408
DA 2024-11-01
ER

PT J
AU Joshi, PR
   Vetterke, M
   Hauburger, A
   Tacik, P
   Stoltenburg, G
   Hanisch, F
AF Joshi, Pushpa Raj
   Vetterke, Mirjam
   Hauburger, Anja
   Tacik, Pawel
   Stoltenburg, Gisela
   Hanisch, Frank
TI Functional relevance of mitochondrial abnormalities in sporadic inclusion body myositis
SO JOURNAL OF CLINICAL NEUROSCIENCE
LA English
DT Article
DE Cycle ergometry test; Forearm exercise test; Mitochondria; Multiple deletions; Oxygen consumption; Sporadic inclusion body myositis
ID aerobic forearm exercise; dna deletions; inflammatory myopathy; muscle; disease; disorders; features; mtdna
AB Cytochrome c oxidase (COX)-deficient fibers and multiple mitochondrial DNA (mtDNA) deletions are frequent findings in sporadic inclusion body myositis (s-IBM). However, the functional impact of these defects is not known. We investigated oxygen desaturation during exercise using the forearm exercise test, accumulation of lactate during exercise using a cycle ergometry test and mitochondrial changes (COX-deficient fibers, biochemical activities of respiratory chain complexes, multiple mtDNA deletions by long-range polymerase chain reaction) in 10 patients with s-IBM and compared the findings with age and sex-matched normal and diseased controls (without mitochondrial disorders) as well as patients with mitochondrial disorder due to nuclear gene defects resulting in multiple mtDNA deletions (MITO group). The mean age of the s-IBM patients was 68.2 +/- 5.7 years (range: 56-75). Patients with s-IBM had statistically significantly reduced oxygen desaturation (Delta sO(2)) during the handgrip exercise (p < 0.05) and elevated peak serum lactate levels during cycle ergometry compared to normal controls (p < 0.05). The percentage of COX-deficient fibers in s-IBM and MITO patients was significantly increased compared to normal controls (p < 0.01). Five out of nine s-IBM patients had multiple mtDNA deletions. Thirty-three percent of s-IBM patients showed an increased citrate synthase content and decreased activities of complex IV (COX). The biochemical pattern of respiratory chain complexes in patients with s-IBM and MITO was similar. Histopathological analysis showed similar changes in s-IBM and MITO due to nuclear gene defects. Functional tests reflecting mitochondrial impairment suggest a contribution of mitochondrial defects to disease-related symptoms such as fatigue and exertion-induced symptoms. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Joshi, Pushpa Raj; Vetterke, Mirjam; Hauburger, Anja; Stoltenburg, Gisela; Hanisch, Frank] Univ Halle Wittenberg, Dept Neurol, D-06120 Halle, Saale, Germany.
   [Tacik, Pawel] Hannover Med Sch, Dept Neurol, Hannover, Germany.
   [Stoltenburg, Gisela] Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany.
C3 Martin Luther University Halle Wittenberg; Hannover Medical School; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin
RP Joshi, PR (corresponding author), Univ Halle Wittenberg, Dept Neurol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.
EM pushpa.joshi@medizin.uni-halle.de
CR Argov Z, 1998, MUSCLE NERVE, V21, P1523, DOI 10.1002/(SICI)1097-4598(199811)21:11<1523::AID-MUS22>3.0.CO;2-#
   Askanas V, 2006, NEUROLOGY, V66, PS39, DOI 10.1212/01.wnl.0000192128.13875.1e
   Askanas V, 2012, J NEUROPATH EXP NEUR, V71, P680, DOI 10.1097/NEN.0b013e31826183c8
   Badrising UA, 2005, J NEUROL, V252, P1448, DOI 10.1007/s00415-005-0884-y
   Brady S, 2013, J NEUROL NEUROSUR PS, V84, P1240, DOI 10.1136/jnnp-2013-305690
   Chariot P, 1996, ACTA NEUROPATHOL, V91, P530, DOI 10.1007/s004010050462
   Alverne ARDM, 2013, ACTA REUMATOL PORT, V38, P179
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   Hanisch F, 2006, J NEUROL, V253, P417, DOI 10.1007/s00415-006-0987-0
   Jensen TD, 2002, NEUROLOGY, V58, P1533, DOI 10.1212/WNL.58.10.1533
   Jones K, 2013, J NEUROL NEUROSUR PS, V84, P0, DOI 10.1136/jnnp-2013-306573.204
   Joshi PR, 2009, NEUROMUSCULAR DISORD, V19, P654, DOI 10.1016/j.nmd.2009.06.341
   Koene S, 2013, MITOCHONDRION, V13, P15, DOI 10.1016/j.mito.2012.11.002
   Krasnianski A, 2005, BRAIN, V128, P1870, DOI 10.1093/brain/awh540
   Mancuso M, 2012, NEUROMUSCULAR DISORD, V22, PS226, DOI 10.1016/j.nmd.2012.10.012
   Meulemans A, 2007, ACTA NEUROL BELG, V107, P78
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Peng A, 2000, NEUROLOGY, V55, P296, DOI 10.1212/WNL.55.2.296
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   SAYERS ME, 1992, J RHEUMATOL, V19, P1385
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Varadhachary AS, 2010, CURR OPIN RHEUMATOL, V22, P651, DOI 10.1097/BOR.0b013e32833f108a
NR 28
TC 18
Z9 19
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0967-5868
EI 1532-2653
J9 J CLIN NEUROSCI
JI J. Clin. Neurosci.
PD NOV 15
PY 2014
VL 21
IS 11
BP 1959
EP 1963
DI 10.1016/j.jocn.2014.05.051
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AU4TK
UT WOS:000345604100022
PM 25311418
DA 2024-11-01
ER

PT J
AU Lombès, A
   Auré, K
   Bellanné-Chantelot, C
   Gilleron, M
   Jardel, C
AF Lombes, Anne
   Aure, Karine
   Bellanne-Chantelot, Christine
   Gilleron, Mylene
   Jardel, Claude
TI Unsolved issues related to human mitochondrial diseases
SO BIOCHIMIE
LA English
DT Review
DE Mitochondrial DNA; Heteroplasmy; Oxidative phosphorylation; Human diseases; Tissue specificity
ID hereditary optic neuropathy; human skeletal-muscle; kearns-sayre syndrome; tissue-specificity; rapid segregation; mtdna mutation; melas syndrome; dna deletions; mouse model; phenotype
AB Human mitochondrial diseases, defined as the diseases due to a mitochondrial oxidative phosphorylation defect, represent a large group of very diverse diseases with respect to phenotype and genetic causes. They present with many unsolved issues, the comprehensive analysis of which is beyond the scope of this review. We here essentially focus on the mechanisms underlying the diversity of targeted tissues, which is an important component of the large panel of these diseases phenotypic expression. The reproducibility of genotype/phenotype expression, the presence of modifying factors, and the potential causes for the restricted pattern of tissular expression are reviewed. Special emphasis is made on heteroplasmy, a specific feature of mitochondrial diseases, defined as the coexistence within the cell of mutant and wild type mitochondrial DNA molecules. Its existence permits unequal segregation during mitoses of the mitochondrial DNA populations and consequently heterogeneous tissue distribution of the mutation load. The observed tissue distributions of recurrent human mitochondrial DNA deleterious mutations are diverse but reproducible for a given mutation demonstrating that the segregation is not a random process. Its extent and mechanisms remain essentially unknown despite recent advances obtained in animal models. (C) 2013 Elsevier Masson SAS. All rights reserved.
C1 [Lombes, Anne; Aure, Karine; Gilleron, Mylene; Jardel, Claude] INSERM, U1016, Inst Cochin, UMR 8104,CNRS, F-75014 Paris, France.
   [Lombes, Anne] Univ Paris 05, F-75014 Paris, France.
   [Lombes, Anne; Bellanne-Chantelot, Christine; Gilleron, Mylene; Jardel, Claude] GHU Pitie Salpetriere, AP HP, Serv Biochim Metab, F-75651 Paris, France.
   [Lombes, Anne; Bellanne-Chantelot, Christine; Gilleron, Mylene; Jardel, Claude] GHU Pitie Salpetriere, Ctr Genet Mol & Chromosom, F-75651 Paris, France.
   [Aure, Karine] Hop Ambroise Pare, AP HP, Serv Explorat Fonct, F-92100 Boulogne, France.
   [Aure, Karine] Univ Versailles St Quentin Yvelines, Fac Med, F-78180 Versailles, France.
C3 Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Paris Cite; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris Saclay
RP Lombès, A (corresponding author), INSERM, U1016, Inst Cochin, Fac Med, 24 Rue Fb St Jacques, F-75014 Paris, France.
EM anne.lombes@inserm.fr; karine.aure@apr.aphp.fr; Christine.bellanne-chantelot@psl.aphp.fr; mylene.gilleron@psl.aphp.fr; claude.jardel@psl.aphp.fr
FU Association Francaise contre les Myopathies (AFM); Association contre les Maladies Mitochondriales (AMMO); Fondation pour la Recherche Medicale (FRM)
CR Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Battersby BJ, 2007, NAT GENET, V39, P571, DOI 10.1038/ng0507-571
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chinnery PF, 2002, TRENDS GENET, V18, P173, DOI 10.1016/S0168-9525(01)02636-1
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Hudson G, 2010, MOL VIS, V16, P2760
   Hudson G, 2009, MOL VIS, V15, P870
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jokinen R, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001161
   Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Noe N, 2013, MITOCHONDRION, V13, P417, DOI 10.1016/j.mito.2012.12.003
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
NR 45
TC 17
Z9 19
U1 0
U2 16
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD MAY 15
PY 2014
VL 100
IS 
BP 171
EP 176
DI 10.1016/j.biochi.2013.08.012
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AG0JI
UT WOS:000335101400019
PM 23973280
DA 2024-11-01
ER

PT J
AU Vajapey, R
   Rini, D
   Walston, J
   Abadir, P
AF Vajapey, Ramya
   Rini, David
   Walston, Jeremy
   Abadir, Peter
TI The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balance
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Review
DE mitochondria; angiotensin II; angiotensin II type 1 receptor blockers; mitochondrial a ngiotensin system; redox regulation; aging; frailty
ID free-radical production; dna-deletion mutations; kappa-b activation; factor receptor transactivation; liver xanthine dehydrogenase; protein-kinase activation; oxygen species mediate; nadph oxidase activity; ii type-1 receptors; smooth-muscle-cells
AB Aging is associated with the accumulation of various deleterious changes in cells. According to the free radical and mitochondrial theory of aging, mitochondria initiate most of the deleterious changes in aging and govern life span. The failure of mitochondrial reduction-oxidation (redox) homeostasis and the formation of excessive free radicals are tightly linked to dysregulation in the Renin Angiotensin System (RAS). A main rate-controlling step in RAS is renin, an enzyme that hydrolyzes angiotensinogen to generate angiotensin I. Angiotensin I is further converted to Angiotensin II (Ang II) by angiotensin-converting enzyme (ACE). Ang II binds with equal affinity to two main angiotensin receptors type 1 (AT(1)R) and type 2 (AT(2)R). The binding of Ang II to AT(1)R activates NADPH oxidase, which leads to increased generation of cytoplasmic reactive oxygen species (ROS). This Ang II-AT(1)R-NADPH-ROS signal triggers the opening of mitochondrial K-ATP channels and mitochondrial ROS production in a positive feedback loop. Furthermore, RAS has been implicated in the decrease of many of ROS scavenging enzymes, thereby leading to detrimental levels of free radicals in the cell. AT2R is less understood, but evidence supports an anti-oxidative and mitochondria-protective function for AT2R. The overlap between age related changes in RAS and mitochondria, and the consequences of this overlap on age-related diseases are quite complex. RAS dysregulation has been implicated in many pathological conditions due to its contribution to mitochondrial dysfunction. Decreased age-related, renal and cardiac mitochondrial dysfunction was seen in patients treated with angiotensin receptor blockers. The aim of this review is to: (a) report the most recent information elucidating the role of RAS in mitochondrial redox hemostasis and (b) discuss the effect of age-related activation of RAS on generation of free radicals.
C1 [Vajapey, Ramya] Northeast Ohio Med Univ, Sch Med, Rootstown, OH USA.
   [Rini, David] Johns Hopkins Univ, Div Cellular & Mol Med, Baltimore, MD 21224 USA.
   [Walston, Jeremy; Abadir, Peter] Johns Hopkins Univ, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD 21224 USA.
C3 University System of Ohio; Northeast Ohio Medical University (NEOMED); Johns Hopkins University; Johns Hopkins University
RP Abadir, P (corresponding author), Johns Hopkins Univ, 5501 Hopkins Bayview Circle,Rm 1A62, Baltimore, MD 21224 USA.
EM pabadir1@jhmi.edu
FU Johns Hopkins Older Americans Independence Center National Institute on Aging [P30 AG021334]; National Institute on Aging [1R01AG046441, K23 AG035005]; Nathan Shock in Aging Scholarship Award; Medical Student in Aging Research (MSTAR)
CR Abadir PM, 2012, PEPTIDES, V38, P437, DOI 10.1016/j.peptides.2012.09.016
   Abadir PM, 2011, P NATL ACAD SCI USA, V108, P14849, DOI 10.1073/pnas.1101507108
   Abadir PM, 2011, CLIN GERIATR MED, V27, P53, DOI 10.1016/j.cger.2010.08.004
   Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389
   Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071
   Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104
   AMAYA Y, 1990, J BIOL CHEM, V265, P14170
   Andrukhiv A, 2006, AM J PHYSIOL-HEART C, V291, PH2067, DOI 10.1152/ajpheart.00272.2006
   Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016
   Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200
   Aon MA, 2007, J BIOL CHEM, V282, P21889, DOI 10.1074/jbc.M702841200
   Aon MA, 2012, J GEN PHYSIOL, V139, P479, DOI 10.1085/jgp.201210772
   Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701
   Arbabi S, 2002, CRIT CARE MED, V30, PS74, DOI 10.1097/00003246-200201001-00010
   Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193
   BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041
   Baker KM, 2004, REGUL PEPTIDES, V120, P5, DOI 10.1016/j.regpep.2004.04.004
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Barja G, 1998, J BIOENERG BIOMEMBR, V30, P235, DOI 10.1023/A:1020592719405
   Bayraktutan U, 1998, CARDIOVASC RES, V38, P256, DOI 10.1016/S0008-6363(98)00003-0
   Beal M Flint, 2007, NOVARTIS FOUND SYMP, V287, P183
   Bechara RI, 2005, AM J PHYSIOL-LUNG C, V289, PL363, DOI 10.1152/ajplung.00141.2005
   BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703
   BERGELSON S, 1994, ONCOGENE, V9, P565
   Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014
   Boncompain G, 2010, INFECT IMMUN, V78, P80, DOI 10.1128/IAI.00725-09
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034
   Brewer AC, 2011, FREE RADICAL BIO MED, V51, P205, DOI 10.1016/j.freeradbiomed.2011.04.022
   Briones AM, 2011, J AM SOC HYPERTENS, V5, P137, DOI 10.1016/j.jash.2011.02.001
   Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904
   Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102
   Byrne JA, 2003, CIRC RES, V93, P802, DOI 10.1161/01.RES.0000099504.30207.F5
   Cadeddu C, 2010, AM HEART J, V160, P0, DOI 10.1016/j.ahj.2010.05.037
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Cadenas Enrique, 2004, MOLECULAR ASPECTS OF MEDICINE, V25, P17, DOI 10.1016/j.mam.2004.02.005
   Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840
   Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5
   Calabró P, 2009, J MOL CELL CARDIOL, V46, P142, DOI 10.1016/j.yjmcc.2008.11.002
   Carey RM, 2000, HYPERTENSION, V35, P155, DOI 10.1161/01.HYP.35.1.155
   Carey RM, 2012, AM J PHYSIOL-REG I, V302, PR479, DOI 10.1152/ajpregu.00656.2011
   Carlström M, 2010, HYPERTENSION, V56, P907, DOI 10.1161/HYPERTENSIONAHA.110.159301
   Cat AND, 2013, ANTIOXID REDOX SIGN, V19, P1110, DOI 10.1089/ars.2012.4641
   Ceriello A, 2005, CIRCULATION, V111, P2518, DOI 10.1161/01.CIR.0000165070.46111.9F
   Chandel NS, 2014, BMC BIOL, V12, P0, DOI 10.1186/1741-7007-12-34
   Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200
   Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013
   Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200
   Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chose O, 2008, J CARDIOVASC PHARM, V51, P131, DOI 10.1097/FJC.0b013e31815d781d
   Cirillo SLG, 2009, INFECT IMMUN, V77, P2557, DOI 10.1128/IAI.01481-08
   Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18
   Coffer PJ, 1998, BIOCH J 1, V335, P1
   Combs AP, 2010, J MED CHEM, V53, P2333, DOI 10.1021/jm901090b
   Conley KE, 2007, CURR OPIN CLIN NUTR, V10, P688, DOI 10.1097/MCO.0b013e3282f0dbfb
   Conti S, 2012, HYPERTENSION, V60, P878, DOI 10.1161/HYPERTENSIONAHA.110.155895
   Cook JL, 2001, CIRC RES, V89, P1138, DOI 10.1161/hh2401.101270
   Cook JL, 2012, AM J PHYSIOL-REG I, V302, PR482, DOI 10.1152/ajpregu.00493.2011
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI 10.1529/biophysj.105.076174
   Cortassa S, 2014, BBA-BIOENERGETICS, V1837, P287, DOI 10.1016/j.bbabio.2013.11.007
   Cristovam PC, 2008, EXP BIOL MED, V233, P1035, DOI 10.3181/0708-RM-229
   Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7
   Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140
   Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403
   Daiber A, 2010, BBA-BIOENERGETICS, V1797, P897, DOI 10.1016/j.bbabio.2010.01.032
   de Cavanagh EMV, 2007, AM J NEPHROL, V27, P545, DOI 10.1159/000107757
   de Cavanagh EMV, 2006, AM J PHYSIOL-REG I, V290, PR1616, DOI 10.1152/ajpregu.00615.2005
   De Mello WC, 2011, PEPTIDES, V32, P1774, DOI 10.1016/j.peptides.2011.06.018
   De Mello WC, 2008, REGUL PEPTIDES, V151, P54, DOI 10.1016/j.regpep.2008.06.003
   Delles C, 2004, STROKE, V35, P1289, DOI 10.1161/01.STR.0000126597.11534.3b
   Di Lisa F, 2007, HEART FAIL REV, V12, P249, DOI 10.1007/s10741-007-9028-z
   Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013
   Dikalov SI, 2013, AM J PHYSIOL-HEART C, V305, PH1417, DOI 10.1152/ajpheart.00089.2013
   Dikalov SI, 2013, ANTIOXID REDOX SIGN, V19, P1085, DOI 10.1089/ars.2012.4604
   Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800
   Dröse S, 2013, BBA-BIOENERGETICS, V1827, P578, DOI 10.1016/j.bbabio.2013.01.004
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a
   Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890
   Eguchi S, 1996, J BIOL CHEM, V271, P14169, DOI 10.1074/jbc.271.24.14169
   Ellis B, 2012, AM J PHYSIOL-REG I, V302, PR494, DOI 10.1152/ajpregu.00487.2011
   Eto K, 2002, HYPERTENSION, V39, P474, DOI 10.1161/hy02t2.102961
   EXTON JH, 1985, AM J PHYSIOL, V248, PE633, DOI 10.1152/ajpendo.1985.248.6.E633
   Ferder M, 2013, AM J PHYSIOL-CELL PH, V304, PC1027, DOI 10.1152/ajpcell.00403.2011
   Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6
   Fukai T, 2009, HYPERTENSION, V54, P224, DOI 10.1161/HYPERTENSIONAHA.109.134403
   Fulton DJR, 2009, ANTIOXID REDOX SIGN, V11, P2443, DOI 10.1089/ars.2009.2587
   Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002
   Gao J, 2012, J RENIN-ANGIO-ALDO S, V13, P341, DOI 10.1177/1470320312443720
   Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897
   Golden TR, 2001, MECH AGEING DEV, V122, P1577, DOI 10.1016/S0047-6374(01)00288-3
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Griendling KK, 2000, REGUL PEPTIDES, V91, P21, DOI 10.1016/S0167-0115(00)00136-1
   GRIENDLING KK, 1993, CIRCULATION, V87, P1816, DOI 10.1161/01.CIR.87.6.1816
   Gwathmey TM, 2012, AM J PHYSIOL-REG I, V302, PR518, DOI 10.1152/ajpregu.00525.2011
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   Harris RC, 2004, ACTA PHYSIOL SCAND, V181, P543, DOI 10.1111/j.1365-201X.2004.01329.x
   Heinzel FR, 2005, CIRC RES, V97, P583, DOI 10.1161/01.RES.0000181171.65293.65
   Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Heymes C, 1998, ENDOCRINOLOGY, V139, P2579, DOI 10.1210/en.139.5.2579
   Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6
   HOEK JB, 1988, BIOCHEM J, V254, P1
   Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95
   Hongpaisan J, 2004, J NEUROSCI, V24, P10878, DOI 10.1523/JNEUROSCI.3278-04.2004
   Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263
   Hornig B, 2001, CIRCULATION, V103, P799, DOI 10.1161/01.CIR.103.6.799
   HUNT MK, 1992, AM J PHYSIOL, V263, PF363, DOI 10.1152/ajprenal.1992.263.3.F363
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   INAGAMI T, 1988, CARDIOVASC DRUG THER, V2, P453, DOI 10.1007/BF00051182
   INAGAMI T, 1986, J HYPERTENS, V4, P0
   INAGAMI T, 1990, KIDNEY INT, V38, P0
   Inagami T, 2011, CIRC RES, V109, P1323, DOI 10.1161/RES.0b013e31823f05e0
   Jackson JB, 2003, FEBS LETT, V545, P18, DOI 10.1016/S0014-5793(03)00388-0
   Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032
   Kaneto H, 2010, MEDIAT INFLAMM, V2010, P0, DOI 10.1155/2010/453892
   Kang J, 2012, BIOCHEM RES INT, V2012, P0, DOI 10.1155/2012/896751
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kelley EE, 2010, FREE RADICAL BIO MED, V48, P493, DOI 10.1016/j.freeradbiomed.2009.11.012
   Kembro JM, 2014, SYSTEMS BIOL FREE RA, V0, P1047
   Khaper N, 2001, J AM COLL CARDIOL, V37, P1461, DOI 10.1016/S0735-1097(01)01126-3
   Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102
   Kimura S, 2005, HYPERTENSION, V45, P438, DOI 10.1161/01.HYP.0000157169.27818.ae
   Kodama H, 1997, CIRC RES, V81, P656
   Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, PR18, DOI 10.1152/ajpregu.00327.2006
   Kumar R, 2008, CURR OPIN NEPHROL HY, V17, P168, DOI 10.1097/MNH.0b013e3282f521a8
   Kumar R, 2007, TRENDS ENDOCRIN MET, V18, P208, DOI 10.1016/j.tem.2007.05.001
   Kumar R, 2012, CLIN SCI, V123, P273, DOI 10.1042/CS20120089
   Kuno A, 2002, J CARDIOVASC PHARM, V39, P49, DOI 10.1097/00005344-200201000-00006
   Kurita S, 2008, EUR J PHARMACOL, V588, P316, DOI 10.1016/j.ejphar.2008.04.028
   Kurz S, 1999, CIRCULATION, V99, P3181, DOI 10.1161/01.CIR.99.24.3181
   Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172
   Landmesser U, 2007, ARTERIOSCL THROM VAS, V27, P943, DOI 10.1161/01.ATV.0000258415.32883.bf
   Larkin JE, 2004, PHYSIOL GENOMICS, V18, P152, DOI 10.1152/physiolgenomics.00057.2004
   Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002
   Lassègue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299
   Lemay J, 2000, J RENIN ANGIOTENSIN ALDOSTERONE SYST, V1, P46, DOI 10.3317/jraas.2000.010
   Li XC, 2012, AM J PHYSIOL-RENAL, V303, PF1617, DOI 10.1152/ajprenal.00219.2012
   Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102
   Ma J, 1998, KIDNEY INT, V53, P937, DOI 10.1111/j.1523-1755.1998.00893.x
   Malhotra R, 1999, CIRC RES, V85, P137, DOI 10.1161/01.RES.85.2.137
   Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003
   Marín-García J, 2002, J CARD FAIL, V8, P93, DOI 10.1054/jcaf.2002.32501
   García IM, 2012, AM J PHYSIOL-RENAL, V302, PF1595, DOI 10.1152/ajprenal.00617.2011
   Mercure C, 1998, FEBS LETT, V422, P395, DOI 10.1016/S0014-5793(98)00052-0
   Min LJ, 2009, AGEING RES REV, V8, P113, DOI 10.1016/j.arr.2008.12.002
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691
   Mohanty P, 2000, J CLIN ENDOCR METAB, V85, P2970, DOI 10.1210/jc.85.8.2970
   Monteiro P, 2005, EUR J PHARMACOL, V518, P158, DOI 10.1016/j.ejphar.2005.06.013
   Moore AZ, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011069
   Mori J, 2013, AM J PHYSIOL-HEART C, V304, PH1103, DOI 10.1152/ajpheart.00636.2012
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200
   Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000
   Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200
   Nickel A, 2014, J MOL CELL CARDIOL, V73, P26, DOI 10.1016/j.yjmcc.2014.03.011
   Nickenig G, 1998, CIRCULATION, V98, P2453, DOI 10.1161/01.CIR.98.22.2453
   Nickenig G, 2004, CIRCULATION, V110, P1013, DOI 10.1161/01.CIR.0000139857.85424.45
   Nickenig G, 2002, CIRCULATION, V105, P530, DOI 10.1161/hc0402.102619
   Nishida Y, 2006, BIOCHEM BIOPH RES CO, V350, P530, DOI 10.1016/j.bbrc.2006.09.083
   Nozoe M, 2008, J HYPERTENS, V26, P2176, DOI 10.1097/HJH.0b013e32830dd5d3
   Pain T, 2000, CIRC RES, V87, P460
   Panahpour Hamdollah, 2012, IRANIAN BIOMEDICAL JOURNAL, V16, P202, DOI 10.6091/IBJ.1096.2012
   Pandur S, 2014, MOL CELL BIOCHEM, V388, P149, DOI 10.1007/s11010-013-1906-1
   Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004
   Persson P, 1900, P8, V0, P0
   Peters J, 2008, J MOL MED, V86, P711, DOI 10.1007/s00109-008-0328-0
   Peters J, 2012, PEPTIDES, V34, P427, DOI 10.1016/j.peptides.2012.01.023
   Prathapan A, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0096220
   Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645, DOI 10.1161/01.ATV.20.3.645
   PURI PL, 1995, J BIOL CHEM, V270, P22129, DOI 10.1074/jbc.270.38.22129
   Qadri F, 2001, JPN J PHARMACOL, V85, P365, DOI 10.1254/jjp.85.365
   Quijano C, 2001, J BIOL CHEM, V276, P11631, DOI 10.1074/jbc.M009429200
   Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898
   RASHED HM, 1988, J BIOL CHEM, V263, P5700
   RE RN, 1984, BIOCHEM BIOPH RES CO, V119, P220, DOI 10.1016/0006-291X(84)91641-3
   Redmond EM, 2012, CARDIOVASC RES, V93, P386, DOI 10.1093/cvr/cvs020
   Ricci Craig, 2005, EXP CLIN CARDIOL, V10, P160
   Rich PR, 2010, ESSAYS BIOCHEM, V47, P1, DOI 10.1042/BSE0470001
   ROBERTSON AL, 1971, SCIENCE, V172, P1138, DOI 10.1126/science.172.3988.1138
   Rodriguez-Iturbe B, 2007, J APPL PHYSIOL, V102, P255, DOI 10.1152/japplphysiol.00513.2006
   Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005
   SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W
   Saitoh Y, 2009, DIABETES METAB, V35, P392, DOI 10.1016/j.diabet.2009.04.005
   Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873
   Schröder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054
   Shah PK, 2001, CIRCULATION, V104, P1878, DOI 10.1161/circ.104.16.1878
   Shao JQ, 2006, BIOCHEM BIOPH RES CO, V344, P1224, DOI 10.1016/j.bbrc.2006.04.011
   Sherrod M, 2005, AM J PHYSIOL-REG I, V288, PR539, DOI 10.1152/ajpregu.00594.2004
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shiomi T, 2004, CIRCULATION, V109, P544, DOI 10.1161/01.CIR.0000109701.77059.E9
   Singh H, 2012, J PHYSIOL-LONDON, V590, P5937, DOI 10.1113/jphysiol.2011.215533
   Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9
   Sovari AA, 2013, CIRC-ARRHYTHMIA ELEC, V6, P623, DOI 10.1161/CIRCEP.112.976787
   Spooner R, 2011, INT J MOL SCI, V12, P334, DOI 10.3390/ijms12010334
   SQUADRITO GL, 1995, CHEM-BIOL INTERACT, V96, P203, DOI 10.1016/0009-2797(94)03591-U
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   STEVENSON MA, 1994, CANCER RES, V54, P12
   Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004
   SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296
   Sunggip C, 2013, CURR PHARM DESIGN, V19, P3022
   Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6
   Szanto I, 2005, J PATHOL, V207, P164, DOI 10.1002/path.1824
   Takac I, 2012, CURR HYPERTENS REP, V14, P70, DOI 10.1007/s11906-011-0238-3
   Takemori K, 2005, LIFE SCI, V77, P2233, DOI 10.1016/j.lfs.2004.12.048
   Takemori K, 2013, LIPIDS HEALTH DIS, V12, P0, DOI 10.1186/1476-511X-12-108
   Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200
   Tanito M, 2004, ANTIOXID REDOX SIGN, V6, P89, DOI 10.1089/152308604771978381
   Thareja S, 2012, MED RES REV, V32, P459, DOI 10.1002/med.20219
   THRASHER AJ, 1994, BBA-MOL BASIS DIS, V1227, P1, DOI 10.1016/0925-4439(94)90100-7
   Toblli JE, 2008, OBESITY, V16, P770, DOI 10.1038/oby.2007.114
   Touyz R M, 2000, CURR HYPERTENS REP, V2, P98, DOI 10.1007/s11906-000-0066-3
   Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018
   Toyz RM, 2002, BRAZ J MED BIOL RES, V35, P1001, DOI 10.1590/S0100-879X2002000900001
   Tracy RP, 2003, INT J OBESITY, V27, PS29, DOI 10.1038/sj.ijo.0802497
   TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P401, DOI 10.1016/0003-9861(82)90518-5
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421
   Unger T, 2002, AM J CARDIOL, V89, P0
   Ungvari Z, 2007, AM J PHYSIOL-HEART C, V293, PH37, DOI 10.1152/ajpheart.01346.2006
   Ushio-Fukai M, 2001, ARTERIOSCL THROM VAS, V21, P489, DOI 10.1161/01.ATV.21.4.489
   Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699
   Valente AJ, 2012, AM J PHYSIOL-HEART C, V303, PH282, DOI 10.1152/ajpheart.00231.2012
   Venkatesan B, 2007, J CELL PHYSIOL, V211, P457, DOI 10.1002/jcp.20953
   Vidotti DB, 2004, AM J PHYSIOL-RENAL, V286, PF1039, DOI 10.1152/ajprenal.00371.2003
   Viedt C, 2000, ARTERIOSCL THROM VAS, V20, P940, DOI 10.1161/01.ATV.20.4.940
   Vila-Porcile E, 1998, J HISTOCHEM CYTOCHEM, V46, P301, DOI 10.1177/002215549804600303
   Volpato S, 2001, CIRCULATION, V103, P947
   Wallace DC, 2011, COLD SH Q B, V76, P1, DOI 10.1101/sqb.2011.76.010462
   Wallace D C, 2001, NOVARTIS FOUND SYMP, V235, P247
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103
   Wang G, 2006, HYPERTENSION, V48, P482, DOI 10.1161/01.HYP.0000236647.55200.07
   Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471
   Wang MY, 2003, HYPERTENSION, V41, P1308, DOI 10.1161/01.HYP.0000073843.56046.45
   Wangler NJ, 2012, J BIOL CHEM, V287, P114, DOI 10.1074/jbc.M111.273052
   Warnholtz A, 1999, CIRCULATION, V99, P2027, DOI 10.1161/01.CIR.99.15.2027
   WAUD WR, 1976, ARCH BIOCHEM BIOPHYS, V172, P365, DOI 10.1016/0003-9861(76)90088-6
   Wei YZ, 2009, AM J PATHOL, V174, P1329, DOI 10.2353/ajpath.2009.080697
   Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004
   Whaley-Connell A, 2008, AM J PHYSIOL-ENDOC M, V295, PE103, DOI 10.1152/ajpendo.00752.2007
   Widder JD, 2009, HYPERTENSION, V54, P338, DOI 10.1161/HYPERTENSIONAHA.108.127928
   Wilkinson-Berka JL, 2014, ANTIOXID REDOX SIGN, V20, P2726, DOI 10.1089/ars.2013.5357
   WILLIAMSON JR, 1985, AM J PHYSIOL, V248, PC203, DOI 10.1152/ajpcell.1985.248.3.C203
   Wingler M, 2001, FREE RADICAL BIO MED, V31, P1456, DOI 10.1016/S0891-5849(01)00727-4
   Wood E J, 2006, BIOCHEM MOL BIOL EDUC, V34, P395, DOI 10.1002/bmb.2006.494034052660
   Wosniak J, 2009, ANTIOXID REDOX SIGN, V11, P1265, DOI 10.1089/ars.2009.2392
   Xia Y, 1998, J BIOL CHEM, V273, P12593, DOI 10.1074/jbc.273.20.12593
   Xiong SQ, 2010, J BIOL CHEM, V285, P2474, DOI 10.1074/jbc.M109.065235
   Yan C, 2003, ARTERIOSCL THROM VAS, V23, P26, DOI 10.1161/01.ATV.0000046231.17365.9D
   Yu E, 2012, CARDIOVASC RES, V95, P173, DOI 10.1093/cvr/cvs111
   Zaobornyj T, 2012, AM J PHYSIOL-HEART C, V303, PH1283, DOI 10.1152/ajpheart.00674.2011
   Zhang GX, 2007, CARDIOVASC RES, V76, P204, DOI 10.1016/j.cardiores.2007.07.014
   Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107
   Zhou Y, 2003, BLOOD, V101, P4098, DOI 10.1182/blood-2002-08-2512
   Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001
NR 273
TC 53
Z9 60
U1 0
U2 14
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-042X
EI 
J9 FRONT PHYSIOL
JI Front. Physiol.
PD NOV 24
PY 2014
VL 5
IS 
BP 
EP 
DI 10.3389/fphys.2014.00439
PG 17
WC Physiology
SC Physiology
GA AX9HE
UT WOS:000347213400002
PM 25505418
DA 2024-11-01
ER

PT J
AU Ho, J
   Pacaud, D
   Rakic, M
   Khan, A
AF Ho, Josephine
   Pacaud, Daniele
   Rakic, Maja
   Khan, Aneal
TI Diabetes in Pediatric Patients with Kearns-Sayre Syndrome: Clinical Presentation of 2 Cases and a Review of Pathophysiology
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Article
DE children; diabetes; mitochondria
ID mitochondrial myopathy; ophthalmoplegia
AB Kearns-Sayre syndrome (KSS), resulting from a mitochondrial DNA deletion, is a rare cause of diabetes in children. We report 2 pediatric cases of KSS associated with diabetes that presented with hyperosmolar hyperglycemia with minimal ketosis. Both patients were treated initially with isotonic fluid resuscitation followed by intravenous insulin infusion. The first case was a boy of Blackfoot Aboriginal ancestry who presented with failure to thrive, developmental delay and Fanconi syndrome and was diagnosed with KSS at 3 years of age. At 4 years he presented with a cough and left upper lobe lung infiltrate as well as a hyperosmolar hyperglycemic episode. He subsequently required multiple daily insulin injections. This patient developed cardiomyopathy and died at the age of 10 years. The second case was a 6-year-old boy of Asian ancestry who presented with ataxia exacerbated by intercurrent illnesses, decreased exercise tolerance, gross motor and fine motor delays, anorexia and recurrent episodes of vomiting associated with dehydration, and he was subsequently diagnosed with KSS. At 11 years of age, the patient developed hyperosmolar hyperglycemia, and after treatment for it, he required multiple daily insulin injections. He died of end stage congestive heart failure secondary to cardiomyopathy at 13 years of age. These 2 cases are presented to describe the possible pathophysiology of mitochondrial diabetes and to emphasize the need to monitor for the development of diabetes in patients with known mitochondrial disease and also to be aware of possible mitochondrial disease in pediatric patients who present with hyperglycemia in the context of multisystem involvement. (C) 2014 Canadian Diabetes Association
C1 [Ho, Josephine; Pacaud, Daniele] Univ Calgary, Dept Pediat, Div Pediat Endocrinol, Calgary, AB T2N 1N4, Canada.
   [Rakic, Maja] Univ Calgary, Fac Med, Bachelor Hlth Sci Program, Calgary, AB, Canada.
   [Khan, Aneal] Univ Calgary, Dept Med Genet & Pediat, Metab Clin, Calgary, AB, Canada.
C3 University of Calgary; University of Calgary; University of Calgary
RP Khan, A (corresponding author), Alberta Childrens Prov Gen Hosp, Dept Med Genet & Pediat, Metab Clin, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.
EM khaa@ucalgary.ca
CR Barrett TG, 2001, BEST PRACT RES CL EN, V15, P325, DOI 10.1053/beem.2001.0149
   Debray FG, 2006, AM J MED GENET A, V140A, P2330, DOI 10.1002/ajmg.a.31457
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Gerbitz KD, 1996, DIABETES, V45, P113, DOI 10.2337/diabetes.45.2.113
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   OKA Y, 1993, LANCET, V342, P527, DOI 10.1016/0140-6736(93)91649-7
   PICCOLO G, 1989, J NEUROL SCI, V94, P163, DOI 10.1016/0022-510X(89)90226-8
   POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366
   Turner N, 2008, TRENDS ENDOCRIN MET, V19, P324, DOI 10.1016/j.tem.2008.08.001
NR 9
TC 17
Z9 17
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1499-2671
EI 
J9 CAN J DIABETES
JI Can. J. Diabetes
PD AUG 15
PY 2014
VL 38
IS 4
BP 225
EP 228
DI 10.1016/j.jcjd.2014.04.003
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AU1FD
UT WOS:000345365500006
PM 25092642
DA 2024-11-01
ER

PT J
AU Kopajtich, R
   Nicholls, TJ
   Rorbach, J
   Metodiev, MD
   Freisinger, P
   Mandel, H
   Vanlander, A
   Ghezzi, D
   Carrozzo, R
   Taylor, RW
   Marquard, K
   Murayama, K
   Wieland, T
   Schwarzmayr, T
   Mayr, JA
   Pearce, SF
   Powell, CA
   Saada, A
   Ohtake, A
   Invemizzi, F
   Lamantea, E
   Sommerville, EW
   Pyle, A
   Chinnery, PF
   Crushell, E
   Okazaki, Y
   Kohda, M
   Kishita, Y
   Tokuzawa, Y
   Assouline, Z
   Rio, M
   Feillet, F
   de Camaret, BM
   Chretien, D
   Munnich, A
   Menten, B
   Sante, T
   Smet, J
   Regal, L
   Lorber, A
   Khoury, A
   Zeviani, M
   Strom, TM
   Meitinger, T
   Bertini, ES
   Van Coster, R
   Klopstock, T
   Rötig, A
   Haack, TB
   Minczuk, M
   Prokisch, H
AF Kopajtich, Robert
   Nicholls, Thomas J.
   Rorbach, Joanna
   Metodiev, Metodi D.
   Freisinger, Peter
   Mandel, Hanna
   Vanlander, Arnaud
   Ghezzi, Daniele
   Carrozzo, Rosalba
   Taylor, Robert W.
   Marquard, Klaus
   Murayama, Kei
   Wieland, Thomas
   Schwarzmayr, Thomas
   Mayr, Johannes A.
   Pearce, Sarah F.
   Powell, Christopher A.
   Saada, Ann
   Ohtake, Akira
   Invemizzi, Federica
   Lamantea, Eleonora
   Sommerville, Ewen W.
   Pyle, Angela
   Chinnery, Patrick F.
   Crushell, Ellen
   Okazaki, Yasushi
   Kohda, Masakazu
   Kishita, Yoshihito
   Tokuzawa, Yoshimi
   Assouline, Zahra
   Rio, Marlene
   Feillet, Francois
   de Camaret, Benedict Mousson
   Chretien, Dominique
   Munnich, Arnold
   Menten, Bjoern
   Sante, Tom
   Smet, Joel
   Regal, Luc
   Lorber, Abraham
   Khoury, Asaad
   Zeviani, Massimo
   Strom, Tim M.
   Meitinger, Thomas
   Bertini, Enrico S.
   Van Coster, Rudy
   Klopstock, Thomas
   Roetig, Agnes
   Haack, Tobias B.
   Minczuk, Michal
   Prokisch, Holger
TI Mutations in <i>GTPBP3</i> Cause a Mitochondria! Translation Defect Associated with Hypertrophic Cardiomyopathy, Lactic Acidosis, and Encephalopathy
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID transfer-rna; oxidative defects; galactose medium; screening-test; myopathy; cells
AB Respiratory chain deficiencies exhibit a wide variety of clinical phenotypes resulting from defective mitochondrial energy production through oxidative phosphorylation. These defects can be caused by either mutations in the mtDNA or mutations in nuclear genes coding for mitochondrial proteins. The underlying pathomechanisms can affect numerous pathways involved in mitochondrial physiology. By whole-exome and candidate gene sequencing, we identified 11 individuals from 9 families carrying compound heterozygous or homozygous mutations in GTPBP3, encoding the mitochondrial GTP-binding protein 3. Affected individuals from eight out of nine families presented with combined respiratory chain complex deficiencies in skeletal muscle. Mutations in GTPBP3 are associated with a severe mitochondrial translation defect, consistent with the predicted function of the protein in catalyzing the formation of 5-taurinomethyluridine (tau m(5)U) in the anticodon wobble position of five mitochondrial tRNAs. All case subjects presented with lactic acidosis and nine developed hypertrophic cardiomyopathy. In contrast to individuals with mutations in MTO1, the protein product of which is predicted to participate in the generation of the same modification, most individuals with GTPBP3 mutations developed neurological symptoms and MRI involvement of thalamus, putamen, and brainstem resembling Leigh syndrome. Our study of a mitochondrial translation disorder points toward the importance of posttranscriptional modification of mitochondrial tRNAs for proper mitochondrial function.
C1 [Kopajtich, Robert; Wieland, Thomas; Schwarzmayr, Thomas; Strom, Tim M.; Meitinger, Thomas; Haack, Tobias B.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, German Res Ctr Environm Hlth, D-85764 Neuherberg, Germany.
   [Nicholls, Thomas J.; Rorbach, Joanna; Pearce, Sarah F.; Powell, Christopher A.; Zeviani, Massimo; Minczuk, Michal] MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Metodiev, Metodi D.; Chretien, Dominique; Munnich, Arnold; Roetig, Agnes] Univ Paris 05, Sorbonne Paris Cite, INSERM, U1163,Inst Imagine, F-75015 Paris, France.
   [Freisinger, Peter] Klinikum Reutlingen, Dept Pediat, D-72764 Reutlingen, Germany.
   [Mandel, Hanna] Childrens Hosp, Metab Unit, IL-31096 Haifa, Israel.
   [Vanlander, Arnaud; Smet, Joel; Van Coster, Rudy] Univ Hosp Ghent, Dept Pediat Neurol & Metab, B-9000 Ghent, Belgium.
   [Ghezzi, Daniele; Invemizzi, Federica; Lamantea, Eleonora; Zeviani, Massimo] Fdn IRCCS Ist Ricovero & Cura CarattereSci, Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
   [Carrozzo, Rosalba; Bertini, Enrico S.] IRCCS Osped Pediat Bambino Gesu, Lab Med Mol, Dipartimento Neurosci, Unita Malattie Neuromuscolari & Neurodegenerat, I-00165 Rome, Italy.
   [Taylor, Robert W.; Sommerville, Ewen W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Marquard, Klaus] Klinikum Stuttgart, Dept Neuropediat, D-70176 Stuttgart, Germany.
   [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba 2660007, Japan.
   [Wieland, Thomas; Schwarzmayr, Thomas; Strom, Tim M.; Meitinger, Thomas; Haack, Tobias B.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.
   [Mayr, Johannes A.] Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria.
   [Saada, Ann] Hadassah Hebrew Univ, Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel.
   [Saada, Ann] Hadassah Hebrew Univ, Med Ctr, Dept Genet & Metab Dis, IL-91120 Jerusalem, Israel.
   [Ohtake, Akira] Saitama Med Univ, Dept Pediat, Fac Med, Saitama 3500495, Japan.
   [Pyle, Angela; Chinnery, Patrick F.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Crushell, Ellen] Temple St Childrens Univ Hosp, Natl Ctr Inherited Metab Disorders, Dublin 12, Ireland.
   [Okazaki, Yasushi; Kohda, Masakazu] Saitama Med Univ, Res Ctr Genom Med, Dept Translat Res, Saitama 3501241, Japan.
   [Okazaki, Yasushi; Kishita, Yoshihito; Tokuzawa, Yoshimi] Saitama Med Univ, Res Ctr Genom Med, Dept Funct Genom & Syst Med, Saitama 3501241, Japan.
   [Assouline, Zahra; Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Pediat, F-75015 Paris, France.
   [Assouline, Zahra; Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France.
   [Feillet, Francois] CHU Nancy, Serv Med Infantile, Hop Enfants Brabois, F-54511 Vandoeuvre Les Nancy, France.
   [de Camaret, Benedict Mousson] CHU Lyon, Serv Malad Hereditaires Metab, F-69677 Bron, France.
   [Menten, Bjoern; Sante, Tom] Univ Ghent, Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium.
   [Regal, Luc] Univ Hosp Leuven, Dept Pediat, Metab Ctr, B-3000 Leuven, Belgium.
   [Lorber, Abraham; Khoury, Asaad] Rambam Med Ctr, Dept Pediat Cardiol, IL-31096 Haifa, Israel.
   [Meitinger, Thomas] DZHK German Ctr Cardiovasc Res, D-81675 Munich, Germany.
   [Meitinger, Thomas] Munich Heart Alliance, D-80802 Munich, Germany.
   [Meitinger, Thomas; Klopstock, Thomas] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany.
   [Klopstock, Thomas] German Res Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany.
   [Klopstock, Thomas] Univ Munich, Friedrich Baur Inst, Dept Neurol, D-80336 Munich, Germany.
C3 Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Ghent University; Ghent University Hospital; Fondazione IRCCS Istituto Neurologico Carlo Besta; IRCCS Bambino Gesu; Newcastle University - UK; Klinikum Stuttgart; Chiba Children's Hospital; Technical University of Munich; Paracelsus Private Medical University; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Saitama Medical University; Newcastle University - UK; Childrens University Hospital - Temple Street; Saitama Medical University; Saitama Medical University; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; CHU de Nancy; CHU Lyon; Ghent University; Ghent University Hospital; KU Leuven; University Hospital Leuven; Rambam Health Care Campus; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich
RP Minczuk, M (corresponding author), MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.
EM michal.minczuk@mrc-mbu.cam.ac.uk; prokisch@helmholtz-muenchen.de
FU Deutsche Forschungsgemeinschaft [EXC 1010]; German Bundesministerium fur Bildung und Forschung (BMBF) through E-Rare project GENOMIT [01GM1207, 2011-RARE-005-03, J41J11000420001, FWF I 920-B13]; German Network for Mitochondrial Disorders [mito-NET 01GM1113C, 01GM1113A]; German Center for Heart Research [Z76010017300, Z56010015300]; European Commission [N261123]; Medical Research Council, UK [MC_U105697135]; Wellcome Trust [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; UK NHS; Fund for Scientific Research Belgium (FWO) [G.0200.10]; Fondazione Telethon [GGP11011, GPP10005]; Italian Ministry of Health [GR2010-2316392]; CARIPLO [2011/0526]; Pierfranco and Luisa Mariani Foundation; Italian Association of Mitochondrial Disease Patients and Families (Mitocon); Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation); Promotion and Mutual Aid Corporation for Private Schools of Japan from MEXT; Ministry of Health, Labour and Welfare of Japan; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; Association Francaise contre les Myopathies (AFM); AFM [16615]; MRC [MC_UP_1002/1, G0601943, MC_U105697135] Funding Source: UKRI
CR Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393
   Björk GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945
   Danhauser K, 2011, MOL GENET METAB, V103, P161, DOI 10.1016/j.ymgme.2011.03.004
   Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002
   Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200
   Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861
   Osawa S, 1995, EVOLUTION OF THE GENETIC CODE, V0, P0
   PETROVABENEDICT R, 1992, J INHERIT METAB DIS, V15, P943, DOI 10.1007/BF01800243
   ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   RUSTIN P, 1991, LANCET, V338, P60, DOI 10.1016/0140-6736(91)90057-V
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361
   Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Villarroya M, 2008, MOL CELL BIOL, V28, P7514, DOI 10.1128/MCB.00946-08
   Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002
   Yarham JW, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004424
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 30
TC 114
Z9 123
U1 0
U2 21
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD DEC 4
PY 2014
VL 95
IS 6
BP 708
EP 720
DI 10.1016/j.ajhg.2014.10.017
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA AX0DH
UT WOS:000346623100007
PM 25434004
DA 2024-11-01
ER

PT J
AU Abe, S
   Nagano, M
   Nishio, S
   Kumakawa, K
   Usami, S
AF Abe, Satoko
   Nagano, Makoto
   Nishio, Shin-ya
   Kumakawa, Kozo
   Usami, Shin-ichi
TI High-Frequency Involved Hearing Loss Caused by Novel Mitochondrial DNA Mutation in 16S Ribosomal RNA Gene
SO OTOLOGY & NEUROTOLOGY
LA English
DT Article
DE Hearing loss; Mitochondrial DNA; 16S ribosomal RNA
ID sensorineural deafness; cardiomyopathy; myopathy; genome
AB Objective: To clarify the responsible gene for a family associated with hearing loss but having no well-known mitochondrial mutations. Subjects: A Japanese family showing late-onset, progressive, and ski-sloping sensorineural hearing loss. Results: Whole mitochondrial genome sequencing identified the 1673T>C mutation, a novel mitochondrial DNA mutation in the 16S ribosomal RNA gene. Conclusion: Whole mitochondrial genome sequencing is a powerful tool to identify the responsible gene for plausible mitochondrially inherited families. This is additional evidence that mitochondrial gene mutations may cause late-onset, progressive, and ski-sloping sensorineural hearing loss.
C1 [Abe, Satoko] Abe ENT Clin, Tokyo 1430026, Japan.
   [Abe, Satoko; Kumakawa, Kozo] Toranomon Gen Hosp, Dept Otorhinolaryngol, Tokyo, Japan.
   [Nagano, Makoto] Biomed Labs Inc, Dept Clin Genom, Kawagoe, Saitama, Japan.
   [Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan.
C3 Toranomon Hospital; Shinshu University
RP Abe, S (corresponding author), Abe ENT Clin, Ota Ku, 2-2-5 Nishimagome, Tokyo 1430026, Japan.
EM abe3387@ybb.ne.jp
FU Ministry of Health and Welfare of Japan
CR Abe S, 2007, GENET TEST, V11, P333, DOI 10.1089/gte.2007.0002
   Choo-Kang ATW, 2002, DIABETES, V51, P2317, DOI 10.2337/diabetes.51.7.2317
   Coulbault L, 2007, BIOCHEM BIOPH RES CO, V362, P601, DOI 10.1016/j.bbrc.2007.08.040
   Ellaway CJ, 1999, J INHERIT METAB DIS, V22, P946, DOI 10.1023/A:1005616229456
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Feigenbaum A, 2006, AM J MED GENET A, V140A, P2216, DOI 10.1002/ajmg.a.31436
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   Kameoka K, 1998, BIOCHEM BIOPH RES CO, V245, P523, DOI 10.1006/bbrc.1998.8437
   Leveque M, 2007, EUR J HUM GENET, V15, P1145, DOI 10.1038/sj.ejhg.5201891
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885
   Seibel P, 2008, NUCLEIC ACIDS RES, V36, P5872, DOI 10.1093/nar/gkn592
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Tang S, 2010, MITOCHONDRION, V10, P350, DOI 10.1016/j.mito.2010.02.003
   Usami S, 2000, ADV OTO-RHINO-LARYNG, V56, P203
   Usami S, 2010, AUDIOLOGICAL MED, V8, P28
   Usami S, 2012, ACTA OTO-LARYNGOL, V132, P377, DOI 10.3109/00016489.2011.649493
   Verma A, 1997, PEDIATR RES, V42, P448, DOI 10.1203/00006450-199710000-00005
NR 20
TC 2
Z9 2
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1531-7129
EI 1537-4505
J9 OTOL NEUROTOL
JI Otol. Neurotol.
PD JUL 15
PY 2014
VL 35
IS 6
BP 1087
EP 1090
DI 
PG 4
WC Clinical Neurology; Otorhinolaryngology
SC Neurosciences & Neurology; Otorhinolaryngology
GA AJ9MA
UT WOS:000338034100026
PM 24770403
DA 2024-11-01
ER

PT J
AU Kowald, A
   Kirkwood, TBL
AF Kowald, Axel
   Kirkwood, Thomas B. L.
TI Transcription could be the key to the selection advantage of mitochondrial deletion mutants in aging
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
LA English
DT Article
DE mitochondrial mutations; mathematical model
ID skeletal-muscle fibers; dna mutations; degenerative diseases; clonal expansion; mtdna mutations; replication; accumulation; turnover; fusion; cells
AB The mitochondrial theory of aging is widely popular but confronted by several apparent inconsistencies. On the one hand, mitochondrial energy production is of central importance to the health and proper functioning of cells, and single-cell studies have shown that mtDNA deletion mutants accumulate in a clonal fashion in various mammalian species, displacing the wild-type mtDNAs. On the other hand, no explanation exists yet for the clonal expansion of mtDNA mutants that is compatible with experimental observations. We present here a new idea based on the distinctive connection between transcription and replication of metazoan mtDNA. Bioinformatic analysis of mtDNA deletion spectra strongly supports the predictions of this hypothesis and identifies specific candidates for proteins involved in transcriptional control of mtDNA replication. Computer simulations show the mechanism to be compatible with the available data from short-and long-lived mammalian species.
C1 [Kowald, Axel; Kirkwood, Thomas B. L.] Newcastle Univ, Inst Ageing & Hlth, Ctr Integrated Syst Biol Ageing & Nutr, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
C3 Newcastle University - UK
RP Kowald, A (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Ctr Integrated Syst Biol Ageing & Nutr, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
EM axel.kowald@ncl.ac.uk
FU Glenn Foundation; National Institute for Health Research Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals National Health Service Foundation Trust; Newcastle University; MRC [MR/K006312/1] Funding Source: UKRI
CR [Anonymous], 2010, MATHEMATICA, V7.0, P0
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BERK AJ, 1974, J MOL BIOL, V86, P801, DOI 10.1016/0022-2836(74)90355-6
   BOGENHAGEN DF, 1986, J BIOL CHEM, V261, P8488
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Greaves LC, 2011, MECH AGEING DEV, V132, P588, DOI 10.1016/j.mad.2011.10.004
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HUEMER RP, 1971, EXP GERONTOL, V6, P327, DOI 10.1016/0531-5565(71)90001-5
   Khaidakov M, 2006, MECH AGEING DEV, V127, P808, DOI 10.1016/j.mad.2006.07.008
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kowald A, 2005, AGING CELL, V4, P273, DOI 10.1111/j.1474-9726.2005.00169.x
   Kowald A, 2014, J THEOR BIOL, V340, P111, DOI 10.1016/j.jtbi.2013.09.009
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   LABBE D, 1991, J BIOL CHEM, V266, P10844
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Lakshmanan LN, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035271
   Lane N, 2011, BIOESSAYS, V33, P860, DOI 10.1002/bies.201100051
   Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Markham Nicholas R, 2008, V453, V0, PP3, DOI 10.1007/978-1-60327-429-6_1
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Sloan DB, 2012, PLOS BIOL, V10, P0, DOI 10.1371/journal.pbio.1001241
   Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
NR 56
TC 42
Z9 47
U1 0
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 25
PY 2014
VL 111
IS 8
BP 2972
EP 2977
DI 10.1073/pnas.1314970111
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC0JP
UT WOS:000332180900029
PM 24569805
DA 2024-11-01
ER

PT J
AU Dominic, EA
   Ramezani, A
   Anker, SD
   Verma, M
   Mehta, N
   Rao, M
AF Dominic, Elizabeth A.
   Ramezani, Ali
   Anker, Stefan D.
   Verma, Mukesh
   Mehta, Nehal
   Rao, Madhumathi
TI Mitochondrial cytopathies and cardiovascular disease
SO HEART
LA English
DT Review
DE Heart Failure; Coronary Artery Disease
ID dilated cardiomyopathy; respiratory-chain; heart-failure; cardiac-hypertrophy; dna mutations; myocardium; mtdna; amplification; mechanisms; muscle
AB The global epidemic of cardiovascular disease remains the leading cause of death in the USA and across the world. Functional and structural integrity of mitochondria are essential for the physiological function of the cardiovascular system. The metabolic adaptation observed in normal heart is lost in the failing myocardium, which becomes progressively energy depleted leading to impaired myocardial contraction and relaxation. Uncoupling of electron transfer from ATP synthesis leads to excess generation of reactive species, leading to widespread cellular injury and cardiovascular disease. Accumulation of mitochondrial DNA mutation has been linked to ischaemic heart disease, cardiomyopathy and atherosclerotic vascular disease. Mitochondria are known to regulate apoptotic and autophagic pathways that have been shown to play an important role in the development of cardiomyopathy and atherosclerosis. A number of pharmacological and non-pharmacological treatment options have been explored in the management of mitochondrial diseases with variable success.
C1 [Dominic, Elizabeth A.; Ramezani, Ali] George Washington Sch Med, Washington, DC USA.
   [Anker, Stefan D.] Campus Virchow Klinikum, CharitA, Dept Cardiol, Berlin, Germany.
   [Verma, Mukesh] NCI, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA.
   [Mehta, Nehal] NHLBI, Sect Inflammat & Cardiometabol Dis, Bethesda, MD 20892 USA.
   [Rao, Madhumathi] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA.
C3 George Washington University; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tufts University
RP Ramezani, A (corresponding author), George Washington Univ, Dept Med, 2300 1 St NW, Washington, DC 20037 USA.
EM Ramezani@gwu.edu
CR Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   Ashrafian H, 2002, CIRCULATION, V105, P0
   Balakrishnan VS, 2010, CLIN J AM SOC NEPHRO, V5, P996, DOI 10.2215/CJN.09141209
   Belardinelli R, 2001, EUR HEART J, V22, P2164, DOI 10.1053/euhj.2001.2653
   Bristow M, 2000, LANCET, V356, P1621, DOI 10.1016/S0140-6736(00)03149-4
   BUCHWALD A, 1990, EUR HEART J, V11, P509, DOI 10.1093/oxfordjournals.eurheartj.a059743
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Elsässer A, 2004, J AM COLL CARDIOL, V43, P2191, DOI 10.1016/j.jacc.2004.02.053
   Graham D, 2009, HYPERTENSION, V54, P322, DOI 10.1161/HYPERTENSIONAHA.109.130351
   Hafstad AD, 2011, J APPL PHYSIOL, V111, P1235, DOI 10.1152/japplphysiol.00594.2011
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lerman-Sagie T, 2001, J INHERIT METAB DIS, V24, P28, DOI 10.1023/A:1005642302316
   LI YY, 1995, BIOCHEM BIOPH RES CO, V210, P211, DOI 10.1006/bbrc.1995.1648
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Oie E, 2013, LIPIDS, V48, P139, DOI 10.1007/s11745-012-3749-z
   Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610
   Radpour R, 2009, BREAST J, V15, P505, DOI 10.1111/j.1524-4741.2009.00767.x
   Rao M, 2008, J AM SOC NEPHROL, V18, P255
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Sethumadhavan S, 2006, J GERONTOL A-BIOL, V61, P650, DOI 10.1093/gerona/61.7.650
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wong LJC, 2003, J MED GENET, V40, P0
   Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102
   ZAK R, 1980, BASIC RES CARDIOL, V75, P171, DOI 10.1007/BF02001410
   Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441
NR 30
TC 58
Z9 69
U1 0
U2 11
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1355-6037
EI 1468-201X
J9 HEART
JI Heart
PD APR 15
PY 2014
VL 100
IS 8
BP 611
EP 618
DI 10.1136/heartjnl-2013-304657
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AE0RA
UT WOS:000333672600006
PM 24449718
DA 2024-11-01
ER

PT J
AU Pinto, M
   Moraes, CT
AF Pinto, Milena
   Moraes, Carlos T.
TI Mitochondrial genome changes and neurodegenerative diseases
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Review
DE Mitochondrion; mtDNA; Encephalopathy
ID complex-i-deficiency; progressive external ophthalmoplegia; hereditary optic neuropathy; multiple mtdna deletions; dna polymerase-gamma; mouse model; alzheimers-disease; leigh-syndrome; oxidative stress; pearson-syndrome
AB Mitochondria are essential organelles within the cell where most of the energy production occurs by the oxidative phosphorylation system (OXPHOS). Critical components of the OXPHOS are encoded by the mitochondrial DNA (mtDNA) and therefore, mutations involving this genome can be deleterious to the cell. Post-mitotic tissues, such as muscle and brain, are most sensitive to mtDNA changes, due to their high energy requirements and non-proliferative status. It has been proposed that mtDNA biological features and location make it vulnerable to mutations, which accumulate over time. However, although the role of mtDNA damage has been conclusively connected to neuronal impairment in mitochondrial diseases, its role in age-related neurodegenerative diseases remains speculative. Here we review the pathophysiology of mtDNA mutations leading to neurodegeneration and discuss the insights obtained by studying mouse models of mtDNA dysfunction. This article is part of a Special Issue entitled: Misfolded Proteins, Mitochondrial Dysfunction, and Neurodegenerative Diseases. (C) 2013 Published by Elsevier B.V.
C1 [Pinto, Milena; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Grad Program Neurosci, Miami, FL 33136 USA.
   [Pinto, Milena; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
C3 University of Miami; University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Dept Neurol, 1420 NW 9th Ave, Coconut Grove, FL 33133 USA.
EM cmoraes@med.miami.edu
FU NEI NIH HHS [R01 EY010804] Funding Source: Medline; NIA NIH HHS [R01 AG036871] Funding Source: Medline; NINDS NIH HHS [R01 NS079965] Funding Source: Medline
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Andalib S, 2013, J NEUROL SCI, V330, P10, DOI 10.1016/j.jns.2013.04.018
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Borthwick Gillian M, 2006, ANN NEUROL, V59, P570, DOI 10.1002/ana.20758
   Bourdon A, 1900, V39, V0, P0
   Braak H, 2002, J NEUROL S3, V249, P1, DOI 10.1007/s00415-002-1301-4
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381
   Campbell GR, 2013, NEUROPATH APPL NEURO, V39, P377, DOI 10.1111/j.1365-2990.2012.01290.x
   Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009
   Chen JX, 2010, J ALZHEIMERS DIS, V20, PS569, DOI 10.3233/JAD-2010-100357
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   DeBrosse S, 2012, SEMIN PEDIATR NEUROL, V19, P194, DOI 10.1016/j.spen.2012.09.006
   Dhaliwal GK, 2000, NEUROREPORT, V11, P2507, DOI 10.1097/00001756-200008030-00032
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Donovan LE, 2006, J CLIN ENDOCR METAB, V91, P4737, DOI 10.1210/jc.2006-1498
   Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066
   Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2009, PARKINSONISM RELAT D, V15, PS185, DOI 10.1016/S1353-8020(09)70811-9
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2006, HUM GENET, V119, P241, DOI 10.1007/s00439-005-0123-8
   Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Fukae J, 2007, MITOCHONDRION, V7, P58, DOI 10.1016/j.mito.2006.12.002
   FUKUHARA N, 1991, REV NEUROL, V147, P476
   Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Ingram CJE, 2012, AMYOTROPH LATERAL SC, V13, P341, DOI 10.3109/17482968.2012.654394
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Keeney PM, 2010, MOL NEURODEGENER, V5, P0, DOI 10.1186/1750-1326-5-21
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Kirches E, 1999, PATHOBIOLOGY, V67, P214, DOI 10.1159/000028075
   Koilkonda RD, 2011, J OPHTHALMOL, V2011, P0, DOI 10.1155/2011/179412
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2012, NEUROBIOL AGING, V33, P2210, DOI 10.1016/j.neurobiolaging.2011.08.009
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1995, MUSCLE NERVE, V0, PS102
   Lauritzen KH, 2011, MECH AGEING DEV, V132, P424, DOI 10.1016/j.mad.2011.02.006
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Leshinsky-Silver E, 2003, MOL GENET METAB, V79, P288, DOI 10.1016/S1096-7192(03)00097-0
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Long JG, 2012, J ALZHEIMERS DIS, V30, P545, DOI 10.3233/JAD-2012-120283
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Lv H, 2013, CLIN NEUROPATHOL, V32, P16, DOI 10.5414/NP300464
   Mancuso Michelangelo, 2008, HUMAN GENOMICS, V3, P71
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   Marin SE, 2013, GENE, V516, P162, DOI 10.1016/j.gene.2012.12.024
   Martín MA, 2005, ARCH NEUROL-CHICAGO, V62, P659, DOI 10.1001/archneur.62.4.659
   McKenzie M, 2004, P NATL ACAD SCI USA, V101, P1685, DOI 10.1073/pnas.0303184101
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Miller C, 2011, BBA-MOL BASIS DIS, V1812, P625, DOI 10.1016/j.bbadis.2011.01.013
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nakada K, 2011, EXP ANIM TOKYO, V60, P421
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Olmos PR, 2011, J OTOLARYNGOL-HEAD N, V40, P93, DOI 10.2310/7070.2010.100078
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   Pandit A, 2009, J NEUROL SCI, V279, P14, DOI 10.1016/j.jns.2009.01.009
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011
   Pinkert CA, 2007, METHOD CELL BIOL, V80, P549, DOI 10.1016/S0091-679X(06)80027-0
   Pinto M, 2013, NEUROBIOL AGING, V34, P2399, DOI 10.1016/j.neurobiolaging.2013.04.014
   Pinto M, 2012, BIOL CHEM, V393, P275, DOI 10.1515/hsz-2011-0236
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011
   Schon EA, 2010, J ALZHEIMERS DIS, V20, PS281, DOI 10.3233/JAD-2010-100495
   Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Sorensen L, 1900, V21, V0, P0
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Spector Reynold, 2010, CEREBROSPINAL FLUID RES, V7, P14, DOI 10.1186/1743-8454-7-14
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 1900, V38, V0, P0
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Spruijt L, 2006, AM J OPHTHALMOL, V141, P676, DOI 10.1016/j.ajo.2005.11.007
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Suh BC, 2013, MOL MED REP, V8, P17, DOI 10.3892/mmr.2013.1479
   Tanaka N, 2010, MITOCHONDRION, V10, P32, DOI 10.1016/j.mito.2009.08.008
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Thorburn DR, 1993, GENEREVIEWS, V0, P0
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Uusimaa J, 2013, EUR J HUM G IN PRESS, V0, P0
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   Weber K, 1997, AM J HUM GENET, V60, P373
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Williams SL, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003990
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Witte ME, 2013, ACTA NEUROPATHOL, V125, P231, DOI 10.1007/s00401-012-1052-y
   Xie W, 1802, BIOCH BIOPHYS ACTA, V0, P0
   Yokota M, 2010, FEBS LETT, V584, P3943, DOI 10.1016/j.febslet.2010.07.048
   Zhao DH, 2013, CLIN NEUROL NEUROSUR, V115, P1490, DOI 10.1016/j.clineuro.2012.11.011
   Zhou L, 1997, J NEUROSCI, V17, P7746
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 140
TC 56
Z9 64
U1 1
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD AUG 15
PY 2014
VL 1842
IS 8
BP 1198
EP 1207
DI 10.1016/j.bbadis.2013.11.012
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA AL2TL
UT WOS:000338978200005
PM 24252612
DA 2024-11-01
ER

PT J
AU Cassereau, J
   Codron, P
   Funalot, B
AF Cassereau, J.
   Codron, P.
   Funalot, B.
TI Inherited peripheral neuropathies due to mitochondrial disorders
SO REVUE NEUROLOGIQUE
LA English
DT Article
DE Peripheral neuropathies; Mitochondrial disorders; Multisystem disease; Bioenergetics; Mitochondrial DNA; Polymerase gamma; Charcot-Marie-Tooth disease
ID marie-tooth-disease; progressive external ophthalmoplegia; transfer rnaleu(uur) gene; mitofusin 2 mutations; dna polymerase-gamma; sensory neuropathy; hereditary motor; axonal neuropathy; lactic-acidosis; leighs syndrome
AB Mitochondrial disorders (MIDs) are frequently responsible for neuropathies with variable severity. Mitochondrial diseases causing peripheral neuropathies (PNP) may be due to mutations of mitochondrial DNA (mtDNA), as is the case in MERRF and MELAS syndromes, or to mutations of nuclear genes. Secondary abnormalities of mtDNA (such as multiple deletions of muscle mtDNA) may result from mitochondrial disorders due to mutations in nuclear genes involved in mtDNA maintenance. This is the case in several syndromes caused by impaired mtDNA maintenance, such as Sensory Ataxic Neuropathy, Dysarthria and Ophthalmoplegia (SANDO) due to recessive mutations in the POLG gene, which encodes the catalytic subunit of mtDNA polymerase (DNA polymerase gamma), or Mitochondrial Neuro-Gastro-Intestinal Encephalomyopathy (MNGIE), due to recessive mutations in the TYMP gene, which encodes thymidine phosphorylase. The last years have seen a growing list of evidence demonstrating that mitochondrial bioenergetics and dynamics might be dysfunctional in axonal Charcot-Marie-Tooth disease (CMT2), and these mechanisms might present a common link between dissimilar CMT2-causing genes. (c) 2014 Elsevier Masson SAS. All rights reserved.
C1 [Cassereau, J.; Codron, P.] CHU Angers, Serv Neurol, F-49033 Angers, France.
   [Cassereau, J.] CNRS UMR 6214, F-49033 Angers, France.
   [Cassereau, J.] Inserm UMR 1083, F-49033 Angers, France.
   [Funalot, B.] CHU Limoges, Ctr Reference Neuropathies Peripher Rare, F-87042 Limoges, France.
   [Funalot, B.] CHU Limoges, Serv Biochim & Genet Mol, F-87042 Limoges, France.
   [Funalot, B.] Fac Med, EA6309, F-87045 Limoges, France.
C3 Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; CHU Limoges; CHU Limoges
RP Cassereau, J (corresponding author), CHU Angers, Serv Neurol, 4 Rue Larrey, F-49033 Angers, France.
EM JuCassereau@chu-angers.fr
CR Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452
   APPENZELLER O, 1976, ARCH NEUROL-CHICAGO, V33, P733, DOI 10.1001/archneur.1976.00500110001001
   Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007
   Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381
   CAPALDI RA, 1988, J BIOENERG BIOMEMBR, V20, P291, DOI 10.1007/BF00769634
   Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082
   Cassereau J, 2011, EXP NEUROL, V227, P31, DOI 10.1016/j.expneurol.2010.09.006
   Cassereau J, 2009, NEUROGENETICS, V10, P145, DOI 10.1007/s10048-008-0166-9
   Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007
   Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   Courchesne Stephanie L, 2011, PLOS ONE, V6, Pe16753, DOI 10.1371/journal.pone.0016753
   dYdewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Echaniz-Laguna A, 2013, NEUROLOGY, V81, P1523, DOI 10.1212/WNL.0b013e3182a4a518
   Estela A, 2011, J BIOL CHEM, V286, P36777, DOI 10.1074/jbc.M111.260042
   Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354
   Fernyhough P, 2003, J PERIPHER NERV SYST, V8, P227, DOI 10.1111/j.1085-9489.2003.03028.x
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guillet V, 2011, FASEB J, V25, P1618, DOI 10.1096/fj.10-173609
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Holve S, 1999, J PEDIATR-US, V135, P482, DOI 10.1016/S0022-3476(99)70172-1
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Hulgan T, 2005, AIDS, V19, P1341, DOI 10.1097/01.aids.0000180786.02930.a1
   Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078
   Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328
   Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kennerson ML, 2013, HUM MOL GENET, V22, P1404, DOI 10.1093/hmg/dds557
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Melberg A, 1996, MUSCLE NERVE, V19, P751
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Nicholson GA, 2008, NEUROLOGY, V70, P1678, DOI 10.1212/01.wnl.0000311275.89032.22
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Noack R, 2012, HUM MOL GENET, V21, P150, DOI 10.1093/hmg/ddr450
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Polke JM, 2011, NEUROLOGY, V77, P168, DOI 10.1212/WNL.0b013e3182242d4d
   Rinaldi C, 2012, AM J HUM GENET, V91, P1095, DOI 10.1016/j.ajhg.2012.10.008
   Rojo M, 2002, J CELL SCI, V115, P1663
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   RUSANEN H, 1995, NEUROLOGY, V45, P1188, DOI 10.1212/WNL.45.6.1188
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Santoro L, 2000, NEUROMUSCULAR DISORD, V10, P450, DOI 10.1016/S0960-8966(99)00122-4
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Vallat JM, 2008, J NEUROPATH EXP NEUR, V67, P1097, DOI 10.1097/NEN.0b013e31818b6cbc
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Vucic S, 2003, NEUROLOGY, V60, P696, DOI 10.1212/01.WNL.0000048561.61921.71
   Weedon MN, 2011, AM J HUM GENET, V89, P308, DOI 10.1016/j.ajhg.2011.07.002
   WILLIAMS LL, 1979, NEUROLOGY, V29, P1492, DOI 10.1212/WNL.29.11.1492
   Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 70
TC 15
Z9 17
U1 0
U2 7
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0035-3787
EI 2213-0004
J9 REV NEUROL-FRANCE
JI Rev. Neurol.
PD MAY 15
PY 2014
VL 170
IS 5
BP 366
EP 374
DI 10.1016/j.neurol.2013.11.005
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA AH4JK
UT WOS:000336093000007
PM 24768438
DA 2024-11-01
ER

PT J
AU Grady, JP
   Murphy, JL
   Blakely, EL
   Haller, RG
   Taylor, RW
   Turnbull, DM
   Tuppen, HAL
AF Grady, John P.
   Murphy, Julie L.
   Blakely, Emma L.
   Haller, Ronald G.
   Taylor, Robert W.
   Turnbull, Doug M.
   Tuppen, Helen A. L.
TI Accurate Measurement of Mitochondrial DNA Deletion Level and Copy Number Differences in Human Skeletal Muscle
SO PLOS ONE
LA English
DT Article
ID real-time pcr; individual cells; disease; quantification; single; mtdna; depletion; assay
AB Accurate and reliable quantification of the abundance of mitochondrial DNA (mtDNA) molecules, both wild-type and those harbouring pathogenic mutations, is important not only for understanding the progression of mtDNA disease but also for evaluating novel therapeutic approaches. A clear understanding of the sensitivity of mtDNA measurement assays under different experimental conditions is therefore critical, however it is routinely lacking for most published mtDNA quantification assays. Here, we comprehensively assess the variability of two quantitative Taqman real-time PCR assays, a widely-applied MT-ND1/MT-ND4 multiplex mtDNA deletion assay and a recently developed MT-ND1/B2M singleplex mtDNA copy number assay, across a range of DNA concentrations and mtDNA deletion/copy number levels. Uniquely, we provide a specific guide detailing necessary numbers of sample and real-time PCR plate replicates for accurately and consistently determining a given difference in mtDNA deletion levels and copy number in homogenate skeletal muscle DNA.
C1 [Grady, John P.; Murphy, Julie L.; Blakely, Emma L.; Taylor, Robert W.; Turnbull, Doug M.; Tuppen, Helen A. L.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.
   [Haller, Ronald G.] VA North Texas Med Ctr, Dallas, TX USA.
   [Haller, Ronald G.] Inst Exercise & Environm Med, Neuromuscular Ctr, Dallas, TX USA.
C3 Newcastle University - UK; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System
RP Tuppen, HAL (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM helen.tuppen@ncl.ac.uk
FU Wellcome Trust Centre for Mitochondrial Research [906919]; National Institutes of Health (National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIAMS) [RO1-AR050597]; MRC [G0700718, MR/K000608/1, MR/K006312/1] Funding Source: UKRI
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Balakrishnan VS, 2010, CLIN J AM SOC NEPHRO, V5, P996, DOI 10.2215/CJN.09141209
   Blackwood JK, 2010, BIOCHEM BIOPH RES CO, V393, P740, DOI 10.1016/j.bbrc.2010.02.072
   BRUGGER RM, 1969, AM STAT, V23, P32
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Damas J, 2014, NUCLEIC ACIDS RES, V42, PD1261, DOI 10.1093/nar/gkt982
   Efron B, 1986, STATISTICAL SCIENCE, V1, P54, DOI 10.1214/SS/1177013815
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067
   Marcuello A, 2005, J APPL PHYSIOL, V99, P1372, DOI 10.1152/japplphysiol.00289.2005
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Pejznochová M, 2008, PHYSIOL RES, V57, P947, DOI 10.33549/physiolres.931246
   Phillips NR, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep03887
   Poe BG, 2007, ANAL BIOCHEM, V362, P193, DOI 10.1016/j.ab.2006.12.035
   PONTE P, 1983, MOL CELL BIOL, V3, P1783, DOI 10.1128/MCB.3.10.1783
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sabatino L, 2013, ENVIRON MOL MUTAGEN, V54, P299, DOI 10.1002/em.21783
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918
   Sochivko DG, 2013, DOKL BIOCHEM BIOPHYS, V449, P105, DOI 10.1134/S1607672913020154
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Venegas V, 2012, METHODS MOL BIOL, V837, P327, DOI 10.1007/978-1-61779-504-6_22
   Wong LJC, 2003, J MED GENET, V40, P0
   Zhang GJ, 2013, DIAGN PATHOL, V8, P0, DOI 10.1186/1746-1596-8-173
NR 31
TC 47
Z9 49
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD DEC 4
PY 2014
VL 9
IS 12
BP 
EP 
DI 10.1371/journal.pone.0114462
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AW6MB
UT WOS:000346382500032
PM 25474153
DA 2024-11-01
ER

PT J
AU Mancuso, M
   Nesti, C
   Ienco, EC
   Orsucci, D
   Pizzanelli, C
   Chiti, A
   Giorgi, FS
   Meschini, MC
   Fontanini, G
   Santorelli, FM
   Logerfo, A
   Romano, A
   Siciliano, G
   Bonuccelli, U
AF Mancuso, Michelangelo
   Nesti, Claudia
   Ienco, Elena Caldarazzo
   Orsucci, Daniele
   Pizzanelli, Chiara
   Chiti, Alberto
   Giorgi, Filippo S.
   Meschini, Maria Chiara
   Fontanini, Gabriella
   Santorelli, Filippo Maria
   Logerfo, Annalisa
   Romano, Alessandro
   Siciliano, Gabriele
   Bonuccelli, Ubaldo
TI Novel <i>MTCYB</i> Mutation in a Young Patient with Recurrent Stroke-like Episodes and Status Epilepticus
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE cytochrome b; genetics MELAS; mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes; mtDNA; stroke
AB The acronym MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) denotes patients with histological, biochemical and/or molecular evidence of mitochondrial disease who experience stroke-like episodes. Here we report on a girl with repeated stroke-like episodes and status epilepticus, who was diagnosed with MELAS due to a novel mitochondrial cytochrome b gene (MTCYB) mutation (m.15092G>A, which predicts p.G116S). Western blotting and in silico analyses suggested that this mutation could affect the stability of complex III. Cytochrome b is the only mtDNA-encoded subunit of respiratory chain complex III. Mutations in MTCYB have been associated with isolated mitochondrial myopathy and exercise intolerance, and rarely with multisystem and/or central nervous system involvement. If the m.3243A>G and other common MELAS mutations are absent in several tissues, MTCYB should be sequenced from muscle in patients with stroke-like episodes, especially if muscle histology does not support a mitochondrial myopathy and lactic acidosis is absent. (c) 2014 Wiley Periodicals, Inc.
C1 [Mancuso, Michelangelo; Ienco, Elena Caldarazzo; Orsucci, Daniele; Pizzanelli, Chiara; Chiti, Alberto; Giorgi, Filippo S.; Logerfo, Annalisa; Siciliano, Gabriele; Bonuccelli, Ubaldo] Univ Pisa, Neurol Clin, Dept Expt & Clin Med, Pisa, Italy.
   [Nesti, Claudia; Meschini, Maria Chiara; Santorelli, Filippo Maria] IRCCS Stella Maris, Mol Med, Pisa, Italy.
   [Fontanini, Gabriella] Univ Pisa, Div Anat Pathol, Dept Surg, Pisa, Italy.
   [Romano, Alessandro] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy.
C3 University of Pisa; IRCCS Fondazione Stella Maris; University of Pisa; University of Salento
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, Dept Expt & Clin Med, Via Roma 67, Pisa, Italy.
EM mancusomichelangelo@gmail.com
CR De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Emmanuele V, 2013, J CHILD NEUROL, V28, P236, DOI 10.1177/0883073812445787
   Mancuso M, 2009, CURR MOL MED, V9, P1095, DOI 10.2174/156652409789839099
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Massie R, 2010, MUSCLE NERVE, V42, P136, DOI 10.1002/mus.21649
   Souilem S, 2011, J NEUROL SCI, V300, P187, DOI 10.1016/j.jns.2010.08.065
NR 6
TC 4
Z9 4
U1 1
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD NOV 15
PY 2014
VL 164
IS 11
BP 2922
EP 2925
DI 10.1002/ajmg.a.36725
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA AS3OB
UT WOS:000344187200034
PM 25125337
DA 2024-11-01
ER

PT J
AU Hiniker, A
   Wong, LJ
   Berven, S
   Truong, CK
   Adesina, AM
   Margeta, M
AF Hiniker, Annie
   Wong, Lee-Jun
   Berven, Sigurd
   Truong, Cavatina K.
   Adesina, Adekunle M.
   Margeta, Marta
TI Axial mitochondrial myopathy in a patient with rapidly progressive adult-onset scoliosis
SO ACTA NEUROPATHOLOGICA COMMUNICATIONS
LA English
DT Article
DE mtDNA; Mitochondrial myopathy; Camptocormia; Adult scoliosis
ID mutation; camptocormia; genome
AB Axial myopathy can be the underlying cause of rapidly progressive adult-onset scoliosis; however, the pathogenesis of this disorder remains poorly understood. Here we present a case of a 69-year old woman with a family history of scoliosis affecting both her mother and her son, who over 4 years developed rapidly progressive scoliosis. The patient had a history of stable scoliosis since adolescence that worsened significantly at age 65, leading to low back pain and radiculopathy. Paraspinal muscle biopsy showed morphologic evidence of a mitochondrial myopathy. Diagnostic deficiencies of electron transport chain enzymes were not detected using standard bioassays, but mitochondrial immunofluorescence demonstrated many muscle fibers totally or partially deficient for complexes I, III, IV-I, and IV-IV. Massively parallel sequencing of paraspinal muscle mtDNA detected multiple deletions as well as a 40.9% heteroplasmic novel m. 12293G > A (MT-TL2) variant, which changes a G:C pairing to an A:C mispairing in the anticodon stem of tRNA LeuCUN. Interestingly, these mitochondrial abnormalities were not detected in the blood of either the patient or her son, suggesting that the patient's rapidly progressive late onset scoliosis was due to the acquired paraspinal mitochondrial myopathy; the cause of non-progressive scoliosis in the other two family members currently remains unexplained. Notably, this case illustrates that isolated mitochondrial myopathy can underlie rapidly-progressive adult-onset scoliosis and should be considered in the differential diagnosis of the primary axial myopathy.
C1 [Hiniker, Annie; Margeta, Marta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.
   [Wong, Lee-Jun; Truong, Cavatina K.] Baylor Coll Med, Dept Mol Human Genet, Houston, TX 77030 USA.
   [Berven, Sigurd] Univ Calif San Francisco, Dept Orthoped Surg, San Francisco, CA 94143 USA.
   [Adesina, Adekunle M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.
C3 University of California System; University of California San Francisco; Baylor College of Medicine; University of California System; University of California San Francisco; Baylor College of Medicine
RP Margeta, M (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.
EM Marta.Margeta@ucsf.edu
CR Berardelli A, 2009, J NEUROL NEUROSUR PS, V80, P145
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Cardaioli E, 2005, BIOCHEM BIOPH RES CO, V327, P675, DOI 10.1016/j.bbrc.2004.11.170
   COKU J, 2010, NEUROL SCI, V290, P166, DOI 10.1016/JJNS.2009.12.001
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gdynia HJ, 2009, PARKINSONISM RELAT D, V15, P633, DOI 10.1016/j.parkreldis.2009.06.003
   Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.20.04.07.007
   Gómez-Puerta JA, 2007, CLIN RHEUMATOL, V26, P1017, DOI 10.1007/s10067-006-0259-5
   Grasso M, 2001, EUR J HUM GENET, V9, P311, DOI 10.1038/sj.ejhg.5200622
   Hanson BJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1281, DOI 10.1177/002215540205001001
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Lenoir T, 2010, EUR SPINE J, V19, P1229, DOI 10.1007/s00586-010-1370-5
   Mahjneh I, 2002, J NEUROL, V249, P730, DOI 10.1007/s00415-002-0701-9
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D
   Sakiyama Y, 2011, ACTA NEUROPATHOL, V121, P775, DOI 10.1007/s00401-011-0818-y
   Serratrice G, 2007, ACTA MYOL, V26, P11
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Wang J, 2009, MOL GENET METAB, V96, P59, DOI 10.1016/j.ymgme.2008.10.006
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wrede A, 2012, ACTA NEUROPATHOL, V123, P419, DOI 10.1007/s00401-011-0927-7
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 25
TC 12
Z9 12
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2051-5960
EI 
J9 ACTA NEUROPATHOL COM
JI Acta Neuropathol. Commun.
PD JUN 15
PY 2014
VL 2
IS 
BP 
EP 
DI 10.1186/s40478-014-0137-3
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA V9K3A
UT WOS:000422389300103
PM 25223649
DA 2024-11-01
ER

PT J
AU Russell, O
   Turnbull, D
AF Russell, Oliver
   Turnbull, Doug
TI Mitochondrial DNA disease-molecular insights and potential routes to a cure
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Review
DE Mitochondrial disease; Treatments; Zinc-finger nucleases; TALENs
ID progressive external ophthalmoplegia; myoclonus epilepsy; transfer-rna; mutation; mtdna; deletions; defect; merrf; trna(lys); electron
AB Mitochondrial DNA diseases are common neurological conditions caused by mutations in the mitochondrial genome or nuclear genes responsible for its maintenance. Current treatments for these disorders are focussed on the management of the symptoms, rather than the correction of biochemical defects caused by the mutation. This review focuses on the molecular effects of mutations, the symptoms they cause and current work focusing on the development of targeted treatments for mitochondrial DNA disease. (C) 2014 The Authors. Published by Elsevier Inc.
C1 [Turnbull, Doug] Newcastle Univ, Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Turnbull, D (corresponding author), Newcastle Univ, Ctr Brain Ageing & Vital, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
FU Newcastle University Centre for Brain Ageing and Vitality - Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council [G0700718]; UK NIHR Biomedical Research Centre in Age and Age Related Diseases award; MRC Centre for Neuromuscular Disease [G000608-1]; Wellcome Trust Centre for Mitochondrial Research [096919/Z/11/Z]]; Lily Foundation; UK NHS Specialist Commissioners "Rare Mitochondrial Disorders of Adults and Children" Service; MRC [G0700718, MR/K006312/1] Funding Source: UKRI
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bacman SR, 2013, NAT MED, V0, P0
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2013, BRAIN, V0, P0
   HARTZOG PE, 1993, J BIOL CHEM, V268, P12250
   Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927
   HOLME E, 1993, AM J HUM GENET, V52, P551
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   LARSSON NG, 1992, BIOCHIM BIOPHYS ACTA, V1139, P311, DOI 10.1016/0925-4439(92)90106-W
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Santorelli FM, 1996, PEDIATR RES, V39, P914, DOI 10.1203/00006450-199605000-00028
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2002, ACTA NEUROL BELG, V102, P39
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 40
TC 68
Z9 73
U1 0
U2 13
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD JUL 1
PY 2014
VL 325
IS 1
BP 38
EP 43
DI 10.1016/j.yexcr.2014.03.012
PG 6
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA AI9QF
UT WOS:000337267100006
PM 24675282
DA 2024-11-01
ER

PT J
AU Amato, P
   Tachibana, M
   Sparman, M
   Mitalipov, S
AF Amato, Paula
   Tachibana, Masahito
   Sparman, Michelle
   Mitalipov, Shoukhrat
TI Three-parent in vitro fertilization: gene replacement for the prevention of inherited mitochondrial diseases
SO FERTILITY AND STERILITY
LA English
DT Article
DE Mitochondria; nuclear transfer; gene replacement
ID diagnosis; oocytes; mtdna; segregation; disorders; mutation; embryos
AB The exchange of nuclear genetic material between oocytes and embryos offers a novel reproductive option for the prevention of inherited mitochondrial diseases. Mitochondrial dysfunction has been recognized as a significant cause of a number of serious multiorgan diseases. Tissues with a high metabolic demand, such as brain, heart, muscle, and central nervous system, are often affected. Mitochondrial disease can be due to mutations in mitochondrial DNA or in nuclear genes involved in mitochondrial function. There is no curative treatment for patients with mitochondrial disease. Given the lack of treatments and the limitations of prenatal and preimplantation diagnosis, attention has focused on prevention of transmission of mitochondrial disease through germline gene replacement therapy. Because mitochondrial DNA is strictly maternally inherited, two approaches have been proposed. In the first, the nuclear genome from the pronuclear stage zygote of an affected woman is transferred to an enucleated donor zygote. A second technique involves transfer of the metaphase II spindle from the unfertilized oocyte of an affected woman to an enucleated donor oocyte. Our group recently reported successful spindle transfer between human oocytes, resulting in blastocyst development and embryonic stem cell derivation, with very low levels of heteroplasmy. In this review we summarize these novel assisted reproductive techniques and their use to prevent transmission of mitochondrial disorders. The promises and challenges are discussed, focusing on their potential clinical application. (Fertil Steril (R) 2014; 101:31-5. (C) 2014 by American Society for Reproductive Medicine.)
C1 [Amato, Paula] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.
   [Tachibana, Masahito] South Miyagi Med Ctr, Dept Obstet & Gynecol, Ishinomaki, Miyagi, Japan.
   [Sparman, Michelle; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Portland, OR 97201 USA.
C3 Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center
RP Amato, P (corresponding author), Oregon Hlth & Sci Univ, 3303 SW Bond Ave,CH10F, Portland, OR 97239 USA.
EM amatop@ohsu.edu
FU NICHD NIH HHS [R01 HD063276] Funding Source: Medline
CR Battaglia DE, 1996, HUM REPROD, V11, P2217
   Bredenoord AL, 2010, BMJ-BRIT MED J, V341, P0, DOI 10.1136/bmj.c6021
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Manipalviratn S, 2009, FERTIL STERIL, V91, P305, DOI 10.1016/j.fertnstert.2009.01.002
   MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553
   Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thorburn DR, 2009, MOL GENET METAB, V98, P5
   Treff NR, 2012, FERTIL STERIL, V98, P1236, DOI 10.1016/j.fertnstert.2012.07.1119
NR 18
TC 81
Z9 99
U1 0
U2 147
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD JAN 15
PY 2014
VL 101
IS 1
BP 31
EP 35
DI 10.1016/j.fertnstert.2013.11.030
PG 5
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 281VJ
UT WOS:000329128800011
PM 24382342
DA 2024-11-01
ER

PT J
AU Lorenzoni, PJ
   Scala, RH
   Kay, CSK
   Silvado, CES
   Werneck, LC
AF Lorenzoni, Paulo Jose
   Scala, Rosana Herminia
   Kamoi Kay, Claudia Suemi
   Silvado, Carlos Eduardo S.
   Werneck, Lineu Cesar
TI When should MERRF (myoclonus epilepsy associated with ragged-red fibers) be the diagnosis?
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Review
DE MERRF; mitochondrial; epilepsy; myoctonus; myopathy
ID stroke-like episodes; mitochondrial trna(lys) gene; clinical-features; skeletal-muscle; lactic-acidosis; transfer rnalys; g8363a mutation; mtdna mutation; blood-vessels; dna mutation
AB Myoclonic epilepsy associated with ragged red fibers (MERRF) is a rare mitochondrial disorder. Diagnostic criteria for MERRF include typical manifestations of the disease: myoclonus, generalized epilepsy, cerebellar ataxia and ragged red fibers (RRF) on muscle biopsy. Clinical features of MERRF are not necessarily uniform in the early stages of the disease, and correlations between clinical manifestations and physiopathology have not been fully elucidated. It is estimated that point mutations in the tRNA(Lys) gene of the DNAmt, mainly A8344G, are responsible for almost 90% of MERRF cases. Morphological changes seen upon muscle biopsy in MERRF include a substantive proportion of RRF, muscle fibers showing a deficient activity of cytochrome c oxidase (COX) and the presence of vessels with a strong reaction for succinate dehydrogenase and COX deficiency. In this review, we discuss mainly clinical and laboratory manifestations, brain images, electrophysiological patterns, histology and molecular findings as well as some differential diagnoses and treatments.
C1 [Lorenzoni, Paulo Jose; Scala, Rosana Herminia; Kamoi Kay, Claudia Suemi; Silvado, Carlos Eduardo S.; Werneck, Lineu Cesar] Univ Fed Parana, Dept Neurol, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil.
C3 Universidade Federal do Parana
RP Scala, RH (corresponding author), UFPR, Hosp Clin, Serv Doencas Neuromusculares, Rua Gen Carneiro 181,3 Andar, BR-80060900 Curitiba, Parana, Brazil.
EM rosana.scola@hc.ufpr.br
CR Arruda W O, 1990, ARQ NEUROPSIQUIATR, V48, P32
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Brackmann F, 2012, EUR J PEDIATR, V171, P859, DOI 10.1007/s00431-011-1662-8
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   COQUET M, 1993, NEUROMUSCULAR DISORD, V3, P593, DOI 10.1016/0960-8966(93)90122-Z
   De Paepe B, 2009, J CLIN PATHOL, V62, P172, DOI 10.1136/jcp.2008.061267
   DiMauro S, 2002, ADV NEUROL, V89, P217
   DiMauro S, 1999, ADV NEUROL, V79, P411
   EKBOM K, 1975, ACTA NEUROL SCAND, V51, P393
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P543, DOI 10.1017/S0317167100008027
   Folbergrová J, 2012, MITOCHONDRION, V12, P35, DOI 10.1016/j.mito.2011.04.004
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   FUKUHARA N, 1995, MUSCLE NERVE SUPPL 1, V18, P0
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1995, MUSCLE NERVE, V0, PS107
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HASEGAWA H, 1993, ACTA NEUROPATHOL, V85, P280
   Hirano M, 1996, HANDBOOK OF MUSCLE DISEASE, V0, P479
   Ito S, 2008, AM J NEURORADIOL, V29, P392, DOI 10.3174/ajnr.A0865
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   Kazakos K, 2012, ANN HUM GENET, V76, P296, DOI 10.1111/j.1469-1809.2012.00711.x
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Lorenzoni PJ, 2009, ARQ NEURO-PSIQUIAT, V67, P668, DOI 10.1590/S0004-282X2009000400018
   Mancuso M, 2007, BIOCHEM BIOPH RES CO, V354, P1058, DOI 10.1016/j.bbrc.2007.01.099
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   MATSUOKA T, 1991, J NEUROL SCI, V106, P193, DOI 10.1016/0022-510X(91)90257-8
   Mita S, 1998, MUSCLE NERVE, V21, P490, DOI 10.1002/(SICI)1097-4598(199804)21:4<490::AID-MUS7>3.0.CO;2-4
   Orcesi S, 2006, J CHILD NEUROL, V21, P79, DOI 10.1177/08830738060210010901
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   OZAWA M, 1995, NEUROMUSCULAR DISORD, V5, P483, DOI 10.1016/0960-8966(95)00009-C
   ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303
   Rossmanith W, 2003, ANN NEUROL, V54, P820, DOI 10.1002/ana.10753
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0
   SHOFFNER JM, 1992, AM J HUM GENET, V51, P1179
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Sinha S, 2007, J NEUROL SCI, V252, P16, DOI 10.1016/j.jns.2006.09.021
   SO N, 1989, BRAIN, V112, P1261, DOI 10.1093/brain/112.5.1261
   TANNO Y, 1991, BIOCHEM BIOPH RES CO, V179, P880, DOI 10.1016/0006-291X(91)91900-W
   Teive HAG, 2008, MOVEMENT DISORD, V23, P1191, DOI 10.1002/mds.21990
   TSAIRIS P, 1973, NEUROLOGY, V23, P408
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Yasukawa T, 2005, FEBS LETT, V579, P2948, DOI 10.1016/j.febslet.2005.04.038
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   ZEVIANI M, 1991, AM J HUM GENET, V48, P203
   Zeviani Massimo, 1993, EUROPEAN JOURNAL OF HUMAN GENETICS, V1, P80
NR 59
TC 33
Z9 37
U1 0
U2 18
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD OCT 15
PY 2014
VL 72
IS 10
BP 803
EP 811
DI 10.1590/0004-282X20140124
PG 9
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA AS0FM
UT WOS:000343953600013
PM 25337734
DA 2024-11-01
ER

PT J
AU Debray, FG
   Seneca, S
   Gonce, M
   Vancampenhaut, K
   Bianchi, E
   Boemer, F
   Weekers, L
   Smet, J
   Van Coster, R
AF Debray, Francois-Guillaume
   Seneca, Sara
   Gonce, Michel
   Vancampenhaut, Kim
   Bianchi, Elettra
   Boemer, Francois
   Weekers, Laurent
   Smet, Joel
   Van Coster, Rudy
TI Mitochondrial encephalomyopathy with cytochrome <i>c</i> oxidase deficiency caused by a novel mutation in the <i>MTCO1</i> gene
SO MITOCHONDRION
LA English
DT Article
DE Encephalomyopathy; Mitochondrial DNA; Cytochrome c oxidase; MTCO1
ID cox-i gene; subunit-i; nonsense mutation; missense mutation; lactic-acidosis; dna; myopathy; patient
AB Cytochrome c oxidase (COX) deficiency is one of the most common respiratory chain deficiencies. A woman was presented at the age of 18 y with acute loss of consciousness, non-convulsive status epilepticus, slow neurological deterioration, transient cortical blindness, exercise intolerance, muscle weakness, hearing loss, cataract and cognitive decline. Muscle biopsy revealed ragged-red fibers, COX negative fibers and a significant decreased activity of complex IV in a homogenate. Using next generation massive parallel sequencing of the mtDNA, a novel heteroplasmic mutation was identified in MTCO1, m.7402delC, causing frameshift and a premature termination codon. Single fiber PCR showed co-segregation of high mutant load in COX negative fibers. Mutation in mitochondrially encoded complex IV subunits should be considered in mitochondrial encephalomyopathies and COX negative fibers after the common mtDNA mutations have been excluded. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Debray, Francois-Guillaume; Boemer, Francois; Weekers, Laurent] Sart Tilman Univ Hosp, Dept Med Genet, Metab Unit, B-4000 Liege, Belgium.
   [Seneca, Sara; Vancampenhaut, Kim] Vrije Univ Brussel, UZ Brussel & Reprod & Genet REGE, Ctr Med Genet, B-1090 Brussels, Belgium.
   [Gonce, Michel] CHR Citadelle, Dept Neurol, B-4000 Liege, Belgium.
   [Bianchi, Elettra] Sart Tilman Univ Hosp, Dept Neuropathol, B-4000 Liege, Belgium.
   [Smet, Joel; Van Coster, Rudy] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, B-9000 Ghent, Belgium.
C3 Vrije Universiteit Brussel; Ghent University; Ghent University Hospital
RP Debray, FG (corresponding author), Sart Tilman Univ Hosp, Dept Med Genet, Metab Unit, Bat B35 DomaineSart Tilman, B-4000 Liege, Belgium.
EM fg.debray@chu.ulg.ac.be
CR Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   DiMauro S, 2013, NEUROLOGY, V81, P281, DOI 10.1212/WNL.0b013e31829bfe89
   DiMauro S, 2012, ADV EXP MED BIOL, V748, P341, DOI 10.1007/978-1-4614-3573-0_14
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Herrero-Martin Maria D, 2008, HUM MUTAT, V29, PE112, DOI 10.1002/humu.20800
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123, DOI 10.1093/jnen/64.2.123
   Lamperti C, 2012, NEUROMUSCULAR DISORD, V22, P990, DOI 10.1016/j.nmd.2012.06.003
   Lucioli S, 2006, NEUROGENETICS, V7, P51, DOI 10.1007/s10048-005-0015-z
   Massie R, 2012, J NEUROL SCI, V319, P158, DOI 10.1016/j.jns.2012.05.003
   Seneca S, 2014, EUR J HUM GENET, V0, P0
   Tam EWY, 2008, NEUROPEDIATRICS, V39, P328, DOI 10.1055/s-0029-1202287
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Vandewoestyne M, 2012, FORENSIC SCI INT-GEN, V6, P258, DOI 10.1016/j.fsigen.2011.06.002
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Zecic A, 2009, PEDIATR RES, V66, P317, DOI 10.1203/PDR.0b013e3181b40a80
NR 18
TC 8
Z9 11
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2014
VL 17
IS 
BP 101
EP 105
DI 10.1016/j.mito.2014.06.003
PG 5
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA AO1LD
UT WOS:000341072700011
PM 24956508
DA 2024-11-01
ER

PT J
AU Vital, A
   Lepreux, S
   Vital, C
AF Vital, Anne
   Lepreux, Sebastien
   Vital, Claude
TI Peripheral neuropathy and parkinsonism: a large clinical and pathogenic spectrum
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Review
DE levodopa; mitochondrial cytopathy; parkin; parkinsonism; peripheral neuropathy
ID machado-joseph-disease; progressive external ophthalmoplegia; chediak-higashi-syndrome; brain iron accumulation; tremor/ataxia syndrome fxtas; dopa-responsive parkinsonism; x premutation carriers; mitochondrial-dna; gaucher-disease; nervous-system
AB Peripheral neuropathy (PN) has been reported in idiopathic and hereditary forms of parkinsonism, but the pathogenic mechanisms are unclear and likely heterogeneous. Levodopa-induced vitamin B12 deficiency has been discussed as a causal factor of PN in idiopathic Parkinson's disease, but peripheral nervous system involvement might also be a consequence of the underlying neurodegenerative process. Occurrence of PN with parkinsonism has been associated with a panel of mitochondrial cytopathies, more frequently related to a nuclear gene defect and mainly polymerase gamma (POLG1) gene. Parkin (PARK2) gene mutations are responsible for juvenile parkinsonism, and possible peripheral nervous system involvement has been reported. Rarely, an association of parkinsonism with PN may be encountered in other neurodegenerative diseases such as fragile X-associated tremor and ataxia syndrome related to premutation CGG repeat expansion in the fragile X mental retardation (FMR1) gene, Machado-Joseph disease related to an abnormal CAG repeat expansion in ataxin-3 (ATXN3) gene, Kufor-Rakeb syndrome caused by mutations in ATP13A2 gene, or in hereditary systemic disorders such as Gaucher disease due to mutations in the beta-glucocerebrosidase (GBA) gene and Chediak-Higashi syndrome due to LYST gene mutations. This article reviews conditions in which PN may coexist with parkinsonism.
C1 [Vital, Anne; Vital, Claude] Univ Bordeaux, Bordeaux, France.
   [Vital, Anne; Vital, Claude] CNRS, Inst Malad Neurodegenerat, Bordeaux, France.
   [Vital, Anne; Lepreux, Sebastien] Bordeaux Univ Hosp, Dept Pathol, Bordeaux, France.
C3 Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CHU Bordeaux
RP Vital, A (corresponding author), Hop Pellegrin, Serv Pathol, Pl Amelie Raba Leon, F-33076 Bordeaux, France.
EM anne.vital@chu-bordeaux.fr
CR Abbruzzese G, 2004, MOVEMENT DISORD, V19, P978, DOI 10.1002/mds.20113
   Apartis E, 2012, NEUROLOGY, V79, P1898, DOI 10.1212/WNL.0b013e318271f7ff
   Gondim FDA, 2010, ANN NEUROL, V68, P973, DOI 10.1002/ana.22258
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Berry-Kravis E, 2007, AM J MED GENET A, V143A, P19, DOI 10.1002/ajmg.a.31559
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Biegstraaten M, 2008, J INHERIT METAB DIS, V31, P337, DOI 10.1007/s10545-008-0832-y
   Biegstraaten M, 2010, BRAIN, V133, P2909, DOI 10.1093/brain/awq198
   Bouillot S, 2002, J PERIPHER NERV SYST, V7, P213, DOI 10.1046/j.1529-8027.2002.02027.x
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   BYRNE E, 1982, J NEUROL NEUROSUR PS, V45, P372, DOI 10.1136/jnnp.45.4.372
   Capelli LP, 2007, MOVEMENT DISORD, V22, P866, DOI 10.1002/mds.21347
   Capelli LP, 2010, ARQ NEURO-PSIQUIAT, V68, P791, DOI 10.1590/S0004-282X2010000500023
   Ceravolo R, 2013, MOVEMENT DISORD, V28, P1391, DOI 10.1002/mds.25585
   Chérin P, 2010, J INHERIT METAB DIS, V33, P331, DOI 10.1007/s10545-010-9095-5
   Costa MD, 2012, PROG NEUROBIOL, V97, P239, DOI 10.1016/j.pneurobio.2011.11.006
   DAbreu A, 2010, PARKINSONISM RELAT D, V16, P2, DOI 10.1016/j.parkreldis.2009.08.012
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Dehay B, 2012, AUTOPHAGY, V8, P1389, DOI 10.4161/auto.21011
   di Poggio MB, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-105
   DiMauro S, 2006, BRAIN, V129, P1637, DOI 10.1093/brain/awl169
   Durcan TM, 2013, FRONT NEUROL, V4, P0, DOI 10.3389/fneur.2013.00046
   Eiberg H, 2012, CLIN GENET, V82, P256, DOI 10.1111/j.1399-0004.2011.01745.x
   Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132
   Fernandez HH, 2013, PARKINSONISM RELAT D, V19, P339, DOI 10.1016/j.parkreldis.2012.11.020
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   GIUNTI P, 1995, BRAIN, V118, P1077, DOI 10.1093/brain/118.5.1077
   Gokden M, 2009, NEUROPATHOLOGY, V29, P280, DOI 10.1111/j.1440-1789.2008.00948.x
   Graves TD, 2011, ARCH NEUROL-CHICAGO, V68, P653, DOI 10.1001/archneurol.2011.86
   Greco CM, 2006, BRAIN, V129, P243, DOI 10.1093/brain/awh683
   Hagerman RJ, 2007, AM J MED GENET A, V143A, P2256, DOI 10.1002/ajmg.a.31920
   Hagerman RJ, 2004, AM J HUM GENET, V74, P1051, DOI 10.1086/420700
   Hall DA, 2009, PARKINSONISM RELAT D, V15, P156, DOI 10.1016/j.parkreldis.2008.04.037
   Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007
   Hase A, 2002, BRAIN RES, V930, P143, DOI 10.1016/S0006-8993(02)02241-2
   Hauser RA, 2000, MOVEMENT DISORD, V15, P705, DOI 10.1002/1531-8257(200007)15:4<705::AID-MDS1016>3.0.CO;2-B
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Hruska KS, 2006, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/JBB/2006/78549
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650
   Jacquemont S, 2004, AM J MENT RETARD, V109, P154, DOI 10.1352/0895-8017(2004)109<154:AIIWTF>2.0.CO;2
   Karceski S, 2011, NEUROLOGY, V77, PE132, DOI 10.1212/WNL.0b013e31823df782
   Keogh MJ, 2012, SEMIN PEDIATR NEUROL, V19, P51, DOI 10.1016/j.spen.2012.03.004
   Khan NL, 2003, BRAIN, V126, P1279, DOI 10.1093/brain/awg142
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kimber T, 2013, PARKINSONISM RELAT D, V19, P847, DOI 10.1016/j.parkreldis.2013.05.002
   KINOSHITA A, 1995, J NEUROL SCI, V130, P48, DOI 10.1016/0022-510X(94)00285-V
   Kruer MC, 2012, SEMIN PEDIATR NEUROL, V19, P67, DOI 10.1016/j.spen.2012.04.001
   Lohmann E, 2003, ANN NEUROL, V54, P176, DOI 10.1002/ana.10613
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Manca D, 2009, MOVEMENT DISORD, V24, P2293, DOI 10.1002/mds.22807
   Mancini F, 2014, PARKINSONISM RELAT D, V20, P27, DOI 10.1016/j.parkreldis.2013.09.007
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   Matos CA, 2011, PROG NEUROBIOL, V95, P26, DOI 10.1016/j.pneurobio.2011.06.007
   Merola A, 2014, ACTA NEUROL SCAND, V129, PE1, DOI 10.1111/ane.12164
   Milone M, 2011, NEUROLOGY, V77, P1847, DOI 10.1212/WNL.0b013e318238863a
   Miyakawa S, 2013, MOVEMENT DISORD, V28, P388, DOI 10.1002/mds.25346
   Montastruc JL, 2010, MOVEMENT DISORD, V25, P660, DOI 10.1002/mds.22878
   Müller T, 2013, PARKINSONISM RELAT D, V19, P501, DOI 10.1016/j.parkreldis.2013.02.006
   Müller T, 2004, ARCH NEUROL-CHICAGO, V61, P657, DOI 10.1001/archneur.61.5.657
   Nolano M, 2011, ANN NEUROL, V69, P427, DOI 10.1002/ana.22330
   Ohsawa Y, 2005, NEUROLOGY, V65, P459, DOI 10.1212/01.wnl.0000171859.85078.3d
   Okuma Y, 2003, PARKINSONISM RELAT D, V9, P313, DOI 10.1016/S1353-8020(02)00114-1
   Onofrj M, 2009, PARKINSONISM RELAT D, V15, PS233, DOI 10.1016/S1353-8020(09)70821-1
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Paisán-Ruiz C, 2010, MOVEMENT DISORD, V25, P1791, DOI 10.1002/mds.23221
   Paulson Henry, 2012, HANDB CLIN NEUROL, V103, P437, DOI 10.1016/B978-0-444-51892-7.00027-9
   Pedroso JL, 2013, MOVEMENT DISORD, V28, P1200, DOI 10.1002/mds.25513
   Poulopoulos M, 2012, MOVEMENT DISORD, V27, P831, DOI 10.1002/mds.24962
   Pramstaller PP, 2005, ANN NEUROL, V58, P411, DOI 10.1002/ana.20587
   Rajabally YA, 2013, J NEUROL, V260, P2844, DOI 10.1007/s00415-013-7079-8
   Rajabally YA, 2011, NEUROLOGY, V77, P1947, DOI 10.1212/WNL.0b013e31823a0ee4
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Ross-Inta C, 2010, BIOCHEM J, V429, P545, DOI 10.1042/BJ20091960
   Santos-García D, 2012, J NEUROL, V259, P1668, DOI 10.1007/s00415-011-6396-z
   Schneider SA, 2012, SEMIN PEDIATR NEUROL, V19, P57, DOI 10.1016/j.spen.2012.03.005
   Seidel K, 2010, ACTA NEUROPATHOL, V120, P449, DOI 10.1007/s00401-010-0717-7
   Shahrizaila N, 2013, PARKINSONISM RELAT D, V19, P391, DOI 10.1016/j.parkreldis.2012.08.002
   Sharp ME, 2014, MOVEMENT DISORD, V29, P566, DOI 10.1002/mds.25792
   Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060
   Silveira-Moriyama L, 2004, MOVEMENT DISORD, V19, P472, DOI 10.1002/mds.10677
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Sutton JP, 1997, NEUROLOGY, V48, P1285, DOI 10.1212/WNL.48.5.1285
   Swan M, 2013, CURR NEUROL NEUROSCI, V13, P0, DOI 10.1007/s11910-013-0368-x
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tardieu M, 2005, BLOOD, V106, P40, DOI 10.1182/blood-2005-01-0319
   Tassone F, 2012, GENES BRAIN BEHAV, V11, P577, DOI 10.1111/j.1601-183X.2012.00779.x
   Tayebi N, 2003, MOL GENET METAB, V79, P104, DOI 10.1016/S1096-7192(03)00071-4
   Teodoro T, 2011, MOVEMENT DISORD, V26, P1966, DOI 10.1002/mds.23760
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Tison F, 2011, NEUROLOGY, V77, P1938, DOI 10.1212/WNL.0b013e31823de107
   Toth C, 2008, MOVEMENT DISORD, V23, P1850, DOI 10.1002/mds.22137
   Toth C, 2010, ANN NEUROL, V68, P28, DOI 10.1002/ana.22021
   TUITE PJ, 1995, ANN NEUROL, V38, P684, DOI 10.1002/ana.410380422
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Urban PP, 2010, MOVEMENT DISORD, V25, P1748, DOI 10.1002/mds.23342
   Usenovic M, 2012, HUM MOL GENET, V21, P3785, DOI 10.1093/hmg/dds206
   UYAMA E, 1994, ACTA NEUROL SCAND, V89, P175
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Vital A, 2014, J PERIPHER NERV SYST, V19, P44, DOI 10.1111/jns5.12056
   Vital A, 2012, J NEUROPATH EXP NEUR, V71, P1036, DOI 10.1097/NEN.0b013e3182764d47
   Weisfeld-Adams JD, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-46
   Yamada M, 2004, NEUROPATH APPL NEURO, V30, P665, DOI 10.1111/j.1365-2990.2004.00583.x
   Yamada M, 2008, ACTA NEUROPATHOL, V115, P71, DOI 10.1007/s00401-007-0287-5
NR 107
TC 14
Z9 16
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD DEC 15
PY 2014
VL 19
IS 4
BP 333
EP 342
DI 10.1111/jns.12099
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CA7JR
UT WOS:000349094100008
PM 25582874
DA 2024-11-01
ER

PT J
AU Nicholls, TJ
   Zsurka, G
   Peeva, V
   Schöler, S
   Szczesny, RJ
   Cysewski, D
   Reyes, A
   Kornblum, C
   Sciacco, M
   Moggio, M
   Dziembowski, A
   Kunz, WS
   Minczuk, M
AF Nicholls, Thomas J.
   Zsurka, Gabor
   Peeva, Viktoriya
   Schoeler, Susanne
   Szczesny, Roman J.
   Cysewski, Dominik
   Reyes, Aurelio
   Kornblum, Cornelia
   Sciacco, Monica
   Moggio, Maurizio
   Dziembowski, Andrzej
   Kunz, Wolfram S.
   Minczuk, Michal
TI Linear mtDNA fragments and unusual mtDNA rearrangements associated with pathological deficiency of MGME1 exonuclease
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID mitochondrial-dna replication; double-strand breaks; progressive external ophthalmoplegia; polymerase-gamma; transcription termination; homologous recombination; lagging-strand; control region; 7s dna; mutations
AB MGME1, also known as Ddk1 or C20orf72, is a mitochondrial exonuclease found to be involved in the processing of mitochondrial DNA (mtDNA) during replication. Here, we present detailed insights on the role of MGME1 in mtDNA maintenance. Upon loss of MGME1, elongated 7S DNA species accumulate owing to incomplete processing of 5' ends. Moreover, an 11-kb linear mtDNA fragment spanning the entire major arc of the mitochondrial genome is generated. In contrast to control cells, where linear mtDNA molecules are detectable only after nuclease S1 treatment, the 11-kb fragment persists in MGME1-deficient cells. In parallel, we observed characteristic mtDNA duplications in the absence of MGME1. The fact that the breakpoints of these mtDNA rearrangements do not correspond to either classical deletions or the ends of the linear 11-kb fragment points to a role of MGME1 in processing mtDNA ends, possibly enabling their repair by homologous recombination. In agreement with its functional involvement in mtDNA maintenance, we show that MGME1 interacts with the mitochondrial replicase PolgA, suggesting that it is a constituent of the mitochondrial replisome, to which it provides an additional exonuclease activity. Thus, our results support the viewpoint that MGME1-mediated mtDNA processing is essential for faithful mitochondrial genome replication and might be required for intramolecular recombination of mtDNA.
C1 [Nicholls, Thomas J.; Reyes, Aurelio; Minczuk, Michal] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Zsurka, Gabor; Peeva, Viktoriya; Schoeler, Susanne; Kunz, Wolfram S.] Univ Bonn, Med Ctr, Dept Epileptol, Bonn, Germany.
   [Zsurka, Gabor; Peeva, Viktoriya; Schoeler, Susanne; Kunz, Wolfram S.] Univ Bonn, Med Ctr, Life & Brain Ctr, Bonn, Germany.
   [Kornblum, Cornelia] Univ Bonn, Med Ctr, Dept Neurol, Bonn, Germany.
   [Szczesny, Roman J.; Cysewski, Dominik; Dziembowski, Andrzej] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Warsaw, Poland.
   [Szczesny, Roman J.; Cysewski, Dominik; Dziembowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.
   [Sciacco, Monica; Moggio, Maurizio] Univ Milan, Ctr Dino Ferrari, Osped Maggiore Policlin, Neuromuscular Unit,Fdn IRCCS Ca Granda, Milan, Italy.
C3 University of Bonn; University of Bonn; University of Bonn; University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico
RP Minczuk, M (corresponding author), MRC, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.
EM wolfram.kunz@ukb.uni-bonn.de; michal.minczuk@mrc-mbu.cam.ac.uk
FU Medical Research Council, UK; Deutsche Forschungsgemeinschaft [KU 911/21-1, ZS 99/3-1]; European Community [279062]; Ministry of Science and Higher Education of Poland [0542/IP1/2011/71]; MRC [MC_U105697135] Funding Source: UKRI
CR Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   BOGENHAGEN D, 1978, J MOL BIOL, V119, P69, DOI 10.1016/0022-2836(78)90270-X
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BROWN GG, 1986, J MOL BIOL, V192, P503, DOI 10.1016/0022-2836(86)90272-X
   Canceill D, 1999, J BIOL CHEM, V274, P27481, DOI 10.1074/jbc.274.39.27481
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   ENGLER MJ, 1983, J BIOL CHEM, V258, P1165
   FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Goodarzi AA, 2013, ADV GENET, V82, P1, DOI 10.1016/B978-0-12-407676-1.00001-9
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a012971
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200
   Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   Orlowska KP, 2013, NUCLEIC ACIDS RES, V41, P0, DOI 10.1093/nar/gkt650
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rudolph CJ, 2013, NATURE, V500, P608, DOI 10.1038/nature12312
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Senkevich TG, 2009, P NATL ACAD SCI USA, V106, P17921, DOI 10.1073/pnas.0909529106
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Wei YH, 1996, ANN NY ACAD SCI, V786, P82, DOI 10.1111/j.1749-6632.1996.tb39054.x
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d
NR 66
TC 58
Z9 63
U1 2
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC 1
PY 2014
VL 23
IS 23
BP 6147
EP 6162
DI 10.1093/hmg/ddu336
PG 16
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AX2MF
UT WOS:000346777400002
PM 24986917
DA 2024-11-01
ER

PT J
AU Cámara, Y
   González-Vioque, E
   Scarpelli, M
   Torres-Torronteras, J
   Caballero, A
   Hirano, M
   Martí, R
AF Camara, Yolanda
   Gonzalez-Vioque, Emiliano
   Scarpelli, Mauro
   Torres-Torronteras, Javier
   Caballero, Andrea
   Hirano, Michio
   Marti, Ramon
TI Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID deoxyguanosine kinase-deficiency; in-vitro supplementation; mutations; myopathy; gene; p53r2; pools
AB Mitochondrial DNA (mtDNA) depletion syndrome (MDS) is characterized by a reduction in mtDNA copy number and consequent mitochondrial dysfunction in affected tissues. A subgroup of MDS is caused by mutations in genes that disrupt deoxyribonucleotide metabolism, which ultimately leads to limited availability of one or several deoxyribonucleoside triphosphates (dNTPs), and subsequent mtDNA depletion. Here, using in vitro experimental approaches (primary cell culture of deoxyguanosine kinase-deficient cells and thymidine-induced mtDNA depletion in culture as a model of mitochondrial neurogastrointestinal encephalomyopathy, MNGIE), we show that supplements of those deoxyribonucleosides (dNs) involved in each biochemical defect (deoxyguanosine or deoxycytidine, dCtd) prevents mtDNA copy number reduction. Similar effects can be obtained by specific inhibition of dN catabolism using tetrahydrouridine (THU; inhibitor of cytidine deaminase) or immucillin H (inhibitor of purine nucleoside phosphorylase). In addition, using an MNGIE animal model, we provide evidence that mitochondrial dNTP content can be modulated in vivo by systemic administration of dCtd or THU. In spite of the severity associated with diseases due to defects in mtDNA replication, there are currently no effective therapeutic options available. Only in the case of MNGIE, allogeneic hematopoietic stem cell transplantation has proven efficient as a long-term therapeutic strategy. We propose increasing cellular availability of the deficient dNTP precursor by direct administration of the dN or inhibition of its catabolism, as a potential treatment for mtDNA depletion syndrome caused by defects in dNTP metabolism.
C1 [Camara, Yolanda; Gonzalez-Vioque, Emiliano; Scarpelli, Mauro; Torres-Torronteras, Javier; Caballero, Andrea; Marti, Ramon] Vall dHebron Inst Recerca, Unitat Patol Mitocondrial, Barcelona 08035, Catalonia, Spain.
   [Camara, Yolanda; Gonzalez-Vioque, Emiliano; Torres-Torronteras, Javier; Marti, Ramon] Ctr Biomed Network Res Rare Dis CIBERER, Barcelona, Catalonia, Spain.
   [Scarpelli, Mauro] Univ Verona, Dept Neurol & Movement Sci, Neurol Sect, I-37100 Verona, Italy.
   [Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Verona; Columbia University
RP Martí, R (corresponding author), Vall dHebron Inst Recerca, Unitat Patol Mitocondrial, Passeig Vall dHebron 119, Barcelona 08035, Catalonia, Spain.
EM ramon.marti@vhir.org
FU Spanish Instituto de Salud Carlos III [PI12/00322]; United Mitochondrial Disease Foundation (UMDF) [12-029]; French Muscular Dystrophy Association-Telethon (AFMTelethon)
CR Al-Kali A, 2010, FUTURE ONCOL, V6, P1211, DOI 10.2217/FON.10.83
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   COWAN MJ, 1985, CLIN IMMUNOL IMMUNOP, V37, P30, DOI 10.1016/0090-1229(85)90132-1
   Del Toro M, 2005, J INHERIT METAB DIS, V28, P135
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   González-Vioque E, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002035
   Hecker SJ, 2008, J MED CHEM, V51, P2328, DOI 10.1021/jm701260b
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MARKERT M L, 1991, IMMUNODEFICIENCY REVIEWS, V3, P45
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saada A, 2008, MOL GENET METAB, V95, P169, DOI 10.1016/j.ymgme.2008.07.007
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4
NR 24
TC 60
Z9 64
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 1
PY 2014
VL 23
IS 9
BP 2459
EP 2467
DI 10.1093/hmg/ddt641
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AE9VL
UT WOS:000334359100019
PM 24362886
DA 2024-11-01
ER

PT J
AU Raz, Y
   Raz, V
AF Raz, Yotam
   Raz, Vered
TI Oculopharyngeal muscular dystrophy as a paradigm for muscle aging
SO FRONTIERS IN AGING NEUROSCIENCE
LA English
DT Review
DE adult myopathy; muscle degeneration; OPMD; PABPN1; RNA metabolism
ID poly(a) binding-protein; nuclear inclusions; molecular-mechanisms; mitochondrial-dna; mouse model; pabp2 gene; in-vivo; aggregation; toxicity; mutation
AB Symptoms in late-onset neuromuscular disorders initiate only from midlife onward and progress with age. These disorders are primarily determined by identified hereditable mutations, but their late-onset symptom manifestation is not fully understood. Here, we review recent research developments on the late-onset autosomal dominant oculopharyngeal muscular dystrophy (OPMD). OPMD is caused by an expansion mutation in the gene encoding for poly-adenylate RNA binding protein1 (PABPN1). The molecular pathogenesis for the disease is still poorly understood. Despite a ubiquitous expression of PABPN1, symptoms in OPMD are limited to skeletal muscles. We discuss recent studies showing that PABPN1 levels in skeletal muscles are lower compared with other tissues, and specifically in skeletal muscles, PABPN1 expression declines from midlife onward. In OPMD, aggregation of expanded PABPN1 causes an additional decline in the level of the functional protein, which is associated with severe muscle weakness in OPMD. Reduced PABNPN1 expression in muscle cell culture causes myogenic defects, suggesting that PABPN1 loss-of-function causes muscle weakness in OPMD and in the elderly. Molecular signatures of OPMD muscles are similar to those of normal muscle aging, although expression trends progress faster in OPMD. We discuss a working hypothesis that aging-associated factors trigger late-onset symptoms in OPMD, and contribute to accelerated muscle weakness in OPMD. We focus on the pharyngeal and eyelid muscles, which are often affected in OPMD patients. We suggest that muscle weakness in OPMD is a paradigm for muscle aging.
C1 [Raz, Yotam; Raz, Vered] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RC Leiden, Netherlands.
C3 Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)
RP Raz, V (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, Einthovenweg 20,Bldg 2,Room R3-17,Postzone S4-P, NL-2300 RC Leiden, Netherlands.
EM v.raz@lumc.nl
FU French Muscular Dystrophy Association, France; Princess Beatrix Muscle Fund, The Netherlands
CR Abu-Baker A, 2005, TRAFFIC, V6, P766, DOI 10.1111/j.1600-0854.2005.00315.x
   Anthony K, 2010, BRAIN RES, V1338, P67, DOI 10.1016/j.brainres.2010.03.008
   Anvar SY, 2013, AGING-US, V5, P412, DOI 10.18632/aging.100567
   Anvar SY, 2011, SKELET MUSCLE, V1, P0, DOI 10.1186/2044-5040-1-15
   Apponi LH, 2013, SKELET MUSCLE, V3, P0, DOI 10.1186/2044-5040-3-23
   Apponi LH, 2010, HUM MOL GENET, V19, P1058, DOI 10.1093/hmg/ddp569
   Beaulieu YB, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003078
   Benoit B, 2005, DEV CELL, V9, P511, DOI 10.1016/j.devcel.2005.09.002
   Berciano MT, 2004, HUM MOL GENET, V13, P829, DOI 10.1093/hmg/ddh101
   Bhattacharjee RB, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0053036
   Blumen SC, 2000, NEUROLOGY, V55, P1267, DOI 10.1212/WNL.55.9.1267
   Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389
   Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164
   Bresson SM, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003893
   Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924
   Catoire H, 2008, HUM MOL GENET, V17, P2108, DOI 10.1093/hmg/ddn109
   Chartier A, 2009, HUM MOL GENET, V18, P1849, DOI 10.1093/hmg/ddp101
   Corbeil-Girard LP, 2005, NEUROBIOL DIS, V18, P551, DOI 10.1016/j.nbd.2004.10.019
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Davies JE, 2008, HUM MOL GENET, V17, P1097, DOI 10.1093/hmg/ddm382
   Davies JE, 2010, SCI TRANSL MED, V2, P0, DOI 10.1126/scitranslmed.3000723
   Davies JE, 2006, HUM MOL GENET, V15, P23, DOI 10.1093/hmg/ddi422
   Davies JE, 2005, NAT MED, V11, P672, DOI 10.1038/nm1242
   de Klerk E, 2012, NUCLEIC ACIDS RES, V40, P9089, DOI 10.1093/nar/gks655
   Eshed I, 2007, ANN RHEUM DIS, V66, P1553, DOI 10.1136/ard.2007.070243
   Fea A, 2013, MINERVA CHIR, V68, P49
   Feng X, 2013, J GERONTOL A-BIOL, V68, P853, DOI 10.1093/gerona/gls225
   Fischmann A, 2012, J NEUROL, V259, P1648, DOI 10.1007/s00415-011-6393-2
   Iida T, 2013, TOHOKU J EXP MED, V231, P223, DOI 10.1620/tjem.231.223
   Jenal M, 2012, CELL, V149, P0, DOI 10.1016/j.cell.2012.03.022
   Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347
   Laberge AM, 2005, CLIN GENET, V68, P287, DOI 10.1111/j.1399-0004.2005.00497.x
   Ney DM, 2009, NUTR CLIN PRACT, V24, P395, DOI 10.1177/0884533609332005
   ORourke JR, 2009, J BIOL CHEM, V284, P7419, DOI 10.1074/jbc.R800025200
   Peter L, 2011, GEN COMP ENDOCR, V172, P39, DOI 10.1016/j.ygcen.2011.02.005
   Purves-Smith FM, 2014, EXERC SPORT SCI REV, V42, P45, DOI 10.1249/JES.0000000000000012
   Raz V, 2014, AM J PATHOL, V184, P1119, DOI 10.1016/j.ajpath.2013.12.011
   Raz V, 2013, NEUROMUSCULAR DISORD, V23, P516, DOI 10.1016/j.nmd.2013.03.001
   Raz V, 2011, AM J PATHOL, V179, P1988, DOI 10.1016/j.ajpath.2011.06.044
   Raz V, 2011, NUCLEUS-PHILA, V2, P208, DOI 10.4161/nucl.2.3.15736
   Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742
   Rüegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537
   Rüegg S, 2005, SWISS MED WKLY, V135, P574
   Salvi SM, 2006, POSTGRAD MED J, V82, P581, DOI 10.1136/pgmj.2005.040857
   Schindler JS, 2002, LARYNGOSCOPE, V112, P589, DOI 10.1097/00005537-200204000-00001
   Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003
   Sluijs B, 2003, J NEUROL, V250, P1307, DOI 10.1007/S00415-003-0201-6
   Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105
   TOME FMS, 1980, ACTA NEUROPATHOL, V49, P85, DOI 10.1007/BF00692226
   Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Willis TA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0070993
   Witting N, 2014, ACTA NEUROL SCAND, V130, P125, DOI 10.1111/ane.12244
   Yokoyama M, 2000, LARYNGOSCOPE, V110, P434, DOI 10.1097/00005537-200003000-00021
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
NR 55
TC 25
Z9 30
U1 0
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND
SN 1663-4365
EI 
J9 FRONT AGING NEUROSCI
JI Front. Aging Neurosci.
PD NOV 10
PY 2014
VL 6
IS 
BP 
EP 
DI 10.3389/fnagi.2014.00317
PG 5
WC Geriatrics & Gerontology; Neurosciences
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA AY9OM
UT WOS:000347880300001
PM 25426070
DA 2024-11-01
ER

PT J
AU Orsucci, D
   Rocchi, A
   Ienco, EC
   Alì, G
   LoGerfo, A
   Petrozzi, L
   Scarpelli, M
   Filosto, M
   Carlesi, C
   Siciliano, G
   Bonuccelli, U
   Mancuso, M
AF Orsucci, D.
   Rocchi, A.
   Ienco, E. Caldarazzo
   Ali, G.
   LoGerfo, A.
   Petrozzi, L.
   Scarpelli, M.
   Filosto, M.
   Carlesi, C.
   Siciliano, G.
   Bonuccelli, U.
   Mancuso, M.
TI Myopathic Involvement and Mitochondrial Pathology in Kennedy Disease and in Other Motor Neuron Diseases
SO CURRENT MOLECULAR MEDICINE
LA English
DT Article
DE ALS; AR; Kennedy's disease; motoneuron disease; multiple deletions; mtDNA; SMA; SBMA
ID bulbar muscular-atrophy; amyotrophic-lateral-sclerosis; skeletal-muscle; androgen receptor; dna depletion; mutation; dysfunction; phenotype; patient; model
AB Kennedy disease (spinal and bulbar muscular atrophy, or SBMA) is a motor neuron disease caused by a CAG expansion in the androgen-receptor (AR) gene. Increasing evidence shows that SBMA may have a primary myopathic component and that mitochondrial dysfunction may have some role in the pathogenesis of this disease. In this article, we review the role of mitochondrial dysfunction and of the mitochondrial genome (mtDNA) in SBMA, and we present the illustrative case of a patient who presented with increased CK levels and exercise intolerance. Molecular analysis led to definitive diagnosis of SBMA, whereas muscle biopsy showed a mixed myopathic and neurogenic process with "mitochondrial features" and multiple mtDNA deletions, supporting some role of mitochondria in the pathogenesis of the myopathic component of Kennedy disease. Furthermore, we briefly review the role of mitochondrial dysfunction in two other motor neuron diseases (namely spinal muscular atrophy and amyotrophic lateral sclerosis). Most likely, in most cases mtDNA does not play a primary role and it is involved subsequently. MtDNA deletions may contribute to the neurodegenerative process, but the exact mechanisms are still unclear. It will be important to develop a better understanding of the role of mitochondrial dysfunction in motoneuron diseases, since it may lead to the development of more effective strategies for the treatment of this devastating disorder.
C1 [Orsucci, D.; Rocchi, A.; Ienco, E. Caldarazzo; LoGerfo, A.; Petrozzi, L.; Carlesi, C.; Siciliano, G.; Bonuccelli, U.; Mancuso, M.] Univ Pisa, Dept Expt & Clin Med, Pisa, Italy.
   [Ali, G.] Univ Pisa, Div Anat Patol, I-56100 Pisa, Italy.
   [Scarpelli, M.] Univ Verona, Div Clin Neurol, I-37100 Verona, Italy.
   [Filosto, M.] Univ Brescia, Neurol Clin, I-25121 Brescia, Italy.
C3 University of Pisa; University of Pisa; University of Verona; University of Brescia
RP Mancuso, M (corresponding author), Univ Pisa, Dept Expt & Clin Med, Pisa, Italy.
EM mancusomichelangelo@gmail.com
CR Acsadi G, 2009, J NEUROSCI RES, V87, P2748, DOI 10.1002/jnr.22106
   Ansved T, 1998, NEUROLOGY, V51, P1442, DOI 10.1212/WNL.51.5.1442
   Artuso L, 2013, AMYOTROPH LAT SCL FR, V14, P261, DOI 10.3109/21678421.2012.735239
   Beitel LK, 2013, FRONT NEUROL, V4, P0, DOI 10.3389/fneur.2013.00053
   Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1
   Borthwick Gillian M, 2006, ANN NEUROL, V59, P570, DOI 10.1002/ana.20758
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128
   Dhaliwal GK, 2000, NEUROREPORT, V11, P2507, DOI 10.1097/00001756-200008030-00032
   Fernández-Rhodes LE, 2011, LANCET NEUROL, V10, P140, DOI 10.1016/S1474-4422(10)70321-5
   Finsterer J, 2010, J NEUROL SCI, V298, P1, DOI 10.1016/j.jns.2010.08.025
   Gajewski CD, 2003, EXP NEUROL, V179, P229, DOI 10.1016/S0014-4886(02)00022-5
   Hamano T, 2004, J NEUROL SCI, V222, P93, DOI 10.1016/j.jns.2004.04.028
   Hashizume A, 2012, BRAIN, V135, P2838, DOI 10.1093/brain/aws170
   Jochum T, 2012, BBA-MOL BASIS DIS, V1822, P1070, DOI 10.1016/j.bbadis.2012.02.006
   Jordan CL, 2008, CURR OPIN PHARMACOL, V8, P752, DOI 10.1016/j.coph.2008.08.006
   Katsuno M, 2012, ARCH NEUROL-CHICAGO, V69, P436, DOI 10.1001/archneurol.2011.2308
   Kirches E, 1999, PATHOBIOLOGY, V67, P214, DOI 10.1159/000028075
   Liu CS, 2008, J NEUROL SCI, V264, P18, DOI 10.1016/j.jns.2007.07.016
   Malik B, 2011, HUM MOL GENET, V20, P1776, DOI 10.1093/hmg/ddr061
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mancuso M, 2010, J NEUROL, V257, P774, DOI 10.1007/s00415-009-5409-7
   Mancuso Michelangelo, 2008, HUMAN GENOMICS, V3, P71
   Mano T, 2012, MUSCLE NERVE, V46, P692, DOI 10.1002/mus.23413
   Meriggioli MN, 2003, MUSCLE NERVE, V27, P249, DOI 10.1002/mus.10295
   Mo KG, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012922
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Pons R, 1996, PEDIATR NEUROL, V15, P153, DOI 10.1016/0887-8994(96)00118-X
   Preisler N, 2009, NEUROLOGY, V72, P317, DOI 10.1212/01.wnl.0000341274.61236.02
   Pronicki M, 2010, EUR J PAEDIATR NEURO, V14, P253, DOI 10.1016/j.ejpn.2009.09.008
   Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310
   Rhodes LE, 2009, BRAIN, V132, P3242, DOI 10.1093/brain/awp258
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015
   Sorarù G, 2008, J NEUROL SCI, V264, P100, DOI 10.1016/j.jns.2007.08.012
   Su SL, 2010, CLIN CHIM ACTA, V411, P626, DOI 10.1016/j.cca.2009.12.007
   Swerdlow RH, 1998, EXP NEUROL, V153, P135, DOI 10.1006/exnr.1998.6866
   Tarnopolsky MA, 2004, AM J MED GENET A, V125A, P310, DOI 10.1002/ajmg.a.20466
   Vucic S, 2011, MUSCLE NERVE, V44, P197, DOI 10.1002/mus.22017
   Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773
NR 40
TC 10
Z9 11
U1 0
U2 5
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1566-5240
EI 1875-5666
J9 CURR MOL MED
JI Curr. Mol. Med.
PD JUN 15
PY 2014
VL 14
IS 5
BP 598
EP 602
DI 10.2174/1566524014666140603100131
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AK6HG
UT WOS:000338528100003
PM 24894177
DA 2024-11-01
ER

PT J
AU Toscano, A
   Musumeci, O
AF Toscano, A.
   Musumeci, O.
TI Mitochondrial Disorders in Adults
SO CURRENT MOLECULAR MEDICINE
LA English
DT Article
DE Adults; mitochondrial disorders; mtDNA; multisystem; myopathies
ID progressive external ophthalmoplegia; hereditary optic neuropathy; thymidine phosphorylase mutations; coenzyme-q deficiency; autosomal-dominant; cerebellar-ataxia; dna instability; muscle; gene; deletions
AB Mitochondrial Disorders (MD) include a heterogeneous group of inherited disorders due to molecular defects mainly affecting the mitochondrial oxidative phosphorylation system. Because the respiratory chain is under control of two different genomes (nuclear DNA-nDNA and mitochondrial DNA-mtDNA), mitochondrial genetics is quite complex and may justify the extreme clinical heterogeneity of these diseases. Clinically, MD usually involve multiple tissues, mainly affecting organs with high energy request as central nervous system and skeletal muscle. They may present at any age, with different onsets, clinical presentation and progression from an isolated involvement of vision or hearing to a multisystemic degenerative disorders with stroke-like episodes, peripheral neuropathy, ophthalmoparesis, seizures, cardiopathy, hepatopathy, endocrinopathies, etc. Over the last 50 years, it became evident that MD represent an important part of the general medicine. The complexity of clinical and genetic spectrum of those disorders is still increasing. The aim of this review is to walk through mitochondrial genetics, highlighting novel clinical entities.
C1 [Toscano, A.; Musumeci, O.] Univ Messina, Dept Neurosci, Messina, Italy.
C3 University of Messina
RP Toscano, A (corresponding author), AOU Policlin, UOC Neurol & Malattie Neuromuscolari, Dept Neurosci, Via C Valeria 1, I-98125 Messina, Italy.
EM atoscano@unime.it
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Berardo A, 2011, ACTA MYOL, V30, P9
   Chowers I, 1999, BRIT J OPHTHALMOL, V83, P190, DOI 10.1136/bjo.83.2.190
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   DiMauro S, 2003, BASIC APPL MYOL, V13, P145
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Hirano M, 2005, GENE, V354, P152, DOI 10.1016/j.gene.2005.04.041
   Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Ji YL, 2010, MOL VIS, V16, P416
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Krähenbühl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Liang WC, 2009, NEUROMUSCULAR DISORD, V19, P212, DOI 10.1016/j.nmd.2009.01.008
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Venhoff N, 2007, ANTIVIR THER, V12, P1075
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 46
TC 4
Z9 4
U1 0
U2 4
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1566-5240
EI 1875-5666
J9 CURR MOL MED
JI Curr. Mol. Med.
PD JUN 15
PY 2014
VL 14
IS 8
BP 1001
EP 1008
DI 10.2174/1566524014666141010152340
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AT4RR
UT WOS:000344929400009
PM 28315632
DA 2024-11-01
ER

PT J
AU Almalki, A
   Alston, CL
   Parker, A
   Simonic, I
   Mehta, SG
   He, LP
   Reza, M
   Oliveira, JMA
   Lightowlers, RN
   McFarland, R
   Taylor, RW
   Chrzanowska-Lightowlers, ZMA
AF Almalki, Abdulraheem
   Alston, Charlotte L.
   Parker, Alasdair
   Simonic, Ingrid
   Mehta, Sarju G.
   He, Langping
   Reza, Mojgan
   Oliveira, Jorge M. A.
   Lightowlers, Robert N.
   McFarland, Robert
   Taylor, Robert W.
   Chrzanowska-Lightowlers, Zofia M. A.
TI Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiency
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Mitochondria; Mitochondrial disease; Aminoacyl-tRNA synthetase; Aminoacylation; Mitochondrial translation; Protein synthesis
ID dna mutations; human-disease; sideroblastic anemia; missense mutations; perrault syndrome; lactic-acidosis; causes myopathy; hearing-loss; brain-stem; leukoencephalopathy
AB Mitochondrial aminoacyl-tRNA synthetases (aaRSs) are essential enzymes in protein synthesis since they charge tRNAs with their cognate amino acids. Mutations in the genes encoding mitochondrial aaRSs have been associated with a wide spectrum of human mitochondrial diseases. Here we report the identification of pathogenic mutations (a partial genomic deletion and a highly conserved p. Asp325Tyr missense variant) in FARS2, the gene encoding mitochondrial phenylalanyl-tRNA synthetase, in a patient with early-onset epilepsy and isolated complex IV deficiency in muscle. The biochemical defect was expressed in myoblasts but not in fibroblasts and associated with decreased steady state levels of COXI and COXII protein and reduced steady state levels of the mt-tRNAPhe transcript. Functional analysis of the recombinant mutant p.Asp325Tyr FARS2 protein showed an inability to bind ATP and consequently undetectable aminoacylation activity using either bacterial tRNA or human mt-tRNAPhe as substrates. Lentiviral transduction of cells with wildtype FARS2 restored complex IV protein levels, confirming that the pAsp325Tyr mutation is pathogenic, causing respiratory chain deficiency and neurological deficits on account of defective aminoacylation of mt-tRNAPhe. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.
C1 [Almalki, Abdulraheem; Alston, Charlotte L.; He, Langping; Oliveira, Jorge M. A.; McFarland, Robert; Taylor, Robert W.; Chrzanowska-Lightowlers, Zofia M. A.] Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Parker, Alasdair] Addenbrookes Hosp, Child Dev Ctr, Cambridge, England.
   [Simonic, Ingrid] Cambridge Univ Hosp NHS Fdn Trust, Med Genet Labs, Cambridge, England.
   [Mehta, Sarju G.] Addenbrookes Hosp, Dept Med Genet, Cambridge, England.
   [Reza, Mojgan] Newcastle Univ, Inst Med Genet, Int Ctr Life, Biobank, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Lightowlers, Robert N.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Almalki, Abdulraheem] Taif Univ, Coll Med, At Taif, Saudi Arabia.
   [Oliveira, Jorge M. A.] Univ Porto, Fac Pharm, Dept Drug Sci, REQUIMTE, P-4050313 Oporto, Portugal.
C3 Newcastle University - UK; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Newcastle University - UK; Newcastle University - UK; Taif University; Universidade do Porto
RP Taylor, RW (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM abdulraheem.almalki@newcastle.ac.uk; charlotte.alston@newcastle.ac.uk; alasdair.parker@addenbrookes.nhs.uk; ingrid.simonic@addenbrookes.nhs.uk; sarju.mehta@addenbrookes.nhs.uk; langping.he@newcastle.ac.uk; mojgan.reza@newcastle.ac.uk; jorgemao@ff.up.pt; robert.lightowlers@newcastle.ac.uk; robert.mcfarland@newcastle.ac.uk; robert.taylor@newcastle.ac.uk; zofia.chrzanowska-lightowlers@ncl.ac.uk
FU Wellcome Trust Strategic Award [096919/Z/11/Z]; Taif University sabbatical scholarship; CLA; NIHR CSO Healthcare Science Fellowship; MRC [G0800674, MR/K000608/1] Funding Source: UKRI; Wellcome Trust [096919/Z/11/Z] Funding Source: Wellcome Trust
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Bayat V, 2012, PLOS BIOL, V10, P0, DOI 10.1371/journal.pbio.1001288
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z
   Bozza M, 2013, EUR J PAEDIATR NEURO, V17, P225, DOI 10.1016/j.ejpn.2012.09.008
   Chomyn A, 1996, METHODS ENZYMOL, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Descipio C, 2007, AM J MED GENET C, V145C, P377, DOI 10.1002/ajmg.c.30156
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Flicek P, 2012, NUCLEIC ACIDS RES, V40, PD84, DOI 10.1093/nar/gkr991
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Klipcan L, 2008, STRUCTURE, V16, P1095, DOI 10.1016/j.str.2008.03.020
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295
   Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518
   Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Shamseldin HE, 2012, J MED GENET, V49, P234, DOI 10.1136/jmedgenet-2012-100836
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Synofzik M, 2011, J MED GENET, V48, P713, DOI 10.1136/jmg.2011.090282
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyreman M, 2009, J MED GENET, V46, P531, DOI 10.1136/jmg.2008.065482
   Yadavalli SS, 2009, FEBS LETT, V583, P3204, DOI 10.1016/j.febslet.2009.09.008
NR 34
TC 56
Z9 63
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 0006-3002
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JAN 15
PY 2014
VL 1842
IS 1
BP 56
EP 64
DI 10.1016/j.bbadis.2013.10.008
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA AC4OO
UT WOS:000332500800006
PM 24161539
DA 2024-11-01
ER

PT J
AU Liu, YH
   Xue, JF
   Zhao, DH
   Chen, L
   Yuan, Y
   Wang, ZX
AF Liu Yuhe
   Xue Junfang
   Zhao Danhua
   Chen Li
   Yuan Yun
   Wang Zhaoxia
TI Audiological evaluation in Chinese patients with mitochondrial encephalomyopathies
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE mitochondrial disorder; hearing impairment; auditory neuropathy spectrum disorder
ID hearing-loss; a3243g mutation; point mutation; dna; children; disease; melas
AB Background Hearing impairment has been reported to be common in patients with mitochondrial disorders, a group of diseases characterized by pleiomorphic clinical manifestations due to defects in oxidative phosphorylation of mitochondria. This study aimed to investigate the audiological characteristics in a large cohort of patients with mitochondria! disease. Methods Comprehensive audiological evaluations, including pure tone audiometry, tympanometry, speech audiometry, otoacoustic emissions, electrocochleography and auditory brainstem evoked potentials, were performed in 73 Chinese patients with mitochondrial encephalomyopathy and with confirmed mitochondria! DNA (mtDNA) defects. Results Among the patients, 71% had hearing impairment. However, the incidence rate and severity of hearing impairment were much less in the chronic progressive external ophthalmoplegia (CPEO) subtype than in the mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), myoclonic epilepsy with ragged red fibers (MERRF) and Kearns-Sayre syndrome (KSS) subtypes. While most of our patients had a predominantly cochlea origin for the hearing deficit, five patients had an auditory neuropathy spectrum disorder and three patients had impairment of both cochlea and auditory cortex. Conclusions Various portions of the auditory system could be involved in patients with mitochondrial diseases, including cochlea, auditory nerve, auditory pathway and cortex. Hearing loss was more associated with multisystem involvement. Genotype, mutant load of mtDNA and other unknown factors could contribute to heterogeneity of hearing impairment in mitochondria! disease.
C1 [Liu Yuhe; Xue Junfang; Chen Li] Peking Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Beijing 100034, Peoples R China.
   [Zhao Danhua; Yuan Yun; Wang Zhaoxia] Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China.
C3 Peking University; Peking University
RP Wang, ZX (corresponding author), Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China.
EM drwangzx@163.com
CR Braverman I, 1996, ARCH OTOLARYNGOL, V122, P1001
   Ceranic B, 2004, J NEUROL NEUROSUR PS, V75, P626, DOI 10.1136/jnnp.2003.017673
   Chennupati SK, 2011, INT J PEDIATR OTORHI, V75, P1519, DOI 10.1016/j.ijporl.2011.08.019
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   Deschauer M, 2001, ARCH NEUROL-CHICAGO, V58, P1885, DOI 10.1001/archneur.58.11.1885
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Edmonds JL, 2002, ARCH OTOLARYNGOL, V128, P355, DOI 10.1001/archotol.128.4.355
   ELVERLAND HH, 1991, AM J OTOL, V12, P459
   Forli F, 2007, BIOSCIENCE REP, V27, P113, DOI 10.1007/s10540-007-9040-5
   Gamez J, 2006, CLIN NEUROPHYSIOL, V117, P2385, DOI 10.1016/j.clinph.2006.07.138
   Iwasaki S, 2011, LARYNGOSCOPE, V121, P1821, DOI 10.1002/lary.21879
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Moilanen JS, 2001, EUR J HUM GENET, V9, P59, DOI 10.1038/sj.ejhg.5200550
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Oshima T, 1999, LARYNGOSCOPE, V109, P334, DOI 10.1097/00005537-199902000-00029
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Scarpelli M, 2012, GENET RES INT, V2012, P0, DOI 10.1155/2012/287432
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Takahashi K, 2003, LARYNGOSCOPE, V113, P1362, DOI 10.1097/00005537-200308000-00018
   Xue Jun-fang, 2012, ZHONGHUA YI XUE ZA ZHI, V92, P2830
   Yamasoba T, 1996, LARYNGOSCOPE, V106, P49, DOI 10.1097/00005537-199601000-00010
   Zwirner P, 2001, LARYNGOSCOPE, V111, P515, DOI 10.1097/00005537-200103000-00024
NR 25
TC 5
Z9 7
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0366-6999
EI 
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD JUN 20
PY 2014
VL 127
IS 12
BP 2304
EP 2309
DI 10.3760/cma.j.issn.0366-6999.20132799
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA AL6CU
UT WOS:000339220700020
PM 24931247
DA 2024-11-01
ER

PT J
AU Pitceathly, RDS
   McFarland, R
AF Pitceathly, Robert D. S.
   McFarland, Robert
TI Mitochondrial myopathies in adults and children: management and therapy development
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Review
DE biomarkers; genotype or phenotype; mitochondrial disease; neurodegeneration; treatment
ID growth-factor 21; point mutations; merrf mutation; dna deletions; disease; prevalence; population; a3243g; epidemiology; dysfunction
AB Purpose of review The clinical and genetic heterogeneity of mitochondrial myopathies presents considerable diagnostic challenges. In addition, mitochondrial dysfunction seems to contribute to the development and progression of many age-related neurodegenerative diseases. This review presents recently published data concerning prevalence, phenotype, gene discovery, disease mechanisms, diagnostic tools and treatment strategies for mitochondrial diseases, and summarizes current understanding concerning the role mitochondria play in the pathogenesis of other common neurological disorders. Recent findings Heteroplasmic levels of pathogenic mitochondrial DNA mutations are common amongst the general population, although there is considerable geographic variation. Mitochondrial abnormalities also occur in common neurodegenerative disorders, implying a mechanistic link between mitochondrial dysfunction and development or progression of disease. The phenotypic spectrum associated with well recognized pathogenic variants continues to expand, whereas next-generation sequencing is identifying new disease-causing nuclear genetic mutations. Biomarkers and imaging modalities for diagnosis and disease monitoring are now in place and novel treatment strategies are emerging. Alas, no clinical trial data for treatment in mitochondrial disease have been published in the last 12 months. Summary Despite rapid advances in gene discovery, details concerning the altered protein products and cellular pathways that result in mitochondrial disease remain elusive. Understanding the consequences of deleterious mutations and the cellular adaptive response is imperative so that therapeutic targets can be identified.
C1 [Pitceathly, Robert D. S.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London WC2R 2LS, England.
   [McFarland, Robert] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [McFarland, Robert] NUTH NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England.
C3 University of London; King's College London; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP Pitceathly, RDS (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London WC2R 2LS, England.
EM robert.pitceathly@kcl.ac.uk
FU NHS England Rare Mitochondrial Disease Service for Adults and Children; Medical Research Council UK; Wellcome Trust; MRC [G0800674] Funding Source: UKRI
CR Abdulhag UN, 2014, EUR J HUM GENET EJHG, V0, P0
   Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Bates MGD, 2013, INT J CARDIOL, V168, P3599, DOI 10.1016/j.ijcard.2013.05.062
   Bax BE, 2013, NEUROLOGY, V81, P1269, DOI 10.1212/WNL.0b013e3182a6cb4b
   Bender A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0062277
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Brady S, 2014, BMJ OPEN, V4, P0, DOI 10.1136/bmjopen-2013-004552
   Bricout M, 2014, J MED GENET, V51, P429, DOI 10.1136/jmedgenet-2013-102256
   Campbell G, 2014, HUM MOL GENET, V0, P0
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Garone C, 2014, EMBO MOL MED, V0, P0
   Gavrilova R, 2013, NEUROLOGY, V81, P1808, DOI 10.1212/01.wnl.0000436076.06159.2c
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hue THD, 2014, EMBO MOL MED, V6, P183, DOI 10.1002/emmm.201303202
   Johri A, 2013, FREE RADICAL BIO MED, V62, P37, DOI 10.1016/j.freeradbiomed.2013.04.016
   Kevelam SH, 2013, BRAIN, V136, P1534, DOI 10.1093/brain/awt054
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Korkiamäki P, 2013, ACTA OPHTHALMOL, V91, P630, DOI 10.1111/j.1755-3768.2012.02506.x
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Nesbitt V, 2014, EUR J HUM GENET, V0, P0
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Pitceathly RDS, 2013, JAMA NEUROL, V70, P1556, DOI 10.1001/jamaneurol.2013.3242
   Pitceathly RDS, 2013, CELL REP, V3, P1795, DOI 10.1016/j.celrep.2013.05.005
   Rygiel KA, 2014, NEUROPATHOL APPL NEU, V0, P0
   Scarpelli M, 2013, NEURORADIOL J, V26, P520, DOI 10.1177/197140091302600505
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Suomalainen Anu, 2013, EXPERT OPIN MED DIAGN, V7, P313, DOI 10.1517/17530059.2013.812070
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Wedding IM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0086340
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
NR 43
TC 27
Z9 29
U1 0
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD OCT 15
PY 2014
VL 27
IS 5
BP 576
EP 582
DI 10.1097/WCO.0000000000000126
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AP1UD
UT WOS:000341856200010
PM 25188013
DA 2024-11-01
ER

PT J
AU Uusimaa, J
   Evans, J
   Smith, C
   Butterworth, A
   Craig, K
   Ashley, N
   Liao, CY
   Carver, J
   Diot, A
   Macleod, L
   Hargreaves, I
   Al-Hussaini, A
   Faqeih, E
   Asery, A
   Al Balwi, M
   Eyaid, W
   Al-Sunaid, A
   Kelly, D
   van Mourik, I
   Ball, S
   Jarvis, J
   Mulay, A
   Hadzic, N
   Samyn, M
   Baker, A
   Rahman, S
   Stewart, H
   Morris, AAM
   Seller, A
   Fratter, C
   Taylor, RW
   Poulton, J
AF Uusimaa, Johanna
   Evans, Julie
   Smith, Conrad
   Butterworth, Anna
   Craig, Kate
   Ashley, Neil
   Liao, Chunyan
   Carver, Janet
   Diot, Alan
   Macleod, Lorna
   Hargreaves, Iain
   Al-Hussaini, Abdulrahman
   Faqeih, Eissa
   Asery, Ali
   Al Balwi, Mohammed
   Eyaid, Wafaa
   Al-Sunaid, Areej
   Kelly, Deirdre
   van Mourik, Indra
   Ball, Sarah
   Jarvis, Joanna
   Mulay, Arundhati
   Hadzic, Nedim
   Samyn, Marianne
   Baker, Alastair
   Rahman, Shamima
   Stewart, Helen
   Morris, Andrew A. M.
   Seller, Anneke
   Fratter, Carl
   Taylor, Robert W.
   Poulton, Joanna
TI Clinical, biochemical, cellular and molecular characterization of mitochondrial DNA depletion syndrome due to novel mutations in the <i>MPV17</i> gene
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE MPV17; mitochondrial DNA depletion; hepatocerebral disease; neonatal liver disease
ID hepatocerebral form; mtdna; neuropathy; diagnosis; deletions; features; muscle
AB Mitochondrial DNA (mtDNA) depletion syndromes (MDS) are severe autosomal recessive disorders associated with decreased mtDNA copy number in clinically affected tissues. The hepatocerebral form (mtDNA depletion in liver and brain) has been associated with mutations in the POLG, PEO1 (Twinkle), DGUOK and MPV17 genes, the latter encoding a mitochondria] inner membrane protein of unknown function. The aims of this study were to clarify further the clinical, biochemical, cellular and molecular genetic features associated with MDS due to MPV17 gene mutations. We identified 12 pathogenic mutations in the MPV17 gene, of which 11 are novel, in 17 patients from 12 families. All patients manifested liver disease. Poor feeding, hypoglycaemia, raised serum lactate, hypotonia and faltering growth were common presenting features. mtDNA depletion in liver was demonstrated in all seven cases where liver tissue was available. Mosaic mtDNA depletion was found in primary fibroblasts by PicoGreen staining. These results confirm that MPV17 mutations are an important cause of hepatocerebral mtDNA depletion syndrome, and provide the first demonstration of mosaic mtDNA depletion in human MPV17 mutant fibroblast cultures. We found that a severe clinical phenotype was associated with profound tissue-specific mtDNA depletion in liver, and, in some cases, mosaic mtDNA depletion in fibroblasts.
C1 [Uusimaa, Johanna; Ashley, Neil; Liao, Chunyan; Carver, Janet; Diot, Alan; Macleod, Lorna; Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Oxford, England.
   [Uusimaa, Johanna] Univ Oulu, Clin Res Ctr, Oulu Univ Hosp, Inst Clin Med Paediat, Oulu, Finland.
   [Evans, Julie; Smith, Conrad; Seller, Anneke; Fratter, Carl] Oxford Univ Hosp NHS Trust, Oxford Med Genet Labs, Oxford, England.
   [Butterworth, Anna; Craig, Kate; Taylor, Robert W.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Hargreaves, Iain] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Al-Hussaini, Abdulrahman; Faqeih, Eissa; Asery, Ali] King Fahad Med City, Dept Pediat, Riyadh, Saudi Arabia.
   [Al Balwi, Mohammed] King Fahad Med City, Dept Pathol & Lab Med, Riyadh, Saudi Arabia.
   [Eyaid, Wafaa; Al-Sunaid, Areej] King Saud Bin Abdulaziz Univ Hlth & Sci, King Abdulaziz Med City, Dept Pediat, Riyadh, Saudi Arabia.
   [Kelly, Deirdre; van Mourik, Indra] Birmingham Childrens Hosp, Paediat Liver Unit, Birmingham, W Midlands, England.
   [Ball, Sarah] Birmingham Childrens Hosp, Dept Newborn Screening & Biochem Genet, Birmingham, W Midlands, England.
   [Jarvis, Joanna] Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England.
   [Mulay, Arundhati] Manor Hosp, Matern Serv, Walsall, W Midlands, England.
   [Hadzic, Nedim; Samyn, Marianne; Baker, Alastair] Kings Coll Hosp London, Paediat Liver Ctr, London, England.
   [Rahman, Shamima] UCL Inst Child Hlth, Mitochondrial Res Grp, London, England.
   [Stewart, Helen] Oxford Univ Hosp NHS Trust, Dept Clin Genet, Oxford, England.
   [Morris, Andrew A. M.] St Marys Hosp, Willink Biochem Genet Unit, Manchester M13 0JH, Lancs, England.
C3 University of Oxford; University of Oulu; Oxford University Hospitals NHS Foundation Trust; Newcastle University - UK; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; King Fahad Medical City; King Fahad Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; University of Birmingham; University of Birmingham; Birmingham Women's Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; University College London; Oxford University Hospitals NHS Foundation Trust; University of Manchester
RP Poulton, J (corresponding author), John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Oxford OX3 9DU, England.
EM Joanna.Poulton@obs-gyn.ox.ac.uk
FU MRC; Wellcome Trust; Angus Memorial Mitochondrial Fund; Foundation for Paediatric Research; Sigrid Juselius Foundation; Academy of Finland [138566]; Wellcome Trust Strategic Award [906919]; Great Ormond Street Hospital Children's Charity; MRC [G0800674, MR/J010448/1, MR/K000608/1] Funding Source: UKRI; Academy of Finland (AKA) [138566] Funding Source: Academy of Finland (AKA)
CR AlSaman A, 2012, SAUDI J GASTROENTERO, V18, P285, DOI 10.4103/1319-3767.98439
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   El-Hattab AW, 1993, GENEREVIEWS, V0, P0
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Hargreaves IP, 1999, J INHERIT METAB DIS, V22, P925, DOI 10.1023/A:1005643508075
   JOHNSEN SD, 1993, NEUROLOGY, V43, P1120, DOI 10.1212/WNL.43.6.1120
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   LI YY, 1995, BIOCHEM BIOPH RES CO, V210, P211, DOI 10.1006/bbrc.1995.1648
   Merkle A N, 2012, AJNR AM J NEURORADIOL, V33, PE34, DOI 10.3174/ajnr.A2455
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Navarro-Sastre A, 2008, MOL GENET METAB, V94, P234, DOI 10.1016/j.ymgme.2008.01.012
   Navarro-Sastre A, 2010, J INHERIT METAB DIS, V33, PS293, DOI 10.1007/s10545-010-9155-x
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
NR 27
TC 41
Z9 48
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD FEB 15
PY 2014
VL 22
IS 2
BP 184
EP 191
DI 10.1038/ejhg.2013.112
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 299SK
UT WOS:000330415800008
PM 23714749
DA 2024-11-01
ER

PT J
AU Ji, KQ
   Liu, KM
   Lin, PF
   Wen, B
   Luo, YB
   Zhao, YY
   Yan, CZ
AF Ji, Kunqian
   Liu, Kaiming
   Lin, Pengfei
   Wen, Bing
   Luo, Yue-Bei
   Zhao, Yuying
   Yan, Chuanzhu
TI <i>Twinkle</i> mutations in two Chinese families with autosomal dominant progressive external ophthalmoplegia
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE Autosomal dominant progressive external ophthalmoplegia; PEO; Twinkle; A475P; R354P; Chinese population
ID onset spinocerebellar ataxia; mitochondrial-dna helicase; structure-function defects; peo1 gene mutation; linker region; mtdna; adpeo; polg; encephalopathy; depletion
AB Autosomal dominant progressive external ophthalmoplegia (adPEO) is a common adult onset mitochondrial disease caused by mutations in nuclear DNA (nDNA). Twinkle is one of the nuclear genes associated with adPEO. Clinical, histochemical, and molecular genetics findings of 6 patients from two Chinese families with adPEO were reported. Two point mutations (c.1423G>C, p.A475P and c.1061G>C, p.R354P) of Twinkle gene have been found. Multiple mtDNA deletions were also detected in patient's muscle and fibroblasts. This study confirms two mutations in Chinese adPEO families, which were first reported in the Chinese population.
C1 [Ji, Kunqian; Liu, Kaiming; Lin, Pengfei; Wen, Bing; Luo, Yue-Bei; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Dept Neurol, Lab Neuromuscular Disorders, Jinan 250012, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Peoples R China.
C3 Shandong University; Shandong University
RP Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurol, Lab Neuromuscular Disorders, Jinan 250012, Peoples R China.
EM chuanzhuyan@163.com
FU National Nature Science Foundation of China [81171182]; National Nature Science Foundation for Young Scholars of China [81101157]; Shandong Provincial Natural Science Foundation, China [2009ZRB01893]
CR Bohlega S, 2009, NEUROMUSCULAR DISORD, V19, P845, DOI 10.1016/j.nmd.2009.10.002
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Dündar H, 2012, PEDIATR NEUROL, V46, P172, DOI 10.1016/j.pediatrneurol.2011.12.006
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Goh V, 2012, J PEDIATR GASTR NUTR, V54, P291, DOI 10.1097/MPG.0b013e318227e53c
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Houshmand M, 2006, NEUROL INDIA, V54, P182
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Jeppesen TD, 2008, NEUROMUSCULAR DISORD, V18, P306, DOI 10.1016/j.nmd.2007.10.007
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Lamperti C, 2009, ACTA MYOL, V28, P2
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Liu ZR, 2008, MOL VIS, V14, P1995
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   Negro R, 2009, NEUROMUSCULAR DISORD, V19, P423, DOI 10.1016/j.nmd.2009.04.008
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Ronchi D, 2011, J NEUROL SCI, V308, P173, DOI 10.1016/j.jns.2011.05.042
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
NR 32
TC 3
Z9 4
U1 0
U2 4
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD MAR 15
PY 2014
VL 35
IS 3
BP 443
EP 448
DI 10.1007/s10072-013-1557-8
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AD3FG
UT WOS:000333123100016
PM 24091712
DA 2024-11-01
ER

PT J
AU Burman, JL
   Itsara, LS
   Kayser, EB
   Suthammarak, W
   Wang, AM
   Kaeberlein, M
   Sedensky, MM
   Morgan, PG
   Pallanck, LJ
AF Burman, Jonathon L.
   Itsara, Leslie S.
   Kayser, Ernst-Bernhard
   Suthammarak, Wichit
   Wang, Adrienne M.
   Kaeberlein, Matt
   Sedensky, Margaret M.
   Morgan, Philip G.
   Pallanck, Leo J.
TI A <i>Drosophila</i> model of mitochondrial disease caused by a complex I mutation that uncouples proton pumping from electron transfer
SO DISEASE MODELS & MECHANISMS
LA English
DT Article
DE Mitochondria; Drosophila; Mitochondrial disease; Respiratory chain; Leigh syndrome; Neurodegeneration
ID hereditary optic neuropathy; caenorhabditis-elegans; muscle degeneration; parkin-mutants; leigh-syndrome; dysfunction; deficiency; dna; melanogaster; sensitivity
AB Mutations affecting mitochondrial complex I, a multi-subunit assembly that couples electron transfer to proton pumping, are the most frequent cause of heritable mitochondrial diseases. However, the mechanisms by which complex I dysfunction results in disease remain unclear. Here, we describe a Drosophila model of complex I deficiency caused by a homoplasmic mutation in the mitochondrial-DNA-encoded NADH dehydrogenase subunit 2 (ND2) gene. We show that ND2 mutants exhibit phenotypes that resemble symptoms of mitochondrial disease, including shortened lifespan, progressive neurodegeneration, diminished neural mitochondrial membrane potential and lower levels of neural ATP. Our biochemical studies of ND2 mutants reveal that complex I is unable to efficiently couple electron transfer to proton pumping. Thus, our study provides evidence that the ND2 subunit participates directly in the proton pumping mechanism of complex I. Together, our findings support the model that diminished respiratory chain activity, and consequent energy deficiency, are responsible for the pathogenesis of complex-I-associated neurodegeneration.
C1 [Burman, Jonathon L.; Itsara, Leslie S.; Pallanck, Leo J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.
   [Itsara, Leslie S.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA.
   [Kayser, Ernst-Bernhard; Suthammarak, Wichit; Sedensky, Margaret M.; Morgan, Philip G.] Seattle Childrens Res Inst, Ctr Dev Therapeut, Seattle, WA 98101 USA.
   [Wang, Adrienne M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
C3 University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle
RP Morgan, PG (corresponding author), Seattle Childrens Res Inst, Ctr Dev Therapeut, Seattle, WA 98101 USA.
EM pgm4@uw.edu; pallanck@uw.edu
FU Parkinson Society Canada Research Fellowship; Canadian Institute of Health Research Fellowship; National Institute of Neurological Disorders and Stroke Fellowship [F31NS071857]; National Institute of Health [1RO1GM086394, 5R01GM104990]; Muscular Dystrophy Association; Genetic Approaches to Aging Training Grant [T32AG000057]; NW Mitochondrial Guild Postdoctoral Fellowship; University of Washington School of Medicine; University of Washington Department of Pathology
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36
   Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346
   [Anonymous], 2000, GENEREVIEWS, V0, P0
   BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24
   Bianchi M, 2011, BIOCHEM BIOPH RES CO, V415, P300, DOI 10.1016/j.bbrc.2011.10.049
   BROWN MD, 1992, GENETICS, V130, P163
   Burman JL, 2012, P NATL ACAD SCI USA, V109, P10438, DOI 10.1073/pnas.1120688109
   Celotto AM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0025823
   Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006
   Cho J, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050644
   Dieteren CEJ, 2008, J BIOL CHEM, V283, P34753, DOI 10.1074/jbc.M807323200
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066
   Falk MJ, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0006607
   Feala JD, 2007, MOL SYST BIOL, V3, P0, DOI 10.1038/msb4100139
   Fergestad Tim, 2006, GENETICS, V173, P1357, DOI 10.1534/genetics.106.057463
   Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   GANETZKY B, 1982, GENETICS, V100, P597
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200
   Klein P, 2014, EMBO J, V33, P341, DOI 10.1002/embj.201284290
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   Poli G, 2000, IUBMB LIFE, V50, P315, DOI 10.1080/15216540051081092
   Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107
   Roberts PG, 2012, J BIOL CHEM, V287, P34743, DOI 10.1074/jbc.M112.384560
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167
   Sun YN, 2014, EXP GERONTOL, V50, P57, DOI 10.1016/j.exger.2013.11.020
   Suthammarak W, 2009, J BIOL CHEM, V284, P6425, DOI 10.1074/jbc.M805733200
   Torraco A, 2009, BBA-MOL CELL RES, V1793, P171, DOI 10.1016/j.bbamcr.2008.06.003
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   Tsai L, 1998, P NATL ACAD SCI USA, V95, P7975, DOI 10.1073/pnas.95.14.7975
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Whelan J, 2010, BRAIN RES, V1316, P120, DOI 10.1016/j.brainres.2009.12.036
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Xu H, 2008, SCIENCE, V321, P575, DOI 10.1126/science.1160226
   Zhang K, 2013, J CELL BIOL, V200, P807, DOI 10.1083/jcb.201208033
NR 43
TC 53
Z9 56
U1 0
U2 14
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND
SN 1754-8403
EI 1754-8411
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD OCT 15
PY 2014
VL 7
IS 10
BP 1165
EP 1174
DI 10.1242/dmm.015321
PG 10
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA AT5TZ
UT WOS:000345006300004
PM 25085991
DA 2024-11-01
ER

PT J
AU Damas, J
   Samuels, DC
   Carneiro, J
   Amorim, A
   Pereira, F
AF Damas, Joana
   Samuels, David C.
   Carneiro, Joao
   Amorim, Antonio
   Pereira, Filipe
TI Mitochondrial DNA Rearrangements in Health and Disease-A Comprehensive Study
SO HUMAN MUTATION
LA English
DT Review
DE mitochondrial DNA; deletions; duplications; breakage hotspots; mitochondrial disease; tumors
ID progressive external ophthalmoplegia; large-scale deletions; kearns-sayre syndrome; d-loop; tandem duplication; multiple deletions; mtdna duplications; gene-mutations; direct repeats; replication
AB Mitochondrial DNA (mtDNA) rearrangements cause a wide variety of highly debilitating and often fatal disorders and have been implicated in aging and age-associated disease. Here, we present a meta-analytical study of mtDNA deletions (n=730) and partial duplications (n=37) using information from more than 300 studies published over the last 30 years. We show that both classes of mtDNA rearrangements are unequally distributed among disorders and their breakpoints have different genomic locations. We also demonstrate that 100% of cases with sporadic mtDNA deletions and 97.3% with duplications have no breakpoints in the 16,071 breakage hotspot site, in contrast with deletions from healthy and aged tissues. Notably, most deletions removing a section of the D-loop are found in tumors. Deleted mtDNA molecules lacking the origin of L-strand replication (O-L) represent only 9.5% of all reported cases, whereas extra origins of replication occur in all duplications. As previously shown for deletions, imperfect stretches of homology are common in duplication breakpoints. Finally, we provide a dedicated Website with detailed information on deleted/duplicated mtDNA regions to facilitate the design of efficient methods for identification and screening of rearranged mitochondrial genomes (available at http://www.portugene.com/mtDNArearrangements.html).
C1 [Damas, Joana; Carneiro, Joao; Amorim, Antonio; Pereira, Filipe] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.
   [Samuels, David C.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA.
   [Amorim, Antonio] Univ Porto, Fac Sci, P-4050123 Oporto, Portugal.
   [Pereira, Filipe] Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, P-4050123 Oporto, Portugal.
C3 Universidade do Porto; Vanderbilt University; Universidade do Porto; Universidade do Porto
RP Pereira, F (corresponding author), Univ Porto, CIIMAR CIMAR, Rua Bragas 289, P-4050123 Oporto, Portugal.
EM fpereirapt@gmail.com
FU Portuguese Foundation for Science and Technology; Fundo Social Europeu; Programa Operacional Potencial Humano [SFRH/BPD/44637/2008, PTDC/CVT/100881/2008]; Investigator FCT program; European Regional Development Fund (ERDF) [PEst-C/MAR/LA0015/2013]; Fundação para a Ciência e a Tecnologia [PTDC/CVT/100881/2008, SFRH/BPD/44637/2008] Funding Source: FCT
CR Antes A, 2010, NUCLEIC ACIDS RES, V38, P6466, DOI 10.1093/nar/gkq493
   Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Bank C, 2000, BIOCHEM BIOPH RES CO, V279, P595, DOI 10.1006/bbrc.2000.3951
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BERK AJ, 1974, J MOL BIOL, V86, P801, DOI 10.1016/0022-2836(74)90355-6
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Bouzidi MF, 1998, HUM MOL GENET, V7, P385, DOI 10.1093/hmg/7.3.385
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Cohen O, 1996, HUM GENET, V97, P659
   Cooper DN, 2011, HUM MUTAT, V32, P1075, DOI 10.1002/humu.21557
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   Di Rienzi SC, 2009, GENOME BIOL EVOL, V1, P350, DOI 10.1093/gbe/evp034
   DiMauro S, 2003, GENEREVIEWS, V0, P0
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619
   EICHLER DC, 1977, J BIOL CHEM, V252, P7888
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Fromenty B, 1997, AM J MED GENET, V71, P443, DOI 10.1002/(SICI)1096-8628(19970905)71:4<443::AID-AJMG14>3.0.CO;2-G
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Hao HL, 1997, AM J HUM GENET, V60, P1363, DOI 10.1086/515474
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   HIXSON JE, 1986, J BIOL CHEM, V261, P2384
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251
   Hou JH, 1996, BIOCHEM J, V318, P1065, DOI 10.1042/bj3181065
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2010, METHODS MOL BIOL, V628, P227, DOI 10.1007/978-1-60327-367-1_13
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Lakshmanan LN, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035271
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Muraki K, 2001, AM J MED GENET, V98, P205, DOI 10.1002/1096-8628(20010122)98:3<205::AID-AJMG1077>3.0.CO;2-P
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   Nardi F, 2012, MITOCHONDRION, V12, P483, DOI 10.1016/j.mito.2012.07.105
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Odoardi F, 2003, AM J MED GENET A, V118A, P247, DOI 10.1002/ajmg.a.20006
   Oliveira P, 2013, PLOS ONE, V8, P0
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pereira F, 2008, MOL BIOL EVOL, V25, P2759, DOI 10.1093/molbev/msn225
   Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100
   POULTON J, 1994, HUM MOL GENET, V3, P947, DOI 10.1093/hmg/3.6.947
   POULTON J, 1989, LANCET, V1, P236
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   POULTON J, 1989, NUCLEIC ACIDS RES, V17, P10223, DOI 10.1093/nar/17.24.10223
   POULTON J, 1992, J INHERIT METAB DIS, V15, P487, DOI 10.1007/BF01799607
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Rogounovitch TI, 2002, CANCER RES, V62, P7031
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   ROTIG A, 1989, LANCET, V1, P902
   Sadikovic B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015687
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sbisà E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sembongi H, 2007, HUM MOL GENET, V16, P2306, DOI 10.1093/hmg/ddm182
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Tang YY, 2000, MOL BIOL CELL, V11, P2349, DOI 10.1091/mbc.11.7.2349
   Tengan CH, 1998, BBA-MOL BASIS DIS, V1406, P73, DOI 10.1016/S0925-4439(97)00087-2
   Tengan CH, 2002, BBA-MOL BASIS DIS, V1588, P65, DOI 10.1016/S0925-4439(02)00140-0
   TORRONI A, 1994, AM J HUM GENET, V55, P760
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   WALBERG MW, 1981, NUCLEIC ACIDS RES, V9, P5411, DOI 10.1093/nar/9.20.5411
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wei YH, 1996, ANN NY ACAD SCI, V786, P82, DOI 10.1111/j.1749-6632.1996.tb39054.x
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005
NR 94
TC 62
Z9 66
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD JAN 15
PY 2014
VL 35
IS 1
BP 1
EP 14
DI 10.1002/humu.22452
PG 14
WC Genetics & Heredity
SC Genetics & Heredity
GA 289JP
UT WOS:000329678600001
PM 24115352
DA 2024-11-01
ER

PT J
AU Kowald, A
   Dawson, M
   Kirkwood, TBL
AF Kowald, Axel
   Dawson, Marcus
   Kirkwood, Thomas B. L.
TI Mitochondrial mutations and ageing: Can mitochondrial deletion mutants accumulate via a size based replication advantage?
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
DE Mitochondrial mutation; Mathematical model; Ageing
ID free-radical theory; aged muscle-fibers; dna mutations; degenerative diseases; in-vivo; turnover; segregation; fission; tissue; cells
AB The mitochondrial theory of ageing is one of the main contenders to explain the biochemical basis of the ageing process. An important line of support comes from the observation that mtDNA deletions accumulate over the life course in post-mitotic cells of many species. A single mutant expands clonally and finally replaces the wild-type population of a whole cell. One proposal to explain the driving force behind this accumulation states that the reduced size leads to a shorter replication time, which provides a selection advantage. However, this idea has been questioned on the grounds that the mitochondrial half-life is much longer than the replication time, so that the latter cannot be a rate limiting step. To clarify this question, we modelled this process mathematically and performed extensive deterministic and stochastic computer simulations to study the effects of replication time, mitochondrial half-life and deletion size. Our study shows that the shorter size does in principle provide a selection advantage, which can lead to an accumulation of the deletion mutant. However, this selection advantage diminishes the shorter is the replication time of wt mtDNA in relation to its half-life. Using generally accepted literature values, the resulting time frame for the accumulation of mutant mtDNAs is only compatible with the ageing process in very long lived species like humans, but could not reasonably explain ageing in short lived species like mice and rats. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Kowald, Axel; Dawson, Marcus; Kirkwood, Thomas B. L.] Newcastle Univ, Ctr Integrated Syst Biol Ageing & Nutr, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Dawson, Marcus] Univ Manchester, Manchester M13 9PT, Lancs, England.
C3 Newcastle University - UK; University of Manchester
RP Kowald, A (corresponding author), Newcastle Univ, Ctr Integrated Syst Biol Ageing & Nutr, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
EM Axel.Kowald@ncl.ac.uk; Tom.Kirkwood@ncl.ac.uk; Marcus.Dawson@student.manchester.ac.uk
FU Glenn Foundation; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre; MRC [MR/K006312/1] Funding Source: UKRI
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BERK AJ, 1974, J MOL BIOL, V86, P801, DOI 10.1016/0022-2836(74)90355-6
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002
   Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883
   de Grey ADJ, 1999, MITOCHONDRIAL FREE R, V0, P0
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   HUEMER RP, 1971, EXP GERONTOL, V6, P327, DOI 10.1016/0531-5565(71)90001-5
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768
   Kirkwood TBL, 1996, BIOESSAYS, V18, P1009, DOI 10.1002/bies.950181211
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kowald A, 2013, AGING CELL, V0, P0
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
NR 33
TC 24
Z9 29
U1 0
U2 20
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
EI 1095-8541
J9 J THEOR BIOL
JI J. Theor. Biol.
PD JAN 7
PY 2014
VL 340
IS 
BP 111
EP 118
DI 10.1016/j.jtbi.2013.09.009
PG 8
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology
GA 261TZ
UT WOS:000327688800013
PM 24055401
DA 2024-11-01
ER

PT J
AU Ridge, PG
   Maxwell, TJ
   Foutz, SJ
   Bailey, MH
   Corcoran, CD
   Tschanz, JT
   Norton, MC
   Munger, RG
   O'Brien, E
   Kerber, RA
   Cawthon, RM
   Kauwe, JSK
AF Ridge, Perry G.
   Maxwell, Taylor J.
   Foutz, Spencer J.
   Bailey, Matthew H.
   Corcoran, Christopher D.
   Tschanz, JoAnn T.
   Norton, Maria C.
   Munger, Ronald G.
   O'Brien, Elizabeth
   Kerber, Richard A.
   Cawthon, Richard M.
   Kauwe, John S. K.
TI Mitochondrial genomic variation associated with higher mitochondrial copy number: the Cache County Study on Memory Health and Aging
SO BMC BIOINFORMATICS
LA English
DT Article
ID transcription factor; genetic-structure; utah mormons; mutation; age; activation; muscle; damage; proliferation; prevalence
AB Background: The mitochondria are essential organelles and are the location of cellular respiration, which is responsible for the majority of ATP production. Each cell contains multiple mitochondria, and each mitochondrion contains multiple copies of its own circular genome. The ratio of mitochondrial genomes to nuclear genomes is referred to as mitochondrial copy number. Decreases in mitochondrial copy number are known to occur in many tissues as people age, and in certain diseases. The regulation of mitochondrial copy number by nuclear genes has been studied extensively. While mitochondrial variation has been associated with longevity and some of the diseases known to have reduced mitochondrial copy number, the role that the mitochondrial genome itself has in regulating mitochondrial copy number remains poorly understood. Results: We analyzed the complete mitochondrial genomes from 1007 individuals randomly selected from the Cache County Study on Memory Health and Aging utilizing the inferred evolutionary history of the mitochondrial haplotypes present in our dataset to identify sequence variation and mitochondrial haplotypes associated with changes in mitochondrial copy number. Three variants belonging to mitochondrial haplogroups U5A1 and T2 were significantly associated with higher mitochondrial copy number in our dataset. Conclusions: We identified three variants associated with higher mitochondrial copy number and suggest several hypotheses for how these variants influence mitochondrial copy number by interacting with known regulators of mitochondrial copy number. Our results are the first to report sequence variation in the mitochondrial genome that causes changes in mitochondrial copy number. The identification of these variants that increase mtDNA copy number has important implications in understanding the pathological processes that underlie these phenotypes.
C1 [Ridge, Perry G.; Foutz, Spencer J.; Bailey, Matthew H.; Kauwe, John S. K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.
   [Ridge, Perry G.] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA.
   [Maxwell, Taylor J.] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA.
   [Corcoran, Christopher D.] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA.
   [Corcoran, Christopher D.; Tschanz, JoAnn T.; Norton, Maria C.; Munger, Ronald G.] Utah State Univ, Ctr Epidemiol Studies, Logan, UT 84322 USA.
   [Tschanz, JoAnn T.; Norton, Maria C.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA.
   [Norton, Maria C.] Utah State Univ, Dept Family Consumer & Human Dev, Logan, UT 84322 USA.
   [Munger, Ronald G.] Utah State Univ, Dept Nutr Dietet & Food Sci, Logan, UT 84322 USA.
   [O'Brien, Elizabeth; Kerber, Richard A.] Univ Louisville, Dept Epidemiol & Populat Hlth, Louisville, KY 40292 USA.
   [Cawthon, Richard M.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA.
C3 Brigham Young University; Utah System of Higher Education; University of Utah; ARUP Laboratories; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Louisville; Utah System of Higher Education; University of Utah
RP Ridge, PG (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.
FU NIH [R01AG11380, R01AG21136, R01AG31272, R01AG042611]; Alzheimer's Association [MNIRG-11-205368]; Utah Science, Technology, and Research initiative (USTAR); Brigham Young University Gerontology Program (JSKK)
CR Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bianchi M, 2011, BIOCHEM BIOPH RES CO, V415, P300, DOI 10.1016/j.bbrc.2011.10.049
   Blokhin A, 2008, J MOL NEUROSCI, V35, P283, DOI 10.1007/s12031-008-9115-1
   Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321
   Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004
   Carnesecchi S, 2006, EXP CELL RES, V312, P3413, DOI 10.1016/j.yexcr.2006.07.003
   Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, P0, DOI 10.1093/nar/gkn1027
   Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Gianotti TF, 2011, METABOLISM, V60, P1142, DOI 10.1016/j.metabol.2010.12.008
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Finsterer J, 2007, ACTA HAEMATOL-BASEL, V118, P88, DOI 10.1159/000105676
   Gao N, 2002, J BIOL CHEM, V277, P45041, DOI 10.1074/jbc.M202775200
   Gu M, 2000, LANCET, V356, P469, DOI 10.1016/S0140-6736(00)02556-3
   Guo JH, 2011, CANCER RES, V71, P2978, DOI 10.1158/0008-5472.CAN-10-3482
   Hartmann N, 2011, AGING CELL, V10, P824, DOI 10.1111/j.1474-9726.2011.00723.x
   Hassanin A, 2009, J MOL EVOL, V68, P293, DOI 10.1007/s00239-009-9208-7
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   JORDE LB, 1987, AM J PHYS ANTHROPOL, V72, P403, DOI 10.1002/ajpa.1330720313
   JORDE LB, 1982, HUM BIOL, V54, P583
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   KERBER RA, 1995, GENET EPIDEMIOL, V12, P291, DOI 10.1002/gepi.1370120306
   Kleefstra T, 2011, EUR J HUM GENET, V19, P138, DOI 10.1038/ejhg.2010.171
   Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300
   Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345
   Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111
   Kulawiec Mariola, 2009, J CARCINOG, V8, P8, DOI 10.4103/1477-3163.50893
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Lamson Davis W, 2002, ALTERN MED REV, V7, P94
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lassus P, 2000, ONCOGENE, V19, P2377, DOI 10.1038/sj.onc.1203553
   Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572
   Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355
   Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024
   Lee JE, 2009, EXP MOL MED, V41, P253, DOI 10.3858/emm.2009.41.4.028
   Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107
   Li ZW, 2006, IUBMB LIFE, V58, P581, DOI 10.1080/15216540600946456
   Liu HY, 2009, J BIOL CHEM, V284, P14087, DOI 10.1074/jbc.M807992200
   Lu YJ, 2010, AM J RESP CELL MOL, V42, P432, DOI 10.1165/rcmb.2009-0002OC
   Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002
   Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, PD225, DOI 10.1093/nar/gkq1189
   Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107
   McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029
   OBRIEN E, 1994, HUM BIOL, V66, P743
   Parfait B, 1998, BIOCHEM BIOPH RES CO, V247, P57, DOI 10.1006/bbrc.1998.8666
   Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310
   Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303
   Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200
   Posada D, 2005, BIOINFORMATICS, V21, P2130, DOI 10.1093/bioinformatics/bti293
   Ridge PG, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0045134
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Santos RX, 2010, INT J CLIN EXP PATHO, V3, P570
   Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926
   Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176
   Sequeira Adolfo, 2012, FRONTIERS IN GENETICS, V3, P103, DOI 10.3389/fgene.2012.00103
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731
   Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045
   Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, PS265, DOI 10.3233/JAD-2010-100339
   Swerdlow RH, 2009, EXP NEUROL, V218, P308, DOI 10.1016/j.expneurol.2009.01.011
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053
   Templeton AR, 2005, GENETICS, V169, P441, DOI 10.1534/genetics.104.030080
   Tewari S, 2012, ANTIOXID REDOX SIGN, V17, P492, DOI 10.1089/ars.2011.4333
   Thompson Julie D, 2002, CURR PROTOC BIOINFORMATICS, VChapter 2, P0, DOI 10.1002/0471250953.bi0203s00
   Thyagarajan B, 2012, CANC EPIDEMIOLOGY BI, V0, P0
   Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Vendelbo MH, 2011, BBA-MOL CELL RES, V1813, P634, DOI 10.1016/j.bbamcr.2011.01.029
   VILMING ST, 1986, ACTA NEUROL SCAND, V73, P502, DOI 10.1111/j.1600-0404.1986.tb04594.x
   Westfall PH, 1993, RESAMPLING BASED MUL, V0, P0
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Yu M, 2010, CLIN CHIM ACTA, V411, P679, DOI 10.1016/j.cca.2010.01.035
   Zaid A, 1999, J BIOENERG BIOMEMBR, V31, P129, DOI 10.1023/A:1005499727732
   Zou T, 2010, ACTA BIOCH BIOPH SIN, V42, P908, DOI 10.1093/abbs/gmq102
NR 93
TC 17
Z9 18
U1 0
U2 17
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
EI 
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD MAY 28
PY 2014
VL 15
IS 
BP 
EP 
DI 10.1186/1471-2105-15-S7-S6
PG 14
WC Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology
GA AJ2DP
UT WOS:000337465800006
PM 25077862
DA 2024-11-01
ER

PT J
AU Neuhaus, JFG
   Baris, OR
   Hess, S
   Moser, N
   Schröder, H
   Chinta, SJ
   Andersen, JK
   Kloppenburg, P
   Wiesner, RJ
AF Neuhaus, Johannes F. G.
   Baris, Olivier R.
   Hess, Simon
   Moser, Natasha
   Schroeder, Hannsjoerg
   Chinta, Shankar J.
   Andersen, Julie K.
   Kloppenburg, Peter
   Wiesner, Rudolf J.
TI Catecholamine metabolism drives generation of mitochondrial DNA deletions in dopaminergic neurons
SO BRAIN
LA English
DT Article
DE mitochondrial dysfunction; Parkinson's disease; mtDNA deletion; dopamine
ID substantia-nigra; parkinsons-disease; clonal expansion; skeletal-muscle; sh-sy5y cells; human brain; damage; mtdna; neuromelanin; calcium
AB Accumulation of mitochondrial DNA deletions is observed especially in dopaminergic neurons of the substantia nigra during ageing and even more in Parkinson's disease. The resulting mitochondrial dysfunction is suspected to play an important role in neurodegeneration. However, the molecular mechanisms involved in the preferential generation of mitochondrial DNA deletions in dopaminergic neurons are still unknown. To study this phenomenon, we developed novel polymerase chain reaction strategies to detect distinct mitochondrial DNA deletions and monitor their accumulation patterns. Applying these approaches in in vitro and in vivo models, we show that catecholamine metabolism drives the generation and accumulation of these mitochondrial DNA mutations. As in humans, age-related accumulation of mitochondrial DNA deletions is most prominent in dopaminergic areas of mouse brain and even higher in the catecholaminergic adrenal medulla. Dopamine treatment of terminally differentiated neuroblastoma cells, as well as stimulation of dopamine turnover in mice over-expressing monoamine oxidase B both induce multiple mitochondrial DNA deletions. Our results thus identify catecholamine metabolism as the driving force behind mitochondrial DNA deletions, probably being an important factor in the ageing-associated degeneration of dopaminergic neurons.
C1 [Neuhaus, Johannes F. G.; Baris, Olivier R.; Wiesner, Rudolf J.] Univ Cologne, Fac Med, Inst Vegetat Physiol, Ctr Physiol & Pathophysiol, Cologne, Germany.
   [Hess, Simon; Kloppenburg, Peter] Univ Cologne, Bioctr, Inst Zool, Cologne, Germany.
   [Moser, Natasha; Schroeder, Hannsjoerg] Univ Cologne, Fac Med, Dept Anat 2, Cologne, Germany.
   [Chinta, Shankar J.; Andersen, Julie K.] Buck Inst Res Ageing, Novato, CA USA.
   [Kloppenburg, Peter; Wiesner, Rudolf J.] Univ Cologne, CMMC, Cologne, Germany.
   [Kloppenburg, Peter; Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.
C3 University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne
RP Wiesner, RJ (corresponding author), Uniklin Koln, Inst Vegetat Physiol, Robert Koch Str 39, D-50931 Cologne, Germany.
EM rudolf.wiesner@uni-koeln.de
FU Deutsche Forschungsgemeinschaft (Cologne Excellence Cluster on Cellular Stress Responses in Ageing-associated Diseases, CECAD); Center of Molecular Medicine Cologne (CMMC)
CR Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   BARDEN H, 1983, BRAIN RES BULL, V10, P847, DOI 10.1016/0361-9230(83)90218-6
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   CALNE DB, 1983, LANCET, V2, P1457, DOI 10.1016/S0140-6736(83)90802-4
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9
   deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Elstner M, 2011, MOL BRAIN, V4, P0, DOI 10.1186/1756-6606-4-43
   Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x
   Fasano M, 2006, J NEUROCHEM, V96, P909, DOI 10.1111/j.1471-4159.2005.03638.x
   FORNSTEDT B, 1986, NEUROPHARMACOLOGY, V25, P451, DOI 10.1016/0028-3908(86)90242-X
   Gautam AH, 2011, BBA-BIOENERGETICS, V1807, P819, DOI 10.1016/j.bbabio.2011.03.013
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005
   Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536
   HALLIWELL B, 1984, METHOD ENZYMOL, V105, P47
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Könner AC, 2011, CELL METAB, V13, P720, DOI 10.1016/j.cmet.2011.03.021
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   LACEY MG, 1989, J NEUROSCI, V9, P1233
   Li YB, 2002, NEUROSCI LETT, V330, P69, DOI 10.1016/S0304-3940(02)00444-5
   Liang CL, 1996, NEUROSCIENCE, V75, P523, DOI 10.1016/0306-4522(96)00228-X
   Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570
   Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102
   Mallajosyula JK, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001616
   MARSDEN CD, 1961, J ANAT, V95, P256
   McCoy MK, 2012, ANTIOXID REDOX SIGN, V16, P869, DOI 10.1089/ars.2011.4019
   McRitchie DA, 1996, J COMP NEUROL, V364, P121, DOI 10.1002/(SICI)1096-9861(19960101)364:1<121::AID-CNE11>3.0.CO;2-1
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   MOLDEUS P, 1983, MUTAT RES, V124, P9
   Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x
   Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Richards CD, 1997, NEUROSCIENCE, V80, P545, DOI 10.1016/S0306-4522(97)00093-6
   ROSENGREN E, 1985, J NEURAL TRANSM, V63, P247, DOI 10.1007/BF01252029
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   SOONG NW, 1992, NAT GENET, V2, P318
   Spencer JPE, 2002, J NEUROCHEM, V81, P122, DOI 10.1046/j.1471-4159.2002.00808.x
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009
   Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6
   Surmeier DJ, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a009290
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   UHL GR, 1985, NEUROLOGY, V35, P1215, DOI 10.1212/WNL.35.8.1215
   Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168
   Zecca L, 2008, J NEUROCHEM, V106, P1866, DOI 10.1111/j.1471-4159.2008.05541.x
NR 61
TC 37
Z9 41
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD FEB 15
PY 2014
VL 137
IS 
BP 354
EP 365
DI 10.1093/brain/awt291
PG 12
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AA7QB
UT WOS:000331290900008
PM 24163249
DA 2024-11-01
ER

PT J
AU Gawel, M
   Kierdaszuk, B
   Tonska, K
   Kaliszewska, M
   Kubiszewska, J
   Jamrozik, Z
   Bartnik, E
   Kwiecinski, H
   Kaminska, AM
AF Gawel, Malgorzata
   Kierdaszuk, Biruta
   Tonska, Katarzyna
   Kaliszewska, Magdalena
   Kubiszewska, Justyna
   Jamrozik, Zygmunt
   Bartnik, Ewa
   Kwiecinski, Hubert
   Kaminska, Anna M.
TI Mitochondrial encephalomyopathy: Towards diagnosis. A case report
SO NEUROLOGIA I NEUROCHIRURGIA POLSKA
LA English
DT Article
DE Mitochondrial encephalomyopathy; Molecular genetics; mtDNA; Muscle biopsy
ID dna; deletions; mutations; disease; update
AB Mitochondrial diseases may cause a wide range of central and peripheral nervous system disorders, as well as muscle disorders. The diagnostic workup routinely includes electrophysiological, morphological, neuroimaging and genetic studies. In some cases, the diagnosis may be ascertained only when mitochondrial DNA (mtDNA) examination in the muscle is performed. We report on a case of a 24-year-old woman, with a 7-year history of slowly progressive cerebellar syndrome and bilateral ptosis. Mitochondrial encephalomyopathy was suspected, based on the clinical picture and results of examinations, but the typical red ragged fibers were not found in the muscle biopsy. The results of molecular analysis of mtDNA showed a mtDNA deletion in the muscle and, on a level detectable only with polymerase chain reaction method, in blood leukocytes. This case emphasizes the important role of mtDNA studies in muscle in nonspecific multisystem mitochondrial disorders, even without clinical muscle involvement. (C) 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
C1 [Gawel, Malgorzata; Kierdaszuk, Biruta; Kubiszewska, Justyna; Jamrozik, Zygmunt; Kwiecinski, Hubert; Kaminska, Anna M.] Med Univ Warsaw, Dept Neurol, Warsaw, Poland.
   [Tonska, Katarzyna; Kaliszewska, Magdalena; Bartnik, Ewa] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Warsaw, Poland.
   [Bartnik, Ewa] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.
C3 Medical University of Warsaw; University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences
RP Gawel, M (corresponding author), Warszawski Uniwersytet Med, Neurol Klin, Ul Banacha 1a, PL-02097 Warsaw, Poland.
EM mgawel@wum.edu.pl
FU Polish Ministry of Science and Higher Education [N N401 049238];  [VENTURES/2011-8/3]
CR Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   Dubowitz V, 2007, MUSCLE BIOPSY PRACTI, V0, P3
   Femandez-Silva P, 2003, EXP PHYSIOL, V88, P41
   Fernández-Moreno MA, 2000, MOL GENET METAB, V71, P481, DOI 10.1006/mgme.2000.3083
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kierdaszuk B, 2009, NEUROL NEUROCHIR POL, V43, P216
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Soong N W, 1996, METHODS ENZYMOL, V264, P421, DOI 10.1016/S0076-6879(96)64038-5
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Zeviani Massimo, 2003, CURR NEUROL NEUROSCI REP, V3, P423, DOI 10.1007/s11910-003-0026-9
NR 16
TC 1
Z9 1
U1 0
U2 6
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA WENEDOW ST 9-1, POZNAN, 61-614, POLAND
SN 0028-3843
EI 
J9 NEUROL NEUROCHIR POL
JI Neurol. Neurochir. Pol.
PD JUN 15
PY 2014
VL 48
IS 1
BP 76
EP 80
DI 10.1016/j.pjnns.2013.09.003
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA AE8OL
UT WOS:000334261100013
PM 24636775
DA 2024-11-01
ER

PT J
AU Mori, M
   Mytinger, JR
   Martin, LC
   Bartholomew, D
   Hickey, S
AF Mori, Mari
   Mytinger, John R.
   Martin, Lisa C.
   Bartholomew, Dennis
   Hickey, Scott
TI m.8993T&gt;G-Associated Leigh Syndrome with Hypocitrullinemia on Newborn Screening
SO JIMD REPORTS, VOL 17
LA English
DT Article; Book Chapter
ID mitochondrial disease; deficiency; citrulline; mutation; ornithine; arginine
AB Citrulline is among the metabolites measured by expanded newborn screening (NBS). While hypocitrullinemia can be a marker for deficiency of proximal urea cycle enzymes such as ornithine transcarbamylase (OTC), only a handful of state newborn screening programs in the United States officially report a low citrulline value for further work-up due to low positive predictive value. We report a case of a male infant who was found to have hypocitrullinemia on NBS. After excluding proximal urea cycle disorders by DNA sequencing, his NBS result was felt to be a false positive. At 4 months of age, he developed poor feeding, failure to thrive, apnea and infantile spasms with a progression to intractable seizures, as well as persistent hypocitrullinemia. He was diagnosed with Leigh syndrome due to a maternally inherited homoplasmic m.8993T>G mutation in the ATPase 6 gene. His mother, who had previously been diagnosed with cerebral palsy, was concurrently diagnosed with neuropathy, ataxia, and retinitis pigmentosa (NARP) due to heteroplasmy of the same mutation. She had progressive muscle weakness, ataxia, and speech dyspraxia. The m.8993T>G mutation causes mitochondrial ATP synthase deficiency and it is hypothesized to undermine the synthesis of citrulline by CPS1. In addition to proximal urea cycle disorders, the evaluation of an infant with persistent hypocitrullinemia should include testing for the m.8993T>G mutation and other disorders that cause mitochondrial dysfunction.
C1 [Mori, Mari; Bartholomew, Dennis; Hickey, Scott] Nationwide Childrens Hosp, Sect Human & Mol Genet, Columbus, OH USA.
   [Mytinger, John R.] Nationwide Childrens Hosp, Div Pediat Neurol, Dept Pediat, Columbus, OH USA.
   [Martin, Lisa C.] Nationwide Childrens Hosp, Sect Chief Emergency Radiol, Columbus, OH USA.
   [Mytinger, John R.; Martin, Lisa C.; Bartholomew, Dennis; Hickey, Scott] Ohio State Univ, Sch Med & Publ Hlth, Columbus, OH 43210 USA.
C3 University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University
RP Mori, M (corresponding author), Nationwide Childrens Hosp, Sect Human & Mol Genet, Columbus, OH USA.
EM Mari.Mori@nationwidechildrens.org
CR Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106
   Baumgartner MR, 2000, HUM MOL GENET, V9, P2853, DOI 10.1093/hmg/9.19.2853
   Cavicchi C, 2009, J PHARMACEUT BIOMED, V49, P1292, DOI 10.1016/j.jpba.2009.03.001
   Debray FG, 2010, J CHILD NEUROL, V25, P1000, DOI 10.1177/0883073809351983
   Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001
   Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009
   Henriques M, 2012, J CHILD NEUROL, V27, P1059, DOI 10.1177/0883073811431015
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Laird PW, 2006, AM J OPHTHALMOL, V142, P186, DOI 10.1016/j.ajo.2006.02.051
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009
   PERRY TL, 1989, J INHERIT METAB DIS, V12, P23, DOI 10.1007/BF01805527
   Rabier D, 1995, AMINO ACIDS, V9, P299, DOI 10.1007/BF00807268
   Rabier D, 1998, J INHERIT METAB DIS, V21, P216, DOI 10.1023/A:1005391300203
   RIBES A, 1993, J INHERIT METAB DIS, V16, P537, DOI 10.1007/BF00711675
   Watson MS, 2006, GENET MED, V8, P1S, DOI 10.1097/01.gim.0000223891.82390.ad
NR 19
TC 13
Z9 13
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
EI 
J9 JIMD REP
PD JUN 15
PY 2014
VL 17
IS 
BP 47
EP 51
DI 10.1007/8904_2014_332
PG 5
WC Endocrinology & Metabolism; Genetics & Heredity
SC Endocrinology & Metabolism; Genetics & Heredity
GA BE8SI
UT WOS:000376980200008
PM 25240982
DA 2024-11-01
ER

PT J
AU Ramezani, RJ
   Stacpoole, PW
AF Ramezani, Ryan J.
   Stacpoole, Peter W.
TI Sleep Disorders Associated with Primary Mitochondrial Diseases
SO JOURNAL OF CLINICAL SLEEP MEDICINE
LA English
DT Review
DE sleep apnea; mitochondrial disease; congenital lactic acidosis
ID pyruvate-dehydrogenase complex; respiratory-chain disorders; central hypoventilation; diagnostic-criteria; leigh-disease; children; apnea; encephalomyopathy; patient; ophthalmoplegia
AB Study Objectives: Primary mitochondrial diseases are caused by heritable or spontaneous mutations in nuclear DNA or mitochondrial DNA. Such pathological mutations are relatively common in humans and may lead to neurological and neuromuscular complication that could compromise normal sleep behavior. To gain insight into the potential impact of primary mitochondrial disease and sleep pathology, we reviewed the relevant English language literature in which abnormal sleep was reported in association with a mitochondrial disease. Design: We examined publications reported in Web of Science and PubMed from February 1976 through January 2014, and identified 54 patients with a proven or suspected primary mitochondrial disorder who were evaluated for sleep disturbances. Measurements and Results: Both nuclear DNA and mitochondrial DNA mutations were associated with abnormal sleep patterns. Most subjects who underwent polysomnography had central sleep apnea, and only 5 patients had obstructive sleep apnea. Twenty-four patients showed decreased ventilatory drive in response to hypoxia and/or hypercapnia that was not considered due to weakness of the intrinsic muscles of respiration. Conclusions: Sleep pathology may be an underreported complication of primary mitochondrial diseases. The probable underlying mechanism is cellular energy failure causing both central neurological and peripheral neuromuscular degenerative changes that commonly present as central sleep apnea and poor ventilatory response to hypercapnia. Increased recognition of the genetics and clinical manifestations of mitochondrial diseases by sleep researchers and clinicians is important in the evaluation and treatment of all patients with sleep disturbances. Prospective population-based studies are required to determine the true prevalence of mitochondrial energy failure in subjects with sleep disorders, and conversely, of individuals with primary mitochondrial diseases and sleep pathology.
C1 [Ramezani, Ryan J.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA.
   [Stacpoole, Peter W.] Univ Florida, Coll Med, Div Endocrinol Metab & Diabet, Gainesville, FL USA.
   [Stacpoole, Peter W.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.
C3 State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida
RP Stacpoole, PW (corresponding author), POB 100226, Gainesville, FL 32610 USA.
EM pws@ufl.edu
CR Araki S, 1997, PEDIATR NEUROL, V16, P329, DOI 10.1016/S0887-8994(97)00020-9
   BAROHN RJ, 1990, NEUROLOGY, V40, P103, DOI 10.1212/WNL.40.1.103
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   CARROLL JE, 1976, NEUROLOGY, V26, P140, DOI 10.1212/WNL.26.2.140
   CUMMISKEY J, 1987, NEUROLOGY, V37, P1876, DOI 10.1212/WNL.37.12.1876
   DIMAURO S, 2006, MITOCHONDRIAL MED, V0, P0
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Gibson K, 2008, PEDIATRICS, V122, P1003, DOI 10.1542/peds.2007-3502
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   JOHNSTON K, 1984, PEDIATRICS, V74, P1034
   Kerr D, 2012, METHODS MOL BIOL, V837, P93, DOI 10.1007/978-1-61779-504-6_7
   Kisler JE, 2010, DEV MED CHILD NEUROL, V52, P422, DOI 10.1111/j.1469-8749.2009.03605.x
   MANNI R, 1991, EUR NEUROL, V31, P12, DOI 10.1159/000116627
   Mermigkis C, 2013, SLEEP BREATH, V17, P1129, DOI 10.1007/s11325-013-0816-5
   OBrien A, 1998, EUR RESPIR J, V12, P742, DOI 10.1183/09031936.98.12030742
   Osanai S, 2001, RESPIROLOGY, V6, P163, DOI 10.1046/j.1440-1843.2001.00318.x
   Patel KP, 2012, MOL GENET METAB, V106, P384, DOI 10.1016/j.ymgme.2012.03.016
   Pincherle A, 2006, SLEEP MED, V7, P663, DOI 10.1016/j.sleep.2006.06.005
   Sakaue S, 2002, TOHOKU J EXP MED, V196, P203, DOI 10.1620/tjem.196.203
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Sembrano E, 1997, NEUROLOGY, V49, P1714, DOI 10.1212/WNL.49.6.1714
   Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smits BW, 2012, EUR J NEUROL, V19, P176, DOI 10.1111/j.1468-1331.2011.03496.x
   Stacpoole PW, 2012, MITOCHONDRION, V12, P623, DOI 10.1016/j.mito.2012.09.005
   Stacpoole PW, 1997, METABOLISM, V46, P306, DOI 10.1016/S0026-0495(97)90259-6
   Stacpoole PW, 2007, CLIN STUDIES MED BIO, V0, P77
   Suzuki Y, 1997, DIABETES RES CLIN PR, V35, P61, DOI 10.1016/S0168-8227(96)01358-7
   Tan ALW, 2013, SINGAP MED J, V54, PE250, DOI 10.11622/smedj.2013252
   TATSUMI C, 1988, EUR NEUROL, V28, P64, DOI 10.1159/000116231
   Vetrugno R, 2010, SLEEP MED, V11, P426, DOI 10.1016/j.sleep.2009.08.007
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Yasaki E, 2001, NEUROPEDIATRICS, V32, P299
NR 34
TC 28
Z9 34
U1 0
U2 9
PU AMER ACAD SLEEP MEDICINE
PI DARIEN
PA 2510 N FRONTAGE RD, DARIEN, IL 60561 USA
SN 1550-9389
EI 1550-9397
J9 J CLIN SLEEP MED
JI J. Clin. Sleep Med.
PD JUN 15
PY 2014
VL 10
IS 11
BP 1233
EP 1239
DI 10.5664/jcsm.4212
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA AT8XT
UT WOS:000345213100012
PM 25325607
DA 2024-11-01
ER

PT J
AU Donti, TR
   Stromberger, C
   Ge, M
   Eldin, KW
   Craigen, WJ
   Graham, BH
AF Donti, Taraka R.
   Stromberger, Carmen
   Ge, Ming
   Eldin, Karen W.
   Craigen, William J.
   Graham, Brett H.
TI Screen for abnormal mitochondrial phenotypes in mouse embryonic stem cells identifies a model for succinyl-CoA ligase deficiency and mtDNA depletion
SO DISEASE MODELS & MECHANISMS
LA English
DT Article
DE TCA cycle; Mitochondrial DNA depletion; Gene trap; Mitochondria
ID nucleoside-diphosphate kinase; tandem mass-spectrometry; methylmalonic acid; placental calcification; thymidine phosphorylase; deoxynucleotide pools; sucla2 mutations; dna maintenance; mice; disease
AB Mutations in subunits of succinyl-CoA synthetase/ligase (SCS), a component of the citric acid cycle, are associated with mitochondrial encephalomyopathy, elevation of methylmalonic acid (MMA), and mitochondrial DNA (mtDNA) depletion. A FACS-based retroviral-mediated gene trap mutagenesis screen in mouse embryonic stem (ES) cells for abnormal mitochondrial phenotypes identified a gene trap allele of Sucla2 (Sucla2(SA beta geo)), which was used to generate transgenic mice. Sucla2 encodes the ADP-specific beta-subunit isoform of SCS. Sucla2(SA beta geo) homozygotes exhibited recessive lethality, with most mutants dying late in gestation (e18.5). Mutant placenta and embryonic (e17.5) brain, heart and muscle showed varying degrees of mtDNA depletion (20-60%). However, there was no mtDNA depletion in mutant liver, where the gene is not normally expressed. Elevated levels of MMA were observed in embryonic brain. SCS-deficient mouse embryonic fibroblasts (MEFs) demonstrated a 50% reduction in mtDNA content compared with wild-type MEFs. The mtDNA depletion resulted in reduced steady state levels of mtDNA encoded proteins and multiple respiratory chain deficiencies. mtDNA content could be restored by reintroduction of Sucla2. This mouse model of SCS deficiency and mtDNA depletion promises to provide insights into the pathogenesis of mitochondrial diseases with mtDNA depletion and into the biology of mtDNA maintenance. In addition, this report demonstrates the power of a genetic screen that combines gene trap mutagenesis and FACS analysis in mouse ES cells to identify mitochondrial phenotypes and to develop animal models of mitochondrial dysfunction.
C1 [Donti, Taraka R.; Stromberger, Carmen; Ge, Ming; Craigen, William J.; Graham, Brett H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Eldin, Karen W.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.
   [Craigen, William J.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine
RP Graham, BH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.
EM bgraham@bcm.edu
FU National Institutes of Health [R03 AR052112, R21 HL084239, R01 GM098387]; March of Dimes [5-FY05-96, 1-FY07-507]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [P30HD024064]; Cytometry and Cell Sorting Core at Baylor College of Medicine; National Institute of Health [AI036211, CA125123, RR024574]
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Chen KH, 2012, ULTRASOUND MED BIOL, V38, P1011, DOI 10.1016/j.ultrasmedbio.2012.02.004
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Conner DA, 2001, CURR PROTOC MOL BIOL, V51, P0
   De Paepe B, 2009, J CLIN PATHOL, V62, P172, DOI 10.1136/jcp.2008.061267
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513
   González-Vioque E, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002035
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Graham BH, 2012, METHODS MOL BIOL, V837, P35, DOI 10.1007/978-1-61779-504-6_3
   Graham BH, 2010, J BIOL CHEM, V285, P11143, DOI 10.1074/jbc.M109.080317
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002
   KAVANAUGHBLACK A, 1994, P NATL ACAD SCI USA, V91, P5883, DOI 10.1073/pnas.91.13.5883
   Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Kushnir MM, 2001, CLIN CHEM, V47, P1993
   Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200
   LEISER R, 1994, EXP CLIN ENDOCRINOL, V102, P122, DOI 10.1055/s-0029-1211275
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Malassiné A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043
   Martínez-Azorín F, 2008, J NEUROCHEM, V105, P165, DOI 10.1111/j.1471-4159.2007.05122.x
   Mattiasson G, 2004, CYTOM PART A, V60A, P145, DOI 10.1002/cyto.a.20024
   Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108
   Miller C, 2011, BBA-MOL BASIS DIS, V1812, P625, DOI 10.1016/j.bbadis.2011.01.013
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Peters H, 2003, J BIOL CHEM, V278, P52909, DOI 10.1074/jbc.M310533200
   Poggi SH, 2001, PLACENTA, V22, P591, DOI 10.1053/plac.2001.0688
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schmedes A, 2006, CLIN CHEM, V52, P754, DOI 10.1373/clinchem.2005.058586
   Soares MJ, 1996, PLACENTA, V17, P277, DOI 10.1016/S0143-4004(96)90051-X
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Voss AK, 1998, DEV DYNAM, V212, P258
   Yang H, 2013, MOL CELL ENDOCRINOL, V367, P21, DOI 10.1016/j.mce.2012.12.012
   Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910
NR 46
TC 23
Z9 25
U1 0
U2 5
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND
SN 1754-8403
EI 1754-8411
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD FEB 15
PY 2014
VL 7
IS 2
BP 271
EP 280
DI 10.1242/dmm.013466
PG 10
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA AJ4CY
UT WOS:000337619300014
PM 24271779
DA 2024-11-01
ER

PT J
AU Morino, H
   Pierce, SB
   Matsuda, Y
   Walsh, T
   Ohsawa, R
   Newby, M
   Hiraki-Kamon, K
   Kuramochi, M
   Lee, MK
   Klevit, RE
   Martin, A
   Maruyama, H
   King, MC
   Kawakami, H
AF Morino, Hiroyuki
   Pierce, Sarah B.
   Matsuda, Yukiko
   Walsh, Tom
   Ohsawa, Ryosuke
   Newby, Marta
   Hiraki-Kamon, Keiko
   Kuramochi, Masahito
   Lee, Ming K.
   Klevit, Rachel E.
   Martin, Alan
   Maruyama, Hirofumi
   King, Mary-Claire
   Kawakami, Hideshi
TI Mutations in Twinkle primase-helicase cause Perrault syndrome with neurologic features
SO NEUROLOGY
LA English
DT Article
ID onset spinocerebellar ataxia; progressive external ophthalmoplegia; structure-function defects; cause ovarian dysgenesis; transfer-rna synthetase; hearing-loss; recessive mutations; linker region; dna helicase; mitochondrial
AB Objective:To identify the genetic cause in 2 families of progressive ataxia, axonal neuropathy, hyporeflexia, and abnormal eye movements, accompanied by progressive hearing loss and ovarian dysgenesis, with a clinical diagnosis of Perrault syndrome.Methods:Whole-exome sequencing was performed to identify causative mutations in the 2 affected sisters in each family. Family 1 is of Japanese ancestry, and family 2 is of European ancestry.Results:In family 1, affected individuals were compound heterozygous for chromosome 10 open reading frame 2 (C10orf2) p.Arg391His and p.Asn585Ser. In family 2, affected individuals were compound heterozygous for C10orf2 p.Trp441Gly and p.Val507Ile. C10orf2 encodes Twinkle, a primase-helicase essential for replication of mitochondrial DNA. Conservation and structural modeling support the causality of the mutations. Twinkle is known also to harbor multiple mutations, nearly all missenses, leading to dominant progressive external ophthalmoplegia type 3 and to recessive mitochondrial DNA depletion syndrome 7, also known as infantile-onset spinocerebellar ataxia.Conclusions:Our study identifies Twinkle mutations as a cause of Perrault syndrome accompanied by neurologic features and expands the phenotypic spectrum of recessive disease caused by mutations in Twinkle. The phenotypic heterogeneity of conditions caused by Twinkle mutations and the genetic heterogeneity of Perrault syndrome call for genomic definition of these disorders.
C1 [Morino, Hiroyuki; Matsuda, Yukiko; Ohsawa, Ryosuke; Hiraki-Kamon, Keiko; Kuramochi, Masahito; Kawakami, Hideshi] Hiroshima Univ, Dept Epidemiol, Res Inst Radiat Biol & Med, Hiroshima 730, Japan.
   [Maruyama, Hirofumi] Hiroshima Univ, Dept Clin Neurosci & Therapeut, Hiroshima 730, Japan.
   [Pierce, Sarah B.; Walsh, Tom; Lee, Ming K.; King, Mary-Claire] Univ Washington, Dept Med Med Genet & Genome Sci, Seattle, WA 98195 USA.
   [Pierce, Sarah B.; Walsh, Tom; Lee, Ming K.; King, Mary-Claire] Univ Washington, Dept Biochem, Seattle, WA 98195 USA.
   [Newby, Marta; Martin, Alan] Texas Hlth Presbyterian Hosp, Neuromuscular Ctr, Dallas, TX USA.
C3 Hiroshima University; Hiroshima University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle
RP Kawakami, H (corresponding author), Hiroshima Univ, Dept Epidemiol, Res Inst Radiat Biol & Med, Hiroshima 730, Japan.
EM sbpierce@uw.edu; hkawakam@hiroshima-u.ac.jp
FU Funding Program for Next Generation World-Leading Researchers from the Cabinet Office of the Government of Japan; Ministry of Education, Science, Sports, and Culture of Japan; Research Committee of CNS Degenerative Diseases from the Ministry of Health, Labour, and Welfare of Japan; Grants-in-Aid for Scientific Research [26242085, 26293211] Funding Source: KAKEN
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Dündar H, 2012, PEDIATR NEUROL, V46, P172, DOI 10.1016/j.pediatrneurol.2011.12.006
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Fiumara A, 2004, AM J MED GENET A, V128A, P246, DOI 10.1002/ajmg.a.20616
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gottschalk ME, 1996, AM J MED GENET, V65, P274, DOI 10.1002/(SICI)1096-8628(19961111)65:4<274::AID-AJMG5>3.0.CO;2-P
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hartley JN, 2012, CASE REP PEDIAT, V2012, P0, DOI 10.1155/2012/303096
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Hong DJ, 2010, MUSCLE NERVE, V41, P92, DOI 10.1002/mus.21439
   Jenkinson EM, 2013, AM J HUM GENET, V92, P605, DOI 10.1016/j.ajhg.2013.02.013
   Ji KQ, 2014, NEUROL SCI, V35, P443, DOI 10.1007/s10072-013-1557-8
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/s1415-47572013000300002
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Milone M, 2013, JAMA NEUROL, V70, P1429, DOI 10.1001/jamaneurol.2013.3521
   Morino H, 2014, BMC NEUROL, V14, P0, DOI 10.1186/1471-2377-14-5
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   NISHI Y, 1988, AM J MED GENET, V31, P623, DOI 10.1002/ajmg.1320310317
   PERRAULT M, 1951, BULL MEM SOC MED HOP PARIS, V67, P79
   Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007
   Prasad C, 2013, MOL GENET METAB, V108, P190, DOI 10.1016/j.ymgme.2012.12.007
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010
NR 38
TC 73
Z9 85
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD NOV 25
PY 2014
VL 83
IS 22
BP 2054
EP 2061
DI 10.1212/WNL.0000000000001036
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA AU3TE
UT WOS:000345535700015
PM 25355836
DA 2024-11-01
ER

PT J
AU Ye, CQ
   Lou, WJ
   Li, YR
   Chatzispyrou, IA
   Hüttemann, M
   Lee, I
   Houtkooper, RH
   Vaz, FM
   Chen, SL
   Greenberg, ML
AF Ye, Cunqi
   Lou, Wenjia
   Li, Yiran
   Chatzispyrou, Iliana A.
   Huettemann, Maik
   Lee, Icksoo
   Houtkooper, Riekelt H.
   Vaz, Frederic M.
   Chen, Shuliang
   Greenberg, Miriam L.
TI Deletion of the Cardiolipin-specific Phospholipase Cld1 Rescues Growth and Life Span Defects in the Tafazzin Mutant <i>IMPLICATIONS FOR BARTH SYNDROME</i>
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Cardiolipin; Mitochondria; Phospholipase; Phospholipid; Respiration; Barth Syndrome; Tafazzin
ID cytochrome-c-oxidase; suppresses temperature sensitivity; linked cardioskeletal myopathy; adp/atp carrier protein; respiratory-chain; saccharomyces-cerevisiae; mitochondrial-dna; mass-spectrometry; bc(1) complex; up-regulation
AB Background: Cardiolipin (CL) is deacylated by Cld1 to monolysocardiolipin, which is transacylated by tafazzin (Taz1) to form unsaturated CL. Results: Deletion of CLD1 rescues growth and respiration defects in taz1, whereas overexpression is deleterious to growth and respiration. Conclusion: Decreased CL/MLCL, not decreased unsaturated CL, causes defects in tafazzin-deficient cells. Significance: Attenuation of CL phospholipases may potentially treat Barth syndrome. Cardiolipin (CL) that is synthesized de novo is deacylated to monolysocardiolipin (MLCL), which is reacylated by tafazzin. Remodeled CL contains mostly unsaturated fatty acids. In eukaryotes, loss of tafazzin leads to growth and respiration defects, and in humans, this results in the life-threatening disorder Barth syndrome. Tafazzin deficiency causes a decrease in the CL/MLCL ratio and decreased unsaturated CL species. Which of these biochemical outcomes contributes to the physiological defects is not known. Yeast cells have a single CL-specific phospholipase, Cld1, that can be exploited to distinguish between these outcomes. The cld1 mutant has decreased unsaturated CL, but the CL/MLCL ratio is similar to that of wild type cells. We show that cld1 rescues growth, life span, and respiratory defects of the taz1 mutant. This suggests that defective growth and respiration in tafazzin-deficient cells are caused by the decreased CL/MLCL ratio and not by a deficiency in unsaturated CL. CLD1 expression is increased during respiratory growth and regulated by the heme activator protein transcriptional activation complex. Overexpression of CLD1 leads to decreased mitochondrial respiration and growth and instability of mitochondrial DNA. However, ATP concentrations are maintained by increasing glycolysis. We conclude that transcriptional regulation of Cld1-mediated deacylation of CL influences energy metabolism by modulating the relative contribution of glycolysis and respiration.
C1 [Chen, Shuliang; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.
   [Huettemann, Maik] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA.
   [Huettemann, Maik] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48201 USA.
   [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si 330714, Chungcheongnam, South Korea.
   [Chatzispyrou, Iliana A.; Houtkooper, Riekelt H.; Vaz, Frederic M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.
C3 Wayne State University; Wayne State University; Wayne State University; Dankook University; University of Amsterdam; Academic Medical Center Amsterdam
RP Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.
EM mlgreen@sun.science.wayne.edu
FU Barth Syndrome Foundation; Barth Syndrome Foundation of Canada; Association Barth France; Wayne State University Thomas C. Rumble University Fellowship; Wayne State University Summer Dissertation Fellowship; Wayne State University; Academisch Medisch Centrum Ph.D. fellowship; ZonMw/Veni [91613050]; AMC
CR Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439
   Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733
   Baile MG, 2013, MOL BIOL CELL, V24, P2008, DOI 10.1091/mbc.E13-03-0121
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936
   Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200
   BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001
   Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256
   Bu Y, 1998, NUCLEIC ACIDS RES, V26, P1002, DOI 10.1093/nar/26.4.1002
   Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829
   Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933
   Chen SL, 2010, J BIOL CHEM, V285, P10397, DOI 10.1074/jbc.M110.100784
   Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152
   Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020
   Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896
   DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098
   Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9
   Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497
   EBLE KS, 1990, J BIOL CHEM, V265, P19434
   Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x
   Fontanesi F, 2008, HUM MOL GENET, V17, P775, DOI 10.1093/hmg/ddm349
   Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2
   Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074
   Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200
   Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8
   Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x
   HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P507, DOI 10.1016/0005-2760(72)90065-3
   Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5
   Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054
   Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032
   Hsu YH, 2013, PLOS ONE, V8, P0
   Hu Jia, 2013, METHODS MOL BIOL, V965, P463, DOI 10.1007/978-1-62703-239-1_30
   Hüttemann M, 2012, ADV EXP MED BIOL, V748, P237, DOI 10.1007/978-1-4614-3573-0_10
   JAKOVCIC S, 1971, J CELL BIOL, V48, P490, DOI 10.1083/jcb.48.3.490
   Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x
   Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199
   Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167
   Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024
   KELLY BL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P144, DOI 10.1016/0005-2760(90)90181-V
   Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728
   Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007
   KOHRER K, 1991, METHOD ENZYMOL, V194, P398
   Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687
   Kwast KE, 1999, P NATL ACAD SCI USA, V96, P5446, DOI 10.1073/pnas.96.10.5446
   Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591
   LECOCQ J, 1964, BIOCHEMISTRY-US, V3, P976, DOI 10.1021/bi00895a023
   Lee I, 2010, BBA-MOL BASIS DIS, V1802, P275, DOI 10.1016/j.bbadis.2009.10.005
   Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106
   NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x
   Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013
   Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98
   Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200
   PANGBORN MC, 1947, J BIOL CHEM, V168, P351
   Paradies G, 2001, MITOCHONDRION, V1, P151, DOI 10.1016/S1567-7249(01)00011-3
   Paradies G, 1998, FEBS LETT, V424, P155, DOI 10.1016/S0014-5793(98)00161-6
   Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6
   Petrosillo G, 2007, BBA-BIOENERGETICS, V1767, P1260, DOI 10.1016/j.bbabio.2007.07.011
   PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3
   Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200
   Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006
   Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9
   Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015
   Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176
   Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022
   Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019
   Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004
   Schüller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8
   Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618
   Su XF, 2006, MOL CELL BIOL, V26, P743, DOI 10.1128/MCB.26.3.743-753.2006
   Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908
   TAMAI KT, 1990, BIOCHIM BIOPHYS ACTA, V1046, P214, DOI 10.1016/0005-2760(90)90192-Z
   Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491
   Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1
   Valianpour F, 2003, J LIPID RES, V44, P560, DOI 10.1194/jlr.M200217-JLR200
   Valianpour F, 2002, CLIN CHEM, V48, P1390
   Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200
   Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952
   Wu JP, 1998, YEAST, V14, P985, DOI 10.1002/(SICI)1097-0061(199808)14:11<985::AID-YEA294>3.3.CO;2-3
   Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200
   Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103
   Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200
   Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808
   Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200
   Zhou JM, 2009, J BIOL CHEM, V284, P18106, DOI 10.1074/jbc.M109.003236
NR 87
TC 47
Z9 61
U1 0
U2 15
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 7
PY 2014
VL 289
IS 6
BP 3114
EP 3125
DI 10.1074/jbc.M113.529487
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AA8TU
UT WOS:000331368700002
PM 24318983
DA 2024-11-01
ER

PT J
AU Wedding, IM
   Koht, J
   Tran, GT
   Misceo, D
   Selmer, KK
   Holmgren, A
   Frengen, E
   Bindoff, L
   Tallaksen, CME
   Tzoulis, C
AF Wedding, Iselin Marie
   Koht, Jeanette
   Gia Tuong Tran
   Misceo, Doriana
   Selmer, Kaja Kristine
   Holmgren, Asbjorn
   Frengen, Eirik
   Bindoff, Laurence
   Tallaksen, Chantal M. E.
   Tzoulis, Charalampos
TI Spastic Paraplegia Type 7 Is Associated with Multiple Mitochondrial DNA Deletions
SO PLOS ONE
LA English
DT Article
ID progressive external ophthalmoplegia; m-aaa protease; real-time pcr; optic atrophy; spinocerebellar ataxia; spg7 mutations; gene; instability; disease
AB Spastic paraplegia 7 is an autosomal recessive disorder caused by mutations in the gene encoding paraplegin, a protein located at the inner mitochondrial membrane and involved in the processing of other mitochondrial proteins. The mechanism whereby paraplegin mutations cause disease is unknown. We studied two female and two male adult patients from two Norwegian families with a combination of progressive external ophthalmoplegia and spastic paraplegia. Sequencing of SPG7 revealed a novel missense mutation, c.2102A>C, p. H 701P, which was homozygous in one family and compound heterozygous in trans with a known pathogenic mutation c.1454_1462del in the other. Muscle was examined from an additional, unrelated adult female patient with a similar phenotype caused by a homozygous c.1047insC mutation in SPG7. Immunohistochemical studies in skeletal muscle showed mosaic deficiency predominantly affecting respiratory complex I, but also complexes III and IV. Molecular studies in single, microdissected fibres showed multiple mitochondrial DNA deletions segregating at high levels (38-97%) in respiratory deficient fibres. Our findings demonstrate for the first time that paraplegin mutations cause accumulation of mitochondrial DNA damage and multiple respiratory chain deficiencies. While paraplegin is not known to be directly associated with the mitochondrial nucleoid, it is known to process other mitochondrial proteins and it is possible therefore that paraplegin mutations lead to mitochondrial DNA deletions by impairing proteins involved in the homeostasis of the mitochondrial genome. These studies increase our understanding of the molecular pathogenesis of SPG7 mutations and suggest that SPG7 testing should be included in the diagnostic workup of autosomal recessive, progressive external ophthalmoplegia, especially if spasticity is present.
C1 [Wedding, Iselin Marie; Tallaksen, Chantal M. E.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway.
   [Wedding, Iselin Marie; Koht, Jeanette; Misceo, Doriana; Selmer, Kaja Kristine; Holmgren, Asbjorn; Frengen, Eirik; Tallaksen, Chantal M. E.] Univ Oslo, Fac Med, Oslo, Norway.
   [Misceo, Doriana; Selmer, Kaja Kristine; Holmgren, Asbjorn; Frengen, Eirik] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway.
   [Gia Tuong Tran; Bindoff, Laurence; Tzoulis, Charalampos] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Gia Tuong Tran; Bindoff, Laurence; Tzoulis, Charalampos] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Koht, Jeanette] Vestre Viken Hlth Trust, Drammen Hosp, Dept Neurol, Al, Norway.
C3 University of Oslo; University of Oslo; University of Oslo; University of Bergen; University of Bergen; Haukeland University Hospital
RP Tzoulis, C (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.
EM charalampos.tzoulis@helse-bergen.no
FU South-Eastern Norway Regional Health Authority; Western Norway Health Trust; University of Oslo; University of Bergen
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Arnoldi A, 2008, HUM MUTAT, V29, P522, DOI 10.1002/humu.20682
   Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112
   Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946
   Brugman F, 2008, NEUROLOGY, V71, P1500, DOI 10.1212/01.wnl.0000319700.11606.21
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Casari G, 1993, SPASTIC PARAPLEGIA, V0, P0
   Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405
   De Michele G, 1998, AM J HUM GENET, V63, P135, DOI 10.1086/301930
   Dürr A, 2008, NEUROLOGY, V71, P236, DOI 10.1212/01.wnl.0000320131.36091.a5
   Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Fink JK, 2002, ANN NEUROL, V51, P669, DOI 10.1002/ana.10258
   Fink JK, 2008, NEUROLOGY, V71, P1468, DOI 10.1212/01.wnl.0000334294.99658.2d
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   HARDING AE, 1983, LANCET, V1, P1151
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Karlberg T, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0006975
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241
   Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lee V, 2002, BRIT J OPHTHALMOL, V86, P1282, DOI 10.1136/bjo.86.11.1282
   McDermott CJ, 2001, NEUROLOGY, V56, P467, DOI 10.1212/WNL.56.4.467
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pierson TM, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002325
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rozen S, 2000, METHODS MOL BIOL, V132, P365
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8
   Schlipf NA, 2011, CLIN GENET, V80, P148, DOI 10.1111/j.1399-0004.2011.01715.x
   Schmitz-Hübsch T, 2006, MOVEMENT DISORD, V21, P699, DOI 10.1002/mds.20781
   Schüle R, 2006, NEUROLOGY, V67, P430, DOI 10.1212/01.wnl.0000228242.53336.90
   Schüle R, 2011, SEMIN NEUROL, V31, P484, DOI 10.1055/s-0031-1299787
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Tzoulis C, 2008, J NEUROL, V255, P1142, DOI 10.1007/s00415-008-0858-y
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Tzoulis C, 2013, BMC NEUROL, V13, P0, DOI 10.1186/1471-2377-13-55
   van Gassen KLI, 2012, BRAIN, V135, P2994, DOI 10.1093/brain/aws224
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandesompele J, 2002, GENOME BIOL, V3, P0, DOI 10.1186/gb-2002-3-7-research0034
   Warnecke T, 2007, NEUROLOGY, V69, P368, DOI 10.1212/01.wnl.0000266667.91074.fe
   Wechsler D, 1997, WECHSLER ADULT INTELLIGENCE SCALE - FOURTH EDITION (WAIS-IV), V0, P0
   Wilkinson PA, 2004, BRAIN, V127, P973, DOI 10.1093/brain/awh125
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 53
TC 40
Z9 44
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD JAN 22
PY 2014
VL 9
IS 1
BP 
EP 
DI 10.1371/journal.pone.0086340
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 297VL
UT WOS:000330283100142
PM 24466038
DA 2024-11-01
ER

PT J
AU Kondo, H
   Tanda, K
   Tabata, C
   Hayashi, K
   Kihara, M
   Kizaki, Z
   Taniguchi-Ikeda, M
   Mori, M
   Murayama, K
   Ohtake, A
AF Kondo, Hidehito
   Tanda, Koichi
   Tabata, Chihiro
   Hayashi, Kohei
   Kihara, Minako
   Kizaki, Zenro
   Taniguchi-Ikeda, Mariko
   Mori, Masato
   Murayama, Kei
   Ohtake, Akira
TI Leigh syndrome with Fukuyama congenital muscular dystrophy: A case report
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE Leigh syndrome; FCMD; Mitochondria; Complex I plus II deficiency
ID deficiency; succinate; children; adults
AB We report the first case of Leigh syndrome (LS) with Fukuyama congenital muscular dystrophy (FCMD). A neonate suffered from lactic acidosis and subsequently presented with poor feeding, muscle weakness, hypotonia, cardiopulmonary dysfunction, and hydrocephalus. He died at 17 months. The findings of brain magnetic resonance imaging indicated some specific features of both LS and FCMD, and FCMD gene mutation was detected. Decreased mitochondrial respiratory complex I and II activity was noted. Mitochondrial DNA sequencing showed no pathogenic mutation. A case with complex I + II deficiency has rarely been reported, suggesting a nuclear gene mutation. (C) 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Kondo, Hidehito; Tanda, Koichi; Tabata, Chihiro; Hayashi, Kohei; Kihara, Minako; Kizaki, Zenro] Japanese Red Cross Kyoto Daiichi Hosp, Dept Pediat & Neonatol, Kyoto, Japan.
   [Kondo, Hidehito] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan.
   [Taniguchi-Ikeda, Mariko] Kobe Univ, Grad Sch Med, Div Pediat, Kobe, Hyogo, Japan.
   [Mori, Masato] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan.
   [Ohtake, Akira] Saitama Med Univ Hosp, Dept Pediat, Saitama, Japan.
C3 Osaka University; Kobe University; Jichi Medical University; Saitama Medical University
RP Kondo, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Pediat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM hkondo@ped.med.osaka-u.ac.jp
FU Innovative Cell Biology grant from Innovative Technology (Cell Innovation Program) of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare of Japan
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Brockmann K, 2002, ANN NEUROL, V52, P38, DOI 10.1002/ana.10232
   Burgeois M, 1992, BRAIN DEV, V14, P404
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Kato T, 2000, PEDIATR NEUROL, V23, P385, DOI 10.1016/S0887-8994(00)00210-1
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Saito K, 2000, AM J MED GENET, V92, P184, DOI 10.1002/(SICI)1096-8628(20000529)92:3<184::AID-AJMG5>3.0.CO;2-N
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Watanabe M, 2005, AM J MED GENET A, V138A, P344, DOI 10.1002/ajmg.a.30978
NR 10
TC 2
Z9 3
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 1872-7131
J9 BRAIN DEV-JPN
JI Brain Dev.
PD SEP 15
PY 2014
VL 36
IS 8
BP 730
EP 733
DI 10.1016/j.braindev.2013.09.005
PG 4
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA CB2AN
UT WOS:000349429200014
PM 24113355
DA 2024-11-01
ER

PT J
AU Pallotti, F
   Binelli, G
   Fabbri, R
   Valentino, ML
   Vicenti, R
   Macciocca, M
   Cevoli, S
   Baruzzi, A
   DiMauro, S
   Carelli, V
AF Pallotti, Francesco
   Binelli, Giorgio
   Fabbri, Raffaella
   Valentino, Maria L.
   Vicenti, Rossella
   Macciocca, Maria
   Cevoli, Sabina
   Baruzzi, Agostino
   DiMauro, Salvatore
   Carelli, Valerio
TI A Wide Range of 3243A&gt;G/tRNALeu(UUR) (MELAS) Mutation Loads May Segregate in Offspring through the Female Germline Bottleneck
SO PLOS ONE
LA English
DT Article
ID mammalian mitochondrial-dna; random genetic drift; mutant mtdna; a3243g mutation; rapid segregation; human oocytes; human-cells; heteroplasmy; disease; complementation
AB Segregation of mutant mtDNA in human tissues and through the germline is debated, with no consensus about the nature and size of the bottleneck hypothesized to explain rapid generational shifts in mutant loads. We investigated two maternal lineages with an apparently different inheritance pattern of the same pathogenic mtDNA 3243A > G/tRNA(Leu(UUR)) (MELAS) mutation. We collected blood cells, muscle biopsies, urinary epithelium and hair follicles from 20 individuals, as well as oocytes and an ovarian biopsy from one female mutation carrier, all belonging to the two maternal lineages to assess mutant mtDNA load, and calculated the theoretical germline bottleneck size (number of segregating units). We also evaluated "mother-to-offspring'' segregations from the literature, for which heteroplasmy assessment was available in at least three siblings besides the proband. Our results showed that mutation load was prevalent in skeletal muscle and urinary epithelium, whereas in blood cells there was an inverse correlation with age, as previously reported. The histoenzymatic staining of the ovarian biopsy failed to show any cytochrome-c-oxidase defective oocyte. Analysis of four oocytes and one offspring from the same unaffected mother of the first family showed intermediate heteroplasmic mutant loads (10% to 75%), whereas very skewed loads of mutant mtDNA (0% or 81%) were detected in five offspring of another unaffected mother from the second family. Bottleneck size was 89 segregating units for the first mother and 84 for the second. This was remarkably close to 88, the number of "segregating units'' in the "mother-to-offspring'' segregations retrieved from literature. In conclusion, a wide range of mutant loads may be found in offspring tissues and oocytes, resulting from a similar theoretical bottleneck size.
C1 [Pallotti, Francesco; DiMauro, Salvatore] Columbia Univ, Dept Neurol, New York, NY USA.
   [Pallotti, Francesco] Univ Insubria, Dipartimento Sci Chirurg & Morfol, Varese, Italy.
   [Binelli, Giorgio] Univ Insubria, Dipartimento Sci Teor & Appl, Varese, Italy.
   [Fabbri, Raffaella; Vicenti, Rossella; Macciocca, Maria] Univ Bologna, Osped S Orsola Malpighi, Unita Operat Ginecol & Fisiopatol Riprod Umana, Bologna, Italy.
   [Fabbri, Raffaella; Vicenti, Rossella; Macciocca, Maria] Univ Bologna, Dipartimento Sci Med & Chirurg DIMEC, Bologna, Italy.
   [Valentino, Maria L.; Cevoli, Sabina; Baruzzi, Agostino; Carelli, Valerio] Osped Bellaria, IRCCS, Ist Sci Neurol Bologna, Bologna, Italy.
   [Valentino, Maria L.; Cevoli, Sabina; Baruzzi, Agostino; Carelli, Valerio] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie DIBINEM, Bologna, Italy.
C3 Columbia University; University of Insubria; University of Insubria; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna
RP Carelli, V (corresponding author), Osped Bellaria, IRCCS, Ist Sci Neurol Bologna, Bologna, Italy.
EM valerio.carelli@unibo.it
FU FAR (Fondo di Ateneo per la Ricerca) from University of Bologna; FAR (Fondo di Ateneo per la Ricerca) from University of Insubria
CR ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Cao LQ, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000756
   Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004
   Cevoli S, 2010, CEPHALALGIA, V30, P919, DOI 10.1177/0333102409354654
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DAurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   DEVRIES D, 1994, J NEUROL SCI, V124, P77, DOI 10.1016/0022-510X(94)90014-0
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   Dubowitz V, 2007, MUSCLE BIOPSY: A PRACTICAL APPROACH, V0, P0
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Enríquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207
   Fabbri R, 2003, GYNECOL ONCOL, V89, P259, DOI 10.1016/S0090-8258(02)00098-7
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HOWELL N, 1992, HUM GENET, V90, P117
   Huang CC, 1996, ACTA NEUROL SCAND, V93, P198
   Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   KOEHLER CM, 1991, GENETICS, V129, P247
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lehtinen SK, 2000, GENETICS, V154, P363
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   LIOU CW, 1994, ACTA NEUROL SCAND, V90, P354
   Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009
   Marchington DR, 1997, AM J HUM GENET, V60, P408
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Poe BG, 2010, ANAL BIOANAL CHEM, V397, P3397, DOI 10.1007/s00216-010-3751-3
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Takai D, 1997, J BIOL CHEM, V272, P6028, DOI 10.1074/jbc.272.9.6028
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wonnapinij P, 2010, AM J HUM GENET, V86, P540, DOI 10.1016/j.ajhg.2010.02.023
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
   Zsurka G, 2007, AM J HUM GENET, V80, P298, DOI 10.1086/511282
NR 57
TC 12
Z9 13
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD MAY 7
PY 2014
VL 9
IS 5
BP 
EP 
DI 10.1371/journal.pone.0096663
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AG9HB
UT WOS:000335728900079
PM 24805791
DA 2024-11-01
ER

PT J
AU Zeng, LL
   Yang, Y
   Hu, YJ
   Sun, Y
   Du, ZD
   Xie, Z
   Zhou, T
   Kong, WJ
AF Zeng, Lingling
   Yang, Yang
   Hu, Yujuan
   Sun, Yu
   Du, Zhengde
   Xie, Zhen
   Zhou, Tao
   Kong, Weijia
TI Age-Related Decrease in the Mitochondrial Sirtuin Deacetylase Sirt3 Expression Associated with ROS Accumulation in the Auditory Cortex of the Mimetic Aging Rat Model
SO PLOS ONE
LA English
DT Article
ID 4977 bp deletion; superoxide-dismutase; dna-damage; oxidative damage; skeletal-muscle; cell-death; metabolism; restriction; deficiency; proteins
AB Age-related dysfunction of the central auditory system, also known as central presbycusis, can affect speech perception and sound localization. Understanding the pathogenesis of central presbycusis will help to develop novel approaches to prevent or treat this disease. In this study, the mechanisms of central presbycusis were investigated using a mimetic aging rat model induced by chronic injection of D-galactose (D-Gal). We showed that malondialdehyde (MDA) levels were increased and manganese superoxide dismutase (SOD2) activity was reduced in the auditory cortex in natural aging and D-Gal-induced mimetic aging rats. Furthermore, mitochondrial DNA (mtDNA) 4834 bp deletion, abnormal ultrastructure and cell apoptosis in the auditory cortex were also found in natural aging and D-Gal mimetic aging rats. Sirt3, a mitochondrial NAD+dependent deacetylase, has been shown to play a crucial role in controlling cellular reactive oxygen species (ROS) homeostasis. However, the role of Sirt3 in the pathogenesis of age-related central auditory cortex deterioration is still unclear. Here, we showed that decreased Sirt3 expression might be associated with increased SOD2 acetylation, which negatively regulates SOD2 activity. Oxidative stress accumulation was likely the result of low SOD2 activity and a decline in ROS clearance. Our findings indicate that Sirt3 might play an essential role, via the mediation of SOD2, in central presbycusis and that manipulation of Sirt3 expression might provide a new approach to combat aging and oxidative stress-related diseases.
C1 [Zeng, Lingling; Yang, Yang; Hu, Yujuan; Sun, Yu; Xie, Zhen; Zhou, Tao; Kong, Weijia] Huazhong Univ Sci & Technol, Dept Otorhinolaryngol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China.
   [Du, Zhengde] Guangdong Med Coll, Dept Otorhinolaryngol, Nanshan Affiliated Hosp, Shenzhen, Peoples R China.
C3 Huazhong University of Science & Technology; Guangdong Medical University
RP Kong, WJ (corresponding author), Huazhong Univ Sci & Technol, Dept Otorhinolaryngol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China.
EM entwjkong@hust.edu.cn
FU Major State Basic Research Development Program of China (973 Program) [2011CB504504]; National twelfth-Five Year Research Program of China [2012BAI12B02]; National Natural Science Foundation of China [81230021, 30872865, 30672309]; National Nature Science Foundation of China [81200745, 81000409]
CR Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   BOHR VA, 1995, MUTAT RES-DNAGING G, V338, P25, DOI 10.1016/0921-8734(95)00008-T
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Buler M, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0049863
   Chen B, 2011, MOL BIOL REP, V38, P3635, DOI 10.1007/s11033-010-0476-5
   Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65
   Chetty C, 2008, CANCER RES, V68, P4736, DOI 10.1158/0008-5472.CAN-07-6612
   Choudhury M, 2011, AGING-US, V3, P175, DOI 10.18632/aging.100289
   CUATRECASAS P, 1966, SCIENCE, V153, P549, DOI 10.1126/science.153.3735.549
   Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3
   DAquila P, 2012, GENE, V497, P323, DOI 10.1016/j.gene.2012.01.042
   Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194
   Dumont M, 2011, FREE RADICAL BIO MED, V51, P1014, DOI 10.1016/j.freeradbiomed.2010.11.026
   Engle JR, 2012, FRONT AGING NEUROSCI, V4, P0, DOI 10.3389/fnagi.2012.00036
   Fetoni AR, 2011, EXP GERONTOL, V46, P413, DOI 10.1016/j.exger.2010.12.003
   Finley LWS, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0023295
   Fortunato G, 2004, CLIN CHEM, V50, P2012, DOI 10.1373/clinchem.2004.037788
   Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Humes LE, 2012, J AM ACAD AUDIOL, V23, P635, DOI 10.3766/jaaa.23.8.5
   Imai S, 2000, COLD SPRING HARB SYM, V65, P297, DOI 10.1101/sqb.2000.65.297
   Jacono AA, 1998, HEARING RES, V117, P31, DOI 10.1016/S0378-5955(97)00214-1
   Jiang H, 2007, NEUROBIOL AGING, V28, P1605, DOI 10.1016/j.neurobiolaging.2006.06.025
   Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108
   Jordens RG, 1999, NEUROCHEM RES, V24, P227, DOI 10.1023/A:1022510004220
   King AJ, 2007, HEARING RES, V229, P106, DOI 10.1016/j.heares.2007.01.001
   Kong WJ, 2006, EXP GERONTOL, V41, P628, DOI 10.1016/j.exger.2006.04.008
   Kong WJ, 2006, BIOCHEM BIOPH RES CO, V344, P425, DOI 10.1016/j.bbrc.2006.03.060
   Kong XX, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011707
   Lei H, 2003, ACTA PHARMACOL SIN, V24, P230
   Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Mao PZ, 2012, BBA-MOL BASIS DIS, V1822, P111, DOI 10.1016/j.bbadis.2011.10.014
   Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005
   Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218
   McFadden SL, 1999, NEUROBIOL AGING, V20, P1, DOI 10.1016/S0197-4580(99)00018-4
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018
   Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033
   Patten DA, 2010, J ALZHEIMERS DIS, V20, PS357, DOI 10.3233/JAD-2010-100498
   Pellegrini L, 2012, CELL DEATH DIFFER, V19, P1815, DOI 10.1038/cdd.2012.62
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010
   Reddy, 2009, CNS SPECTRUMS, V14, P16
   Reddy PH, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024901
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Ross OA, 2002, EXP GERONTOL, V37, P329, DOI 10.1016/S0531-5565(01)00200-5
   Sack MN, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a013102
   Seidman MD, 2000, LARYNGOSCOPE, V110, P727, DOI 10.1097/00005537-200005000-00003
   Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200
   Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003
   Someya S, 2010, MECH AGEING DEV, V131, P480, DOI 10.1016/j.mad.2010.04.006
   Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013
   Tian J, 2005, P NATL ACAD SCI USA, V102, P11846, DOI 10.1073/pnas.0504759102
   Tretter L, 2004, NEUROCHEM RES, V29, P569, DOI 10.1023/B:NERE.0000014827.94562.4b
   WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Weir HJM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0048225
   Wu YT, 2013, BBA-MOL BASIS DIS, V1832, P216, DOI 10.1016/j.bbadis.2012.10.002
   Zhang Q, 2005, NEUROL RES, V27, P552, DOI 10.1179/016164105X25126
NR 65
TC 92
Z9 103
U1 1
U2 41
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD FEB 4
PY 2014
VL 9
IS 2
BP 
EP 
DI 10.1371/journal.pone.0088019
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI6GY
UT WOS:000336971300037
PM 24505357
DA 2024-11-01
ER

PT J
AU Tarnopolsky, MA
AF Tarnopolsky, Mark A.
TI Exercise as a Therapeutic Strategy for Primary Mitochondrial Cytopathies
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE endurance exercise; mitochondrial gene shifting; mitochondrial myopathy; resistance exercise; satellite cells
ID quality-of-life; muscle stem-cells; oxidative stress; skeletal-muscle; physical-activity; endurance exercise; cardiac rehabilitation; creatine monohydrate; resistance exercise; point mutation
AB Patients with mitochondrial cytopathies often experience exercise intolerance and may have fixed muscle weakness, leading to impaired functional capacity and lower quality of life. Endurance exercise training increases Vo (2) (max), respiratory chain enzyme activity, and improves quality of life. Resistance exercise training increases muscle strength and may lower mutational burden in patients with mitochondrial DNA deletions. Both modes of exercise appear to be well tolerated. Patients with mitochondrial cytopathy should consider alternating both types of exercise to derive the benefits from each (endurance = greater aerobic fitness; resistance = greater strength). Patients should start an exercise program at a low intensity and duration, gradually increasing duration and intensity. They should listen to their body and not exercise on days they have fever, superimposed illness, muscle pain, or cramps, and/or if they have fasted for more than 12 hours. Children often respond best to play-based exercise and tend to enjoy intermittent activity.
C1 [Tarnopolsky, Mark A.] McMaster Univ, Div Neuromuscular & Neurometab Dis, Hamilton, ON, Canada.
C3 McMaster University
RP Tarnopolsky, MA (corresponding author), McMaster Univ Med Ctr, 1200 Main St W,HSC-2H26, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
FU Natural Science and Engineering Research Council (NSERC); Canadian Institutes of Health Research (CIHR); MitoCanada
CR Andrews RM, 1999, EYE, V13, P769, DOI 10.1038/eye.1999.225
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Bacon CG, 2002, DIABETES CARE, V25, P1458, DOI 10.2337/diacare.25.8.1458
   Bates MGD, 2013, INT J CARDIOL, V168, P3599, DOI 10.1016/j.ijcard.2013.05.062
   Brose A, 2003, J GERONTOL A-BIOL, V58, P11
   Brown JC, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0036735
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638
   Cress ME, 1999, J GERONTOL A-BIOL, V54, PM242, DOI 10.1093/gerona/54.5.M242
   Fakhry F, 2011, ARCH PHYS MED REHAB, V92, P1066, DOI 10.1016/j.apmr.2011.02.007
   FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029
   FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002
   Grontved A, 2012, ARCH INTERN MED, V172, P1306, DOI 10.1001/archinternmed.2012.3138
   Hegbom Finn, 2006, J CARDIOPULM REHABIL, V26, P24, DOI 10.1097/00008483-200601000-00005
   Hegbom F, 2007, INT J CARDIOL, V116, P86, DOI 10.1016/j.ijcard.2006.03.034
   Hong S, 2003, MED SCI SPORT EXER, V35, P1088, DOI 10.1249/01.MSS.0000074566.94791.24
   Hsu CJ, 2011, TRANSPL P, V43, P2714, DOI 10.1016/j.transproceed.2011.04.025
   Huisinga JM, 2011, J REHABIL RES DEV, V48, P881, DOI 10.1682/JRRD.2010.08.0152
   Ikawa M, 2012, EUR NEUROL, V67, P232, DOI 10.1159/000336568
   Izawa K, 2004, CIRC J, V68, P315, DOI 10.1253/circj.68.315
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Joanisse S, 2013, FASEB J, V27, P4596, DOI 10.1096/fj.13-229799
   Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kwon HR, 2011, DIABETES METAB J, V35, P364, DOI 10.4093/dmj.2011.35.4.364
   Loprinzi PD, 2013, PREV MED, V57, P545, DOI 10.1016/j.ypmed.2013.07.009
   McKay BR, 2010, J PHYSIOL-LONDON, V588, P3307, DOI 10.1113/jphysiol.2010.190876
   McKinnell IW, 2005, CURR TOP DEV BIOL, V71, P113, DOI 10.1016/S0070-2153(05)71004-8
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024
   Paterson DH, 2004, J AM GERIATR SOC, V52, P1632, DOI 10.1111/j.1532-5415.2004.52454.x
   Paterson DH, 1999, MED SCI SPORT EXER, V31, P1813, DOI 10.1097/00005768-199912000-00018
   Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Phillips SM, 1996, AM J PHYSIOL-ENDOC M, V270, PE265, DOI 10.1152/ajpendo.1996.270.2.E265
   Phillips SM, 1995, J APPL PHYSIOL, V79, P1862, DOI 10.1152/jappl.1995.79.6.1862
   PICCOLO G, 1991, J NEUROL SCI, V105, P57, DOI 10.1016/0022-510X(91)90118-Q
   Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498
   Roef MJ, 2002, AM J CLIN NUTR, V75, P237, DOI 10.1093/ajcn/75.2.237
   Ruiz JR, 2008, BMJ-BRIT MED J, V337, P0, DOI 10.1136/bmj.a439
   Ruiz JR, 2009, CANCER EPIDEM BIOMAR, V18, P1468, DOI 10.1158/1055-9965.EPI-08-1075
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   SALE DG, 1988, MED SCI SPORT EXER, V20, PS135, DOI 10.1249/00005768-198810001-00009
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schreuder L, 2010, NEUROL INT, V2, P20, DOI 10.4081/ni.2010.e4
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Siciliano G, 2000, NEUROMUSCULAR DISORD, V10, P40, DOI 10.1016/S0960-8966(99)00068-1
   Siciliano G, 2012, NEUROMUSCULAR DISORD, V22, PS172, DOI 10.1016/j.nmd.2012.10.005
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 1998, NEUROLOGY, V50, P1055, DOI 10.1212/WNL.50.4.1055
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Taivassalo T, 2012, BRAIN, V135, P53, DOI 10.1093/brain/awr293
   Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Tarnopolsky M, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000991
   Vanhees L, 2012, EUR J PREV CARDIOL, V19, P1333, DOI 10.1177/2047487312437063
   Vital A, 2012, J NEUROPATH EXP NEUR, V71, P1036, DOI 10.1097/NEN.0b013e3182764d47
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916
   Williams PT, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0081098
   Williams PT, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031436
   Zachwieja JJ, 1996, ENDOCRIN METAB CLIN, V25, P965, DOI 10.1016/S0889-8529(05)70365-0
NR 72
TC 23
Z9 26
U1 1
U2 12
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD SEP 15
PY 2014
VL 29
IS 9
BP 1225
EP 1234
DI 10.1177/0883073814538512
PG 10
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA AP1FK
UT WOS:000341812400015
PM 25008908
DA 2024-11-01
ER

PT J
AU Xu, HL
   Wang, ZX
   Zheng, LM
   Zhang, W
   Lv, H
   Jin, SQ
   Yuan, Y
AF Xu, Hongliang
   Wang, Zhaoxia
   Zheng, Lemin
   Zhang, Wei
   Lv, He
   Jin, Suqin
   Yuan, Yun
TI Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion
SO JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Article
ID chronic hepatitis-b; cultured human-cells; long-term; dynamics; toxicity; therapy; complementation; cytotoxicity; telbivudine; zidovudine
AB Aims Myopathy or neuropathy has been associated with lamivudine/telbivudine therapy in hepatitis B patients. We aim to describe the pathological changes of lamivudine/telbivudine-associated neuromyopathy. Methods We retrospectively recruited six patients who were diagnosed with nucleotide analogues-associated myopathy or neuropathy. Muscle and nerve biopsy were performed, and the specimens were prepared for the light microscopy and electron microscopy. Genomic DNA was extracted from frozen muscle specimens, and the mitochondrial DNA (mtDNA) content was quantified by real-time PCR. Results Recovery of the myopathy can be achieved after the discontinuation or changing the drugs to entecavir. Muscle and nerve biopsy revealed similar changes under either the light or electronic microscopy in all the subjects. Quantitative real-time PCR revealed decrease of mtDNA content in the affected muscle. Conclusions MtDNA depletion results in mitochondrial dysfunction in the lamivudine/telbivudine-associated neuromyopathy. Myopathy was characterised by mitochondrial dysfunction accompanied with neurogenic damage due to axonal neuropathy. Ultrastructure changes of mitochondria included vacuolisation, simplification of the cristae and homogenised matrix.
C1 [Xu, Hongliang; Wang, Zhaoxia; Zhang, Wei; Lv, He; Jin, Suqin; Yuan, Yun] Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China.
   [Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Cardiovasc Sci, Beijing 100191, Peoples R China.
   [Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Syst Biomed,Sch Basic Med Sci, Beijing 100191, Peoples R China.
   [Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China.
C3 Peking University; Peking University; Peking University; Peking University
RP Yuan, Y (corresponding author), Peking Univ, Hosp 1, Dept Neurol, 8 Xishiku St, Beijing 100034, Peoples R China.
EM yuanyun2002@sohu.com
FU National Natural Science Foundation of China [30870864]; Twelfth Five Years Plan [2011ZX09307-001-07]
CR Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   CHEN CH, 1989, J BIOL CHEM, V264, P11934
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Divi RL, 2007, ENVIRON MOL MUTAGEN, V48, P179, DOI 10.1002/em.20245
   Fleischer RD, 2009, J HEPATOL, V51, P787, DOI 10.1016/j.jhep.2009.06.011
   Fontana RJ, 2009, HEPATOLOGY, V49, PS185, DOI 10.1002/hep.22885
   Gilkerson RW, 2000, FEBS LETT, V474, P1, DOI 10.1016/S0014-5793(00)01527-1
   Harkisoen S, 2012, ANN HEPATOL, V0, P0
   Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422
   Lee H, 2003, BIOCHEMISTRY-US, V42, P14711, DOI 10.1021/bi035596s
   Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026
   Mazzucco CE, 2008, ANTIMICROB AGENTS CH, V52, P598, DOI 10.1128/AAC.01122-07
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Sato A, 2009, BIOFACTORS, V35, P130, DOI 10.1002/biof.14
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Seok JI, 2009, HEPATOLOGY, V49, P2080, DOI 10.1002/hep.22959
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Vidal F, 2006, ANTIMICROB AGENTS CH, V50, P3824, DOI 10.1128/AAC.00437-06
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
NR 25
TC 26
Z9 27
U1 0
U2 7
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0021-9746
EI 1472-4146
J9 J CLIN PATHOL
JI J. Clin. Pathol.
PD NOV 15
PY 2014
VL 67
IS 11
BP 999
EP 1005
DI 10.1136/jclinpath-2013-202069
PG 7
WC Pathology
SC Pathology
GA AS1UP
UT WOS:000344067700012
PM 25190818
DA 2024-11-01
ER

PT J
AU Park, MH
   Woo, HM
   Hong, YB
   Park, JH
   Yoon, BR
   Park, JM
   Yoo, JH
   Koo, H
   Chae, JH
   Chung, KW
   Choi, BO
   Koo, SK
AF Park, Mi-Hyun
   Woo, Hae-Mi
   Hong, Young Bin
   Park, Ji Hoon
   Yoon, Bo Ram
   Park, Jin-Mo
   Yoo, Jeong Hyun
   Koo, Heasoo
   Chae, Jong-Hee
   Chung, Ki Wha
   Choi, Byung-Ok
   Koo, Soo Kyung
TI Recessive <i>C10orf2</i> mutations in a family with infantile-onset spinocerebellar ataxia, sensorimotor polyneuropathy, and myopathy
SO NEUROGENETICS
LA English
DT Article
DE C10orf2; Whole exome sequencing (WES); Infantile-onset spinocerebellar ataxia (IOSCA); Neuropathy; Myopathy; Mitochondria
ID progressive external ophthalmoplegia; marie-tooth-disease; mitochondrial-dna; sensory neuropathy; twinkle mutations; encephalopathy; depletion; deletions
AB Recessive mutations in chromosome 10 open reading frame 2 (C10orf2) are relevant in infantile-onset spinocerebellar ataxia (IOSCA). In this study, we investigated the causative mutation in a Korean family with combined phenotypes of IOSCA, sensorimotor polyneuropathy, and myopathy. We investigated recessive mutations in a Korean family with two individuals affected by IOSCA. Causative mutations were investigated using whole exome sequencing. Electrophysiological analyses and muscle and nerve biopsies were performed, along with magnetic resonance imaging (MRI) of the brain and lower extremities. Compound heterozygous mutations c.1460C > T and c.1485-1G > A in C10orf2 were identified as causative of IOSCA. Skeletal muscle showed mitochondrial DNA (mtDNA) deletions. Both patients showed a period of normal development until 12-15 months, followed by ataxia, athetosis, hearing loss, and intellectual disability. Electrophysiological findings indicated motor and sensory polyneuropathies. Muscle biopsy revealed variations in the size and shape of myofibers with scattered, small, and angulated degenerating myofibers containing abnormal mitochondria; these observations are consistent with myopathy and may be the result of mtDNA deletions. Sural nerve biopsy revealed an axonal neuropathy. High-signal-intensity lesions in the middle cerebellar peduncles were correlated with clinical severity, and MRI of the lower legs was compatible with the hypothesis of length-dependent axonal degeneration. We identified novel compound heterozygous mutations of the C10orf2 gene as the cause of IOSCA with sensorimotor polyneuropathy and myopathy. Signs of motor neuropathy and myopathy were discovered for the first time in IOSCA patients with C10orf2 mutations. These results suggest that the clinical spectrum of IOSCA caused by C10orf2 mutations may be more variable than previously reported.
C1 [Park, Mi-Hyun; Woo, Hae-Mi; Koo, Soo Kyung] Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Cheongwon Gun 363951, Chungcheongbuk, South Korea.
   [Hong, Young Bin; Choi, Byung-Ok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul 135710, South Korea.
   [Park, Ji Hoon; Yoon, Bo Ram; Chung, Ki Wha] Kongju Natl Univ, Dept Biol Sci, Gongju, South Korea.
   [Park, Jin-Mo] Ewha Womans Univ, Sch Med, Dept Neurol, Seoul, South Korea.
   [Yoo, Jeong Hyun] Ewha Womans Univ, Sch Med, Dept Radiol, Seoul, South Korea.
   [Koo, Heasoo] Ewha Womans Univ, Sch Med, Dept Pathol, Seoul, South Korea.
   [Chae, Jong-Hee] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea.
C3 Korea Disease Control & Prevention Agency (KDCA); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Sungkyunkwan University (SKKU); Samsung Medical Center; Kongju National University; Ewha Womans University; Ewha Womans University; Ewha Womans University; Seoul National University (SNU)
RP Koo, SK (corresponding author), Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Osong Hlth Technol Adm Complex 643, Cheongwon Gun 363951, Chungcheongbuk, South Korea.
EM bochoi@skku.edu; skkoo@nih.go.kr
FU Korea National Institute of Health; Korea National Institute of Health [4800-4845-302-210-13 (2012-N61001-00), 4800-4861-307-210-13 (2012-NG61004-00)]; Basic Science Research Program through the National Research Foundation (NRF) - Ministry of Education [2011-0021533]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A120182]
CR Birouk N, 1998, NEUROLOGY, V50, P1074, DOI 10.1212/WNL.50.4.1074
   Choi BO, 2013, NEUROGENETICS, V14, P35, DOI 10.1007/s10048-012-0346-5
   Choi BO, 2012, HUM MUTAT, V33, P1610, DOI 10.1002/humu.22143
   Dündar H, 2012, PEDIATR NEUROL, V46, P172, DOI 10.1016/j.pediatrneurol.2011.12.006
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hartley JN, 2012, CASE REP PEDIAT, V2012, P0, DOI 10.1155/2012/303096
   Hong D, 2011, NUCLEIC ACIDS RES, V39, PD883, DOI 10.1093/nar/gkq1101
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Sanchez-Martinez A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0043954
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Shy ME, 2005, NEUROLOGY, V64, P1209, DOI 10.1212/01.WNL.0000156517.00615.A3
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Woo HM, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-72
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 23
TC 8
Z9 9
U1 2
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1364-6745
EI 1364-6753
J9 NEUROGENETICS
JI Neurogenetics
PD AUG 15
PY 2014
VL 15
IS 3
BP 171
EP 182
DI 10.1007/s10048-014-0405-1
PG 12
WC Genetics & Heredity; Clinical Neurology
SC Genetics & Heredity; Neurosciences & Neurology
GA AM5JE
UT WOS:000339892700005
PM 24816431
DA 2024-11-01
ER

PT J
AU Mancuso, M
   Orsucci, D
   Angelini, C
   Bertini, E
   Carelli, V
   Comi, GP
   Donati, A
   Minetti, C
   Moggio, M
   Mongini, T
   Servidei, S
   Tonin, P
   Toscano, A
   Uziel, G
   Bruno, C
   Ienco, EC
   Filosto, M
   Lamperti, C
   Catteruccia, M
   Moroni, I
   Musumeci, O
   Pegoraro, E
   Ronchi, D
   Santorelli, FM
   Sauchelli, D
   Scarpelli, M
   Sciacco, M
   Valentino, ML
   Vercelli, L
   Zeviani, M
   Siciliano, G
AF Mancuso, Michelangelo
   Orsucci, Daniele
   Angelini, Corrado
   Bertini, Enrico
   Carelli, Valerio
   Comi, Giacomo Pietro
   Donati, Alice
   Minetti, Carlo
   Moggio, Maurizio
   Mongini, Tiziana
   Servidei, Serenella
   Tonin, Paola
   Toscano, Antonio
   Uziel, Graziella
   Bruno, Claudio
   Ienco, Elena Caldarazzo
   Filosto, Massimiliano
   Lamperti, Costanza
   Catteruccia, Michela
   Moroni, Isabella
   Musumeci, Olimpia
   Pegoraro, Elena
   Ronchi, Dario
   Santorelli, Filippo Maria
   Sauchelli, Donato
   Scarpelli, Mauro
   Sciacco, Monica
   Valentino, Maria Lucia
   Vercelli, Liliana
   Zeviani, Massimo
   Siciliano, Gabriele
TI The m.3243A&gt;G mitochondrial DNA mutation and related phenotypes. A matter of gender?
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE A3243G; MELAS; MIDD; Mitochondrial DNA; PEO; Stroke-like episodes
ID 3243a-greater-than-g mutation; clinical phenotypes; features; heteroplasmy; disorders; melas; merrf; load
AB The m.3243A > G "MELAS" (mitochondrial encephalopathy with lactic acidosis and stroke-like episodes) mutation is one of the most common point mutations of the mitochondrial DNA, but its phenotypic variability is incompletely understood. The aim of this study was to revise the phenotypic spectrum associated with the mitochondrial m.3243A > G mutation in 126 Italian carriers of the mutation, by a retrospective, database-based study ("Nation-wide Italian Collaborative Network of Mitochondrial Diseases"). Our results confirmed the high clinical heterogeneity of the m.3243A > G mutation. Hearing loss and diabetes were the most frequent clinical features, followed by stroke-like episodes. "MIDD" (maternally-inherited diabetes and deafness) and "PEO" (progressive external ophthalmoplegia) are nosographic terms without any real prognostic value, because these patients may be even more prone to the development of multisystem complications such as stroke-like episodes and heart involvement. The "MELAS" acronym is convincing and useful to denote patients with histological, biochemical and/or molecular evidence of mitochondrial disease who experience stroke-like episodes. Of note, we observed for the first time that male gender could represent a risk factor for the development of stroke-like episodes in Italian m.3243A > G carriers. Gender effect is not a new concept in mitochondrial medicine, but it has never been observed in MELAS. A better elucidation of the complex network linking mitochondrial dysfunction, apoptosis, estrogen effects and stroke-like episodes may hold therapeutic promises.
C1 [Mancuso, Michelangelo; Orsucci, Daniele; Ienco, Elena Caldarazzo; Siciliano, Gabriele] Univ Pisa, Neurol Clin, I-56100 Pisa, Italy.
   [Angelini, Corrado; Pegoraro, Elena] Univ Padua, Neurol Clin, Padua, Italy.
   [Angelini, Corrado; Pegoraro, Elena] IRCCS S Camillo, Venice, Italy.
   [Bertini, Enrico; Catteruccia, Michela] Bambino Gesu Pediat Hosp, Mol Med Lab, Rome, Italy.
   [Carelli, Valerio; Valentino, Maria Lucia] IRCCS Ist Sci Neurol Bologna, Bologna, Italy.
   [Carelli, Valerio; Valentino, Maria Lucia] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.
   [Comi, Giacomo Pietro; Ronchi, Dario] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat DEPT, Neurosci Sect,Neurol Unit,Dino Ferrari Ctr, Milan, Italy.
   [Donati, Alice] Univ Florence, A Meyer Childrens Hosp, Florence, Italy.
   [Minetti, Carlo; Bruno, Claudio] Univ Genoa, G Gaslini Inst, Neuropediat & Muscle Disorders Unit, Genoa, Italy.
   [Moggio, Maurizio; Sciacco, Monica] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuromuscular Unit, Dino Ferrari Ctr, Milan, Italy.
   [Mongini, Tiziana; Vercelli, Liliana] Univ Turin, Dept Neurosci, Turin, Italy.
   [Servidei, Serenella; Sauchelli, Donato] Univ Cattolica Sacro Cuore, Inst Neurol, I-00168 Rome, Italy.
   [Tonin, Paola; Scarpelli, Mauro] Univ Verona, Neurol Clin, I-37100 Verona, Italy.
   [Toscano, Antonio; Musumeci, Olimpia] Univ Messina, Dept Neurosci, Messina, Italy.
   [Uziel, Graziella; Moroni, Isabella] IRCCS, Fdn Carlo Besta Inst Neurol, Child Neurol Unit, Milan, Italy.
   [Filosto, Massimiliano] Univ Hosp Spedali Civili, Neurol Clin, Brescia, Italy.
   [Lamperti, Costanza; Zeviani, Massimo] IRCCS, Unit Mol Neurogenet, Fdn Carlo Besta Inst Neurol, Milan, Italy.
   [Santorelli, Filippo Maria] IRCCS Stella Maris, Pisa, Italy.
C3 University of Pisa; University of Padua; IRCCS Ospedale San Camillo; IRCCS Bambino Gesu; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Turin; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Verona; University of Messina; Fondazione IRCCS Istituto Neurologico Carlo Besta; Hospital Spedali Civili Brescia; Fondazione IRCCS Istituto Neurologico Carlo Besta; IRCCS Fondazione Stella Maris
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, Via Roma 67, I-56100 Pisa, Italy.
EM mancusomichelangelo@gmail.com
FU Telethon [GUP09004, GTB07001ER]; Pierfranco and Luisa Mariani Foundation Italy, Ricerca; Fondazione Giuseppe Tomasello ONLUS; Fondazione Telethon-Italy [GGP07019, GPP10005]; Associazione Amici del Centro Dino Ferrari; Telethon grant "Network of Genetic Biobanks" [GTB07001]; MRC [MC_UP_1002/1] Funding Source: UKRI
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Mancuso M, 2009, CURR MOL MED, V9, P1095, DOI 10.2174/156652409789839099
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Schreihofer DA, 2013, BRAIN RES, V1514, P107, DOI 10.1016/j.brainres.2013.02.051
NR 15
TC 97
Z9 109
U1 0
U2 12
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD MAR 15
PY 2014
VL 261
IS 3
BP 504
EP 510
DI 10.1007/s00415-013-7225-3
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA AC8OA
UT WOS:000332791600007
PM 24375076
DA 2024-11-01
ER

PT J
AU Andalib, S
   Vafaee, MS
   Gjedde, A
AF Andalib, Sasan
   Vafaee, Manouchehr Seyedi
   Gjedde, Albert
TI Parkinson's disease and mitochondrial gene variations: A review
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Review
DE Parkinson's disease; Mitochondrial DNA variations; Mitochondrial dysfunction; Mitochondrial DNA nucleotide position; Genetic susceptibility; Central nervous system
ID hereditary optic neuropathy; progressive external ophthalmoplegia; transfer-rna genes; dna mutations; oxidative damage; sequence-analysis; lactic-acidosis; alpha-synuclein; complex i; phylogenetic analysis
AB Parkinson's disease (PD) is a common disorder of the central nervous system in the elderly. The pathogenesis of PD is a complex process, with genetics as an important contributing factor. This factor may stem from mitochondrial gene variations and mutations as well as from nuclear gene variations and mutations. More recently, a particular role of mitochondrial dysfunction has been suggested, arising from mitochondrial DNA variations or acquired mutations in PD pathogenesis. The present review summarizes and weighs the evidence in support of mitochondrial DNA (mtDNA) variations as important contributors to the development and course of PD. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Andalib, Sasan] Tabriz Univ Med Sci, Imam Reza Hosp, Neurosci Res Ctr, Tabriz, Iran.
   [Vafaee, Manouchehr Seyedi; Gjedde, Albert] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark.
C3 Tabriz University of Medical Science; University of Copenhagen
RP Andalib, S (corresponding author), Tabriz Univ Med Sci, Imam Reza Hosp, Neurosci Res Ctr, Tabriz, Iran.
EM andalibsa@tbzmed.ac.ir
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Andalib S, 2013, J NEUROL SCI, V330, P10, DOI 10.1016/j.jns.2013.04.018
   [Anonymous], 2002, MOV DISORD, V17 Suppl 4, P0
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524
   Bandmann O, 1997, J NEUROL, V244, P262, DOI 10.1007/s004150050082
   BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131
   Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0
   Borghammer P, 2008, ACTA NEUROL SCAND, V117, P317, DOI 10.1111/j.1600-0404.2007.00943.x
   Borghammer P, 2012, J NEUROL SCI, V313, P123, DOI 10.1016/j.jns.2011.09.010
   Bronte-Stewart HM, 2002, BRAIN, V125, P2100, DOI 10.1093/brain/awf207
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   Brown MD, 1997, AM J HUM GENET, V60, P381
   Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Caballol N, 2007, MOVEMENT DISORD, V22, PS358, DOI 10.1002/mds.21677
   Carod-Artal FJ, 2006, NEUROLOGIA, V21, P357
   Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8
   Chen CM, 2007, J NEURAL TRANSM, V114, P1017, DOI 10.1007/s00702-007-0658-z
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   CHUI HC, 1985, NEUROLOGY, V35, P1544, DOI 10.1212/WNL.35.11.1544
   Clark J, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-69
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   CURTIS L, 1984, LANCET, V2, P211
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013
   de la Monte SM, 2000, LAB INVEST, V80, P1323, DOI 10.1038/labinvest.3780140
   de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9
   DITTER SM, 1987, NEUROLOGY, V37, P754, DOI 10.1212/WNL.37.5.754
   Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Egensperger R, 1997, NEUROPATH APPL NEURO, V23, P315, DOI 10.1046/j.1365-2990.1997.4098040.x
   Floor E, 1998, J NEUROCHEM, V70, P268
   García-Lozano JR, 2002, EUR NEUROL, V48, P34, DOI 10.1159/000064955
   Gaweda-Walerych K, 2010, NEUROSCI LETT, V469, P24, DOI 10.1016/j.neulet.2009.11.037
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198
   Golbe LI, 1996, ANN NEUROL, V40, P767, DOI 10.1002/ana.410400513
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   Grazina M, 2006, GENES BRAIN BEHAV, V5, P92, DOI 10.1111/j.1601-183X.2006.00225.x
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924
   Hoehn MM, 2001, NEUROLOGY, V57, P0
   HOWELL N, 1995, GENETICS, V140, P285
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Inoue M, 2003, CURR MED CHEM, V10, P2495, DOI 10.2174/0929867033456477
   Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045
   Jenner P, 1995, NEUROLOGY, V45, P0
   Jenner P, 2003, ANN NEUROL, V53, PS26, DOI 10.1002/ana.10483
   Jenner P, 1998, ANN NEUROL, V44, PS72, DOI 10.1002/ana.410440712
   Jenner P, 1998, MOVEMENT DISORD, V13, P24
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   Jun AS, 1996, MOL CELL BIOL, V16, P771
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017
   Kirchner SC, 2000, NEUROTOXICOLOGY, V21, P441
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Klein C, 2006, NAT CLIN PRACT NEURO, V2, P136, DOI 10.1038/ncpneuro0126
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540
   Lesage S, 2009, HUM MOL GENET, V18, PR48, DOI 10.1093/hmg/ddp012
   Lin CH, 2008, NEUROLOGY, V71, P1727, DOI 10.1212/01.wnl.0000335167.72412.68
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lodi R, 2000, BRAIN, V123, P1896, DOI 10.1093/brain/123.9.1896
   Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102
   Lücking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Marder K, 1996, NEUROLOGY, V47, P155, DOI 10.1212/WNL.47.1.155
   Matsumine H, 1997, AM J HUM GENET, V60, P588
   MAYEUX R, 1985, NEUROLOGY, V35, P453, DOI 10.1212/WNL.35.4.453
   Mellick GD, 2009, PARKINSONISM RELAT D, V15, P105, DOI 10.1016/j.parkreldis.2007.11.016
   Mihailova SM, 2007, EUR J NEUROL, V14, P44, DOI 10.1111/j.1468-1331.2006.01541.x
   Mizuno Y, 1998, ANN NEUROL, V44, PS99, DOI 10.1002/ana.410440715
   Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165
   Otaegui D, 2004, NEUROSCI LETT, V370, P171, DOI 10.1016/j.neulet.2004.08.012
   Paisán-Ruíz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PAYAMI H, 1994, ANN NEUROL, V36, P659, DOI 10.1002/ana.410360417
   Perry G, 2002, FREE RADICAL BIO MED, V33, P1475, DOI 10.1016/S0891-5849(02)01113-9
   Petrozzi L, 2007, BIOSCIENCE REP, V27, P87, DOI 10.1007/s10540-007-9038-z
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884
   Richard Irene H, 2004, COGN BEHAV NEUROL, V17, P201
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   RINNE UK, 1972, Z NEUROL, V202, P1, DOI 10.1007/BF00316422
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Rozen TD, 2004, HEADACHE, V44, P674, DOI 10.1111/j.1526-4610.2004.04126.x
   Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8
   Sapir S, 2008, CURR OPIN OTOLARYNGO, V16, P205, DOI 10.1097/MOO.0b013e3282febd3a
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Schapira AHV, 2006, NEUROLOGY, V66, PS10, DOI 10.1212/WNL.66.10_suppl_4.S10
   Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   SPEHLMANN R, 1976, LANCET, V1, P724
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Takasaki S, 2008, COMPUT BIOL CHEM, V32, P332, DOI 10.1016/j.compbiolchem.2008.03.014
   TANAKA M, 1991, BIOCHEM BIOPH RES CO, V174, P861, DOI 10.1016/0006-291X(91)91497-Z
   Thomas B, 2010, MOVEMENT DISORD, V25, PS155, DOI 10.1002/mds.22781
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Tsunemi T, 2012, PROG NEUROBIOL, V97, P142, DOI 10.1016/j.pneurobio.2011.10.004
   Vafaee MS, 2004, NEUROIMAGE, V22, P966, DOI 10.1016/j.neuroimage.2004.02.019
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wallace DC, 2001, THE METABOLIC AND MOLECULAR BASIS OF INHERITED DISEASE, V0, P2425
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x
   Yen MY, 2002, JPN J OPHTHALMOL, V46, P45, DOI 10.1016/S0021-5155(01)00460-9
   Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5
NR 140
TC 23
Z9 28
U1 0
U2 29
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD NOV 15
PY 2014
VL 346
IS 1-2
BP 11
EP 19
DI 10.1016/j.jns.2014.07.067
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AU9YH
UT WOS:000345947400004
PM 25151610
DA 2024-11-01
ER

PT J
AU Fu, Y
   Dominissini, D
   Rechavi, G
   He, C
AF Fu, Ye
   Dominissini, Dan
   Rechavi, Gideon
   He, Chuan
TI Gene expression regulation mediated through reversible m<SUP>6</SUP>A RNA methylation
SO NATURE REVIEWS GENETICS
LA English
DT Review
ID arabidopsis messenger-rna; fto gene; nuclear-rna; posttranscriptional regulation; saccharomyces-cerevisiae; mitochondrial myopathy; missense mutation; crystal-structure; p-body; dna
AB Cellular RNAs carry diverse chemical modifications that used to be regarded as static and having minor roles in 'fine-tuning' structural and functional properties of RNAs. In this Review, we focus on reversible methylation through the most prevalent mammalian mRNA internal modification, N-6-methyladenosine (m(6)A). Recent studies have discovered protein 'writers', 'erasers' and 'readers' of this RNA chemical mark, as well as its dynamic deposition on mRNA and other types of nuclear RNA. These findings strongly indicate dynamic regulatory roles that are analogous to the well-known reversible epigenetic modifications of DNA and histone proteins. This reversible RNA methylation adds a new dimension to the developing picture of post-transcriptional regulation of gene expression.
C1 [Fu, Ye; Dominissini, Dan; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA.
   [Fu, Ye; Dominissini, Dan; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA.
   [Dominissini, Dan; Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel.
   [Dominissini, Dan; Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.
C3 University of Chicago; University of Chicago; Chaim Sheba Medical Center; Tel Aviv University
RP He, C (corresponding author), Univ Chicago, Dept Chem, 929 East 57th St, Chicago, IL 60637 USA.
EM chuanhe@uchicago.edu
FU US National Institutes of Health [GM071440]; EUREKA [GM088599]; Israel Science Foundation; Flight Attendant Medical Research Institute (FAMRI); Israeli Centers of Research Excellence
CR Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4
   Agarwala SD, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002732
   Aik W, 2014, NUCL ACIDS RES, V0, P0
   Alexandrov A, 2002, RNA, V8, P1253, DOI 10.1017/S1355838202024019
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611
   Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021
   Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012
   BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X
   Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042
   Bird A, 2001, SCIENCE, V294, P2113, DOI 10.1126/science.1066726
   Bodi Z, 2012, FRONT PLANT SCI, V3, P0, DOI 10.3389/fpls.2012.00048
   Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266
   Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002
   Bokar JA, 1997, RNA, V3, P1233
   Bokar JA, 2005, TOP CURR GENET, V12, P141, DOI 10.1007/b106365
   Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080
   Bujnicki JM, 2002, J MOL EVOL, V55, P431, DOI 10.1007/s00239-002-2339-8
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   CARROLL SM, 1990, MOL CELL BIOL, V10, P4456, DOI 10.1128/MCB.10.9.4456
   Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990
   Chen WZ, 2014, FEBS LETT, V588, P892, DOI 10.1016/j.febslet.2014.02.021
   Chujo T, 2012, RNA, V18, P2269, DOI 10.1261/rna.035600.112
   Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713
   Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573
   CSEPANY T, 1990, J BIOL CHEM, V265, P20117
   Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107
   Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Dormoy-Raclet V, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3388
   Edelheit S, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003602
   Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080
   Fernández IS, 2013, NATURE, V500, P107, DOI 10.1038/nature12302
   Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
   Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848
   Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634
   Fu Y, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2822
   Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242
   Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026
   Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106
   Ge JH, 2013, TRENDS BIOCHEM SCI, V38, P210, DOI 10.1016/j.tibs.2013.01.002
   Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710
   Ghosh S, 2010, WIRES RNA, V1, P351, DOI 10.1002/wrna.25
   Grosjean H, 2005, FINE TUNING RNA FUNC, V0, P0
   Grosjean HBR, 1998, MODIFICATION EDITING, V0, P0
   Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110
   Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017
   Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921
   Harcourt EM, 2013, J AM CHEM SOC, V135, P19079, DOI 10.1021/ja4105792
   Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881
   He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482
   He L, 2004, NAT REV GENET, V5, P522
   He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944
   Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449
   Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108
   Horiuchi K, 2013, J BIOL CHEM, V288, P33292, DOI 10.1074/jbc.M113.500397
   Hussain S, 2013, GENOME BIOL, V14, P0, DOI 10.1186/gb4143
   Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402
   Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597
   Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580
   Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019
   Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI 10.1038/NCHEMBIO.687
   Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230
   Karijolich J, 2011, NATURE, V474, P395, DOI 10.1038/nature10165
   Karikó K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008
   Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020
   Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111
   KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1
   Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379
   Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4472, DOI 10.1093/nar/gkg633
   Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945
   Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750
   KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976
   Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008
   Leulliot N, 2008, STRUCTURE, V16, P52, DOI 10.1016/j.str.2007.10.025
   Little NA, 2000, HUM MOL GENET, V9, P2231, DOI 10.1093/oxfordjournals.hmg.a018914
   Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432
   Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113
   Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, PD262, DOI 10.1093/nar/gks1007
   Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Mishina Y, 2006, CHEM REV, V106, P215, DOI 10.1021/cr0404702
   Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79
   Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007
   NARAYAN P, 1988, SCIENCE, V242, P1159, DOI 10.1126/science.3187541
   NARAYAN P, 1994, NUCLEIC ACIDS RES, V22, P419, DOI 10.1093/nar/22.3.419
   Newby MI, 2002, NAT STRUCT BIOL, V9, P958, DOI 10.1038/nsb873
   Ozanick S, 2005, RNA, V11, P1281, DOI 10.1261/rna.5040605
   Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121
   Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3
   Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861
   Robbens S, 2008, J MOL EVOL, V66, P80, DOI 10.1007/s00239-007-9059-z
   ROTTMAN F, 1974, CELL, V3, P197, DOI 10.1016/0092-8674(74)90131-7
   Rottman F M, 1976, PROG NUCLEIC ACID RES MOL BIOL, V19, P21
   Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158
   Saletore Y, 2012, GENOME BIOL, V13, P0, DOI 10.1186/gb-2012-13-10-175
   SCHIBLER U, 1977, J MOL BIOL, V115, P695, DOI 10.1016/0022-2836(77)90110-3
   Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160
   Schwanhäusser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047
   Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115
   Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312
   Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320
   Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218
   Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144
   Srikantan S, 2011, MOL CELL, V43, P319, DOI 10.1016/j.molcel.2011.07.016
   Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412
   Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341
   Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116
   van den Born E, 2011, NAT COMMUN, V2, P0, DOI 10.1038/ncomms1173
   Vilfan ID, 2013, J NANOBIOTECHNOL, V11, P0, DOI 10.1186/1477-3155-11-8
   Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730
   Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902
   WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023
   WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0
   Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223
   Yang F, 2004, MOL CELL, V14, P435, DOI 10.1016/S1097-2765(04)00264-3
   Zheng GQ, 2013, RNA BIOL, V10, P915, DOI 10.4161/rna.24711
   Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015
   Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883
NR 122
TC 1348
Z9 1515
U1 42
U2 678
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0056
EI 1471-0064
J9 NAT REV GENET
JI Nat. Rev. Genet.
PD MAY 15
PY 2014
VL 15
IS 5
BP 293
EP 306
DI 10.1038/nrg3724
PG 14
WC Genetics & Heredity
SC Genetics & Heredity
GA AF3GM
UT WOS:000334599700008
PM 24662220
DA 2024-11-01
ER

PT J
AU Rubegni, A
   Cardaioli, E
   Chini, E
   Da Pozzo, P
   Battisti, C
   Malandrini, A
   Federico, A
AF Rubegni, Anna
   Cardaioli, Elena
   Chini, Elena
   Da Pozzo, Paola
   Battisti, Carla
   Malandrini, Alessandro
   Federico, Antonio
TI A case of 3243A&gt;G mutation in mtDNA presenting as apparently idiopathic hyperCKemia
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE MELAS syndrome; Mitochondrial myopathy; Idiopathic hyperCKemia; 3243A > G mutation; Heteroplasmy; Mutation load
ID mitochondrial-dna; clinical phenotypes; melas; population; heteroplasmy; diagnosis; disease; urine; blood; merrf
AB The 3243A>G mutation of mtDNA usually is associated with MELAS syndrome. Here we report a patient with the 3243A>G mutation presenting only recurrent muscle fatigue and elevated levels of serum creatine kinase (CK). The mother of the proband was referred to us for type 2 diabetes mellitus, muscle pain and sensorineural hearing loss. The percentage of mutation load in different tissues was similar in both subjects, except in the urinary epithelium. The mutation load in the son's urinary epithelial cells (UEC) was consistently higher (nearly 50%) than in his muscle (nearly 20%). We conclude that a correlation between the proportion of the UEC mutation load and the severity of the disease was lacking in this pedigree. The use of UEC as the tissue of choice in the noninvasive diagnosis of the 3243A>G mutation offers a very attractive alternative to muscle biopsy. Finally, our data expand the clinical spectrum of the 3243A>G mutation. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Rubegni, Anna; Cardaioli, Elena; Chini, Elena; Da Pozzo, Paola; Battisti, Carla; Malandrini, Alessandro; Federico, Antonio] Univ Siena, Dept Med Surg & Neurol Sci, I-53100 Siena, Italy.
C3 University of Siena
RP Malandrini, A (corresponding author), Univ Siena, Dept Med Surg & Neurol Sci, Neurometab Unit, Viale Bracci 2, I-53100 Siena, Italy.
EM alessandro.malandrini@unisi.it
CR Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Mancuso M, 2012, NEUROMUSCULAR DISORD, V22, PS226, DOI 10.1016/j.nmd.2012.10.012
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 14
TC 4
Z9 4
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAR 15
PY 2014
VL 338
IS 1-2
BP 232
EP 234
DI 10.1016/j.jns.2014.01.010
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AE3NO
UT WOS:000333883400044
PM 24468540
DA 2024-11-01
ER

PT J
AU Puente-Maestu, L
   Chancafe-Morgan, J
AF Puente-Maestu, Luis
   Chancafe-Morgan, Jorge
TI Mitochondrial Function in Lung Health and Disease
SO MITOCHONDRIAL FUNCTION IN LUNG HEALTH AND DISEASE
LA English
DT Article; Book Chapter
DE Apoptosis; Mitochondria; Permeability transition pore; Electron transport chain; Reactive oxygen species; Hypoxic vasoconstriction; Cell signaling; Skeletal muscle dysfunction; Remodeling; HIF; Mitochondrial DNA mutations
ID obstructive pulmonary-disease; epithelial-cell apoptosis; permeability transition pore; quadriceps femoris muscle; metabolic enzyme-activity; vastus lateralis muscle; oxidative stress; skeletal-muscle; complex-iii; oxygen dependence
AB The mitochondrion is a membrane-enclosed organelle found in most eukaryotic cells. In addition to supplying cellular energy, mitochondria are involved in a range of other processes, such as signaling and cell death. The mitochondrion is able to sense PO2 throughout the progressive reduction of cytochrome c with increasing hypoxia. This information is converted into an increase in reactive oxygen species production at complex III that acts as cell signal. Such signal is believed to be responsible for phenomena such as hypoxic vasoconstriction, activation of HIF, and internalization of the sodium-potassium pump of the alveolar epithelium. Mitochondrial DNA mutations are frequent in cancer cells. These mutations lead to an impaired oxidative metabolism and to decreased susceptibility to apoptosis. These two features are needed for survival of the cancer cell. There are two major signaling pathways of apoptosis and one of them involves the mitochondria. Apoptosis plays an important role in most lung diseases in two different ways. First, failure to clear unwanted cells by apoptosis will prolong the inflammation; second, excessive apoptosis may cause diseases. Finally the skeletal muscle dysfunction associated with COPD involves the loss of oxidative capacity, mainly due to the loss of mitochondrial density.
C1 [Puente-Maestu, Luis; Chancafe-Morgan, Jorge] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Dept Resp Med Neumol, Madrid 28007, Spain.
C3 General University Gregorio Maranon Hospital; Complutense University of Madrid
RP Puente-Maestu, L (corresponding author), Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Dept Resp Med Neumol, Calle Doctor Ezquerdo 46, Madrid 28007, Spain.
EM lpuente.hgugm@salud.madrid.org
CR Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600
   Aoshiba K, 2003, AM J RESP CELL MOL, V28, P555, DOI 10.1165/rcmb.2002-0090OC
   Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200
   Barbas-Filho JV, 2001, J CLIN PATHOL, V54, P132, DOI 10.1136/jcp.54.2.132
   Bardales RH, 1996, AM J PATHOL, V149, P845
   Barreiro E, 2005, AM J RESP CELL MOL, V33, P636, DOI 10.1165/rcmb.2005-0114OC
   Becker LB, 1999, AM J PHYSIOL-HEART C, V277, PH2240, DOI 10.1152/ajpheart.1999.277.6.H2240
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Brenner C, 2006, ONCOGENE, V25, P4744, DOI 10.1038/sj.onc.1209609
   Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002
   Bucchieri F, 2002, AM J RESP CELL MOL, V27, P179, DOI 10.1165/ajrcmb.27.2.4699
   Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, PL955, DOI 10.1152/ajplung.00466.2001
   Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605
   Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200
   Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715
   Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604
   Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924
   Cheng WC, 2006, ONCOGENE, V25, P4697, DOI 10.1038/sj.onc.1209596
   Cohen L, 2007, AM J RESP CRIT CARE, V176, P138, DOI 10.1164/rccm.200607-1062OC
   Comellas AP, 2006, CIRC RES, V98, P1314, DOI 10.1161/01.RES.0000222418.99976.1d
   Connolly MJ, 2010, RESP PHYSIOL NEUROBI, V174, P165, DOI 10.1016/j.resp.2010.08.016
   Couillard A, 2002, EUR RESPIR J, V20, P1123, DOI 10.1183/09031936.02.00014302
   Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233
   Dasgupta S, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0006533
   Dean RT, 1997, BIOCHEM J, V324, P1
   den Hoed M, 2008, J APPL PHYSIOL, V105, P561, DOI 10.1152/japplphysiol.00091.2008
   Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200
   Doucet M, 2004, EUR RESPIR J, V24, P971, DOI 10.1183/09031936.04.00020204
   Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619
   Evans AM, 2011, CURR OPIN ANESTHESIO, V24, P13, DOI 10.1097/ACO.0b013e3283421201
   Evans AM, 2009, ADV EXP MED BIOL, V648, P351, DOI 10.1007/978-90-481-2259-2_40
   Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606
   Fujita M, 1998, INT ARCH ALLERGY IMM, V117, P202, DOI 10.1159/000024011
   Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Guinee D, 1997, AM J PATHOL, V151, P999
   Guinee D, 1996, AM J PATHOL, V149, P531
   Gusarova GA, 2009, MOL CELL BIOL, V29, P3455, DOI 10.1128/MCB.00054-09
   Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001
   Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07
   Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506
   Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200
   Henson Peter M, 2006, PROC AM THORAC SOC, V3, P713, DOI 10.1513/pats.200605-104SF
   Henson Peter M, 2006, PROC AM THORAC SOC, V3, P512
   Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a
   Hiromatsu T, 2003, J INFECT DIS, V187, P1442, DOI 10.1086/374643
   Hoppeler H, 1998, J EXP BIOL, V201, P1051
   Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987
   JAKOBSSON P, 1995, AM J RESP CRIT CARE, V151, P374, DOI 10.1164/ajrccm.151.2.7842194
   Ji LL, 1996, AM J SPORT MED, V24, PS20, DOI 10.1177/036354659602406S05
   Kang MJ, 2007, J IMMUNOL, V178, P1948, DOI 10.4049/jimmunol.178.3.1948
   Kim KH, 2011, BIOCHEM BIOPH RES CO, V404, P541, DOI 10.1016/j.bbrc.2010.12.022
   King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594
   Koechlin C, 2004, AM J RESP CRIT CARE, V169, P1022, DOI 10.1164/rccm.200310-1465OC
   Kroemer G, 2006, ONCOGENE, V25, P4630, DOI 10.1038/sj.onc.1209589
   Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994
   Kuwano K, 1996, AM J RESP CRIT CARE, V154, P477, DOI 10.1164/ajrccm.154.2.8756825
   Kuwano K, 1999, AM J RESP CELL MOL, V20, P53, DOI 10.1165/ajrcmb.20.1.2941
   Kuwano K, 2008, INTERNAL MED, V47, P345, DOI 10.2169/internalmedicine.47.0713
   Kuwano K, 2007, CELL MOL IMMUNOL, V4, P419
   Levine S, 2002, J APPL PHYSIOL, V92, P1205, DOI 10.1152/japplphysiol.00116.2001
   Maltais F, 2000, THORAX, V55, P848, DOI 10.1136/thorax.55.10.848
   Maltais F, 1996, AM J RESP CRIT CARE, V154, P442, DOI 10.1164/ajrccm.154.2.8756820
   Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003
   Matthay MA, 1996, NEW ENGL J MED, V334, P1469, DOI 10.1056/NEJM199605303342209
   Matute-Bello G, 2001, AM J PHYSIOL-LUNG C, V281, PL328, DOI 10.1152/ajplung.2001.281.2.L328
   McBride HM, 2006, CURR BIOL, V16, PR551, DOI 10.1016/j.cub.2006.06.054
   McKeough ZJ, 2006, RESP MED, V100, P1817, DOI 10.1016/j.rmed.2006.01.017
   Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601
   Nagasawa T, 1997, BIOCHEM BIOPH RES CO, V231, P37, DOI 10.1006/bbrc.1996.6034
   Naimi AI, 2011, CLIN PHYSIOL FUNCT I, V31, P124, DOI 10.1111/j.1475-097X.2010.00988.x
   Paine R, 2003, AM J PATHOL, V163, P2397, DOI 10.1016/S0002-9440(10)63594-8
   Picard M, 2008, AM J RESP CRIT CARE, V178, P1040, DOI 10.1164/rccm.200807-1005OC
   Pinho RA, 2007, RESP MED, V101, P1830, DOI 10.1016/j.rmed.2007.02.004
   Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007
   Puente-Maestu L, 2003, EUR J APPL PHYSIOL, V88, P580, DOI 10.1007/s00421-002-0743-9
   Puente-Maestu L, 2009, EUR RESPIR J, V33, P1045, DOI 10.1183/09031936.00112408
   Puente-Maestu L, 2012, AM J RESP CELL MOL, V47, P358, DOI 10.1165/rcmb.2011-0382OC
   Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031
   Rabinovich RA, 2007, EUR RESPIR J, V29, P643, DOI 10.1183/09031936.00086306
   Ribera F, 2003, AM J RESP CRIT CARE, V167, P873, DOI 10.1164/rccm.200206-519OC
   Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595
   Robin E, 2007, J BIOL CHEM, V282, P19133, DOI 10.1074/jbc.M701917200
   RUMSEY WL, 1990, J BIOL CHEM, V265, P15392
   Saltin B, 1977, ANN N Y ACAD SCI, V301, P224, DOI 10.1111/j.1749-6632.1977.tb38201.x
   SANCHEZ J, 1984, B EUR PHYSIOPATH RES, V20, P535
   SAULEDA J, 1995, AM J RESP CRIT CARE, V152, P1137, DOI 10.1164/ajrccm.152.3.7663793
   Schumacker Paul T, 2011, PROC AM THORAC SOC, V8, P477, DOI 10.1513/pats.201103-032MW
   Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69
   Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581
   Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC
   Tonkonogi M, 2000, J PHYSIOL-LONDON, V528, P379, DOI 10.1111/j.1469-7793.2000.00379.x
   Uhal Bruce D, 1998, AMERICAN JOURNAL OF PHYSIOLOGY, V275, P0
   Vadász I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723
   van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V292, PL1211, DOI 10.1152/ajplung.00291.2006
   Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092
   Ward NS, 2000, AM J RESP CELL MOL, V22, P535, DOI 10.1165/ajrcmb.22.5.3808
   Waxman AB, 1998, J CLIN INVEST, V101, P1970, DOI 10.1172/JCI1337
   Waypa GB, 2001, CIRC RES, V88, P1259, DOI 10.1161/hh1201.091960
   Waypa GB, 2002, CIRC RES, V91, P719, DOI 10.1161/01.RES.0000036751.04896.F1
   Waypa GB, 2006, CIRC RES, V99, P970, DOI 10.1161/01.RES.0000247068.75808.3f
   Waypa GB, 2010, RESP PHYSIOL NEUROBI, V174, P201, DOI 10.1016/j.resp.2010.08.007
   Waypa GB, 2010, CIRC RES, V106, P526, DOI 10.1161/CIRCRESAHA.109.206334
   Wijnhoven JH, 2006, RESP MED, V100, P1064, DOI 10.1016/j.rmed.2005.09.029
   WILSON DF, 1988, J BIOL CHEM, V263, P2712
   WILSON DF, 1985, CHEST, V88, PS229, DOI 10.1378/chest.88.4_Supplement.229S
   Zamzami N, 1998, ONCOGENE, V16, P2265, DOI 10.1038/sj.onc.1201989
NR 107
TC 0
Z9 0
U1 0
U2 1
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 2197-7372
EI 2197-7380
J9 RESPIR MED SER
PD JUN 15
PY 2014
VL 15
IS 
BP 161
EP 176
DI 10.1007/978-1-4939-0829-5_8
PG 16
WC Medicine, General & Internal; Respiratory System
SC General & Internal Medicine; Respiratory System
GA BB7TT
UT WOS:000345997400009
DA 2024-11-01
ER

PT J
AU Stumpf, JD
   Copeland, WC
AF Stumpf, Jeffrey D.
   Copeland, William C.
TI MMS Exposure Promotes Increased MtDNA Mutagenesis in the Presence of Replication-Defective Disease-Associated DNA Polymerase γ Variants
SO PLOS GENETICS
LA English
DT Article
ID progressive external ophthalmoplegia; mitochondrial-dna; saccharomyces-cerevisiae; exonuclease activity; catalytic subunit; oxidative stress; mismatch repair; mutations; yeast; gene
AB Mitochondrial DNA (mtDNA) encodes proteins essential for ATP production. Mutant variants of the mtDNA polymerase cause mutagenesis that contributes to aging, genetic diseases, and sensitivity to environmental agents. We interrogated mtDNA replication in Saccharomyces cerevisiae strains with disease-associated mutations affecting conserved regions of the mtDNA polymerase, Mip1, in the presence of the wild type Mip1. Mutant frequency arising from mtDNA base substitutions that confer erythromycin resistance and deletions between 21-nucleotide direct repeats was determined. Previously, increased mutagenesis was observed in strains encoding mutant variants that were insufficient to maintain mtDNA and that were not expected to reduce polymerase fidelity or exonuclease proofreading. Increased mutagenesis could be explained by mutant variants stalling the replication fork, thereby predisposing the template DNA to irreparable damage that is bypassed with poor fidelity. This hypothesis suggests that the exogenous base-alkylating agent, methyl methanesulfonate (MMS), would further increase mtDNA mutagenesis. Mitochondrial mutagenesis associated with MMS exposure was increased up to 30-fold in mip1 mutants containing disease-associated alterations that affect polymerase activity. Disrupting exonuclease activity of mutant variants was not associated with increased spontaneous mutagenesis compared with exonuclease-proficient alleles, suggesting that most or all of the mtDNA was replicated by wild type Mip1. A novel subset of C to G transversions was responsible for about half of the mutants arising after MMS exposure implicating error-prone bypass of methylated cytosines as the predominant mutational mechanism. Exposure to MMS does not disrupt exonuclease activity that suppresses deletions between 21-nucleotide direct repeats, suggesting the MMS-induce mutagenesis is not explained by inactivated exonuclease activity. Further, trace amounts of CdCl2 inhibit mtDNA replication but suppresses MMS-induced mutagenesis. These results suggest a novel mechanism wherein mutations that lead to hypermutation by DNA base-damaging agents and associate with mitochondrial disease may contribute to previously unexplained phenomena, such as the wide variation of age of disease onset and acquired mitochondrial toxicities.
C1 [Stumpf, Jeffrey D.; Copeland, William C.] NIEHS, Mitochondrial DNA Replicat Grp, Mol Genet Lab, NIH,DHHS, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Stumpf, JD (corresponding author), NIEHS, Mitochondrial DNA Replicat Grp, Mol Genet Lab, NIH,DHHS, POB 12233, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU National Institute of Environmental Health Sciences, National Institute of Health [ES-065078]
CR Acevedo-Torres K, 2009, ENVIRON MOL MUTAGEN, V50, P317, DOI 10.1002/em.20462
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   BLACKWOOD W, 1963, ARCH DIS CHILD, V38, P193, DOI 10.1136/adc.38.199.193
   Bogenhagen DF, 2001, PROG NUCLEIC ACID RE, V68, P257
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, MITOCHONDRION, V9, P340, DOI 10.1016/j.mito.2009.05.002
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   COPELAND WC, 1993, J BIOL CHEM, V268, P11028
   Doudican NA, 2005, MOL CELL BIOL, V25, P5196, DOI 10.1128/MCB.25.12.5196-5204.2005
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172
   Johnson AA, 2001, J BIOL CHEM, V276, P38097
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005
   Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Phadnis N, 2006, DNA REPAIR, V5, P829, DOI 10.1016/j.dnarep.2006.04.002
   PIRSEL M, 1993, CARCINOGENESIS, V14, P2105, DOI 10.1093/carcin/14.10.2105
   Pogorzala L, 2009, GENETICS, V182, P699, DOI 10.1534/genetics.109.103796
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313
   Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Yang Y, 2010, DNA REPAIR, V9, P914, DOI 10.1016/j.dnarep.2010.06.005
   Yang Y, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000264
   You HJ, 1999, BIOCHEMISTRY-US, V38, P11298, DOI 10.1021/bi991121i
NR 55
TC 18
Z9 21
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
EI 
J9 PLOS GENET
JI PLoS Genet.
PD OCT 15
PY 2014
VL 10
IS 10
BP 
EP 
DI 10.1371/journal.pgen.1004748
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA AT0UR
UT WOS:000344650700100
PM 25340760
DA 2024-11-01
ER

PT J
AU Copeland, WC
   Longley, MJ
AF Copeland, William C.
   Longley, Matthew J.
TI Mitochondrial genome maintenance in health and disease
SO DNA REPAIR
LA English
DT Article
DE POLG; Mitochondrial DNA replication; mtDNA; Mitochondrial disease; Mutagenesis
ID dna-polymerase-gamma; progressive external ophthalmoplegia; base excision-repair; p55 accessory subunit; mtdna mutator mice; saccharomyces-cerevisiae; point mutations; polg mutations; mammalian mitochondria; oxidative stress
AB Human mitochondria harbor an essential, high copy number, 16,569 base pair, circular DNA genome that encodes 13 gene products required for electron transport and oxidative phosphorylation. Mutation of this genome can compromise cellular respiration, ultimately resulting in a variety of progressive metabolic diseases collectively known as 'mitochondrial diseases'. Mutagenesis of mtDNA and the persistence of mtDNA mutations in cells and tissues is a complex topic, involving the interplay of DNA replication, DNA damage and repair, purifying selection, organelle dynamics, mitophagy, and aging. We briefly review these general elements that affect maintenance of mtDNA, and we focus on nuclear genes encoding the mtDNA replication machinery that can perturb the genetic integrity of the mitochondrial genome. Published by Elsevier B.V.
C1 [Copeland, William C.; Longley, Matthew J.] NIEHS, Mol Genet Lab, NIH, Durham, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, Durham, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU NIH, NIEHS [ES 065078, ES 065080]
CR Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002
   Alexeyev M, 2013, COLD SPRING HARB PERSPECT BIOL, V5, P0, DOI 10.1101/CSHPERSPECT.A012641
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Boyer PL, 2000, P NATL ACAD SCI USA, V97, P3056, DOI 10.1073/pnas.97.7.3056
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   CHI NW, 1994, J BIOL CHEM, V269, P29984
   CHIT NW, 1994, J BIOL CHEM, V269, P29993
   Clayton D A, 1975, BASIC LIFE SCI, V5B, P589
   Cohen BH, 2010, POLG RELATED DISORDE, V0, P0
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Ericson NG, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002689
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407
   García-Gómez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   GROSSMAN LI, 1973, P NATL ACAD SCI USA, V70, P3339, DOI 10.1073/pnas.70.12.3339
   Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Hasson SA, 2013, NATURE, V0, P0
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Kang DC, 2005, CURR MED CHEM, V12, P429, DOI 10.2174/0929867053363081
   Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   McElhinny SAN, 2006, CELL CYCLE, V5, P958, DOI 10.4161/cc.5.9.2736
   McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI 10.1038/nchembio.424
   McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107
   Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Pascucci B, 1997, J MOL BIOL, V273, P417, DOI 10.1006/jmbi.1997.1268
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Pont-Kingdon G, 1998, J MOL EVOL, V46, P419, DOI 10.1007/PL00006321
   PONTKINGDON GA, 1995, NATURE, V375, P109, DOI 10.1038/375109b0
   REENAN RAG, 1992, GENETICS, V132, P975
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767
   Santos Janine H, 2002, METHODS MOL BIOL, V197, P159, DOI 10.1385/1-59259-284-8:159
   Sia EA, 2000, P NATL ACAD SCI USA, V97, P250, DOI 10.1073/pnas.97.1.250
   Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2009, CELL METAB, V10, P437, DOI 10.1016/j.cmet.2009.11.001
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wan L, 2013, EMBO REP, V14, P1104, DOI 10.1038/embor.2013.159
   Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 132
TC 104
Z9 114
U1 0
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1568-7864
EI 1568-7856
J9 DNA REPAIR
JI DNA Repair
PD JUL 15
PY 2014
VL 19
IS 
BP 190
EP 198
DI 10.1016/j.dnarep.2014.03.010
PG 9
WC Genetics & Heredity; Toxicology
SC Genetics & Heredity; Toxicology
GA AK4QC
UT WOS:000338408200022
PM 24780559
DA 2024-11-01
ER

PT J
AU Hue, THD
   Montanari, A
   Rozanska, A
   Tuppen, HA
   Almalki, AA
   Abg-Kamaludin, DP
   Frontali, L
   Francisci, S
   Lightowlers, RN
   Chrzanowska-Lightowlers, ZM
AF Hue Tran Hornig-Do
   Montanari, Arianna
   Rozanska, Agata
   Tuppen, Helen A.
   Almalki, Abdulraheem A.
   Abg-Kamaludin, Dyg P.
   Frontali, Laura
   Francisci, Silvia
   Lightowlers, Robert N.
   Chrzanowska-Lightowlers, Zofia M.
TI Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE aminoacyl tRNA synthetase; disease; mitochondria; protein synthesis; therapy
ID group-i introns; maturase deficiency; trna(leu(uur)) gene; splicing function; crystal-structure; ef-tu; dna; aminoacylation; disease; protein
AB Disorders of the mitochondrial genome cause a wide spectrum of disease, these present mainly as neurological and/or muscle related pathologies. Due to the intractability of the human mitochondrial genome there are currently no effective treatments for these disorders. The majority of the pathogenic mutations lie in the genes encoding mitochondrial tRNAs. Consequently, the biochemical deficiency is due to mitochondrial protein synthesis defects, which manifest as aberrant cellular respiration and ATP synthesis. It has previously been reported that overexpression of mitochondrial aminoacyl tRNA synthetases has been effective, in cell lines, at partially suppressing the defects resulting from mutations in their cognate mt-tRNAs. We now show that leucyl tRNA synthetase is able to partially rescue defects caused by mutations in non-cognate mt-tRNAs. Further, a C terminal peptide alone can enter mitochondria and interact with the same spectrum of mt-tRNAs as the entire synthetase, in intact cells. These data support the possibility that a small peptide could correct at least the biochemical defect associated with many mt-tRNA mutations, inferring a novel therapy for these disorders.
C1 [Hue Tran Hornig-Do; Rozanska, Agata; Tuppen, Helen A.; Almalki, Abdulraheem A.; Abg-Kamaludin, Dyg P.; Chrzanowska-Lightowlers, Zofia M.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Montanari, Arianna; Frontali, Laura; Francisci, Silvia] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Inst Pasteur, Dept Biol & Biotechnol C Darwin, I-00185 Rome, Italy.
   [Lightowlers, Robert N.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK; Fondazione Cenci Bolognetti; Sapienza University Rome; Newcastle University - UK
RP Lightowlers, RN (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM Robert.Lightowlers@ncl.ac.uk; Zofia.Chrzanowska-Lightowlers@ncl.ac.uk
FU Deutsche Forschungsgemeinschaft (DFG); FEBS; Malaysian Government; BBSRC [BB/F011520/1] Funding Source: UKRI
CR AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1
   Bullard JM, 2000, BBA-GENE STRUCT EXPR, V1490, P245, DOI 10.1016/S0167-4781(99)00240-7
   Bullard JN, 1999, J MOL BIOL, V288, P567, DOI 10.1006/jmbi.1999.2708
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0
   Chomyn A, 1996, METHODS ENZYMOL, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Chrzanowska-Lightowlers Z M A, 2011, NEUROMUSCUL DISORD, V21, P142, DOI 10.1016/j.nmd.2010.10.005
   Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351
   De Luca C, 2006, GENE, V377, P169, DOI 10.1016/j.gene.2006.04.003
   Dennerlein S, 2010, BIOCHEM J, V430, P551, DOI 10.1042/BJ20100757
   DUJARDIN G, 1980, MOL GEN GENET, V179, P469, DOI 10.1007/BF00271736
   Fender A, 2012, BIOCHIMIE, V94, P1090, DOI 10.1016/j.biochi.2012.02.030
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Francisci S, 2011, MITOCHONDRION, V11, P919, DOI 10.1016/j.mito.2011.08.006
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   HERBERT CJ, 1988, EMBO J, V7, P473, DOI 10.1002/j.1460-2075.1988.tb02835.x
   Hornig-Do HT, 2012, EMBO J, V31, P1293, DOI 10.1038/emboj.2011.477
   Hornig-Do HT, 2009, ANAL BIOCHEM, V389, P1, DOI 10.1016/j.ab.2009.02.040
   Houman F, 2000, P NATL ACAD SCI USA, V97, P13743, DOI 10.1073/pnas.240465597
   Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200
   Keogh MJ, 2013, CLIN NEUROL NEUROSUR, V115, P948, DOI 10.1016/j.clineuro.2012.09.030
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   KITTLE JD, 1991, GENE DEV, V5, P1009, DOI 10.1101/gad.5.6.1009
   LABOUESSE M, 1987, EMBO J, V6, P713, DOI 10.1002/j.1460-2075.1987.tb04812.x
   LABOUESSE M, 1985, CELL, V41, P133, DOI 10.1016/0092-8674(85)90068-6
   LABOUESSE M, 1990, MOL GEN GENET, V224, P209, DOI 10.1007/BF00271554
   Larkin DC, 2002, NUCLEIC ACIDS RES, V30, P2103, DOI 10.1093/nar/30.10.2103
   Li GY, 1996, MOL GEN GENET, V252, P667, DOI 10.1007/s004380050275
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   MAJUMDER AL, 1989, MOL CELL BIOL, V9, P2089, DOI 10.1128/MCB.9.5.2089
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0
   Montanari A, 2010, BBA-MOL CELL RES, V1803, P1050, DOI 10.1016/j.bbamcr.2010.05.003
   Myers CA, 2002, P NATL ACAD SCI USA, V99, P2630, DOI 10.1073/pnas.052596299
   Park H, 2008, RNA, V14, P2407, DOI 10.1261/rna.1208808
   PEGG AE, 1988, CANCER RES, V48, P759
   Perli E, 2012, HUM MOL GENET, V21, P85, DOI 10.1093/hmg/ddr440
   Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75
   Rho SB, 2002, EMBO J, V21, P6874, DOI 10.1093/emboj/cdf671
   Rinaldi T, 1997, CURR GENET, V31, P494, DOI 10.1007/s002940050235
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Sarkar J, 2012, J BIOL CHEM, V287, P14772, DOI 10.1074/jbc.M111.322412
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shaag A, 1997, BIOCHEM BIOPH RES CO, V233, P637, DOI 10.1006/bbrc.1997.6496
   Smits P, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/737385
   Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031
   Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Yao P, 2013, TOP CURR CHEM, V0, P0
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 53
TC 33
Z9 34
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD FEB 15
PY 2014
VL 6
IS 2
BP 183
EP 193
DI 10.1002/emmm.201303202
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AA9BU
UT WOS:000331389500004
PM 24413189
DA 2024-11-01
ER

PT J
AU Ardissone, A
   Lamantea, E
   Invernizzi, F
   Zeviani, M
   Genitrini, S
   Moroni, I
   Uziel, G
AF Ardissone, A.
   Lamantea, E.
   Invernizzi, F.
   Zeviani, M.
   Genitrini, S.
   Moroni, I.
   Uziel, G.
TI Mitochondrial Diseases in Childhood
SO CURRENT MOLECULAR MEDICINE
LA English
DT Article
DE Encephalomyocardiopathy; leigh disease; leukoencephalopathy; mitochondrial depletions syndromes; mitochondrial disorder in childhood; respiratory chain defects
ID recessive twinkle mutations; leigh-syndrome; dna depletion; mtdna depletion; alpers-syndrome; barth-syndrome; white-matter; brain-stem; gene; encephalopathy
AB Mitochondrial disorders are a group of heterogeneous diseases associated with abnormalities of the oxidative phosphorylation (OXPHOS), the most important source of energy for the cell. The number of mitochondrial syndromes and of identified causative genes is constantly increasing. Taken as a whole they are among the most frequent genetic diseases in humans at any age. The respiratory chain is the only metabolic pathway under double genome control and molecular genetics of these disorders is complicated by the existence of strict interactions between mitochondrial DNA and nuclear DNA. In childhood and infancy, clinical presentation differs from mitochondrial disorders with adult onset. The phenotypes are much more severe, often involving brain, frequently presenting as multisystemic disorders and seldom as isolated myopathy. Mutations in nDNA are more frequent than in adulthood. The major phenotypes presenting in infancy are here correlated with genetic defects and biochemical data with the aim to facilitate diagnosis work-up.
C1 [Ardissone, A.; Genitrini, S.; Moroni, I.; Uziel, G.] IRCCS, Fdn Carlo Besta, Unit Child Neurol, Neurol Inst, I-20133 Milan, Italy.
   [Lamantea, E.; Invernizzi, F.; Zeviani, M.] IRCCS, Fdn Carlo Besta, Unit Neurogenet, Neurol Inst, I-20133 Milan, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; Fondazione IRCCS Istituto Neurologico Carlo Besta
RP Uziel, G (corresponding author), IRCCS, Fdn Carlo Besta, Unit Child Neurol, Neurol Inst, Via Celoria 11, I-20133 Milan, Italy.
EM uziel53@gmail.com
FU Telethon-Italy [GUP 09004A]; MRC [MC_UP_1002/1] Funding Source: UKRI
CR ABE K, 1990, NEURORADIOLOGY, V32, P77, DOI 10.1007/BF00593950
   Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Brockmann K, 2002, ANN NEUROL, V52, P38, DOI 10.1002/ana.10232
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Fujii T, 1998, PEDIATR NEUROL, V18, P275, DOI 10.1016/S0887-8994(97)00187-2
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Jaberi E, 2013, J HUM GENET, V58, P526, DOI 10.1038/jhg.2013.45
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Lamperti C, 2012, MOL GENET METAB, V107, P403, DOI 10.1016/j.ymgme.2012.08.020
   Lee IC, 2012, HUM MUTAT, V33, P1192, DOI 10.1002/humu.22095
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   MATTHEWS PM, 1993, ANN NEUROL, V33, P652, DOI 10.1002/ana.410330616
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Mineri R, 2008, J MED GENET, V45, P473, DOI 10.1136/jmg.2008.058271
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moroni I, 2002, NEUROPEDIATRICS, V33, P79, DOI 10.1055/s-2002-32372
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Phadke M, 2012, INDIAN J PEDIATR, V79, P650, DOI 10.1007/s12098-011-0618-3
   Piekutowska-Abramczuk D, 2009, CLIN GENET, V76, P195, DOI 10.1111/j.1399-0004.2009.01195.x
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   Prasad C, 2013, MOL GENET METAB, V108, P190, DOI 10.1016/j.ymgme.2012.12.007
   Rahman S, 2001, ANN NEUROL, V49, P797, DOI 10.1002/ana.1060
   Rouzier C, 2010, J MED GENET, V47, P670, DOI 10.1136/jmg.2009.073445
   Salviati L, 2004, AM J MED GENET A, V128A, P195, DOI 10.1002/ajmg.a.30073
   SAMSOM JF, 1994, EUR J PEDIATR, V153, P510, DOI 10.1007/BF01957007
   Savoiardo M, 2002, ANN NEUROL, V51, P138, DOI 10.1002/ana.10031
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Sofou K, 2013, MITOCHONDRION, V13, P364, DOI 10.1016/j.mito.2013.04.008
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Steward CG, 2010, PRENATAL DIAG, V30, P970, DOI 10.1002/pd.2599
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653
   Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Tumino M, 2011, AM J MED GENET A, V155A, P3063, DOI 10.1002/ajmg.a.34288
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Uziel G, 2011, SEMIN FETAL NEONAT M, V16, P205, DOI 10.1016/j.siny.2011.04.003
   van der Knaap MS, 2002, ANN NEUROL, V53, P252
   vanderKnaap MS, 1996, J INHERIT METAB DIS, V19, P535, DOI 10.1007/BF01799114
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Zeviani M, 1999, ITAL J NEUROL SCI, V20, P401
   Zeviani M, 2006, SCI MED, V10, P154
NR 64
TC 4
Z9 5
U1 0
U2 5
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1566-5240
EI 1875-5666
J9 CURR MOL MED
JI Curr. Mol. Med.
PD JUN 15
PY 2014
VL 14
IS 8
BP 1069
EP 1078
DI 10.2174/1566524014666141010155317
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AT4RR
UT WOS:000344929400014
PM 25323866
DA 2024-11-01
ER

PT J
AU Jeppesen, TD
   Duno, M
   Risom, L
   Wibrand, F
   Rafiq, J
   Krag, T
   Jakobsen, J
   Andersen, H
   Vissing, J
AF Jeppesen, Tina Dysgaard
   Duno, Morten
   Risom, Lotte
   Wibrand, Flemming
   Rafiq, Jabin
   Krag, Thomas
   Jakobsen, Johannes
   Andersen, Henning
   Vissing, John
TI A novel de novo mutation of the mitochondrial tRNA<SUP>lys</SUP> gene mt.8340G&gt;A associated with pure myopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Novel mutation; Mitochondrial DNA; MTTK gene; tRNA(lys)
ID transfer-rna mutations
AB Most patients with mutations in the tRNA(lys) gene (MTTK) present with symptoms from the central nervous system (CNS). We describe a 41-year-old woman with pure myopathy associated with a novel de novo mtDNA mutation, mt.8340G>A, which was heteroplasmic in muscle (53%), blood, urine and mouth epithelial cells (<7%). No other family members, including her mother, carried the mutation. She presented with exercise intolerance from age 9, and since age 20 she experienced ptosis and reduced ocular motility. A muscle biopsy revealed ragged red fibres (10%), no COX negative fibres, and many fibres with central nuclei (30%), indicating ongoing damage and repair. The present case expands the mutational and phenotypic spectrum of diseases associated with mutations in MTTK. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Jeppesen, Tina Dysgaard; Rafiq, Jabin; Krag, Thomas; Vissing, John] Univ Copenhagen, Rigshosp, Sect 3342, Neuromuscular Res Unit, DK-2100 Copenhagen, Denmark.
   [Jeppesen, Tina Dysgaard; Jakobsen, Johannes; Vissing, John] Univ Copenhagen, Rigshosp, Dept Neurol, DK-2100 Copenhagen, Denmark.
   [Duno, Morten; Risom, Lotte; Wibrand, Flemming; Andersen, Henning] Univ Copenhagen, Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark.
   [Jeppesen, Tina Dysgaard; Duno, Morten; Risom, Lotte; Wibrand, Flemming; Krag, Thomas; Jakobsen, Johannes; Andersen, Henning; Vissing, John] Univ Aarhus, Aarhus Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark.
C3 University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; Aarhus University
RP Jeppesen, TD (corresponding author), Univ Copenhagen, Rigshosp, Sect 3342, Neuromuscular Res Unit, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM tina@dysgaard.dk
CR Blakely EL, 2007, J NEUROL, V254, P1283, DOI 10.1007/s00415-006-0490-7
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Houshmand M, 1999, HUM MUTAT, V13, P203, DOI 10.1002/(SICI)1098-1004(1999)13:3<203::AID-HUMU4>3.0.CO;2-3
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Muñoz-Málaga A, 2000, MUSCLE NERVE, V23, P538, DOI 10.1002/(SICI)1097-4598(200004)23:4<538::AID-MUS12>3.3.CO;2-K
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Wibrand F, 2010, MUSCLE NERVE, V41, P607, DOI 10.1002/mus.21541
NR 12
TC 12
Z9 12
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD FEB 15
PY 2014
VL 24
IS 2
BP 162
EP 166
DI 10.1016/j.nmd.2013.08.004
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AD2NI
UT WOS:000333072000009
PM 24161205
DA 2024-11-01
ER

PT J
AU Boczonadi, V
   Horvath, R
AF Boczonadi, Veronika
   Horvath, Rita
TI Mitochondria: Impaired mitochondrial translation in human disease
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE Mitochondrial respiratory chain; Mitochondrial translation; Human mitochondrial disease; Tissue specific presentation; Cytosolic translation
ID transfer-rna-synthetase; c-oxidase deficiency; initiation-factor eif2b; hearing-loss; brain-stem; mutations; gene; leukoencephalopathy; underlie; mutant
AB Defects of the mitochondrial protein synthesis cause a subgroup of mitochondrial diseases, which are usually associated with decreased activities of multiple respiratory chain (RC) enzymes. The clinical presentations of these disorders are often disabling, progressive or fatal, affecting the brain, liver, skeletal muscle, heart and other organs. Currently there are no effective cures for these disorders and treatment is at best symptomatic. The diagnosis in patients with multiple respiratory chain complex defects is particularly difficult because of the massive number of nuclear genes potentially involved in intra-mitochondrial protein synthesis. Many of these genes are not yet linked to human disease. Whole exome sequencing rapidly changed the diagnosis of these patients by identifying the primary defect in DNA, and preventing the need for invasive and complex biochemical testing. Better understanding of the mitochondrial protein synthesis apparatus will help us to explore disease mechanisms and will provide clues for developing novel therapies. (C) 2014 The Authors. Published by Elsevier Ltd. All rights reserved.
C1 [Boczonadi, Veronika; Horvath, Rita] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
C3 Newcastle University - UK
RP Horvath, R (corresponding author), Newcastle Univ, Inst Med Genet, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM Rita.Horvath@ncl.ac.uk
FU MRC [G1000848] Funding Source: UKRI
CR Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Bayat V, 2012, PLOS BIOL, V10, P0, DOI 10.1371/journal.pbio.1001288
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Boczonadi V, 2013, HUM MOL GENET, V0, P0
   Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Christian BE, 2012, BBA-GENE REGUL MECH, V1819, P1035, DOI 10.1016/j.bbagrm.2011.11.009
   Christian BE, 2009, BIOCHEMISTRY-US, V48, P3269, DOI 10.1021/bi8023493
   Chrzanowska-Lightowlers Z M A, 2011, NEUROMUSCUL DISORD, V21, P142, DOI 10.1016/j.nmd.2010.10.005
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Crosby AH, 2010, AM J HUM GENET, V87, P655, DOI 10.1016/j.ajhg.2010.09.013
   Delépine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Gaignard P, 2013, JIMD REP, V11, P117, DOI 10.1007/8904_2013_230
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Garcia-Diaz B, 2012, AM J HUM GENET, V91, P729, DOI 10.1016/j.ajhg.2012.08.019
   Gazda HT, 2006, STEM CELLS, V24, P2034, DOI 10.1634/stemcells.2005-0554
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Harmel J, 2013, J BIOL CHEM, V288, P15510, DOI 10.1074/jbc.M113.471649
   Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32
   Herrmann JM, 2013, BBA-MOL CELL RES, V1833, P286, DOI 10.1016/j.bbamcr.2012.03.007
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Janer A, 2012, AM J HUM GENET, V91, P737, DOI 10.1016/j.ajhg.2012.08.020
   Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727
   Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320
   Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200
   Kuzmenko A, 2013, BIOCHIMIE, V0, P0
   Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Neeve VC, 2013, MITOCHONDRION, V0, P0
   Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   PIETROMONACO SF, 1991, BIOCHIMIE, V73, P827, DOI 10.1016/0300-9084(91)90062-6
   Richter R, 2010, EMBO J, V29, P1116, DOI 10.1038/emboj.2010.14
   Ridanpää M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Rossor AM, 2013, NAT REV NEUROL, V9, P562, DOI 10.1038/nrneurol.2013.179
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Sasarman F, 2011, HUM MOL GENET, V20, P4634, DOI 10.1093/hmg/ddr397
   Schara U, 2011, J INHERIT METAB DIS, V34, P197, DOI 10.1007/s10545-010-9250-z
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014
   Shamseldin HE, 2012, J MED GENET, V49, P234, DOI 10.1136/jmedgenet-2012-100836
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711
   Smits P, 2011, EUR J HUM GENET, V19, P394, DOI 10.1038/ejhg.2010.214
   Smits P, 2011, EUR J HUM GENET, V19, P275, DOI 10.1038/ejhg.2010.208
   Smits P, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/737385
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112
   Wang F, 2013, J BIOL CHEM, V288, P29223, DOI 10.1074/jbc.C113.490599
   Wang G, 2012, P NATL ACAD SCI USA, V109, P4840, DOI 10.1073/pnas.1116792109
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Wredenberg A, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003178
   Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 71
TC 146
Z9 171
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD MAR 15
PY 2014
VL 48
IS 
BP 77
EP 84
DI 10.1016/j.biocel.2013.12.011
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA AB8OI
UT WOS:000332049500010
PM 24412566
DA 2024-11-01
ER

PT J
AU Yarham, JW
   Lamichhane, TN
   Pyle, A
   Mattijssen, S
   Baruffini, E
   Bruni, F
   Donnini, C
   Vassilev, A
   He, LP
   Blakely, EL
   Griffin, H
   Santibanez-Koref, M
   Bindoff, LA
   Ferrero, I
   Chinnery, PF
   McFarland, R
   Maraia, RJ
   Taylor, RW
AF Yarham, John W.
   Lamichhane, Tek N.
   Pyle, Angela
   Mattijssen, Sandy
   Baruffini, Enrico
   Bruni, Francesco
   Donnini, Claudia
   Vassilev, Alex
   He, Langping
   Blakely, Emma L.
   Griffin, Helen
   Santibanez-Koref, Mauro
   Bindoff, Laurence A.
   Ferrero, Ileana
   Chinnery, Patrick F.
   McFarland, Robert
   Maraia, Richard J.
   Taylor, Robert W.
TI Defective i<SUP>6</SUP>A37 Modification of Mitochondrial and Cytosolic tRNAs Results from Pathogenic Mutations in TRIT1 and Its Substrate tRNA
SO PLOS GENETICS
LA English
DT Article
ID structural aspects; nuclear; recognition; biogenesis; myopathy; enzyme; genes
AB Identifying the genetic basis for mitochondrial diseases is technically challenging given the size of the mitochondrial proteome and the heterogeneity of disease presentations. Using next-generation exome sequencing, we identified in a patient with severe combined mitochondrial respiratory chain defects and corresponding perturbation in mitochondrial protein synthesis, a homozygous p.Arg323Gln mutation in TRIT1. This gene encodes human tRNA isopentenyltransferase, which is responsible for i(6)A37 modification of the anticodon loops of a small subset of cytosolic and mitochondrial tRNAs. Deficiency of i(6)A37 was previously shown in yeast to decrease translational efficiency and fidelity in a codon-specific manner. Modelling of the p.Arg323Gln mutation on the co-crystal structure of the homologous yeast isopentenyltransferase bound to a substrate tRNA, indicates that it is one of a series of adjacent basic side chains that interact with the tRNA backbone of the anticodon stem, somewhat removed from the catalytic center. We show that patient cells bearing the p.Arg323Gln TRIT1 mutation are severely deficient in i(6)A37 in both cytosolic and mitochondrial tRNAs. Complete complementation of the i(6)A37 deficiency of both cytosolic and mitochondrial tRNAs was achieved by transduction of patient fibroblasts with wild-type TRIT1. Moreover, we show that a previously-reported pathogenic m.7480A>G mt-tRNA(Ser(UCN)) mutation in the anticodon loop sequence A36A37A38 recognised by TRIT1 causes a loss of i(6)A37 modification. These data demonstrate that deficiencies of i(6)A37 tRNA modification should be considered a potential mechanism of human disease caused by both nuclear gene and mitochondrial DNA mutations while providing insight into the structure and function of TRIT1 in the modification of cytosolic and mitochondrial tRNAs.
C1 [Yarham, John W.; Bruni, Francesco; He, Langping; Blakely, Emma L.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Lamichhane, Tek N.; Mattijssen, Sandy; Vassilev, Alex; Maraia, Richard J.] NICHD, Intramural Res Program, NIH, Bethesda, MD USA.
   [Pyle, Angela; Griffin, Helen; Santibanez-Koref, Mauro; Chinnery, Patrick F.] Newcastle Univ, Sch Med, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Baruffini, Enrico; Donnini, Claudia; Ferrero, Ileana] Univ Parma, Dept Life Sci, I-43100 Parma, Italy.
   [Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
C3 Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Newcastle University - UK; University of Parma; University of Bergen; Haukeland University Hospital; University of Bergen
RP Yarham, JW (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM maraiar@mail.nih.gov; robert.taylor@ncl.ac.uk
FU Medical Research Council (UK) Centenary Early Career Award; HEFCE/DoH Clinical Senior Lecturer Award; Wellcome Trust Strategic Award [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; Lily Foundation; UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service in Newcastle upon Tyne; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health; Fondazione CARIPLO [2011/0526]; Wellcome Trust [096919/Z/11/Z] Funding Source: Wellcome Trust; MRC [G0601943, MR/K000608/1, G0800674] Funding Source: UKRI
CR Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Benko AL, 2000, P NATL ACAD SCI USA, V97, P61, DOI 10.1073/pnas.97.1.61
   Bidooki S, 2004, NEUROMUSCULAR DISORD, V14, P417, DOI 10.1016/j.nmd.2004.03.004
   BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609
   Bruni F, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064670
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   CAPONE JP, 1985, EMBO J, V4, P213, DOI 10.1002/j.1460-2075.1985.tb02338.x
   Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14
   GILLMAN EC, 1991, MOL CELL BIOL, V11, P2382, DOI 10.1128/MCB.11.5.2382
   Golovko A, 2000, GENE, V258, P85, DOI 10.1016/S0378-1119(00)00421-2
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790
   Kalakonda S, 2013, P NATL ACAD SCI USA, V110, PE4213, DOI 10.1073/pnas.1303760110
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lamichhane TN, 2013, MOL CELL BIOL, V33, P4900, DOI 10.1128/MCB.01041-13
   Lamichhane TN, 2013, MOL CELL BIOL, V33, P2918, DOI 10.1128/MCB.00278-13
   Lamichhane TN, 2011, RNA, V17, P1846, DOI 10.1261/rna.2628611
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lemieux J, 2001, GENETICS, V159, P147
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301
   Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996
   McKenzie M, 2009, METHOD ENZYMOL, V456, P321, DOI 10.1016/S0076-6879(08)04418-2
   Nicholls TJ, 2013, INT J BIOCHEM CELL B, V45, P845, DOI 10.1016/j.biocel.2013.01.005
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pratt-Hyatt M, 2013, P NATL ACAD SCI USA, V110, PE3081, DOI 10.1073/pnas.1219946110
   Radichev I, 2006, J BIOL CHEM, V281, P23264, DOI 10.1074/jbc.M603873200
   Spinola M, 2005, ONCOGENE, V24, P5502, DOI 10.1038/sj.onc.1208687
   Spinola M, 2007, LUNG CANCER, V55, P271, DOI 10.1016/j.lungcan.2006.10.023
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tolerico LH, 1999, GENETICS, V151, P57
   Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Yokogawa T, 1991, NUCLEIC ACIDS RES, V19, P6101, DOI 10.1093/nar/19.22.6101
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
   Zhou C, 2008, P NATL ACAD SCI USA, V105, P16142, DOI 10.1073/pnas.0805680105
NR 45
TC 106
Z9 112
U1 0
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
EI 
J9 PLOS GENET
JI PLoS Genet.
PD JUN 15
PY 2014
VL 10
IS 6
BP 
EP 
DI 10.1371/journal.pgen.1004424
PG 14
WC Genetics & Heredity
SC Genetics & Heredity
GA AL0WL
UT WOS:000338847700040
PM 24901367
DA 2024-11-01
ER

PT J
AU Adeva-Andany, M
   López-Ojén, M
   Funcasta-Calderón, R
   Ameneiros-Rodríguez, E
   Donapetry-García, C
   Vila-Altesor, M
   Rodríguez-Seijas, J
AF Adeva-Andany, M.
   Lopez-Ojen, M.
   Funcasta-Calderon, R.
   Ameneiros-Rodriguez, E.
   Donapetry-Garcia, C.
   Vila-Altesor, M.
   Rodriguez-Seijas, J.
TI Comprehensive review on lactate metabolism in human health
SO MITOCHONDRION
LA English
DT Review
DE Glycolysis; Tricarboxylic acid cycle; Respiratory chain; Gluconeogenesis; Insulin resistance; Diabetes mellitus
ID human skeletal-muscle; severe lactic-acidosis; pyruvate-dehydrogenase activation; monocarboxylate transporter mct1; renal tubular dysfunction; na+-coupled transporter; forearm glucose-uptake; insulin-resistance; diabetes-mellitus; adipose-tissue
AB Metabolic pathways involved in lactate metabolism are important to understand the physiological response to exercise and the pathogenesis of prevalent diseases such as diabetes and cancer. Monocarboxylate transporters are being investigated as potential targets for diagnosis and therapy of these and other disorders. Glucose and alanine produce pyruvate which is reduced to lactate by lactate dehydrogenase in the cytoplasm without oxygen consumption. Lactate removal takes place via its oxidation to pyruvate by lactate dehydrogenase. Pyruvate may be either oxidized to carbon dioxide producing energy or transformed into glucose. Pyruvate oxidation requires oxygen supply and the cooperation of pyruvate dehydrogenase, the tricarboxylic acid cycle, and the mitochondrial respiratory chain. Enzymes of the gluconeogenesis pathway sequentially convert pyruvate into glucose. Congenital or acquired deficiency on gluconeogenesis or pyruvate oxidation, including tissue hypoxia, may induce lactate accumulation. Both obese individuals and patients with diabetes show elevated plasma lactate concentration compared to healthy subjects, but there is no conclusive evidence of hyperlactatemia causing insulin resistance. Available evidence suggests an association between defective mitochondrial oxidative capacity in the pancreatic beta-cells and diminished insulin secretion that may trigger the development of diabetes in patients already affected with insulin resistance. Several mutations in the mitochondrial DNA are associated with diabetes mellitus, although the pathogenesis remains unsettled. Mitochondrial DNA mutations have been detected in a number of human cancers. D-lactate is a lactate enantiomer normally formed during glycolysis. Excess D-lactate is generated in diabetes, particularly during diabetic ketoacidosis. D-lactic acidosis is typically associated with small bowel resection. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Adeva-Andany, M.; Funcasta-Calderon, R.; Ameneiros-Rodriguez, E.; Donapetry-Garcia, C.; Vila-Altesor, M.; Rodriguez-Seijas, J.] Hosp Gen Juan Cardona, Div Nephrol, La Coruna 15406, Spain.
   [Lopez-Ojen, M.] Policlin Assistens, Div Internal Med, La Coruna 15009, Spain.
RP Adeva-Andany, M (corresponding author), Hosp Gen Juan Cardona, Div Nephrol, Ave Pardo Bazan S-N, La Coruna 15406, Spain.
EM madevaa@yahoo.com
CR Abbot EL, 2005, FEBS J, V272, P3004, DOI 10.1111/j.1742-4658.2005.04713.x
   ABER GM, 1966, NATURE, V212, P1589, DOI 10.1038/2121589a0
   AHLBORG G, 1982, J CLIN INVEST, V69, P45, DOI 10.1172/JCI110440
   AHLBORG G, 1975, J APPL PHYSIOL, V39, P718, DOI 10.1152/jappl.1975.39.5.718
   AHLBORG G, 1974, J CLIN INVEST, V53, P1080, DOI 10.1172/JCI107645
   Ananth S, 2010, BIOCHEM BIOPH RES CO, V394, P75, DOI 10.1016/j.bbrc.2010.02.109
   Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048
   ANDRES R, 1956, J CLIN INVEST, V35, P671, DOI 10.1172/JCI103324
   Avogaro A, 1996, J CLIN INVEST, V98, P108, DOI 10.1172/JCI118754
   Bajpeyi S, 2011, J CLIN ENDOCR METAB, V96, P1160, DOI 10.1210/jc.2010-1621
   BARNETT AH, 1981, BMJ-BRIT MED J, V282, P1656, DOI 10.1136/bmj.282.6277.1656
   Battezzati A, 2004, AM J PHYSIOL-ENDOC M, V286, PE129, DOI 10.1152/ajpendo.00486.2002
   Baud FJ, 2002, CRIT CARE MED, V30, P2044, DOI 10.1097/00003246-200209000-00015
   BAVEREL G, 1979, FEBS LETT, V101, P282, DOI 10.1016/0014-5793(79)81026-1
   Beck-Nielsen H, 2012, DIABETES-METAB RES, V28, P635, DOI 10.1002/dmrr.2337
   Benaissa ML, 2003, INTENS CARE MED, V29, P1372, DOI 10.1007/s00134-003-1866-0
   BENTAL M, 1993, MAGN RESON MED, V29, P317, DOI 10.1002/mrm.1910290307
   Bergman BC, 1999, J APPL PHYSIOL, V87, P1684, DOI 10.1152/jappl.1999.87.5.1684
   Bergman BC, 2009, J PHYSIOL-LONDON, V587, P2087, DOI 10.1113/jphysiol.2008.168286
   Bernal W, 2002, LANCET, V359, P558, DOI 10.1016/S0140-6736(02)07743-7
   BIHARI D, 1985, J HEPATOL, V1, P405, DOI 10.1016/S0168-8278(85)80778-9
   Bokhari S, 2009, AM J PHYSIOL-ENDOC M, V296, PE440, DOI 10.1152/ajpendo.90505.2008
   Bonen A, 2001, EUR J APPL PHYSIOL, V86, P6, DOI 10.1007/s004210100516
   Bonen A, 1998, AM J PHYSIOL-ENDOC M, V274, PE102, DOI 10.1152/ajpendo.1998.274.1.E102
   BONNEFONT JP, 1992, J PEDIATR-US, V121, P255, DOI 10.1016/S0022-3476(05)81199-0
   BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647
   Borron SW, 2012, CURR PHARM BIOTECHNO, V13, P1940
   Borthakur A, 2006, AM J PHYSIOL-GASTR L, V290, PG30, DOI 10.1152/ajpgi.00302.2005
   Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010
   Bouteldja N, 2010, J INHERIT METAB DIS, V33, P105, DOI 10.1007/s10545-010-9053-2
   Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099
   Brindley PG, 2007, CAN MED ASSOC J, V176, P1097, DOI 10.1503/cmaj.061288
   Brown JB, 1998, DIABETES CARE, V21, P1659, DOI 10.2337/diacare.21.10.1659
   Brown SD, 1996, J CRIT CARE, V11, P2, DOI 10.1016/S0883-9441(96)90014-3
   Bruce CR, 2003, J CLIN ENDOCR METAB, V88, P5444, DOI 10.1210/jc.2003-030791
   CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481
   Cao HN, 2004, J CLIN ENDOCR METAB, V89, P898, DOI 10.1210/jc.2003-031361
   CAPALDO B, 1990, J CLIN ENDOCR METAB, V71, P1220, DOI 10.1210/jcem-71-5-1220
   Cersosimo E, 2000, DIABETES, V49, P1186, DOI 10.2337/diabetes.49.7.1186
   Chan CB, 2006, CURR DIABETES REV, V2, P271, DOI 10.2174/157339906777950660
   CHEN YDI, 1993, DIABETES METAB, V19, P348
   CHEN YT, 1990, NEW ENGL J MED, V323, P590, DOI 10.1056/NEJM199008303230907
   Cheng C, 2012, CELL ONCOL, V35, P217, DOI 10.1007/s13402-012-0081-9
   Chi S, 2009, J CARDIOTHOR VASC AN, V23, P711, DOI 10.1053/j.jvca.2009.05.025
   Chioléro R, 1999, ANN SURG, V229, P505, DOI 10.1097/00000658-199904000-00009
   Choi SYC, 2013, J PATHOL, V230, P350, DOI 10.1002/path.4218
   CHRISTENSEN NJ, 1975, EUR J CLIN INVEST, V5, P415, DOI 10.1111/j.1365-2362.1975.tb00473.x
   Coady MJ, 2010, AM J PHYSIOL-CELL PH, V298, PC124, DOI 10.1152/ajpcell.00220.2009
   Coady MJ, 2004, J PHYSIOL-LONDON, V557, P719, DOI 10.1113/jphysiol.2004.063859
   CONNOR H, 1983, ANN NUTR METAB, V27, P481, DOI 10.1159/000176723
   CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550
   CONSOLI A, 1990, AM J PHYSIOL, V259, PE677, DOI 10.1152/ajpendo.1990.259.5.E677
   Cope TE, 2011, MITOCHONDRION, V11, P992, DOI 10.1016/j.mito.2011.08.010
   COPPACK SW, 1990, METABOLISM, V39, P384, DOI 10.1016/0026-0495(90)90253-9
   Coppack SW, 1996, CLIN SCI, V90, P409, DOI 10.1042/cs0900409
   Cox K, 2012, J CRIT CARE, V27, P132, DOI 10.1016/j.jcrc.2011.07.071
   Crawford SO, 2008, AM J HYPERTENS, V21, P1337, DOI 10.1038/ajh.2008.282
   Crawford SO, 2010, INT J EPIDEMIOL, V39, P1647, DOI 10.1093/ije/dyq126
   CRUICKSHANK AM, 1988, INTENS CARE MED, V14, P384, DOI 10.1007/BF00262893
   Cuff MA, 2002, BIOCHEM BIOPH RES CO, V292, P1048, DOI 10.1006/bbrc.2002.6763
   Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421
   Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053
   de Groot R, 2011, NETH J MED, V69, P120
   De Vriese AS, 2006, CLIN INFECT DIS, V42, P1111, DOI 10.1086/501356
   DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902
   DEFRONZO RA, 1991, J CLIN ENDOCR METAB, V73, P1294, DOI 10.1210/jcem-73-6-1294
   DELPRATO S, 1993, J CLIN INVEST, V91, P484, DOI 10.1172/JCI116226
   DEVRESE M, 1990, CLIN NUTR, V9, P23, DOI 10.1016/0261-5614(90)90069-5
   DIAMANT B, 1968, ACTA PHYSIOL SCAND, V72, P383, DOI 10.1111/j.1748-1716.1968.tb03861.x
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Donnino MW, 2007, ANN EMERG MED, V50, P722, DOI 10.1016/j.annemergmed.2006.10.022
   DRUML W, 1986, KLIN WOCHENSCHR, V64, P615, DOI 10.1007/BF01735263
   Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, PE571, DOI 10.1152/ajpendo.2000.278.4.E571
   Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270
   Epker JL, 2010, BMC EMERG MED, V10, P0, DOI 10.1186/1471-227X-10-3
   Essa E, 2011, J CARDIOVASC MAGN R, V13, P0, DOI 10.1186/1532-429X-13-41
   Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112
   Faiz H, 2011, ARCH TOXICOL, V85, P1067, DOI 10.1007/s00204-010-0633-6
   Fannin RD, 2010, HEPATOLOGY, V51, P227, DOI 10.1002/hep.23330
   FELIG P, 1978, DIABETES, V27, P121, DOI 10.2337/diab.27.2.121
   FELIG P, 1971, J CLIN INVEST, V50, P1702, DOI 10.1172/JCI106659
   FELIG P, 1971, J CLIN INVEST, V50, P2703, DOI 10.1172/JCI106771
   FERNANDES J, 1982, LANCET, V1, P113
   Ferriero R, 2013, ONCOTARGET, V4, P804, DOI 10.18632/oncotarget.1000
   Fisher DS, 2013, CLIN TOXICOL, V51, P409, DOI 10.3109/15563650.2013.786833
   Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008
   Fleming JC, 1999, NAT GENET, V22, P305, DOI 10.1038/10379
   Fontenot AP, 2002, CHEST, V122, P1436, DOI 10.1378/chest.122.4.1436
   FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686
   FRALEY DS, 1980, NEW ENGL J MED, V303, P1100, DOI 10.1056/NEJM198011063031907
   Frayn KN, 2012, AM J PHYSIOL-ENDOC M, V302, PE468, DOI 10.1152/ajpendo.00527.2011
   Frederiksen CM, 2008, DIABETOLOGIA, V51, P2068, DOI 10.1007/s00125-008-1122-9
   FRIEDMAN JE, 1994, METABOLISM, V43, P1047, DOI 10.1016/0026-0495(94)90188-0
   FULOP M, 1976, ARCH INTERN MED, V136, P987, DOI 10.1001/archinte.136.9.987
   Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202
   GARCIA CK, 1994, GENOMICS, V23, P500, DOI 10.1006/geno.1994.1532
   Garibotto G, 2004, J AM SOC NEPHROL, V15, P1606, DOI 10.1097/01.ASN.0000127865.26968.36
   Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921
   Gaster M, 2012, BIOCHEM RES INT, V2012, P0, DOI 10.1155/2012/716056
   Gerlinger M, 2012, J PATHOL, V227, P146, DOI 10.1002/path.4006
   GERTZ EW, 1988, J CLIN INVEST, V82, P2017, DOI 10.1172/JCI113822
   Giebelstein J, 2012, DIABETOLOGIA, V55, P1114, DOI 10.1007/s00125-012-2456-x
   Glinghammar B, 2009, INT J MOL MED, V23, P621, DOI 10.3892/ijmm_00000173
   GOLAY A, 1988, DIABETOLOGIA, V31, P585, DOI 10.1007/BF00264764
   GOODGAME JT, 1978, CANCER-AM CANCER SOC, V42, P800, DOI 10.1002/1097-0142(197808)42:2<800::AID-CNCR2820420253>3.0.CO;2-O
   Goodwin Matthew L, 2007, J DIABETES SCI TECHNOL, V1, P558
   Gopal E, 2007, BBA-BIOMEMBRANES, V1768, P2690, DOI 10.1016/j.bbamem.2007.06.031
   Gopal E, 2007, PHARM RES-DORDR, V24, P575, DOI 10.1007/s11095-006-9176-1
   GRAHAM TE, 1989, J APPL PHYSIOL, V66, P561, DOI 10.1152/jappl.1989.66.2.561
   Hadjiagapiou C, 2000, AM J PHYSIOL-GASTR L, V279, PG775, DOI 10.1152/ajpgi.2000.279.4.G775
   HAGSTROM E, 1990, AM J PHYSIOL, V258, PE888, DOI 10.1152/ajpendo.1990.258.5.E888
   Hampson NB, 2012, AM J RESP CRIT CARE, V186, P1095, DOI 10.1164/rccm.201207-1284CI
   HARRIS P, 1962, CLIN SCI, V23, P545
   HEINIG RE, 1979, ARCH INTERN MED, V139, P1229, DOI 10.1001/archinte.139.11.1229
   HENRY RR, 1995, DIABETES, V44, P936, DOI 10.2337/diabetes.44.8.936
   Hey-Mogensen M, 2010, DIABETOLOGIA, V53, P1976, DOI 10.1007/s00125-010-1813-x
   Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200
   Hojlund K, 2010, DIABETOLOGIA, V53, P541, DOI 10.1007/s00125-009-1624-0
   Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006
   Holmäng A, 1998, AM J PHYSIOL-ENDOC M, V274, PE446, DOI 10.1152/ajpendo.1998.274.3.E446
   Hunt TK, 1997, ANN SURG, V226, P108, DOI 10.1097/00000658-199707000-00028
   Huttner HB, 2005, NEUROCRIT CARE, V3, P171, DOI 10.1385/NCC:3:2:171
   Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544
   Ide K, 2000, J PHYSIOL-LONDON, V522, P159, DOI 10.1111/j.1469-7793.2000.t01-2-00159.xm
   Ingaramo M, 2012, J BIOL CHEM, V287, P1813, DOI 10.1074/jbc.M111.275982
   Iwase Kazuhiro, 2002, GASTRIC CANCER, V5, P77, DOI 10.1007/s101200200013
   JACKSON RA, 1986, J CLIN ENDOCR METAB, V63, P594, DOI 10.1210/jcem-63-3-594
   JACKSON RA, 1986, J CLIN ENDOCR METAB, V63, P541, DOI 10.1210/jcem-63-3-541
   JACKSON RA, 1987, METABOLISM, V36, P144, DOI 10.1016/0026-0495(87)90008-4
   JANSSON PA, 1990, DIABETOLOGIA, V33, P253, DOI 10.1007/BF00404805
   JANSSON PA, 1994, J CLIN INVEST, V93, P240, DOI 10.1172/JCI116951
   Ji LN, 2001, CHINESE MED J-PEKING, V114, P1205
   Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709
   Jones DL, 2004, INTERN MED J, V34, P517, DOI 10.1111/j.1444-0903.2004.00659.x
   Jorens PG, 2004, J TOXICOL-CLIN TOXIC, V42, P163, DOI 10.1081/CLT-120030942
   JORFELDT L, 1970, ACTA PHYSIOL SCAND, V0, P1
   Juel C, 2004, J PHYSIOL-LONDON, V556, P297, DOI 10.1113/jphysiol.2003.058222
   JUEL C, 1990, ACTA PHYSIOL SCAND, V140, P147, DOI 10.1111/j.1748-1716.1990.tb08986.x
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   KATZ A, 1986, CLIN PHYSIOL, V6, P365, DOI 10.1111/j.1475-097X.1986.tb00242.x
   Katz J, 1999, AM J PHYSIOL-ENDOC M, V277, PE401, DOI 10.1152/ajpendo.1999.277.3.E401
   Kelleher JK, 1999, AM J PHYSIOL-ENDOC M, V277, PE395, DOI 10.1152/ajpendo.1999.277.3.E395
   KELLER U, 1978, BRIT MED J, V2, P606, DOI 10.1136/bmj.2.6137.606
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   KELLEY DE, 1993, DIABETES CARE, V16, P1158, DOI 10.2337/diacare.16.8.1158
   KELLEY DE, 1990, J CLIN INVEST, V86, P1999, DOI 10.1172/JCI114935
   KELNER MJ, 1985, J ANAL TOXICOL, V9, P40, DOI 10.1093/jat/9.1.40
   Kern PA, 1999, J CLIN ENDOCR METAB, V84, P4185, DOI 10.1210/jc.84.11.4185
   Kerr Caroline A, 2009, BMC RES NOTES, V2, P164, DOI 10.1186/1756-0500-2-164
   Kiilerich K, 2011, J APPL PHYSIOL, V111, P751, DOI 10.1152/japplphysiol.00063.2011
   Kim HJ, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0065283
   King P, 1998, CLIN SCI, V94, P157, DOI 10.1042/cs0940157
   King P, 1997, DIABETIC MED, V14, P19, DOI 10.1002/(SICI)1096-9136(199701)14:1<19::AID-DIA289>3.0.CO;2-0
   KISHIMOTO M, 1995, DIABETOLOGIA, V38, P193, DOI 10.1007/s001250050270
   Klein M, 2004, J EMERG MED, V26, P301, DOI 10.1016/j.jemermed.2003.11.014
   Klier M, 2011, J BIOL CHEM, V286, P27781, DOI 10.1074/jbc.M111.255331
   Koeck T, 2011, CELL METAB, V13, P80, DOI 10.1016/j.cmet.2010.12.007
   KREISBERG RA, 1972, J CLIN ENDOCR METAB, V34, P29, DOI 10.1210/jcem-34-1-29
   KREISBERG RA, 1980, ANN INTERN MED, V92, P227, DOI 10.7326/0003-4819-92-2-227
   KUMAGAI S, 1982, EUR J APPL PHYSIOL, V49, P13, DOI 10.1007/BF00428959
   Kumar A, 2003, CHEST, V123, P1726, DOI 10.1378/chest.123.5.1726
   Landau BR, 1998, AM J PHYSIOL-ENDOC M, V274, PE954, DOI 10.1152/ajpendo.1998.274.5.E954
   Lanza IR, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010538
   Lanza IR, 2009, AM J CLIN NUTR, V89, P467S, DOI 10.3945/ajcn.2008.26717D
   Larsen TS, 2008, J PHYSIOL-LONDON, V586, P2807, DOI 10.1113/jphysiol.2008.151449
   Lauritzen F, 2011, NEUROBIOL DIS, V41, P577, DOI 10.1016/j.nbd.2010.11.005
   Lazzeri C, 2011, DIABETES VASC DIS RE, V8, P35, DOI 10.1177/1479164110396744
   Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107
   Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108
   LEATHERDALE BA, 1980, CLIN SCI, V59, P191, DOI 10.1042/cs0590191
   Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174
   Lemire J, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001550
   LeStunff C, 1996, AM J PHYSIOL-ENDOC M, V271, PE814, DOI 10.1152/ajpendo.1996.271.5.E814
   Levraut J, 1998, AM J RESP CRIT CARE, V157, P1021, DOI 10.1164/ajrccm.157.4.9705037
   Levy B, 2006, CURR OPIN CRIT CARE, V12, P315, DOI 10.1097/01.ccx.0000235208.77450.15
   Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100
   Lin RY, 1998, J BIOL CHEM, V273, P28959, DOI 10.1074/jbc.273.44.28959
   LOVEJOY J, 1992, METABOLISM, V41, P22, DOI 10.1016/0026-0495(92)90185-D
   LOVEJOY J, 1990, INT J OBESITY, V14, P843
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Lu JX, 2011, CLIN CHIM ACTA, V412, P286, DOI 10.1016/j.cca.2010.10.020
   Lubow JM, 2006, AM J PHYSIOL-ENDOC M, V290, PE149, DOI 10.1152/ajpendo.00049.2005
   MACRAE HHS, 1995, PFLUG ARCH EUR J PHY, V430, P964, DOI 10.1007/BF01837410
   MAJANDER A, 1991, PEDIATR RES, V30, P327, DOI 10.1203/00006450-199110000-00007
   Majer M, 1998, MOL GENET METAB, V65, P181, DOI 10.1006/mgme.1998.2748
   Martin PM, 2006, J NEUROCHEM, V98, P279, DOI 10.1111/j.1471-4159.2006.03878.x
   Matthews LT, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0018736
   MCKELVIE RS, 1989, AM J PHYSIOL, V257, PR102, DOI 10.1152/ajpregu.1989.257.1.R102
   Meert KL, 2012, PEDIATR CRIT CARE ME, V13, P28, DOI 10.1097/PCC.0b013e3182196aa2
   Menshikova EV, 2005, AM J PHYSIOL-ENDOC M, V288, PE818, DOI 10.1152/ajpendo.00322.2004
   Messonnier LA, 2013, J APPL PHYSIOL, V114, P1593, DOI 10.1152/japplphysiol.00043.2013
   Metz L, 2005, METABOLISM, V54, P1102, DOI 10.1016/j.metabol.2005.03.015
   Meyer C, 1998, J CLIN INVEST, V102, P619, DOI 10.1172/JCI2415
   Meyer C, 2003, AM J PHYSIOL-ENDOC M, V285, PE819, DOI 10.1152/ajpendo.00145.2003
   Meyer C, 2002, AM J PHYSIOL-ENDOC M, V282, PE428, DOI 10.1152/ajpendo.00116.2001
   Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68
   Misu H, 2007, DIABETOLOGIA, V50, P268, DOI 10.1007/s00125-006-0489-8
   MITCHELL AM, 1955, J CLIN INVEST, V34, P471, DOI 10.1172/JCI103096
   MITRAKOU A, 1990, DIABETES, V39, P1381, DOI 10.2337/diabetes.39.11.1381
   Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200
   Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981
   Moon S, 2011, METABOLISM, V60, P107, DOI 10.1016/j.metabol.2009.12.021
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Muller M, 1996, AM J PHYSIOL-ENDOC M, V271, PE1003, DOI 10.1152/ajpendo.1996.271.6.E1003
   Munoz J, 2011, J CANCER RES THER, V7, P201, DOI 10.4103/0973-1482.82925
   Murray CM, 2005, NAT CHEM BIOL, V1, P371, DOI 10.1038/nchembio744
   Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556
   NAITO E, 1994, PEDIATR RES, V36, P340, DOI 10.1203/00006450-199409000-00013
   NATALI A, 1990, DIABETES, V39, P490, DOI 10.2337/diabetes.39.4.490
   Negrier MLM, 1998, AM J HUM GENET, V63, P1227, DOI 10.1086/302045
   Nichol AD, 2010, CRIT CARE, V14, P0, DOI 10.1186/cc8888
   Nielsen HB, 2002, J APPL PHYSIOL, V92, P1677, DOI 10.1152/japplphysiol.00028.2001
   OHLSON LO, 1988, DIABETOLOGIA, V31, P798
   Olsson AH, 2011, EUR J ENDOCRINOL, V165, P589, DOI 10.1530/EJE-11-0282
   Ortenblad N, 2005, BBA-MOL BASIS DIS, V1741, P206, DOI 10.1016/j.bbadis.2005.04.001
   Otonkoski T, 2007, AM J HUM GENET, V81, P467, DOI 10.1086/520960
   Overgaard M, 2012, FASEB J, V26, P3012, DOI 10.1096/fj.11-191999
   OWEN OE, 1981, J CLIN INVEST, V68, P240, DOI 10.1172/JCI110240
   OWEN OE, 1969, J CLIN INVEST, V48, P574, DOI 10.1172/JCI106016
   PAGLIARA AS, 1972, J CLIN INVEST, V51, P2115, DOI 10.1172/JCI107018
   Paksu MS, 2011, PEDIATR EMERG CARE, V27, P1180, DOI 10.1097/PEC.0b013e31823b412d
   Patel KP, 2012, MOL GENET METAB, V106, P384, DOI 10.1016/j.ymgme.2012.03.016
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   PERRIELLO G, 1995, AM J PHYSIOL-ENDOC M, V269, PE443, DOI 10.1152/ajpendo.1995.269.3.E443
   Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1716, DOI 10.1167/iovs.02-0287
   Pilegaard H, 1999, AM J PHYSIOL-ENDOC M, V276, PE843, DOI 10.1152/ajpendo.1999.276.5.E843
   Pilegaard H, 1999, AM J PHYSIOL-ENDOC M, V276, PE255, DOI 10.1152/ajpendo.1999.276.2.E255
   Price NT, 1998, BIOCHEM J, V329, P321
   PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829
   Queirós O, 2012, J BIOENERG BIOMEMBR, V44, P141, DOI 10.1007/s10863-012-9418-3
   Quinonez SC, 2013, PEDIATR NEUROL, V48, P67, DOI 10.1016/j.pediatrneurol.2012.09.013
   Qvisth V, 2007, AM J PHYSIOL-ENDOC M, V292, PE709, DOI 10.1152/ajpendo.00104.2006
   RADZIUK J, 1983, DIABETES, V32, P977, DOI 10.2337/diabetes.32.11.977
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020
   RECORD CO, 1981, METABOLISM, V30, P638, DOI 10.1016/0026-0495(81)90076-7
   RECORD CO, 1975, GUT, V16, P144, DOI 10.1136/gut.16.2.144
   REMES AM, 1993, NEUROLOGY, V43, P1015, DOI 10.1212/WNL.43.5.1015
   Renault S, 2010, TOXICOL APPL PHARM, V242, P9, DOI 10.1016/j.taap.2009.09.002
   Richardson RS, 1998, J APPL PHYSIOL, V85, P627, DOI 10.1152/jappl.1998.85.2.627
   RINDI G, 1992, J INHERIT METAB DIS, V15, P231, DOI 10.1007/BF01799637
   Ritzhaupt A, 1998, J PHYSIOL-LONDON, V513, P719, DOI 10.1111/j.1469-7793.1998.719ba.x
   ROCHESTER DF, 1973, AM REV RESPIR DIS, V107, P442
   Roth B, 1999, ANN EMERG MED, V33, P452, DOI 10.1016/S0196-0644(99)70312-4
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   SAHLIN K, 1987, BIOCHEM J, V245, P551, DOI 10.1042/bj2450551
   Saksena S, 2009, AM J PHYSIOL-GASTR L, V297, PG878, DOI 10.1152/ajpgi.00283.2009
   Salpeter SR, 2010, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD002967.pub3
   Sandberg Y, 2010, NETH J MED, V68, P320
   Scale T, 2011, CLIN ENDOCRINOL, V74, P191, DOI 10.1111/j.1365-2265.2010.03891.x
   Segrè AV, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001058
   Shah AD, 2011, BRIT J CLIN PHARMACO, V71, P20, DOI 10.1111/j.1365-2125.2010.03765.x
   Shangraw RE, 1998, AM J PHYSIOL-GASTR L, V274, PG569, DOI 10.1152/ajpgi.1998.274.3.G569
   Silverman B, 1997, JAMA-J AM MED ASSOC, V278, P109
   Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166
   Singleton Charles K, 2001, CURRENT MOLECULAR MEDICINE (HILVERSUM), V1, P197, DOI 10.2174/1566524013363870
   Sjöstrand M, 2000, AM J PHYSIOL-ENDOC M, V279, PE1097, DOI 10.1152/ajpendo.2000.279.5.E1097
   Snogdal LS, 2012, DIABETOLOGIA, V55, P340, DOI 10.1007/s00125-011-2377-0
   Soronen J, 2012, BMC MED GENOMICS, V5, P0, DOI 10.1186/1755-8794-5-9
   Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226
   Stades AME, 2004, J INTERN MED, V255, P179, DOI 10.1046/j.1365-2796.2003.01271.x
   Stallknecht B, 1998, SCAND J MED SCI SPOR, V8, P127
   STANLEY WC, 1986, J APPL PHYSIOL, V60, P1116, DOI 10.1152/jappl.1986.60.4.1116
   Steller J, 2014, NEUROPEDIATRICS, V45, P56, DOI 10.1055/s-0033-1341601
   STRINGER W, 1994, J APPL PHYSIOL, V76, P1462, DOI 10.1152/jappl.1994.76.4.1462
   Stumvoll M, 1998, AM J PHYSIOL-ENDOC M, V274, PE817, DOI 10.1152/ajpendo.1998.274.5.E817
   STUMVOLL M, 1995, J CLIN INVEST, V96, P2528, DOI 10.1172/JCI118314
   Suter P M, 2000, J NUTR HEALTH AGING, V4, P69
   Szendroedi J, 2009, DIABETES CARE, V32, P677, DOI 10.2337/dc08-2078
   Talasniemi JP, 2008, CLIN BIOCHEM, V41, P1099, DOI 10.1016/j.clinbiochem.2008.06.011
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   THORBURN AW, 1990, J CLIN INVEST, V85, P522, DOI 10.1172/JCI114468
   Toledo FGS, 2008, DIABETES, V57, P987, DOI 10.2337/db07-1429
   TONSGARD JH, 1982, PEDIATRICS, V69, P64
   Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200
   van der Merwe MT, 2001, J CLIN ENDOCR METAB, V86, P3296, DOI 10.1210/jc.86.7.3296
   van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   vandenBerghe G, 1996, J INHERIT METAB DIS, V19, P470, DOI 10.1007/BF01799108
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Vermeulen RP, 2010, CRIT CARE, V14, P0, DOI 10.1186/cc9253
   WAHREN J, 1971, J CLIN INVEST, V50, P2715, DOI 10.1172/JCI106772
   Walker M, 2005, DIABETIC MED, V22, P18, DOI 10.1111/j.1464-5491.2005.1761f.x
   Walsh TS, 1999, CHEST, V116, P471, DOI 10.1378/chest.116.2.471
   Wang M, 2010, J INT MED RES, V38, P769
   WATERHOUSE C, 1969, J CLIN INVEST, V48, P2359, DOI 10.1172/JCI106202
   WATKINS PJ, 1969, BMJ-BRIT MED J, V1, P744, DOI 10.1136/bmj.1.5646.744
   Watts JA, 2003, ACAD EMERG MED, V10, P985, DOI 10.1197/S1069-6563(03)00319-1
   Willis MS, 2013, INT J BURNS TRAUMA, V3, P1
   WISNESKI JA, 1985, J CLIN INVEST, V76, P1819, DOI 10.1172/JCI112174
   Woerle HJ, 2006, AM J PHYSIOL-ENDOC M, V290, PE67, DOI 10.1152/ajpendo.00529.2004
   Woerle HJ, 2003, AM J PHYSIOL-ENDOC M, V284, PE716, DOI 10.1152/ajpendo.00365.2002
   WOLL PJ, 1979, EUR J CLIN INVEST, V9, P397, DOI 10.1111/j.1365-2362.1979.tb00903.x
   Yánez AJ, 2003, J CELL PHYSIOL, V197, P189, DOI 10.1002/jcp.10337
   YASUDA T, 1993, NEPHRON, V63, P416, DOI 10.1159/000187245
   YKIJARVINEN H, 1990, METABOLISM, V39, P859, DOI 10.1016/0026-0495(90)90133-W
   YKIJARVINEN H, 1985, J CLIN ENDOCR METAB, V61, P941, DOI 10.1210/jcem-61-5-941
   Zar T, 2007, NAT CLIN PRACT NEPHR, V3, P515, DOI 10.1038/ncpneph0573
   ZAWADZKI JK, 1988, DIABETES, V37, P154, DOI 10.2337/diabetes.37.2.154
   Zhang DL, 2003, POSTGRAD MED J, V79, P110, DOI 10.1136/pmj.79.928.110
   Zhang Y, 2010, CANCER GENET CYTOGEN, V196, P124, DOI 10.1016/j.cancergencyto.2009.09.004
   Zosel A, 2010, PHARMACOTHERAPY, V30, P219, DOI 10.1592/phco.30.2.219
   Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136
NR 306
TC 398
Z9 439
U1 8
U2 146
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2014
VL 17
IS 
BP 76
EP 100
DI 10.1016/j.mito.2014.05.007
PG 25
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA AO1LD
UT WOS:000341072700010
PM 24929216
DA 2024-11-01
ER

PT J
AU Chaussenot, A
   Paquis-Flucklinger, V
AF Chaussenot, A.
   Paquis-Flucklinger, V.
TI An overview of neurological and neuromuscular signs in mitochondrial diseases
SO REVUE NEUROLOGIQUE
LA English
DT Article
DE Mitochondrial diseases; MtDNA; Nuclear genome; Progressive external ophthalmoplegia; Exercise intolerance; Cerebellar ataxia; Refractory epilepsy; Movement disorders
ID progressive external ophthalmoplegia; spinal-cord involvement; multiple mtdna deletions; dna-polymerase-gamma; complex i deficiency; high brain lactate; onset spinocerebellar ataxia; hereditary optic neuropathy; stroke-like lesions; polg mutations
AB Mitochondrial disorders have a broad clinical spectrum and are genetically heterogeneous, involving two genomes. These disorders may be develop at any age, with isolated or multiple system involvement, and any pattern of inheritance. Neurological involvement is the most frequent, and concerns muscular, peripheral and central nervous system. Among these diverse signs, some are suggestive of mitochondrial disease, such as progressive external ophthalmoplegia, exercise intolerance, psychomotor regression, stroke-like episodes, refractory epilepsy and Epilepsia Partialis Continua. Others are less specific and mitochondrial hypothesis may be evocated because of either association of different neuromuscular signs or a multisystemic involvement. This review describes the wealth of this neurological and neuromuscular symptomatology through different syndromes reported in the literature, according to preponderant signs and to modes of inheritance, as key elements to guide genetics testing. (C) 2014 Elsevier Masson SAS. All rights reserved.
C1 [Chaussenot, A.; Paquis-Flucklinger, V.] Nice Teaching Hosp, Natl Ctr Mitochondrial Dis, Dept Med Genet, Nice, France.
   [Chaussenot, A.; Paquis-Flucklinger, V.] Univ Nice Sophia Antipolis, UMR CNRS Inserm UNS U1081 7284, IRCAN, F-06189 Nice, France.
C3 CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Cote d'Azur
RP Chaussenot, A (corresponding author), Hop Archet 2 Niveau 3, Serv Genet Med, 151,Route St Antoine de Ginestiere,BP 3079, F-06202 Nice 3, France.
EM chaussenot.a@chu-nice.fr
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Anglin RE, 2012, J NEUROPSYCH CLIN N, V24, P394, DOI 10.1176/appi.neuropsych.11110345
   Auré K, 2004, NEUROLOGY, V63, P727, DOI 10.1212/01.WNL.0000134607.76780.B2
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bayat V, 2012, PLOS BIOL, V10, P0, DOI 10.1371/journal.pbio.1001288
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   BRUYN GW, 1992, J NEUROL SCI, V113, P55, DOI 10.1016/0022-510X(92)90265-M
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Cagnoli C, 2006, BRAIN, V129, P235, DOI 10.1093/brain/awh651
   Cagnoli C, 2010, HUM MUTAT, V31, P1117, DOI 10.1002/humu.21342
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368
   Cerri C, 1983, MITOCHONDRIAL PATHOL, V0, P141
   Chalmers RM, 1996, J NEUROL SCI, V143, P41, DOI 10.1016/S0022-510X(96)00032-9
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   Crosby AH, 2010, AM J HUM GENET, V87, P655, DOI 10.1016/j.ajhg.2010.09.013
   Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Doss S, 2014, J NEUROL, V261, P207, DOI 10.1007/s00415-013-7177-7
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Távora DGF, 2007, ARQ NEURO-PSIQUIAT, V65, P506, DOI 10.1590/S0004-282X2007000300028
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   García-Velasco A, 2003, J INTERN MED, V253, P381, DOI 10.1046/j.1365-2796.2003.01095.x
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gerards M, 2011, BRAIN, V134, P210, DOI 10.1093/brain/awq273
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   Horvath R, 2009, NEUROLOGY, V256, P810
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kevelam SH, 2013, NEUROLOGY, V80, P1577, DOI 10.1212/WNL.0b013e31828f1914
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kolb SJ, 2003, J NEUROL SCI, V216, P11, DOI 10.1016/S0022-510X(03)00218-1
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   Labauge P, 2007, EUR NEUROL, V58, P59, DOI 10.1159/000102171
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Linnankivi T, 2004, NEUROLOGY, V63, P688, DOI 10.1212/01.WNL.0000134658.35601.41
   Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Mendelsohn BA, 2013, JIMD REP, V0, P0
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Ojala T, 2012, PEDIATR RES, V72, P432, DOI 10.1038/pr.2012.92
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Petzold GC, 2006, J NEUROL NEUROSUR PS, V77, P889, DOI 10.1136/jnnp.2005.078568
   Pierson TM, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002325
   Pitceathly RDS, 2013, JAMA NEUROL, V70, P1556, DOI 10.1001/jamaneurol.2013.3242
   Pitceathly RDS, 2013, J NEUROL NEUROSUR PS, V84, P107, DOI 10.1136/jnnp-2012-303232
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Riley LG, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Serkov SV, 2004, NEUROPEDIATRICS, V35, P1, DOI 10.1055/s-2003-43548
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Shimazaki H, 2012, J MED GENET, V49, P777, DOI 10.1136/jmedgenet-2012-101212
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Spiegel R, 2013, EUR J HUM GENET, V2013, P0
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stuart S, 2012, MOL GENET GENOMICS, V287, P837, DOI 10.1007/s00438-012-0723-7
   Szklarczyk R, 2013, HUM MOL GENET, V22, P656, DOI 10.1093/hmg/dds473
   Tarnopolsky MA, 2004, AM J MED GENET A, V125A, P310, DOI 10.1002/ajmg.a.20466
   Thiffault I, 2006, BRAIN, V129, P2332, DOI 10.1093/brain/awl110
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Uluc K, 2008, J NEUROL SCI, V273, P118, DOI 10.1016/j.jns.2008.06.002
   van der Knaap MS, 2003, ANN NEUROL, V53, P252, DOI 10.1002/ana.10456
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Zelnik N, 1996, PEDIATR NEUROL, V14, P251, DOI 10.1016/0887-8994(96)00046-X
NR 140
TC 5
Z9 8
U1 0
U2 8
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0035-3787
EI 2213-0004
J9 REV NEUROL-FRANCE
JI Rev. Neurol.
PD MAY 15
PY 2014
VL 170
IS 5
BP 323
EP 338
DI 10.1016/j.neurol.2014.03.007
PG 16
WC Clinical Neurology
SC Neurosciences & Neurology
GA AH4JK
UT WOS:000336093000003
PM 24792434
DA 2024-11-01
ER

PT J
AU Terawaki, Y
   Nomiyama, T
   Kawanami, T
   Hamaguchi, Y
   Takahashi, H
   Tanaka, T
   Murase, K
   Nagaishi, R
   Tanabe, M
   Yanase, T
AF Terawaki, Yuichi
   Nomiyama, Takashi
   Kawanami, Takako
   Hamaguchi, Yuriko
   Takahashi, Hiroyuki
   Tanaka, Tomoko
   Murase, Kunitaka
   Nagaishi, Ryoko
   Tanabe, Makito
   Yanase, Toshihiko
TI Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury
SO CARDIOVASCULAR DIABETOLOGY
LA English
DT Article
DE DPP-4 inhibitor; Linagliptin; Neointima formation; VSMC proliferation
ID type-2 diabetes-mellitus; glp-1 receptor agonist; cardiovascular safety; mitochondrial-dna; somatic mutation; pooled analysis; sitagliptin; efficacy; disease; cells
AB Background: Recently, glucagon-like peptide-1 (GLP-1)-based therapy, including dipeptidyl peptidase-4 (DPP-4) inhibitors and GLP-1 receptor agonists, has emerged as one of the most popular anti-diabetic therapies. Furthermore, GLP-1-based therapy has attracted increased attention not only for its glucose-lowering ability, but also for its potential as a tissue-protective therapy. In this study, we investigated the vascular-protective effect of the DPP-4 inhibitor, linagliptin, using vascular smooth muscle cells (VSMCs). Methods: Six-week-old male C57BL/6 mice were divided into control (n = 19) and linagliptin (3 mg/kg/day, n = 20) treated groups. Endothelial denudation injuries were induced in the femoral artery at 8 weeks of age, followed by evaluation of neointima formation at 12 weeks. To evaluate cell proliferation of rat aortic smooth muscle cells, a bromodeoxyuridine (BrdU) incorporation assay was performed. Results: Linagliptin treatment reduced vascular injury-induced neointima formation, compared with controls (p < 0.05). In these non-diabetic mice, the body weight and blood glucose levels did not change after treatment with linagliptin. Linagliptin caused an approximately 1.5-fold increase in serum active GLP-1 concentration, compared with controls. In addition, the vascular injury-induced increase in the oxidative stress marker, urinary 8-OHdG, was attenuated by linagliptin treatment, though this attenuation was not statistically significant (p = 0.064). Moreover, linagliptin did not change the serum stromal cell-derived factor-1 alpha (SDF-1 alpha) or the serum platelet-derived growth factor (PDGF) concentration. However, linagliptin significantly reduced in vitro VSMC proliferation. Conclusion: Linagliptin attenuates neointima formation after vascular injury and VSMC proliferation beyond the glucose-lowering effect.
C1 [Terawaki, Yuichi; Nomiyama, Takashi; Kawanami, Takako; Hamaguchi, Yuriko; Takahashi, Hiroyuki; Tanaka, Tomoko; Murase, Kunitaka; Nagaishi, Ryoko; Tanabe, Makito; Yanase, Toshihiko] Fukuoka Univ, Sch Med, Dept Endocrinol & Diabet Mellitus, Jonan Ku, Fukuoka 8140180, Japan.
C3 Fukuoka University
RP Nomiyama, T (corresponding author), Fukuoka Univ, Sch Med, Dept Endocrinol & Diabet Mellitus, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.
EM tnomiyama@fukuoka-u.ac.jp
FU Boehringer Ingelheim; Eli Lilly
CR Albiero M, 2013, VASC PHARMACOL, V58, P253, DOI 10.1016/j.vph.2013.01.003
   Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Ceriello A, 2008, DIABETES VASC DIS RE, V5, P260, DOI 10.3132/dvdr.2008.038
   Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006
   Doupis J, 2014, DRUG DES DEV THER, V8, P431, DOI 10.2147/DDDT.S59523
   Engel SS, 2013, CARDIOVASC DIABETOL, V12, P0, DOI 10.1186/1475-2840-12-3
   Ervinna N, 2013, ENDOCRINOLOGY, V154, P1260, DOI 10.1210/en.2012-1855
   Fadini GP, 2010, DIABETES CARE, V33, P1607, DOI 10.2337/dc10-0187
   Golightly LK, 2012, CLIN PHARMACOKINET, V51, P501, DOI 10.2165/11632930-000000000-00000
   Goto H, 2011, BIOCHEM BIOPH RES CO, V405, P79, DOI 10.1016/j.bbrc.2010.12.131
   Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404
   Ishibashi Y, 2013, CARDIOVASC DIABETOL, V12, P0, DOI 10.1186/1475-2840-12-125
   Johansen OE, 2012, CARDIOVASC DIABETOL, V11, P0, DOI 10.1186/1475-2840-11-3
   Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029
   Kröller-Schön S, 2012, CARDIOVASC RES, V96, P140, DOI 10.1093/cvr/cvs246
   Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707
   Lim S, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035007
   Murohara T, 2012, J AM COLL CARDIOL, V59, P277, DOI 10.1016/j.jacc.2011.09.050
   Nomiyama T, 2004, ANN NY ACAD SCI, V1011, P193, DOI 10.1196/annals.1293.020
   Nomiyama T, 2004, BIOCHEM BIOPH RES CO, V320, P639, DOI 10.1016/j.bbrc.2004.06.019
   Nomiyama T, 2002, DIABETOLOGIA, V45, P1577, DOI 10.1007/s00125-002-0893-7
   Nomiyama T, 2014, DIABETES, V63, P3891, DOI 10.2337/db13-1169
   Nomiyama T, 2012, DIABETES RES CLIN PR, V95, PE27, DOI 10.1016/j.diabres.2011.08.016
   Nomiyama T, 2009, CIRCULATION, V119, P577, DOI 10.1161/CIRCULATIONAHA.108.822056
   Ogawa M, 2006, IND HEALTH, V44, P179, DOI 10.2486/indhealth.44.179
   Pratley Richard E, 2008, REV DIABET STUD, V5, P73, DOI 10.1900/RDS.2008.5.73
   Round EM, 2014, DRUG AGING, V31, P203, DOI 10.1007/s40266-014-0155-7
   Scheen AJ, 2004, DIABETES CARE, V27, P1840, DOI 10.2337/diacare.27.7.1840
   Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684
   Takai S, 2014, J PHARMACOL SCI, V125, P386, DOI 10.1254/jphs.14052FP
   Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F
   Ussher JR, 2014, CIRC RES, V114, P1788, DOI 10.1161/CIRCRESAHA.114.301958
   Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052
   von Eynatten M, 2013, CARDIOVASC DIABETOL, V12, P0, DOI 10.1186/1475-2840-12-60
   White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889
   Zeng ZP, 2013, CURR MED RES OPIN, V29, P921, DOI 10.1185/03007995.2013.805123
NR 37
TC 40
Z9 43
U1 1
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2840
EI 
J9 CARDIOVASC DIABETOL
JI Cardiovasc. Diabetol.
PD NOV 19
PY 2014
VL 13
IS 
BP 
EP 
DI 10.1186/s12933-014-0154-3
PG 8
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism
GA AW1QP
UT WOS:000346064700002
PM 25407968
DA 2024-11-01
ER

PT J
AU Liu, KM
   Zhao, H
   Ji, KQ
   Yan, CZ
AF Liu, Kaiming
   Zhao, Hui
   Ji, Kunqian
   Yan, Chuanzhu
TI MERRF/MELAS overlap syndrome due to the m.3291T&gt;C mutation
SO METABOLIC BRAIN DISEASE
LA English
DT Article
DE Point mutation; m.3291T > C(tRNALeu(UUR)); MERRF; MELAS; Mitochondrial DNA (mtDNA)
ID mitochondrial-dna mutation; merrf-melas overlap; clinical-features; transfer rnalys; point mutation; family; gene; encephalomyopathy; disease; muscle
AB We report the case of a 19-year-old Chinese female harboring the m.3291T > C mutation in the MT-TL1 gene encoding the mitochondrial transfer RNA for leucine. She presented with a complex phenotype characterized by progressive cerebellar ataxia, frequent myoclonus seizures, recurrent stroke-like episodes, migraine-like headaches with nausea and vomiting, and elevated resting lactate blood level. It is known that the myoclonus epilepsy with ragged-red fibers (MERRF) is characterized by cerebellar ataxia and myoclonus epilepsy, while that the mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is characterized by recurrent stroke-like episodes, migraine-like headaches, and elevated resting lactate blood level. So the patient's clinical manifestations suggest the presence of a MERRF/MELAS overlap syndrome. Muscle biopsy of the patient showed the presence of numerous scattered ragged-red fibers, some cytochrome c oxidase-deficient fibers, and several strongly succinate dehygrogenase-reactive vessels, suggestive of a mitochondrial disorder. Direct sequencing of the complete mitochondrial genome of the proband revealed no mutations other than the T-to-C transition at nucleotide position 3291. Restriction fragment length polymorphism analysis of the proband and her family revealed maternal inheritance of the mutation in a heteroplasmic manner. The analysis of aerobic respiration and glycolysis demonstrated that the fibroblasts from the patient had mitochondrial dysfunction. Our results suggest that the m.3291T > C is pathogenic. This study is the first to describe the m.3291T > C mutation in association with the MERRF/MELAS overlap syndrome.
C1 [Liu, Kaiming; Zhao, Hui; Ji, Kunqian; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Lab Neuromuscular Disorders, Jinan 250012, Peoples R China.
   [Liu, Kaiming; Yan, Chuanzhu] Shandong Univ, Qilu Hosp Shandong Univ, Dept Neurol, Jinan 250012, Peoples R China.
   [Liu, Kaiming] Shandong Univ, Qilu Hosp, Dept Geriatr, Jinan 250012, Peoples R China.
   [Zhao, Hui; Ji, Kunqian; Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Peoples R China.
C3 Shandong University; Shandong University; Shandong University; Shandong University
RP Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp Shandong Univ, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Peoples R China.
EM chuanzhuyan@163.com
FU National Nature Science Foundation of China [81171182]; National Natural Science Foundation for Young Scholars of China [81101157]; Shandong Provincial Natural Science Foundation, China [2009ZRB01893]
CR Campos Y, 1996, MUSCLE NERVE, V19, P187, DOI 10.1002/(SICI)1097-4598(199602)19:2<187::AID-MUS10>3.0.CO;2-S
   Ding Y, 2012, MITOCHONDR DNA, V23, P323, DOI 10.3109/19401736.2012.674119
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hao R, 2004, FEBS LETT, V578, P135, DOI 10.1016/j.febslet.2004.11.004
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Luo C, 2013, J CELL BIOCHEM, V114, P212, DOI 10.1002/jcb.24356
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   Nakamura M, 2010, J MED GENET, V47, P659, DOI 10.1136/jmg.2009.072058
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Patel SP, 2009, INVEST OPHTH VIS SCI, V50, P180, DOI 10.1167/iovs.08-1911
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Salsano E, 2011, J NEUROL SCI, V300, P165, DOI 10.1016/j.jns.2010.09.022
   Sano M, 1996, J NEUROL, V243, P441, DOI 10.1007/BF00900496
   Serra G, 1996, BRAIN DEV-JPN, V18, P185, DOI 10.1016/0387-7604(95)00147-6
   Sunami Y, 2011, NEUROL SCI, V32, P861, DOI 10.1007/s10072-011-0719-9
   Uziel G, 2000, NEUROMUSCULAR DISORD, V10, P415, DOI 10.1016/S0960-8966(99)00115-7
   Yarham JW, 2013, J NEUROL SCI, V325, P165, DOI 10.1016/j.jns.2012.12.003
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   Zeviani Massimo, 1993, EUROPEAN JOURNAL OF HUMAN GENETICS, V1, P80
NR 22
TC 15
Z9 22
U1 0
U2 16
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0885-7490
EI 1573-7365
J9 METAB BRAIN DIS
JI Metab. Brain Dis.
PD MAR 15
PY 2014
VL 29
IS 1
BP 139
EP 144
DI 10.1007/s11011-013-9464-5
PG 6
WC Endocrinology & Metabolism; Neurosciences
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA AB7JM
UT WOS:000331965900014
PM 24338029
DA 2024-11-01
ER

PT J
AU Gammage, PA
   Rorbach, J
   Vincent, AI
   Rebar, EJ
   Minczuk, M
AF Gammage, Payam A.
   Rorbach, Joanna
   Vincent, Anna I.
   Rebar, Edward J.
   Minczuk, Michal
TI Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE heteroplasmy; zinc finger nuclease; mitochondrial disease; gene therapy
ID zinc-finger nucleases; sequence-specific modification; restriction-endonuclease; localization signal; mtdna heteroplasmy; dna heteroplasmy; copy number; in-vitro; disease; construction
AB We designed and engineered mitochondrially targeted obligate heterodimeric zinc finger nucleases (mtZFNs) for site-specific elimination of pathogenic human mitochondrial DNA (mtDNA). We used mtZFNs to target and cleave mtDNA harbouring the m.8993T>G point mutation associated with neuropathy, ataxia, retinitis pigmentosa (NARP) and the "common deletion" (CD), a 4977-bp repeat-flanked deletion associated with adult-onset chronic progressive external ophthalmoplegia and, less frequently, Kearns-Sayre and Pearson's marrow pancreas syndromes. Expression of mtZFNs led to a reduction in mutant mtDNA haplotype load, and subsequent repopulation of wild-type mtDNA restored mitochondrial respiratory function in a CD cybrid cell model. This study constitutes proof-of-principle that, through heteroplasmy manipulation, delivery of site-specific nuclease activity to mitochondria can alleviate a severe biochemical phenotype in primary mitochondrial disease arising from deleted mtDNA species.
C1 [Gammage, Payam A.; Rorbach, Joanna; Minczuk, Michal] MRC, Mitochondrial Biol Unit, Cambridge, England.
   [Vincent, Anna I.; Rebar, Edward J.] Sangamo BioSci Inc, Richmond, CA USA.
C3 Sangamo Therapeutics, Inc.
RP Minczuk, M (corresponding author), MRC, Mitochondrial Biol Unit, Cambridge, England.
EM michal.minczuk@mrc-mbu.cam.ac.uk
FU Medical Research Council; MRC [MC_U105697135] Funding Source: UKRI
CR Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   Bacman SR, 2012, GENE THER, V19, P1101, DOI 10.1038/gt.2011.196
   Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004
   Carroll D, 2006, NAT PROTOC, V1, P1329, DOI 10.1038/nprot.2006.231
   Carroll J, 2009, ANAL BIOCHEM, V395, P249, DOI 10.1016/j.ab.2009.08.006
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539
   Ellis BL, 2013, GENE THER, V20, P35, DOI 10.1038/gt.2011.211
   Fernández-Martínez J, 2003, J MOL BIOL, V334, P667, DOI 10.1016/j.jmb.2003.09.072
   Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Kim S, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7a
   Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156
   Lightowlers RN, 2011, EMBO REP, V12, P480, DOI 10.1038/embor.2011.93
   Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   MATHENY C, 1994, J BIOL CHEM, V269, P8176
   Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224
   Minczuk M, 2010, METHODS MOL BIOL, V649, P257, DOI 10.1007/978-1-60761-753-2_16
   Minczuk M, 2010, NAT PROTOC, V5, P342, DOI 10.1038/nprot.2009.245
   Palpant NJ, 2013, GENE THER, V20, P121, DOI 10.1038/gt.2012.2
   Papworth M, 2006, GENE, V366, P27, DOI 10.1016/j.gene.2005.09.011
   Pearson H, 2008, NATURE, V455, P160, DOI 10.1038/455160a
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Rorbach J, 2012, NUCLEIC ACIDS RES, V40, P4097, DOI 10.1093/nar/gkr1282
   Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361
   Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10
   Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
NR 42
TC 216
Z9 245
U1 0
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD APR 15
PY 2014
VL 6
IS 4
BP 458
EP 466
DI 10.1002/emmm.201303672
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AE1PR
UT WOS:000333742100006
PM 24567072
DA 2024-11-01
ER

PT J
AU Kumari, U
   Jun, WY
   Bay, BH
   Lyakhovich, A
AF Kumari, U.
   Jun, W. Ya
   Bay, B. Huat
   Lyakhovich, A.
TI Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi Anemia cells
SO ONCOGENE
LA English
DT Article
DE Fanconi Anemia; reactive oxygen species; mitochondria
ID interstrand cross-link; oxidative stress; reactive oxygen; superoxide-dismutase; skeletal-muscle; dna-repair; pathway; mutation; damage; fancd2
AB Fanconi Anemia (FA) is a rare genetic disorder associated with a bone-marrow failure, cancer predisposition and hypersensitivity to DNA crosslinking agents. Majority of the 15 FA genes and encoded proteins characterized so far are integrated into DNA repair pathways, however, other important functions cannot be excluded. FA cells are sensitive to oxidants, and accumulation of oxidized proteins has been characterized for several FA subgroups. Clinical phenotypes of both FA and other closely related diseases suggest altered functions of mitochondria, organelles responsible for cellular energetic metabolism, and also serving as an important producer and the most susceptible target from reactive oxidative species (ROS). In this study, we have shown that elevated level of mitochondrial ROS in FA cells is in parallel with the decrease of mitochondrial membrane potential, the decrease of ATP production, impaired oxygen uptake and pathological changes in the morphology of mitochondria. This is accompanied by inactivation of enzymes that are essential for the energy production (F1F0ATPase and cytochrome C oxidase) and detoxification of ROS (superoxide dismutase, SOD1). In turn, overexpression of SOD1 could rescue oxygen consumption rate in FA-deficient cells. Importantly, the depletion of mitochondria improved survival rate of mitomycin C treated FA cells suggesting that hypersensitivity of FA cells to chemotherapeutic drugs could be in part due to the mitochondria-mediated oxidative stress. On the basis of our results, we propose that deficiency in FA genes lead to disabling mitochondrial ROS-scavenging machinery further affecting mitochondrial functions and suppressing cell respiration.
C1 [Kumari, U.; Lyakhovich, A.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore.
   [Jun, W. Ya; Bay, B. Huat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore.
C3 National University of Singapore; National University of Singapore
RP Lyakhovich, A (corresponding author), Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Coll Rd,Level 6, Singapore 169857, Singapore.
EM lyakhovich@gmail.com
CR Ali SS, 2010, J BIOL CHEM, V285, P32522, DOI 10.1074/jbc.M110.155432
   Allan AC, 1997, PLANT CELL, V9, P1559, DOI 10.1105/tpc.9.9.1559
   AMANO F, 1995, FEBS LETT, V368, P425, DOI 10.1016/0014-5793(95)00700-J
   Bogliolo M, 2002, MUTAGENESIS, V17, P25, DOI 10.1093/mutage/17.1.25
   Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Cossarizza A, 2001, CURR PROTOC CYTOM, V9, P14
   Cuccarolo P, 2010, J BIOMED SCI, V17, P0, DOI 10.1186/1423-0127-17-63
   DALLAPICCOLA B, 1985, HUM GENET, V69, P62, DOI 10.1007/BF00295530
   Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088
   DEGAN P, 1995, CARCINOGENESIS, V16, P735, DOI 10.1093/carcin/16.4.735
   Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Du W, 2012, BLOOD, V119, P4142, DOI 10.1182/blood-2011-09-381970
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Fridlyand LE, 2005, ANN NY ACAD SCI, V1066, P136, DOI 10.1196/annals.1363.019
   Hadjur S, 2001, BLOOD, V98, P1003, DOI 10.1182/blood.V98.4.1003
   Hütter E, 2007, AGING CELL, V6, P245, DOI 10.1111/j.1474-9726.2007.00282.x
   JOENJE H, 1981, NATURE, V290, P142, DOI 10.1038/290142a0
   Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505
   Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750
   Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259
   Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022
   Lyakhovich A, 2010, MOL CANCER RES, V8, P46, DOI 10.1158/1541-7786.MCR-09-0373
   Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241
   Miller SW, 1996, J NEUROCHEM, V67, P1897
   Moldovan GL, 2009, CELL, V139, P1222, DOI 10.1016/j.cell.2009.12.006
   Mukhopadhyay SS, 2006, J CELL BIOL, V175, P225, DOI 10.1083/jcb.200607061
   NORDENSON I, 1977, HEREDITAS, V86, P147
   ONeill HC, 2011, AM J RESP CELL MOL, V45, P323, DOI 10.1165/rcmb.2010-0214OC
   Pagano G, 2004, CARCINOGENESIS, V25, P1899, DOI 10.1093/carcin/bgh194
   Pagano G, 1997, BLOOD, V89, P1111, DOI 10.1182/blood.V89.3.1111
   Pagano G, 2012, BIOL CHEM, V393, P11, DOI 10.1515/BC-2011-227
   Pallardó FV, 2010, BIOGERONTOLOGY, V11, P401, DOI 10.1007/s10522-010-9269-4
   Petrovic S, 2011, BIOL CHEM, V392, P625, DOI 10.1515/BC.2011.064
   Ponte F, 2011, TOXICOLOGY, V289, P52, DOI 10.1016/j.tox.2011.07.009
   Rachek LI, 2007, ENDOCRINOLOGY, V148, P293, DOI 10.1210/en.2006-0998
   Rani R, 2008, CANCER RES, V68, P9693, DOI 10.1158/0008-5472.CAN-08-1790
   RICHTER C, 1991, CHEM-BIOL INTERACT, V77, P1, DOI 10.1016/0009-2797(91)90002-O
   Rousset S, 2002, PHOTOCHEM PHOTOBIOL, V75, P159, DOI 10.1562/0031-8655(2002)075<0159:MAIFAF>2.0.CO;2
   ROUSSET S, 1990, CANCER RES, V50, P2443
   Ruppitsch W, 1997, HUM GENET, V99, P710, DOI 10.1007/s004390050437
   Saadatzadeh MR, 2004, J BIOL CHEM, V279, P16805, DOI 10.1074/jbc.M313721200
   SCHINDLER D, 1988, AM J HUM GENET, V43, P429
   TAKEUCHI T, 1993, CARCINOGENESIS, V14, P1115, DOI 10.1093/carcin/14.6.1115
   Talbot DA, 2004, FEBS LETT, V556, P111, DOI 10.1016/S0014-5793(03)01386-3
   Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92
   Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6
   Vandenberg CJ, 2003, MOL CELL, V12, P247, DOI 10.1016/S1097-2765(03)00281-8
   Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570
   Wu YL, 2010, BLOOD, V116, P3780, DOI 10.1182/blood-2009-11-256016
   Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054
   Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103
NR 53
TC 86
Z9 91
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
EI 1476-5594
J9 ONCOGENE
JI Oncogene
PD JAN 9
PY 2014
VL 33
IS 2
BP 165
EP 172
DI 10.1038/onc.2012.583
PG 8
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity
GA 286BY
UT WOS:000329440700004
PM 23318445
DA 2024-11-01
ER

PT J
AU Burrage, LC
   Tang, S
   Wang, J
   Donti, TR
   Walkiewicz, M
   Luchak, JM
   Chen, LC
   Schmitt, ES
   Niu, ZY
   Erana, R
   Hunter, JV
   Graham, BH
   Wong, LJ
   Scaglia, F
AF Burrage, Lindsay C.
   Tang, Sha
   Wang, Jing
   Donti, Taraka R.
   Walkiewicz, Magdalena
   Luchak, J. Michael
   Chen, Li-Chieh
   Schmitt, Eric S.
   Niu, Zhiyv
   Erana, Rodrigo
   Hunter, Jill V.
   Graham, Brett H.
   Wong, Lee-Jun
   Scaglia, Fernando
TI Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) plus associated with a novel <i>de novo</i> mutation (m.8969G&gt;A) in the mitochondrial encoded <i>ATP6</i> gene
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE MLASA; Lactic acidosis; Mitochondria; ATP6; Mitochondrial myopathy
ID comparative genomic hybridization; molecular diagnosis; missense mutation; yars2 mutations; dna disorders; pus1 gene; depletion
AB Mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) is a rare mitochondrial disorder that has previously been associated with mutations in PUS1 and YARS2. In the present report, we describe a 6-year old male with an MLASA plus phenotype. This patient had features of MLASA in the setting of developmental delay, sensorineural hearing loss, epilepsy, agenesis of the corpus callosum, failure to thrive, and stroke-like episodes. Sequencing of the mitochondrial genome identified a novel de novo, heteroplasmic mutation in the mitochondrial DNA (mtDNA) encoded ATP6 gene (m.8969G>A, p.S148N). Whole exome sequencing did not identify mutations or variants in PUS1 or YARS2 or any known nuclear genes that could affect mitochondrial function and explain this phenotype. Studies of fibroblasts derived from the patient revealed a decrease in oligomycin-sensitive respiration, a finding which is consistent with a complex V defect. Thus, this mutation in MT-ATP6 may represent the first mtDNA point mutation associated with the MLASA phenotype. (C) 2014 Elsevier Inc All rights reserved.
C1 [Burrage, Lindsay C.; Tang, Sha; Wang, Jing; Donti, Taraka R.; Walkiewicz, Magdalena; Luchak, J. Michael; Chen, Li-Chieh; Schmitt, Eric S.; Niu, Zhiyv; Graham, Brett H.; Wong, Lee-Jun; Scaglia, Fernando] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Erana, Rodrigo] Baylor Coll Med, Div Hematol & Oncol, Dept Pediat, Houston, TX 77030 USA.
   [Hunter, Jill V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine
RP Scaglia, F (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.
EM burrage@bcm.edu; stang@ambrygen.com; jwang7@bcm.edu; donti@bcm.edu; Magdalena.Walkiewicz@bcm.edu; jluchak@bcm.edu; ziv28@hotmail.com; eschmitt@bcm.edu; zniu@bcm.edu; rxerana@txch.org; jvhunter@texaschildrens.org; bgraham@bcm.edu; ljwong@bcm.edu; fscaglia@bcm.edu
FU Genzyme/ACMG Foundation for Genetic and Genomic Medicine Medical Genetics Training Award in Clinical Biochemical Genetics; Medical Genetics Research Fellowship Program NIH/NIGMS [NIH T32 GM07526]; NIH/NIGMS [R01 GM098387]; Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH [NIAID P30AI036211, NCI P30CA125123, NCRR S10RR024574]
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Bachmeyer C, 2010, BLOOD, V116, P3681, DOI 10.1182/blood-2010-07-299453
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Casas K, 2004, AM J MED GENET A, V127A, P44, DOI 10.1002/ajmg.a.20652
   Chinault AC, 2009, GENET MED, V11, P518, DOI 10.1097/GIM.0b013e3181abd83c
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144
   Donti TR, 2014, DIS MODEL MECH, V7, P271, DOI 10.1242/dmm.013466
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   INBAL A, 1995, AM J MED GENET, V55, P372, DOI 10.1002/ajmg.1320550325
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Nakajima J, 2014, J HUM GENET, V59, P229, DOI 10.1038/jhg.2013.143
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   RAWLES JM, 1974, AM J MED, V56, P891, DOI 10.1016/0002-9343(74)90820-1
   Riley LG, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Sasarman F, 2002, HUM MOL GENET, V11, P1669, DOI 10.1093/hmg/11.14.1669
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Shahni R, 2013, AM J MED GENET A, V161, P2334, DOI 10.1002/ajmg.a.36065
   Shanske S, 2004, MITOCHONDRION, V4, P403, DOI 10.1016/j.mito.2004.07.026
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721
   Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 25
TC 58
Z9 63
U1 0
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD NOV 15
PY 2014
VL 113
IS 3
BP 207
EP 212
DI 10.1016/j.ymgme.2014.06.004
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA AT3ON
UT WOS:000344844000009
PM 25037980
DA 2024-11-01
ER

PT J
AU Kalko, SG
   Paco, S
   Jou, C
   Rodríguez, MA
   Meznaric, M
   Rogac, M
   Jekovec-Vrhovsek, M
   Sciacco, M
   Moggio, M
   Fagiolari, G
   De Paepe, B
   De Meirleir, L
   Ferrer, I
   Roig-Quilis, M
   Munell, F
   Montoya, J
   López-Gallardo, E
   Ruiz-Pesini, E
   Artuch, R
   Montero, R
   Torner, F
   Nascimento, A
   Ortez, C
   Colomer, J
   Jimenez-Mallebrera, C
AF Graciela Kalko, Susana
   Paco, Sonia
   Jou, Cristina
   Angels Rodriguez, Maria
   Meznaric, Marija
   Rogac, Mihael
   Jekovec-Vrhovsek, Maja
   Sciacco, Monica
   Moggio, Maurizio
   Fagiolari, Gigliola
   De Paepe, Boel
   De Meirleir, Linda
   Ferrer, Isidre
   Roig-Quilis, Manel
   Munell, Francina
   Montoya, Julio
   Lopez-Gallardo, Ester
   Ruiz-Pesini, Eduardo
   Artuch, Rafael
   Montero, Raquel
   Torner, Ferran
   Nascimento, Andres
   Ortez, Carlos
   Colomer, Jaume
   Jimenez-Mallebrera, Cecilia
TI Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies
SO BMC GENOMICS
LA English
DT Article
DE Gene expression; Microarrays; Bioinformatics; Mitochondrial DNA; Mitochondrial DNA depletion; Mitochondrial encephalomyopathy; Thymidine kinase 2; Skeletal muscle; p53; Apoptosis; GDF-15
ID thymidylate biosynthesis pathway; macrophage inhibitory cytokine-1; gene-expression; dna depletion; mutations; localization; disorders; apoptosis; protein
AB Background: Mutations in the gene encoding thymidine kinase 2 (TK2) result in the myopathic form of mitochondrial DNA depletion syndrome which is a mitochondrial encephalomyopathy presenting in children. In order to unveil some of the mechanisms involved in this pathology and to identify potential biomarkers and therapeutic targets we have investigated the gene expression profile of human skeletal muscle deficient for TK2 using cDNA microarrays. Results: We have analysed the whole transcriptome of skeletal muscle from patients with TK2 mutations and compared it to normal muscle and to muscle from patients with other mitochondrial myopathies. We have identified a set of over 700 genes which are differentially expressed in TK2 deficient muscle. Bioinformatics analysis reveals important changes in muscle metabolism, in particular, in glucose and glycogen utilisation, and activation of the starvation response which affects aminoacid and lipid metabolism. We have identified those transcriptional regulators which are likely to be responsible for the observed changes in gene expression. Conclusion: Our data point towards the tumor suppressor p53 as the regulator at the centre of a network of genes which are responsible for a coordinated response to TK2 mutations which involves inflammation, activation of muscle cell death by apoptosis and induction of growth and differentiation factor 15 (GDF-15) in muscle and serum. We propose that GDF-15 may represent a potential novel biomarker for mitochondrial dysfunction although further studies are required.
C1 [Graciela Kalko, Susana] Hosp Clin Barcelona, IDIBAPS, Bioinformat Core Facil, Barcelona, Spain.
   [Paco, Sonia; Jou, Cristina; Angels Rodriguez, Maria; Nascimento, Andres; Ortez, Carlos; Colomer, Jaume; Jimenez-Mallebrera, Cecilia] Hosp St Joan de Deu, Fdn St Joan de Deu, Dept Neurol, Neuromuscular Unit, Barcelona, Spain.
   [Jou, Cristina] Hosp St Joan de Deu, Dept Pathol, Barcelona, Spain.
   [Meznaric, Marija] Univ Ljubljana, Fac Med, Inst Anat, Ljubljana, Slovenia.
   [Rogac, Mihael; Jekovec-Vrhovsek, Maja] Univ Med Ctr Ljubljana, Childrens Hosp, Dept Child Adolescent & Dev Neurol, Ljubljana, Slovenia.
   [Sciacco, Monica; Moggio, Maurizio; Fagiolari, Gigliola] Fdn Osped Maggiore Mangiagalli & Regina Elena, IRCCS, UOS Diagnost Malattie Neuromuscolari, Milan, Italy.
   [De Paepe, Boel; De Meirleir, Linda] Ghent Univ Hosp, Lab Neuropathol, Ghent, Belgium.
   [Ferrer, Isidre] Bellvitge Hosp, Inst Neuropathol, Barcelona, Spain.
   [Roig-Quilis, Manel; Munell, Francina] Vall dHebron Hosp, Neuropaediat Dept, Barcelona, Spain.
   [Montoya, Julio; Lopez-Gallardo, Ester; Ruiz-Pesini, Eduardo] Univ Zaragoza, Biochem & Mol Biol Dept, Zaragoza, Spain.
   [Montoya, Julio; Lopez-Gallardo, Ester; Ruiz-Pesini, Eduardo; Artuch, Rafael; Montero, Raquel; Nascimento, Andres; Colomer, Jaume; Jimenez-Mallebrera, Cecilia] Inst Salud Carlos III, Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain.
   [Artuch, Rafael; Montero, Raquel] Hosp St Joan de Deu, Clin Biochem Dept, Barcelona, Spain.
   [Torner, Ferran] Hosp St Joan de Deu, Orthopaed Surg & Traumatol Dept, Barcelona, Spain.
C3 University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Barcelona; University of Ljubljana; University Medical Centre Ljubljana; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ghent University; Ghent University Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Universitari Vall d'Hebron; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Barcelona; University of Barcelona
RP Jimenez-Mallebrera, C (corresponding author), Hosp St Joan de Deu, Fdn St Joan de Deu, Dept Neurol, Neuromuscular Unit, Barcelona, Spain.
EM cjimenezm@hsjdbcn.org
FU Ministerio de Ciencia e Innovacion & Instituto de Salud Carlos III, Spain [CP09/00011, PI10/00662]; Associazione Amici del Centro del Dino Ferrari-University of Milan; Telethon Network of Genetic Biobanks [GTB1200]; Eurobionank [LLTR-2011-02769]; Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon y Fondo Social Europeo [Grupo B33]; Duchenne Parent Project Spain; Federacion Espanola de Enfermedades Neuromusculares (ASEM)
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108
   Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055
   Brown DA, 2012, CANCER EPIDEM BIOMAR, V21, P337, DOI 10.1158/1055-9965.EPI-11-0786
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Clancy KP, 1996, GENOMICS, V38, P418, DOI 10.1006/geno.1996.0645
   Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   de Mast Q, 2010, HAEMATOL-HEMATOL J, V95, P1068, DOI 10.3324/haematol.2009.019331
   DiMauro S, 2010, ACTA MYOL, V29, P333
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   Dominguez-Rodriguez A, 2011, AM J CARDIOL, V108, P955, DOI 10.1016/j.amjcard.2011.05.028
   Dubowitz V, 2007, MUSCLE BIOPSY: A PRACTICAL APPROACH, V0, P0
   Engel K, 2009, HUM MUTAT, V30, P300, DOI 10.1002/humu.20847
   Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P173, DOI 10.1016/j.siny.2011.04.009
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hulsen T, 2008, BMC GENOMICS, V9, P0, DOI 10.1186/1471-2164-9-488
   Ikeda K, 2003, J BIOL CHEM, V278, P3514, DOI 10.1074/jbc.M204563200
   Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Kotsinas A, 2012, CANCER LETT, V327, P97, DOI 10.1016/j.canlet.2011.12.009
   Kristiansen M, 2011, BMC GENOMICS, V12, P0, DOI 10.1186/1471-2164-12-551
   Lane D, 2010, CSH PERSPECT BIOL, V2, P0, DOI 10.1101/cshperspect.a000893
   Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004
   MacFarlane AJ, 2011, J BIOL CHEM, V286, P44015, DOI 10.1074/jbc.M111.307629
   Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105
   Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80
   Nevo Y, 2002, J CHILD NEUROL, V17, P499, DOI 10.1177/088307380201700705
   Osada M, 2007, BIOCHEM BIOPH RES CO, V354, P913, DOI 10.1016/j.bbrc.2007.01.089
   Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50
   Paco S, 2012, J NEUROPATH EXP NEUR, V71, P894, DOI 10.1097/NEN.0b013e31826c6f7b
   Puisac B, 2012, MOL BIOL REP, V39, P4777, DOI 10.1007/s11033-011-1270-8
   Roth P, 2010, CLIN CANCER RES, V16, P3851, DOI 10.1158/1078-0432.CCR-10-0705
   Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Strelau J, 2000, ADV RES NEURODEGENER, V8, P273
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tong S, 2012, OBSTET GYNECOL, V119, P1000, DOI 10.1097/AOG.0b013e3182518fd3
   Tulinius M, 2011, SEMIN FETAL NEONAT M, V16, P229, DOI 10.1016/j.siny.2011.04.001
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Uziel G, 2011, SEMIN FETAL NEONAT M, V16, P205, DOI 10.1016/j.siny.2011.04.003
   Vadrot N, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0040879
   Vilá MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Villarroya J, 2009, EXP CELL RES, V315, P1429, DOI 10.1016/j.yexcr.2009.02.018
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
   Zhang Jin, 2008, CURR MOL MED, V8, P845, DOI 10.2174/156652408786733748
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
   Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x
NR 55
TC 99
Z9 108
U1 0
U2 21
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
EI 
J9 BMC GENOMICS
JI BMC Genomics
PD FEB 1
PY 2014
VL 15
IS 
BP 
EP 
DI 10.1186/1471-2164-15-91
PG 22
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA AC5QP
UT WOS:000332575900001
PM 24484525
DA 2024-11-01
ER

PT J
AU Callahan, DM
   Bedrin, NG
   Subramanian, M
   Berking, J
   Ades, PA
   Toth, MJ
   Miller, MS
AF Callahan, Damien M.
   Bedrin, Nicholas G.
   Subramanian, Meenakumari
   Berking, James
   Ades, Philip A.
   Toth, Michael J.
   Miller, Mark S.
TI Age-related structural alterations in human skeletal muscle fibers and mitochondria are sex specific: relationship to single-fiber function
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE aging; mitochondria; muscle ultrastructure; sarcopenia
ID dna deletion mutations; cross-bridge kinetics; physical-activity; heart-failure; oxidative capacity; contractile property; vastus lateralis; strength changes; older-adults; young
AB Age-related loss of skeletal muscle mass and function is implicated in the development of disease and physical disability. However, little is known about how age affects skeletal muscle structure at the cellular and ultrastructural levels or how such alterations impact function. Thus we examined skeletal muscle structure at the tissue, cellular, and myofibrillar levels in young (21-35 yr) and older (65-75 yr) male and female volunteers, matched for habitual physical activity level. Older adults had smaller whole muscle tissue cross-sectional areas (CSAs) and mass. At the cellular level, older adults had reduced CSAs in myosin heavy chain II (MHC II) fibers, with no differences in MHC I fibers. In MHC II fibers, older men tended to have fewer fibers with large CSAs, while older women showed reduced fiber size across the CSA range. Older adults showed a decrease in intermyofibrillar mitochondrial size; however, the age effect was driven primarily by women (i.e., age by sex interaction effect). Mitochondrial size was inversely and directly related to isometric tension and myosin-actin cross-bridge kinetics, respectively. Notably, there were no intermyofibrillar or subsarcolemmal mitochondrial fractional content or myofilament ultrastructural differences in the activity-matched young and older adults. Collectively, our results indicate age-related reductions in whole muscle size do not vary by sex. However, age-related structural alterations at the cellular and subcellular levels are different between the sexes and may contribute to different functional phenotypes in ways that modulate sex-specific reductions in physical capacity with age.
C1 [Callahan, Damien M.; Ades, Philip A.; Toth, Michael J.] Univ Vermont, Dept Med, Burlington, VT 05405 USA.
   [Bedrin, Nicholas G.; Subramanian, Meenakumari; Berking, James; Toth, Michael J.; Miller, Mark S.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.
C3 University of Vermont; University of Vermont
RP Miller, MS (corresponding author), Univ Vermont, 127 Hlth Sci Res Facil Bldg,149 Beaumont Ave, Burlington, VT 05405 USA.
EM Mark.Miller@uvm.edu
FU National Institutes of Health [T32-HL-007647, K01-AG-031303, R01-AG-033547, M01 RR-000109]
CR Ahtiainen M, 2012, AGE, V34, P1249, DOI 10.1007/s11357-011-9298-1
   Bertoni-Freddari C, 2002, J AM AGING ASSOC, V25, P101, DOI 10.1007/s11357-002-0008-x
   Brierley EJ, 1997, ANN NEUROL, V41, P114, DOI 10.1002/ana.410410120
   Broskey NT, 2014, J CLIN ENDOCR METAB, V99, P1852, DOI 10.1210/jc.2013-3983
   Callahan DM, 2011, J APPL PHYSIOL, V111, P1345, DOI 10.1152/japplphysiol.00367.2011
   Calvani R, 2013, BIOL CHEM, V394, P393, DOI 10.1515/hsz-2012-0247
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Cerniglia LM, 2007, CLIN PHYSIOL FUNCT I, V27, P249, DOI 10.1111/j.1475-097X.2007.00742.x
   Crane JD, 2010, J GERONTOL A-BIOL, V65, P119, DOI 10.1093/gerona/glp179
   DAntona G, 2003, J PHYSIOL-LONDON, V552, P499, DOI 10.1113/jphysiol.2003.046276
   DAntona G, 2007, EUR J APPL PHYSIOL, V100, P603, DOI 10.1007/s00421-007-0402-2
   Elliott KJ, 2005, BRIT J SPORT MED, V39, P15, DOI 10.1136/bjsm.2003.009886
   FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644
   Goodpaster BH, 2008, J APPL PHYSIOL, V105, P1498, DOI 10.1152/japplphysiol.90425.2008
   GUNDERSEN HJG, 1981, VIRCHOWS ARCH B, V37, P317, DOI 10.1007/BF02892580
   Hansen M, 2011, SCAND J MED SCI SPOR, V21, P62, DOI 10.1111/j.1600-0838.2009.01002.x
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52
   Höök P, 2001, AM J PHYSIOL-CELL PH, V280, PC782, DOI 10.1152/ajpcell.2001.280.4.C782
   Houmard JA, 1998, J APPL PHYSIOL, V85, P1337, DOI 10.1152/jappl.1998.85.4.1337
   Hughes VA, 2001, J GERONTOL A-BIOL, V56, PB209, DOI 10.1093/gerona/56.5.B209
   Hunter SK, 2000, J GERONTOL A-BIOL, V55, PB264, DOI 10.1093/gerona/55.6.B264
   Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838
   Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x
   KELLEY DE, 1991, AM J CLIN NUTR, V54, P509, DOI 10.1093/ajcn/54.3.509
   Kent-Braun JA, 2000, J APPL PHYSIOL, V89, P1072, DOI 10.1152/jappl.2000.89.3.1072
   Krivickas LS, 2001, AM J PHYS MED REHAB, V80, P447, DOI 10.1097/00002060-200106000-00012
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Larsen RG, 2012, APPL PHYSIOL NUTR ME, V37, P88, DOI 10.1139/h11-135
   Larsson L, 2001, INT J SPORT NUTR EXE, V11, PS28, DOI 10.1123/ijsnem.11.s1.s28
   Larsson L, 1978, ACTA PHYSIOL SCAND SUPPL, V457, P1
   Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003
   LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809
   LEXELL J, 1991, J ANAT, V174, P239
   Little JP, 2011, APPL PHYSIOL NUTR ME, V36, P598, DOI 10.1139/h11-076
   Lynch NA, 1999, J APPL PHYSIOL, V86, P188, DOI 10.1152/jappl.1999.86.1.188
   Macera Caroline A, 2005, PREV CHRONIC DIS, V2, P0
   Macera Caroline A, 2005, CLIN J SPORT MED, V15, P200, DOI 10.1097/01.jsm.0000157394.12890.3c
   Mademli L, 2008, J BIOMECH, V41, P1229, DOI 10.1016/j.jbiomech.2008.01.019
   McClung JM, 2006, J APPL PHYSIOL, V100, P2012, DOI 10.1152/japplphysiol.01583.2005
   Miller MS, 2008, BIOPHYS J, V95, P2391, DOI 10.1529/biophysj.108.130005
   Miller MS, 2010, J PHYSIOL-LONDON, V588, P4039, DOI 10.1113/jphysiol.2010.191957
   Miller MS, 2009, CIRC-HEART FAIL, V2, P700, DOI 10.1161/CIRCHEARTFAILURE.109.876433
   Miller MS, 2013, J APPL PHYSIOL, V115, P1004, DOI 10.1152/japplphysiol.00563.2013
   Narici MV, 2003, J APPL PHYSIOL, V95, P2229, DOI 10.1152/japplphysiol.00433.2003
   Nielsen J, 2010, AM J PHYSIOL-ENDOC M, V299, PE1053, DOI 10.1152/ajpendo.00324.2010
   Ochala J, 2007, EUR J APPL PHYSIOL, V100, P491, DOI 10.1007/s00421-006-0184-y
   Ochala J, 2006, PFLUG ARCH EUR J PHY, V452, P464, DOI 10.1007/s00424-006-0065-6
   Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610
   ORLANDER J, 1978, ACTA PHYSIOL SCAND, V104, P249, DOI 10.1111/j.1748-1716.1978.tb06277.x
   Palmer BM, 2007, BIOPHYS J, V93, P760, DOI 10.1529/biophysj.106.101626
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   POGGI P, 1987, ANAT RECORD, V217, P30, DOI 10.1002/ar.1092170106
   Powers SK, 2012, AM J PHYSIOL-ENDOC M, V303, PE31, DOI 10.1152/ajpendo.00609.2011
   Ramamurthy B, 2013, BIOGERONTOLOGY, V14, P293, DOI 10.1007/s10522-013-9430-y
   Rasmussen UF, 2003, PFLUG ARCH EUR J PHY, V446, P270, DOI 10.1007/s00424-003-1022-2
   Romanello V, 2010, CURR HYPERTENS REP, V12, P433, DOI 10.1007/s11906-010-0157-8
   Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60
   Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050
   SCELSI R, 1980, ACTA NEUROPATHOL, V51, P99, DOI 10.1007/BF00690450
   SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   SJOSTROM M, 1982, J HISTOCHEM CYTOCHEM, V30, P1, DOI 10.1177/30.1.7054271
   Thom JM, 2007, EUR J APPL PHYSIOL, V100, P613, DOI 10.1007/s00421-007-0481-0
   Toth MJ, 2006, AM J PHYSIOL-ENDOC M, V291, PE639, DOI 10.1152/ajpendo.00050.2006
   Toth MJ, 2013, J APPL PHYSIOL, V114, P858, DOI 10.1152/japplphysiol.01474.2012
   Toth MJ, 2012, J APPL PHYSIOL, V112, P1864, DOI 10.1152/japplphysiol.01591.2011
   Toth MJ, 2012, J PHYSIOL-LONDON, V590, P1243, DOI 10.1113/jphysiol.2011.219659
   Toth MJ, 2010, INT J CARDIOL, V143, P276, DOI 10.1016/j.ijcard.2009.02.040
   Trappe S, 2003, J PHYSIOL-LONDON, V552, P47, DOI 10.1113/jphysiol.2003.044966
   Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3
   VAILLANT F, 1995, HUM MOL GENET, V4, P903, DOI 10.1093/hmg/4.5.903
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Widrick JJ, 2003, J GERONTOL A-BIOL, V58, P3
   Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697
   ZACHAROVA G, 1995, J MUSCLE RES CELL M, V16, P295, DOI 10.1007/BF00121138
   ZHAO Y, 1993, BIOPHYS J, V64, P197, DOI 10.1016/S0006-3495(93)81357-2
NR 78
TC 69
Z9 75
U1 0
U2 14
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD JUN 15
PY 2014
VL 116
IS 12
BP 1582
EP 1592
DI 10.1152/japplphysiol.01362.2013
PG 11
WC Physiology; Sport Sciences
SC Physiology; Sport Sciences
GA AL5JE
UT WOS:000339169000007
PM 24790014
DA 2024-11-01
ER

PT J
AU Giordano, C
   Iommarini, L
   Giordano, L
   Maresca, A
   Pisano, A
   Valentino, ML
   Caporali, L
   Liguori, R
   Deceglie, S
   Roberti, M
   Fanelli, F
   Fracasso, F
   Ross-Cisneros, FN
   D'Adamo, P
   Hudson, G
   Pyle, A
   Yu-Wai-Man, P
   Chinnery, PF
   Zeviani, M
   Salomao, SR
   Berezovsky, A
   Belfort, R
   Ventura, DF
   Moraes, M
   Moraes, M
   Barboni, P
   Sadun, F
   De Negri, A
   Sadun, AA
   Tancredi, A
   Mancini, M
   d'Amati, G
   Polosa, PL
   Cantatore, P
   Carelli, V
AF Giordano, Carla
   Iommarini, Luisa
   Giordano, Luca
   Maresca, Alessandra
   Pisano, Annalinda
   Valentino, Maria Lucia
   Caporali, Leonardo
   Liguori, Rocco
   Deceglie, Stefania
   Roberti, Marina
   Fanelli, Francesca
   Fracasso, Flavio
   Ross-Cisneros, Fred N.
   D'Adamo, Pio
   Hudson, Gavin
   Pyle, Angela
   Yu-Wai-Man, Patrick
   Chinnery, Patrick F.
   Zeviani, Massimo
   Salomao, Solange R.
   Berezovsky, Adriana
   Belfort, Rubens, Jr.
   Ventura, Dora Fix
   Moraes, Milton
   Moraes Filho, Milton
   Barboni, Piero
   Sadun, Federico
   De Negri, Annamaria
   Sadun, Alfredo A.
   Tancredi, Andrea
   Mancini, Massimiliano
   d'Amati, Giulia
   Polosa, Paola Loguercio
   Cantatore, Palmiro
   Carelli, Valerio
TI Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy
SO BRAIN
LA English
DT Article
DE LHON penetrance; mitochondrial biogenesis; mtDNA copy number
ID large brazilian pedigree; complex-i; dna; phenotype; mutation; cells; nerve; lhon; involvement; dysfunction
AB Leber's hereditary optic neuropathy is a maternally inherited blinding disease caused as a result of homoplasmic point mutations in complex I subunit genes of mitochondrial DNA. It is characterized by incomplete penetrance, as only some mutation carriers become affected. Thus, the mitochondrial DNA mutation is necessary but not sufficient to cause optic neuropathy. Environmental triggers and genetic modifying factors have been considered to explain its variable penetrance. We measured the mitochondrial DNA copy number and mitochondrial mass indicators in blood cells from affected and carrier individuals, screening three large pedigrees and 39 independently collected smaller families with Leber's hereditary optic neuropathy, as well as muscle biopsies and cells isolated by laser capturing from post-mortem specimens of retina and optic nerves, the latter being the disease targets. We show that unaffected mutation carriers have a significantly higher mitochondrial DNA copy number and mitochondrial mass compared with their affected relatives and control individuals. Comparative studies of fibroblasts from affected, carriers and controls, under different paradigms of metabolic demand, show that carriers display the highest capacity for activating mitochondrial biogenesis. Therefore we postulate that the increased mitochondrial biogenesis in carriers may overcome some of the pathogenic effect of mitochondrial DNA mutations. Screening of a few selected genetic variants in candidate genes involved in mitochondrial biogenesis failed to reveal any significant association. Our study provides a valuable mechanism to explain variability of penetrance in Leber's hereditary optic neuropathy and clues for high throughput genetic screening to identify the nuclear modifying gene(s), opening an avenue to develop predictive genetic tests on disease risk and therapeutic strategies.
C1 [Giordano, Carla; Pisano, Annalinda; Mancini, Massimiliano; d'Amati, Giulia] Univ Rome, Dept Radiol Oncol & Pathol, Rome, Italy.
   [Iommarini, Luisa; Maresca, Alessandra; Valentino, Maria Lucia; Caporali, Leonardo; Liguori, Rocco; Carelli, Valerio] Univ Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, Bologna, Italy.
   [Giordano, Luca; Deceglie, Stefania; Roberti, Marina; Fanelli, Francesca; Fracasso, Flavio; Polosa, Paola Loguercio; Cantatore, Palmiro] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.
   [Maresca, Alessandra; Valentino, Maria Lucia; Caporali, Leonardo; Liguori, Rocco; Carelli, Valerio] Bellaria Hosp, IRCCS Ist Sci Neurol Bologna, I-40139 Bologna, Italy.
   [Ross-Cisneros, Fred N.; Sadun, Alfredo A.] USC, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA USA.
   [Ross-Cisneros, Fred N.; Sadun, Alfredo A.] USC, Keck Sch Med, Dept Neurosurg, Los Angeles, CA USA.
   [D'Adamo, Pio] Univ Trieste, Dept Reprod Sci Dev & Publ Hlth, Trieste, Italy.
   [D'Adamo, Pio] Univ Trieste, IRCCS Burlo Garofolo Children Hosp, Trieste, Italy.
   [Hudson, Gavin; Pyle, Angela; Yu-Wai-Man, Patrick; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Zeviani, Massimo] Fdn Ist Neurol Carlo Besta IRCCS, Unit Mol Neurogenet, Milan, Italy.
   [Zeviani, Massimo] MRC Mitochondrial Biol Unit, Cambridge, England.
   [Salomao, Solange R.; Berezovsky, Adriana; Belfort, Rubens, Jr.; Moraes, Milton; Moraes Filho, Milton] Fed Univ Sao Paulo UNIFESP, Dept Ophthalmol, Sao Paulo, Brazil.
   [Ventura, Dora Fix] Univ Sao Paulo, Inst Psychol, Dept Expt Psychol, Sao Paulo, Brazil.
   [Barboni, Piero] Studio Oculist dAzeglio, Bologna, Italy.
   [Sadun, Alfredo A.] Osped San Giovanni Evangelista, Tivoli, Italy.
   [De Negri, Annamaria] Azienda Osped San Camillo Forlanini, Rome, Italy.
   [Tancredi, Andrea] Univ Rome, Dipartimento Metodi & Modelli Econ Finanza & Terr, Rome, Italy.
   [Mancini, Massimiliano] Univ Rome, Dept Mol Med, Rome, Italy.
C3 Sapienza University Rome; University of Bologna; Universita degli Studi di Bari Aldo Moro; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Southern California; University of Southern California Keck Hospital; University of Southern California; University of Southern California Keck Hospital; University of Trieste; IRCCS Burlo Garofolo; University of Trieste; Newcastle University - UK; Fondazione IRCCS Istituto Neurologico Carlo Besta; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Azienda Ospedaliera San Camillo-Forlanini; Sapienza University Rome; Sapienza University Rome
RP Giordano, C (corresponding author), Policlin Umberto 1, Dept Radiol Oncol & Pathol, Viale Regina Elena 324, I-00161 Rome, Italy.
EM carla.giordano@uniroma1.it; valerio.carelli@unibo.it
FU Telethon [GGP06233, GGP11182, GPP10005]; Associazione Serena Talarico per i giovani nel mondo and Fondazione Giuseppe Tomasello O.N.L.U.S.; Mitocon Onlus; Research to Prevent Blindness; International Foundation for Optic Nerve Diseases (IFOND); Struggling Within Leber's; Poincenot Family; Eierman Foundation; National Eye Institute [EY03040]; MRC [G0701386, MC_UP_1002/1, G1002570, MR/K000608/1] Funding Source: UKRI
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Andrews RM, 1999, BRIT J OPHTHALMOL, V83, P231, DOI 10.1136/bjo.83.2.231
   Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   Barboni P, 2010, OPHTHALMOLOGY, V117, P623, DOI 10.1016/j.ophtha.2009.07.026
   Barron MJ, 2004, BRIT J OPHTHALMOL, V88, P286, DOI 10.1136/bjo.2003.027664
   BENDALL KE, 1995, AM J HUM GENET, V57, P248
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Cossarizza A, 2003, ANTIVIR THER, V8, P315
   Curran JE, 2007, HUM MOL GENET, V16, P1504, DOI 10.1093/hmg/ddm101
   Curran JE, 2010, HUM GENET, V127, P183, DOI 10.1007/s00439-009-0756-0
   DiMauro S, 2003, NEW ENGL J MED, V356, P809
   Floreani M, 2005, FEBS J, V272, P1124, DOI 10.1111/j.1742-4658.2004.04542.x
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   Gilbert MTP, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000537
   Giordano C, 2011, METHODS MOL BIOL, V755, P223, DOI 10.1007/978-1-61779-163-5_18
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gómez-Durán A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014
   Gonzalez-Halphen D, 2011, CELL DEATH DIS, V2, P0, DOI 10.1038/cddis.2011.107
   Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573
   Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963
   Howell N, 1998, AM J HUM GENET, V63, P1220, DOI 10.1086/302049
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Iommarini L, 2012, NEUROLOGY, V79, P1517, DOI 10.1212/WNL.0b013e31826d5f72
   Ji YL, 2010, MOL VIS, V16, P416
   Korsten A, 2010, BBA-BIOENERGETICS, V1797, P197, DOI 10.1016/j.bbabio.2009.10.003
   La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155
   LARSSON NG, 1991, ANN NEUROL, V30, P701, DOI 10.1002/ana.410300511
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   Mackey DA, 2003, EYE, V17, P312, DOI 10.1038/sj.eye.6700362
   Martinelli P, 2010, BBA-BIOENERGETICS, V1797, P1, DOI 10.1016/j.bbabio.2009.07.013
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Moreno-Loshuertos R, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1001379
   Newman NJ, 2005, WALSH HOYTS CLIN NEU, V0, P465
   Nishioka T, 2004, J HUM GENET, V49, P701, DOI 10.1007/s10038-004-0209-5
   Pan BX, 2012, INVEST OPHTH VIS SCI, V53, P7608, DOI 10.1167/iovs.12-10452
   Phasukkijwatana N, 2010, HUM GENET, V128, P39, DOI 10.1007/s00439-010-0821-8
   Ramos CDF, 2009, INVEST OPHTH VIS SCI, V50, P1666, DOI 10.1167/iovs.08-2695
   ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5
   Sadun A A, 2000, TRANS AM OPHTHALMOL SOC, V98, P223
   Sadun AA, 2000, T AM OPHTHAL SOC, V98, P232
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   Sadun Alfredo A, 2006, TRANS AM OPHTHALMOL SOC, V104, P51
   Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010
   Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012
   Suissa S, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000474
   Toompuu M, 1999, HUM MOL GENET, V8, P2275, DOI 10.1093/hmg/8.12.2275
   Ventura DF, 2005, INVEST OPHTH VIS SCI, V46, P4809, DOI 10.1167/iovs.05-0455
   VERGANI L, 1995, BIOCHEM BIOPH RES CO, V210, P880, DOI 10.1006/bbrc.1995.1740
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Yen MY, 2002, BRIT J OPHTHALMOL, V86, P1027, DOI 10.1136/bjo.86.9.1027
   Yen MY, 1996, BRIT J OPHTHALMOL, V80, P78, DOI 10.1136/bjo.80.1.78
   Zhang AM, 2010, HUM GENET, V128, P465, DOI 10.1007/s00439-010-0875-7
NR 63
TC 141
Z9 156
U1 0
U2 30
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD FEB 15
PY 2014
VL 137
IS 
BP 335
EP 353
DI 10.1093/brain/awt343
PG 19
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AA7QB
UT WOS:000331290900007
PM 24369379
DA 2024-11-01
ER

PT J
AU Ohnuki, Y
   Takahashi, K
   Iijima, E
   Takahashi, W
   Suzuki, S
   Ozaki, Y
   Kitao, R
   Mihara, M
   Ishihara, T
   Nakamura, M
   Sawano, Y
   Goto, Y
   Izumi, S
   Kulski, JK
   Shiina, T
   Takizawa, S
AF Ohnuki, Yuko
   Takahashi, Kazumi
   Iijima, Eri
   Takahashi, Wakoh
   Suzuki, Shingo
   Ozaki, Yuki
   Kitao, Ruriko
   Mihara, Masatoshi
   Ishihara, Tadayuki
   Nakamura, Michiyo
   Sawano, Yoshie
   Goto, Yu-ichi
   Izumi, Shunichiro
   Kulski, Jerzy K.
   Shiina, Takashi
   Takizawa, Shunya
TI Multiple Deletions in Mitochondrial DNA in a Patient with Progressive External Ophthalmoplegia, Leukoencephalopathy and Hypogonadism
SO INTERNAL MEDICINE
LA English
DT Article
DE mitochondrial DNA (mtDNA); multiple deletion; progressive external ophthalmoplegia (PEO); hypogonadism; leukoencephalopathy
ID mutations
AB Progressive external ophthalmoplegia (PEO) is one of a number of major types of mitochondrial disorders. Most sporadic PEO patients have a heteroplasmic large deletion of mitochondrial DNA (mtDNA) in the mitochondria in skeletal muscles. We herein analyzed mtDNA deletions using sub-cloning and Sanger sequencing of PCR products in a 31-year-old Japanese man with multiple symptoms, including PEO, muscle weakness, hearing loss, leukoencephalopathy and hypogonadism. A large number of multiple deletions was detected, as well as four kinds of deletion breakpoints identified in different locations, including m.3347_12322, m.5818_13964, m.5829_13964 and m.5837_13503.
C1 [Ohnuki, Yuko; Suzuki, Shingo; Ozaki, Yuki; Kulski, Jerzy K.; Shiina, Takashi] Tokai Univ, Sch Med, Dept Mol Life Sci Basic Med Sci & Mol Med, Hiratsuka, Kanagawa 25912, Japan.
   [Ohnuki, Yuko; Takahashi, Kazumi; Izumi, Shunichiro] Tokai Univ Hosp, Dept Clin Genet, Hiratsuka, Kanagawa, Japan.
   [Takahashi, Kazumi; Izumi, Shunichiro] Tokai Univ, Sch Med, Dept Obstet & Gynecol, Hiratsuka, Kanagawa 25912, Japan.
   [Iijima, Eri; Takahashi, Wakoh; Takizawa, Shunya] Tokai Univ, Sch Med, Dept Internal Med, Div Neurol, Hiratsuka, Kanagawa 25912, Japan.
   [Mihara, Masatoshi; Ishihara, Tadayuki] Natl Hakone Hosp, Dept Neurol, Odawara, Kanagawa, Japan.
   [Nakamura, Michiyo; Sawano, Yoshie; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Kulski, Jerzy K.] Univ Western Australia, Ctr Forens Sci, Nedlands, WA 6009, Australia.
C3 Tokai University; Tokai University; Tokai University; Tokai University; National Center for Neurology & Psychiatry - Japan; University of Western Australia
RP Ohnuki, Y (corresponding author), Tokai Univ, Sch Med, Dept Mol Life Sci Basic Med Sci & Mol Med, Hiratsuka, Kanagawa 25912, Japan.
EM yukom@is.icc.u-tokai.ac.jp
CR Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a
   CHEN X, 1995, AM J HUM GENET, V57, P239
   DiMauro S, 2011, GENEREVIEWS GENETEST, V0, P1993
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Melberg A, 1996, MUSCLE NERVE, V19, P1561, DOI 10.1002/(SICI)1097-4598(199612)19:12<1561::AID-MUS5>3.0.CO;2-8
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
NR 11
TC 6
Z9 7
U1 0
U2 0
PU JAPAN SOC INTERNAL MEDICINE
PI TOKYO
PA 34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN
SN 0918-2918
EI 1349-7235
J9 INTERNAL MED
JI Intern. Med.
PD JUN 15
PY 2014
VL 53
IS 12
BP 1365
EP 1369
DI 10.2169/internalmedicine.53.1320
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA AJ7UP
UT WOS:000337904300019
PM 24930659
DA 2024-11-01
ER

PT J
AU Demarest, ST
   Whitehead, MT
   Turnacioglu, S
   Pearl, PL
   Gropman, AL
AF Demarest, Scott T.
   Whitehead, Matthew T.
   Turnacioglu, Sinan
   Pearl, Phillip L.
   Gropman, Andrea L.
TI Phenotypic Analysis of Epilepsy in the Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strokelike Episodes-Associated Mitochondrial DNA A3243G Mutation
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE electroencephalogram; Lennox-Gastaut syndrome; mitochondria; seizures
ID partial status epilepticus; l-arginine; chain defects; melas; encephalopathy; myopathy; disorders; children; patient
AB The A to G mitochondrial DNA point mutation at position 3243 (A3243G) is the most common cause of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS), a systemic multiorgan disease. Epilepsy is a common finding but there is wide phenotypic variation that has not been thoroughly explored. We report the epilepsy phenotypes of 7 patients with the A3243G mutation. Most presented with typical MELAS and epilepsy characterized by infrequent prolonged focal seizures, including epilepsia partialis continua, hemiclonic status epilepticus, nonconvulsive status, and occipital status epilepticus. Seizures usually occurred during the acute phase of a strokelike episode. Periodic lateralized epileptiform discharges may be seen electrographically. Some patients with this mutation are completely asymptomatic or have mild symptoms typical for mitochondrial diseases. Slow spike-wave activity consistent with Lennox-Gastaut syndrome and electrographic status epilepticus was seen in 1 patient who responded to ethosuximide.
C1 [Demarest, Scott T.; Whitehead, Matthew T.; Turnacioglu, Sinan; Gropman, Andrea L.] George Washington Univ Sch Med, Childrens Natl Med Ctr, Washington, DC USA.
   [Pearl, Phillip L.] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA.
C3 George Washington University; Children's National Health System; Harvard University; Boston Children's Hospital; Harvard Medical School
RP Gropman, AL (corresponding author), Childrens Natl Med Ctr, Div Neurogenet & Dev Pediat, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM AGropman@childrensnational.org
CR Anglin RE, 2012, J NEUROPSYCH CLIN N, V24, P394, DOI 10.1176/appi.neuropsych.11110345
   Bolszak M, 2009, EPILEPSY RES, V85, P300, DOI 10.1016/j.eplepsyres.2009.03.004
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Corda D, 2006, EPILEPSY BEHAV, V8, P655, DOI 10.1016/j.yebeh.2005.12.011
   Craig AK, 2012, SEIZURE-EUR J EPILEP, V21, P17, DOI 10.1016/j.seizure.2011.08.010
   Funakawa I, 1997, ELECTROEN CLIN NEURO, V103, P370, DOI 10.1016/S0013-4694(97)00020-9
   Kanaumi T, 2006, PEDIATR NEUROL, V34, P235, DOI 10.1016/j.pediatrneurol.2005.08.024
   Kang HC, 2013, BRAIN DEV-JPN, V35, P757, DOI 10.1016/j.braindev.2013.01.006
   Karkare S, 2009, J CHILD NEUROL, V24, P1564, DOI 10.1177/0883073809334386
   Kaufman KR, 2010, EPILEPSY BEHAV, V18, P494, DOI 10.1016/j.yebeh.2010.05.020
   Kim IO, 1996, AM J ROENTGENOL, V166, P641, DOI 10.2214/ajr.166.3.8623642
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005
   Lee YM, 2008, EPILEPSIA, V49, P685, DOI 10.1111/j.1528-1167.2007.01522.x
   Leff AP, 1998, EPILEPSIA, V39, P438, DOI 10.1111/j.1528-1157.1998.tb01397.x
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Ribacoba R, 2006, NEUROLOGIA, V21, P1
   Toribe Yasuhisa, 2007, NO TO HATTATSU, V39, P38
   Tzoulis C, 2012, BRAIN, V135, P3627, DOI 10.1093/brain/aws223
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Yuen AWC, 2011, MED HYPOTHESES, V77, P536, DOI 10.1016/j.mehy.2011.06.025
NR 24
TC 23
Z9 25
U1 0
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD SEP 15
PY 2014
VL 29
IS 9
BP 1249
EP 1256
DI 10.1177/0883073814538511
PG 8
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA AP1FK
UT WOS:000341812400018
PM 25038129
DA 2024-11-01
ER

PT J
AU Mkaouar-Rebai, E
   Ben Mahmoud, A
   Chamkha, I
   Chabchoub, I
   Kammoun, T
   Hachicha, M
   Fakhfakh, F
AF Mkaouar-Rebai, Emna
   Ben Mahmoud, Afif
   Chamkha, Imen
   Chabchoub, Imen
   Kammoun, Thouraya
   Hachicha, Mongia
   Fakhfakh, Faiza
TI A novel MT-CO2 m.8249G&gt;A pathogenic variation and the MT-TW m.5521G&gt;A mutation in patients with mitochondrial myopathy
SO MITOCHONDRIAL DNA
LA English
DT Article
DE m.5521G.> A; m.8249G > A; mitochondrial mutations; MT-CO2; MT-TW; myopathy
ID hereditary optic neuropathy; point mutation; disease; rna; dna; gene; trna(asn); deafness; impact
AB Mitochondrial DNA (mtDNA) defects were known to be associated with a large spectrum of human diseases and patients might present wide range of clinical features with various combinations. Mutations in mitochondrial tRNAs, rRNAs and protein-coding genes or largescale rearrangements have been implicated in several cytopathies. Mitochondrial myopathies, usually maternally inherited group of neuromuscular diseases caused by mitochondrial dysfunction occurring before the age of 20 years and often begin with exercise intolerance, muscle weakness and neurodevelopmental retardation. We studied the mtDNA in three Tunisian patients with mitochondrial myopathy. The mutational analysis screening revealed the presence of two mitochondrial mutations: the m. 5521G>A mutation in the D-stem region of the tRNA(Trp) gene which could lead to a disruption of the secondary structure of this tRNA and affect the tRNA-ribosome interaction with a consequent decrease in the rate of synthesis of mitochondrial proteins. The second mutation is the m. 8249G>A (p.G222R) variation in the MT-CO2 gene which may affect the electrons transfer from cytochrome c to the bimetallic center of the catalytic subunit I.
C1 [Mkaouar-Rebai, Emna; Ben Mahmoud, Afif; Chamkha, Imen; Fakhfakh, Faiza] Univ Sfax, Fac Med, Lab Human Mol Genet, Sfax, Tunisia.
   [Chabchoub, Imen; Kammoun, Thouraya; Hachicha, Mongia] CHU Habib Bourguiba Sfax, Serv Pediat, Sfax, Tunisia.
C3 Universite de Sfax; Universite de Sfax; Hopital Hedi Chaker; Hopital Habib Bourguiba
RP Mkaouar-Rebai, E (corresponding author), Fac Med Sfax, Lab Genet Mol Humaine, Sfax, Tunisia.
EM emna_mkaouar@mail2world.com; faiza.fakhfakh@gmail.com
FU Ministry of the Higher Education; Scientific Research in Tunisia
CR Abu-Amero KK, 2008, MOL VIS, V14, P29
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   BROWN MD, 1994, AM J HUM GENET, V55, P410
   Bruno C, 2011, BIOCHEM BIOPH RES CO, V412, P518, DOI 10.1016/j.bbrc.2011.06.155
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599
   JOHNS DR, 1993, BIOCHEM BIOPH RES CO, V196, P810, DOI 10.1006/bbrc.1993.2321
   KOGA Y, 1995, MUSCLE NERVE, V0, PS119
   Levinger L, 2001, NUCLEIC ACIDS RES, V29, P4334, DOI 10.1093/nar/29.21.4334
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   MEHTA AB, 1989, ANN HUM GENET, V53, P303, DOI 10.1111/j.1469-1809.1989.tb01799.x
   Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566
   OOSTRA RJ, 1995, AM J HUM GENET, V57, P954
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Pinós T, 2013, NEUROMUSCULAR DISORD, V23, P330, DOI 10.1016/j.nmd.2013.01.001
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Yasukawa T, 2000, NUCLEIC ACIDS RES, V28, P3779, DOI 10.1093/nar/28.19.3779
   Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001
NR 29
TC 6
Z9 6
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1940-1736
EI 1940-1744
J9 MITOCHONDR DNA
JI Mitochondrial DNA
PD OCT 15
PY 2014
VL 25
IS 5
BP 394
EP 399
DI 10.3109/19401736.2013.803086
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA AP3RG
UT WOS:000341994200027
PM 23841600
DA 2024-11-01
ER

PT J
AU Tzoulis, C
   Tran, GT
   Coxhead, J
   Bertelsen, B
   Lilleng, PK
   Balafkan, N
   Payne, B
   Miletic, H
   Chinnery, PF
   Bindoff, LA
AF Tzoulis, Charalampos
   Gia Tuong Tran
   Coxhead, Jonathan
   Bertelsen, Bjorn
   Lilleng, Peer K.
   Balafkan, Novin
   Payne, Brendan
   Miletic, Hrvoje
   Chinnery, Patrick F.
   Bindoff, Laurence A.
TI Molecular Pathogenesis of Polymerase Gamma-Related Neurodegeneration
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID mitochondrial-dna polymerase; progressive external ophthalmoplegia; substantia-nigra neurons; parkinson-disease; w748s mutation; recessive ataxia; deletions; disorders; epilepsy; a467t
AB Objective: Polymerase gamma (POLG) mutations are a common cause of mitochondrial disease and have also been linked to neurodegeneration and aging. We studied the molecular mechanisms underlying POLG-related neurodegeneration using postmortem tissue from a large number of patients. Methods: Clinical information was available from all subjects. Formalin-fixed and frozen brain tissue from 15 patients and 23 controls was studied employing a combination of histopathology, immunohistochemistry, and molecular studies of microdissected neurons. Results: The primary consequence of POLG mutation in neurons is mitochondrial DNA depletion. This was already present in infants with little evidence of neuronal loss or mitochondrial dysfunction. With longer disease duration, we found an additional, progressive accumulation of mitochondrial DNA deletions and point mutations accompanied by increasing numbers of complex I-deficient neurons. Progressive neurodegeneration primarily affected the cerebellar systems and dopaminergic cells of the substantia nigra. Superimposed on this chronic process were acute, focal cortical lesions that correlated with epileptogenic foci and that showed massive neuronal loss. Interpretation: POLG mutations appear to compromise neuronal respiration via a combination of early and stable depletion and a progressive somatic mutagenesis of the mitochondrial genome. This leads to 2 distinct but overlapping biological processes: a chronic neurodegeneration reflected clinically by progressive ataxia and cognitive impairment, and an acute focal neuronal necrosis that appears to be related to the presence of epileptic seizures. Our findings offer an explanation of the acute-on-chronic clinical course of this common mitochondrial encephalopathy.
C1 [Tzoulis, Charalampos; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Tzoulis, Charalampos; Gia Tuong Tran; Balafkan, Novin; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Coxhead, Jonathan; Payne, Brendan; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Coxhead, Jonathan] Newcastle Univ, Newcastle Biomed Res Ctr Ageing & Chron Dis, Natl Inst Hlth Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Bertelsen, Bjorn; Lilleng, Peer K.; Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway.
   [Lilleng, Peer K.] Univ Bergen, Haukeland Univ Hosp, Dept Clin Med, Gade Lab Pathol, Bergen, Norway.
   [Miletic, Hrvoje] Univ Bergen, Dept Biomed, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of Bergen; Newcastle University - UK; Newcastle University - UK; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen
RP Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
FU Western Norway Health Trust; University of Bergen; Meltzer Foundation; MRC [MR/K000608/1, G0800470] Funding Source: UKRI
CR Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Elstner M, 2011, MOL BRAIN, V4, P0, DOI 10.1186/1756-6606-4-43
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Kann O, 2011, BRAIN, V134, P345, DOI 10.1093/brain/awq333
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lascano AM, 2013, EPILEPSY RES, V105, P245, DOI 10.1016/j.eplepsyres.2012.12.010
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Rodin E, 2005, CLIN EEG NEUROSCI, V36, P263, DOI 10.1177/155005940503600405
   Sequeira KM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0053204
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wiest R, 2013, J NEUROL, V260, P1601, DOI 10.1007/s00415-013-6841-2
   Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d
NR 31
TC 62
Z9 65
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD JUL 15
PY 2014
VL 76
IS 1
BP 66
EP 81
DI 10.1002/ana.24185
PG 16
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AM7JQ
UT WOS:000340043200008
PM 24841123
DA 2024-11-01
ER

PT J
AU Bannwarth, S
   Ait-El-Mkadem, S
   Chaussenot, A
   Genin, EC
   Lacas-Gervais, S
   Fragaki, K
   Berg-Alonso, L
   Kageyama, Y
   Serre, V
   Moore, DG
   Verschueren, A
   Rouzier, C
   Le Ber, I
   Augé, G
   Cochaud, C
   Lespinasse, F
   N'Guyen, K
   de Septenville, A
   Brice, A
   Yu-Wai-Man, P
   Sesaki, H
   Pouget, J
   Paquis-Flucklinger, V
AF Bannwarth, Sylvie
   Ait-El-Mkadem, Samira
   Chaussenot, Annabelle
   Genin, Emmanuelle C.
   Lacas-Gervais, Sandra
   Fragaki, Konstantina
   Berg-Alonso, Laetitia
   Kageyama, Yusuke
   Serre, Valerie
   Moore, David G.
   Verschueren, Annie
   Rouzier, Cecile
   Le Ber, Isabelle
   Auge, Gaelle
   Cochaud, Charlotte
   Lespinasse, Francoise
   N'Guyen, Karine
   de Septenville, Anne
   Brice, Alexis
   Yu-Wai-Man, Patrick
   Sesaki, Hiromi
   Pouget, Jean
   Paquis-Flucklinger, Veronique
TI A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through <i>CHCHD10</i> involvement
SO BRAIN
LA English
DT Article
DE CHCHD10; mitochondrial DNA instability; mitochondrial disorder; FTD-ALS
ID dominant optic atrophy; respiratory-chain supercomplexes; oxidative-phosphorylation; external ophthalmoplegia; hexanucleotide repeat; multiple deletions; dna instability; protein; mutations; fusion
AB Using whole-exome sequencing, Bannwarth et al. identify a missense mutation in the mitochondrial gene, CHCHD10, in two families with frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS). CHCHD10 helps to maintain the morphology of mitochondrial cristae and the stability of mitochondrial DNA. Other cases of FTD-ALS may be mitochondrial in origin.Mitochondrial DNA instability disorders are responsible for a large clinical spectrum, among which amyotrophic lateral sclerosis-like symptoms and frontotemporal dementia are extremely rare. We report a large family with a late-onset phenotype including motor neuron disease, cognitive decline resembling frontotemporal dementia, cerebellar ataxia and myopathy. In all patients, muscle biopsy showed ragged-red and cytochrome c oxidase-negative fibres with combined respiratory chain deficiency and abnormal assembly of complex V. The multiple mitochondrial DNA deletions found in skeletal muscle revealed a mitochondrial DNA instability disorder. Patient fibroblasts present with respiratory chain deficiency, mitochondrial ultrastructural alterations and fragmentation of the mitochondrial network. Interestingly, expression of matrix-targeted photoactivatable GFP showed that mitochondrial fusion was not inhibited in patient fibroblasts. Using whole-exome sequencing we identified a missense mutation (c.176C > T; p.Ser59Leu) in the CHCHD10 gene that encodes a coiled-coil helix coiled-coil helix protein, whose function is unknown. We show that CHCHD10 is a mitochondrial protein located in the intermembrane space and enriched at cristae junctions. Overexpression of a CHCHD10 mutant allele in HeLa cells led to fragmentation of the mitochondrial network and ultrastructural major abnormalities including loss, disorganization and dilatation of cristae. The observation of a frontotemporal dementia-amyotrophic lateral sclerosis phenotype in a mitochondrial disease led us to analyse CHCHD10 in a cohort of 21 families with pathologically proven frontotemporal dementia-amyotrophic lateral sclerosis. We identified the same missense p.Ser59Leu mutation in one of these families. This work opens a novel field to explore the pathogenesis of the frontotemporal dementia-amyotrophic lateral sclerosis clinical spectrum by showing that mitochondrial disease may be at the origin of some of these phenotypes.
C1 [Bannwarth, Sylvie; Ait-El-Mkadem, Samira; Chaussenot, Annabelle; Genin, Emmanuelle C.; Fragaki, Konstantina; Berg-Alonso, Laetitia; Rouzier, Cecile; Auge, Gaelle; Lespinasse, Francoise; Paquis-Flucklinger, Veronique] Univ Nice Sophia Antipolis, Sch Med, UNS, IRCAN,UMR CNRS 7284,INSERM U1081, Nice, France.
   [Bannwarth, Sylvie; Ait-El-Mkadem, Samira; Chaussenot, Annabelle; Fragaki, Konstantina; Rouzier, Cecile; Auge, Gaelle; Cochaud, Charlotte; Paquis-Flucklinger, Veronique] Nice Teaching Hosp, Dept Med Genet, Natl Ctr Mitochondrial Dis, Nice, France.
   [Lacas-Gervais, Sandra] Univ Nice Sophia Antipolis, Joint Ctr Appl Electron Microscopy, Nice, France.
   [Kageyama, Yusuke; Sesaki, Hiromi] Johns Hopkins Univ Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.
   [Serre, Valerie] Paris Diderot Univ, CNRS UMR7592, Inst Jacques Monod, Paris, France.
   [Moore, David G.; Yu-Wai-Man, Patrick] Newcastle Univ, Int Ctr Life, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Verschueren, Annie; Pouget, Jean] Marseille Teaching Hosp, Timone Hosp, Dept Neurol, Marseille, France.
   [Le Ber, Isabelle; de Septenville, Anne; Brice, Alexis] Univ Paris 06, Sorbonne Univ, UM75, Inserm U1127,Cnrs UMR7225,Inst Cerveau & Moelle E, F-75013 Paris, France.
   [Le Ber, Isabelle] Grp Hosp Pitie Salpetriere, AP HP, Natl Reference Ctr Rare Dementias, F-75634 Paris, France.
   [N'Guyen, Karine] Marseille Teaching Hosp, Timone Hosp, Dept Med Genet, Marseille, France.
C3 Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Universite Cote d'Azur; Johns Hopkins University; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Newcastle University - UK; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille
RP Paquis-Flucklinger, V (corresponding author), UNS, INSERM U1081, IRCAN UMR CNRS 7284, Sch Med, 28 Av Valombrose, F-06107 Nice 2, France.
EM paquis@hermes.unice.fr
FU Association Francaise contre les Myopathies (AFM); Fondation pour la Recherche Medicale (FRM); National Institutes of Health [GM089853]; program 'Investissements d'avenir' [ANR-10-IAIHU-06]; The Programme Hospitalier de Recherche Clinique; European Union [E12009DD]; Medical Research Council (UK) [G1002570]; MRC [G0701386, G1002570] Funding Source: UKRI
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103
   Banci L, 2012, J STRUCT BIOL, V180, P190, DOI 10.1016/j.jsb.2012.07.007
   Banci L, 2009, FEBS LETT, V583, P1699, DOI 10.1016/j.febslet.2009.03.061
   Bannwarth S, 2012, MITOCHONDRION, V12, P654, DOI 10.1016/j.mito.2012.07.111
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11
   Cavallaro G, 2010, MOL BIOSYST, V6, P2459, DOI 10.1039/c0mb00058b
   Chen H, 2010, ANN NY ACAD SCI, V1201, P21, DOI 10.1111/j.1749-6632.2010.05615.x
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Darshi M, 2012, J BIOL CHEM, V287, P0, DOI 10.1074/jbc.M112.387696
   Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975
   DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jans DC, 2013, P NATL ACAD SCI USA, V110, P8936, DOI 10.1073/pnas.1301820110
   Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kim JS, 2011, MOL CELL BIOL, V31, P2756, DOI 10.1128/MCB.01323-10
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041
   Martherus RSRM, 2010, BIOCHEM BIOPH RES CO, V402, P203, DOI 10.1016/j.bbrc.2010.09.109
   Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Paul R, 1996, TRENDS GENET, V12, P131
   Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rouzier C, 2010, J MED GENET, V47, P670, DOI 10.1136/jmg.2009.073445
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schägger H, 2001, J BIOL CHEM, V276, P37861
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Stojanovski D, 2012, BBA-MOL CELL RES, V1823, P1142, DOI 10.1016/j.bbamcr.2012.04.014
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551
   van der Laan M, 2012, TRENDS CELL BIOL, V22, P185, DOI 10.1016/j.tcb.2012.01.004
   Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013
   Zuchner S, 2004, NAT GENET, V36, P459
NR 46
TC 352
Z9 393
U1 0
U2 58
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD AUG 15
PY 2014
VL 137
IS 
BP 2329
EP 2345
DI 10.1093/brain/awu138
PG 17
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AM7MI
UT WOS:000340051100023
PM 24934289
DA 2024-11-01
ER

PT J
AU Guney, O
   Ak, H
   Atay, S
   Ozkaya, AB
   Aydin, HH
AF Guney, Ozgur
   Ak, Handan
   Atay, Sevcan
   Ozkaya, Ali Burak
   Aydin, Hikmet Hakan
TI Mitochondrial DNA polymorphisms associated with longevity in the Turkish population
SO MITOCHONDRION
LA English
DT Article
DE Aging; Mitochondrial DNA; Sequencing; Longevity; Turkish
ID human skeletal-muscle; control region; japanese centenarians; mutations accumulate; alzheimers patients; point mutations; d-loop; haplogroup; sequence; increase
AB The accumulation of mutations in mitochondrial DNA is a widely recognized mechanism for aging and age related diseases. However, studies indicate that some mutations could be beneficial to longevity by slowing down the function of the electron transport chain, reducing free radical production. In this study, we re-sequenced the entire mitochondrial DNA from 50 individuals and examined aging-related variations in the Turkish population. We evaluated sequence data by comparing whole SNP frequencies, individual SNP frequencies, the effect of SNPs, SNP accumulation in certain mtDNA regions and haplotype profiles between elderly and control groups. The frequency of total mitochondrial SNPs was significantly higher in nonagenarians than controls (p = 0.0094). Furthermore, non-coding, synonymous and tRNA mutations were more prevalent in the 90 + group compared to controls (p = 0.0001, p < 0.001, p = 0.0096, respectively). A73G and C152T polymorphisms were significantly associated with longevity in the Turkish population (p = 0.0086 and p = 0.004, respectively). Additionally, C150T was specific to the 90 + group, but the difference failed to reach statistical significance (p = 0.053). We also detected a novel transversion in the ATPase6 gene (C8899A) that was negatively associated with longevity (p = 0.0016). Examining the distribution of SNPs among genes and functionally associated gene regions revealed a significant accumulation of mutations in the D-loop region and genes encoding Complex I subunits (ND1-6) (p < 0.0001, p = 0.0302, respectively). Moreover, there was an increase in the non-synonymous mutation frequency of Complex I genes in aged subjects (p < 0.0001). Haplotype H was also significantly increased in the control group (p = 0.0405). Overall, our findings support a role for mitochondrial genome variations and the functionality of oxidative phosphorylation in longevity. In this report, we sequenced the whole mtDNA of the Turkish population for the first time. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Guney, Ozgur; Ak, Handan; Atay, Sevcan; Ozkaya, Ali Burak; Aydin, Hikmet Hakan] Ege Univ, Sch Med, Dept Med Biochem, TR-35100 Izmir, Turkey.
C3 Ege University
RP Aydin, HH (corresponding author), Ege Univ, Sch Med, Dept Med Biochem, TR-35100 Izmir, Turkey.
EM hhakan.aydin@gmail.com
FU Ege University Research Funds [2010 TIP 013]
CR Alexe G, 2007, HUM GENET, V121, P347, DOI 10.1007/s00439-007-0330-6
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Bandelt HJ, 2014, J HUM GENET, V59, P66, DOI 10.1038/jhg.2013.120
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Beekman M, 2013, AGING CELL, V12, P184, DOI 10.1111/acel.12039
   Bilal E, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002421
   Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chen A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0046473
   Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100
   Czarnecka AM, 2010, ONCOL REP, V24, P1521, DOI 10.3892/or_00001014
   Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Feng J, 2011, EXP GERONTOL, V46, P987, DOI 10.1016/j.exger.2011.09.001
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Jin KL, 2010, AGING DIS, V1, P72
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Kenney MC, 2013, BIOCHIM BIOPHYS ACTA, V1842, P208
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mergen H, 2004, J GENET, V83, P39, DOI 10.1007/BF02715828
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mueller EE, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0030874
   Navaglia F, 2006, AM J CLIN PATHOL, V126, P593, DOI 10.1309/GQFCCJMH5KHNVX73
   Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186
   Rea IM, 2013, AGE, V35, P1445, DOI 10.1007/s11357-012-9444-4
   Ren WH, 2008, CLIN EXP PHARMACOL P, V35, P1477, DOI 10.1111/j.1440-1681.2008.05028.x
   Richards M, 1996, AM J HUM GENET, V59, P185
   Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   SOONG NW, 1992, NAT GENET, V2, P318
   Takasaki S, 2008, COMPUT BIOL CHEM, V32, P332, DOI 10.1016/j.compbiolchem.2008.03.014
   Takasaki S, 2009, J GENET GENOMICS, V36, P425, DOI 10.1016/S1673-8527(08)60132-0
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Vianello D, 2013, HUM MUTAT, V34, P1189, DOI 10.1002/humu.22356
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Yang IS, 2013, J FORENSIC SCI, V58, P972, DOI 10.1111/1556-4029.12139
   Yang XR, 2012, MOL BIOL REP, V39, P9123, DOI 10.1007/s11033-012-1784-8
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Zhang CF, 1998, HUM MUTAT, V11, P360
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
NR 56
TC 11
Z9 14
U1 11
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2014
VL 17
IS 
BP 7
EP 13
DI 10.1016/j.mito.2014.04.013
PG 7
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA AO1LD
UT WOS:000341072700002
PM 24792352
DA 2024-11-01
ER

PT J
AU Oh, J
   Lee, YD
   Wagers, AJ
AF Oh, Juhyun
   Lee, Yang David
   Wagers, Amy J.
TI Stem cell aging: mechanisms, regulators and therapeutic opportunities
SO NATURE MEDICINE
LA English
DT Review
ID mitochondrial-dna mutations; mouse skeletal-muscle; age-related-changes; life-span; oxidative stress; self-renewal; caenorhabditis-elegans; damage-response; caloric restriction; tumor suppression
AB Aging tissues experience a progressive decline in homeostatic and regenerative capacities, which has been attributed to degenerative changes in tissue-specific stem cells, stem cell niches and systemic cues that regulate stem cell activity. Understanding the molecular pathways involved in this age-dependent deterioration of stem cell function will be critical for developing new therapies for diseases of aging that target the specific causes of age-related functional decline. Here we explore key molecular pathways that are commonly perturbed as tissues and stem cells age and degenerate. We further consider experimental evidence both supporting and refuting the notion that modulation of these pathways per se can reverse aging phenotypes. Finally, we ask whether stem cell aging establishes an epigenetic 'memory' that is indelibly written or one that can be reset.
C1 [Oh, Juhyun; Lee, Yang David; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.
   [Oh, Juhyun; Lee, Yang David; Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA.
   [Lee, Yang David] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.
   [Wagers, Amy J.] Howard Hughes Med Inst, Cambridge, MA USA.
C3 Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute
RP Wagers, AJ (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.
EM amy_wagers@harvard.edu
FU US National Cancer Institute from the Massachusetts General Hospital Department of Pathology [T32CA-0216]; US National Institutes of Health (NIH) [T32DK007260]; NIH [1R01 AG033053, 5U01 HL100402]; Paul F. Glenn Laboratories for the Biological Mechanisms of Aging
CR Abe M, 2008, J PHARMACOL SCI, V106, P571, DOI 10.1254/jphs.FP0071664
   Abramovich A, 2008, REJUV RES, V11, P489, DOI 10.1089/rej.2008.0658
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ahmad KA, 2003, ANN NY ACAD SCI, V1010, P365, DOI 10.1196/annals.1299.067
   Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399
   Attema JL, 2009, ONCOGENE, V28, P2238, DOI 10.1038/onc.2009.94
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448
   Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016
   Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017
   Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928
   de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007
   Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465
   Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009
   Borchin B, 2013, STEM CELL REP, V1, P620, DOI 10.1016/j.stemcr.2013.10.007
   Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a
   Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944
   Campisi J, 2000, IN VIVO, V14, P183
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Canela A, 2004, MOL CELL BIOL, V24, P4275, DOI 10.1128/MCB.24.10.4275-4293.2004
   Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x
   Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049
   Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002
   Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438
   Charville GW, 2011, PHILOS T R SOC B, V366, P85, DOI 10.1098/rstb.2010.0279
   Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297
   Chen C, 2009, SCI SIGNAL, V2, P0, DOI 10.1126/scisignal.2000559
   Chen HQ, 2014, AGEING RES REV, V13, P55, DOI 10.1016/j.arr.2013.12.002
   Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804
   Cheung HH, 2014, STEM CELL REP, V2, P534, DOI 10.1016/j.stemcr.2014.02.006
   Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591
   Chhabra P, 2013, STEM CELL TRANSL MED, V2, P328, DOI 10.5966/sctm.2012-0116
   Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019
   Clement MV, 1996, EMBO J, V15, P216, DOI 10.1002/j.1460-2075.1996.tb00352.x
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Cook C, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005888
   Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511
   Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007
   Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006
   Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011
   Drowley L, 2010, MOL THER, V18, P1865, DOI 10.1038/mt.2010.160
   Dupressoir A, 1995, BBA-GENE STRUCT EXPR, V1264, P397, DOI 10.1016/0167-4781(95)00181-6
   Elabd C, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5082
   Erol A, 2011, CELL SIGNAL, V23, P1076, DOI 10.1016/j.cellsig.2010.11.023
   Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791
   Feng YL, 2014, STEM CELLS, V32, P462, DOI 10.1002/stem.1571
   Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008
   Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007
   Fortini P, 2013, MUTAT RES-FUND MOL M, V743, P160, DOI 10.1016/j.mrfmmm.2013.03.004
   Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, PG914, DOI 10.1152/ajpgi.00402.2011
   Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466
   Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   González-Suárez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572
   Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195
   Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25
   GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622
   Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002
   Han S, 2012, TRENDS CELL BIOL, V22, P42, DOI 10.1016/j.tcb.2011.11.001
   HARMAN D, 1972, AM J CLIN NUTR, V25, P839
   Harris JM, 2013, BLOOD, V121, P2483, DOI 10.1182/blood-2012-12-471201
   Hewitt G, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms1708
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106
   Hur JH, 2013, AGING-US, V5, P662, DOI 10.18632/aging.100595
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989
   Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015
   Jones M, 2014, J CLIN INVEST, V124, P353, DOI 10.1172/JCI67871
   Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023
   Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054
   Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kobayashi Y, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0052787
   Kolosova NG, 2012, AGING-US, V4, P686, DOI 10.18632/aging.100493
   Kondratov RV, 2009, AGING-US, V1, P979, DOI 10.18632/aging.100113
   Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107
   Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x
   Li WH, 2013, NAT NEUROSCI, V16, P529, DOI 10.1038/nn.3368
   Liang R, 2014, ANTIOXID REDOX SIGN, V20, P1902, DOI 10.1089/ars.2013.5300
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Mandal PK, 2011, NAT REV MOL CELL BIO, V12, P198, DOI 10.1038/nrm3060
   Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004
   Maxwell PH, 2011, P NATL ACAD SCI USA, V108, P20376, DOI 10.1073/pnas.1100271108
   McArdle A, 2004, FASEB J, V18, P0, DOI 10.1096/fj.03-0395fje
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Miller RA, 2004, AGING CELL, V3, P53, DOI 10.1111/j.1474-9728.2004.00084.x
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001
   Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002
   Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532
   Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038
   Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145
   Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001
   Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789
   Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162
   Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571
   Nakamura M, 2013, CELL RES, V23, P70, DOI 10.1038/cr.2012.171
   Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965
   Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723
   Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313
   Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013
   Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010
   Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088
   Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804
   Peserico A, 2013, CELL MOL LIFE SCI, V70, P2015, DOI 10.1007/s00018-012-1244-6
   Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012
   Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014
   Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019
   Rübe CE, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0017487
   Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580
   Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039
   Sadowska AM, 2007, PULM PHARMACOL THER, V20, P9, DOI 10.1016/j.pupt.2005.12.007
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Sakata H, 2012, BRAIN, V135, P3298, DOI 10.1093/brain/aws259
   Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113
   Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x
   Sato T, 2011, NAT COMMUN, V2, P0, DOI 10.1038/ncomms1478
   Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637
   Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002
   Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002
   Tabebordbar M, 2013, ANNU REV PATHOL-MECH, V8, P441, DOI 10.1146/annurev-pathol-011811-132450
   Takahashi K, 2013, DEVELOPMENT, V140, P2457, DOI 10.1242/dev.092551
   Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011
   Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237
   Taylor RC, 2011, CSH PERSPECT BIOL, V3, P0, DOI 10.1101/cshperspect.a004440
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Tomaru U, 2012, AM J PATHOL, V180, P963, DOI 10.1016/j.ajpath.2011.11.012
   Tomás-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034
   Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Wahlestedt M, 2013, BLOOD, V121, P4257, DOI 10.1182/blood-2012-11-469080
   Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x
   Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895
   Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048
   Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385
   Xu Y, 2013, GENOME, V56, P9, DOI 10.1139/gen-2012-0124
   Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200
   Yang SA, 2013, DEV BIOL, V382, P124, DOI 10.1016/j.ydbio.2013.07.018
   Yilmaz ÖH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163
   Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022
   Yuan HF, 2012, J MOL MED, V90, P389, DOI 10.1007/s00109-011-0825-4
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002
   Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 190
TC 512
Z9 588
U1 3
U2 107
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD AUG 15
PY 2014
VL 20
IS 8
BP 870
EP 880
DI 10.1038/nm.3651
PG 11
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine
GA AM7UQ
UT WOS:000340074600018
PM 25100532
DA 2024-11-01
ER

PT J
AU Rötig, A
AF Roetig, A.
TI Genetics of mitochondrial respiratory chain deficiencies
SO REVUE NEUROLOGIQUE
LA English
DT Article
DE Genetic diseases; Mitochondria; Respiratory chain
ID cytochrome-c-oxidase; transfer-rna-synthetase; complex-iii deficiency; progressive external ophthalmoplegia; sideroblastic anemia-mlasa; atp synthase deficiency; dna depletion; lactic-acidosis; leigh-syndrome; oxidative-phosphorylation
AB Oxidative phosphorylation, i.e. ATP synthesis by the oxygen-consuming respiratory chain (RC), supplies most organs and tissues with a readily usable energy source, and is already fully functioning before birth. This means that, in theory, RC deficiency can give rise to any symptom in any organ or tissue at any age and with any mode of inheritance, due to the twofold genetic origin of RC components (nuclear DNA and mitochondrial DNA). It has long been erroneously believed that RC disorders originate from mutations of mtDNA as, for some time, only mutations or deletions of mtDNA could be identified. However, the number of disease-causing mutations in nuclear genes is now steadily growing. These genes not only encode the various subunits of each complex, but also the ancillary proteins involved in the different stages of holoenzyme biogenesis, including transcription, translation, chaperoning, addition of prosthetic groups and assembly of proteins, as well as the various enzymes involved in mtDNA metabolism. (C) 2014 Elsevier Masson SAS. All rights reserved.
C1 Univ Paris 05, Sorbonne Paris Cite, Hop Necker Enfants Malad, Inserm U1163, F-75015 Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Rötig, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Hop Necker Enfants Malad, Inserm U1163, 149 Rue Sevres, F-75015 Paris, France.
EM agnes.rotig@inserm.fr
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   Bayat V, 2012, PLOS BIOL, V10, P0, DOI 10.1371/journal.pbio.1001288
   Baysal BE, 2008, J MED GENET, V45, P689, DOI 10.1136/jmg.2008.058560
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392
   Bouchet C, 2006, J MED GENET, V43, P788, DOI 10.1136/jmg.2005.034140
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Bugiani M, 2005, J MED GENET, V42, P0, DOI 10.1136/jmg.2004.029926
   Bundschuh FA, 2009, J BIOL CHEM, V284, P25735, DOI 10.1074/jbc.M109.040295
   Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   CORMIER V, 1991, J PEDIATR-US, V119, P951, DOI 10.1016/S0022-3476(05)83054-9
   Crosby AH, 2010, AM J HUM GENET, V87, P655, DOI 10.1016/j.ajhg.2010.09.013
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elo JM, 2012, HUM MOL GENET, V0, P0
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Garcia-Diaz B, 2012, AM J HUM GENET, V91, P729, DOI 10.1016/j.ajhg.2012.08.019
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Grivell LA, 1999, FEBS LETT, V452, P57, DOI 10.1016/S0014-5793(99)00532-3
   Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Janer A, 2012, AM J HUM GENET, V91, P737, DOI 10.1016/j.ajhg.2012.08.020
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kevelam SH, 2013, NEUROLOGY, V80, P1577, DOI 10.1212/WNL.0b013e31828f1914
   Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nicolino M, 1997, J CLIN ENDOCR METAB, V82, P3063, DOI 10.1210/jc.82.9.3063
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Oquendo CE, 2004, J MED GENET, V41, P540, DOI 10.1136/jmg.2003.017426
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Paquis-Flucklinger V, 1998, DIABETOLOGIA, V41, P740, DOI 10.1007/s001250050978
   Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Rotig A, 2009, BIOCH BIOPHYS ACTA, V0, P0
   Rötig A, 2007, MITOCHONDRION, V7, PS112, DOI 10.1016/j.mito.2007.02.008
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2012, J MED GENET, V49, P187, DOI 10.1136/jmedgenet-2011-100394
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Souied EH, 1998, AM J OPHTHALMOL, V125, P100, DOI 10.1016/S0002-9394(99)80243-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4
   Szklarczyk R, 2013, HUM MOL GENET, V22, P656, DOI 10.1093/hmg/dds473
   Tenisch EV, 2012, NEUROLOGY, V79, P391, DOI 10.1212/WNL.0b013e3182611232
   Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vedrenne V, 2012, AM J HUM GENET, V91, P912, DOI 10.1016/j.ajhg.2012.09.001
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   von Ameln S, 2012, AM J HUM GENET, V91, P919, DOI 10.1016/j.ajhg.2012.09.002
   von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957
   Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 132
TC 7
Z9 12
U1 0
U2 15
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0035-3787
EI 2213-0004
J9 REV NEUROL-FRANCE
JI Rev. Neurol.
PD MAY 15
PY 2014
VL 170
IS 5
BP 309
EP 322
DI 10.1016/j.neurol.2013.11.006
PG 14
WC Clinical Neurology
SC Neurosciences & Neurology
GA AH4JK
UT WOS:000336093000002
PM 24798924
DA 2024-11-01
ER

PT J
AU Rouzier, C
   Chaussenot, A
   Serre, V
   Fragaki, K
   Bannwarth, S
   Ait-El-Mkadem, S
   Attarian, S
   Kaphan, E
   Cano, A
   Delmont, E
   Sacconi, S
   de Camaret, BM
   Rio, M
   Lebre, AS
   Jardel, C
   Deschamps, R
   Richelme, C
   Pouget, J
   Chabrol, B
   Paquis-Flucklinger, V
AF Rouzier, Cecile
   Chaussenot, Annabelle
   Serre, Valerie
   Fragaki, Konstantina
   Bannwarth, Sylvie
   Ait-El-Mkadem, Samira
   Attarian, Shahram
   Kaphan, Elsa
   Cano, Aline
   Delmont, Emilien
   Sacconi, Sabrina
   de Camaret, Benedicte Mousson
   Rio, Marlene
   Lebre, Anne-Sophie
   Jardel, Claude
   Deschamps, Romain
   Richelme, Christian
   Pouget, Jean
   Chabrol, Brigitte
   Paquis-Flucklinger, Veronique
TI Quantitative multiplex PCR of short fluorescent fragments for the detection of large intragenic <i>POLG</i> rearrangements in a large French cohort
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE POLG; QMPSF; intragenic deletion; EPC; polyendocrinopathy
ID dna-polymerase-gamma; progressive external ophthalmoplegia; mitochondrial-dna; hepatocerebral syndrm; autosomal-dominant; alpers-syndrome; copy number; mutations; deletions; disease
AB Polymerase gamma (POLG) is the gene most commonly involved in mitochondrial disorders with mitochondrial DNA instability and causes a wide range of diseases with recessive or dominant transmission. More than 170 mutations have been reported. Most of them are missense mutations, although nonsense mutations, splice-site mutations, small deletions and insertions have also been identified. However, to date, only one large-scale rearrangement has been described in a child with Alpers syndrome. Below, we report a large cohort of 160 patients with clinical, molecular and/or biochemical presentation suggestive of POLG deficiency. Using sequencing, we identified POLG variants in 22 patients (18 kindreds) including five novel pathogenic mutations. Two patients with novel mutations had unusual clinical presentation: the first exhibited an isolated ataxic neuropathy and the second was a child who presented with endocrine signs. We completed the sequencing step by quantitative multiplex PCR of short fluorescent fragments (QMPSF) analysis in 37 patients with either only one POLG heterozygous variant or a family history suggesting a dominant transmission. We identified a large intragenic deletion encompassing part of intron 21 and exon 22 of POLG in a child with refractory epilepsia partialis continua. In conclusion, we describe the first large French cohort of patients with POLG mutations, expanding the wide clinical and molecular spectrum observed in POLG disease. We confirm that large deletions in the POLG gene are rare events and we highlight the importance of QMPSF in patients with a single heterozygous POLG mutation, particularly in severe infantile phenotypes.
C1 [Rouzier, Cecile; Chaussenot, Annabelle; Fragaki, Konstantina; Bannwarth, Sylvie; Ait-El-Mkadem, Samira; Paquis-Flucklinger, Veronique] Nice Teaching Hosp, Dept Med Genet, Natl Ctr Mitochondrial Dis, Nice, France.
   [Rouzier, Cecile; Fragaki, Konstantina; Bannwarth, Sylvie; Ait-El-Mkadem, Samira; Paquis-Flucklinger, Veronique] Univ Nice Sophia Antipolis, CNRS UMR 7284, Sch Med, IRCAN,INSERM U1081,UNS, F-06189 Nice, France.
   [Serre, Valerie] Univ Paris Diderot, Inst Jacques Monod, CNRS, Paris, France.
   [Attarian, Shahram; Kaphan, Elsa; Pouget, Jean] Marseille Teaching Hosp, Timone Hosp, Dept Neurol, Marseille, France.
   [Cano, Aline; Chabrol, Brigitte] Marseille Teaching Hosp, Timone Hosp, Dept Neuropediat, Marseille, France.
   [Delmont, Emilien; Sacconi, Sabrina] Nice Teaching Hosp, Dept Neurol, Nice, France.
   [de Camaret, Benedicte Mousson] Lyon Teaching Hosp, Dept Metab Dis, Biol & Pathol Ctr Est, Lyon, France.
   [Rio, Marlene; Lebre, Anne-Sophie] Paris Teaching Hosp, Necker Hosp, Dept Med Genet, Paris, France.
   [Jardel, Claude] Paris Teaching Hosp, Pitie Salpetriere Hosp, Dept Mol & Chromosomal Genet, Paris, France.
   [Deschamps, Romain] Ft France Teaching Hosp, Dept Neuromuscular Disorders, Fort De France, Martinique, France.
   [Richelme, Christian] Nice Teaching Hosp, Lenval Hosp, Dept Pediat, Nice, France.
C3 CHU Nice; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Nice; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; CHU Martinique; CHU Nice
RP Paquis-Flucklinger, V (corresponding author), IRCAN, CNRS UMR 7284, Sch Med, INSERM U1081,UNS, 28 Valombrose, F-06107 Nice, France.
EM paquis@hermes.unice.fr
FU Association Francaise contre les Myopathies (AFM); CHU of Nice
CR Amara A, 2012, EUR J PAEDIATR NEURO, V16, P167, DOI 10.1016/j.ejpn.2011.07.007
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Ceulemans S, 2012, METHODS MOL BIOL, V838, P311, DOI 10.1007/978-1-61779-507-7_15
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Charbonnier F, 2000, CANCER RES, V60, P2760
   Compton AG, 2011, MITOCHONDRION, V11, P104, DOI 10.1016/j.mito.2010.07.012
   Férec C, 2006, EUR J HUM GENET, V14, P567, DOI 10.1038/sj.ejhg.5201590
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Gouas L, 2008, PATHOL BIOL, V56, P345, DOI 10.1016/j.patbio.2008.03.010
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Paul R, 1996, TRENDS GENET, V12, P131
   Reichenbach J, 2006, PEDIATR RES, V60, P321, DOI 10.1203/01.pdr.0000233252.60457.cf
   Rouzier C, 2010, J MED GENET, V47, P670, DOI 10.1136/jmg.2009.073445
   Saugier-Veber P, 2006, EUR J HUM GENET, V14, P1009, DOI 10.1038/sj.ejhg.5201661
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 34
TC 28
Z9 28
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD APR 15
PY 2014
VL 22
IS 4
BP 542
EP 550
DI 10.1038/ejhg.2013.171
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AD0QE
UT WOS:000332938400026
PM 23921535
DA 2024-11-01
ER

PT J
AU Dong, DW
   Pereira, F
   Barrett, SP
   Kolesar, JE
   Cao, KJ
   Damas, J
   Yatsunyk, LA
   Johnson, FB
   Kaufman, BA
AF Dong, Dawei W.
   Pereira, Filipe
   Barrett, Steven P.
   Kolesar, Jill E.
   Cao, Kajia
   Damas, Joana
   Yatsunyk, Liliya A.
   Johnson, F. Brad
   Kaufman, Brett A.
TI Association of G-quadruplex forming sequences with human mtDNA deletion breakpoints
SO BMC GENOMICS
LA English
DT Article
DE G-quadruplex; mtDNA deletions; Mitochondrial disease; Mitochondrial genome instability; Non-B DNA; Nucleic acid structures
ID mitochondrial-dna deletions; progressive external ophthalmoplegia; large-scale deletions; human pif1 helicase; secondary structures; genome instability; direct repeats; replication; mutations; stability
AB Background: Mitochondrial DNA (mtDNA) deletions cause disease and accumulate during aging, yet our understanding of the molecular mechanisms underlying their formation remains rudimentary. Guanine-quadruplex (GQ) DNA structures are associated with nuclear DNA instability in cancer; recent evidence indicates they can also form in mitochondrial nucleic acids, suggesting that these non-B DNA structures could be associated with mtDNA deletions. Currently, the multiple types of GQ sequences and their association with human mtDNA stability are unknown. Results: Here, we show an association between human mtDNA deletion breakpoint locations (sites where DNA ends rejoin after deletion of a section) and sequences with G-quadruplex forming potential (QFP), and establish the ability of selected sequences to form GQ in vitro. QFP contain four runs of either two or three consecutive guanines (2G and 3G, respectively), and we identified four types of QFP for subsequent analysis: intrastrand 2G, intrastrand 3G, duplex derived interstrand (ddi) 2G, and ddi 3G QFP sequences. We analyzed the position of each motif set relative to either 5' or 3' unique mtDNA deletion breakpoints, and found that intrastrand QFP sequences, but not ddi QFP sequences, showed significant association with mtDNA deletion breakpoint locations. Moreover, a large proportion of these QFP sequences occur at smaller distances to breakpoints relative to distribution-matched controls. The positive association of 2G QFP sequences persisted when breakpoints were divided into clinical subgroups. We tested in vitro GQ formation of representative mtDNA sequences containing these 2G QFP sequences and detected robust GQ structures by UV-VIS and CD spectroscopy. Notably, the most frequent deletion breakpoints, including those of the "common deletion", are bounded by 2G QFP sequence motifs. Conclusions: The potential for GQ to influence mitochondrial genome stability supports a high-priority investigation of these structures and their regulation in normal and pathological mitochondrial biology. These findings emphasize the potential importance of helicases that subsequently resolve GQ to maintain the stability of the mitochondrial genome.
C1 [Dong, Dawei W.; Kolesar, Jill E.; Kaufman, Brett A.] Univ Penn, Sch Vet Med, Dept Biol Anim, Philadelphia, PA 19104 USA.
   [Dong, Dawei W.] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA.
   [Pereira, Filipe; Damas, Joana] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal.
   [Pereira, Filipe] Univ Porto, CIIMAR CIMAR, Interdisciplinary Ctr Marine & Environm Res, P-4100 Oporto, Portugal.
   [Barrett, Steven P.; Yatsunyk, Liliya A.] Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA.
   [Cao, Kajia] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.
   [Johnson, F. Brad] Univ Penn, Perelman Sch Med, Dept Lab Med & Pathol, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; University of Pennsylvania; Universidade do Porto; Universidade do Porto; Swarthmore College; University of Pennsylvania; University of Pennsylvania
RP Kaufman, BA (corresponding author), Univ Penn, Sch Vet Med, Dept Biol Anim, Philadelphia, PA 19104 USA.
EM bkauf@vet.upenn.edu
FU University Research Foundation; University of Pennsylvania; NIH [R01-AG021521, P01-AG031862, P30-DK050306]; Portuguese Foundation for Science and Technology (FCT); Fundo Social Europeu and Programa Operacional Potencial Humano [PTDC/CVT/100881/2008]; Swarthmore College; Fundação para a Ciência e a Tecnologia [PTDC/CVT/100881/2008] Funding Source: FCT
CR ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bhattacharjee AJ, 2011, BIOCHIMIE, V93, P1297, DOI 10.1016/j.biochi.2011.05.038
   Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296
   Cao KJ, 2012, METHODS, V57, P3, DOI 10.1016/j.ymeth.2012.05.002
   Capra JA, 2010, PLOS COMPUT BIOL, V6, P0, DOI 10.1371/journal.pcbi.1000861
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089
   Douarre C, 2013, NUCLEIC ACIDS RES, V41, P3588, DOI 10.1093/nar/gkt073
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   George T, 2009, NUCLEIC ACIDS RES, V37, P6491, DOI 10.1093/nar/gkp671
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hou JH, 1996, BIOCHEM J, V318, P1065, DOI 10.1042/bj3181065
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Huppert JL, 2008, BIOCHIMIE, V90, P1140, DOI 10.1016/j.biochi.2008.01.014
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Kazak L, 2013, NUCLEIC ACIDS RES, V41, P2354, DOI 10.1093/nar/gks1347
   Kikin O, 2006, NUCLEIC ACIDS RES, V34, PW676, DOI 10.1093/nar/gkl253
   Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152
   Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, P0, DOI 10.1093/nar/gks1324
   Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Lakshmanan LN, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035271
   Lee DY, 1996, J BIOL CHEM, V271, P24262, DOI 10.1074/jbc.271.39.24262
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316
   Markham Nicholas R, 2008, V453, V0, PP3, DOI 10.1007/978-1-60327-429-6_1
   Mergny JL, 2005, NUCLEIC ACIDS RES, V33, P0, DOI 10.1093/nar/gni134
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213
   Oliveira PH, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059907
   Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149
   Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015
   Petraccone L, 2005, NUCLEOS NUCLEOT NUCL, V24, P757, DOI 10.1081/NCN-200060080
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806
   Ribeyre C, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000475
   Risitano A, 2004, NUCLEIC ACIDS RES, V32, P2598, DOI 10.1093/nar/gkh598
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009
   Smith JS, 2011, NAT STRUCT MOL BIOL, V18, P478, DOI 10.1038/nsmb.2033
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   VANTUYLE GC, 1985, J CELL BIOL, V100, P251, DOI 10.1083/jcb.100.1.251
   Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802
   Wanrooij PH, 2010, P NATL ACAD SCI USA, V107, P16072, DOI 10.1073/pnas.1006026107
   Yang JN, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0073318
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 67
TC 85
Z9 90
U1 0
U2 51
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
EI 
J9 BMC GENOMICS
JI BMC Genomics
PD AUG 13
PY 2014
VL 15
IS 
BP 
EP 
DI 10.1186/1471-2164-15-677
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA AO0XG
UT WOS:000341035600001
PM 25124333
DA 2024-11-01
ER

PT J
AU Liang, C
   Ahmad, K
   Sue, CM
AF Liang, Christina
   Ahmad, Kate
   Sue, Carolyn M.
TI The broadening spectrum of mitochondrial disease: Shifts in the diagnostic paradigm
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Review
DE Mitochondrial disease; FGF21; Next-generation-sequencing
ID respiratory-chain disorders; transfer rnaleu(uur) gene; a3243g point mutation; stroke-like episodes; ragged-red fibers; lactic-acidosis; melas syndrome; dna mutations; prevalence; children
AB Background: The diagnosis of mitochondrial disease requires a complex synthesis of clinical, biochemical, histological, and genetic investigations. An expanding number of mitochondrial diseases are being recognized, despite their phenotypic diversity, largely due to improvements in methods to detect mutations in affected individuals and the discovery of genes contributing to mitochondrial function. Improved understanding of the investigational pitfalls and the development of new laboratory methodologies that lead to a molecular diagnosis have necessitated the field to rapidly adopt changes to its diagnostic approach. Scope of review: We review the clinical, investigational and genetic challenges that have resulted in shifts to the way we define and diagnose mitochondrial disease. Incorporation of changes, including the use of fibroblast growth factor 21 (FGF-21) and next generation sequencing techniques, may allow affected patients access to earlier molecular diagnosis and management. Major conclusions: There have been important shifts in the diagnostic paradigm for mitochondrial disease. Diagnosis of mitochondrial disease is no longer reliant on muscle biopsy alone, but should include clinical assessment accompanied by the use of serological biomarkers and genetic analysis. Because affected patients will be defined on a molecular basis, oligosymptomatic mutation carriers should be included in the spectrum of mitochondrial disease. Use of new techniques such as the measurement of serum FGF-21 levels and next-generation-sequencing protocols should simplify the diagnosis of mitochondrial disease. General significance: Improvements in the diagnostic pathway for mitochondrial disease will result in earlier, cheaper and more accurate methods to identify patients with mitochondrial disease. This article is part of a Special Issue entitled Frontiers of Mitochondrial Research. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.
C1 [Liang, Christina; Ahmad, Kate; Sue, Carolyn M.] Royal N Shore Hosp, Dept Neurol, St Leonards, NSW 2065, Australia.
   [Sue, Carolyn M.] Royal N Shore Hosp, Kolling Inst Med Res, Dept Neurogenet, St Leonards, NSW 2065, Australia.
   [Sue, Carolyn M.] Univ Sydney, St Leonards, NSW 2065, Australia.
C3 Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney
RP Sue, CM (corresponding author), Univ Sydney, Royal N Shore Hosp, Dept Neurol, St Leonards, NSW 2065, Australia.
EM carolyn.sue@sydney.edu.au
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Brinjikji W, 2011, JIMD REP, V1, P89, DOI 10.1007/8904_2011_22
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   CRIMMINS D, 1993, J NEUROL NEUROSUR PS, V56, P900, DOI 10.1136/jnnp.56.8.900
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer Josef, 2012, OPEN NEUROL J, V6, P26, DOI 10.2174/1874205X01206010026
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gebhart SSP, 1996, METABOLISM, V45, P526, DOI 10.1016/S0026-0495(96)90231-0
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, V0, PS107
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Liang C, 2011, AUSTR DOCTOR, V25, P27
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Ma YY, 2013, MITOCHONDR DNA, V24, P297, DOI 10.3109/19401736.2012.760071
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Manwaring N, 2008, ANN NEUROL, V64, P471, DOI 10.1002/ana.21469
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Moore DD, 2007, SCIENCE, V316, P1436, DOI 10.1126/science.1144837
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Nolte KW, 2013, NEUROPATHOLOGY, V33, P59, DOI 10.1111/j.1440-1789.2012.01317.x
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   POULTON J, 1993, ANN NEUROL, V34, P116, DOI 10.1002/ana.410340124
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shigemoto M, 1998, INTERNAL MED, V37, P265, DOI 10.2169/internalmedicine.37.265
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sue CM, 2010, MED J AUSTRALIA, V193, P195, DOI 10.5694/j.1326-5377.2010.tb03864.x
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Thorburn DR, 2001, J INHERIT METAB DIS, V24, P312, DOI 10.1023/A:1010347808082
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   Vasta V, 2012, PEDIATR INT, V54, P585, DOI 10.1111/j.1442-200X.2012.03644.x
   Vento JM, 2013, NEUROTHERAPEUTICS, V10, P243, DOI 10.1007/s13311-012-0173-2
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
NR 53
TC 42
Z9 45
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD APR 15
PY 2014
VL 1840
IS 4
BP 1360
EP 1367
DI 10.1016/j.bbagen.2013.10.040
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AD8GQ
UT WOS:000333504900015
PM 24239706
DA 2024-11-01
ER

PT J
AU Blakely, EL
   Alston, CL
   Lecky, B
   Chakrabarti, B
   Falkous, G
   Turnbull, DM
   Taylor, RW
   Gorman, GS
AF Blakely, Emma L.
   Alston, Charlotte L.
   Lecky, Bryan
   Chakrabarti, Biswajit
   Falkous, Gavin
   Turnbull, Douglass M.
   Taylor, Robert W.
   Gorman, Grainne S.
TI Distal weakness with respiratory insufficiency caused by the m.8344A &gt; G "MERRF" mutation
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondria; Distal myopathy; MERRF syndrome
ID mitochondrial-dna disease; family; epilepsy
AB The m.8344A > G mutatfon in the mt-tRNA(Lys) gene, first described in myoclonic epilepsy and ragged red fibers (MERRF), accounts for approximately 80% of mutations in individuals with MERRF syndrome. Although originally described in families with a classical syndrome of myoclonus, ataxia, epilepsy and ragged red fibers in muscle biopsy, the m.8344A > G mutation is increasingly recognised to exhibit marked phenotypic heterogeneity. This paper describes the clinical, morphological and laboratory features of an unusual phenotype in a patient harboring the m.8344A > G 'MERRF' mutation. We present the case of a middle-aged woman with distal weakness since childhood who also had ptosis and facial weakness and who developed mid-life respiratory insufficiency necessitating non-invasive nocturnal ventilator support. Neurophysiological and acetylcholine receptor antibody analyses excluded myasthenia gravis whilst molecular genetic testing excluded myotonic dystrophy, prompting a diagnostic needle muscle biopsy. Mitochondrial histochemical abnoinialities including subsarcolemmal mitochondrial accumulation (ragged-red fibers) and in excess of 90% COX-deficient fibers, was seen leading to sequencing of the mitochondrial genome in muscle. This identified the m.8344A > G mutation commonly associated with the MERRF phenotype. This case extends the evolving phenotypic spectrum of the m.8344A > G mutation and emphasizes that it may cause indolent distal weakness with respiratory insufficiency, with marked histochemical defects in muscle. Our findings support consideration of screening of this gene in cases of indolent myopathy resembling distal limb-girdle muscular dystrophy in which screening of the common genes prove negative. (C) 2014 The Authors. Published by Elsevier B.V.
C1 [Blakely, Emma L.; Alston, Charlotte L.; Falkous, Gavin; Turnbull, Douglass M.; Taylor, Robert W.; Gorman, Grainne S.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Lecky, Bryan] Walton Ctr NHS Fdn Trust, Liverpool L9 7LJ, Merseyside, England.
   [Chakrabarti, Biswajit] Aintree Univ Hosp NHS Fdn Trust, Aintree Chest Ctr, Liverpool L9 7AL, Merseyside, England.
C3 Newcastle University - UK; Walton Centre; Aintree University Hospitals NHS Foundation Trust
RP Gorman, GS (corresponding author), Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM grainne.gorman@ncl.ac.uk
FU Wellcome Trust [096919Z/11/Z, 074454/Z/04/Z]; Medical Research Council [G0601943, G0800674]; UK National Institute for Health Research Biomedical Research Centre for Ageing and Age-related Diseases; UK NHS Specialized Services; Newcastle upon Tyne Hospitals NHS Foundation Trust 'Rare Mitochondrial Disorders of Adults and Children' Diagnostic Service; MRC [MR/K000608/1, G0800674, G0700718, G0601943] Funding Source: UKRI
CR Alston CL, 2011, EUR J HUM GENET, V19, P1226, DOI 10.1038/ejhg.2011.124
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Kazakos K, 2012, ANN HUM GENET, V76, P296, DOI 10.1111/j.1469-1809.2012.00711.x
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Tuppen HAL, 2010, BRAIN, V133, P2952, DOI 10.1093/brain/awq232
NR 7
TC 25
Z9 27
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN 15
PY 2014
VL 24
IS 6
BP 533
EP 536
DI 10.1016/j.nmd.2014.03.011
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AJ7EZ
UT WOS:000337861300011
PM 24792523
DA 2024-11-01
ER

PT J
AU Castro-Gago, M
   Dacruz-Alvarez, D
   Pintos-Martínez, E
   Beiras-Iglesias, A
   Delmiro, A
   Arenas, J
   Martín, MA
   Martínez-Azorín, F
AF Castro-Gago, Manuel
   Dacruz-Alvarez, David
   Pintos-Martinez, Elena
   Beiras-Iglesias, Andres
   Delmiro, Aitor
   Arenas, Joaquin
   Martin, Miguel Angel
   Martinez-Azorin, Francisco
TI Exome sequencing identifies a <i>CHKB</i> mutation in Spanish patient with Megaconial Congenital Muscular Dystrophy and mtDNA depletion
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Article
DE CHKB; Megaconial Congenital Muscular; Dystrophy; Mitochondria; mtDNA depletion; Whole-exome sequencing
ID choline kinase beta; mitochondrial structural abnormality; gene; eastern; defect
AB Background: Choline kinase beta gene (CHKB) mutations have been identified in Megaconial Congenital Muscular Dystrophy (MDCMC) patients, but never in patients with an additional combined deficiency of complexes I, III and IV and mitochondrial DNA (mtDNA) depletion. Aims: To report mutations in carry genes for MDCMC with respiratory chain defects and mtDNA depletion. Methods: Whole-exome sequencing (WES) was used to identify the carry genes in a Spanish child with muscle weakness, mild hypotonia at lower limb muscles, mildly elevated creatine kinase (CK), enlarged mitochondria in the periphery of the fibers, combined deficiency of complex I, III and IV and depletion of mtDNA. Results: With WES data, it was possible to get the whole mtDNA sequencing and discard any pathogenic variant in this genome. The first filter of WES data with the nuclear-encoded mitochondrial genes (MitoCarta) did not get any candidate. However, the analysis of whole exome uncovered a homozygous nonsense pathogenic mutation in CHKB gene (NM_005198.4:c.810T>A, p.Tyr270*). Conclusions: Our data confirm the role of CHKB in MDCMC and point to this gene as unique candidate for the combined deficiency of respiratory chain and mtDNA depletion observed in this patient. (C) 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
C1 [Castro-Gago, Manuel; Dacruz-Alvarez, David] Hosp Clin Univ, Fac Med, Dept Pediat, Serv Neuropediat, Santiago De Compostela, Spain.
   [Pintos-Martinez, Elena; Beiras-Iglesias, Andres] Hosp Clin Univ, Fac Med, Serv Anatomia Patol, Santiago De Compostela, Spain.
   [Delmiro, Aitor; Arenas, Joaquin; Martin, Miguel Angel; Martinez-Azorin, Francisco] Inst Invest Hosp 12 Octubre i 12, Lab Enfermedades Mitocondri, E-28041 Madrid, Spain.
   [Delmiro, Aitor; Arenas, Joaquin; Martin, Miguel Angel; Martinez-Azorin, Francisco] CIBERER, E-28041 Madrid, Spain.
C3 Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER
RP Martínez-Azorín, F (corresponding author), Inst Invest Hosp 12 Octubre i 12, CAA, Lab Enfermedades Mitocondri, 6a Planta,Bloque E,Avda Cordoba S-N, E-28041 Madrid, Spain.
EM fmartinez@h12o.es
FU Spanish Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III (ISCIII) [CP08/00018, PI10/00063, PI12/01683];  [ISCIII-PI12/01683]
CR Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Delmiro A, 2013, HUM MUTAT, V34, P1623, DOI 10.1002/humu.22445
   Hagopian K, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012696
   Mitsuhashi S, 2013, CURR OPIN NEUROL, V26, P536, DOI 10.1097/WCO.0b013e328364c82d
   Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305
   Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010
   Nishino I, 1998, MUSCLE NERVE, V21, P40, DOI 10.1002/(SICI)1097-4598(199801)21:1<40::AID-MUS6>3.0.CO;2-G
   Ottoni C, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013378
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Quinlivan R, 2013, NEUROMUSCULAR DISORD, V23, P549, DOI 10.1016/j.nmd.2013.04.002
   Ríos PG, 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI 10.1001/archneurol.2011.2333
   Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173
   Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304
   Yamazaki N, 2000, J BIOL CHEM, V275, P31739, DOI 10.1074/jbc.M006322200
NR 14
TC 21
Z9 24
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD NOV 15
PY 2014
VL 18
IS 6
BP 796
EP 800
DI 10.1016/j.ejpn.2014.06.005
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA AS7LO
UT WOS:000344437800022
PM 24997086
DA 2024-11-01
ER

PT J
AU Thornton, B
   Cohen, B
   Copeland, W
   Maria, BL
AF Thornton, Ben
   Cohen, Bruce
   Copeland, William
   Maria, Bernard L.
TI Mitochondrial Disease: Clinical Aspects, Molecular Mechanisms, Translational Science, and Clinical Frontiers
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE mitochondrial disease
ID mtdna
AB Mitochondrial medicine provides a metabolic perspective on the pathology of conditions linked with inadequate oxidative phosphorylation. Dysfunction in the mitochondrial machinery can result in improper energy production, leading to cellular injury or even apoptosis. Clinical presentations are often subtle, so clinicians must have a high index of suspicion to make early diagnoses. Symptoms could include muscle weakness and pain, seizures, loss of motor control, decreased visual and auditory functions, metabolic acidosis, acute developmental regression, and immune system dysfunction. The 2013 Neurobiology of Disease in Children Symposium, held in conjunction with the 42nd Annual Meeting of the Child Neurology Society, aimed to (1) describe accepted clinical phenotypes of mitochondrial disease produced from various mitochondrial mutations, (2) discuss contemporary understanding of molecular mechanisms that contribute to disease pathology, (3) highlight the systemic effects produced by dysfunction within the mitochondrial machinery, and (4) introduce current strategies that are being translated from bench to bedside as potential therapeutics.
C1 [Thornton, Ben; Maria, Bernard L.] Georgia Regents Univ, Dept Pediat, Augusta, GA USA.
   [Cohen, Bruce] Akron Childrens Hosp, Akron, OH USA.
   [Copeland, William] NIEHS, Res Triangle Pk, NC 27709 USA.
C3 University System of Georgia; Augusta University; Akron Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Maria, BL (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Pediat, 1446 Harper St,BT-1850, Augusta, GA 30912 USA.
EM bmaria@gru.edu
FU Intramural NIH HHS [Z01 ES065078-14] Funding Source: Medline
CR Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
NR 5
TC 8
Z9 8
U1 0
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD SEP 15
PY 2014
VL 29
IS 9
BP 1179
EP 1207
DI 10.1177/0883073814537379
PG 29
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA AP1FK
UT WOS:000341812400012
PM 24916430
DA 2024-11-01
ER

PT J
AU Al-Hussaini, A
   Faqeih, E
   El-Hattab, AW
   Alfadhel, M
   Asery, A
   Alsaleem, B
   Bakhsh, E
   Ali, A
   Alasmari, A
   Lone, K
   Nahari, A
   Eyaid, W
   Al Balwi, M
   Craig, K
   Butterworth, A
   He, LP
   Taylor, RW
AF Al-Hussaini, Abdulrahman
   Faqeih, Eissa
   El-Hattab, Ayman W.
   Alfadhel, Majid
   Asery, Ali
   Alsaleem, Badr
   Bakhsh, Eman
   Ali, Ashraf
   Alasmari, Ali
   Lone, Khurram
   Nahari, Ahmed
   Eyaid, Wafaa
   Al Balwi, Mohammed
   Craig, Kate
   Butterworth, Anna
   He, Langping
   Taylor, Robert W.
TI Clinical and Molecular Characteristics of Mitochondrial DNA Depletion Syndrome Associated with Neonatal Cholestasis and Liver Failure
SO JOURNAL OF PEDIATRICS
LA English
DT Article
ID deoxyguanosine kinase; mtdna depletion; mutations; features; gene; myopathy; disease
AB Objective To determine the frequency of mitochondrial DNA depletion syndrome (MDS) in infants with cholestasis and liver failure and to further clarify the clinical, biochemical, radiologic, histopathologic, and molecular features associated with MDS due to deoxyguanosine kinase (DGUOK) and MPV17 gene mutations. Study design We studied 20 infants with suspected hepatocerebral MDS referred to our tertiary care center between 2007 and 2013. Genomic DNA was isolated from blood leukocytes, liver, and/or skeletal muscle samples by standard methods. Mitochondrial DNA copy number relative to nuclear DNA levels was determined in muscle and/or liver DNA using real-time quantitative polymerase chain reaction and compared with age-matched controls. Nuclear candidate genes, including polymerase gamma, MPV17, and DGUOK were sequenced using standard analyses. Results We identified pathogenic MPV17 and DGUOK mutations in 11 infants (6 females) representing 2.5% of the 450 cases of infantile cholestasis and 22% of the 50 cases of infantile liver failure referred to our center during the study period. All of the 11 patients manifested cholestasis that was followed by a rapidly progressive liver failure and death before 2 years of life. Mitochondrial DNA depletion was demonstrated in liver or muscle for 8 out of the 11 cases where tissue was available. Seven patients had mutations in the MPV17 gene (3 novel mutations), 4 patients had DGUOK mutations (of which 2 were novel mutations). Conclusion Mutations in the MPV17 and DGUOK genes are present in a significant percentage of infants with liver failure and are associated with poor prognosis.
C1 [Al-Hussaini, Abdulrahman; Asery, Ali; Alsaleem, Badr; Lone, Khurram; Nahari, Ahmed] King Saud bin Abdulaziz Univ Hlth Sci, Div Pediat Gastroenterol, Childrens Hosp, King Fahad Med City,Coll Med, Riyadh 11525, Saudi Arabia.
   [Faqeih, Eissa; El-Hattab, Ayman W.; Alasmari, Ali] King Saud bin Abdulaziz Univ Hlth Sci, Div Med Genet, Childrens Hosp, King Fahad Med City,Coll Med, Riyadh 11525, Saudi Arabia.
   [Alfadhel, Majid; Eyaid, Wafaa] King Saud bin Abdulaziz Univ Hlth Sci, Div Genet, Dept Pediat, King Abdulaziz Med City, Riyadh 11525, Saudi Arabia.
   [Bakhsh, Eman] King Saud bin Abdulaziz Univ Hlth Sci, Dept Radiol, King Fahad Med City, Riyadh 11525, Saudi Arabia.
   [Ali, Ashraf; Al Balwi, Mohammed] King Saud bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, Dept Pathol, Riyadh 11525, Saudi Arabia.
   [Al Balwi, Mohammed] King Saud bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, King Abdullah Int Med Res Ctr, Riyadh 11525, Saudi Arabia.
   [Craig, Kate; Butterworth, Anna; He, Langping; Taylor, Robert W.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Mitochondrial Highly Specialized Serv D, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 King Saud Bin Abdulaziz University for Health Sciences; King Fahad Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Fahad Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; Newcastle University - UK
RP Al-Hussaini, A (corresponding author), King Saud bin Abdulaziz Univ Hlth Sci, Div Pediat Gastroenterol Hepatol & Nutr, Childrens Hosp, King Fahad Med City,Coll Med, POB 59046, Riyadh 11525, Saudi Arabia.
EM aa_alhussaini@yahoo.com
FU Medical Research Council [MR/K000608/1] Funding Source: Medline; Wellcome Trust [096919] Funding Source: Medline; MRC [MR/K000608/1] Funding Source: UKRI
CR Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Brahimi N, 2009, MOL GENET METAB, V97, P221, DOI 10.1016/j.ymgme.2009.03.007
   Brunetti-Pierri N, 2008, NEUROPEDIATRICS, V39, P179, DOI 10.1055/s-0028-1093334
   Chinnery PF, 2005, J HEPATOL, V43, P207, DOI 10.1016/j.jhep.2005.05.012
   deBruyn JC, 2007, J PEDIATR GASTR NUTR, V45, P252, DOI 10.1097/MPG.0b013e318048838f
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Labarthe F, 2005, J HEPATOL, V43, P333, DOI 10.1016/j.jhep.2005.03.023
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Merkle A N, 2012, AJNR AM J NEURORADIOL, V33, PE34, DOI 10.3174/ajnr.A2455
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Wang LY, 2003, FEBS LETT, V554, P319, DOI 10.1016/S0014-5793(03)01181-5
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
NR 25
TC 34
Z9 39
U1 0
U2 9
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3476
EI 1097-6833
J9 J PEDIATR-US
JI J. Pediatr.
PD MAR 15
PY 2014
VL 164
IS 3
BP 553
EP +
DI 10.1016/j.jpeds.2013.10.082
PG 9
WC Pediatrics
SC Pediatrics
GA AB1GI
UT WOS:000331539100025
PM 24321534
DA 2024-11-01
ER

PT J
AU Zhang, YL
   Song, FL
   Gao, ZY
   Ding, W
   Qiao, LX
   Yang, SF
   Chen, X
   Jin, RH
   Chen, DX
AF Zhang, Yulin
   Song, Fengli
   Gao, Ziyun
   Ding, Wei
   Qiao, Luxin
   Yang, Sufang
   Chen, Xi
   Jin, Ronghua
   Chen, Dexi
TI Long-Term Exposure of Mice to Nucleoside Analogues Disrupts Mitochondrial DNA Maintenance in Cortical Neurons
SO PLOS ONE
LA English
DT Article
ID reverse-transcriptase inhibitors; active antiretroviral therapy; lactic-acidosis; toxicity; dysfunction; brain; hyperlactatemia; hiv/aids; capture; genome
AB Nucleoside analogue reverse transcriptase inhibitor (NRTI), an integral component of highly active antiretroviral therapy (HAART), was widely used to inhibit HIV replication. Long-term exposure to NRTIs can result in mitochondrial toxicity which manifests as lipoatrophy, lactic acidosis, cardiomyopathy and myopathy, as well as polyneuropathy. But the cerebral neurotoxicity of NRTIs is still not well known partly due to the restriction of blood-brain barrier (BBB) and the complex microenvironment of the central nervous system (CNS). In this study, the Balb/c mice were administered 50 mg/kg stavudine (D4T), 100 mg/kg zidovudine (AZT), 50 mg/kg lamivudine (3TC) or 50 mg/kg didanosine (DDI) per day by intraperitoneal injection, five days per week for one or four months, and primary cortical neurons were cultured and exposed to 25 mu M D4T, 50 mu M AZT, 25 mu M 3TC or 25 mu M DDI for seven days. Then, single neuron was captured from mouse cerebral cortical tissues by laser capture microdissection. Mitochondrial DNA (mtDNA) levels of the primary cultured cortical neurons, and captured neurons or glial cells, and the tissues of brains and livers and muscles were analyzed by relative quantitative real-time PCR. The data showed that mtDNA did not lose in both NRTIs exposed cultured neurons and one month NRTIs treated mouse brains. In four months NRTIs treated mice, brain mtDNA levels remained unchanged even if the mtDNA levels of liver (except for 3TC) and muscle significantly decreased. However, mtDNA deletion was significantly higher in the captured neurons from mtDNA unchanged brains. These results suggest that long-term exposure to NRTIs can result in mtDNA deletion in mouse cortical neurons.
C1 [Zhang, Yulin; Song, Fengli; Ding, Wei; Qiao, Luxin; Yang, Sufang; Jin, Ronghua; Chen, Dexi] Capital Med Univ, Beijing You An Hosp, Dept Infect Dis, Beijing, Peoples R China.
   [Gao, Ziyun] Nanchang Univ, Affiliated Hosp 2, Dept Neurosurg, Nanchang, Jiangxi, Peoples R China.
   [Chen, Xi] Nanjing Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Nanjing, Jiangsu, Peoples R China.
C3 Capital Medical University; Nanchang University; Nanjing Medical University
RP Chen, X (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Nanjing, Jiangsu, Peoples R China.
EM jsxycx@sina.com; jin_eagle@sina.com; dexi0963@yahoo.com
FU National Natural Science Foundation of China [81371399, 81272266, 30910103915]; Twelfth Key Science and Technology Five Year Plan of China [2012ZX10001-002, 2012ZX10001-003, 2012ZX10001-004]; Beijing Natural Science Foundation [7092045, 7101005]
CR Brogly SB, 2011, AIDS RES HUM RETROV, V27, P777, DOI 10.1089/aid.2010.0204
   Dagan T, 2002, MITOCHONDRION, V1, P397, DOI 10.1016/S1567-7249(02)00003-X
   Dalakas MC, 2001, J PERIPHER NERV SYST, V6, P14, DOI 10.1046/j.1529-8027.2001.006001014.x
   Davison FD, 1996, J NEUROL, V243, P648, DOI 10.1007/BF00878661
   Dragovic G, 2012, BIOMED PHARMACOTHER, V66, P308, DOI 10.1016/j.biopha.2011.09.016
   Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2<107::AID-DVG3>3.0.CO;2-D
   Einsiedel L, 2010, MITOCHONDRION, V10, P534, DOI 10.1016/j.mito.2010.05.010
   Ewings EL, 2000, J ACQ IMMUN DEF SYND, V24, P100
   FELDMAN D, 1994, ACTA NEUROPATHOL, V87, P71
   FLINT OP, 1994, TOXICOL IN VITRO, V8, P677, DOI 10.1016/0887-2333(94)90042-6
   Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25
   Gallagher RI, 2012, METHODS MOL BIOL, V823, P157, DOI 10.1007/978-1-60327-216-2_11
   Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1
   Kandanearatchi A, 2003, BRAIN PATHOL, V13, P104, DOI 10.1111/j.1750-3639.2003.tb00011.x
   Koczor C, 2010, METHODS, V51, P399, DOI 10.1016/j.ymeth.2009.12.013
   Kohler JJ, 2008, CARDIOVASC TOXICOL, V8, P57, DOI 10.1007/s12012-008-9015-1
   Kohler JJ, 2011, METHODS MOL BIOL, V755, P267, DOI 10.1007/978-1-61779-163-5_22
   Lanoy E, 2011, NEUROLOGY, V76, P644, DOI 10.1212/WNL.0b013e31820c3089
   Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31
   Mothobi NZ, 2012, CURR OPIN INFECT DIS, V25, P4, DOI 10.1097/QCO.0b013e32834ef586
   Moyle G, 2000, DRUG SAFETY, V23, P467, DOI 10.2165/00002018-200023060-00001
   Nolan D, 2004, ANTIVIR THER, V9, P849
   Obiako O R, 2011, WEST AFR J MED, V30, P354
   Papp E, 2008, J ANTIMICROB CHEMOTH, V61, P1048, DOI 10.1093/jac/dkn067
   Pavili L, 2010, FERTIL STERIL, V94, P2151, DOI 10.1016/j.fertnstert.2009.12.080
   Rook MS, 2004, AM J PATHOL, V164, P23, DOI 10.1016/S0002-9440(10)63092-1
   Seok JI, 2009, HEPATOLOGY, V49, P2080, DOI 10.1002/hep.22959
   Smurzynski M, 2011, AIDS, V25, P357, DOI 10.1097/QAD.0b013e32834171f8
   Tozzi V, 2001, J ACQ IMMUN DEF SYND, V28, P19, DOI 10.1097/00042560-200109010-00004
   Walker UA, 2002, AIDS, V16, P2165, DOI 10.1097/00002030-200211080-00009
   Wester CW, 2012, AIDS RES HUM RETROV, V28, P759, DOI 10.1089/aid.2011.0303
   Zhang YL, 2012, BRAIN RES, V1458, P1, DOI 10.1016/j.brainres.2012.04.001
NR 32
TC 35
Z9 38
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD JAN 20
PY 2014
VL 9
IS 1
BP 
EP 
DI 10.1371/journal.pone.0085637
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 297FH
UT WOS:000330240500063
PM 24465628
DA 2024-11-01
ER

PT J
AU Nogueira, C
   Almeida, LS
   Nesti, C
   Pezzini, I
   Videira, A
   Vilarinho, L
   Santorelli, FM
AF Nogueira, Celia
   Almeida, Ligia S.
   Nesti, Claudia
   Pezzini, Ilaria
   Videira, Arnaldo
   Vilarinho, Laura
   Santorelli, Filippo M.
TI Syndromes associated with mitochondrial DNA depletion
SO ITALIAN JOURNAL OF PEDIATRICS
LA English
DT Review
DE Mitochondrial DNA depletion syndrome; Mitochondrial myopathy; Mitochondrial encephalomyopathy; Hepatocerebral syndrome; mtDNA; OxPhos; Alpers-Huttenlocher syndrome
ID neurogastrointestinal encephalomyopathy mngie; stem-cell transplantation; polymerase-gamma; molecular-features; clinical spectrum; mtdna depletion; mutations; deficiency; disorders; disease
AB Mitochondrial dysfunction accounts for a large group of inherited metabolic disorders most of which are due to a dysfunctional mitochondrial respiratory chain (MRC) and, consequently, deficient energy production. MRC function depends on the coordinated expression of both nuclear (nDNA) and mitochondrial (mtDNA) genomes. Thus, mitochondrial diseases can be caused by genetic defects in either the mitochondrial or the nuclear genome, or in the cross-talk between the two. This impaired cross-talk gives rise to so-called nuclear-mitochondrial intergenomic communication disorders, which result in loss or instability of the mitochondrial genome and, in turn, impaired maintenance of qualitative and quantitative mtDNA integrity. In children, most MRC disorders are associated with nuclear gene defects rather than alterations in the mtDNA itself. The mitochondrial DNA depletion syndromes (MDSs) are a clinically heterogeneous group of disorders with an autosomal recessive pattern of transmission that have onset in infancy or early childhood and are characterized by a reduced number of copies of mtDNA in affected tissues and organs. The MDSs can be divided into least four clinical presentations: hepatocerebral, myopathic, encephalomyopathic and neurogastrointestinal. The focus of this review is to offer an overview of these syndromes, listing the clinical phenotypes, together with their relative frequency, mutational spectrum, and possible insights for improving diagnostic strategies.
C1 [Nogueira, Celia; Almeida, Ligia S.; Vilarinho, Laura] Natl Inst Hlth, Dept Genet, Res & Dev Unit, P-4000055 Oporto, Portugal.
   [Nesti, Claudia; Pezzini, Ilaria; Santorelli, Filippo M.] IRCCS Stella Maris, Pisa, Italy.
   [Videira, Arnaldo] Natl Inst Hlth, ICBAS, P-4000055 Oporto, Portugal.
   [Santorelli, Filippo M.] Univ Pisa, Dept Child Neurol & Neurogenet, IRCCS Stella Maris, I-56128 Pisa, Italy.
   [Vilarinho, Laura] Natl Inst Hlth, Dept Genet, Newborn Screening Metab & Genet Unit, P-4000055 Oporto, Portugal.
C3 IRCCS Fondazione Stella Maris; Universidade do Porto; IRCCS Fondazione Stella Maris; University of Pisa
RP Vilarinho, L (corresponding author), Natl Inst Hlth, Dept Genet, Res & Dev Unit, P-4000055 Oporto, Portugal.
EM laura.vilarinho@insa.min-saude.pt; filippo3364@gmail.com
FU Portuguese Foundation for Science and Technology [SFRH/BD/45247/2008, FCT C2008/INSA/P4]; Fundação para a Ciência e a Tecnologia [SFRH/BD/45247/2008] Funding Source: FCT
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Chinnery Patrick F, 2008, NEUROMUSCUL DISORD, V18, P259, DOI 10.1016/j.nmd.2007.11.005
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Delarue A, 2000, PEDIATR TRANSPLANT, V4, P67, DOI 10.1034/j.1399-3046.2000.00090.x
   DiMauro S, 2004, BBA-BIOENERGETICS, V1659, P107, DOI 10.1016/j.bbabio.2004.08.003
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   DiMauro S, 2010, DEV DISABIL RES REV, V16, P106, DOI 10.1002/ddrr.102
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dündar H, 2012, PEDIATR NEUROL, V46, P172, DOI 10.1016/j.pediatrneurol.2011.12.006
   El-Hattab AW, 2009, MOL GENET METAB S12, V1792, P1109
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2012, J NEUROL, V259, P2699, DOI 10.1007/s00415-012-6572-9
   Finsterer J, 2013, CAN J NEUROL SCI, V40, P635, DOI 10.1017/S0317167100014852
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hasselmann O, 2010, MOL GENET METAB, V99, P58, DOI 10.1016/j.ymgme.2009.08.005
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Ji JQ, 2010, MITOCHONDRION, V10, P188, DOI 10.1016/j.mito.2009.11.002
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Kayihan N, 2000, PEDIATR TRANSPLANT, V4, P211, DOI 10.1034/j.1399-3046.2000.00115.x
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morava E, 2009, MITOCHONDRION, V9, P438, DOI 10.1016/j.mito.2009.08.003
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nogueira C, 2011, J CHILD NEUROL, V26, P866, DOI 10.1177/0883073811402072
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Rivera H, 2010, MITOCHONDRION, V10, P362, DOI 10.1016/j.mito.2010.03.003
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Rouzier C, 2010, J MED GENET, V47, P670, DOI 10.1136/jmg.2009.073445
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   Vasta V, 2009, GENOME MED, V1, P0, DOI 10.1186/gm100
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   Zhang SL, 2010, MOL GENET METAB, V99, P53, DOI 10.1016/j.ymgme.2009.09.003
NR 71
TC 40
Z9 52
U1 0
U2 18
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1720-8424
EI 1824-7288
J9 ITAL J PEDIATR
JI Ital. J. Pediatr.
PD APR 3
PY 2014
VL 40
IS 
BP 
EP 
DI 10.1186/1824-7288-40-34
PG 10
WC Pediatrics
SC Pediatrics
GA AF8JR
UT WOS:000334962500001
PM 24708634
DA 2024-11-01
ER

PT J
AU Haghighi, A
   Haack, TB
   Atiq, M
   Mottaghi, H
   Haghighi-Kakhki, H
   Bashir, RA
   Ahting, U
   Feichtinger, RG
   Mayr, JA
   Rötig, A
   Lebre, AS
   Klopstock, T
   Dworschak, A
   Pulido, N
   Saeed, MA
   Saleh-Gohari, N
   Holzerova, E
   Chinnery, PF
   Taylor, RW
   Prokisch, H
AF Haghighi, Alireza
   Haack, Tobias B.
   Atiq, Mehnaz
   Mottaghi, Hassan
   Haghighi-Kakhki, Hamidreza
   Bashir, Rani A.
   Ahting, Uwe
   Feichtinger, Rene G.
   Mayr, Johannes A.
   Rotig, Agnes
   Lebre, Anne-Sophie
   Klopstock, Thomas
   Dworschak, Andrea
   Pulido, Nathan
   Saeed, Mahmood A.
   Saleh-Gohari, Nasrollah
   Holzerova, Eliska
   Chinnery, Patrick F.
   Taylor, Robert W.
   Prokisch, Holger
TI Sengers syndrome: six novel <i>AGK</i> mutations in seven new families and review of the phenotypic and mutational spectrum of 29 patients
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Article
DE Sengers syndrome; AGK; Acylglycerol Kinase; Mutation; Genotype-Phenotype Correlation
ID acylglycerol kinase; mitochondrial myopathy; barth-syndrome; congenital cataract; lactic-acidosis; membrane; cardiolipin; skeletal; protein; muscle
AB Background: Sengers syndrome is an autosomal recessive condition characterized by congenital cataract, hypertrophic cardiomyopathy, skeletal myopathy and lactic acidosis. Mutations in the acylglycerol kinase (AGK) gene have been recently described as the cause of Sengers syndrome in nine families. Methods: We investigated the clinical and molecular features of Sengers syndrome in seven new families; five families with the severe and two with the milder form. Results: Sequence analysis of AGK revealed compound heterozygous or homozygous predicted loss-of-function mutations in all affected individuals. A total of eight different disease alleles were identified, of which six were novel, homozygous c.523_524delAT (p.Ile175Tyrfs*2), c.424-1G > A (splice site), c.409C > T (p.Arg137*)and c.877 + 3G > T (splice site), and compound heterozygous c.871C > T (p.Gln291*)and c.1035dup (p.Ile346Tyrfs*39). All patients displayed perinatal or early-onset cardiomyopathy and cataract, clinical features pathognomonic for Sengers syndrome. Other common findings included blood lactic acidosis and tachydyspnoea while nystagmus, eosinophilia and cervical meningocele were documented in only either one or two cases. Deficiency of the adenine nucleotide translocator was found in heart and skeletal muscle biopsies from two patients associated with respiratory chain complex I deficiency. In contrast to previous findings, mitochondrial DNA content was normal in both tissues. Conclusion: We compare our findings to those in 21 previously reported AGK mutation-positive Sengers patients, confirming that Sengers syndrome is a clinically recognisable disorder of mitochondrial energy metabolism.
C1 [Haghighi, Alireza] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.
   [Haghighi, Alireza] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.
   [Haghighi, Alireza] Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.
   [Haack, Tobias B.; Ahting, Uwe; Holzerova, Eliska; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany.
   [Haack, Tobias B.; Ahting, Uwe; Holzerova, Eliska; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.
   [Atiq, Mehnaz] Aga Khan Univ, Dept Pediat, Karachi, Pakistan.
   [Mottaghi, Hassan] Mashhad Univ Med Sci, Imam Reza Hosp, Dept Pediat, Mashhad, Iran.
   [Haghighi-Kakhki, Hamidreza] Mashhad Azad Univ, Fac Med, Mashhad, Iran.
   [Bashir, Rani A.; Saeed, Mahmood A.] Kuwait Oil Co, Dept Paediat & Neonatol, Ahmadi Hosp, Kuwait, Kuwait.
   [Feichtinger, Rene G.; Mayr, Johannes A.] Paracelsus Med Univ, Dept Paediat, Salzburg, Austria.
   [Rotig, Agnes] Paris Descartes Univ, Imagine Inst, INSERM, UMR 1163, Paris, France.
   [Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany.
   [Dworschak, Andrea] Rhein Westfal TH Aachen, Univ Hosp, Dept Pediat Cardiol, Aachen, Germany.
   [Pulido, Nathan] Hosp Dr Gustavo Fricke, Dept Pediat, Vina Del Mar, Chile.
   [Saleh-Gohari, Nasrollah] Kerman Univ Med Sci, Sch Med, Dept Genet, Kerman, Iran.
   [Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Aga Khan University; Mashhad University of Medical Sciences; Kuwait Oil Company; Paracelsus Private Medical University; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Munich; RWTH Aachen University; RWTH Aachen University Hospital; Kerman University of Medical Sciences; Newcastle University - UK; Newcastle University - UK
RP Haghighi, A (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
EM haghighi@genetics.med.harvard.edu; prokisch@helmholtz-muenchen.de
FU EU FP7 Mitochondrial European Educational Training project (MEET); E-Rare project GENOMIT [01GM1207, FWF I 920-B13]; German Federal Ministry of Education and Research (BMBF, Bonn, Germany) [01GM1113A]; Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service; MRC [MR/K000608/1] Funding Source: UKRI
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Aldahmesh MA, 2012, HUM MUTAT, V33, P960, DOI 10.1002/humu.22071
   Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123
   Borchman D, 2010, J LIPID RES, V51, P2473, DOI 10.1194/jlr.R004119
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Clarke SLN, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-23
   Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Kalari S, 2009, AM J PHYSIOL-LUNG C, V296, PL328, DOI 10.1152/ajplung.90431.2008
   Karkucinska-Wieckowska A, 2013, J INHERIT METAB DIS, V36, P929, DOI 10.1007/s10545-013-9584-4
   KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   Perry MS, 2008, PEDIATR NEUROL, V39, P113, DOI 10.1016/j.pediatrneurol.2008.05.003
   SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4
   Siriwardena K, 2013, MOL GENET METAB, V108, P40, DOI 10.1016/j.ymgme.2012.11.282
   SMEITINK JAM, 1989, EUR J PEDIATR, V148, P656, DOI 10.1007/BF00441527
   VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157
   Waggoner DW, 2004, J BIOL CHEM, V279, P38228, DOI 10.1074/jbc.M405932200
NR 21
TC 67
Z9 70
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1750-1172
EI 
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD AUG 20
PY 2014
VL 9
IS 
BP 
EP 
DI 10.1186/s13023-014-0119-3
PG 12
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA AU5QM
UT WOS:000345661700001
PM 25208612
DA 2024-11-01
ER

PT J
AU Hoptasz, M
   Szczucinski, A
   Losy, J
AF Hoptasz, Magdalena
   Szczucinski, Adam
   Losy, Jacek
TI Heterogeneous phenotypic manifestations of maternally inherited deafness associated with the mitochondrial A3243G mutation. Case report
SO NEUROLOGIA I NEUROCHIRURGIA POLSKA
LA English
DT Article
DE Mitochondrial disorder; A3243G mutation; Maternally inherited deafness; Mitochondrial encephalomyopathy lactic acidosis and strokelike episodes
ID dna mutation; heteroplasmy; melas
AB The A3243G mutation is one of the most frequent mutations of mitochondrial DNA. The phenotypic expression of the A3243G mutation is variable and causes a wide range of syndromic and non-syndromic clinical disorders. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome is the most frequent syndromic manifestation of the A3243G mutation. Stroke-like episodes seem to be the dominant feature of MELAS. We have investigated the case of a family with A3243G mutation, in which a dominant symptom in three generations was the maternally inherited hearing loss with absence of stroke-like episodes. Besides deafness, we found also other clinical features such as myopathy, neuropathy, migraine, ataxia, short stature, diabetes mellitus, and cardiomyopathy. (C) 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
C1 [Hoptasz, Magdalena; Szczucinski, Adam; Losy, Jacek] Univ Med Sci, Clin Hosp H Swiecicki, Dept Clin Neurol, Poznan, Poland.
   [Szczucinski, Adam] Univ Med Sci, Dept Neurochem & Neuropathol, Poznan, Poland.
   [Losy, Jacek] Univ Med Sci, Chair Neurol, Dept Clin Neuroimmunol, Poznan, Poland.
   [Losy, Jacek] Polish Acad Sci, Inst Expt & Clin Med, Neuroimmunol Unit, Poznan, Poland.
C3 Polish Academy of Sciences
RP Szczucinski, A (corresponding author), UM K Marcinkowskiego Poznaniu, Zaklad Neurochem & Neuropatol, Ul Przybyszewskiego 49, PL-60355 Poznan, Poland.
EM adamszczucinski@poczta.onet.pl
CR Blum S, 2011, INTERN MED J, V41, P200, DOI 10.1111/j.1445-5994.2010.02379.x
   Chinnery PF, 2010, MITOCHONDRIAL DISORDERS OVERVIEW, V0, P0
   DiMauro S, 2012, GENEREVIEWS, V0, P0
   Donovan LE, 2006, J CLIN ENDOCR METAB, V91, P4737, DOI 10.1210/jc.2006-1498
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2012, OPEN NEUROL J, V6, P26, DOI 10.2174/1874205X01206010026
   Finsterer J, 2009, INT J CARDIOL, V137, P60, DOI 10.1016/j.ijcard.2008.04.089
   Frederiksen AL, 2009, J CLIN ENDOCR METAB, V94, P2872, DOI 10.1210/jc.2009-0235
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Liou CW, 2001, DIABETES RES CLIN PR, V54, PS39, DOI 10.1016/S0168-8227(01)00334-5
   Olsson C, 1998, HUM MUTAT, V12, P52, DOI 10.1002/(SICI)1098-1004(1998)12:1<52::AID-HUMU8>3.0.CO;2-K
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 14
TC 5
Z9 6
U1 0
U2 3
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA WENEDOW ST 9-1, POZNAN, 61-614, POLAND
SN 0028-3843
EI 
J9 NEUROL NEUROCHIR POL
JI Neurol. Neurochir. Pol.
PD JUN 15
PY 2014
VL 48
IS 2
BP 150
EP 153
DI 10.1016/j.pjnns.2013.12.007
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA AI4YU
UT WOS:000336873400012
PM 24821643
DA 2024-11-01
ER

PT J
AU Kowald, A
   Klipp, E
AF Kowald, Axel
   Klipp, Edda
TI Mathematical Models of Mitochondrial Aging and Dynamics
SO MITOCHONDRION IN AGING AND DISEASE
LA English
DT Review; Book Chapter
ID dna deletion mutations; free-radical theory; aged muscle-fibers; oxidative-phosphorylation; skeletal-muscle; regulatory networks; cell-cycle; defective mitochondria; degenerative diseases; clonal expansion
AB Research on the role of mitochondria in aging and disease is rapidly growing. Furthermore, in recent years, it also became clear that mitochondria are dynamic structures undergoing constant and rapid cycles of fusion and fission. The involvement of mitochondria in multiple complex processes makes them a prime target for mathematical and computational modeling. This review consists of two parts. In the first (Section 2), we provide a detailed introduction to the underlying concepts of mathematical modeling to help the reader who is not so familiar with these techniques to judge the requirements and results that can be obtained through modeling. In the second part (Section 3), we review existing mathematical and computational models that investigate mitochondrial dynamics and the role of mitochondria for the aging process.
C1 [Kowald, Axel; Klipp, Edda] Univ Berlin, Inst Biol, Berlin, Germany.
RP Kowald, A (corresponding author), Univ Berlin, Inst Biol, Berlin, Germany.
CR Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bazil JN, 2013, BIOPHYS J, V105, P343, DOI 10.1016/j.bpj.2013.05.033
   Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036
   BERK AJ, 1974, J MOL BIOL, V86, P801, DOI 10.1016/0022-2836(74)90355-6
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338
   Busch KB, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0442
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   COMFORT A, 1974, MECH AGEING DEV, V3, P1, DOI 10.1016/0047-6374(74)90002-5
   Cornish-Bowden A, 2004, BIOL CELL, V96, P713, DOI 10.1016/j.biolcel.2004.06.006
   Davidich MI, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001672
   de Grey ADJ, 1999, MITOCHONDRIAL FREE R, V0, P0
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Delbriick M, 1949, UNITES BIOLOGIQUES DOUEES DE CONTINUITY GENETIQUE, V8, P33
   DICE JF, 1989, EXP GERONTOL, V24, P451
   Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fauré A, 2006, BIOINFORMATICS, V22, PE124, DOI 10.1093/bioinformatics/btl210
   Figge MT, 2013, BIOESSAYS, V35, P314, DOI 10.1002/bies.201200125
   Figge MT, 2012, PLOS COMPUT BIOL, V8, P0, DOI 10.1371/journal.pcbi.1002576
   Flöttmann M, 2012, FRONT PHYSIOL, V3, P0, DOI 10.3389/fphys.2012.00216
   GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Gouze Jean-Luc, 1998, JOURNAL OF BIOLOGICAL SYSTEMS, V6, P11, DOI 10.1142/S0218339098000054
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Guldberg C, 1879, ERDMANNS J F R PRACT, V127, P69, DOI 10.1002/PRAC.18790190111
   Gupta S, 2007, J THEOR BIOL, V244, P463, DOI 10.1016/j.jtbi.2006.08.014
   HARMAN D, 1984, AGE, V7, P111, DOI 10.1007/BF02431866
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   HUEMER RP, 1971, EXP GERONTOL, V6, P327, DOI 10.1016/0531-5565(71)90001-5
   KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0
   Kauffman Stuart A, 1993, THE ORIGINS OF ORDER, V0, P0
   Kervizic G, 2008, BMC SYST BIOL, V2, P0, DOI 10.1186/1752-0509-2-99
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768
   Kirschner DE, 2010, CURR OPIN BIOTECH, V21, P524, DOI 10.1016/j.copbio.2010.06.002
   Klipp E, 2005, SYSTEMS BIOLOGY IN PRACTICE: CONCEPTS, V0, P1, DOI 10.1002/3527603603
   Klipp E, 2007, YEAST, V24, P943, DOI 10.1002/yea.1544
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   KORZENIEWSKI B, 1991, BIOCHIM BIOPHYS ACTA, V1060, P210, DOI 10.1016/S0005-2728(09)91009-X
   Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3
   Korzeniewski B, 2000, BIOPHYS CHEM, V83, P19, DOI 10.1016/S0301-4622(99)00120-9
   Korzeniewski B, 2014, J APPL PHYSIOL, V116, P83, DOI 10.1152/japplphysiol.00759.2013
   Korzeniewski B, 2013, J APPL PHYSIOL, V115, P605, DOI 10.1152/japplphysiol.00469.2013
   KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047
   KOWALD A, 1993, MUTAT RES, V295, P93, DOI 10.1016/0921-8734(93)90011-Q
   Kowald A, 2005, AGING CELL, V4, P273, DOI 10.1111/j.1474-9726.2005.00169.x
   Kowald A, 1996, MUTAT RES-DNAGING G, V316, P209, DOI 10.1016/S0921-8734(96)90005-3
   Kowald A, 2000, J THEOR BIOL, V202, P145, DOI 10.1006/jtbi.1999.1046
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kowald A, 2014, J THEOR BIOL, V340, P111, DOI 10.1016/j.jtbi.2013.09.009
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   LAVIE L, 1982, BIOCHEM J, V202, P47, DOI 10.1042/bj2020047
   Le Novère N, 2006, NUCLEIC ACIDS RES, V34, PD689, DOI 10.1093/nar/gkj092
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101
   Liebermeister W, 2006, THEOR BIOL MED MODEL, V3, P0, DOI 10.1186/1742-4682-3-41
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lubitz T, 2010, J PHYS CHEM B, V114, P16298, DOI 10.1021/jp108764b
   Matthews L, 2009, NUCLEIC ACIDS RES, V37, PD619, DOI 10.1093/nar/gkn863
   McDonald SAC, 2006, CELL CYCLE, V5, P808, DOI 10.4161/cc.5.8.2641
   McKiernan SH, 2009, EXP GERONTOL, V44, P170, DOI 10.1016/j.exger.2008.09.014
   Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593
   Mendoza L, 2006, THEOR BIOL MED MODEL, V3, P0, DOI 10.1186/1742-4682-3-13
   Michaelis L, 1913, BIOCHEM Z, V49, P333
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Nazaret C, 2009, J THEOR BIOL, V258, P455, DOI 10.1016/j.jtbi.2008.09.037
   Olivier BG, 2004, BIOINFORMATICS, V20, P2143, DOI 10.1093/bioinformatics/bth200
   Plahte E, 1995, JOURNAL OF BIOLOGICAL SYSTEMS, VOL 3, P409, DOI 10.1142/S0218339095000381
   Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023
   Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163
   Samal A, 2008, BMC SYST BIOL, V2, P0, DOI 10.1186/1752-0509-2-21
   Schomburg I, 2004, NUCLEIC ACIDS RES, V32, PD431, DOI 10.1093/nar/gkh081
   SCHWARTZ RM, 1978, SCIENCE, V199, P395, DOI 10.1126/science.202030
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261
   Sklar E, 2007, ARTIF LIFE, V13, P303, DOI 10.1162/artl.2007.13.3.303
   SKULACHEV VP, 1990, J MEMBRANE BIOL, V114, P97, DOI 10.1007/BF01869092
   Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7
   Snoep JL, 2003, MICROBIOL-SGM, V149, P3045, DOI 10.1099/mic.0.C0124-0
   Snoussi El Houssine, 1998, JOURNAL OF BIOLOGICAL SYSTEMS, V6, P3, DOI 10.1142/S0218339098000042
   Sridharan S, 2012, BMC GENOMICS, V13, P0, DOI 10.1186/1471-2164-13-S6-S4
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Tam ZY, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0076230
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Terfve C, 2012, BMC SYST BIOL, V6, P0, DOI 10.1186/1752-0509-6-133
   Thieffry D, 1995, JOURNAL OF BIOLOGICAL SYSTEMS, VOL 3, P457
   THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   van Eunen K, 2013, PLOS COMPUT BIOL, V9, P0, DOI 10.1371/journal.pcbi.1003186
   VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wilkens V, 2013, J CELL SCI, V126, P103, DOI 10.1242/jcs.108852
   Wu F, 2007, J BIOL CHEM, V282, P24525, DOI 10.1074/jbc.M701024200
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   YOUNG VR, 1978, FED PROC, V37, P2291
   Zoladz JA, 2013, EXP PHYSIOL, V98, P883, DOI 10.1113/expphysiol.2012.069443
NR 112
TC 7
Z9 9
U1 0
U2 13
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1877-1173
EI 
J9 PROG MOL BIOL TRANSL
JI Prog. Molec. Biol. Transl. Sci.
PD JUN 15
PY 2014
VL 127
IS 
BP 63
EP 92
DI 10.1016/B978-0-12-394625-6.00003-9
PG 30
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BB1YQ
UT WOS:000341461400003
PM 25149214
DA 2024-11-01
ER

PT J
AU Pfeffer, G
   Gorman, GS
   Griffin, H
   Kurzawa-Akanbi, M
   Blakely, EL
   Wilson, I
   Sitarz, K
   Moore, D
   Murphy, JL
   Alston, CL
   Pyle, A
   Coxhead, J
   Payne, B
   Gorrie, GH
   Longman, C
   Hadjivassiliou, M
   McConville, J
   Dick, D
   Imam, I
   Hilton, D
   Norwood, F
   Baker, MR
   Jaiser, SR
   Yu-Wai-Man, P
   Farrell, M
   McCarthy, A
   Lynch, T
   McFarland, R
   Schaefer, AM
   Turnbull, DM
   Horvath, R
   Taylor, RW
   Chinnery, PF
AF Pfeffer, Gerald
   Gorman, Grainne S.
   Griffin, Helen
   Kurzawa-Akanbi, Marzena
   Blakely, Emma L.
   Wilson, Ian
   Sitarz, Kamil
   Moore, David
   Murphy, Julie L.
   Alston, Charlotte L.
   Pyle, Angela
   Coxhead, Jon
   Payne, Brendan
   Gorrie, George H.
   Longman, Cheryl
   Hadjivassiliou, Marios
   McConville, John
   Dick, David
   Imam, Ibrahim
   Hilton, David
   Norwood, Fiona
   Baker, Mark R.
   Jaiser, Stephan R.
   Yu-Wai-Man, Patrick
   Farrell, Michael
   McCarthy, Allan
   Lynch, Timothy
   McFarland, Robert
   Schaefer, Andrew M.
   Turnbull, Douglass M.
   Horvath, Rita
   Taylor, Robert W.
   Chinnery, Patrick F.
TI Mutations in the <i>SPG7</i> gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance
SO BRAIN
LA English
DT Article
DE chronic progressive external ophthalmoplegia; hereditary spastic paraplegia; paraplegin; mtDNA maintenance; SPG7
ID dominant optic atrophy; hereditary spastic paraplegia; m-aaa protease; multiple deletions; clonal expansion; disease; dysfunction; neuropathy; myopathy; muscle
AB Progressive external ophthalmoplegia (PEO) is a canonical feature of mitochondrial disease, but in many patients its genetic basis is unknown. Using exome sequencing, Pfeffer et al. identify mutations in SPG7 as an important cause of PEO associated with spasticity and ataxia, and uncover evidence of disordered mtDNA maintenance in patients.Despite being a canonical presenting feature of mitochondrial disease, the genetic basis of progressive external ophthalmoplegia remains unknown in a large proportion of patients. Here we show that mutations in SPG7 are a novel cause of progressive external ophthalmoplegia associated with multiple mitochondrial DNA deletions. After excluding known causes, whole exome sequencing, targeted Sanger sequencing and multiplex ligation-dependent probe amplification analysis were used to study 68 adult patients with progressive external ophthalmoplegia either with or without multiple mitochondrial DNA deletions in skeletal muscle. Nine patients (eight probands) were found to carry compound heterozygous SPG7 mutations, including three novel mutations: two missense mutations c.2221G > A; p.(Glu741Lys), c.2224G > A; p.(Asp742Asn), a truncating mutation c.861dupT; p.Asn288*, and seven previously reported mutations. We identified a further six patients with single heterozygous mutations in SPG7, including two further novel mutations: c.184-3C > T (predicted to remove a splice site before exon 2) and c.1067C > T; p.(Thr356Met). The clinical phenotype typically developed in mid-adult life with either progressive external ophthalmoplegia/ptosis and spastic ataxia, or a progressive ataxic disorder. Dysphagia and proximal myopathy were common, but urinary symptoms were rare, despite the spasticity. Functional studies included transcript analysis, proteomics, mitochondrial network analysis, single fibre mitochondrial DNA analysis and deep re-sequencing of mitochondrial DNA. SPG7 mutations caused increased mitochondrial biogenesis in patient muscle, and mitochondrial fusion in patient fibroblasts associated with the clonal expansion of mitochondrial DNA mutations. In conclusion, the SPG7 gene should be screened in patients in whom a disorder of mitochondrial DNA maintenance is suspected when spastic ataxia is prominent. The complex neurological phenotype is likely a result of the clonal expansion of secondary mitochondrial DNA mutations modulating the phenotype, driven by compensatory mitochondrial biogenesis.
C1 [Pfeffer, Gerald; Gorman, Grainne S.; Griffin, Helen; Kurzawa-Akanbi, Marzena; Blakely, Emma L.; Wilson, Ian; Sitarz, Kamil; Moore, David; Murphy, Julie L.; Alston, Charlotte L.; Pyle, Angela; Coxhead, Jon; Payne, Brendan; Yu-Wai-Man, Patrick; McFarland, Robert; Schaefer, Andrew M.; Turnbull, Douglass M.; Horvath, Rita; Taylor, Robert W.; Chinnery, Patrick F.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Pfeffer, Gerald; Griffin, Helen; Kurzawa-Akanbi, Marzena; Wilson, Ian; Sitarz, Kamil; Moore, David; Pyle, Angela; Coxhead, Jon; Payne, Brendan; Yu-Wai-Man, Patrick; Horvath, Rita; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Gorman, Grainne S.; Blakely, Emma L.; Murphy, Julie L.; Alston, Charlotte L.; McFarland, Robert; Schaefer, Andrew M.; Turnbull, Douglass M.; Taylor, Robert W.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Gorman, Grainne S.; Blakely, Emma L.; Murphy, Julie L.; Alston, Charlotte L.; McFarland, Robert; Schaefer, Andrew M.; Turnbull, Douglass M.; Taylor, Robert W.] Newcastle Univ, NIHR Biomed Res Ctr Ageing, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Gorrie, George H.; Longman, Cheryl] So Gen Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland.
   [Hadjivassiliou, Marios] Acad Dept Neurosci, Sheffield S10 2JF, S Yorkshire, England.
   [Hadjivassiliou, Marios] Univ Sheffield, Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England.
   [McConville, John] Belfast City Hosp, Belfast BT9 7AD, Antrim, North Ireland.
   [Dick, David] Norfolk & Norwich Univ Hosp, Dept Neurol, Norwich NR4 7UY, Norfolk, England.
   [Imam, Ibrahim; Hilton, David] Torbay Hosp, Dept Neurol, Torquay TQ2 7AA, Devon, England.
   [Norwood, Fiona] Kings Coll Hosp London, Dept Neurol, Ruskin Wing, London, England.
   [Baker, Mark R.; Jaiser, Stephan R.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick] Royal Victoria Infirm, Newcastle Eye Ctr, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Farrell, Michael] Beaumont Hosp, Dept Neuropathol, Dublin 9, Ireland.
   [McCarthy, Allan; Lynch, Timothy] Mater Hosp, Dublin Neurol Inst, Dublin, Ireland.
   [McCarthy, Allan; Lynch, Timothy] Univ Coll Dublin, Dublin, Ireland.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Glasgow; University of Sheffield; Belfast City Hospital; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; Newcastle University - UK; Newcastle University - UK; Mater Misericordiae University Hospital; University College Dublin; University College Dublin
RP Chinnery, PF (corresponding author), Inst Med Genet, Cent Pkwy, Newcastle Upon Tyne, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
FU Bisby Fellowship from the Canadian Institutes of Health Research; Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease research [G0601943]; Medical Research Council (UK) Mitochondrial Disease Patient Cohort [G0800674]; UK NHS Highly Specialised 'Rare Mitochondrial Disorders of Adults and Children' Service; EU FP7 TIRCON; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust; Newcastle University; National Institute for Health Research (NIHR) [NIHR-HCS-D12-03-04]; NIHR; Wellcome Trust; Academy of Medical Sciences; MRC [G0701386, MR/K006312/1, G1002570, G0601943, G0800470, G0800674, G1000848, MR/K000608/1] Funding Source: UKRI
CR Almajan ER, 2012, J CLIN INVEST, V122, P4048, DOI 10.1172/JCI64604
   Arnoldi A, 2008, HUM MUTAT, V29, P522, DOI 10.1002/humu.20682
   Baker MR, 2011, NEUROLOGY, V77, P1309, DOI 10.1212/WNL.0b013e318230a15a
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bonn F, 2010, HUM MUTAT, V31, P617, DOI 10.1002/humu.21226
   Brugman F, 2008, NEUROLOGY, V71, P1500, DOI 10.1212/01.wnl.0000319700.11606.21
   Cagnoli C, 2010, HUM MUTAT, V31, P1117, DOI 10.1002/humu.21342
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Duvezin-Caubet S, 2007, MOL BIOL CELL, V18, P3582, DOI 10.1091/mbc.E07-02-0164
   Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084
   Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   Lang N, 2011, CLIN NEUROPHYSIOL, V122, P1417, DOI 10.1016/j.clinph.2010.12.033
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Maltecca F, 2012, HUM MOL GENET, V21, P3858, DOI 10.1093/hmg/dds214
   McDermott CJ, 2001, NEUROLOGY, V56, P467, DOI 10.1212/WNL.56.4.467
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Sánchez-Ferrero E, 2013, CLIN GENET, V83, P257, DOI 10.1111/j.1399-0004.2012.01896.x
   Schlipf NA, 2011, CLIN GENET, V80, P148, DOI 10.1111/j.1399-0004.2011.01715.x
   Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Taylor RW, 1997, ORGANELLE DIS, V0, P0
   Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89
   van Gassen KLI, 2012, BRAIN, V135, P2994, DOI 10.1093/brain/aws224
   Warnecke T, 2010, MOVEMENT DISORD, V25, P413, DOI 10.1002/mds.22949
   Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2009, INVEST OPHTH VIS SCI, V50, P4561, DOI 10.1167/iovs.09-3634
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 40
TC 124
Z9 129
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD MAY 15
PY 2014
VL 137
IS 
BP 1323
EP 1336
DI 10.1093/brain/awu060
PG 14
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AH6PK
UT WOS:000336252800013
PM 24727571
DA 2024-11-01
ER

PT J
AU Van Bergen, NJ
   Blake, RE
   Crowston, JG
   Trounce, IA
AF Van Bergen, Nicole J.
   Blake, Rachel E.
   Crowston, Jonathan G.
   Trounce, Ian A.
TI Oxidative phosphorylation measurement in cell lines and tissues
SO MITOCHONDRION
LA English
DT Article
DE Mitochondria; Oxidative phosphorylation; Enzymology; Respiration; Protocol; ATP synthesis
ID high-resolution respirometry; mitochondrial-dna mutations; lymphoblast mitochondria; atp synthesis; rat-brain; complex-i; muscle; respiration; metabolism; defects
AB Mitochondrial oxidative phosphorylation (OXPHOS) dysfunction is implicated in a growing spectrum of diseases, from neurodegeneration to cancer. Where tissues or transformed cells are available, respirometry and enzymology allow a sophisticated analysis of OXPHOS with modest-cost equipment. The isolation of organelle fractions is also invaluable for determining association of proteins of interest. Here we revisit and consolidate methods to measure whole cell mitochondrial ATP synthesis, respiration, isolation of mitochondria from cultured cells and tissues, and OXPHOS enzymology. We also explain common pitfalls, guide optimisation of the methods for new users, and provide full laboratory protocols in Supplementary materials. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Van Bergen, Nicole J.; Blake, Rachel E.; Crowston, Jonathan G.; Trounce, Ian A.] Ctr Eye Res Australia, Melbourne, Vic 3002, Australia.
   [Van Bergen, Nicole J.; Blake, Rachel E.; Crowston, Jonathan G.; Trounce, Ian A.] Univ Melbourne, Dept Ophthalmol, Melbourne, Vic 3002, Australia.
   [Van Bergen, Nicole J.; Blake, Rachel E.; Crowston, Jonathan G.; Trounce, Ian A.] Royal Victorian Eye & Ear Hosp, Melbourne, Vic 3002, Australia.
   [Trounce, Ian A.] St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia.
C3 Centre for Eye Research Australia; University of Melbourne; Royal Victorian Eye & Ear Hospital; St Vincent's Health; St Vincent's Hospital Melbourne; NSW Health; St Vincents Hospital Sydney
RP Trounce, IA (corresponding author), Univ Melbourne, Ctr Eye Res Australia, 32 Gisborne St, Melbourne, Vic 3002, Australia.
EM i.trounce@unimelb.edu.au
FU Victorian Government
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36
   Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480
   Anderson MF, 2000, BRAIN RES PROTOC, V5, P95, DOI 10.1016/S1385-299X(99)00060-4
   Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171
   Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200
   Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018
   Chretien D, 1998, BIOCHEM J, V0, P329
   CLARK JB, 1970, J BIOL CHEM, V245, P4724
   ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J
   Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4
   Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007
   Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z
   Graham JM, 1999, CURRENT PROTOCOLS CE, V33, P0
   Holtzman E, 1989, LYSOSOMES, V0, P0
   Hussain T, 2012, INDIAN J MED RES, V135, P820
   Hütter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   KANG CH, 1977, J BIOL CHEM, V252, P919
   Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395
   Lai J C, 1979, METHODS ENZYMOL, V55, P51
   Lee S, 2012, INVEST OPHTH VIS SCI, V53, P2431, DOI 10.1167/iovs.12-9596
   Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3
   Mayorov Vladimir I, 2008, BMC BIOCHEMISTRY, V9, P9, DOI 10.1186/1471-2091-9-22
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Miró O, 1998, J NEUROSCI METH, V80, P107, DOI 10.1016/S0165-0270(97)00204-5
   MOREADITH RW, 1984, ANAL BIOCHEM, V137, P360, DOI 10.1016/0003-2697(84)90098-8
   Pecinová A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Scatena R, 2012, ADV EXP MED BIOL, V942, P287, DOI 10.1007/978-94-007-2869-1_13
   Schoer JK, 2000, BIOCHEMISTRY-US, V39, P7662, DOI 10.1021/bi992686h
   SHERRATT HSA, 1988, METHOD BIOCHEM ANAL, V33, P243
   SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x
   SPECK SH, 1984, P NATL ACAD SCI-BIOL, V81, P347, DOI 10.1073/pnas.81.2.347
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Stadlmann S, 2002, TRANSPLANTATION, V74, P1800, DOI 10.1097/01.TP.0000039262.25355.67
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   TAYLOR RW, 1993, BIOCHIM BIOPHYS ACTA, V1181, P261, DOI 10.1016/0925-4439(93)90030-5
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Van Bergen NJ, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021347
   VANDENBOGERT C, 1992, J CELL PHYSIOL, V152, P632, DOI 10.1002/jcp.1041520323
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wu M, 2007, AM J PHYSIOL-CELL PH, V292, PC125, DOI 10.1152/ajpcell.00247.2006
   Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274
   Ye F, 2013, ANAL BIOCHEM, V437, P52, DOI 10.1016/j.ab.2013.02.010
   Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5
   ZHENG XX, 1990, BIOCHIM BIOPHYS ACTA, V1019, P1, DOI 10.1016/0005-2728(90)90118-N
NR 51
TC 25
Z9 25
U1 1
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2014
VL 15
IS 
BP 24
EP 33
DI 10.1016/j.mito.2014.03.003
PG 10
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA AH3FR
UT WOS:000336009600004
PM 24657935
DA 2024-11-01
ER

PT J
AU Horga, A
   Pitceathly, RDS
   Blake, JC
   Woodward, CE
   Zapater, P
   Fratter, C
   Mudanohwo, EE
   Plant, GT
   Houlden, H
   Sweeney, MG
   Hanna, MG
   Reilly, MM
AF Horga, Alejandro
   Pitceathly, Robert D. S.
   Blake, Julian C.
   Woodward, Catherine E.
   Zapater, Pedro
   Fratter, Carl
   Mudanohwo, Ese E.
   Plant, Gordon T.
   Houlden, Henry
   Sweeney, Mary G.
   Hanna, Michael G.
   Reilly, Mary M.
TI Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia
SO BRAIN
LA English
DT Article
DE mitochondrial DNA; mitochondrial DNA deletion; peripheral neuropathy; POLG; progressive external ophthalmoplegia
ID progressive external ophthalmoplegia; kearns-sayre-syndrome; dna deletions; clinical phenotypes; ataxic neuropathy; a3243g mutation; disease; spectrum; melas; ant1
AB Progressive external ophthalmoplegia is a common clinical feature in mitochondrial disease caused by nuclear DNA defects and single, large-scale mitochondrial DNA deletions and is less frequently associated with point mutations of mitochondrial DNA. Peripheral neuropathy is also a frequent manifestation of mitochondrial disease, although its prevalence and characteristics varies considerably among the different syndromes and genetic aetiologies. Based on clinical observations, we systematically investigated whether the presence of peripheral neuropathy could predict the underlying genetic defect in patients with progressive external ophthalmoplegia. We analysed detailed demographic, clinical and neurophysiological data from 116 patients with genetically-defined mitochondrial disease and progressive external ophthalmoplegia. Seventy-eight patients (67%) had a single mitochondrial DNA deletion, 12 (10%) had a point mutation of mitochondrial DNA and 26 (22%) had mutations in either POLG, C10orf2 or RRM2B, or had multiple mitochondrial DNA deletions in muscle without an identified nuclear gene defect. Seventy-seven patients had neurophysiological studies; of these, 16 patients (21%) had a large-fibre peripheral neuropathy. The prevalence of peripheral neuropathy was significantly lower in patients with a single mitochondrial DNA deletion (2%) as compared to those with a point mutation of mitochondrial DNA or with a nuclear DNA defect (44% and 52%, respectively; P < 0.001). Univariate analyses revealed significant differences in the distribution of other clinical features between genotypes, including age at disease onset, gender, family history, progressive external ophthalmoplegia at clinical presentation, hearing loss, pigmentary retinopathy and extrapyramidal features. However, binomial logistic regression analysis identified peripheral neuropathy as the only independent predictor associated with a nuclear DNA defect (P = 0.002; odds ratio 8.43, 95% confidence interval 2.24-31.76). Multinomial logistic regression analysis identified peripheral neuropathy, family history and hearing loss as significant predictors of the genotype, and the same three variables showed the highest performance in genotype classification in a decision tree analysis. Of these variables, peripheral neuropathy had the highest specificity (91%), negative predictive value (83%) and positive likelihood ratio (5.87) for the diagnosis of a nuclear DNA defect. These results indicate that peripheral neuropathy is a rare finding in patients with single mitochondrial DNA deletions but that it is highly predictive of an underlying nuclear DNA defect. This observation may facilitate the development of diagnostic algorithms. We suggest that nuclear gene testing may enable a more rapid diagnosis and avoid muscle biopsy in patients with progressive external ophthalmoplegia and peripheral neuropathy.
C1 [Horga, Alejandro; Pitceathly, Robert D. S.; Houlden, Henry; Hanna, Michael G.; Reilly, Mary M.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Horga, Alejandro; Pitceathly, Robert D. S.; Plant, Gordon T.; Houlden, Henry; Hanna, Michael G.; Reilly, Mary M.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Blake, Julian C.] Norfolk & Norwich Univ Hosp, Dept Clin Neurophysiol, Norwich NR4 7UY, Norfolk, England.
   [Woodward, Catherine E.; Mudanohwo, Ese E.; Sweeney, Mary G.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
   [Zapater, Pedro] Hosp Gen Univ, Clin Pharmacol Sect, Alicante 03010, Spain.
   [Fratter, Carl] Oxford Univ Hosp NHS Trust, Oxford Med Genet Labs, Oxford OX3 7LE, England.
C3 University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; General University Hospital of Alicante; Oxford University Hospitals NHS Foundation Trust
RP Horga, A (corresponding author), UCL Inst Neurol, MRC Ctr Neuromuscular Dis, Queen Sq, London WC1N 3BG, England.
EM a.horga@ucl.ac.uk
FU Medical Research Council (MRC) Centre [G0601943]; UK NHS Specialised Service for Rare Mitochondrial Diseases of Adults and Children; National Institute for Health Research University College London (UCL) Hospitals/UCL Comprehensive Biomedical Research Centre; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; National Institute of Neurological Disorders and Stroke/Office of Rare Diseases [1U54NS065712-01]; Myositis Support Group; Caja Madrid Foundation, Spain; MRC [MR/K000608/1, MR/J004758/1, G0601943, G108/638, G0802760, G1001253] Funding Source: UKRI
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Boles RG, 1998, EUR J PEDIATR, V157, P643, DOI 10.1007/s004310050902
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   Chinnery P F, 2010, DISORDERS OF VOLUNTARY MUSCLE, V0, P363
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   EYMARD B, 1991, REV NEUROL, V147, P508
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Herrmann DN, 2002, MUSCLE NERVE, V26, P232, DOI 10.1002/mus.10204
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Caballero PEJ, 2007, NEUROLOGIST, V13, P33, DOI 10.1097/01.nrl.0000252953.49721.f5
   KAGEYAMA Y, 1991, ACTA NEUROPATHOL, V83, P99, DOI 10.1007/BF00294438
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lee Andrew G, 2002, CURR NEUROL NEUROSCI REP, V2, P413, DOI 10.1007/s11910-002-0067-5
   Liu CH, 2012, J FORMOS MED ASSOC, V111, P489, DOI 10.1016/j.jfma.2011.06.014
   LOVE S, 1993, J PATHOL, V170, P9, DOI 10.1002/path.1711700103
   Martikainen MH, 2012, NEUROEPIDEMIOLOGY, V38, P114, DOI 10.1159/000336112
   Molnar M, 1996, ACTA NEUROPATHOL, V91, P654, DOI 10.1007/s004010050480
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Park KP, 2011, J CLIN NEUROL, V7, P25, DOI 10.3988/jcn.2011.7.1.25
   PARTANEN J, 1995, NEW ENGL J MED, V333, P89, DOI 10.1056/NEJM199507133330203
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   PONZETTO C, 1990, J NEUROL SCI, V96, P207, DOI 10.1016/0022-510X(90)90133-8
   Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D
   Raffelsberger T, 2001, NEUROLOGY, V57, P2298, DOI 10.1212/WNL.57.12.2298
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   REICHMANN H, 1991, EUR NEUROL, V31, P108, DOI 10.1159/000116656
   Rodríguez-Hernández M, 2000, REV NEUROLOGIA, V30, P1001, DOI 10.33588/rn.3011.2000037
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Smits BW, 2007, J NEUROL, V254, P1614, DOI 10.1007/s00415-007-0608-6
   SWEENEY MG, 1993, Q J MED, V86, P435
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 52
TC 29
Z9 30
U1 0
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD DEC 15
PY 2014
VL 137
IS 
BP 3200
EP 3212
DI 10.1093/brain/awu279
PG 13
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AX2GJ
UT WOS:000346761200023
PM 25281868
DA 2024-11-01
ER

PT J
AU Bisceglia, M
   Crociani, P
   Fogli, D
   Centola, A
   Galliani, CA
   Pasquinelli, G
AF Bisceglia, Michele
   Crociani, Paola
   Fogli, Danilo
   Centola, Antonio
   Galliani, Carlos A.
   Pasquinelli, Gianandrea
TI Selected Case From the Arkadi M. Rywlin International Pathology Slide Series Mitochondrial Myopathy Presenting With Chronic Progressive External Ophthalmoplegia (CPEO): A Case Report
SO ADVANCES IN ANATOMIC PATHOLOGY
LA English
DT Article
DE mitochondria; myopathy; progressive external ophthalmoplegia; ragged-red fiber; intramitochondrial paracrystalline inclusions
ID ocular myopathy; diagnosis; disease; ptosis; adults
AB A 43-year-old female patient diagnosed with chronic progressive external ophthalmoplegia (CPEO) because of mitochondrial myopathy documented by muscle biopsy is presented. The chief complaints were represented by blepharoptosis and ophthalmoplegia. The muscle biopsy was evaluated by histology, using the appropriate histochemical and histoenzimological stains. Ragged red fibers with Gomori trichrome stain were seen, which showed cytochrome c oxydase deficiency and abnormal succinate dehydrogenase staining in around 20% of muscle fibres. Electron microscopy was also performed which demonstrated abnormal, hyperplastic, pleomorphic, and hypertrophic mitochondria, characterized by paracrystalline inclusions arranged in parallel rows (parking-lot inclusions), consisting of rectangular arrays of mitochondrial membranes in a linear or grid-like pattern. In conclusion, mitochondrial myopathy was definitely diagnosed. Although molecular analysis, which was subsequently carried out, failed to reveal mutations in the mitochondrial DNA or in selected nuclear genes, the pathologic diagnosis was not changed. The differential diagnosis of CPEO with other forms of ocular myopathies as well as the possible association of CPEO with systemic syndromes is discussed. Ophtalmologists and medical internists should always suspect CPEO when dealing with patients affected by ocular myopathy, either in its pure form or in association with other myopathic or systemic signs.
C1 [Bisceglia, Michele] Referral Canc Ctr Basilicata, IRCCS, Rionero In Vulture, PZ, Italy.
   [Crociani, Paola; Fogli, Danilo] IRCCS Casa Sollievo Sofferenza, Neurol Unit, San Giovanni Rotondo, FG, Italy.
   [Centola, Antonio] F Lastaria Hosp, Ophthalmol Unit, Lucera, Italy.
   [Pasquinelli, Gianandrea] Univ Bologna, S Orsola Polyclin, Dept Clin Pathol, Bologna, Italy.
   [Galliani, Carlos A.] Childrens Hosp & Clin Minnesota, Dept Pathol, Minneapolis, MN USA.
C3 IRCCS CROB; IRCCS Casa Sollievo Della Sofferenza; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Children's Hospitals & Clinics of Minnesota
RP Bisceglia, M (corresponding author), Via Santa Chiara 9, I-71043 Manfredonia, FG, Italy.
EM bismich@alice.it
CR Barton JJS, 2010, J NEURO-OPHTHALMOL, V30, P248, DOI 10.1097/WNO.0b013e3181e014c8
   Ben Yaou R, 2006, REV NEUROL-FRANCE, V162, P339, DOI 10.1016/S0035-3787(06)75020-2
   Clauser L, 2006, J CRANIOFAC SURG, V17, P246, DOI 10.1097/00001665-200603000-00008
   Cohen BH, 2013, NEUROTHERAPEUTICS, V10, P227, DOI 10.1007/s13311-013-0188-3
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   DiMauro S, 2010, ACTA MYOL, V29, P333
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   DiMauro S, 2013, NEUROLOGY, V81, P281, DOI 10.1212/WNL.0b013e31829bfe89
   Doherty M, 2013, ORBIT, V32, P12, DOI 10.3109/01676830.2012.736599
   Lucci LMD, 2009, ARQ BRAS OFTALMOL, V72, P159, DOI 10.1590/S0004-27492009000200005
   Farrugia ME, 2011, J ROY COLL PHYS EDIN, V41, P43, DOI 10.4997/JRCPE.2011.111
   Filosto M, 2009, J NEUROL NEUROSUR PS, V80, P448, DOI 10.1136/jnnp.2008.150540
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Gallagher CL, 2002, J CHILD NEUROL, V17, P453, DOI 10.1177/088307380201700612
   Gautier D, 2012, EUR J NEUROL, V19, PE38, DOI 10.1111/j.1468-1331.2011.03657.x
   Gimenes AC, 2007, EUR RESP J S, V51, P0
   Goldstein AC, 2013, NEUROTHERAPEUTICS, V10, P212, DOI 10.1007/s13311-013-0185-6
   Lee Andrew G, 2002, CURR NEUROL NEUROSCI REP, V2, P413, DOI 10.1007/s11910-002-0067-5
   Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582
   Owens William E, 2005, J CLIN NEUROMUSCUL DIS, V6, P188, DOI 10.1097/01.cnd.0000167098.73931.41
   Pénisson-Besnier I, 2008, REV NEUROL-FRANCE, V164, P902, DOI 10.1016/j.neurol.2008.02.036
   Perez-Atayde AR, 2013, HUM PATHOL, V44, P1440, DOI 10.1016/j.humpath.2012.12.005
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Scarpelli Mauro, 2010, RECENT PAT CNS DRUG DISCOV, V5, P203, DOI 10.2174/157488910793362412
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schoser BGH, 2006, STRABISMUS, V14, P107, DOI 10.1080/09273970600701218
   SERRATRICE G, 1987, PRESSE MED, V16, P1969
   SERRATRICE G, 1991, REV NEUROL, V147, P474
   Servidei Serenella, 2004, NEUROMUSCUL DISORD, V14, P107
   Soejima K, 2006, ANN PLAS SURG, V56, P439, DOI 10.1097/01.sap.0000202885.98998.0a
   Thiriez C, 2010, REV NEUROL-FRANCE, V166, P538, DOI 10.1016/j.neurol.2009.12.004
NR 31
TC 3
Z9 4
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1072-4109
EI 1533-4031
J9 ADV ANAT PATHOL
JI Adv. Anat. Pathol.
PD NOV 15
PY 2014
VL 21
IS 6
BP 461
EP 468
DI 10.1097/PAP.0000000000000045
PG 8
WC Pathology
SC Pathology
GA AS4ND
UT WOS:000344252100008
PM 25299315
DA 2024-11-01
ER

PT J
AU González-Hunt, CP
   Leung, MCK
   Bodhicharla, RK
   McKeever, MG
   Arrant, AE
   Margillo, KM
   Ryde, IT
   Cyr, DD
   Kosmaczewski, SG
   Hammarlund, M
   Meyer, JN
AF Gonzalez-Hunt, Claudia P.
   Leung, Maxwell C. K.
   Bodhicharla, Rakesh K.
   McKeever, Madeline G.
   Arrant, Andrew E.
   Margillo, Kathleen M.
   Ryde, Ian T.
   Cyr, Derek D.
   Kosmaczewski, Sara G.
   Hammarlund, Marc
   Meyer, Joel N.
TI Exposure to Mitochondrial Genotoxins and Dopaminergic Neurodegeneration in <i>Caenorhabditis elegans</i>
SO PLOS ONE
LA English
DT Article
ID nuclear-dna damage; environmental risk-factors; parkinsons-disease; caloric restriction; oxidative damage; complex-i; repair; mechanisms; brain; neurons
AB Neurodegeneration has been correlated with mitochondrial DNA (mtDNA) damage and exposure to environmental toxins, but causation is unclear. We investigated the ability of several known environmental genotoxins and neurotoxins to cause mtDNA damage, mtDNA depletion, and neurodegeneration in Caenorhabditis elegans. We found that paraquat, cadmium chloride and aflatoxin B-1 caused more mitochondrial than nuclear DNA damage, and paraquat and aflatoxin B-1 also caused dopaminergic neurodegeneration. 6-hydroxydopamine (6-OHDA) caused similar levels of mitochondrial and nuclear DNA damage. To further test whether the neurodegeneration could be attributed to the observed mtDNA damage, C. elegans were exposed to repeated low-dose ultraviolet C radiation (UVC) that resulted in persistent mtDNA damage; this exposure also resulted in dopaminergic neurodegeneration. Damage to GABAergic neurons and pharyngeal muscle cells was not detected. We also found that fasting at the first larval stage was protective in dopaminergic neurons against 6-OHDA-induced neurodegeneration. Finally, we found that dopaminergic neurons in C. elegans are capable of regeneration after laser surgery. Our findings are consistent with a causal role for mitochondrial DNA damage in neurodegeneration, but also support non mtDNA-mediated mechanisms.
C1 [Gonzalez-Hunt, Claudia P.; Leung, Maxwell C. K.; Bodhicharla, Rakesh K.; McKeever, Madeline G.; Margillo, Kathleen M.; Ryde, Ian T.; Meyer, Joel N.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.
   [Arrant, Andrew E.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA.
   [Cyr, Derek D.] Duke Univ, Ctr Appl Genom & Technol, Durham, NC USA.
   [Kosmaczewski, Sara G.; Hammarlund, Marc] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, Dept Genet, New Haven, CT USA.
C3 Duke University; Duke University; Duke University; Yale University
RP Meyer, JN (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.
EM joel.meyer@duke.edu
FU Society of Toxicology Colgate-Palmolive Award for Student Research Training in Alternative Methods; American Foundation of Aging Research GlaxoSmithKline Foundation Award; RJR-Duke Leon Golberg Toxicology Training Program; National Institute of Neurological Disorders and Stroke [R21 NS065468]; National Institute of Environmental Health Sciences [R01-ES017540-01A2]; National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]
CR Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x
   ALLEN JA, 1980, NATURE, V287, P244, DOI 10.1038/287244a0
   Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054
   BACKER JM, 1982, CANCER RES, V42, P2764
   Barlow BK, 2007, REPROD TOXICOL, V23, P457, DOI 10.1016/j.reprotox.2007.01.007
   Bedard LL, 2006, CANCER LETT, V241, P174, DOI 10.1016/j.canlet.2005.11.018
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Benedetto A, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001084
   Benedetto A, 2009, CHEM REV, V109, P4862, DOI 10.1021/cr800536y
   Bernstein AI, 2011, MOL NEURODEGENER, V6, P0, DOI 10.1186/1750-1326-6-2
   Bess AS, 2012, NUCL ACIDS RES, V0, P0
   Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X
   Boamah EK, 2010, CHEM RES TOXICOL, V23, P1151, DOI 10.1021/tx900420k
   Borenstein AR, 2006, ALZ DIS ASSOC DIS, V20, P63, DOI 10.1097/01.wad.0000201854.62116.d7
   Boyd WA, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0007024
   Brar SS, 2012, AM J PHYSL LUNG CELL, V0, P0
   Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018
   Bronstein J, 2008, ENV HLTH PERSPECT, V117, P0
   Bronstein J, 2009, ENVIRON HEALTH PERSP, V117, P117, DOI 10.1289/ehp.11702
   Brooks PJ, 2007, NEUROSCIENCE, V145, P1407, DOI 10.1016/j.neuroscience.2006.10.025
   Byrne AB, 2011, IN VIVO LASER AXOTOMY IN C. ELEGANS, V0, Pe2707
   Cannino G, 2009, MITOCHONDRION, V9, P377, DOI 10.1016/j.mito.2009.08.009
   Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005
   Cline SD, 2010, NUCLEIC ACIDS RES, V38, P7546, DOI 10.1093/nar/gkq656
   Cochemé HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200
   Cohen BH, 2010, DEV DISABIL RES REV, V16, P189, DOI 10.1002/ddrr.106
   Cover C, 2005, J PHARMACOL EXP THER, V315, P879, DOI 10.1124/jpet.105.088898
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012
   Drechsel DA, 2009, METHOD ENZYMOL, V456, P381, DOI 10.1016/S0076-6879(08)04421-2
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   El Bejjani R, 2012, ANNU REV GENET, V46, P499, DOI 10.1146/annurev-genet-110711-155550
   Ergün E, 2006, DEUT TIERARZTL WOCH, V113, P363
   Franco R, 2010, CHEM-BIOL INTERACT, V188, P289, DOI 10.1016/j.cbi.2010.06.003
   Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008
   Furda Amy M, 2012, METHODS MOL BIOL, V920, P111, DOI 10.1007/978-1-61779-998-3_9
   GAINES G, 1984, J MOL BIOL, V172, P451, DOI 10.1016/S0022-2836(84)80017-0
   Gomez C, 2007, FRONT BIOSCI-LANDMRK, V12, P1079, DOI 10.2741/2128
   Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378
   Groopman JD, 2005, TOXICOL APPL PHARM, V206, P131, DOI 10.1016/j.taap.2004.09.020
   Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI 10.1289/ehp.0901748
   Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527
   Hollins DL, 2006, FREE RADICAL BIO MED, V40, P1220, DOI 10.1016/j.freeradbiomed.2005.11.011
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Hunter SE, 2012, DNA REPAIR, V11, P857, DOI 10.1016/j.dnarep.2012.08.002
   Hunter SE, 2010, METHODS, V51, P444, DOI 10.1016/j.ymeth.2010.01.033
   Ishiguro H, 2001, IUBMB LIFE, V51, P263, DOI 10.1080/152165401753311816
   Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926
   Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kobayashi H, 2008, FREE RADICAL RES, V42, P651, DOI 10.1080/10715760802270334
   Kohler JJ, 2007, ENVIRON MOL MUTAGEN, V48, P166, DOI 10.1002/em.20223
   Korr H, 2001, CHEM-BIOL INTERACT, V134, P217, DOI 10.1016/S0009-2797(01)00154-5
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kurochkin IO, 2011, AM J PHYSIOL-REG I, V300, PR21, DOI 10.1152/ajpregu.00279.2010
   Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571
   Larosche I, 2010, J PHARMACOL EXP THER, V332, P886, DOI 10.1124/jpet.109.160879
   Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002
   Leung MCK, 2013, BMC PHARMACOL TOXICO, V14, P0, DOI 10.1186/2050-6511-14-9
   Leung MCK, 2010, TOXICOL SCI, V118, P444, DOI 10.1093/toxsci/kfq295
   Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200
   Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583
   Loft S, 1998, FREE RADICAL RES, V29, P525, DOI 10.1080/10715769800300571
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002
   Mandavilli BS, 2000, BRAIN RES, V885, P45, DOI 10.1016/S0006-8993(00)02926-7
   Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002
   Maswood N, 2004, P NATL ACAD SCI USA, V101, P18171, DOI 10.1073/pnas.0405831102
   MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510
   Melrose HL, 2006, EXP BRAIN RES, V173, P196, DOI 10.1007/s00221-006-0461-3
   Mendenhall AR, 2009, PHYSIOL GENOMICS, V36, P167, DOI 10.1152/physiolgenomics.90278.2008
   Meyer JN, 2007, GENOME BIOL, V8, P0, DOI 10.1186/gb-2007-8-5-r70
   Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102
   Meyer JN, 2010, ECOTOXICOLOGY, V19, P804, DOI 10.1007/s10646-009-0457-4
   Miller DB, 2008, METABOLISM, V57, PS44, DOI 10.1016/j.metabol.2008.07.011
   Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999
   Nass R, 2007, CURRENT PROTOCOLS IN TOXICOLOGY, V0, P1.9.1
   Negga R, 2011, NEUROTOXICOLOGY, V32, P331, DOI 10.1016/j.neuro.2011.02.002
   NIRANJAN BG, 1986, CANCER RES, V46, P3637
   NIRANJAN BG, 1982, SCIENCE, V215, P73, DOI 10.1126/science.6797067
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Pinto M, 2013, BIOCH BIOPHYSICA ACT, V0, P0
   Pinto M, 2012, BIOL CHEM, V393, P275, DOI 10.1515/hsz-2011-0236
   Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9
   Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264
   Rooney JP, 2014, EXP GERONTOL, V0, P0
   Ruan QM, 2010, NEUROBIOL DIS, V37, P330, DOI 10.1016/j.nbd.2009.10.011
   SACHS C, 1975, BIOCHEM PHARMACOL, V24, P1, DOI 10.1016/0006-2952(75)90304-4
   Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009
   Sajan M P, 1996, J BIOCHEM TOXICOL, V11, P235
   Sajan MP, 1997, INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, V35, P1187
   Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5
   Samokhvalov V, 2008, AUTOPHAGY, V4, P1034, DOI 10.4161/auto.6994
   Sanders LH, 2014, NEUROBIOL DIS, V70, P214, DOI 10.1016/j.nbd.2014.06.014
   Santos Janine H, 2006, METHODS MOL BIOL, V314, P183
   Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Schmidt CW, 2010, ENV HLTH PERSPECT, V118, P0
   Shaughnessy DT, 2010, MITOCHONDRION, V10, P579, DOI 10.1016/j.mito.2010.02.001
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Sulston J, 1988, NEMATODE CAENORHABDI, V0, P0
   Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009
   SUZUKI J, 1995, FREE RADICAL BIO MED, V18, P431, DOI 10.1016/0891-5849(94)00152-A
   Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839
   Tokunaga I, 1997, BIOCHEM MOL BIOL INT, V43, P73
   Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394
   Tsang WY, 2001, J BIOL CHEM, V276, P32240, DOI 10.1074/jbc.M103999200
   van der Mark M, 2012, ENVIRON HEALTH PERSP, V120, P340, DOI 10.1289/ehp.1103881
   Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x
   Wang XK, 2010, FRONT AGING NEUROSCI, V2, P0, DOI 10.3389/fnagi.2010.00012
   Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061
   WILLIAMS PL, 1988, TOXICOL IND HEALTH, V4, P469, DOI 10.1177/074823378800400406
   WUNDERLIV, 1970, BIOCHEM J, V118, P99, DOI 10.1042/bj1180099
   WUNDERLICH V, 1971, CHEM-BIOL INTERACT, V4, P81, DOI 10.1016/0009-2797(72)90001-4
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023
   Yu BP, 2001, ANN NY ACAD SCI, V928, P39
   Yumino K, 2002, J BIOCHEM, V131, P565, DOI 10.1093/oxfordjournals.jbchem.a003135
   Zhou Shaoyu, 2013, INT J BIOCHEM MOL BIOL, V4, P191
NR 127
TC 50
Z9 62
U1 0
U2 37
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD DEC 8
PY 2014
VL 9
IS 12
BP 
EP 
DI 10.1371/journal.pone.0114459
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX4MX
UT WOS:000346907600058
PM 25486066
DA 2024-11-01
ER

PT J
AU Carossa, V
   Ghelli, A
   Tropeano, CV
   Valentino, ML
   Iommarini, L
   Maresca, A
   Caporali, L
   La Morgia, C
   Liguori, R
   Barboni, P
   Carbonelli, M
   Rizzo, G
   Tonon, C
   Lodi, R
   Martinuzzi, A
   De Nardo, V
   Rugolo, M
   Ferretti, L
   Gandini, F
   Pala, M
   Achilli, A
   Olivieri, A
   Torroni, A
   Carelli, V
AF Carossa, Valeria
   Ghelli, Anna
   Tropeano, Concetta Valentina
   Valentino, Maria Lucia
   Iommarini, Luisa
   Maresca, Alessandra
   Caporali, Leonardo
   La Morgia, Chiara
   Liguori, Rocco
   Barboni, Piero
   Carbonelli, Michele
   Rizzo, Giovanni
   Tonon, Caterina
   Lodi, Raffaele
   Martinuzzi, Andrea
   De Nardo, Vera
   Rugolo, Michela
   Ferretti, Luca
   Gandini, Francesca
   Pala, Maria
   Achilli, Alessandro
   Olivieri, Anna
   Torroni, Antonio
   Carelli, Valerio
TI A Novel in-Frame 18-bp Microdeletion in <i>MT</i>-<i>CYB</i> Causes a Multisystem Disorder with Prominent Exercise Intolerance
SO HUMAN MUTATION
LA English
DT Article
DE mtDNA; MT-CYB; exercise intolerance; multi system mitochondrial disease; cybrid
ID cytochrome-b gene; human mitochondrial-dna; complex-iii deficiency; respiratory-chain; mutation; deletion; tree
AB A novel heteroplasmic mitochondrial DNA (mtDNA) microdeletion affecting the cytochrome b gene (MT-CYB) was identified in an Italian female patient with a multisystem disease characterized by sensorineural deafness, cataracts, retinal pigmentary dystrophy, dysphagia, postural and gait instability, and myopathy with prominent exercise intolerance. The deletion is 18-base pair long and encompasses nucleotide positions 15,649-15,666, causing the loss of six amino acids (Ile-Leu-Ala-Met-Ile-Pro) in the protein, but leaving the remaining of the MT-CYB sequence in frame. The defective complex III function was cotransferred with mutant mtDNA in cybrids, thus unequivocally establishing its pathogenic role. Maternal relatives failed to show detectable levels of the deletion in blood and urinary epithelium, suggesting a de novo mutational event. This is the second report of an in-frame intragenic deletion in MT-CYB, which most likely occurred in early stages of embryonic development, associated with a severe multisystem disorder with prominent exercise intolerance. (C) 2014 Wiley Periodicals, Inc.
C1 [Carossa, Valeria; Ferretti, Luca; Gandini, Francesca; Pala, Maria; Olivieri, Anna; Torroni, Antonio] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy.
   [Ghelli, Anna; Tropeano, Concetta Valentina; Iommarini, Luisa; Rugolo, Michela] Univ Bologna, Dipartimento Farm & Biotecnol, Bologna, Italy.
   [Valentino, Maria Lucia; Maresca, Alessandra; Caporali, Leonardo; La Morgia, Chiara; Liguori, Rocco; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, Bologna, Italy.
   [Valentino, Maria Lucia; Maresca, Alessandra; La Morgia, Chiara; Liguori, Rocco; Rizzo, Giovanni; Carelli, Valerio] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Unita Neurol, Bologna, Italy.
   [Barboni, Piero; Carbonelli, Michele] Studio Oculist DAzeglio, Bologna, Italy.
   [Rizzo, Giovanni; Tonon, Caterina; Lodi, Raffaele] Univ Bologna, Policlin S Orsola Malpighi, Dipartimento Sci Biomed & Neuromotorie, Unita RM Funz, Bologna, Italy.
   [Martinuzzi, Andrea] IRCSS E Medea La Nostra Famiglia, Conegliano, TV, Italy.
   [De Nardo, Vera] Univ Padua, Dipartimento Sci Farmaco, Padua, Italy.
   [Achilli, Alessandro] Univ Perugia, Dipartimento Chim Biol & Biotecnol, I-06100 Perugia, Italy.
   [Torroni, Antonio] IRCCS Ist Neurol Nazl C Mondino, Pavia, Italy.
C3 University of Pavia; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Eugenio Medea; University of Padua; University of Perugia; IRCCS Fondazione Casimiro Mondino
RP Carelli, V (corresponding author), Univ Bologna, Neurogenet Lab, IRCCS Inst Neurol Sci Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, Via Altura 3, Bologna, Italy.
EM valerio.carelli@unibo.it
FU Italian Ministry of Education, University and Research: Progetti Futuro in Ricerca [RBFR08U07M, RBFR126B8I]; Progetti Ricerca Interesse Nazionale; National Institutes of Health [GM 38237]
CR Acín-Pérez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002
   Bénit P, 2009, BBA-MOL CELL RES, V1793, P181, DOI 10.1016/j.bbamcr.2008.06.004
   Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Diaz F, 2012, MOL CELL BIOL, V32, P415, DOI 10.1128/MCB.06051-11
   Fragaki K, 2009, MITOCHONDRION, V9, P346, DOI 10.1016/j.mito.2009.06.002
   Ghelli A, 2013, HUM MOL GENET, V22, P2141, DOI 10.1093/hmg/ddt067
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9
   Robinson B H, 1996, METHODS ENZYMOL, V264, P454, DOI 10.1016/S0076-6879(96)64041-5
   Schägger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200
   Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
NR 20
TC 35
Z9 36
U1 1
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD AUG 15
PY 2014
VL 35
IS 8
BP 954
EP 958
DI 10.1002/humu.22596
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA AL9AL
UT WOS:000339431600008
PM 24863938
DA 2024-11-01
ER

PT J
AU Miller, DK
   Menezes, MJ
   Simons, C
   Riley, LG
   Cooper, ST
   Grimmond, SM
   Thorburn, DR
   Christodoulou, J
   Taft, RJ
AF Miller, David K.
   Menezes, Minal J.
   Simons, Cas
   Riley, Lisa G.
   Cooper, Sandra T.
   Grimmond, Sean M.
   Thorburn, David R.
   Christodoulou, John
   Taft, Ryan J.
TI Rapid Identification of a Novel Complex I <i>MT-ND3</i> m.10134C>A Mutation in a Leigh Syndrome Patient
SO PLOS ONE
LA English
DT Article
ID mitochondrial-dna mutation; nd3 gene; deficiency; disease
AB Leigh syndrome (LS) is a rare progressive multi-system neurodegenerative disorder, the genetics of which is frequently difficult to resolve. Rapid determination of the genetic etiology of LS in a 5-year-old girl facilitated inclusion in Edison Pharmaceutical's phase 2B clinical trial of EPI-743. SNP-arrays and high-coverage whole exome sequencing were performed on the proband, both parents and three unaffected siblings. Subsequent multi-tissue targeted high-depth mitochondrial sequencing was performed using custom long-range PCR amplicons. Tissue-specific mutant load was also assessed by qPCR. Complex I was interrogated by spectrophotometric enzyme assays and Western Blot. No putatively causal mutations were identified in nuclear-encoded genes. Analysis of low-coverage off-target mitochondrial reads revealed a previously unreported mitochondrial mutation in the proband in MT-ND3 (m.10134C>A, p.Q26K), a Complex I mitochondrial gene previously associated with LS. Targeted investigations demonstrated that this mutation was 1% heteroplasmic in the mother's blood and homoplasmic in the proband's blood, fibroblasts, liver and muscle. Enzyme assays revealed decreased Complex I activity. The identification of this novel LS MT-ND3 variant, the genomics of which was accomplished in less than 3.5 weeks, indicates that rapid genomic approaches may prove useful in time-sensitive cases with an unresolved genetic diagnosis.
C1 [Miller, David K.; Grimmond, Sean M.] Univ Queensland, Queensland Ctr Med Gen, Inst Mol Biosci, St Lucia, Qld, Australia.
   [Menezes, Minal J.; Riley, Lisa G.; Christodoulou, John] Childrens Hosp Westmead, Kids Res Inst, Genet Metab Disorders Res Unit, Sydney, NSW, Australia.
   [Menezes, Minal J.; Cooper, Sandra T.; Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Camperdown, NSW, Australia.
   [Simons, Cas; Taft, Ryan J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.
   [Cooper, Sandra T.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW, Australia.
   [Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia.
   [Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Genet Med, Camperdown, NSW, Australia.
   [Taft, Ryan J.] George Washington Univ, Sch Med, Dept Integrat Syst Biol, Washington, DC USA.
   [Taft, Ryan J.] George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20052 USA.
C3 University of Queensland; NSW Health; The Children's Hospital at Westmead; University of Sydney; University of Sydney; University of Queensland; NSW Health; The Children's Hospital at Westmead; University of Sydney; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Victorian Clinical Genetics Services; University of Melbourne; University of Sydney; George Washington University; George Washington University
RP Christodoulou, J (corresponding author), Childrens Hosp Westmead, Kids Res Inst, Genet Metab Disorders Res Unit, Sydney, NSW, Australia.
EM john.christodoulou@health.nsw.gov.au; r.taft@uq.edu.au
FU Illumina Inc.; National Health and Medical Research Council of Australia (NHMRC) [1026891]; University of Queensland Foundation Research Excellence Award; Crane family; Perkins family
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Baertling F, 2013, J NEUROL NEUROSUR PS, V0, P1
   Choi Y, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0046688
   Cooper ST, 2007, NEUROMUSCULAR DISORD, V17, P276, DOI 10.1016/j.nmd.2006.12.010
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4
   Goldstein AC, 2013, NEUROTHERAPEUTICS, V10, P212, DOI 10.1007/s13311-013-0185-6
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Nesbitt V, 2012, DEV MED CHILD NEUROL, V54, P500, DOI 10.1111/j.1469-8749.2012.04224.x
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Tarnopoisky M, 2013, AM J MED GENET A, V161, P2020, DOI 10.1002/ajmg.a.36000
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Thorburn DR, 2003, GENEREVIEWS, V0, P1
NR 20
TC 8
Z9 8
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD AUG 12
PY 2014
VL 9
IS 8
BP 
EP 
DI 10.1371/journal.pone.0104879
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO3LJ
UT WOS:000341230400100
PM 25118196
DA 2024-11-01
ER

PT J
AU Fuke, S
   Kametani, M
   Yamada, K
   Kasahara, T
   Kubota-Sakashita, M
   Kujoth, GC
   Prolla, TA
   Hitoshi, S
   Kato, T
AF Fuke, Satoshi
   Kametani, Mizue
   Yamada, Kazuyuki
   Kasahara, Takaoki
   Kubota-Sakashita, Mie
   Kujoth, Gregory C.
   Prolla, Tomas A.
   Hitoshi, Seiji
   Kato, Tadafumi
TI Heterozygous <i>Polg</i> mutation causes motor dysfunction due to mtDNA deletions
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
AB Objective: Mutations in nuclear-encoded mitochondrial DNA (mtDNA) polymerase (POLG) are known to cause autosomal dominant chronic progressive external ophthalmoplegia (adCPEO) with accumulation of multiple mtDNA deletions in muscles. However, no animal model with a heterozygous Polg mutation representing mtDNA impairment and symptoms of CPEO has been established. To understand the pathogenic mechanism of CPEO, it is important to determine the age dependency and tissue specificity of mtDNA impairment resulting from a heterozygous mutation in the Polg gene in an animal model. Methods: We assessed behavioral phenotypes, tissue-specific accumulation of mtDNA deletions, and its age dependency in heterozygous Polg(D257A) knock-in mice carrying a proofreading-deficient mutation in the Polg. Results: Heterozygous Polg(D257A) knock-in mice exhibited motor dysfunction in a rotarod test. Polg(+/D257A) mice had significant accumulation of multiple mtDNA deletions, but did not show significant accumulation of point mutations or mtDNA depletion in the brain. While mtDNA deletions increased in an age-dependent manner regardless of the tissue even in Polg(+/+) mice, the age-dependent accumulation of mtDNA deletions was enhanced in muscles and in the brain of Polg(+/D257A) mice. Interpretation: Heterozygous Polg(D257A) knock-in mice showed tissue-specific, age-dependent accumulation of multiple mtDNA deletions in muscles and the brain which was likely to result in neuromuscular symptoms. Polg(+/D257A) mice may be used as an animal model of adCPEO associated with impaired mtDNA maintenance.
C1 [Fuke, Satoshi; Kametani, Mizue; Kasahara, Takaoki; Kubota-Sakashita, Mie; Kato, Tadafumi] RIKEN, Lab Mol Dynam Mental Disorders, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
   [Fuke, Satoshi; Hitoshi, Seiji] Shiga Univ Med Sci, Dept Integrat Physiol, Otsu, Shiga 5202192, Japan.
   [Yamada, Kazuyuki] RIKEN, Brain Sci Inst, Res Resources Ctr, Wako, Saitama 3510198, Japan.
   [Kujoth, Gregory C.] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.
C3 RIKEN; Shiga University of Medical Science; RIKEN; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison
RP Kato, T (corresponding author), RIKEN, Lab Mol Dynam Mental Disorders, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM kato@brain.riken.jp
FU Grants-in-Aid for Scientific Research [26110710, 24116005, 25650005] Funding Source: KAKEN
CR Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469
   Carrozzo R, 1998, NEUROLOGY, V50, P99, DOI 10.1212/WNL.50.1.99
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fuke S, 2011, BBA-BIOENERGETICS, V1807, P270, DOI 10.1016/j.bbabio.2010.11.016
   Hayashi A, 2007, J BIOL CHEM, V282, P34525, DOI 10.1074/jbc.M704300200
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kato T, 2007, CNS DRUGS, V21, P1, DOI 10.2165/00023210-200721010-00001
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Melberg A, 1996, MUSCLE NERVE, V19, P1561, DOI 10.1002/(SICI)1097-4598(199612)19:12<1561::AID-MUS5>3.0.CO;2-8
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
NR 40
TC 17
Z9 18
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
EI 
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD NOV 15
PY 2014
VL 1
IS 11
BP 909
EP 920
DI 10.1002/acn3.133
PG 12
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA V45KO
UT WOS:000209815700006
PM 25540805
DA 2024-11-01
ER

PT J
AU Piteau, SJ
   Rossiter, JP
   Smith, RG
   MacKenzie, JJ
AF Piteau, Shalea J.
   Rossiter, John P.
   Smith, R. Garth
   MacKenzie, Jennifer J.
TI Congenital Myopathy With Cap-Like Structures and Nemaline Rods: Case Report and Literature Review
SO PEDIATRIC NEUROLOGY
LA English
DT Review
DE cap myopathy; nemaline rods; NEB; case report; literature review
ID tropomyosin gene tpm2; nebulin gene; distal myopathy; mutations; disease; core
AB BACKGROUND: Cap myopathy is a rare congenital myopathy characterized by cap structures located at the periphery of the muscle fiber. Cap structures consist of disarranged thin filaments with enlarged Z discs. The clinical presentation and natural history of cap myopathy is variable and overlaps with other congenital myopathies. METHODS: We describe a 10-year-old boy with cap myopathy and contrast him with 20 other individuals reported in the literature. RESULTS: Our patient presented at birth with hypotonia and weakness and subsequently developed respiratory failure in infancy. He is ambulatory but has increasing fatigue and requires a wheelchair by midafternoon. His muscle biopsy at 3 months revealed a nemaline myopathy and secondary fiber-type disproportion with type 1 hypotrophy and predominance. A repeat muscle biopsy at age 6 years revealed numerous peripherally located cap-like structures containing nemaline rods and exhibited a spectrum of Z-disk and myofibrillar abnormalities. Molecular genetic testing was performed for NEB, TPM2, TPM3, ACTA1, TNNT1, SEPN1, SMN1, DMPK, FSHMD1A, and mtDNA. A known pathogenic mutation, c.1152+F1G>A, and a previously unreported variant, c.1782+4_1782+5delAG, were detected in NEB. CONCLUSION: Our patient has a more severe phenotype than most reported patients and is the first patient with cap myopathy to have a mutation in NEB. Our case supports the identification of cap myopathy as a congenital myopathy with significant overlapping features with nemaline myopathies and further elucidates the phenotype of this disease.
C1 [Piteau, Shalea J.; Smith, R. Garth; MacKenzie, Jennifer J.] Queens Univ, Dept Pediat, Kingston, ON K7L 2V7, Canada.
   [Rossiter, John P.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 2V7, Canada.
   [Rossiter, John P.] Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada.
C3 Queens University - Canada; Queens University - Canada; McMaster University; Queens University - Canada
RP Piteau, SJ (corresponding author), Queens Univ, Kingston Gen Hosp, Dept Pediat, 76 Stuart St, Kingston, ON K7L 2V7, Canada.
EM shaleapiteau@hotmail.com
CR Clarke NF, 2008, ANN NEUROL, V63, P329, DOI 10.1002/ana.21308
   Clarke NF, 2009, NEUROMUSCULAR DISORD, V19, P348, DOI 10.1016/j.nmd.2009.03.003
   Cuisset JM, 2006, NEUROMUSCULAR DISORD, V16, P277, DOI 10.1016/j.nmd.2006.01.014
   De Paula AM, 2009, NEUROMUSCULAR DISORD, V19, P685, DOI 10.1016/j.nmd.2009.06.365
   de Winter JM, 2013, J MED GENET, V50, P383, DOI 10.1136/jmedgenet-2012-101470
   FIDZIANSKA A, 1981, NEUROLOGY, V31, P1113, DOI 10.1212/WNL.31.9.1113
   Fidzianska A, 2002, J NEUROL SCI, V201, P27, DOI 10.1016/S0022-510X(02)00156-9
   Gajda A, 2013, J CHILD NEUROL, V0, P0
   GIBBELS E, 1992, ACTA NEUROPATHOL, V83, P371, DOI 10.1007/BF00713528
   Goebel HH, 2007, NEUROMUSCULAR DISORD, V17, P429, DOI 10.1016/j.nmd.2007.03.011
   Hung RM, 2010, NEUROMUSCULAR DISORD, V20, P238, DOI 10.1016/j.nmd.2010.01.011
   Jungbluth H, 2003, EUR J PAEDIATR NEURO, V7, P23, DOI 10.1016/S1090-3798(02)00136-8
   Karasoy H, 2009, NEUROMUSCULAR DISORD, V19, P590, DOI 10.1016/j.nmd.2009.06.149
   Lehtokari VL, 2007, NEUROMUSCULAR DISORD, V17, P433, DOI 10.1016/j.nmd.2007.02.015
   Lehtokari VL, 2006, HUM MUTAT, V27, P946, DOI 10.1002/humu.20370
   North K, 2008, NEUROMUSCULAR DISORD, V18, P433, DOI 10.1016/j.nmd.2008.04.002
   Ohlsson M, 2008, NEUROLOGY, V71, P1896, DOI 10.1212/01.wnl.0000336654.44814.b8
   Ohlsson M, 2009, NEUROLOGY, V72, P1961, DOI 10.1212/WNL.0b013e3181a82659
   Romero NB, 2009, NEUROLOGY, V73, P1159, DOI 10.1212/WNL.0b013e3181bacf45
   Ryan MM, 2003, NEUROLOGY, V60, P665, DOI 10.1212/01.WNL.0000046585.81304.BC
   Scoto M, 2013, EUR J HUM GENET, V21, P1249, DOI 10.1038/ejhg.2013.31
   Tajsharghi H, 2007, ARCH NEUROL-CHICAGO, V64, P1334, DOI 10.1001/archneur.64.9.1334
   Tasca G, 2013, ACTA NEUROPATHOL, V125, P169, DOI 10.1007/s00401-012-1049-6
   Udd B, 2009, NEUROMUSCUL DISORD, V19, P429, DOI 10.1016/j.nmd.2009.04.002
   Waddell LB, 2010, NEUROMUSCULAR DISORD, V20, P464, DOI 10.1016/j.nmd.2010.05.012
   Wallgren-Pettersson C, 2000, NEUROMUSCUL DISORD, V10, P299, DOI 10.1016/S0960-8966(99)00129-7
   Wallgren-Pettersson Carina, 2005, EUR J PAEDIATR NEUROL, V9, P27, DOI 10.1016/j.ejpn.2004.10.007
   Wallgren-Pettersson C, 2007, BRAIN, V130, P1465, DOI 10.1093/brain/awm094
   Wallgren-Pettersson C, 2011, SEMIN PEDIATR NEUROL, V18, P230, DOI 10.1016/j.spen.2011.10.004
   WALLGRENPETTERSSON C, 1989, J NEUROL SCI, V89, P1, DOI 10.1016/0022-510X(89)90002-6
NR 30
TC 14
Z9 15
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD AUG 15
PY 2014
VL 51
IS 2
BP 192
EP 197
DI 10.1016/j.pediatrneurol.2014.04.002
PG 6
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA AM1XC
UT WOS:000339641600003
PM 25079567
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Kothari, S
AF Finsterer, Josef
   Kothari, Sonam
TI Cardiac manifestations of primary mitochondrial disorders
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Review
DE Mitochondrial disorder; Myopathy; Neuropathy; Cardiac involvement; Arrhythmias; Heart failure; Systolic dysfunction; Sudden cardiac death; Takotsubo; Cardiomyopathy
ID kearns-sayre-syndrome; hypertrophic cardiomyopathy; lactic-acidosis; histiocytoid cardiomyopathy; a3243g mutation; point mutation; autonomic dysfunction; clinical-features; dna mutations; heart-disease
AB Objectives: One of the most frequently affected organs in mitochondrial disorders (MIDs), defined as hereditary diseases due to affection of the mitochondrial energy metabolism, is the heart. Cardiac involvement (CI) in MIDs has therapeutic and prognostic implications. This review aims at summarizing and discussing the various cardiac manifestations in MIDs. Methods: Data for this review were identified by searches of MEDLINE, Current Contents, and PubMed using appropriate search terms. Results: CI in MIDs may be classified according to various different criteria. In the present review cardiac abnormalities in MIDs are discussed according to their frequency with which they occur. CI in MIDs includes cardiomyopathy, arrhythmias, heart failure, pulmonary hypertension, dilation of the aortic root, pericardial effusion, coronary heart disease, autonomous nervous system dysfunction, congenital heart defects, or sudden cardiac death. The most frequent among the cardiomyopathies is hypertrophic cardiomyopathy, followed by dilated cardiomyopathy, and noncompaction. Conclusions: CI in MID is more variable and prevalent than previously thought. All tissues of the heart may be variably affected. The most frequently affected tissue is the myocardium. MIDs should be included in the differential diagnoses of cardiac disease. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Kothari, Sonam] NIMHANS, Bangalore, Karnataka, India.
C3 Rudolfstiftung Hospital; National Institute of Mental Health & Neurosciences - India
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Abaci N, 2014, CARDIOL YOU IN PRESS, V1-2, P0
   Akavia UD, 2008, J CELL PHYSIOL, V216, P663, DOI 10.1002/jcp.21442
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Atay Z, 2013, GENE, V515, P197, DOI 10.1016/j.gene.2012.11.044
   Ayalon N, 2013, INT J CARDIOL, V167, PE143, DOI 10.1016/j.ijcard.2013.04.018
   Barisic N, 2002, CROAT MED J, V43, P37
   Barragan-Campos Hector Manuel, 1999, ARCHIVOS DEL INSTITUTO DE CARDIOLOGIA DE MEXICO, V69, P559
   Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393
   Bates MGD, 2012, INT J CARDIOL, V155, P305, DOI 10.1016/j.ijcard.2011.11.063
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bregel LV, 2012, KARDIOLOGIYA, V52, P93
   BRESOLIN N, 1987, ANN NEUROL, V21, P564, DOI 10.1002/ana.410210607
   Brunetti-Pierri N, 2011, MOL GENET METAB, V103, P167, DOI 10.1016/j.ymgme.2011.02.007
   Campos Y, 2000, NEUROMUSCULAR DISORD, V10, P56, DOI 10.1016/S0960-8966(99)00072-3
   Cardaioli E, 2012, J NEUROL SCI, V321, P92, DOI 10.1016/j.jns.2012.07.027
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Casali C, 1999, J AM COLL CARDIOL, V33, P1584, DOI 10.1016/S0735-1097(99)00079-0
   Cave D, 2013, CONGENIT HEART DIS, V8, PE20, DOI 10.1111/j.1747-0803.2011.00569.x
   Chamkha I, 2012, BIOCHEM BIOPH RES CO, V429, P31, DOI 10.1016/j.bbrc.2012.10.105
   Choi JH, 2007, INT J MOL MED, V19, P81
   Dhandapany PS, 2007, INT J CARDIOL, V120, P284, DOI 10.1016/j.ijcard.2006.07.229
   Di Leo R, 2007, J NEUROL, V254, P1498, DOI 10.1007/s00415-007-0536-5
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Ergul Y, 2011, CARDIOL J, V18, P176
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Fassone E, 2011, J MED GENET, V48, P691, DOI 10.1136/jmedgenet-2011-100340
   Fijolek Justyna, 2003, PNEUMONOL ALERGOL POL, V71, P449
   Finsterer J, 2007, MINERVA GASTROENTEROL DIETOL, V53, P285
   Finsterer J, 2000, EUR NEUROL, V44, P37, DOI 10.1159/000008190
   Finsterer J, 2004, ACTA CARDIOL, V59, P187, DOI 10.2143/AC.59.2.2005175
   Finsterer J, 2012, NUTR METAB CARDIOVAS, V22, P393, DOI 10.1016/j.numecd.2012.01.002
   Finsterer J, 2003, CARDIOLOGY, V100, P48, DOI 10.1159/000072393
   Finsterer J, 2001, J INHERIT METAB DIS, V24, P560, DOI 10.1023/A:1012415810881
   Finsterer J, 2008, CLIN CARDIOL, V31, P225, DOI 10.1002/clc.20224
   Finsterer J, 2007, J CARDIOVASC MED, V8, P859, DOI 10.2459/JCM.0b013e3280103d1b
   Finsterer J, 2013, WIEN MED WOCHENSCHR, V163, P505, DOI 10.1007/s10354-013-0243-z
   Finsterer J, 2013, INT J CARDIOL, V167, PE101, DOI 10.1016/j.ijcard.2013.03.194
   Finsterer Josef, 2011, KOBE J MED SCI, V56, P0
   Finsterer J, 2010, EUR J HEART FAIL, V12, P637, DOI 10.1093/eurjhf/hfq046
   Finsterer J, 2009, INT J LEGAL MED, V123, P507, DOI 10.1007/s00414-008-0290-y
   Finsterer J, 2009, PEDIATR CARDIOL, V30, P659, DOI 10.1007/s00246-008-9359-0
   Franklin JA, 2005, CLEFT PALATE-CRAN J, V42, P327, DOI 10.1597/03-040.1
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Gerber B, 2010, BMJ CASE REP, V0, P0
   Giordano C, 2013, HUM PATHOL, V44, P1262, DOI 10.1016/j.humpath.2012.10.011
   GONSKA BD, 1985, Z KARDIOL, V74, P281
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Govindaraj P, 2014, MITOCHONDRION, V16, P65, DOI 10.1016/j.mito.2013.10.006
   Guo H, 2012, BBA-MOL BASIS DIS, V1822, P1535, DOI 10.1016/j.bbadis.2012.06.010
   Hernández-Luis C, 2007, REV ESP CARDIOL, V60, P89, DOI 10.1016/S0300-8932(07)74995-3
   Hollingsworth KG, 2012, NEUROMUSCULAR DISORD, V22, P592, DOI 10.1016/j.nmd.2012.03.001
   Hung PC, 2012, BRAIN DEV-JPN, V34, P866, DOI 10.1016/j.braindev.2012.02.011
   Inamori M, 1997, J CARDIOL, V30, P341
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   ISHIKAWA Y, 1995, PATHOL RES PRACT, V191, P64, DOI 10.1016/S0344-0338(11)80927-1
   Jain-Ghai S, 2013, AM J MED GENET A, V161A, P285, DOI 10.1002/ajmg.a.35714
   Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256
   Johnson ECB, 2011, NEUROHOSPITALIST, V1, P48, DOI 10.1177/1941875210385948
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Jose T, 2011, INT J CARDIOL, V149, PE24, DOI 10.1016/j.ijcard.2009.03.057
   Josef F, 2006, INT J CARDIOVAS IMAG, V22, P393, DOI 10.1007/s10554-005-9073-4
   Kanjwal K, 2010, CLIN CARDIOL, V33, P626, DOI 10.1002/clc.20805
   Karanikis P, 2005, INT J CARDIOL, V101, P147, DOI 10.1016/j.ijcard.2004.01.027
   Kawagoe Izumi, 2013, MASUI, V62, P431
   Leary SC, 2013, HUM MUTAT, V34, P1366, DOI 10.1002/humu.22385
   Lee K T, 2001, KAOHSIUNG J MED SCI, V17, P336
   Letsas Konstantinos P, 2006, AM HEART HOSP J, V4, P301, DOI 10.1111/j.1541-9215.2006.06040.x
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Limongelli G, 2012, FUTUR CARDIOL, V8, P71, DOI 10.2217/fca.11.79
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Liu CH, 2012, J FORMOS MED ASSOC, V111, P489, DOI 10.1016/j.jfma.2011.06.014
   Liu HY, 2011, J BIOMED SCI, V18, P0, DOI 10.1186/1423-0127-18-29
   Liu Z, 2014, J MED GENET, V51, P176, DOI 10.1136/jmedgenet-2013-101818
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Majamaa-Voltti K, 2004, ANN MED, V36, P225, DOI 10.1080/07853890410028456
   Majamaa-Voltti Kirsi, 2002, BMC CARDIOVASC DISORD, V2, P12
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   MATSUSHITA T, 1993, PEDIATR NEUROL, V9, P391, DOI 10.1016/0887-8994(93)90109-P
   Meyers Deborah E, 2013, TEX HEART INST J, V40, P635
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V411, P247, DOI 10.1016/j.bbrc.2011.06.106
   Mima A, 2011, RENAL FAILURE, V33, P622, DOI 10.3109/0886022X.2011.585730
   Mkaouar-Rebai E, 2013, MITOCHONDR DNA, V24, P163, DOI 10.3109/19401736.2012.748045
   Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005
   Ngu LH, 2012, BIOCHIM BIOPHYS ACTA, V0, P168
   Obara-Moszynska M, 2013, BMC PEDIATR, V13, P0, DOI 10.1186/1471-2431-13-27
   Oginosawa Y, 2003, PACE, V26, P1911, DOI 10.1046/j.1460-9592.2003.00292.x
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   ORTIZ RG, 1992, AM J OPHTHALMOL, V113, P561, DOI 10.1016/S0002-9394(14)74730-0
   Palecek T, 2012, INT HEART J, V53, P383, DOI 10.1536/ihj.53.383
   Parikh S, 2013, SEMIN PEDIATR NEUROL, V20, P31, DOI 10.1016/j.spen.2013.01.003
   Park SY, 2014, AM J PHYSIOL-HEART C, V307, PH346, DOI 10.1152/ajpheart.00227.2014
   Parsons T, 2010, ARCH NEUROL-CHICAGO, V67, P976, DOI 10.1001/archneurol.2010.174
   Riera ARP, 2008, J ELECTROCARDIOL, V41, P675, DOI 10.1016/j.jelectrocard.2008.04.001
   Polisecki EY, 2004, J FORENSIC SCI, V49, P1335
   Prasad GN, 2006, INT J CARDIOL, V109, P432, DOI 10.1016/j.ijcard.2005.07.065
   Rahman OU, 2013, DIAGN PATHOL, V8, P0, DOI 10.1186/1746-1596-8-78
   Rashid A, 2002, J CARDIOVASC ELECTR, V13, P184, DOI 10.1046/j.1540-8167.2002.00184.x
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ryan JJ, 2013, AM J RESP CRIT CARE, V187, P865, DOI 10.1164/rccm.201209-1687OC
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Santorelli FM, 2002, NEUROMUSCULAR DISORD, V12, P56, DOI 10.1016/S0960-8966(01)00248-6
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schwarz K, 2014, INT J CARDIOL, V171, P134, DOI 10.1016/j.ijcard.2013.12.014
   Shahni R, 2013, AM J MED GENET A, V161, P2334, DOI 10.1002/ajmg.a.36065
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   Smits P, 2011, EUR J HUM GENET, V19, P394, DOI 10.1038/ejhg.2010.214
   Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008
   Sproule DM, 2008, J INHERIT M IN PRESS, V0, P0
   Stalder N, 2012, CIRC-HEART FAIL, V5, PE1, DOI 10.1161/CIRCHEARTFAILURE.111.963900
   Stollberger Claudia, 2009, CLIN CARDIOL, V32, PE46, DOI 10.1002/clc.20366
   Subbiah RN, 2007, PACE, V30, P137
   Taniguchi Akira, 2002, NIHON RINSHO, V60 Suppl 4, P606
   Torraco Alessandra, 2012, NEUROGENETICS, V13, P375, DOI 10.1007/s10048-012-0343-8
   Tsujita Y, 2008, INT J CARDIOL, V128, PE43, DOI 10.1016/j.ijcard.2007.05.072
   Vallance HD, 2004, PEDIATR CARDIOL, V25, P538, DOI 10.1007/s00246-003-0446-y
   Van Hove JLK, 2008, EUR J PEDIATR, V167, P771, DOI 10.1007/s00431-007-0587-8
   Verdijk RM, 2008, AM J MED GENET A, V146A, P2822, DOI 10.1002/ajmg.a.32523
   Verhoeven WMA, 2011, NEUROPSYCH DIS TREAT, V7, P293, DOI 10.2147/NDT.S20153
   Vilarinho L, 1997, J MED GENET, V34, P607, DOI 10.1136/jmg.34.7.607
   Villar P, 2013, CIRC J, V77, P2799, DOI 10.1253/circj.CJ-13-0557
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
   Vondrácková A, 2014, EUR J HUM GENET, V22, P431, DOI 10.1038/ejhg.2013.148
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wang Shi-Bing, 2008, PEDIATRICS AND NEONATOLOGY, V49, P145, DOI 10.1016/S1875-9572(08)60030-3
   Wang Shu-Mei, 2006, ACTA PAEDIATRICA TAIWANICA, V47, P83
   Wang W, 2008, AM J EMERG MED, V26, P0, DOI 10.1016/j.ajem.2007.05.027
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Wei Xiao-Qiong, 2009, ZHONGGUO DANG DAI ER KE ZA ZHI, V11, P333
   Wilichowski E, 1998, J NEUROL SCI, V157, P206, DOI 10.1016/S0022-510X(98)00068-9
   Wilmin Stephan, 2012, PRACT NEUROL, V12, P199, DOI 10.1136/practneurol-2012-000256
   Wortmann SB, 2012, EUR J MED GENET, V55, P552, DOI 10.1016/j.ejmg.2012.06.002
   Yajima N, 2009, J NUCL CARDIOL, V16, P989, DOI 10.1007/s12350-009-9149-y
   Yaplito-Lee J, 2007, J PEDIATR-US, V150, P407, DOI 10.1016/j.jpeds.2006.12.047
   Yilmaz A, 2012, CLIN RES CARDIOL, V101, P255, DOI 10.1007/s00392-011-0387-z
   Zaragoza MV, 2011, EUR J HUM GENET, V19, P200, DOI 10.1038/ejhg.2010.169
   Zarrouk-Mahjoub S, 2013, HERZ IN PRESS, V0, P0
   Zhang Li-hua, 2009, ZHONGHUA XIN XUE GUAN BING ZA ZHI, V37, P892
NR 140
TC 82
Z9 87
U1 0
U2 15
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0167-5273
EI 1874-1754
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD DEC 20
PY 2014
VL 177
IS 3
BP 754
EP 763
DI 10.1016/j.ijcard.2014.11.014
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU6EX
UT WOS:000345697200044
PM 25465824
DA 2024-11-01
ER

PT J
AU Chen, T
   Pu, CQ
   Shi, Q
   Wang, Q
   Cong, L
   Liu, JX
   Luo, HY
   Fei, LN
   Tang, W
   Yu, SS
AF Chen, Ting
   Pu, Chuanqiang
   Shi, Qiang
   Wang, Qian
   Cong, Lu
   Liu, Jiexiao
   Luo, Hongyu
   Fei, Lingna
   Tang, Wei
   Yu, Shanshan
TI Chronic progressive external ophthalmoplegia with inflammatory myopathy
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
LA English
DT Article
DE Chronic progressive external ophthalmoplegia; mitochondrial DNA deletions; inflammatory myopathy
ID muscle mitochondrial-dna; deletions; mutations; reads
AB Chronic progressive external ophthalmoplegia is one of mitochondrial disorders, characterized by ptosis, limitation of eye movement, variably severe bulbar muscle weakness and proximal limb weakness. Chronic progressive external ophthalmoplegia complicated with acquired disease is extremely rare. We report a 44 years old male patient with more than 20 years of chronic progressive bilateral ptosis and limitation of eye movements manifested dysarthria, dysphagia and neck muscle weakness for 3 years. The first muscle biopsy showed red-ragged fibers and cytochrome c oxidase negative fibers as well as inflammatory cells infiltration. Electron microscopy revealed paracrystalline inclusions. Mitochondrial genetic analysis demonstrated a large-scale mtDNA deletion of m.8470_13446del4977. The patient was treated with prednisone. In a three-year follow-up study, the second biopsy was performed. Before the treatment, except bilateral ptosis and external ophthalmopelgia, this patient presented bulbar muscle weakness and neck muscle weakness. After treated with prednisone, the symptoms of dysphagia, dysarthria and neck muscle weakness were significantly improved, and the second biopsy showed only mitochondrial myopathy pathology but the inflammations disappeared. Here, we report a patient with chronic progressive external ophthalmoplegia complicated with inflammatory myopathy and after treated with prednisone as myositis, he had a significant therapeutic effect.
C1 [Chen, Ting; Pu, Chuanqiang; Shi, Qiang; Cong, Lu; Liu, Jiexiao] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing 100853, Peoples R China.
   [Chen, Ting; Pu, Chuanqiang] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.
   [Luo, Hongyu; Fei, Lingna; Tang, Wei; Yu, Shanshan] BGI Shenzhen, Shenzhen 518083, Peoples R China.
   [Wang, Qian] Chinese Armed Police Gen Hosp, Dept Emergency, Beijing 100039, Peoples R China.
C3 Chinese People's Liberation Army General Hospital; Nankai University; Beijing Genomics Institute (BGI)
RP Pu, CQ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, 28 Fu Xing Rd, Beijing 100853, Peoples R China.
EM pucq30128@sina.cn; yushanshan@genomics.cn
FU National Natural Science Foundation of China [81271399]; Natural Science Foundation of Beijing [7132216]
CR Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350
   Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465
   Mancuso M, 2013, NEUROMUSCULAR DISORD, V23, P907, DOI 10.1016/j.nmd.2013.07.011
   Marotta R, 2009, J CLIN NEUROSCI, V16, P1223, DOI 10.1016/j.jocn.2008.11.012
   Negro R, 2009, NEUROMUSCULAR DISORD, V19, P423, DOI 10.1016/j.nmd.2009.04.008
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schröder J, 2014, BIOINFORMATICS, V30, P1064, DOI 10.1093/bioinformatics/btt767
   Tengan CH, 1996, BIOCHEM MOL MED, V58, P130, DOI 10.1006/bmme.1996.0040
   Varadhachary AS, 2010, CURR OPIN RHEUMATOL, V22, P651, DOI 10.1097/BOR.0b013e32833f108a
   Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394
NR 15
TC 7
Z9 7
U1 0
U2 4
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1936-2625
EI 
J9 INT J CLIN EXP PATHO
JI Int. J. Clin. Exp. Pathol.
PD JUN 15
PY 2014
VL 7
IS 12
BP 8887
EP 8892
DI 
PG 6
WC Oncology; Pathology
SC Oncology; Pathology
GA AZ6RG
UT WOS:000348345900064
PM 25674260
DA 2024-11-01
ER

PT J
AU Bharti, SK
   Sommers, JA
   Zhou, J
   Kaplan, DL
   Spelbrink, JN
   Mergny, JL
   Brosh, RM
AF Bharti, Sanjay Kumar
   Sommers, Joshua A.
   Zhou, Jun
   Kaplan, Daniel L.
   Spelbrink, Johannes N.
   Mergny, Jean-Louis
   Brosh, Robert M., Jr.
TI DNA Sequences Proximal to Human Mitochondrial DNA Deletion Breakpoints Prevalent in Human Disease Form G-quadruplexes, a Class of DNA Structures Inefficiently Unwound by the Mitochondrial Replicative Twinkle Helicase
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Review
DE DNA Helicase; DNA Replication; G-quadruplex; Genetic Disease; Genomic Instability; Mitochondria; Twinkle
ID kearns-sayre syndrome; progressive external ophthalmoplegia; substantia-nigra neurons; marrow-pancreas syndrome; large-scale deletions; saccharomyces-cerevisiae; direct repeats; homologous recombination; genomic stability; parkinson-disease
AB Background: Mitochondrial DNA deletions are prominent in human genetic disorders and cancer. Results: Predicted mitochondrial G-quadruplex-forming sequences map in close proximity to known deletion breakpoints and form G-quadruplexes in vitro. Conclusion: The mitochondrial replicative helicase Twinkle inefficiently unwinds intra- and intermolecular G-quadruplexes. Significance: Mitochondrial G-quadruplexes are likely to cause genome instability by perturbing replication machinery. Mitochondrial DNA deletions are prominent in human genetic disorders, cancer, and aging. It is thought that stalling of the mitochondrial replication machinery during DNA synthesis is a prominent source of mitochondrial genome instability; however, the precise molecular determinants of defective mitochondrial replication are not well understood. In this work, we performed a computational analysis of the human mitochondrial genome using the Pattern Finder G-quadruplex (G4) predictor algorithm to assess whether G4-forming sequences reside in close proximity (within 20 base pairs) to known mitochondrial DNA deletion breakpoints. We then used this information to map G4P sequences with deletions characteristic of representative mitochondrial genetic disorders and also those identified in various cancers and aging. Circular dichroism and UV spectral analysis demonstrated that mitochondrial G-rich sequences near deletion breakpoints prevalent in human disease form G-quadruplex DNA structures. A biochemical analysis of purified recombinant human Twinkle protein (gene product of c10orf2) showed that the mitochondrial replicative helicase inefficiently unwinds well characterized intermolecular and intramolecular G-quadruplex DNA substrates, as well as a unimolecular G4 substrate derived from a mitochondrial sequence that nests a deletion breakpoint described in human renal cell carcinoma. Although G4 has been implicated in the initiation of mitochondrial DNA replication, our current findings suggest that mitochondrial G-quadruplexes are also likely to be a source of instability for the mitochondrial genome by perturbing the normal progression of the mitochondrial replication machinery, including DNA unwinding by Twinkle helicase.
C1 [Bharti, Sanjay Kumar; Sommers, Joshua A.; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA.
   [Zhou, Jun; Mergny, Jean-Louis] Univ Bordeaux 2, ARNA Lab, F-33000 Bordeaux, France.
   [Zhou, Jun; Mergny, Jean-Louis] IECB, INSERM U869, F-33600 Pessac, France.
   [Kaplan, Daniel L.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32312 USA.
   [Spelbrink, Johannes N.] Univ Tampere, Pirkanmaa Hosp Dist, BioMediTech, FinMIT Ctr Excellence, FI-33014 Tampere, Finland.
   [Spelbrink, Johannes N.] Univ Tampere, Pirkanmaa Hosp Dist, Tampere Univ Hosp, FI-33014 Tampere, Finland.
   [Spelbrink, Johannes N.] Radboud Univ Nijmegen, Med Ctr, Nijmegan Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universite de Bordeaux; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); State University System of Florida; Florida State University; Tampere University; Pirkanmaa Hospital District; Pirkanmaa Hospital District; Tampere University; Tampere University Hospital; Radboud University Nijmegen
RP Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.
EM broshr@mail.nih.gov
FU National Institutes of Health, NIA; European Union; Academy of Finland (Centre of Excellence funding); Netherlands Organization for Scientific Research (NWO), VICI Grant [865.10.004]; Fondation ARC; Aquitaine Regional Council; Agence Nationale de la Recherche (ANR)
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arimondo PB, 2000, NUCLEIC ACIDS RES, V28, P4832, DOI 10.1093/nar/28.24.4832
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Barros P, 2009, FEBS J, V276, P2983, DOI 10.1111/j.1742-4658.2009.07013.x
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463
   Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Capra JA, 2010, PLOS COMPUT BIOL, V6, P0, DOI 10.1371/journal.pcbi.1000861
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   DEGOUL F, 1991, J NEUROL SCI, V101, P168, DOI 10.1016/0022-510X(91)90042-6
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234
   GOLIK P, 1995, CURR GENET, V28, P217, DOI 10.1007/BF00309780
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   HARDING AE, 1992, J INHERIT METAB DIS, V15, P480, DOI 10.1007/BF01799606
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957
   Horton TM, 1996, GENE CHROMOSOME CANC, V15, P95, DOI 10.1002/(SICI)1098-2264(199602)15:2<95::AID-GCC3>3.0.CO;2-Z
   JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059
   Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1
   Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026
   Lam EYN, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2792
   Largy E, 2013, TOP CURR CHEM, V330, P111, DOI 10.1007/128_2012_346
   LARSSON NG, 1992, BIOCHIM BIOPHYS ACTA, V1139, P311, DOI 10.1016/0925-4439(92)90106-W
   Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011
   Levy G, 2007, ARCH NEUROL-CHICAGO, V64, P1242, DOI 10.1001/archneur.64.9.1242
   Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g
   Lin WQ, 2013, EMBO J, V32, P1425, DOI 10.1038/emboj.2013.88
   Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316
   LORENZ JG, 1994, HUM BIOL, V66, P777
   MADSEN CS, 1993, P NATL ACAD SCI USA, V90, P7671, DOI 10.1073/pnas.90.16.7671
   Maizels N, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003468
   Markaryan A, 2008, MUTAT RES-FUND MOL M, V640, P38, DOI 10.1016/j.mrfmmm.2007.12.007
   Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Mergny JL, 2005, NUCLEIC ACIDS RES, V33, P0, DOI 10.1093/nar/gni134
   Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   Oliveira PH, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059907
   Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149
   Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015
   Pandey M, 2014, CELL REP, V6, P1129, DOI 10.1016/j.celrep.2014.02.025
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Piazza A, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003033
   Piazza A, 2010, NUCLEIC ACIDS RES, V38, P4337, DOI 10.1093/nar/gkq136
   Pinto M, 2013, BIOCHIM BIOPHYS ACTA, V1842, P1198
   Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Ribeyre C, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000475
   Rogounovitch T, 2004, ENDOCR J, V51, P265, DOI 10.1507/endocrj.51.265
   Rogounovitch TI, 2002, CANCER RES, V62, P7031
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   ROTIG A, 1991, GENOMICS, V10, P502, DOI 10.1016/0888-7543(91)90342-C
   Rubicz R, 2003, HUM BIOL, V75, P809, DOI 10.1353/hub.2004.0009
   Rubicz RC, 2007, ANTHROPOLOGICAL GENETICS: THEORY, V0, P141
   Sabouri N, 2012, GENE DEV, V26, P581, DOI 10.1101/gad.184697.111
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612
   SAVRETRAIN I, 1992, HUM MOL GENET, V1, P203, DOI 10.1093/hmg/1.3.203
   Schaffitzel C, 2010, METHODS MOL BIOL, V608, P159, DOI 10.1007/978-1-59745-363-9_11
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   STEPIEN PP, 1992, P NATL ACAD SCI USA, V89, P6813, DOI 10.1073/pnas.89.15.6813
   Suhasini AN, 2012, J BIOL CHEM, V287, P19188, DOI 10.1074/jbc.M112.352757
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tseng TY, 2013, NUCLEIC ACIDS RES, V41, P10605, DOI 10.1093/nar/gkt814
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802
   Wanrooij PH, 2010, P NATL ACAD SCI USA, V107, P16072, DOI 10.1073/pnas.1006026107
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07
   Wu YL, 2012, J BIOL CHEM, V287, P21699, DOI 10.1074/jbc.M112.351338
   Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x
   XU BJ, 1995, MOL CELL BIOL, V15, P580, DOI 10.1128/MCB.15.1.580
   Yadav VK, 2008, NUCLEIC ACIDS RES, V36, PD381, DOI 10.1093/nar/gkm781
   YAMAMOTO H, 1992, BIOCHEM BIOPH RES CO, V182, P913, DOI 10.1016/0006-291X(92)91819-C
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Zapico SC, 2013, AGING DIS, V4, P364, DOI 10.14336/AD.2013.0400364
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zheng SZ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031322
   ZUPANC ML, 1991, ANN NEUROL, V29, P680, DOI 10.1002/ana.410290619
NR 102
TC 99
Z9 114
U1 1
U2 40
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 24
PY 2014
VL 289
IS 43
BP 29975
EP 29993
DI 10.1074/jbc.M114.567073
PG 19
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AS6JU
UT WOS:000344370800039
PM 25193669
DA 2024-11-01
ER

PT J
AU Wei, J
   Gao, DF
   Wang, H
   Yan, R
   Liu, ZQ
   Yuan, ZY
   Liu, J
   Chen, MX
AF Wei, Jin
   Gao, Deng-Feng
   Wang, Hao
   Yan, Rui
   Liu, Zhi-Quan
   Yuan, Zu-Yi
   Liu, Jian
   Chen, Ming-Xia
TI Impairment of Myocardial Mitochondria in Viral Myocardial Disease and Its Reflective Window in Peripheral Cells
SO PLOS ONE
LA English
DT Article
ID idiopathic dilated cardiomyopathy; heart-failure; dna mutations; deletion; metabolism; classification; epidemiology; association; cardiology; diagnosis
AB Background: Viral myocardial disease (VMD) is a common disease inducing heart failure. It has not been clear the roles of mitochondrial damage in the pathological changes of cardiomyocytes in VMD. Methods: Myocardial tissues and lymphocytes were collected from 83 VMD patients. Control groups included 12 cases of healthy accidental death with myocardial autopsy and 23 healthy blood donors. The mouse model of viral myocarditis (VMC) was established by Coxsackie virus B-3 infection and myocardial tissues and skeletal muscle were collected. Mitochondrial DNA (mtDNA) deletion rate was quantitatively determined using polymerase chain reaction. Results: There was significantly difference of myocardial mitochondrial DNA deletion rate between VMD or VMC group and control group (P<0.05). Moreover, the loss of mitochondrial membrane phospholipids was significantly different between VMD or VMC group and control group. In VMC mice, there were negative correlations between myocardial mtDNA(3867) deletion rate and left ventricular peak systolic pressure (LVPSP) (r=-0.66, P<0.05), and between myocardial mtDNA(3867) deletion rate and +dp/dt(max) (r=-0.79, P<0.05), while there was positive correlation between myocardial mtDNA3867 deletion rate and -dp/dt(max) (r=0.80, P<0.05). Conclusion: Mitochondrial damage is an important pathophysiological mechanism leading to myocardial injury and cardiac dysfunction. The mitochondrial damage in the skeletal muscle and lymphocytes reflect a "window" of myocardial mitochondrial damage.
C1 [Wei, Jin; Gao, Deng-Feng; Yan, Rui] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 2, Xian 710049, Shaanxi, Peoples R China.
   [Wang, Hao] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27157 USA.
   [Liu, Zhi-Quan; Yuan, Zu-Yi] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 1, Xian 710049, Shaanxi, Peoples R China.
   [Liu, Jian; Chen, Ming-Xia] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Shaanxi, Peoples R China.
C3 Xi'an Jiaotong University; Wake Forest University; Wake Forest Baptist Medical Center; Xi'an Jiaotong University; Xi'an Jiaotong University
RP Wei, J (corresponding author), Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 2, Xian 710049, Shaanxi, Peoples R China.
EM weijin@mail.xjtu.edu.cn
FU Science and Technology Projects of Shaanxi Province [2007K13-03]; National Natural Science Foundation of China [81170209]
CR ADACHI K, 1993, BIOCHEM BIOPH RES CO, V195, P945, DOI 10.1006/bbrc.1993.2135
   Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   Blauwet LA, 2010, PROG CARDIOVASC DIS, V52, P274, DOI 10.1016/j.pcad.2009.11.006
   Caforio ALP, 1997, EUR HEART J, V18, P1051
   Carvajal K, 2003, ARCH MED RES, V34, P89, DOI 10.1016/S0188-4409(03)00004-3
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   Chinese Heart Association, 2000, CHINESE J PRACTICAL, V15, P75
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   Craigen WJ, 2012, METHODS MOL BIOL, V837, P3, DOI 10.1007/978-1-61779-504-6_1
   Eynon N, 2011, PHYSIOL GENOMICS, V43, P789, DOI 10.1152/physiolgenomics.00029.2011
   Fan Zh, 2010, J LIAONING MED U, V31, P370
   GRIFFITHS GM, 1992, P NATL ACAD SCI USA, V89, P549, DOI 10.1073/pnas.89.2.549
   Haiyan D, 2006, J CHINESE MODERN PED, V3, P407
   Hanaki Y, 1989, J MOL CELL CARDIOL, V21, P175
   Hill MF, 1997, CIRCULATION, V96, P2414
   Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301
   INGWALL JS, 1993, CIRCULATION, V87, P58
   Jing Y, 2012, J CLIN CARDIOLOGY CH, V28, P81
   Kao SH, 1997, BIOCHEM MOL BIOL INT, V42, P285
   Katz Arnold M, 1998, CARDIOLOGY CLINICS, V16, P633, DOI 10.1016/S0733-8651(05)70040-0
   Kim HE, 2000, J CLIN INVEST, V106, P857, DOI 10.1172/JCI8040
   Lan Y, 1998, J SHANXI MED, V27, P598
   Lezza AMS, 1999, FASEB J, V13, P1083, DOI 10.1096/fasebj.13.9.1083
   Lv SC, 2013, HELL J CARDIOL, V54, P382
   Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536
   Marín-García J, 2002, J CARD FAIL, V8, P347, DOI 10.1054/jcaf.2002.127774
   Marin-Garcia J, 1999, CARDIOVASC PATHOL, V8, P217, DOI 10.1016/S1054-8807(99)00010-1
   MarinGarcia J, 1996, CARDIOVASC RES, V31, P306
   Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287
   Molina H, 1997, MECH AGEING DEV, V97, P1, DOI 10.1016/S0047-6374(97)01876-9
   Panfoli I, 2011, EXPERT REV PROTEOMIC, V8, P231, DOI 10.1586/EPR.11.1
   Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841
   ROBINSON NC, 1982, BIOCHEMISTRY-US, V21, P184, DOI 10.1021/bi00530a031
   Rose NR, 2008, CURR TOP MICROBIOL, V323, P293
   Sen Z, 1964, PROGR PHYSL SCI, V6, P122
   Shenkar R, 1996, AM J HUM GENET, V59, P772
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Wu F, 2009, P NATL ACAD SCI USA, V106, P7143, DOI 10.1073/pnas.0812768106
   Yajima T, 2009, CIRCULATION, V119, P2615, DOI 10.1161/CIRCULATIONAHA.108.766022
   Yanagawa B, 2003, LAB INVEST, V83, P75, DOI 10.1097/01.LAB.0000049349.56211.09
   Zhang XX, 2002, CHINESE MED J-PEKING, V115, P1390
   Zhiquan L, 1992, J MOL CELL CARDIOL, V24, P239
   Zhiquan L, 1993, CHINESE J CARDIOLOGY, V21, P209
NR 43
TC 7
Z9 9
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD DEC 31
PY 2014
VL 9
IS 12
BP 
EP 
DI 10.1371/journal.pone.0116239
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX7UC
UT WOS:000347119100113
PM 25551390
DA 2024-11-01
ER

PT J
AU Garcia-Diaz, B
   Garone, C
   Barca, E
   Mojahed, H
   Gutierrez, P
   Pizzorno, G
   Tanji, K
   Arias-Mendoza, F
   Quinzii, CM
   Hirano, M
AF Garcia-Diaz, Beatriz
   Garone, Caterina
   Barca, Emanuele
   Mojahed, Hamed
   Gutierrez, Purification
   Pizzorno, Giuseppe
   Tanji, Kurenai
   Arias-Mendoza, Fernando
   Quinzii, Caterina M.
   Hirano, Michio
TI Deoxynucleoside stress exacerbates the phenotype of a mouse model of mitochondrial neurogastrointestinal encephalopathy
SO BRAIN
LA English
DT Article
DE MNGIE; animal model; thymidine; deoxyuridine; deoxynucleotide; mitochondrial DNA
ID thymidine phosphorylase gene; enzyme-replacement therapy; encephalomyopathy mngie; multiple deletions; mtdna maintenance; dna depletion; nucleoside; transporters; toxicity; metabolism
AB Mitochondrial neurogastrointestinal encephalopathy (MNGIE) is an autosomal recessive disease caused by thymidine phosphorylase mutations. Garcia-Diaz et al. describe a mouse model of MNGIE, in which the clinical phenotype, leukoencephalopathy, and biochemical defects are exacerbated by thymidine and deoxyuridine administration.Balanced pools of deoxyribonucleoside triphosphate precursors are required for DNA replication, and alterations of this balance are relevant to human mitochondrial diseases including mitochondrial neurogastrointestinal encephalopathy. In this disease, autosomal recessive TYMP mutations cause severe reductions of thymidine phosphorylase activity; marked elevations of the pyrimidine nucleosides thymidine and deoxyuridine in plasma and tissues, and somatic multiple deletions, depletion and site-specific point mutations of mitochondrial DNA. Thymidine phosphorylase and uridine phosphorylase double knockout mice recapitulated several features of these patients including thymidine phosphorylase activity deficiency, elevated thymidine and deoxyuridine in tissues, mitochondrial DNA depletion, respiratory chain defects and white matter changes. However, in contrast to patients with this disease, mutant mice showed mitochondrial alterations only in the brain. To test the hypothesis that elevated levels of nucleotides cause unbalanced deoxyribonucleoside triphosphate pools and, in turn, pathogenic mitochondrial DNA instability, we have stressed double knockout mice with exogenous thymidine and deoxyuridine, and assessed clinical, neuroradiological, histological, molecular, and biochemical consequences. Mutant mice treated with exogenous thymidine and deoxyuridine showed reduced survival, body weight, and muscle strength, relative to untreated animals. Moreover, in treated mutants, leukoencephalopathy, a hallmark of the disease, was enhanced and the small intestine showed a reduction of smooth muscle cells and increased fibrosis. Levels of mitochondrial DNA were depleted not only in the brain but also in the small intestine, and deoxyribonucleoside triphosphate imbalance was observed in the brain. The relative proportion, rather than the absolute amount of deoxyribonucleoside triphosphate, was critical for mitochondrial DNA maintenance. Thus, our results demonstrate that stress of exogenous pyrimidine nucleosides enhances the mitochondrial phenotype of our knockout mice. Our mouse studies provide insights into the pathogenic role of thymidine and deoxyuridine imbalance in mitochondrial neurogastrointestinal encephalopathy and an excellent model to study new therapeutic approaches.
C1 [Garcia-Diaz, Beatriz; Garone, Caterina; Barca, Emanuele; Gutierrez, Purification; Quinzii, Caterina M.; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
   [Garone, Caterina] Univ Bologna, Human Genet Joint PhD Program, I-10126 Turin, Italy.
   [Garone, Caterina] Univ Turin, Human Genet Joint PhD Program, I-10126 Turin, Italy.
   [Mojahed, Hamed] Columbia Univ, Med Ctr, Dept Biomed Engn, New York, NY 10032 USA.
   [Pizzorno, Giuseppe] Desert Res Inst, Human Hlth & Environm Program, Las Vegas, NV 89135 USA.
   [Tanji, Kurenai] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.
   [Arias-Mendoza, Fernando] Columbia Univ, Med Ctr, Dept Radiol, New York, NY 10032 USA.
C3 Columbia University; University of Bologna; University of Turin; Columbia University; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Columbia University; Columbia University
RP Hirano, M (corresponding author), Columbia Univ, Med Ctr, 630 West 168th St,P&S 4-423, New York, NY 10032 USA.
EM mh29@columbia.edu
FU National Institutes of Health (NIH) [R01 HD056103]; "Fundacion Alfonso Martin Escudero", Spain; NIH [R01 HD057543, U54 NS078059, P01 HD032062]; Muscular Dystrophy Association (MDA); Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF)
CR Blazquez A, 2005, NEUROMUSCULAR DISORD, V15, P775, DOI 10.1016/j.nmd.2005.07.008
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   De Vocht C, 2009, J CONTROL RELEASE, V137, P246, DOI 10.1016/j.jconrel.2009.03.020
   DESGRANGES C, 1981, BIOCHIM BIOPHYS ACTA, V654, P211, DOI 10.1016/0005-2787(81)90174-X
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2<107::AID-DVG3>3.0.CO;2-D
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Ferraro P, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkp1141
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   González-Vioque E, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002035
   Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100
   Hirano M, 2004, TOP CURR GENET, V8, P177
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Johansson M, 2003, BIOCHEM BIOPH RES CO, V307, P41, DOI 10.1016/S0006-291X(03)01062-3
   Koczor CA, 2012, EXPERT OPIN DRUG MET, V8, P665, DOI 10.1517/17425255.2012.680885
   la Marca G, 2006, J MASS SPECTROM, V41, P586, DOI 10.1002/jms.1013
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Levene M, 2013, TOXICOL SCI, V131, P311, DOI 10.1093/toxsci/kfs278
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Martí R, 2003, CLIN CHEM LAB MED, V41, P845, DOI 10.1515/CCLM.2003.128
   Martí R, 2012, METHODS MOL BIOL, V837, P135, DOI 10.1007/978-1-61779-504-6_9
   Massaquoi SG, 1998, PARKINSONS DIS MOVEM, V0, P623
   Minuesa G, 2009, J PHARMACOL EXP THER, V329, P252, DOI 10.1124/jpet.108.146225
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Quinzii CM, 2013, FASEB J, V27, P612, DOI 10.1096/fj.12-209361
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schupbach M, 2009, NEUROLOGY, V73, P332
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007
NR 46
TC 15
Z9 16
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD MAY 15
PY 2014
VL 137
IS 
BP 1337
EP 1349
DI 10.1093/brain/awu068
PG 13
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AH6PK
UT WOS:000336252800014
PM 24727567
DA 2024-11-01
ER

PT J
AU Gouspillou, G
   Sgarioto, N
   Kapchinsky, S
   Purves-Smith, F
   Norris, B
   Pion, CH
   Barbat-Artigas, S
   Lemieux, F
   Taivassalo, T
   Morais, JA
   Aubertin-Leheudre, M
   Hepple, RT
AF Gouspillou, Gilles
   Sgarioto, Nicolas
   Kapchinsky, Sophia
   Purves-Smith, Fennigje
   Norris, Brandon
   Pion, Charlotte H.
   Barbat-Artigas, Sebastien
   Lemieux, Francois
   Taivassalo, Tanja
   Morais, Jose A.
   Aubertin-Leheudre, Mylene
   Hepple, Russell T.
TI Increased sensitivity to mitochondrial permeability transition and myonuclear translocation of endonuclease G in atrophied muscle of physically active older humans
SO FASEB JOURNAL
LA English
DT Article
DE reactive oxygen species; sarcopenia; aging; mitophagy
ID human skeletal-muscle; lysosomal axis theory; oxidative capacity; degenerative diseases; dna mutations; in-vivo; age; apoptosis; pore; accumulation
AB Mitochondrial dysfunction is implicated in skeletal muscle atrophy and dysfunction with aging, with strong support for an increased mitochondrial-mediated apoptosis in sedentary rodent models. Whether this applies to aged human muscle is unknown, nor is it clear whether these changes are caused by sedentary behavior. Thus, we examined mitochondrial function [respiration, reactive oxygen species (ROS) emission, and calcium retention capacity (CRC)] in permeabilized myofibers obtained from vastus lateralis muscle biopsies of healthy physically active young (23.7 +/- 2.7 yr; mean +/- sd) and older (71.2 +/- 4.9 yr) men. Although mitochondrial ROS and maximal respiratory capacity were unaffected, the acceptor control ratio was reduced by 18% with aging, suggesting mild uncoupling of oxidative phosphorylation. CRC was reduced by 50% with aging, indicating sensitization of the mitochondrial permeability transition pore (mPTP) to apoptosis. Consistent with the mPTP sensitization, older muscles showed a 3-fold greater fraction of endonuclease G (a mitochondrial proapoptotic factor)-positive myonuclei. Aged muscles also had lower mitophagic potential, based on a 43% reduction in Parkin to the voltage-dependent anion channel (VDAC) protein ratio. Collectively, these results show that mitochondrial-mediated apoptotic signaling is increased in older human muscle and suggest that accumulation of dysfunctional mitochondria with exaggerated apoptotic sensitivity is due to impaired mitophagy.-Gouspillou, G., Sgarioto, N., Kapchinsky, S., Purves-Smith, F., Norris, B., Pion, C. H., Barbat-Artigas, S., Lemieux, F., Taivassalo, T., Morais, J. A., Aubertin-Leheudre, M., Hepple, R. T. Increased sensitivity to mitochondrial permeability transition and myonuclear translocation of endonuclease G in atrophied muscle of physically active older humans.
C1 [Gouspillou, Gilles; Sgarioto, Nicolas; Norris, Brandon; Morais, Jose A.; Hepple, Russell T.] McGill Univ, McGill Univ Hlth Ctr, Montreal, PQ, Canada.
   [Kapchinsky, Sophia; Purves-Smith, Fennigje; Taivassalo, Tanja; Hepple, Russell T.] McGill Univ, Dept Kinesiol, Montreal, PQ, Canada.
   [Hepple, Russell T.] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada.
   [Gouspillou, Gilles; Pion, Charlotte H.; Barbat-Artigas, Sebastien; Lemieux, Francois; Aubertin-Leheudre, Mylene] Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada.
C3 McGill University; McGill University; McGill University; University of Quebec; University of Quebec Montreal
RP Hepple, RT (corresponding author), Royal Victoria Hosp, Dept Crit Care Med, 687 Pine Ave W, Montreal, PQ H3A 1A, Canada.
EM russell.hepple@mcgill.ca
FU Canadian Institutes of Health Research [MOP125986, MOP119583]; Quebec Network for Research on Aging; Canadian Foundation for Innovation; Fonds de Recherche du Quebec-Sante; McGill University Health Center
CR Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104
   Brenner C, 2012, CIRC RES, V111, P1237, DOI 10.1161/CIRCRESAHA.112.265942
   Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x
   Capel F, 2005, MECH AGEING DEV, V126, P505, DOI 10.1016/j.mad.2004.11.001
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003
   Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb
   Ghosh S, 2011, DIABETES, V60, P2051, DOI 10.2337/db11-0121
   Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110
   Gouspillou G, 2014, AGING CELL, V13, P39, DOI 10.1111/acel.12147
   Gouspillou G, 2010, BBA-BIOENERGETICS, V1797, P143, DOI 10.1016/j.bbabio.2009.09.004
   Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252
   Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021
   Hanson BJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1281, DOI 10.1177/002215540205001001
   Hepple RT, 2011, SARCOPENIA-AGE-RELATED MUSCLE WASTING AND WEAKNESS: MECHANISMS AND TREATMENTS, V0, PP135, DOI 10.1007/978-90-481-9713-2_7
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Hütter E, 2007, AGING CELL, V6, P245, DOI 10.1111/j.1474-9726.2007.00282.x
   Hunter SK, 1999, J APPL PHYSIOL, V86, P1858, DOI 10.1152/jappl.1999.86.6.1858
   Hernández-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305
   Joseph AM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069327
   Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x
   Karakelides H, 2010, DIABETES, V59, P89, DOI 10.2337/db09-0591
   Konopka AR, 2014, J GERONTOL A-BIOL, V69, P371, DOI 10.1093/gerona/glt107
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Leeuwenburgh C, 2005, AM J PHYSIOL-REG I, V288, PR1288, DOI 10.1152/ajpregu.00576.2004
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005
   Marzetti E, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032829
   Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007
   Narayanan N, 1996, AM J PHYSIOL-CELL PH, V271, PC1032, DOI 10.1152/ajpcell.1996.271.4.C1032
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Nauratil M, 2008, EXP CELL RES, V314, P164, DOI 10.1016/j.yexcr.2007.09.013
   Picard M, 2008, AM J PHYSIOL-REG I, V295, PR659, DOI 10.1152/ajpregu.90357.2008
   Picard M, 2012, AM J PHYSIOL-CELL PH, V302, PC629, DOI 10.1152/ajpcell.00368.2011
   Picard M, 2011, AGING CELL, V10, P1047, DOI 10.1111/j.1474-9726.2011.00745.x
   Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712
   Picard Martin, 2010, AGING CELL, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x
   Piquereau J, 2013, AUTOPHAGY, V9, P1837, DOI 10.4161/auto.26502
   Purves-Smith FM, 2012, EXP GERONTOL, V47, P913, DOI 10.1016/j.exger.2012.07.013
   Rasmussen UF, 2003, PFLUG ARCH EUR J PHY, V446, P270, DOI 10.1007/s00424-003-1022-2
   Rowan SL, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0029082
   Rowan SL, 2011, EXP GERONTOL, V46, P660, DOI 10.1016/j.exger.2011.03.005
   Russ DW, 2004, SPORTS MED, V34, P221, DOI 10.2165/00007256-200434040-00002
   Safdar A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010778
   Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257
   Selman C, 2003, BIOGERONTOLOGY, V4, P141, DOI 10.1023/A:1024149923693
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sun Y, 2012, J BIOL CHEM, V287, P40652, DOI 10.1074/jbc.M112.419721
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Terman A, 2004, EXP GERONTOL, V39, P701, DOI 10.1016/j.exger.2004.01.005
   Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598
   Tonkonogi M, 2000, J PHYSIOL-LONDON, V528, P379, DOI 10.1111/j.1469-7793.2000.00379.x
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Varanyuwatana P, 2012, MITOCHONDRION, V12, P120, DOI 10.1016/j.mito.2011.04.006
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Whitman SA, 2005, PFLUG ARCH EUR J PHY, V450, P437, DOI 10.1007/s00424-005-1473-8
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
NR 66
TC 156
Z9 177
U1 1
U2 21
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR 15
PY 2014
VL 28
IS 4
BP 1621
EP 1633
DI 10.1096/fj.13-242750
PG 13
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology
GA AG3UC
UT WOS:000335344300011
PM 24371120
DA 2024-11-01
ER

PT J
AU Horan, MP
   Cooper, DN
AF Horan, Martin P.
   Cooper, David N.
TI The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease
SO HUMAN GENETICS
LA English
DT Review
ID dna copy number; oxidative stress-response; human skeletal-muscle; neuronal cell-death; loss-of-function; alzheimers-disease; cancer-cells; neurodegenerative diseases; neuroprotective factor; depletion syndrm
AB Mitochondrial malfunction appears to be intimately associated with age and age-related complex disorders but the precise pathological relevance of such malfunction remains unclear. Mitochondrial, and more specifically bioenergetic, malfunction is commonly encountered in cancer, degenerative disorders and aging. The identification of a mitochondrial-nuclear retrograde signaling pathway in yeast has facilitated the study of the corresponding retrograde signaling mechanisms induced in response to mitochondrial malfunction in mammals including human. Mitochondrial-nuclear crosstalk is critical for the maintenance of cellular homeostasis, and some mitochondrial DNA mutations may perturb crosstalk signaling. However, ascertaining whether mitochondrial malfunction is a cause or a consequence of disease development will be key to determining whether or not impaired crosstalk signaling is of direct pathological and hence therapeutic relevance. Here, we review what is known about the nuclear adaptive compensatory mechanisms induced in response to mitochondrial malfunction. We discuss the role of mitochondrial DNA variants in modulating the penetrance of human inherited disease caused by mutations in the nuclear genome and explore the underlying mechanisms by which they influence the retrograde response. We conclude that mitochondrial DNA variants have the potential to induce molecular signals through the mitochondrial-nuclear crosstalk mechanism, thereby promoting nuclear compensation in response to mitochondrial malfunction. The implications for the development of genetic or pharmaceutical interventions for the treatment of mitochondrial malfunction in complex disease are also explored.
C1 [Horan, Martin P.; Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales.
C3 Cardiff University
RP Horan, MP (corresponding author), Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales.
EM martinp_007@yahoo.co.uk
CR Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590
   Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372
   Aidt FH, 2013, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0071904
   Arning L, 2010, J MOL MED, V88, P431, DOI 10.1007/s00109-010-0589-2
   Arnold RS, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/239257
   Arnold RS, 2009, PROSTATE, V69, P1, DOI 10.1002/pros.20854
   Bae JW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0042463
   Bär F, 2013, GASTROENTEROLOGY, V145, P1055, DOI 10.1053/j.gastro.2013.07.015
   Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554
   Ballard JWO, 2011, EVOLUTION, V65, P1400, DOI 10.1111/j.1558-5646.2010.01209.x
   Ballard JWO, 2010, AM NAT, V176, PE98, DOI 10.1086/656263
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753
   Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783
   Bellizzi D, 2012, EPIGENOMICS-UK, V4, P17, DOI 10.2217/EPI.11.109
   Bi R, 2012, MOL VIS, V18, P3087
   Bodzioch M, 2009, GENOMICS, V94, P247, DOI 10.1016/j.ygeno.2009.05.006
   Bonaïti B, 2010, EUR J HUM GENET, V18, P948, DOI 10.1038/ejhg.2010.36
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Braidy N, 2013, NEUROTOX RE IN PRESS, V0, P0
   Braidy N, 2013, TRANSL NEURODEGENER, V2, P0, DOI 10.1186/2047-9158-2-20
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Burgess DJ, 2013, NAT REV GENET, V14, P0, DOI 10.1038/nrg3581
   Burgstaller JP, 2007, BMC DEV BIOL, V7, P0, DOI 10.1186/1471-213X-7-141
   BUTOW RA, 1988, PHILOS T R SOC B, V319, P127
   Cannon MV, 2011, MITOCHONDRION, V11, P33, DOI 10.1016/j.mito.2010.07.003
   Celotto AM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0025823
   Chae S, 2013, SCI SIGNAL, V6, P0, DOI 10.1126/scisignal.2003266
   Chang CJ, 2009, CELL. MOL. LIFE SCI., V66, P1755
   Chen EI, 2012, J BIOENERG BIOMEMBR, V44, P619, DOI 10.1007/s10863-012-9465-9
   Chen LY, 2012, MOL CELL, V47, P839, DOI 10.1016/j.molcel.2012.07.002
   Choi SJ, 2011, BIOCHEM BIOPH RES CO, V407, P23, DOI 10.1016/j.bbrc.2011.02.078
   Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002
   Collerton J, 2013, NEUROBIOL AGING, V34, P0, DOI 10.1016/j.neurobiolaging.2013.04.001
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Cortes NG, 2012, HUM MUTAT, V33, P681, DOI 10.1002/humu.22023
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   Courtenay MD, 2012, HUM GENET, V131, P201, DOI 10.1007/s00439-011-1060-3
   Cronin-Furman EN, 2013, MOL NEURODEGENER, V8, P0, DOI 10.1186/1750-1326-8-6
   Crovetto F, 2013, GYNECOL ENDOCRINOL, V29, P259, DOI 10.3109/09513590.2012.736556
   Cui HH, 2013, BMC CANCER, V13, P0, DOI 10.1186/1471-2407-13-110
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Damiano M, 2013, HUM MOL GENET, V22, P3869, DOI 10.1093/hmg/ddt242
   Dato S, 2013, INT J MOL SCI, V14, P16443, DOI 10.3390/ijms140816443
   de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575
   De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125
   De Smet C, 1999, MOL CELL BIOL, V19, P7327
   Dhillon VS, 2014, MUTAT RES-REV MUTAT, V759, P1, DOI 10.1016/j.mrrev.2013.09.001
   Dickinson A, 2013, CELL DEATH DIFFER, V20, P1644, DOI 10.1038/cdd.2013.115
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Ding Y, 2013, INT J MOL MED, V32, P768, DOI 10.3892/ijmm.2013.1459
   Dubec SJ, 2008, REJUV RES, V11, P611, DOI 10.1089/rej.2007.0617
   Dunn DA, 2012, BBA-GEN SUBJECTS, V1820, P601, DOI 10.1016/j.bbagen.2011.08.005
   Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066
   Dupuis L, 2014, BIOCHIMIE, V100, P177, DOI 10.1016/j.biochi.2013.07.033
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/epi.09.33
   Eid T, 2013, SCI TRANSL MED, V5, P0
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629
   Feldhaus P, 2011, METAB BRAIN DIS, V26, P229, DOI 10.1007/s11011-011-9253-y
   Fernández-Caggiano M, 2013, MITOCHONDRION, V13, P263, DOI 10.1016/j.mito.2013.03.005
   Fernández-Caggiano M, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044128
   Fernández-Moreno M, 2011, BMC MUSCULOSKEL DIS, V12, P0, DOI 10.1186/1471-2474-12-283
   Fernández-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Fetterman JL, 2013, BIOCHEM J, V455, P157, DOI 10.1042/BJ20130029
   Finsterer J, 2013, CAN J NEUROL SCI, V40, P635, DOI 10.1017/S0317167100014852
   Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008
   Gill T, 2013, J BIOL CHEM, V288, P26246, DOI 10.1074/jbc.M113.476895
   Gómez-Durán A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014
   Gouspillou G, 2013, AGING CELL, V0, P0
   Gu XL, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0072834
   Guardado-Estrada M, 2012, J HUM GENET, V57, P269, DOI 10.1038/jhg.2012.17
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007
   Guha M, 2010, BBA-BIOENERGETICS, V1797, P1055, DOI 10.1016/j.bbabio.2010.02.008
   Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627
   Guo WW, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0070718
   Guo ZJ, 2012, EXP THER MED, V3, P499, DOI 10.3892/etm.2011.434
   Gupta S, 2013, CARCINOGENE IN PRESS, V0, P0
   Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546
   Hannah-Shmouni F, 2013, JIMD REP IN PRESS, V0, P0
   Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498
   He SL, 2013, EXP CELL RES, V319, P2604, DOI 10.1016/j.yexcr.2013.07.018
   Helbling D, 2013, J PEDIATR GASTR NUTR, V57, P438, DOI 10.1097/MPG.0b013e31829ef4b4
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Horan MP, 2013, EUR J HUM GENET, V21, P1335, DOI 10.1038/ejhg.2013.75
   Horan MP, 2013, J HUM GENET, V58, P127, DOI 10.1038/jhg.2012.144
   Horvath R, 2012, MOVEMENT DISORD, V27, P789, DOI 10.1002/mds.24980
   Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045
   Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028
   Hung WY, 2010, BBA-GEN SUBJECTS, V1800, P264, DOI 10.1016/j.bbagen.2009.06.006
   Hwang S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022116
   Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Jin YNN, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0057932
   Jones AWE, 2012, MITOCHONDRION, V12, P86, DOI 10.1016/j.mito.2011.09.009
   Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235
   Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852
   Joseph AM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069327
   Jung HJ, 2013, J MOL MED, V91, P1117, DOI 10.1007/s00109-013-1049-6
   Kabekkodu SP, 2013, MITOCHONDRION, V0, P0, DOI DOI 10.1016/j.mito.2013.07.001
   Kaipparettu BA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0061747
   Kao LP, 2012, TOXICOL APPL PHARM, V261, P42, DOI 10.1016/j.taap.2012.03.009
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kelly RDW, 2013, STEM CELLS, V31, P703, DOI 10.1002/stem.1313
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Kenney MC, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-4
   Kenney MC, 2013, PLOS ONE, V8, P0
   Keogh M, 2013, CELL METAB, V18, P463, DOI 10.1016/j.cmet.2013.09.015
   Khan NA, 2013, MOL VIS, V19, P1282
   Khan NA, 2013, INVEST OPHTH VIS SCI, V54, P3999, DOI 10.1167/iovs.13-11925
   Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851
   Koczor CA, 2013, PHYSIOL GENOMICS, V45, P590, DOI 10.1152/physiolgenomics.00014.2013
   Kohlhaas M, 2013, CARDIOVASC RES, V98, P259, DOI 10.1093/cvr/cvt032
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259
   Kumar M, 2013, MOL VIS, V19, P220
   Kumarasamy S, 2013, AM J PHYSIOL-HEART C, V304, PH22, DOI 10.1152/ajpheart.00534.2012
   Laberge RM, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.199
   Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974
   Lando D, 2003, EUR J BIOCHEM, V270, P781, DOI 10.1046/j.1432-1033.2003.03445.x
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee CH, 2013, TRENDS ENDOCRIN MET, V24, P222, DOI 10.1016/j.tem.2013.01.005
   Lee HC, 2010, AGEING RES REV, V9, PS47, DOI 10.1016/j.arr.2010.08.009
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Lerner C, 2013, AGING CELL, V12, P966, DOI 10.1111/acel.12122
   Li XY, 2013, J HEMATOL ONCOL, V6, P0, DOI 10.1186/1756-8722-6-19
   Lin TK, 2012, OXID MED CELL LONGEV, V2012, P0, DOI 10.1155/2012/824275
   Ling XL, 2012, INT J MED SCI, V9, P545, DOI 10.7150/ijms.4648
   Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   Lloyd RE, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069003
   López-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002
   Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019
   Martínez-Reyes I, 2012, BIOCHEM J, V444, P249, DOI 10.1042/BJ20111829
   Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024
   Maybury BD, 2013, ANTICANCER RES, V33, P3543
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051
   Minocherhomji S, 2012, EPIGENETICS-US, V7, P326, DOI 10.4161/epi.19547
   Mito T, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0055789
   Mondal R, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0057771
   Monnot S, 2013, HUM MOL GENET, V22, P1867, DOI 10.1093/hmg/ddt040
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moreno-Loshuertos R, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1001379
   Mueller EE, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0052367
   Mueller EE, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0030874
   Müller-Höcker J, 2011, J CELL MOL MED, V15, P445, DOI 10.1111/j.1582-4934.2009.00819.x
   Murphy MP, 2013, CELL METAB, V18, P145, DOI 10.1016/j.cmet.2013.07.006
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Muzumdar RH, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0006334
   Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764
   Nardelli C, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/631082
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Ngo JK, 2013, REDOX BIOL, V1, P258, DOI 10.1016/j.redox.2013.01.015
   Niikura T, 2006, CURR NEUROPHARMACOL, V4, P139, DOI 10.2174/157015906776359577
   Nishimoto I, 2004, TRENDS MOL MED, V10, P102, DOI 10.1016/j.molmed.2004.01.001
   OHagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012
   Osellame LD, 2013, AUTOPHAGY, V9, P1633, DOI 10.4161/auto.25878
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pallardó FV, 2010, BIOGERONTOLOGY, V11, P401, DOI 10.1007/s10522-010-9269-4
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892
   Park TY, 2013, J CONTROL RELEASE, V166, P307, DOI 10.1016/j.jconrel.2012.12.022
   Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893
   Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303
   Peng LR, 2011, MOL CELL BIOL, V31, P4720, DOI 10.1128/MCB.06147-11
   Peng YZ, 2013, AVIAN PATHOL, V42, P327, DOI 10.1080/03079457.2013.800941
   Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233
   PETERSEN KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMOA031314
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Purdue MP, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0043149
   Qu FL, 2011, CANCER-AM CANCER SOC, V117, P3148, DOI 10.1002/cncr.25906
   Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111
   Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027
   Ramos A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074636
   Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003
   Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105
   Ridge PG, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074158
   Ridge PG, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0045134
   Rivera-Torres J, 2013, J PROTEOMICS, V91, P466, DOI 10.1016/j.jprot.2013.08.008
   Ro S, 2013, CELL RES, V23, P759, DOI 10.1038/cr.2013.37
   Rose G, 2007, BMC GENOMICS, V8, P0, DOI 10.1186/1471-2164-8-293
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Sánchez-Aragó M, 2010, CARCINOGENESIS, V31, P567, DOI 10.1093/carcin/bgq012
   Sánchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480
   Sanjuán-Pla A, 2005, FEBS LETT, V579, P2669, DOI 10.1016/j.febslet.2005.03.088
   Santoro A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012037
   Schagdarsurengin U, 2010, MOL CANCER, V9, P0, DOI 10.1186/1476-4598-9-264
   Scheibye-Knudsen M, 2013, AGING-US, V5, P192, DOI 10.18632/aging.100546
   Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003
   Selvanayagam P, 1996, LAB INVEST, V74, P592
   Shen J, 2010, MITOCHONDRION, V10, P62, DOI 10.1016/j.mito.2009.09.004
   Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shimasaki Y, 2013, CIRC RES, V113, P891, DOI 10.1161/CIRCRESAHA.113.301319
   Sikorska M, 2009, MUSCLE NERVE, V40, P381, DOI 10.1002/mus.21355
   Silva DF, 2013, HUM MOL GENET, V22, P3931, DOI 10.1093/hmg/ddt247
   Singhapol C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0052989
   Sitarz KS, 2012, BRAIN, V135, P0, DOI 10.1093/brain/aws049
   Smiraglia DJ, 2008, CANCER BIOL THER, V7, P1182, DOI 10.4161/cbt.7.8.6215
   Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Su YC, 2013, HUM MOL GENET, V22, P4545, DOI 10.1093/hmg/ddt301
   Sun CX, 2010, FREE RADICAL BIO MED, V48, P430, DOI 10.1016/j.freeradbiomed.2009.11.015
   Suzuki Satoru, 2009, BMJ CASE REP, V2009, P0, DOI 10.1136/bcr.03.2009.1648
   Synofzik M, 2012, EUR J NEUROL, V19, Pe114, DOI 10.1111/j.1468-1331.2012.03812.x
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4
   Takasugi M, 2010, BMC GENOMICS, V11, P0, DOI 10.1186/1471-2164-11-481
   Takibuchi G, 2013, MITOCHONDRION, V13, P881, DOI 10.1016/j.mito.2013.07.117
   Tao R, 2013, ANTIOXID RE IN PRESS, V0, P0
   Tarnopoisky M, 2013, AM J MED GENET A, V161, P2020, DOI 10.1002/ajmg.a.36000
   Teng LL, 2012, MITOCHONDR DNA, V23, P461, DOI 10.3109/19401736.2012.710205
   Thyagarajan B, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0065968
   Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T
   Tiao MM, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003696
   Torroni A, 1996, GENETICS, V144, P1835
   TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098
   Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001
   Tranah GJ, 2011, AGEING RES REV, V10, P238, DOI 10.1016/j.arr.2010.06.003
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326
   Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646
   Ussakli CH, 2013, JNCI-J NATL CANCER I, V105, P1239, DOI 10.1093/jnci/djt167
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang B, 2013, FREE RADICAL BIO MED, V65, P882, DOI 10.1016/j.freeradbiomed.2013.08.173
   Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069
   Wang D, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0038848
   Wang X, 2013, HUM MOL GENET, V22, P3976, DOI 10.1093/hmg/ddt251
   Weng SW, 2013, MITOCHONDRION, V13, P888, DOI 10.1016/j.mito.2013.08.001
   Widmer RJ, 2013, AM J PHYSIOL-HEART C, V304, PH393, DOI 10.1152/ajpheart.00765.2012
   Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213
   Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783
   Xia P, 2009, BMC CANCER, V9, P0, DOI 10.1186/1471-2407-9-454
   Xie CH, 2007, BIOCHEM BIOPH RES CO, V364, P656, DOI 10.1016/j.bbrc.2007.10.047
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Xu EP, 2013, CARCINOGENESIS, V34, P2521, DOI 10.1093/carcin/bgt230
   Yamada T, 2012, J PHYSIOL-LONDON, V590, P6187, DOI 10.1113/jphysiol.2012.240077
   Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014
   Yang JN, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0073318
   Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002
   Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106
   Yao Z, 2013, ONCOGENE, V32, P2592, DOI 10.1038/onc.2012.259
   Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu M, 2013, TRANSL RES, V161, P165, DOI 10.1016/j.trsl.2012.10.011
   Zacharias DG, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031065
   Zhang FF, 2013, GENOME BIOL EVOL, V5, P1781, DOI 10.1093/gbe/evt129
   Zhang WJ, 2012, PHARMACOL BIOCHEM BE, V100, P361, DOI 10.1016/j.pbb.2011.09.012
   Zheng H, 2013, J BIOL CHEM, V288, P25727, DOI 10.1074/jbc.M113.462291
   Zheng SZ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031322
   Zuo L, 2013, GENE, V532, P18, DOI 10.1016/j.gene.2013.07.085
NR 278
TC 28
Z9 29
U1 1
U2 28
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0340-6717
EI 1432-1203
J9 HUM GENET
JI Hum. Genet.
PD APR 15
PY 2014
VL 133
IS 4
BP 435
EP 458
DI 10.1007/s00439-013-1402-4
PG 24
WC Genetics & Heredity
SC Genetics & Heredity
GA AD2JA
UT WOS:000333059800007
PM 24305784
DA 2024-11-01
ER

PT J
AU Campbell, G
   Krishnan, KJ
   Deschauer, M
   Taylor, RW
   Turnbull, DM
AF Campbell, Georgia
   Krishnan, Kim J.
   Deschauer, Marcus
   Taylor, Robert W.
   Turnbull, Doug M.
TI Dissecting the mechanisms underlying the accumulation of mitochondrial DNA deletions in human skeletal muscle
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID clonal expansion; mutations; mtdna; replication; disease; genm; fibers; length
AB Large-scale mitochondrial DNA (mtDNA) deletions are an important cause of mitochondrial disease, while somatic mtDNA deletions cause focal respiratory chain deficiency associated with ageing and neurodegenerative disorders. As mtDNA deletions only cause cellular pathology at high levels of mtDNA heteroplasmy, an mtDNA deletion must accumulate to levels which can result in biochemical dysfunction-a process known as clonal expansion. A number of hypotheses have been proposed for clonal expansion of mtDNA deletions, including a replicative advantage for deleted mitochondrial genomes inferred by their smaller size-implying that the largest mtDNA deletions would also display a replicative advantage over smaller mtDNA deletions. We proposed that in muscle fibres from patients with mtDNA maintenance disorders, which lead to the accumulation of multiple mtDNA deletions, we would observe the largest mtDNA deletions spreading the furthest longitudinally through individual muscle fibres by means of a greater rate of clonal expansion. We characterized mtDNA deletions in patients with mtDNA maintenance disorders from a range of 'large' and 'small' cytochrome c oxidase (COX)-deficient regions in skeletal muscle fibres. We measured the size of clonally expanded deletions in 62 small and 60 large individual COX-deficient f regions. No significant difference was observed in individual patients or in the total dataset (small fibre regions mean 6.59 kb-large fibre regions mean 6.51 kb). Thus no difference existed in the rate of clonal expansion throughout muscle fibres between mtDNA deletions of different sizes; smaller mitochondrial genomes therefore do not appear to have an inherent replicative advantage in human muscle.
C1 [Campbell, Georgia; Krishnan, Kim J.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Campbell, Georgia; Krishnan, Kim J.; Turnbull, Doug M.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Univ Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Deschauer, Marcus] Univ Halle Wittenberg, Dept Neurol, D-06120 Halle, Saale, Germany.
C3 Newcastle University - UK; Newcastle University - UK; Martin Luther University Halle Wittenberg
RP Turnbull, DM (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Newcastle Univ Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
FU Medical Research Council; MRC [MR/K006312/1, MC_G0802536, MR/K000608/1, G0700718] Funding Source: UKRI
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Coller HA, 2002, ANN NY ACAD SCI, V959, P434, DOI 10.1111/j.1749-6632.2002.tb02113.x
   Cottrell DA, 2000, J NEUROPATH EXP NEUR, V59, P621, DOI 10.1093/jnen/59.7.621
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herbst A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059006
   HUEMER RP, 1971, EXP GERONTOL, V6, P327, DOI 10.1016/0531-5565(71)90001-5
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Weber K, 1997, AM J HUM GENET, V60, P373
NR 33
TC 34
Z9 36
U1 2
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD SEP 1
PY 2014
VL 23
IS 17
BP 4612
EP 4620
DI 10.1093/hmg/ddu176
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AM9YU
UT WOS:000340238200011
PM 24740879
DA 2024-11-01
ER

PT J
AU Hepple, RT
AF Hepple, Russell T.
TI Mitochondrial involvement and impact in aging skeletal muscle
SO FRONTIERS IN AGING NEUROSCIENCE
LA English
DT Review
DE sarcopenia; bioenergetics; mitochondria; skeletal muscle; reactive oxygen species; permeability transition; oxidative stress; muscle atrophy
ID permeability transition pore; respiratory-chain function; in-vivo; oxidative capacity; vastus lateralis; soleus muscle; dna-deletion; dietary restriction; metabolic-response; fiber atrophy
AB Atrophy is a defining feature of aging skeletal muscle that contributes to progressive weakness and an increased risk of mobility impairment, falls, and physical frailty in very advanced age. Amongst the most frequently implicated mechanisms of aging muscle atrophy is mitochondrial dysfunction. Recent studies employing methods that are well-suited to interrogating intrinsic mitochondrial function find that mitochondrial respiration and reactive oxygen species emission changes are inconsistent between aging rat muscles undergoing atrophy and appear normal in human skeletal muscle from septuagenarian physically active subjects. On the other hand, a sensitization to permeability transition seems to be a general property of atrophying muscle with aging and this effect is even seen in atrophying muscle from physically active septuagenarian subjects. In addition to this intrinsic alteration in mitochondrial function, factors extrinsic to the mitochondria may also modulate mitochondrial function in aging muscle. In particular, recent evidence implicates oxidative stress in the aging milieu as a factor that depresses respiratory function in vivo (an effect that is not present ex vivo). Furthermore, in very advanced age, not only does muscle atrophy become more severe and clinically relevant in terms of its impact, but also there is evidence that this is driven by an accumulation of severely atrophied denervated myofibers. As denervation can itself modulate mitochondrial function and recruit mitochondrial-mediated atrophy pathways, future investigations need to address the degree to which skeletal muscle mitochondrial alterations in very advanced age are a consequence of denervation, rather than a primary organelle defect, to refine our understanding of the relevance of mitochondria as a therapeutic target at this more advanced age.
C1 [Hepple, Russell T.] McGill Univ, Ctr Hlth, Dept Kinesiol, Montreal, PQ, Canada.
C3 McGill University
RP Hepple, RT (corresponding author), Royal Victoria Hosp, Dept Crit Care Med, 675 Pine Ave West, Montreal, PQ H3A 1A1, Canada.
EM russell.hepple@mcgill.ca
CR Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104
   Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, PC844, DOI 10.1152/ajpcell.00402.2005
   Baloh RH, 2007, MUSCLE NERVE, V36, P107, DOI 10.1002/mus.20755
   Barrientos A, 1996, BIOCHEM BIOPH RES CO, V229, P536, DOI 10.1006/bbrc.1996.1839
   BASS A, 1975, GERONTOLOGY, V21, P31, DOI 10.1159/000212028
   Betik AC, 2009, AM J PHYSIOL-REG I, V297, PR744, DOI 10.1152/ajpregu.90959.2008
   Bhattacharya A, 2009, J BIOL CHEM, V284, P46, DOI 10.1074/jbc.M806311200
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Callahan DM, 2014, J APPL PHYSIOL, V116, P1582, DOI 10.1152/japplphysiol.01362.2013
   Capel F, 2005, MECH AGEING DEV, V126, P505, DOI 10.1016/j.mad.2004.11.001
   Carter EE, 2010, EXP GERONTOL, V45, P662, DOI 10.1016/j.exger.2010.04.001
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   CHANCE B, 1956, J BIOL CHEM, V221, P477
   Chu CT, 2010, HUM MOL GENET, V19, PR28, DOI 10.1093/hmg/ddq143
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Cruz-Jentoft AJ, 2010, CURR OPIN CLIN NUTR, V13, P1, DOI 10.1097/MCO.0b013e328333c1c1
   Csukly K, 2006, J PHYSIOL-LONDON, V574, P319, DOI 10.1113/jphysiol.2006.109702
   Desai VG, 1996, ARCH BIOCHEM BIOPHYS, V333, P145, DOI 10.1006/abbi.1996.0375
   Dirks A, 2002, AM J PHYSIOL-REG I, V282, PR519, DOI 10.1152/ajpregu.00458.2001
   Drummond MJ, 2014, J GERONTOL A-BIOL, V69, P1040, DOI 10.1093/gerona/glu004
   Edström E, 2005, AGING CELL, V4, P65, DOI 10.1111/j.1474-9728.2005.00145.x
   Edström E, 2007, PHYSIOL BEHAV, V92, P129, DOI 10.1016/j.physbeh.2007.05.040
   Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012
   Gouspillou G, 2014, FASEB J, V28, P1621, DOI 10.1096/fj.13-242750
   Gouspillou G, 2014, AGING CELL, V13, P39, DOI 10.1111/acel.12147
   Gouspillou G, 2010, BBA-BIOENERGETICS, V1797, P143, DOI 10.1016/j.bbabio.2009.09.004
   Hagen JL, 2004, J GERONTOL A-BIOL, V59, P1099, DOI 10.1093/gerona/59.11.1099
   Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013
   Hemion C, 2014, FREE RADICAL BIO MED, V75, P121, DOI 10.1016/j.freeradbiomed.2014.07.016
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Houmard JA, 1998, J APPL PHYSIOL, V85, P1337, DOI 10.1152/jappl.1998.85.4.1337
   Huang JH, 2010, J GERONTOL A-BIOL, V65, P138, DOI 10.1093/gerona/glp201
   Hütter E, 2007, AGING CELL, V6, P245, DOI 10.1111/j.1474-9726.2007.00282.x
   Joseph AM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069327
   Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x
   Joseph AM, 2010, AM J PHYSIOL-CELL PH, V298, PC1308, DOI 10.1152/ajpcell.00644.2008
   KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kent-Braun JA, 2000, J APPL PHYSIOL, V89, P1072, DOI 10.1152/jappl.2000.89.3.1072
   Kerner J, 2001, AM J PHYSIOL-ENDOC M, V281, P0
   Koltai E, 2012, AM J PHYSIOL-REG I, V303, PR127, DOI 10.1152/ajpregu.00337.2011
   Konopka AR, 2014, J GERONTOL A-BIOL, V69, P371, DOI 10.1093/gerona/glt107
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lanza IR, 2005, J APPL PHYSIOL, V99, P1736, DOI 10.1152/japplphysiol.00566.2005
   Lawrenson L, 2003, AM J PHYSIOL-HEART C, V285, PH1023, DOI 10.1152/ajpheart.00135.2003
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   Leeuwenburgh C, 2005, AM J PHYSIOL-REG I, V288, PR1288, DOI 10.1152/ajpregu.00576.2004
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   Li W, 2014, J BIOL CHEM, V289, P10691, DOI 10.1074/jbc.M113.537050
   Ljubicic V, 2009, AGING-US, V1, P818, DOI 10.18632/aging.100083
   Ljubicic V, 2009, AGING CELL, V8, P394, DOI 10.1111/j.1474-9726.2009.00483.x
   Lyons CN, 2006, J GERONTOL A-BIOL, V61, P3, DOI 10.1093/gerona/61.1.3
   Mahler M, 1985, J GEN PHYSIOL, V86, P165
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782
   Martin KR, 2014, J AM GERIATR SOC, V62, P1263, DOI 10.1111/jgs.12893
   Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005
   Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007
   Mathieu-Costello O, 2005, J APPL PHYSIOL, V99, P281, DOI 10.1152/japplphysiol.00750.2004
   MCCULLY KK, 1993, J APPL PHYSIOL, V75, P813, DOI 10.1152/jappl.1993.75.2.813
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   MEYER RA, 1988, AM J PHYSIOL, V254, PC548, DOI 10.1152/ajpcell.1988.254.4.C548
   Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x
   Muller FL, 2007, AM J PHYSIOL-REG I, V293, PR1159, DOI 10.1152/ajpregu.00767.2006
   ODA K, 1984, J NEUROL SCI, V66, P327, DOI 10.1016/0022-510X(84)90021-2
   ORLANDER J, 1978, ACTA PHYSIOL SCAND, V104, P249, DOI 10.1111/j.1748-1716.1978.tb06277.x
   Picard M, 2008, AM J PHYSIOL-REG I, V295, PR659, DOI 10.1152/ajpregu.90357.2008
   Picard M, 2012, AM J PHYSIOL-CELL PH, V302, PC629, DOI 10.1152/ajpcell.00368.2011
   Picard M, 2011, AGING CELL, V10, P1047, DOI 10.1111/j.1474-9726.2011.00745.x
   Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712
   Picard M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0018317
   Picard Martin, 2010, AGING CELL, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x
   Poole JG, 2003, AM J PHYSIOL-HEART C, V284, PH1251, DOI 10.1152/ajpheart.00790.2002
   Prompers JJ, 2014, INT J BIOCHEM CELL B, V50, P67, DOI 10.1016/j.biocel.2014.02.014
   Rasmussen UF, 2003, PFLUG ARCH EUR J PHY, V446, P270, DOI 10.1007/s00424-003-1022-2
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   ROCKSTEIN M, 1963, SCIENCE, V139, P1049, DOI 10.1126/science.139.3559.1049
   Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60
   Rowan SL, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0029082
   Rowan SL, 2011, EXP GERONTOL, V46, P660, DOI 10.1016/j.exger.2011.03.005
   Rudolf R, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00099
   RUMSEY WL, 1987, EXP GERONTOL, V22, P271, DOI 10.1016/0531-5565(87)90006-4
   Safdar A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010778
   SCELSI R, 1980, ACTA NEUROPATHOL, V51, P99, DOI 10.1007/BF00690450
   Scheibye-Knudsen M, 2014, AUTOPHAGY, V10, P1468, DOI 10.4161/auto.29321
   Schiavi A, 2014, EXP GERONTOL, V56, P147, DOI 10.1016/j.exger.2014.02.015
   Siegel MP, 2013, AGING CELL, V12, P763, DOI 10.1111/acel.12102
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Siu PM, 2005, AM J PHYSIOL-REG I, V289, PR1015, DOI 10.1152/ajpregu.00198.2005
   Snow LM, 2005, ANAT REC PART A, V286A, P866, DOI 10.1002/ar.a.20218
   Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x
   Stary CM, 2004, EXP PHYSIOL, V89, P617, DOI 10.1113/expphysiol.2004.027763
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598
   TOMONAGA M, 1977, J AM GERIATR SOC, V25, P125, DOI 10.1111/j.1532-5415.1977.tb00274.x
   Tonkonogi M, 2000, J PHYSIOL-LONDON, V528, P379, DOI 10.1111/j.1469-7793.2000.00379.x
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang ZM, 2005, J PHYSIOL-LONDON, V565, P757, DOI 10.1113/jphysiol.2005.087601
   YANG JSJ, 1991, NEURON, V7, P421, DOI 10.1016/0896-6273(91)90294-A
NR 108
TC 114
Z9 126
U1 0
U2 32
PU FRONTIERS RESEARCH FOUNDATION
PI LAUSANNE
PA PO BOX 110, LAUSANNE, 1015, SWITZERLAND
SN 1663-4365
EI 
J9 FRONT AGING NEUROSCI
JI Front. Aging Neurosci.
PD SEP 10
PY 2014
VL 6
IS 
BP 
EP 
DI 10.3389/fnagi.2014.00211
PG 13
WC Geriatrics & Gerontology; Neurosciences
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA AO9SD
UT WOS:000341696000001
PM 25309422
DA 2024-11-01
ER

PT J
AU Kuncova, K
   Sedlackova, M
   Vencovsky, J
   Mann, H
   Tomcik, M
   Wenchich, L
   Zamecnik, J
AF Kuncova, Klara
   Sedlackova, Marie
   Vencovsky, Jiri
   Mann, Herman
   Tomcik, Michal
   Wenchich, Laszlo
   Zamecnik, Josef
TI Inflammatory myopathy associated with statins: report of three cases
SO MODERN RHEUMATOLOGY
LA English
DT Article
DE Drug-induced myopathy; Muscle biopsy; Inflammatory myopathy; Statins
ID coa reductase inhibitors; mediated necrotizing myopathy; reticulum stress-response; induced dermatomyositis; autoimmune myositis; polymyositis; simvastatin; activation; mutations; therapy
AB Statins are well-established lipid-lowering drugs that reduce morbidity and mortality due to cardiovascular disease and cause adverse effects relatively rarely. It is still unclear whether statins are capable of inducing an immune-mediated response directed against skeletal muscle. Here, we present the cases of three patients who developed inflammatory myopathy in the course of statin treatment. Moreover, multiple mitochondrial DNA deletions were found in two of them. The ability of statins to induce an immune-mediated response and their interactions with mitochondrial metabolism pathways are discussed.
C1 [Kuncova, Klara; Zamecnik, Josef] Charles Univ Prague, Fac Med 2, Dept Pathol & Mol Med, Prague 15006 5, Czech Republic.
   [Kuncova, Klara; Zamecnik, Josef] Charles Univ Prague, Univ Hosp Motol, Prague 15006 5, Czech Republic.
   [Sedlackova, Marie] Thomayer Hosp, Dept Rheumatol & Rehabil, Prague 4, Czech Republic.
   [Vencovsky, Jiri; Mann, Herman; Tomcik, Michal] Charles Univ Prague, Fac Med 1, Inst Rheumatol, Dept Rheumatol, Prague 2, Czech Republic.
   [Wenchich, Laszlo] Charles Univ Prague, Fac Med 1, Dept Pediat, Prague 2, Czech Republic.
C3 Motol University Hospital; Charles University Prague; Charles University Prague; Motol University Hospital; Thomayer Hospital; Institute of Rheumatology; Charles University Prague; Charles University Prague
RP Zamecnik, J (corresponding author), Charles Univ Prague, Fac Med 2, Dept Pathol & Mol Med, Uvalu 84, Prague 15006 5, Czech Republic.
EM josef.zamecnik@lf2.cuni.cz
FU Ministry of Health of the Czech Republic [00064203]
CR Ahmad A, 2000, TENN MED, V93, P21
   [Anonymous], 2004, DRUGS, V64, P1181
   BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807
   BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706
   Caso G, 2007, AM J CARDIOL, V99, P1409, DOI 10.1016/j.amjcard.2006.12.063
   Christopher-Stine L, 2010, ARTHRITIS RHEUM-US, V62, P2757, DOI 10.1002/art.27572
   Dalakas MC, 2009, J NEUROL NEUROSUR PS, V80, P832, DOI 10.1136/jnnp.2008.168294
   Fauchais AL, 2004, REV MED INTERNE, V25, P294, DOI 10.1016/j.revmed.2003.10.013
   Folzenlogen D, 2001, JCR-J CLIN RHEUMATOL, V7, P340, DOI 10.1097/00124743-200110000-00019
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Ghirardello A, 2006, AUTOIMMUNITY, V39, P217, DOI 10.1080/08916930600622645
   Giordano N, 1997, LANCET, V349, P1600, DOI 10.1016/S0140-6736(05)61628-5
   Grable-Esposito P, 2010, MUSCLE NERVE, V41, P185, DOI 10.1002/mus.21486
   Henriques-Pons A, 2009, CURR OPIN RHEUMATOL, V21, P581, DOI 10.1097/BOR.0b013e3283319265
   KHATTAK FH, 1994, BRIT J RHEUMATOL, V33, P199
   Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219
   Kwak BR, 2003, AUTOIMMUN REV, V2, P332, DOI 10.1016/S1568-9972(03)00049-1
   Lamperti C, 2005, ARCH NEUROL-CHICAGO, V62, P1709, DOI 10.1001/archneur.62.11.1709
   Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748
   Liebhaber MI, 1999, CHEST, V115, P886, DOI 10.1378/chest.115.3.886
   Mach F, 2004, CIRCULATION, V109, P15, DOI 10.1161/01.CIR.0000129502.10459.fe
   Mammen AL, 2011, ARTHRITIS RHEUM-US, V63, P713, DOI 10.1002/art.30156
   McClure DL, 2007, PHARMACOEPIDEM DR S, V16, P132, DOI 10.1002/pds.1341
   Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103
   Needham M, 2007, NEUROMUSCULAR DISORD, V17, P194, DOI 10.1016/j.nmd.2006.10.007
   Noël B, 2001, AM J MED, V110, P670, DOI 10.1016/S0002-9343(01)00711-2
   Pascuzzi Robert M, 1998, CURRENT OPINION IN RHEUMATOLOGY, V10, P511, DOI 10.1097/00002281-199811000-00003
   Paulweber B, 1999, WIEN MED WOCHENSCHR, V149, P129
   Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009
   Radcliffe KA, 2008, CURR NEUROL NEUROSCI, V8, P66, DOI 10.1007/s11910-008-0011-4
   RodriguezGarcia JL, 1996, POSTGRAD MED J, V72, P694, DOI 10.1136/pgmj.72.853.694
   Rudski L, 1998, MEDICINE, V77, P378, DOI 10.1097/00005792-199811000-00002
   Sadeghi MM, 2001, TRANSPLANTATION, V71, P1262, DOI 10.1097/00007890-200105150-00014
   Scalvini Tiziano, 1995, RECENTI PROGRESSI IN MEDICINA, V86, P198
   Sieb JP, 2003, MUSCLE NERVE, V27, P142, DOI 10.1002/mus.10244
   Takagi Akio, 2004, RINSHO SHINKEIGAKU, V44, P25
   Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681
   Thual N, 2005, ANN DERMATOL VENER, V132, P996, DOI 10.1016/S0151-9638(05)79565-X
   Toth Peter P, 2008, EXPERT REV CARDIOVASC THER, V6, P955, DOI 10.1586/14779072.6.7.955
   Vogel H, 2005, J NEUROPATH EXP NEUR, V64, P181, DOI 10.1093/jnen/64.3.181
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Young JA, 2007, AM J CARDIOL, V100, P1400, DOI 10.1016/j.amjcard.2007.06.030
   Zamecnik J, 2007, NEUROMUSCULAR DISORD, V17, P935, DOI 10.1016/j.nmd.2007.05.010
   Zuech P, 2005, REV MED INTERNE, V26, P897, DOI 10.1016/j.revmed.2005.07.005
NR 44
TC 6
Z9 7
U1 1
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1439-7595
EI 1439-7609
J9 MOD RHEUMATOL
JI Mod. Rheumatol.
PD MAR 15
PY 2014
VL 24
IS 2
BP 366
EP 371
DI 10.3109/14397595.2013.852848
PG 6
WC Rheumatology
SC Rheumatology
GA AC4IC
UT WOS:000332483500027
PM 24593216
DA 2024-11-01
ER

PT J
AU Roos, S
   Lindgren, U
   Ehrstedt, C
   Moslemi, AR
   Oldfors, A
AF Roos, S.
   Lindgren, U.
   Ehrstedt, C.
   Moslemi, A. R.
   Oldfors, A.
TI Mitochondrial DNA depletion in single fibers in a patient with novel <i>TK2</i> mutations
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial DNA depletion syndrome; Myopathy; Thymidine kinase 2; TK2; Mitochondrial myopathy
ID mtdna depletion; thymidine kinase; coenzyme q(10); gene; deletions; myopathy; muscle; defects
AB The mitochondrial DNA (mtDNA) depletion syndrome is a genetically heterogeneous group of diseases caused by nuclear gene mutations and secondary reduction in mtDNA copy number. We describe a patient with progressive muscle weakness and increased creatine kinase and lactate levels. Muscle weakness was first noted at age 1.5 years and he died of respiratory failure and bronchopneumonia at age 3.5 years. The muscle biopsy showed dystrophic features with ragged red fibers and numerous cytochrome c oxidase (COX)-negative fibers. qPCR analysis demonstrated depletion of mtDNA and sequence analysis of the mitochondrial thymidine kinase 2 (TK2) gene revealed two novel heterozygous variants, c.332C > T, p.(T111I) and c.156 + 5G > C. Quantitative analysis of mtDNA in single muscle fibers demonstrated that COX-deficient fibers showed more pronounced depletion of mtDNA when compared with fibers with residual COX activity (P < 0.01, n = 25). There was no evidence of manifestations from other organs than skeletal muscle although there was an apparent reduction of mtDNA copy number also in liver. The patient showed a pronounced, albeit transient, improvement in muscle strength after onset of treatment with coenzyme Q10, asparaginase, and increased energy intake, suggesting that nutritional modulation may be a therapeutic option in myopathic mtDNA depletion syndrome. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Roos, S.; Lindgren, U.; Moslemi, A. R.; Oldfors, A.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol, SE-41345 Gothenburg, Sweden.
   [Ehrstedt, C.] Uppsala Univ, Childrens Hosp, Dept Womens & Childrens Hlth, Uppsala, Sweden.
C3 University of Gothenburg; Uppsala University
RP Roos, S (corresponding author), Univ Gothenburg, Inst Biomed, Dept Pathol, Gula Straket 8, SE-41345 Gothenburg, Sweden.
EM sara.roos@gu.se
FU Swedish Research Council [07122]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; Lung GO Sequencing Project [HL-102923]
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Betts MJ, 2002, BIOINFORMATICS GENET, V0, P289
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Carrozzo R, 2003, HUM MUTAT, V21, P0, DOI 10.1002/humu.9135
   Collins J, 2009, NEUROMUSCULAR DISORD, V19, P784, DOI 10.1016/j.nmd.2009.08.002
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Johansson K, 2001, NAT STRUCT BIOL, V8, P616, DOI 10.1038/89661
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   MarinGarcia J, 1997, J INHERIT METAB DIS, V20, P674, DOI 10.1023/A:1005322409330
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   Montero R, 2013, MITOCHONDRION, V13, P337, DOI 10.1016/j.mito.2013.04.001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morava E, 2006, J INHERIT METAB DIS, V29, P589, DOI 10.1007/s10545-006-0227-x
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Pohjoismäki JLO, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010426
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   Poulton Joanna, 2009, NEUROMUSCUL DISORD, V19, P439, DOI 10.1016/j.nmd.2009.04.009
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saada-Reisch A, 2004, NUCLEOS NUCLEOT NUCL, V23, P1205, DOI 10.1081/NCN-200027480
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Santorelli FM, 2002, NEUROMUSCULAR DISORD, V12, P56, DOI 10.1016/S0960-8966(01)00248-6
   Sofou K, 2012, EUR J PAEDIATR NEURO, V16, P379, DOI 10.1016/j.ejpn.2011.12.006
   Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Zhang SL, 2010, MOL GENET METAB, V99, P53, DOI 10.1016/j.ymgme.2009.09.003
NR 43
TC 10
Z9 14
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD AUG 15
PY 2014
VL 24
IS 8
BP 713
EP 720
DI 10.1016/j.nmd.2014.05.009
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AN1BH
UT WOS:000340317200009
PM 24953930
DA 2024-11-01
ER

PT J
AU Copeland, WC
AF Copeland, William C.
TI Defects of Mitochondrial DNA Replication
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE Alpers syndrome; ataxia-neuropathy; DNA polymerase; mitochondrial DNA depletion syndrome; mitochondrial DNA replication; POLG; progressive external ophthalmoplegia
ID progressive external ophthalmoplegia; recessive twinkle mutations; polymerase-gamma; multiple deletions; accessory subunit; disease mutations; polg mutations; saccharomyces-cerevisiae; exonuclease activity; phenotypic spectrum
AB Mitochondrial DNA is replicated by DNA polymerase in concert with accessory proteins such as the mitochondrial DNA helicase, single-stranded DNA binding protein, topoisomerase, and initiating factors. Defects in mitochondrial DNA replication or nucleotide metabolism can cause mitochondrial genetic diseases due to mitochondrial DNA deletions, point mutations, or depletion, which ultimately cause loss of oxidative phosphorylation. These genetic diseases include mitochondrial DNA depletion syndromes such as Alpers or early infantile hepatocerebral syndromes, and mitochondrial DNA deletion disorders, such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy. This review focuses on our current knowledge of genetic defects of mitochondrial DNA replication (POLG, POLG2, C10orf2, and MGME1) that cause instability of mitochondrial DNA and mitochondrial disease.
C1 NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, POB 12233, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU National Institute of Environmental Health Sciences, National Institutes of Health [ES 065078, ES 065080]; National Institute of Neurological Disorders and Stroke [R13NS04925]
CR Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Cohen BH, 1997, POLG RELATED DISORDE, V0, P0
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 78
TC 37
Z9 43
U1 2
U2 53
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD SEP 15
PY 2014
VL 29
IS 9
BP 1216
EP 1224
DI 10.1177/0883073814537380
PG 9
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA AP1FK
UT WOS:000341812400014
PM 24985751
DA 2024-11-01
ER

PT J
AU Dai, Y
   Zheng, KN
   Clark, J
   Swerdlow, RH
   Pulst, SM
   Sutton, JP
   Shinobu, LA
   Simon, DK
AF Dai, Ying
   Zheng, Kangni
   Clark, Joanne
   Swerdlow, Russell H.
   Pulst, Stefan M.
   Sutton, James P.
   Shinobu, Leslie A.
   Simon, David K.
TI Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID hereditary optic neuropathy; mtdna mutations; oxidative stress; skeletal-muscle; gene-therapy; cybrid cells; autophagy; mitophagy; disease; cancer
AB Mitochondrial DNA(mtDNA) mutations cause a variety of mitochondrial disorders for which effective treatments are lacking. Emerging data indicate that selective mitochondrial degradation through autophagy (mitophagy) plays a critical role in mitochondrial quality control. Inhibition of mammalian target of rapamycin (mTOR) kinase activity can activate mitophagy. To test the hypothesis that enhancing mitophagy would drive selection against dysfunctional mitochondria harboring higher levels of mutations, thereby decreasing mutation levels over time, we examined the impact of rapamycin on mutation levels in a human cytoplasmic hybrid (cybrid) cell line expressing a heteroplasmic mtDNA G11778A mutation, the most common cause of Leber's hereditary optic neuropathy. Inhibition of mTORC1/S6 kinase signaling by rapamycin induced colocalization of mitochondria with autophagosomes, and resulted in a striking progressive decrease in levels of the G11778A mutation and partial restoration of ATP levels. Rapamycin-induced upregulation of mitophagy was confirmed by electron microscopic evidence of increased autophagic vacuoles containing mitochondria-like organelles. The decreased mutational burden was not due to rapamycin-induced cell death or mtDNA depletion, as there was no significant difference in cytotoxicity/apoptosis or mtDNA copy number between rapamycin and vehicle treated cells. These data demonstrate the potential for pharmacological inhibition of mTOR kinase activity to activate mitophagy as a strategy to drive selection against a heteroplasmic mtDNA G11778A mutation and raise the exciting possibility that rapamycin may have therapeutic potential for the treatment of mitochondrial disorders associated with heteroplasmic mtDNA mutations, although further studies are needed to determine if a similar strategy will be effective for other mutations and other cell types.
C1 [Dai, Ying; Zheng, Kangni; Clark, Joanne; Simon, David K.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.
   [Dai, Ying; Zheng, Kangni; Clark, Joanne; Shinobu, Leslie A.; Simon, David K.] Harvard Univ, Sch Med, Boston, MA 02215 USA.
   [Swerdlow, Russell H.] Univ Kansas, Sch Med, Dept Neurol, Kansas City, KS 66160 USA.
   [Swerdlow, Russell H.] Univ Kansas, Sch Med, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA.
   [Swerdlow, Russell H.] Univ Kansas, Sch Med, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA.
   [Pulst, Stefan M.] Univ Utah, Dept Neurol, Salt Lake City, UT 84132 USA.
   [Sutton, James P.] Pacific Neurosci Med Grp, Oxnard, CA 93030 USA.
   [Shinobu, Leslie A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02215 USA.
C3 Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Utah System of Higher Education; University of Utah; Harvard University; Massachusetts General Hospital
RP Dai, Y (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Room CLS 628, Boston, MA 02215 USA.
EM ydai@bidmc.harvard.edu
FU National Institute of Neurological Disorders and Stroke [1R21NS077758]; United Mitochondrial Disease Foundation [UMDF11-095]
CR Adhya S, 2011, MITOCHONDRION, V11, P839, DOI 10.1016/j.mito.2011.06.003
   Bakker A, 2000, PEDIATR RES, V48, P143, DOI 10.1203/00006450-200008000-00005
   Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Chu CT, 2010, HUM MOL GENET, V19, PR28, DOI 10.1093/hmg/ddq143
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   de Vries RLA, 2012, AUTOPHAGY, V8, P699, DOI 10.4161/auto.19470
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Geoerger B, 2001, CANCER RES, V61, P1527
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7
   Jefferies HB, 1997, EMBO J, V16, P3693
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Mahalati K, 2001, CLIN PHARMACOKINET, V40, P573, DOI 10.2165/00003088-200140080-00002
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Newman NJ, 2002, J NEURO-OPHTHALMOL, V22, P257, DOI 10.1097/00041327-200212000-00001
   NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021
   Pan T, 2009, NEUROSCIENCE, V164, P541, DOI 10.1016/j.neuroscience.2009.08.014
   Peterson RT, 1998, CURR BIOL, V8, PR248, DOI 10.1016/S0960-9822(98)70152-6
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Sangatsuda Y, 2012, MITOCHONDRION, V12, P617, DOI 10.1016/j.mito.2012.10.002
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Simon DK, 1999, ANNU REV MED, V50, P111
   SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tashima K, 2009, AM J PHYSIOL-GASTR L, V296, PG319, DOI 10.1152/ajpgi.90355.2008
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyler B, 2011, NEURO-ONCOLOGY, V13, P700, DOI 10.1093/neuonc/nor050
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Yano T, 2010, INT J MOL MED, V25, P153, DOI 10.3892/ijmm_00000325
   Zhang CF, 1998, HUM MUTAT, V11, P360
NR 52
TC 61
Z9 72
U1 0
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD FEB 1
PY 2014
VL 23
IS 3
BP 637
EP 647
DI 10.1093/hmg/ddt450
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AA1FK
UT WOS:000330841700006
PM 24101601
DA 2024-11-01
ER

PT J
AU Mercer, JR
AF Mercer, John R.
TI Mitochondrial bioenergetics and therapeutic intervention in cardiovascular disease
SO PHARMACOLOGY & THERAPEUTICS
LA English
DT Review
DE Vascular smooth muscle cell; Mitochondria; Energetic; Fluxomics; TALENS; Heteroplasmy
ID ubiquitin-proteasome system; smooth-muscle-cells; activated protein-kinase; ischemia-reperfusion injury; mtdna copy number; dna-damage; atherosclerotic plaque; intraplaque hemorrhage; ataxia-telangiectasia; respiratory-chain
AB Cardiovascular disease remains the commonest form of mortality and morbidity in the Western World. It accounts for more deaths than the combined incidence of all cancers. There remains an urgency to identify and translate therapies to reduce the effects of this disease and its associated co-morbidities. Atherosclerotic disease accounts for over two thirds of all cardiovascular related deaths. Arterial vessel wall plaques rupture and cause death due to loss of integrity of the overlaying vascular smooth muscle cell (VSMC) cap. Although plaques contain a heterogeneous pool of different cell types, it is the VSMCs that by their nature are responsible for rupture. VSMC are the primary source of extracellular matrix and collagen and it has been suggested that loss of viability and vitality of these cells contributes to plaque vulnerability and rupture. While DNA damage has long been associated with atherosclerotic plaques only relatively recently has the contribution of mitochondrial DNA damage been suggested to play a role. The mitochondrial respiratory chain is a source of ATP that the cell requires for all its energetic functions but is also a source of free radicals that produce reactive species (RS). While these RS exacerbate DNA damage and attack lipids and proteins, it is the loss of ATP that may ultimately be more detrimental. Therapeutic intervention for mitochondria dysfunction is one route on alleviating this burden. Finding alternative sources of ATP synthesis by energetic reconfiguration may also provide a vital link in delaying the kinetics of plaque rupture. (C) 2013 Elsevier Inc. All rights reserved.
C1 Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland.
C3 University of Glasgow
RP Mercer, JR (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.
EM john.mercer@glasgow.ac.uk
CR Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com
   Amaral S, 2008, CURR DIABETES REV, V4, P46, DOI 10.2174/157339908783502398
   Bacman SR, 2007, METHOD CELL BIOL, V80, P503, DOI 10.1016/S0091-679X(06)80025-7
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106
   Bock H H, 2007, HANDB EXP PHARMACOL, V0, P407
   Calise J, 2013, AM J PHYSIOL-HEART C, V304, PH337, DOI 10.1152/ajpheart.00604.2012
   Caroppi P, 2009, CURR MED CHEM, V16, P4058, DOI 10.2174/092986709789378206
   Cascante M, 2008, ESSAYS BIOCHEM, V45, P67, DOI 10.1042/BSE0450067
   Catalano D, 2006, BMC BIOINFORMATICS, V7, P0, DOI 10.1186/1471-2105-7-36
   Chan NC, 2011, AUTOPHAGY, V7, P771, DOI 10.4161/auto.7.7.15453
   Chan NN, 2001, J AM COLL CARDIOL, V38, P1814, DOI 10.1016/S0735-1097(01)01669-2
   Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212
   Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459
   Cochemé HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003
   Conley KE, 2007, EXERC SPORT SCI REV, V35, P43
   DSouza AD, 2013, MOL THER, V21, P42, DOI 10.1038/mt.2012.203
   Dandapani M, 2013, BIOCHEM SOC T, V41, P687, DOI 10.1042/BST20120351
   DAVIES MJ, 1985, BRIT HEART J, V53, P363
   de Grey ADNJ, 2002, EUR J BIOCHEM, V269, P1995, DOI 10.1046/j.1432-1033.2002.02866.x
   Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739
   Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196
   Gawaz M, 1998, CIRCULATION, V98, P1164, DOI 10.1161/01.CIR.98.12.1164
   Giorgi C, 2011, MITOCHONDRION, V0, P0
   Giunta S, 2011, CELL CYCLE, V10, P1215, DOI 10.4161/cc.10.8.15334
   Graham D, 2009, HYPERTENSION, V54, P322, DOI 10.1161/HYPERTENSIONAHA.109.130351
   Gredilla Ricardo, 2010, J AGING RES, V2011, P257093, DOI 10.4061/2011/257093
   Grüning NM, 2011, CELL METAB, V14, P415, DOI 10.1016/j.cmet.2011.06.017
   Harrison CM, 2010, ENV HLTH PERSPECT, V119, P676
   Herrmann J, 2010, CARDIOVASC RES, V85, P291, DOI 10.1093/cvr/cvp333
   Hosseini SH, 2007, AM J PATHOL, V170, P865, DOI 10.2353/ajpath.2007.060655
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200
   Kim Y, 2013, NAT METHODS, V10, P185, DOI 10.1038/NMETH.2364
   KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0
   Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007
   Launay N, 2013, BRAIN, V136, P891, DOI 10.1093/brain/aws370
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Levi F, 2009, EUR J CARDIOV PREV R, V16, P333, DOI 10.1097/HJR.0b013e328325d67d
   LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844
   Linden MD, 2010, INT J BIOCHEM CELL B, V42, P1762, DOI 10.1016/j.biocel.2010.07.012
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Mahmoudi M, 2006, CARDIOVASC RES, V71, P259, DOI 10.1016/j.cardiores.2006.03.002
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Marfella R, 2008, J GERONTOL A-BIOL, V63, P200, DOI 10.1093/gerona/63.2.200
   Marrache S, 2013, P NATL ACAD SCI USA, V110, P9445, DOI 10.1073/pnas.1301929110
   Mathers CD, 2006, PLOS MED, V3, P0, DOI 10.1371/journal.pmed.0030442
   Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc
   Matthews PM, 1997, ITAL J NEUROL SCI, V18, P341, DOI 10.1007/BF02048237
   Mercer JR, 2011, FREE RADIC BIOL MED, V0, P0, DOI DOI 10.1016/J.FREERADBI0MED.2011.1011.1026
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Moreno C, 2011, HYPERTENSION, V57, P614, DOI 10.1161/HYPERTENSIONAHA.110.163840
   Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Papworth M, 2006, GENE, V366, P27, DOI 10.1016/j.gene.2005.09.011
   Prime TA, 2012, FREE RADICAL BIO MED, V53, P544, DOI 10.1016/j.freeradbiomed.2012.05.033
   Prime TA, 2009, P NATL ACAD SCI USA, V106, P10764, DOI 10.1073/pnas.0903250106
   Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062
   Ralser M, 2009, NAT BIOTECHNOL, V27, P604, DOI 10.1038/nbt0709-604
   Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009
   Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103
   Ross GF, 2003, BIOCONJUGATE CHEM, V14, P962, DOI 10.1021/bc034050f
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x
   Shanahan CM, 1998, ARTERIOSCL THROM VAS, V18, P333, DOI 10.1161/01.ATV.18.3.333
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Spelbrink JN, 1997, CURR GENET, V32, P115, DOI 10.1007/s002940050255
   Srivastava RAK, 2012, J LIPID RES, V53, P2490, DOI 10.1194/jlr.R025882
   Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727
   Suo Qi-Feng, 2011, SICHUAN DA XUE XUE BAO YI XUE BAN, V42, P610
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509
   Taylor RC, 2011, CSH PERSPECT BIOL, V3, P0, DOI 10.1101/cshperspect.a004440
   Teng ZZ, 2012, ATHEROSCLEROSIS, V223, P321, DOI 10.1016/j.atherosclerosis.2012.06.015
   Thorp E, 2009, ARTERIOSCL THROM VAS, V29, P169, DOI 10.1161/ATVBAHA.108.176495
   Tosatol V, 2013, FRONT ONCOL, V2, P0, DOI 10.3389/fonc.2012.00212
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18
   Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773
   Weissberg PL, 1996, LANCET, V347, P305, DOI 10.1016/S0140-6736(96)90472-9
   Weissig V, 2011, PHARM RES-DORDR, V28, P2657, DOI 10.1007/s11095-011-0556-9
   Winter G, 2012, ENV MICROBIOL, V0, P0
   Xu QA, 2010, J CELL MOL MED, V14, P2604, DOI 10.1111/j.1582-4934.2010.01179.x
   Yamano K, 2008, J BIOL CHEM, V283, P27325, DOI 10.1074/jbc.M805249200
   Yu HX, 2011, ARTERIOSCL THROM VAS, V31, P1291, DOI 10.1161/ATVBAHA.110.218578
   Zhang YY, 2012, MOL CELL BIOCHEM, V368, P69, DOI 10.1007/s11010-012-1344-5
NR 96
TC 22
Z9 24
U1 0
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0163-7258
EI 
J9 PHARMACOL THERAPEUT
JI Pharmacol. Ther.
PD JAN 15
PY 2014
VL 141
IS 1
BP 13
EP 20
DI 10.1016/j.pharmthera.2013.07.011
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 290PY
UT WOS:000329772000002
PM 23911986
DA 2024-11-01
ER

PT J
AU Jeong, MH
   Kim, JH
   Seo, KS
   Kwak, TH
   Park, WJ
AF Jeong, Moon Hee
   Kim, Jin Hwan
   Seo, Kang-sik
   Kwak, Tae Hwan
   Park, Woo Jin
TI β-Lapachone attenuates mitochondrial dysfunction in MELAS cybrid cells
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE beta-Lapachone; NQO1; MELAS; Mitochondria
ID protein-synthesis; disease; disorders; sirtuins; dna; fibroblasts; activation; expression; mutations; induction
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a mitochondrial disease caused by mutations in the mitochondrial genome. This study investigated the efficacy of B-lapachone (beta-lap), a natural quinone compound, in rescuing mitochondrial dysfunction in MELAS cybrid cells. beta-Lap significantly restored energy production and mitochondrial membrane potential as well as normalized the elevated ROS level in MELAS cybrid cells. Additionally, beta-lap reduced lactic acidosis and restored glucose uptake in the MELAS cybrid cells. Finally, beta-lap activated Sirt1 by increasing the intracellular NAD(+)/NADH ratio, which was accompanied by increased mtDNA content. Two other quinone compounds (idebenone and CoQ10) that have rescued mitochondrial dysfunction in previous studies of MELAS cybrid cells had a minimal effect in the current study. Taken together, these results demonstrated that beta-lap may provide a novel therapeutic modality for the treatment of MELAS. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Jeong, Moon Hee; Park, Woo Jin] Gwangju Inst Sci & Technol, Coll Life Sci, Kwangju 500712, South Korea.
   [Kim, Jin Hwan; Seo, Kang-sik; Kwak, Tae Hwan] KT&G Life Sci Corp, R&D Ctr, Suwon, South Korea.
C3 Gwangju Institute of Science & Technology (GIST); Samsung
RP Park, WJ (corresponding author), Gwangju Inst Sci & Technol, Coll Life Sci, 123 Cheomdan Gwagiro, Kwangju 500712, South Korea.
EM woojinpark@me.com
FU Global Research Laboratory Program of the Korean Ministry of Education, Science and Technology [M6-0605-00-0001]; Systems Biology Infrastructure Establishment Program of GIST
CR Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486
   Haefeli RH, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0017963
   Hussein Ahmed, 2009, EUR J INTERN MED, V20, Pe114, DOI 10.1016/j.ejim.2008.09.018
   Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183
   Jacobs HT, 2003, HUM MOL GENET, V12, PR293, DOI 10.1093/hmg/ddg285
   Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Jeong MH, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0091039
   Kim SY, 2009, CIRC RES, V104, P842, DOI 10.1161/CIRCRESAHA.108.189837
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lazzarino G, 2003, ANAL BIOCHEM, V322, P51, DOI 10.1016/j.ab.2003.07.013
   Lee JS, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0047122
   Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002
   Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140
   Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416
   Rodríguez-Hernández A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174
   Shin BH, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064953
   Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Wang CH, 2013, FEBS J, V280, P1039, DOI 10.1111/febs.12096
   Woo HJ, 2006, J MED FOOD, V9, P161, DOI 10.1089/jmf.2006.9.161
   Wuerzberger SM, 1998, CANCER RES, V58, P1876
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 33
TC 11
Z9 12
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 21
PY 2014
VL 454
IS 3
BP 417
EP 422
DI 10.1016/j.bbrc.2014.10.093
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AX1EJ
UT WOS:000346690600011
PM 25451262
DA 2024-11-01
ER

PT J
AU Sandford, E
   Burmeister, M
AF Sandford, Erin
   Burmeister, Margit
TI Genes and Genetic Testing in Hereditary Ataxias
SO GENES
LA English
DT Review
DE ataxia; genetics; pathways; testing
ID machado-joseph-disease; dominant cerebellar-ataxia; oculomotor apraxia type-2; spinocerebellar ataxia; episodic ataxia; ubiquitin ligase; repeat expansion; diagnostic-tool; strand breaks; channel gene
AB Ataxia is a neurological cerebellar disorder characterized by loss of coordination during muscle movements affecting walking, vision, and speech. Genetic ataxias are very heterogeneous, with causative variants reported in over 50 genes, which can be inherited in classical dominant, recessive, X-linked, or mitochondrial fashion. A common mechanism of dominant ataxias is repeat expansions, where increasing lengths of repeated DNA sequences result in non-functional proteins that accumulate in the body causing disease. Greater understanding of all ataxia genes has helped identify several different pathways, such as DNA repair, ubiquitination, and ion transport, which can be used to help further identify new genes and potential treatments. Testing for the most common mutations in these genes is now clinically routine to help with prognosis and treatment decisions, but next generation sequencing will revolutionize how genetic testing will be done. Despite the large number of known ataxia causing genes, however, many individuals with ataxia are unable to obtain a genetic diagnosis, suggesting that more genes need to be discovered. Utilization of next generation sequencing technologies, expression studies, and increased knowledge of ataxia pathways will aid in the identification of new ataxia genes.
C1 [Sandford, Erin; Burmeister, Margit] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.
   [Burmeister, Margit] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.
   [Burmeister, Margit] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.
   [Burmeister, Margit] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan
RP Burmeister, M (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.
EM esandfor@umich.edu; margit@umich.edu
FU National Institutes of Health (NIH) [R01-NS078560]
CR Andersson PL, 2013, NURS ETHICS, V20, P189, DOI 10.1177/0969733012452686
   Archibald AD, 2013, AM J MED GENET A, V161A, P48, DOI 10.1002/ajmg.a.35674
   Baloh Robert W, 2012, HANDB CLIN NEUROL, V103, P595, DOI 10.1016/B978-0-444-51892-7.00042-5
   Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005
   Bertini E, 2000, AM J MED GENET, V92, P53, DOI 10.1002/(SICI)1096-8628(20000501)92:1<53::AID-AJMG9>3.0.CO;2-F
   Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680
   Bidichandani SI, 1997, AM J HUM GENET, V60, P1251
   Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110
   BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771
   Castelnovo G, 2000, J NEUROL NEUROSUR PS, V69, P693, DOI 10.1136/jnnp.69.5.693
   Chapdelaine P, 2013, MOL THER-NUCL ACIDS, V2, P0, DOI 10.1038/mtna.2013.41
   Cleary JD, 2013, HUM MOL GENET, V22, PR45, DOI 10.1093/hmg/ddt371
   Conroy J, 2014, EUR J HUM GENET, V22, P505, DOI 10.1038/ejhg.2013.173
   Coutinho P, 2013, JAMA NEUROL, V70, P746, DOI 10.1001/jamaneurol.2013.1707
   Cruz-Mariño T, 2013, J COMMUN GENET, V4, P451, DOI 10.1007/s12687-013-0147-z
   Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1
   Doi H, 2013, INTERNAL MED, V52, P1629, DOI 10.2169/internalmedicine.52.0252
   Dombrowski C, 2002, HUM MOL GENET, V11, P371, DOI 10.1093/hmg/11.4.371
   Duarri A, 2012, ANN NEUROL, V72, P870, DOI 10.1002/ana.23700
   Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452
   Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6
   Dussault I, 1998, MECH DEVELOP, V70, P147, DOI 10.1016/S0925-4773(97)00187-1
   El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314
   Embiruçu EK, 2009, ARQ NEURO-PSIQUIAT, V67, P1143, DOI 10.1590/S0004-282X2009000600036
   Erez A, 2010, AM J MED GENET A, V152A, P1774, DOI 10.1002/ajmg.a.33432
   Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909
   Faruq M, 2014, CLIN GENET, V86, P335, DOI 10.1111/cge.12279
   Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6
   FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5
   HABERHAUSEN G, 1995, J NEUROL SCI, V132, P71, DOI 10.1016/0022-510X(95)90927-I
   Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127
   Hammer MB, 2013, EUR J NEUROL, V20, P486, DOI 10.1111/j.1468-1331.2012.03883.x
   Hartley JN, 2012, CASE REP PEDIAT, V2012, P0, DOI 10.1155/2012/303096
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Huang LJ, 2012, ORPHANET J RARE DIS, V7, P0, DOI 10.1186/1750-1172-7-67
   Iwaki A, 2008, J MED GENET, V45, P32, DOI 10.1136/jmg.2007.053942
   Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a
   Jia DD, 2012, INT J NEUROSCI, V122, P560, DOI 10.3109/00207454.2012.690796
   Joo BE, 2012, CEREBELLUM, V11, P733, DOI 10.1007/s12311-011-0332-8
   Ju H, 2013, J NEUROSCI, V33, P9328, DOI 10.1523/JNEUROSCI.3465-12.2013
   KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221
   Knight MA, 2003, NEUROBIOL DIS, V13, P147, DOI 10.1016/S0969-9961(03)00029-9
   Koht J, 2007, ACTA NEUROL SCAND, V115, P76, DOI 10.1111/j.1600-0404.2007.00853.x
   Konno A, 2014, CEREBELLUM, V13, P29, DOI 10.1007/s12311-013-0516-5
   Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038
   Le Ber I, 2004, BRAIN, V127, P759, DOI 10.1093/brain/awh080
   Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297
   Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014
   Lee YC, 2012, ANN NEUROL, V72, P859, DOI 10.1002/ana.23701
   Lhatoo SD, 2001, NEUROLOGY, V56, P1776, DOI 10.1212/WNL.56.12.1776
   Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032
   Lu JP, 2011, J BIOL CHEM, V286, P24426, DOI 10.1074/jbc.M111.251983
   Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993
   Mitsui J, 2013, NEW ENGL J MED, V369, P233, DOI 10.1056/NEJMoa1212115
   Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189
   Nemeth AH, 2013, BRAIN, V136, P3106, DOI 10.1093/brain/awt236
   Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Ohba C, 2013, NEUROGENETICS, V14, P225, DOI 10.1007/s10048-013-0375-8
   Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2
   ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221
   Paulson HL, 2009, J NEURO-OPHTHALMOL, V29, P227, DOI 10.1097/WNO0b013e3181b416de
   Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269
   Regal JA, 2013, HUM MOL GENET, V22, P5146, DOI 10.1093/hmg/ddt368
   Rodriguez-Revenga L, 2009, EUR J HUM GENET, V17, P1359, DOI 10.1038/ejhg.2009.51
   ROUSSEAU F, 1995, AM J HUM GENET, V57, P1006
   Sailer A, 2012, CURR NEUROL NEUROSCI, V12, P227, DOI 10.1007/s11910-012-0267-6
   Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277
   Sawyer SL, 2014, HUM MUTAT, V35, P45, DOI 10.1002/humu.22451
   SCHWARTZ CE, 1994, AM J MED GENET, V51, P400, DOI 10.1002/ajmg.1320510419
   Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036
   Shi CH, 2014, HUM MOL GENET, V23, P1013, DOI 10.1093/hmg/ddt497
   STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0
   Sun Y, 2013, HUM MUTAT, V34, P706, DOI 10.1002/humu.22292
   Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042
   Suraweera A, 2009, HUM MOL GENET, V18, P3384, DOI 10.1093/hmg/ddp278
   Suzuki K, 2012, NEUROBIOL DIS, V46, P336, DOI 10.1016/j.nbd.2012.01.014
   Synofzik M, 2012, CEREBELLUM, V11, P1002, DOI 10.1007/s12311-012-0378-2
   Takahashi T, 2007, NUCLEIC ACIDS RES, V35, P3797, DOI 10.1093/nar/gkm158
   Tanaka K, 2013, J HUM GENET, V58, P560, DOI 10.1038/jhg.2013.34
   Tassone F, 2012, GENOME MED, V4, P0, DOI 10.1186/gm401
   Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026
   Valdmanis PN, 2011, BRAIN, V134, P602, DOI 10.1093/brain/awq329
   van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758
   Winkelmann J, 2012, HUM MOL GENET, V21, P2205, DOI 10.1093/hmg/dds035
   Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555
   Zamba-Papanicolaou E, 2009, ACTA MYOL, V28, P24
   Zanni G, 2012, P NATL ACAD SCI USA, V109, P14514, DOI 10.1073/pnas.1207488109
   Zhou T, 2005, NUCLEIC ACIDS RES, V33, P289, DOI 10.1093/nar/gki170
   Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62
   Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108
NR 98
TC 25
Z9 25
U1 0
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4425
EI 
J9 GENES-BASEL
JI Genes
PD SEP 15
PY 2014
VL 5
IS 3
BP 586
EP 603
DI 10.3390/genes5030586
PG 18
WC Genetics & Heredity
SC Genetics & Heredity
GA CA4EU
UT WOS:000348857800007
PM 25055202
DA 2024-11-01
ER

PT J
AU Vartiainen, S
   Chen, S
   George, J
   Tuomela, T
   Luoto, KR
   O'Dell, KMC
   Jacobs, HT
AF Vartiainen, Suvi
   Chen, Shanjun
   George, Jack
   Tuomela, Tea
   Luoto, Kaisa R.
   O'Dell, Kevin M. C.
   Jacobs, Howard T.
TI Phenotypic rescue of a <i>Drosophila</i> model of mitochondrial ANT1 disease
SO DISEASE MODELS & MECHANISMS
LA English
DT Article
DE Adenine nucleotide translocase; Mitochondrial disease; Mitochondrial biogenesis; Alternative oxidase
ID adenine-nucleotide translocase; progressive external ophthalmoplegia; alternative-oxidase; gene-expression; nuclear genes; oxidative-phosphorylation; neuronal failure; sengers-syndrome; cell-migration; protein s12
AB A point mutation in the Drosophila gene that codes for the major adult isoform of adenine nuclear translocase (ANT) represents a model for human diseases that are associated with ANT insufficiency [stress-sensitive B-1 (sesB(1))]. We characterized the organismal, bioenergetic and molecular phenotype of sesB(1) flies then tested strategies to compensate the mutant phenotype. In addition to developmental delay and mechanical-stress-induced seizures, sesB(1) flies have an impaired response to sound, defective male courtship, female sterility and curtailed lifespan. These phenotypes, excluding the latter two, are shared with the mitoribosomal protein S12 mutant, tko(25t). Mitochondria from sesB(1) adults showed a decreased respiratory control ratio and downregulation of cytochrome oxidase. sesB(1) adults exhibited ATP depletion, lactate accumulation and changes in gene expression that were consistent with a metabolic shift towards glycolysis, characterized by activation of lactate dehydrogenase and anaplerotic pathways. Females also showed downregulation of many genes that are required for oogenesis, and their eggs, although fertilized, failed to develop to the larval stages. The sesB(1) phenotypes of developmental delay and mechanical-stress-induced seizures were alleviated by an altered mitochondrial DNA background. Female sterility was substantially rescued by somatic expression of alternative oxidase (AOX) from the sea squirt Ciona intestinalis, whereas AOX did not alleviate developmental delay. Our findings illustrate the potential of different therapeutic strategies for ANT-linked diseases, based on alleviating metabolic stress.
C1 [Vartiainen, Suvi; Chen, Shanjun; George, Jack; Tuomela, Tea; Luoto, Kaisa R.; Jacobs, Howard T.] Univ Tampere, BioMediTech, FI-33014 Tampere, Finland.
   [Vartiainen, Suvi; Chen, Shanjun; George, Jack; Tuomela, Tea; Luoto, Kaisa R.; Jacobs, Howard T.] Univ Tampere, Tampere Univ Hosp, FI-33014 Tampere, Finland.
   [O'Dell, Kevin M. C.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.
   [Jacobs, Howard T.] Univ Helsinki, Res Program Mol Neurol, FI-00014 Helsinki, Finland.
C3 Tampere University; Tampere University; Tampere University Hospital; University of Glasgow; University of Helsinki
RP Jacobs, HT (corresponding author), Univ Tampere, BioMediTech, FI-33014 Tampere, Finland.
EM howard.t.jacobs@uta.fi
FU Academy of Finland (FinMIT Centre of Excellence); Sigrid Juselius Foundation; Tampere University Hospital Medical Research Fund; European Research Council [2326738]; EU [IOF 255472]
CR Barca E, 2013, NEUROL SCI, V34, P217, DOI 10.1007/s10072-012-0976-2
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890
   Charlier C, 2012, BMC GENOMICS, V13, P0, DOI 10.1186/1471-2164-13-560
   Chaturvedi RK, 2013, MOL CELL NEUROSCI, V55, P101, DOI 10.1016/j.mcn.2012.11.011
   Chen SJ, 2012, GENETICS, V192, P483, DOI 10.1534/genetics.112.143719
   Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Deng WM, 1998, INT J DEV BIOL, V42, P541
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Dobson SL, 2002, GENETICS, V160, P1087
   El-Khoury R, 2014, BRIT J PHARMACOL, V171, P2243, DOI 10.1111/bph.12570
   El-Khoury R, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003182
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Farhadian SF, 2012, PHYSIOL BEHAV, V105, P544, DOI 10.1016/j.physbeh.2011.09.007
   Fergestad Tim, 2006, GENETICS, V173, P1357, DOI 10.1534/genetics.106.057463
   Fernández-Ayala DJM, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0008549
   Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Forlani G, 2010, HUM MOL GENET, V19, P3114, DOI 10.1093/hmg/ddq214
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Hofer A, 2014, HUM MOL GENET, V23, P2400, DOI 10.1093/hmg/ddt631
   Humphrey DM, 2012, HUM MOL GENET, V21, P2698, DOI 10.1093/hmg/dds096
   Hurd TR, 2012, TRENDS CELL BIOL, V22, P107, DOI 10.1016/j.tcb.2011.11.002
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   Kemppainen E, 2009, MITOCHONDRION, V9, P353, DOI 10.1016/j.mito.2009.07.002
   Kemppainen KK, 2014, HUM MOL GENET, V23, P2078, DOI 10.1093/hmg/ddt601
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Komen JC, 2014, BRIT J PHARMACOL, V171, P1818, DOI 10.1111/bph.12413
   Lee J, 2009, BBA-BIOENERGETICS, V1787, P364, DOI 10.1016/j.bbabio.2009.01.014
   Lomas MF, 2013, CELL REP, V4, P791, DOI 10.1016/j.celrep.2013.07.038
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Michaud Sebastien, 2002, PROG MOL SUBCELL BIOL, V28, P79
   Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7
   Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Narula N, 2011, JACC-CARDIOVASC IMAG, V4, P1, DOI 10.1016/j.jcmg.2010.06.018
   NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9
   Noe N, 2013, MITOCHONDRION, V13, P417, DOI 10.1016/j.mito.2012.12.003
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Parker L, 2011, GENETICS, V187, P523, DOI 10.1534/genetics.110.123299
   PAVLIDIS P, 1994, CELL, V79, P23, DOI 10.1016/0092-8674(94)90397-2
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Phillips MJ, 2010, INVEST OPHTH VIS SCI, V51, P6744, DOI 10.1167/iovs.10-5421
   Poulton JS, 2007, DEV BIOL, V311, P1, DOI 10.1016/j.ydbio.2007.08.030
   Rikhy R, 2003, GENETICS, V165, P1243
   Rorth P, 2000, MOL CELL, V6, P23
   Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9
   ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0
   ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9
   Saada A, 2004, DNA CELL BIOL, V23, P797
   Sanz A, 2010, AGING-US, V2, P200, DOI 10.18632/aging.100137
   Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107
   Shah ZH, 1997, GENE, V204, P55, DOI 10.1016/S0378-1119(97)00521-0
   Sharer JD, 2005, IUBMB LIFE, V57, P607, DOI 10.1080/15216540500217735
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2009, HUM MOL GENET, V18, P1805, DOI 10.1093/hmg/ddp093
   Stein D, 2013, FLY, V7, P161, DOI 10.4161/fly.25141
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Terhzaz S, 2010, PHYSIOL GENOMICS, V41, P33, DOI 10.1152/physiolgenomics.00147.2009
   Tiefenböck SK, 2010, EMBO J, V29, P171, DOI 10.1038/emboj.2009.330
   Toivonen JM, 2001, GENETICS, V159, P241
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Veal E, 2011, ANTIOXID REDOX SIGN, V15, P147, DOI 10.1089/ars.2011.3968
   Wang XW, 2008, HUM MOL GENET, V17, P4036, DOI 10.1093/hmg/ddn306
   Wang Y, 2009, EXP PHYSIOL, V94, P220, DOI 10.1113/expphysiol.2008.044800
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Yamamoto M, 2007, J EXP MED, V204, P2233, DOI 10.1084/jem.20070183
   Zhang HG, 2002, GENETICS, V162, P1283
   Zhang YQ, 1999, GENETICS, V153, P891
NR 78
TC 28
Z9 29
U1 0
U2 10
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND
SN 1754-8403
EI 1754-8411
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD JUN 15
PY 2014
VL 7
IS 6
BP 635
EP 648
DI 10.1242/dmm.016527
PG 14
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA AT5SQ
UT WOS:000345002600005
PM 24812436
DA 2024-11-01
ER

PT J
AU Lin, J
   Zhao, CB
   Lu, JH
   Wang, HJ
   Zhu, WH
   Xi, JY
   Lu, J
   Luo, SS
   Ma, D
   Wang, Y
   Xiao, BG
   Lu, CZ
AF Lin, Jie
   Zhao, Chong-Bo
   Lu, Jia-Hong
   Wang, Hui-Jun
   Zhu, Wen-Hua
   Xi, Jian-Ying
   Lu, Jun
   Luo, Su-Shan
   Ma, Duan
   Wang, Yin
   Xiao, Bao-Guo
   Lu, Chuan-Zhen
TI Novel mutations m.3959G&gt;A and m.3995A&gt;G in mitochondrial gene <i>MT</i>-<i>ND1</i> associated with MELAS
SO MITOCHONDRIAL DNA
LA English
DT Article
DE MELAS; mitochondrial DNA; ND1 gene; novel mutations
ID hereditary optic neuropathy; complex-i; nd1 gene; parkinsons-disease; lactic-acidosis; encephalopathy; identification; haplogroups; sequences; criteria
AB Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) are progressive neurodegenerative disorder associated with polygenetic, maternally inherited mutations in mitochondrial DNA. Approximately 80% of MELAS cases are caused by the mutation m. 3243A>G of the mitochondrial tRNA Leu (UUR) gene (MT-TL1). We reported two probands with MELAS features. Muscle biopsy identified ragged-red fibers (RRF) in Gomori Trichrome staining. A respiratory chain function study showed decreased activity of mitochondrial respiratory chain complex I in both probands. Sequencing of the mitochondrial DNA revealed two novel MT-ND1 gene missense mutations, m. 3959G>A and m. 3995A>G, which are highly conserved among species. Protein secondary structure predictions demonstrated that these mutations may alter the peptide structure and may lead to decreased ND1 gene stability. Our findings suggest that these two novel mutations may contribute to the MELAS phenotypes of the patients in our study.
C1 [Lin, Jie; Zhao, Chong-Bo; Lu, Jia-Hong; Zhu, Wen-Hua; Xi, Jian-Ying; Lu, Jun; Luo, Su-Shan; Lu, Chuan-Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.
   [Wang, Hui-Jun; Ma, Duan] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 200433, Peoples R China.
   [Wang, Yin] Fudan Univ, Huashan Hosp, Dept Neuropathol, Shanghai 200433, Peoples R China.
   [Xiao, Bao-Guo; Lu, Chuan-Zhen] Fudan Univ, Inst Neurol, Shanghai 200433, Peoples R China.
C3 Fudan University; Fudan University; Fudan University; Fudan University
RP Lu, JH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.
EM lujiahong@yahoo.com; duanma@shmu.edu.cn
FU Science and Technology Commission of Shanghai Municipality [10411961300]
CR Bhuvaneswar Chaya G, 2008, PRIM CARE COMPANION J CLIN PSYCHIATRY, V10, P237
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   Campos Y, 1997, BIOCHEM BIOPH RES CO, V238, P323, DOI 10.1006/bbrc.1997.7166
   Cavelier L, 2001, HEREDITAS, V135, P65, DOI 10.1111/j.1601-5223.2001.00065.x
   Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001
   FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I
   Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hao XD, 2013, GENE, V512, P460, DOI 10.1016/j.gene.2012.10.054
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HOWELL N, 1991, AM J HUM GENET, V49, P939
   Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109
   Kim JY, 2002, ANN NEUROL, V51, P630, DOI 10.1002/ana.10177
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Li XY, 2007, GENOMICS, V90, P474, DOI 10.1016/j.ygeno.2007.06.006
   Liang M, 2009, BIOCHEM BIOPH RES CO, V383, P286, DOI 10.1016/j.bbrc.2009.03.097
   McKenzie M, 2011, J MOL BIOL, V414, P413, DOI 10.1016/j.jmb.2011.10.012
   Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003
   NAKAGAWA Y, 1995, BIOCHEM BIOPH RES CO, V209, P664, DOI 10.1006/bbrc.1995.1550
   Oppenheim MLS, 2009, J INHERIT METAB DIS, V32, P269, DOI 10.1007/s10545-009-1061-8
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Shanske S, 2004, MITOCHONDRION, V4, P403, DOI 10.1016/j.mito.2004.07.026
   Sheehan DC, 1987, THEORY AND PRACTICE OF HISTOTECHNOLOGY, V0, P0
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Simon DK, 2003, NEUROGENETICS, V4, P199, DOI 10.1007/s10048-003-0150-3
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236
   Zhang AM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027750
   Zhang ML, 2010, MOL GENET METAB, V101, P192, DOI 10.1016/j.ymgme.2010.07.014
NR 35
TC 17
Z9 19
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1940-1736
EI 1940-1744
J9 MITOCHONDR DNA
JI Mitochondrial DNA
PD FEB 15
PY 2014
VL 25
IS 1
BP 56
EP 62
DI 10.3109/19401736.2013.779259
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA 302FU
UT WOS:000330588500028
PM 23834081
DA 2024-11-01
ER

PT J
AU Grünewald, A
   Lax, NZ
   Rocha, MC
   Reeve, AK
   Hepplewhite, PD
   Rygiel, KA
   Taylor, RW
   Turnbull, DM
AF Gruenewald, Anne
   Lax, Nichola Z.
   Rocha, Mariana C.
   Reeve, Amy K.
   Hepplewhite, Philippa D.
   Rygiel, Karolina A.
   Taylor, Robert W.
   Turnbull, Doug M.
TI Quantitative quadruple-label immunofluorescence of mitochondrial and cytoplasmic proteins in single neurons from human midbrain tissue
SO JOURNAL OF NEUROSCIENCE METHODS
LA English
DT Article
DE Mitochondria; Complex I; Complex IV; Single cell analysis; Midbrain neurons; Immunofluorescent labelling
ID substantia-nigra neurons; complex i deficiency; dna mutations; respiratory-chain; oxidative-phosphorylation; parkinsons-disease; skeletal-muscle; channel vdac; deletions; membrane
AB Background: Respiratory chain (RC) deficiencies are found in primary mtDNA diseases. Focal RC defects are also associated with ageing and neurodegenerative disorders, e.g. in substantia nigra (SN) neurons from Parkinson's disease patients. In mitochondrial disease and ageing, mtDNA mutational loads vary considerably between neurons necessitating single cell-based assessment of RC deficiencies. Evaluating the full extent of RC deficiency within SN neurons is challenging because their size precludes investigations in serial sections. We developed an assay to measure RC abnormalities in individual SN neurons using quadruple immunofluorescence. New method: Using antibodies against subunits of complex I (Cl) and IV, porin and tyrosine hydroxylase together with IgG subtype-specific fluorescent labelled secondary antibodies, we quantified the expression of CI and CIV compared to mitochondrial mass in dopaminergic neurons. CI:porin and CIV:porin ratios were determined relative to a standard control. Results: Quantification of expression of complex subunits in midbrain sections from patients with mtDNA disease and known RC deficiencies consistently showed reduced CI: porin and/or CIV:porin ratios. Comparison with existing method(s): The standard histochemical method to investigate mitochondrial dysfunction, the cytochrome c oxidase/succinate dehydrogenase assay, measures CIV and CH activities. To also study CI in a patient, immunohistology in additional sections, i.e. in different neurons, is required. Our method allows correlation of the expression of CI, CIV and mitochondrial mass at a single cell level. Conclusion: Quantitative quadruple-label immunofluorescence is a reliable tool to measure RC deficiencies in individual neurons that will enable new insights in the molecular mechanisms underlying inherited and acquired mitochondrial dysfunction. 0 2014 The Authors. Published by Elsevier B.V.
C1 [Gruenewald, Anne; Lax, Nichola Z.; Rocha, Mariana C.; Reeve, Amy K.; Hepplewhite, Philippa D.; Rygiel, Karolina A.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Gruenewald, Anne] Med Univ Lubeck, Inst Neurogenet, D-23538 Lubeck, Germany.
C3 Newcastle University - UK; University of Lubeck
RP Turnbull, DM (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM anne.gruenewald@newcastle.ac.uk; nichola.lax@newcastle.ac.uk; m.rocha@newcastle.ac.uk; amy.reeve@newcastle.ac.uk; philippa.hepplewhite@newcastle.ac.uk; karolina.rygiel@newcastle.ac.uk; Robert.taylor@newcastle.ac.uk; doug.turnbull@newcastle.ac.uk
FU German Research Foundation; Newcastle University Centre for Brain Ageing and Vitality; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council [G0700718]; Wellcome Trust Centre for Mitochondrial Research [G906919]; MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK) [G0800674]; UK NIHR Biomedical Research Centre in Age and Age Related Diseases; UK Medical Research Council [G0400074]; MRC [G0400074, G1100540, G0800674, G0900652, MR/K000608/1, G0700718, G0502157] Funding Source: UKRI
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006
   BLACHLYDYSON E, 1994, GENOMICS, V20, P62, DOI 10.1006/geno.1994.1127
   Campbell GR, 2013, MULT SCLER J, V19, P1858, DOI 10.1177/1352458513490547
   Colombini M, 1980, ANN N Y ACAD SCI, V341, P552, DOI 10.1111/j.1749-6632.1980.tb47198.x
   de Vries RLA, 2013, MOL CELL NEUROSCI, V55, P37, DOI 10.1016/j.mcn.2012.07.008
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Flatmark T, 1999, CHEM REV, V99, P2137, DOI 10.1021/cr980450y
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   JOHNSON MA, 1988, J NEUROL SCI, V87, P75, DOI 10.1016/0022-510X(88)90056-1
   Koob AO, 2012, ANAL BIOCHEM, V425, P120, DOI 10.1016/j.ab.2012.02.034
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Mahad DJ, 2009, J NEUROSCI METH, V184, P310, DOI 10.1016/j.jneumeth.2009.08.020
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Romijn HJ, 1999, J HISTOCHEM CYTOCHEM, V47, P229, DOI 10.1177/002215549904700211
   Rowan SL, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0029082
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Sisková Z, 2010, AM J PATHOL, V177, P1411, DOI 10.2353/ajpath.2010.091037
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Tanji K, 2008, METHODS, V46, P274, DOI 10.1016/j.ymeth.2008.09.027
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
NR 27
TC 25
Z9 25
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0270
EI 1872-678X
J9 J NEUROSCI METH
JI J. Neurosci. Methods
PD JUL 30
PY 2014
VL 232
IS 
BP 143
EP 149
DI 10.1016/j.jneumeth.2014.05.026
PG 7
WC Biochemical Research Methods; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA AL4ZW
UT WOS:000339144300018
PM 24880043
DA 2024-11-01
ER

PT J
AU Jung, Y
   Brack, AS
AF Jung, Yunjoon
   Brack, Andrew S.
TI Cellular Mechanisms of Somatic Stem Cell Aging
SO STEM CELLS IN DEVELOPMENT AND DISEASE
LA English
DT Review; Book Chapter
ID nf-kappa-b; mitochondrial-dna mutations; hematopoietic stem; self-renewal; life-span; epigenetic inheritance; telomere dysfunction; mediated autophagy; tissue homeostasis; progenitor cells
AB Tissue homeostasis and regenerative capacity rely on rare populations of somatic stem cells endowed with the potential to self-renew and differentiate. During aging, many tissues show a decline in regenerative potential coupled with a loss of stem cell function. Cells including somatic stem cells have evolved a series of checks and balances to sense and repair cellular damage to maximize tissue function. However, during aging the mechanisms that protect normal cell function begin to fail. In this review, we will discuss how common cellular mechanisms that maintain tissue fidelity and organismal lifespan impact somatic stem cell function. We will highlight context-dependent changes and commonalities that define aging, by focusing on three age-sensitive stem cell compartments: blood, neural, and muscle. Understanding the interaction between extrinsic regulators and intrinsic effectors that operate within different stem cell compartments is likely to have important implications for identifying strategies to improve health span and treat age-related degenerative diseases.
C1 [Jung, Yunjoon; Brack, Andrew S.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.
   [Brack, Andrew S.] Harvard Univ, Sch Med, Boston, MA USA.
   [Brack, Andrew S.] Harvard Stem Cell Inst, Boston, MA USA.
C3 Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University
RP Brack, AS (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.
FU NIAMS NIH HHS [R01 AR060868, R01 AR061002] Funding Source: Medline
CR Adler AS, 2008, CELL CYCLE, V7, P556, DOI 10.4161/cc.7.5.5490
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1
   Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382
   Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017
   Beerman I, 2010, CURR OPIN IMMUNOL, V22, P500, DOI 10.1016/j.coi.2010.06.007
   Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107
   Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007
   BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4
   Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983
   Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024
   Biteau B, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001159
   Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012
   Bocker MT, 2011, BLOOD, V117, PE182, DOI 10.1182/blood-2011-01-331926
   Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002
   Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001
   Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   CARLSON BM, 1989, AM J PHYSIOL, V256, P0
   Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034
   Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x
   Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2
   Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002
   Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438
   Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002
   Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201
   Chen C, 2009, SCI SIGNAL, V2, P0, DOI 10.1126/scisignal.2000559
   Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891
   Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372
   Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Conboy MJ, 2013, AGING CELL, V12, P525, DOI 10.1111/acel.12065
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Didier N, 2012, EMBO MOL MED, V4, P910, DOI 10.1002/emmm.201101075
   Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507
   Ellis RJ, 2002, NATURE, V416, P483, DOI 10.1038/416483a
   Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010
   Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730
   Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043
   Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001
   Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197
   Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008
   Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007
   Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517
   Furutachi S, 2013, EMBO J, V32, P970, DOI 10.1038/emboj.2013.50
   Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433
   Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572
   Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195
   Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X
   Grompe M, 2012, CELL STEM CELL, V10, P685, DOI 10.1016/j.stem.2012.04.006
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   Herranz D, 2010, NAT COMMUN, V1, P0, DOI 10.1038/ncomms1001
   Heslop L, 2000, J CELL SCI, V113, P2299
   Hidalgo I, 2012, CELL STEM CELL, V11, P649, DOI 10.1016/j.stem.2012.08.001
   Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506
   Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578
   Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570
   Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kapetanaki MG, 2013, J PATHOL, V229, P310, DOI 10.1002/path.4122
   KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X
   Kempermann G, 1998, J NEUROSCI, V18, P3206
   Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013
   KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Korhonen P, 1997, NEUROSCI LETT, V225, P61, DOI 10.1016/S0304-3940(97)00190-0
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015
   Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980
   Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228
   Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572
   Li J, 2012, J INVEST DERMATOL, V132, P2681, DOI 10.1038/jid.2012.206
   Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794
   Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016
   Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000
   Lugert Sebastian, 2012, NAT COMMUN, V3, P670, DOI 10.1038/ncomms1670
   Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017
   Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013
   Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109
   Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026
   Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059
   Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784
   Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949
   Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001
   Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060
   Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318
   Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038
   Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145
   Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/j.cell.2005.11.044
   Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789
   Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047
   Navarro S, 2006, MOL THER, V14, P525, DOI 10.1016/j.ymthe.2006.05.018
   Nebbioso A, 2012, MOL ONCOL, V6, P657, DOI 10.1016/j.molonc.2012.09.004
   Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044
   Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875
   Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593
   Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269
   Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025
   Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013
   Paliouras GN, 2012, J NEUROSCI, V32, P15012, DOI 10.1523/JNEUROSCI.2248-12.2012
   Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010
   Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587
   Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655
   Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002
   Pineda JR, 2013, EMBO MOL MED, V5, P548, DOI 10.1002/emmm.201202197
   Pollina EA, 2011, ONCOGENE, V30, P3105, DOI 10.1038/onc.2011.45
   Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035
   Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019
   Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352
   Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002
   Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010
   Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0
   Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015
   Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, PB316, DOI 10.1093/gerona/51A.5.B316
   Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103
   Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001
   Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033
   Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269
   Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608
   Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354
   Smythe GM, 2008, EXP GERONTOL, V43, P550, DOI 10.1016/j.exger.2008.02.005
   So AY, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0019503
   Song ZF, 2012, AGING CELL, V11, P449, DOI 10.1111/j.1474-9726.2012.00802.x
   Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420
   Tomás-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034
   Tóth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618
   Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427
   van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005
   Vaziri H, 1996, EXP GERONTOL, V31, P295, DOI 10.1016/0531-5565(95)02025-X
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030
   Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895
   Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048
   Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385
   Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244
   Yilmaz ÖH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163
   Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004
   Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003
NR 176
TC 50
Z9 55
U1 0
U2 11
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0070-2153
EI 
J9 CURR TOP DEV BIOL
JI Curr. Top. Dev. Biol.
PD JUN 15
PY 2014
VL 107
IS 
BP 405
EP 438
DI 10.1016/B978-0-12-416022-4.00014-7
PG 34
WC Developmental Biology
SC Developmental Biology
GA BA1FN
UT WOS:000332424400014
PM 24439814
DA 2024-11-01
ER

PT J
AU Jackson, CB
   Neuwirth, C
   Hahn, D
   Nuoffer, JM
   Frank, S
   Gallati, S
   Schaller, A
AF Jackson, Christopher B.
   Neuwirth, Christoph
   Hahn, Dagmar
   Nuoffer, J-M
   Frank, Stephan
   Gallati, Sabina
   Schaller, Andre
TI Novel mitochondrial tRNA<SUP>Ile</SUP> m. 4282A&gt;G gene mutation leads to chronic progressive external ophthalmoplegia plus phenotype
SO BRITISH JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID transfer-rna isoleucine; dna point mutation; mtdna mutation; disease; database; patient
AB Background/aim To investigate the underlying pathomechanism in a 33-year-old female Caucasian patient presenting with chronic progressive external ophthalmoplegia (CPEO) plus symptoms. Methods Histochemical anaylsis of skeletal muscle and biochemical measurements of individual oxidative phosphorylation (OXPHOS) complexes. Genetic analysis of mitochondrial DNA in various tissues with subsequent investigation of single muscle fibres for correlation of mutational load. Results The patient's skeletal muscle showed 20% of cytochrome c oxidase-negative fibres and 8% ragged-red fibres. Genetic analysis of the mitochondrial DNA revealed a novel point mutation in the mitochondrial tRNA(Ile) (MTTI) gene at position m. 4282G> A. The heteroplasmy was determined in blood, buccal cells and muscle by restriction fragment length polymorphism (RFLP) combined with a last fluorescent cycle. The total mutational load was 38% in skeletal muscle, but was not detectable in blood or buccal cells of the patient. The phenotype segregated with the mutational load as determined by analysis of single cytochrome c oxidasenegative/ positive fibres by laser capture microdissection and subsequent LFC-RFLP. Conclusions We describe a novel MTTI transition mutation at nucleotide position m. 4282G> A associated with a CPEO plus phenotype. The novel variant at position m. 4282G> A disrupts the middle bond of the D-stem of the tRNA(Ile) and is highly conserved. The conservation and phenotype-genotype segregation strongly suggest pathogenicity and is in good agreement with the MTTI gene being frequently associated with CPEO. This novel variant broadens the spectrum of MTTI mutations causing CPEO.
C1 [Jackson, Christopher B.; Gallati, Sabina; Schaller, Andre] Univ Bern, Inselspital, Div Human Genet, Dept Pediat, CH-3010 Bern, Switzerland.
   [Jackson, Christopher B.; Gallati, Sabina; Schaller, Andre] Univ Bern, Inselspital, Div Human Genet, Dept Clin Res, CH-3010 Bern, Switzerland.
   [Jackson, Christopher B.; Hahn, Dagmar; Nuoffer, J-M] Univ Bern, Inselspital, Inst Clin Chem, CH-3010 Bern, Switzerland.
   [Jackson, Christopher B.] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3010 Bern, Switzerland.
   [Neuwirth, Christoph] Cantonal Hosp St Gallen, Neuromuscular Dis Ctr, St Gallen, Switzerland.
   [Frank, Stephan] Basle Univ Hosp, Inst Pathol, Div Neuropathol, Basel, Switzerland.
C3 University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; Kantonsspital St. Gallen
RP Schaller, A (corresponding author), Univ Bern, Inselspital, Div Human Genet, Dept Pediat, Freiburgstr, CH-3010 Bern, Switzerland.
EM andre.schaller@insel.ch
FU Novartis Foundation for medical biological research; Vinetum Foundation; Gottfried and Julia Bangerter Foundation
CR Al-Dosary M, 2009, NEUROMUSCULAR DISORD, V19, P841, DOI 10.1016/j.nmd.2009.10.001
   Berardo A, 2010, NEUROMUSCULAR DISORD, V20, P204, DOI 10.1016/j.nmd.2010.01.006
   Borthwick Gillian M, 2006, ANN NEUROL, V59, P570, DOI 10.1002/ana.20758
   Campos Y, 2002, MUSCLE NERVE, V25, P185, DOI 10.1002/mus.10012.abs
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Cox R, 2012, MITOCHONDRION, V12, P258, DOI 10.1016/j.mito.2011.09.006
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   Emmanuele V, 2011, J NEUROL SCI, V303, P39, DOI 10.1016/j.jns.2011.01.018
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177
   Liechti-Gallati S, 1999, EUR J HUM GENET, V7, P590, DOI 10.1038/sj.ejhg.5200338
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Schaller A, 2011, MITOCHONDRION, V11, P488, DOI 10.1016/j.mito.2011.01.005
   Schaller A, 2011, BMC NEUROL, V11, P0, DOI 10.1186/1471-2377-11-4
   SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597
   Silvestri G, 1996, BIOCHEM BIOPH RES CO, V220, P623, DOI 10.1006/bbrc.1996.0453
   Sissler M, 2008, METHODS, V44, P176, DOI 10.1016/j.ymeth.2007.11.002
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
NR 25
TC 7
Z9 8
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0007-1161
EI 1468-2079
J9 BRIT J OPHTHALMOL
JI Br. J. Ophthalmol.
PD OCT 15
PY 2014
VL 98
IS 10
BP 1453
EP 1459
DI 10.1136/bjophthalmol-2014-305300
PG 7
WC Ophthalmology
SC Ophthalmology
GA AQ3HF
UT WOS:000342681400031
PM 25034047
DA 2024-11-01
ER

PT J
AU Fraidakis, MJ
   Jardel, C
   Allouche, S
   Nelson, I
   Auré, K
   Slama, A
   Lemière, I
   Thenint, JP
   Hamon, JB
   Zagnoli, F
   Heron, D
   Sedel, F
   Lombès, A
AF Fraidakis, Matthew J.
   Jardel, Claude
   Allouche, Stephane
   Nelson, Isabelle
   Aure, Karine
   Slama, Abdelhamid
   Lemiere, Isabelle
   Thenint, Jean Philippe
   Hamon, Jean Baptiste
   Zagnoli, Fabien
   Heron, Delphine
   Sedel, Frederic
   Lombes, Anne
TI Phenotypic diversity associated with the <i>MT-TV</i> gene m.1644G &gt; A mutation, a matter of quantity
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA; Heteroplasmy; Mitochondrial diseases; Clinical diagnosis
ID widespread tissue distribution; mitochondrial-dna; melas syndrome; mtdna; diagnosis
AB We describe four patients from three independent families with the m.1 644G> A in the MT-1Vgene, previously reported without demonstration of its deleterious impact. Very high mutation proportion co-segregated with cytochrome oxidase defect in single muscle fibers and respiratory defect in cybrids as shown by spectrophotometric assays and polarography. The mutation appeared to have a very steep threshold effect with asymptomatic life up to 70% mutation propor: tion, progressive encephalopathy above 80% and severe Leigh-like syndrome above 95% mutation. One patient did not fit within that frame but presented with characteristics suggesting the presence of an additional disease. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Fraidakis, Matthew J.; Sedel, Frederic] Hop La Pitie Salpetriere, AP HP, F-75651 Paris, France.
   [Jardel, Claude; Lemiere, Isabelle; Lombes, Anne] Hop La Pitie Salpetriere, AP HP, Serv Biochim Metab, F-75651 Paris, France.
   [Jardel, Claude; Lemiere, Isabelle; Lombes, Anne] Ctr Genet Mol & Chromosom, F-75651 Paris, France.
   [Jardel, Claude; Aure, Karine; Lombes, Anne] Inst Cochin, INSERM, UMRS 1016, F-75014 Paris, France.
   [Allouche, Stephane] CHU, Serv Biochim, F-14033 Caen 09, France.
   [Allouche, Stephane] Normandie Univ UNICAEN, EA 4650, F-14032 Caen, France.
   [Nelson, Isabelle] Hop La Pitie Salpetriere, Inst Myol, INSERM, U974, F-75654 Paris, France.
   [Aure, Karine] Hop Ambroise Pare, AP HP, Serv Explorat Fonctionnelles, F-92100 Boulogne, France.
   [Aure, Karine] Univ Versailles St Quentin Yvelines, F-78180 Versailles, France.
   [Slama, Abdelhamid] Hop Bicetre, AP HP, Serv Biochim, F-94275 Le Kremlin Bicetre, France.
   [Thenint, Jean Philippe] CHG Serv Neurol, F-61000 Alencon, France.
   [Hamon, Jean Baptiste] CHU, Hop Cavale Blanche, F-29200 Brest, France.
   [Zagnoli, Fabien] Hop Instruct Armees, Serv Neurol, F-29200 Brest, France.
   [Heron, Delphine] Hop La Pitie Salpetriere, AP HP, Ctr Reference Deficiences Intellectuelles Causes, GRC, F-75651 Paris, France.
   [Lombes, Anne] CNRS, Inst Cochin, UMR 8104, F-75014 Paris, France.
   [Lombes, Anne] Univ Paris 05, F-75014 Paris, France.
C3 Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Universite Paris Saclay; Hopital Universitaire Bicetre - APHP; CHU Brest; Universite de Bretagne Occidentale; Val-de-Grace Hospital; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite
RP Lombès, A (corresponding author), Inst Cochin, 24 Rue Fb St Jacques, F-75014 Paris, France.
EM anne.lombes@inserm.fr
FU NR (Agence Nationale pour la Recherche) (ANR MNP Mitopark) [ANR-08-MNPS-020-01]; AFM (Association Francaise contre les Myopathies); AMMi (Association contre les Maladies Mitochondriales)
CR Auré K, 2007, NEUROMUSCULAR DISORD, V17, P368, DOI 10.1016/j.nmd.2007.01.019
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Kim MJ, 2008, ANTIMICROB AGENTS CH, V52, P1670, DOI 10.1128/AAC.01449-07
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Menotti Francesca, 2004, ITAL HEART J, V5, P460
   Rehder CW, 2013, GENET MED, V15, P150, DOI 10.1038/gim.2012.169
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Tanji K, 2008, J NEUROL SCI, V270, P23, DOI 10.1016/j.jns.2008.01.016
   Tuppen HAL, 2008, J MED GENET, V45, P55, DOI 10.1136/jmg.2007.051185
   van Eijsden RGE, 2006, GENET MED, V8, P620, DOI 10.1097/01.gim.0000237782.94878.05
NR 15
TC 7
Z9 8
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2014
VL 15
IS 
BP 34
EP 39
DI 10.1016/j.mito.2014.03.010
PG 6
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA AH3FR
UT WOS:000336009600005
PM 24691472
DA 2024-11-01
ER

PT J
AU Imasawa, T
   Tanaka, M
   Yamaguchi, Y
   Nakazato, T
   Kitamura, H
   Nishimura, M
AF Imasawa, Toshiyuki
   Tanaka, Masashi
   Yamaguchi, Yutaka
   Nakazato, Takashi
   Kitamura, Hiroshi
   Nishimura, Motonobu
TI 7501 T&gt;A mitochondrial DNA variant in a patient with glomerulosclerosis
SO RENAL FAILURE
LA English
DT Article
DE Glomerulosclerosis; granular swollen epithelial cell; mitochondria; mitochondrial DNA
ID focal segmental glomerulosclerosis; gene mutation; nephropathy; involvement
AB The presence of granular swollen epithelial cells (GSECs) in tubular cells was recently reported to be a specific change associated with mitochondrial cytopathy. However, at present, GSEC is not routinely evaluated. We, in this study, present a case of glomerulosclerosis, in which the presence of GSECs should provide us one clue to understand the pathogenesis of its progressive decline of renal function. A 54-year-old Japanese female, who had been diagnosed with Graves' disease, was referred for the examination and treatment of her proteinuria (5.4 g/gCre at the first visit to our hospital). A kidney biopsy showed 28.6% of the glomeruli to be globally sclerosed and 10.7% of the glomeruli to have completely collapsed. However, according to a light microscopic analysis, all other glomeruli showed an almost normal appearance, except for some slight enlargement. Almost 30% of the interstitium was damaged by fibrosis. Characteristically, GSECs were observed in the medulla collecting ducts. Although she had no symptoms of either myopathy or encephalopathy, no history of stroke-like episodes or difficulty in hearing, her serum concentrations of lactate and pyruvate were both elevated. Therefore, mitochondrial DNA sequencing was performed to assess the etiopathogenesis of her nephropathy. Consequently, a homoplasmic 7501 T>A replacement, which has not been previously reported in patients with renal diseases, was detected. This case suggests that the routine evaluation of GSECs can provide important clues to assess the etiopathogenesis of cryptogenic glomerulosclerosis.
C1 [Imasawa, Toshiyuki; Kitamura, Hiroshi; Nishimura, Motonobu] Chiba East Hosp, Natl Hosp Org, Kidney & Diabet Ctr, Chiba 2608712, Japan.
   [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Itabashi Ku, Tokyo, Japan.
   [Yamaguchi, Yutaka] Yamaguchi Pathol Lab, Matsudo, Chiba, Japan.
   [Nakazato, Takashi] Natl Hosp Org, Chiba Med Ctr, Dept Cardiol, Chiba, Japan.
C3 Tokyo Metropolitan Institute of Gerontology
RP Imasawa, T (corresponding author), Chiba East Hosp, Natl Hosp Org, Kidney & Diabet Ctr, Chuoh Ku, 673 Nitona Cho, Chiba 2608712, Japan.
EM imasawa@cehpnet.com
FU JSPS (Japan Society for the Promotion Science) KAKENHI [80348276]; National Hospital Organization of Japan; Grants-in-Aid for Scientific Research [25242062] Funding Source: KAKEN
CR Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833
   Doleris LM, 2000, KIDNEY INT, V58, P1851, DOI 10.1046/j.1523-1755.2000.00356.x
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Imasawa T, 2013, INT J BIOCHEM CELL B, V45, P2109, DOI 10.1016/j.biocel.2013.06.013
   Ishii R, 2010, ENDOCR J, V57, P73, DOI 10.1507/endocrj.K09E-230
   Kobayashi A, 2010, AM J SURG PATHOL, V34, P262, DOI 10.1097/PAS.0b013e3181cb4ed3
   Möllers M, 2005, NUCLEIC ACIDS RES, V33, P5647, DOI 10.1093/nar/gki876
   Mutai H, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-135
   OToole JF, 2014, INT J NEPHROL RENOV, V7, P57, DOI 10.2147/IJNRD.S37887
   Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067
   Zaragoza MV, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012295
NR 13
TC 5
Z9 7
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0886-022X
EI 1525-6049
J9 RENAL FAILURE
JI Ren. Fail.
PD OCT 15
PY 2014
VL 36
IS 9
BP 1461
EP 1465
DI 10.3109/0886022X.2014.945181
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA AS6RY
UT WOS:000344391200020
PM 25088491
DA 2024-11-01
ER

PT J
AU Prasad, M
   Narayan, B
   Prasad, AN
   Rupar, CA
   Levin, S
   Kronick, J
   Ramsay, D
   Tay, KY
   Prasad, C
AF Prasad, M.
   Narayan, B.
   Prasad, A. N.
   Rupar, C. A.
   Levin, S.
   Kronick, J.
   Ramsay, D.
   Tay, K. Y.
   Prasad, C.
TI MELAS: A Multigenerational Impact of the <i>MTTL1 A3243G</i> MELAS Mutation
SO CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
LA English
DT Article
ID stroke-like episodes; l-arginine; lactic-acidosis; mitochondrial myopathy; molecular pathology; clinical phenotype; encephalopathy; dysfunction; patient; blood
AB Background: The maternally inherited MTTLI A3243G mutation in the mitochondrial genome causes MELAS (Mitochondrial Encephalopathy Lactic Acidosis with Stroke-like Episodes), a condition that is multisystemic but affects primarily the nervous system. Significant intra-familial variation in phenotype and severity of disease is well recognized. Methods: Retrospective and ongoing study of an extended family carrying the MTTLI A3243G mutation with multiple symptomatic individuals. Tissue heteroplasmy is reviewed based on the clinical presentations, imaging studies, laboratory findings in affected individuals and pathological material obtained at autopsy in two of the family members. Results: There were seven affected individuals out of thirteen members in this three generation family who each carried the MTTLI A3243G mutation. The clinical presentations were varied with symptoms ranging from hearing loss, migraines, dementia, seizures, diabetes, visual manifestations, and stroke like episodes. Three of the family members are deceased from MELAS or to complications related to MELAS. Conclusions: The results of the clinical, pathological and radiological findings in this family provide strong support to the current concepts of maternal inheritance, tissue heteroplasmy and molecular pathogenesis in MELAS. Neurologists (both adult and paediatric) are the most likely to encounter patients with MELAS in their practice. Genetic counselling is complex in view of maternal inheritance and heteroplasmy. Newer therapeutic options such as arginine are being used for acute and preventative management of stroke like episodes.
C1 [Prasad, A. N.; Rupar, C. A.; Levin, S.; Prasad, C.] Univ Western Ontario, Dept Paediat, London, ON, Canada.
   [Rupar, C. A.; Ramsay, D.] Univ Western Ontario, Dept Pathol & Lab Med, London, ON, Canada.
   [Tay, K. Y.] Univ Western Ontario, Dept Med Imaging, London, ON, Canada.
   [Rupar, C. A.] Univ Western Ontario, Dept Biochem, London, ON, Canada.
   [Rupar, C. A.; Prasad, C.] Univ Western Ontario, Childrens Hlth Res Inst, London, ON, Canada.
   [Prasad, M.; Narayan, B.] London Hlth Sci Ctr, London, ON, Canada.
   [Kronick, J.] Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada.
C3 Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre; University of Toronto; Hospital for Sick Children (SickKids)
RP Prasad, C (corresponding author), Childrens Hosp, London Hlth Sci Ctr, 800 Commissioners Rd East, London, ON N6C 2V5, Canada.
EM Chitra.Prasad@lhsc.on.ca
CR Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2012, ACTA NEUROL SCAND, V126, P1, DOI 10.1111/j.1600-0404.2012.01649.x
   Finsterer J, 2008, J NEUROL SCI, V272, P20, DOI 10.1016/j.jns.2008.05.011
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hirata K, 2008, BRAIN DEV-JPN, V30, P238, DOI 10.1016/j.braindev.2007.08.007
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   Kaido M, 1996, ACTA NEUROPATHOL, V92, P312, DOI 10.1007/s004010050524
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Lekoubou A, 2011, REV NEUROL-FRANCE, V167, P852, DOI 10.1016/j.neurol.2011.02.038
   MIZUKAMI K, 1992, ACTA NEUROPATHOL, V83, P449, DOI 10.1007/BF00713541
   Morán M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Poulton J, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001066
   Poulton J, 2009, BMJ-BRIT MED J, V338, P0, DOI 10.1136/bmj.b94
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Sarnat HB, 2012, NEUROPATHOLOGY, V32, P617, DOI 10.1111/j.1440-1789.2012.01308.x
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Yokoyama T, 2010, NEUROPATHOLOGY, V30, P56, DOI 10.1111/j.1440-1789.2009.01026.x
NR 34
TC 12
Z9 14
U1 0
U2 3
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0317-1671
EI 2057-0155
J9 CAN J NEUROL SCI
JI Can. J. Neurol. Sci.
PD MAR 15
PY 2014
VL 41
IS 2
BP 210
EP 219
DI 10.1017/S0317167100016607
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA AY4WL
UT WOS:000347575800015
PM 24534033
DA 2024-11-01
ER

PT J
AU Wu, SB
   Wu, YT
   Wu, TP
   Wei, YH
AF Wu, Shi-Bei
   Wu, Yu-Ting
   Wu, Tsung-Pu
   Wei, Yau-Huei
TI Role of AMPK-mediated adaptive responses in human cells with mitochondrial dysfunction to oxidative stress
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Review
DE AMPK; Mitochondrial disease; Oxidative stress; Metabolic reprogramming; Antioxidant enzyme; Autophagy
ID activated protein-kinase; skeletal-muscle autophagy; dna mutations; glucose-metabolism; degenerative diseases; hydrogen-peroxide; gene-expression; life-span; phosphorylation; antioxidant
AB Background: Mitochondrial DNA (mtDNA) mutations are an important cause of mitochondrial diseases, for which there is no effective treatment due to complex pathophysiology. It has been suggested that mitochondrial dysfunction-elicited reactive oxygen species (ROS) plays a vital role in the pathogenesis of mitochondrial diseases, and the expression levels of several clusters of genes are altered in response to the elevated oxidative stress. Recently, we reported that glycolysis in affected cells with mitochondrial dysfunction is upregulated by AMP-activated protein kinase (AMPK), and such an adaptive response of metabolic reprogramming plays an important role in the pathophysiology of mitochondrial diseases. Scope of review: We summarize recent findings regarding the role of AMPK-mediated signaling pathways that are involved in: (1) metabolic reprogramming, (2) alteration of cellular redox status and antioxidant enzyme expression, (3) mitochondrial biogenesis, and (4) autophagy, a master regulator of mitochondrial quality control in skin fibroblasts from patients with mitochondrial diseases. Major conclusion: Induction of adaptive responses via AMPK-PFK2, AMPK-FOXO3a, AMPK-PGC-1 alpha, and AMPK-mTOR signaling pathways, respectively is modulated for the survival of human cells under oxidative stress induced by mitochondrial dysfunction. We suggest that AMPK may be a potential target for the development of therapeutic agents for the treatment of mitochondrial diseases. General significance: Elucidation of the adaptive mechanism involved in AMPK activation cascades would lead us to gain a deeper insight into the crosstalk between mitochondria and the nucleus in affected tissue cells from patients with mitochondrial diseases. This article is part of a Special Issue entitled Frontiers of Mitochondrial Research. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Wu, Shi-Bei; Wu, Yu-Ting; Wu, Tsung-Pu; Wei, Yau-Huei] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.
   [Wei, Yau-Huei] Mackay Med Coll, Dept Med, New Taipei City 252, Taiwan.
C3 National Yang Ming Chiao Tung University; Mackay Medical College
RP Wei, YH (corresponding author), Natl Yang Ming Univ, Dept Biochem & Mol Biol, 155,Sec 2,Li Nong St, Taipei 112, Taiwan.
EM joeman@ym.edu.tw
FU National Science Council; Executive Yuan, Taiwan [NSC100-2320-B-010-024-MY3, NSC101-2811-B-010-029]; Mackay Medical College [982A01]
CR Abnous K, 2008, MOL CELL BIOCHEM, V319, P41, DOI 10.1007/s11010-008-9875-5
   Aguer C, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028536
   Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080
   Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910
   Annunen-Rasila J, 2007, PROTEOMICS, V7, P2189, DOI 10.1002/pmic.200601031
   [Anonymous], 2007, J BIOL-LONDON, V0, P0
   Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666
   BenYoseph O, 1996, NEUROCHEM RES, V21, P1005, DOI 10.1007/BF02532410
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028
   Cabello A, 1998, REV NEUROL, V26, P44
   Calegari VC, 2011, J ENDOCRINOL, V208, P257, DOI 10.1530/JOE-10-0450
   Cantó C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Cao C, 2008, CELL SIGNAL, V20, P1830, DOI 10.1016/j.cellsig.2008.06.010
   Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005
   Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012
   Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715
   Chang CC, 2011, J BIOMED SCI, V18, P0, DOI 10.1186/1423-0127-18-47
   Chang JC, 2013, NEUROSIGNALS, V21, P160, DOI 10.1159/000341981
   Chen CY, 2011, MITOCHONDRION, V11, P739, DOI 10.1016/j.mito.2011.05.014
   Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49
   Chen YW, 2010, INT J BIOCHEM CELL B, V42, P2072, DOI 10.1016/j.biocel.2010.09.017
   Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035
   Chiribau CB, 2008, J BIOL CHEM, V283, P8211, DOI 10.1074/jbc.M710610200
   Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200
   Cidad P, 2004, BIOCHEM J, V384, P629, DOI 10.1042/BJ20040886
   Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613
   Comellas AP, 2006, CIRC RES, V98, P1314, DOI 10.1161/01.RES.0000222418.99976.1d
   CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Craigen WJ, 2012, METHODS MOL BIOL, V837, P3, DOI 10.1007/978-1-61779-504-6_1
   Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034
   Pinheiro CHD, 2010, FREE RADICAL BIO MED, V48, P953, DOI 10.1016/j.freeradbiomed.2010.01.016
   De la Mata M, 2012, NEUROTHERAPEUTICS, V9, P446, DOI 10.1007/s13311-012-0103-3
   Dilova I, 2004, J BIOL CHEM, V279, P46527, DOI 10.1074/jbc.M409012200
   DiMauro S, 2009, BBA-MOL BASIS DIS, V1792, P1159, DOI 10.1016/j.bbadis.2008.10.015
   Dzamko NL, 2009, ACTA PHYSIOL, V196, P115, DOI 10.1111/j.1748-1716.2009.01969.x
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019
   Essick EE, 2010, OXID MED CELL LONGEV, V3, P168, DOI 10.4161/oxim.3.3.12106
   Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030
   Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943
   Filomeni G, 2010, AUTOPHAGY, V6, P999, DOI 10.4161/auto.6.7.12754
   Filosto M, 2002, ACTA NEUROPATHOL, V103, P215, DOI 10.1007/s004010100455
   Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003
   Folbergrová J, 2012, MITOCHONDRION, V12, P35, DOI 10.1016/j.mito.2011.04.004
   Frantz MC, 2010, ENVIRON MOL MUTAGEN, V51, P462, DOI 10.1002/em.20554
   Fu JR, 2012, J BIOL CHEM, V287, P24460, DOI 10.1074/jbc.M112.382226
   Fulda S, 2012, AUTOPHAGY, V8, P1250, DOI 10.4161/auto.20669
   Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003
   García-Nogales P, 2003, J BIOL CHEM, V278, P864, DOI 10.1074/jbc.M206835200
   García-Nogales P, 1999, J NEUROCHEM, V72, P1750, DOI 10.1046/j.1471-4159.1999.721750.x
   Gough DR, 2011, CELL DEATH DIS, V2, P0, DOI 10.1038/cddis.2011.96
   Grant Chris M, 2008, J BIOL, V7, P1, DOI 10.1186/jbiol63
   Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200
   Gusarova GA, 2009, MOL CELL BIOL, V29, P3455, DOI 10.1128/MCB.00054-09
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Han YY, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015420
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   Hou XG, 2010, BIOCHEM BIOPH RES CO, V396, P199, DOI 10.1016/j.bbrc.2010.04.017
   Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   Izyumov DS, 2010, BIOCHEMISTRY-MOSCOW+, V75, P123, DOI 10.1134/S000629791002001X
   Joseph AM, 2004, AM J PHYSIOL-CELL PH, V286, PC867, DOI 10.1152/ajpcell.00191.2003
   Kirchman PA, 1999, GENETICS, V152, P179
   Klaus A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0062497
   Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023
   Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.1.120
   Kyriakouli DS, 2008, GENE THER, V15, P1017, DOI 10.1038/gt.2008.91
   Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lee CF, 2006, FREE RADICAL BIO MED, V40, P2136, DOI 10.1016/j.freeradbiomed.2006.02.008
   Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105
   Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451
   Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662
   Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512
   Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107
   Liu C, 2010, J BIOL CHEM, V285, P15346, DOI 10.1074/jbc.M110.102491
   Liu CY, 2009, J FORMOS MED ASSOC, V108, P599, DOI 10.1016/S0929-6646(09)60380-6
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   Lu CY, 2003, MOL GENET METAB, V80, P321, DOI 10.1016/j.ymgme.2003.08.005
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Ma YS, 2009, BBA-GEN SUBJECTS, V1790, P1021, DOI 10.1016/j.bbagen.2009.04.012
   Mackenzie RM, 2013, CLIN SCI, V124, P403, DOI 10.1042/CS20120239
   Majora M, 2009, AM J PATHOL, V175, P1019, DOI 10.2353/ajpath.2009.080832
   McBride A, 2009, ACTA PHYSIOL, V196, P99, DOI 10.1111/j.1748-1716.2009.01975.x
   McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008
   Menzies KJ, 2009, AM J PHYSIOL-CELL PH, V296, PC355, DOI 10.1152/ajpcell.00415.2007
   Miceli MV, 2005, EXP CELL RES, V302, P270, DOI 10.1016/j.yexcr.2004.09.006
   Michel S, 2012, J CELL PHYSIOL, V227, P2297, DOI 10.1002/jcp.23021
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   Mora R, 2009, GLIA, V57, P561, DOI 10.1002/glia.20785
   MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729
   Nardin RA, 2001, MUSCLE NERVE, V24, P170, DOI 10.1002/1097-4598(200102)24:2<170::AID-MUS30>3.0.CO;2-0
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Oexle K, 1997, HUM MOL GENET, V6, P905, DOI 10.1093/hmg/6.6.905
   Ogasawara Y, 2008, BLOOD CELL MOL DIS, V41, P237, DOI 10.1016/j.bcmd.2008.05.007
   Öst A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023
   Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Pasinetti GM, 2011, EXP NEUROL, V232, P1, DOI 10.1016/j.expneurol.2011.08.014
   Pessina S, 2010, CELL CYCLE, V9, P2189, DOI 10.4161/cc.9.11.11847
   Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200
   Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6
   Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap
   Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009
   Rodríguez-Hernández A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174
   Romero-Moya D, 2013, HAEMATOLOGICA, V98, P1022, DOI 10.3324/haematol.2012.079244
   Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297
   Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005
   Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399
   Sanger TD, 1996, PEDIATR NEUROL, V14, P57, DOI 10.1016/0887-8994(95)00226-X
   Sasaki S, 2011, J NEUROPATH EXP NEUR, V70, P349, DOI 10.1097/NEN.0b013e3182160690
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623
   SCHOLTE HR, 1988, J BIOENERG BIOMEMBR, V20, P161, DOI 10.1007/BF00768393
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Shacka JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P718, DOI 10.2741/2714
   Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192
   Sid B, 2013, BIOCHEM PHARMACOL, V2952, P291
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010
   Srivastava S, 2009, HUM MOL GENET, V18, P1805, DOI 10.1093/hmg/ddp093
   Stöckl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Tangeman Larissa, 2012, J RNAI GENE SILENCING, V8, P470
   Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105
   Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001
   Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, P0
   Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007
   Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05
   Tryoen-Tóth P, 2003, J BIOL CHEM, V278, P24314, DOI 10.1074/jbc.M301530200
   van Eijsden RGE, 2008, J MED GENET, V45, P525, DOI 10.1136/jmg.2008.057497
   Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098
   Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x
   Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061
   Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   Wang Q, 2011, PLOS ONE, V28, P0
   Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467
   Wang XF, 2011, CHINESE MED J-PEKING, V124, P1876, DOI 10.3760/cma.j.issn.0366-6999.2011.12.020
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002
   Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005
   Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Wu Y, 2012, DIABETOLOGIA, V55, P245, DOI 10.1007/s00125-011-2326-y
   Wu YT, 2013, BBA-MOL BASIS DIS, V1832, P216, DOI 10.1016/j.bbadis.2012.10.002
   Wu YT, 2010, ANN NY ACAD SCI, V1201, P147, DOI 10.1111/j.1749-6632.2010.05631.x
   Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103
   Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x
   Young LH, 1997, CIRCULATION, V95, P415
   Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zeviani Massimo, 2003, CURR NEUROL NEUROSCI REP, V3, P423, DOI 10.1007/s11910-003-0026-9
   Zhang D, 2005, CARDIOVASC PATHOL, V14, P61, DOI 10.1016/j.carpath.2005.01.006
   Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541
   Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685
   Zrelli H, 2011, EUR J PHARMACOL, V660, P275, DOI 10.1016/j.ejphar.2011.03.045
NR 173
TC 135
Z9 149
U1 1
U2 58
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD APR 15
PY 2014
VL 1840
IS 4
BP 1331
EP 1344
DI 10.1016/j.bbagen.2013.10.034
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AD8GQ
UT WOS:000333504900012
PM 24513455
DA 2024-11-01
ER

PT J
AU Goto, M
   Komaki, H
   Saito, T
   Saito, Y
   Nakagawa, E
   Sugai, K
   Sasaki, M
   Nishino, I
   Goto, Y
AF Goto, Masahide
   Komaki, Hirofumi
   Saito, Takashi
   Saito, Yoshiaki
   Nakagawa, Eiji
   Sugai, Kenji
   Sasaki, Masayuki
   Nishino, Ichizo
   Goto, Yu-ichi
TI MELAS phenotype associated with m.3302A&gt;G mutation in mitochondrial tRNA<SUP>Leu(UUR)</SUP> gene
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE MELAS; Myopathy; m.3302A > G mutation
ID a3302g mutation; dna; disease
AB The m.3302A > G mutation in the mitochondrial tRNA(Leu(UUR)) gene has been identified in only 12 patients from 6 families, all manifesting adult-onset slowly progressive myopathy with minor central nervous system involvement. An 11-year-old boy presented with progressive proximal-dominant muscle weakness from age 7 years. At age 10, he developed recurrent stroke-like episodes. Mitochondrial myopathy, encephalopathy, lactic acidosis, plus stroke-like episodes (MELAS) was diagnosed by clinical symptoms and muscle biopsy findings. Mitochondrial gene analysis revealed a heteroplasmic m.3302A > G mutation. Histological examination showed strongly SDH reactive blood vessels (SSVs), not present in previous cases with myopathies due to the m.3302A > G mutation. These findings broaden the phenotypic spectrum of this mutation. (C) 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Goto, Masahide; Komaki, Hirofumi; Saito, Takashi; Saito, Yoshiaki; Nakagawa, Eiji; Sugai, Kenji; Sasaki, Masayuki] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Dept Child Neurol, Tokyo, Japan.
   [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
C3 National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan
RP Komaki, H (corresponding author), NCNP, Dept Child Neurol, Natl Ctr Hosp, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878551, Japan.
EM komakih@ncnp.go.jp
FU Ministry of Health, Labour and Welfare of Japan [21A-6]
CR Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004
   BALLHAUSEN D, 1900, DOI 10.1007/S10545-010-9098-2, V0, P0
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   GOTO Y, 1995, MUSCLE NERVE, V0, PS107
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Hutchison WM, 2005, ARCH NEUROL-CHICAGO, V62, P1920, DOI 10.1001/archneur.62.12.1920
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   TROUNCE LA, 1996, METHOD ENZYMOL, V264, P484
   van den Bosch BJC, 2004, NEUROMUSCULAR DISORD, V14, P683, DOI 10.1016/j.nmd.2004.06.004
NR 10
TC 10
Z9 11
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 1872-7131
J9 BRAIN DEV-JPN
JI Brain Dev.
PD FEB 15
PY 2014
VL 36
IS 2
BP 180
EP 182
DI 10.1016/j.braindev.2013.03.001
PG 3
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 295YD
UT WOS:000330151400016
PM 23582502
DA 2024-11-01
ER

PT J
AU Chong, JW
   Annuar, AA
   Wong, KT
   Thong, MK
   Goh, KJ
AF Chong, Jia-Woei
   Annuar, Azlina Ahmad
   Wong, Kum-Thong
   Thong, Meow-Keong
   Goh, Khean-Jin
TI Single mitochondrial DNA deletions in chronic progressive external ophthalmoplegia (CPEO) and Kearns-Sayre syndrome (KSS) patients from a multiethnic Asian population
SO NEUROLOGY ASIA
LA English
DT Article
ID direct repeats; mutations
AB Mitochondrial DNA (mtDNA) deletions are a major cause of chronic progressive external ophthalmoplegia (CPEO) and Kearns-Sayre syndrome (KSS). We analyzed single mtDNA deletions in 11 CPEO and one KSS patients by means of Southern blot and long polymerase chain reaction (PCR) assays. The deletion sizes ranged from 3.4 kb to 6.9 kb whereas the heteroplasmy level varied from 18.8% to 85.5%. Two unique deletions sized 4320 bp and 4717 bp were found. This study represents the first genetic screen of mtDNA disorders in Malaysia, and it follows the data seen in other published reports on CPEO and KSS genetic aetiology.
C1 [Chong, Jia-Woei; Goh, Khean-Jin] Univ Malaya, Dept Med, Div Neurol, Kuala Lumpur 50603, Malaysia.
   [Annuar, Azlina Ahmad] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia.
   [Wong, Kum-Thong] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur 50603, Malaysia.
   [Thong, Meow-Keong] Univ Malaya, Fac Med, Dept Pediat, Kuala Lumpur 50603, Malaysia.
C3 Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya
RP Goh, KJ (corresponding author), Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia.
EM gohkj@ummc.edu.my
FU Ministry of Science, Technology and Innovation, Malaysia [12-02-03-2038]
CR Bau V, 2005, STRABISMUS, V13, P133, DOI 10.1080/09273970500216432
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350
   DEGOUL F, 1991, J NEUROL SCI, V101, P168, DOI 10.1016/0022-510X(91)90042-6
   Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200
   Goto YI, 1996, BIOCHEM BIOPH RES CO, V222, P215, DOI 10.1006/bbrc.1996.0724
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   John DR, 1990, BIOCHEM BIOPH RES CO, V174, P244
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nishizuka S, 1998, BIOCHEM BIOPH RES CO, V247, P24, DOI 10.1006/bbrc.1998.8709
   ROWLAND LP, 1983, NEUROLOGY, V33, P1179, DOI 10.1212/WNL.33.9.1179
   Sadikovic B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015687
   Sambrook J, 1990, COLD SPRING HARBOR LABORATORIES, V186, P182
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Schon EA, 2003, GENETICS MITOCHONDRI, V0, P111
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Thajeb P, 2006, CLIN NEUROL NEUROSUR, V108, P407, DOI 10.1016/j.clineuro.2005.01.004
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wong LJC, 2010, DEV DISABIL RES REV, V16, P154, DOI 10.1002/ddrr.104
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 23
TC 1
Z9 1
U1 0
U2 7
PU ASEAN NEUROLOGICAL ASSOC
PI KUALA LUMPUR
PA UNIV MALAYA MEDICAL CENTRE, NEUROLOGY LABORATORY, KUALA LUMPUR, 59100, MALAYSIA
SN 1823-6138
EI 
J9 NEUROL ASIA
JI Neurol. Asia
PD MAR 15
PY 2014
VL 19
IS 1
BP 27
EP 36
DI 
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA AE4NY
UT WOS:000333960600004
DA 2024-11-01
ER

PT J
AU Peverelli, L
   Gold, CA
   Naini, AB
   Tanji, K
   Akman, HO
   Hirano, M
   DiMauro, S
AF Peverelli, Lorenzo
   Gold, Carl A.
   Naini, Ali B.
   Tanji, Kurenai
   Akman, H. Orhan
   Hirano, Michio
   DiMauro, Salvatore
TI MITOCHONDRIAL MYOPATHY WITH DYSTROPHIC FEATURES DUE TO A NOVEL MUTATION IN THE <i>MTTM</i> GENE
SO MUSCLE & NERVE
LA English
DT Article
DE de novo mutation; dystrophic features; late-onset weakness; mitochondrial myopathy; mtDNA; tRNAMet
ID trna(trp) gene; point mutation; dna; disease
AB Introduction: A 61-year-old woman with a 5-year history of progressive muscle weakness and atrophy had a muscle biopsy characterized by a combination of dystrophic features (necrotic fibers and endomysial fibrosis) and mitochondrial alterations [ragged-red, cytochrome c oxidase (COX)-negative fibers]. Methods: Sequencing of the whole mtDNA, assessment of the mutation load in muscle and accessible nonmuscle tissues, and single fiber polymerase chain reaction. Results: Muscle mitochondrial DNA (mtDNA) sequencing revealed a novel heteroplasmic mutation (m.4403G>A) in the gene (MTTM) that encodes tRNA(Met). The mutation was not present in accessible nonmuscle tissues from the patient or 2 asymptomatic sisters. Conclusions: The clinical features and muscle morphology in this patient are very similar to those described in a previous patient with a different mutation, also in MTTM, which suggests that mutations in this gene confer a distinctive "dystrophic" quality. This may be a diagnostic clue in patients with isolated mitochondrial myopathy.
C1 [Peverelli, Lorenzo; Gold, Carl A.; Tanji, Kurenai; Akman, H. Orhan; Hirano, Michio; DiMauro, Salvatore] Columbia Univ, Coll Phys & Surg, Dept Neurol, Med Ctr, New York, NY 10027 USA.
   [Naini, Ali B.; Tanji, Kurenai] Columbia Univ, Coll Phys & Surg, Dept Pathol, Med Ctr, New York, NY USA.
C3 Columbia University; Columbia University
RP DiMauro, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurol, Med Ctr, 630 W 168th St, New York, NY 10027 USA.
EM sd12@columbia.edu
FU NICHD [P01HD032062]; NINDS/NICHD [U54NS078059]; Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF)
CR Baric I, 2013, EUR J HUM GENET, V21, P871, DOI 10.1038/ejhg.2012.272
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Jeppesen TD, 2014, NEUROMUSCULAR DISORD, V24, P162, DOI 10.1016/j.nmd.2013.08.004
   Lombes A, 1998, HUM MUTAT, V0, PS175
   Moslemi AR, 2004, NEUROMUSCULAR DISORD, V14, P46, DOI 10.1016/S0960-8966(03)00168-8
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304
   Tanji K, 2001, METHOD CELL BIOL, V65, P311, DOI 10.1016/S0091-679X(01)65019-2
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
NR 14
TC 7
Z9 7
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD AUG 15
PY 2014
VL 50
IS 2
BP 292
EP 295
DI 10.1002/mus.24262
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AM9YN
UT WOS:000340237500022
PM 24711008
DA 2024-11-01
ER

PT J
AU Sorriento, D
   Pascale, AV
   Finelli, R
   Carillo, AL
   Annunziata, R
   Trimarco, B
   Iaccarino, G
AF Sorriento, Daniela
   Pascale, Antonietta Valeria
   Finelli, Rosa
   Carillo, Anna Lisa
   Annunziata, Roberto
   Trimarco, Bruno
   Iaccarino, Guido
TI RETRACTED: Targeting Mitochondria as Therapeutic Strategy for Metabolic Disorders (Retracted Article)
SO SCIENTIFIC WORLD JOURNAL
LA English
DT Review; Retracted Publication
ID activated protein-kinase; fatty-acid oxidation; insulin-resistance; skeletal-muscle; dna mutations; molecular-mechanisms; endothelial-cells; tumor-suppressor; superoxide-production; respiratory-chain
AB Mitochondria are critical regulator of cell metabolism; thus, mitochondrial dysfunction is associated with many metabolic disorders. Defects in oxidative phosphorylation, ROS production, or mtDNA mutations are the main causes of mitochondrial dysfunction in many pathological conditions such as IR/diabetes, metabolic syndrome, cardiovascular diseases, and cancer. Thus, targeting mitochondria has been proposed as therapeutic approach for these conditions, leading to the development of small molecules to be tested in the clinical scenario. Here we discuss therapeutic interventions to treat mitochondrial dysfunction associated with two major metabolic disorders, metabolic syndrome, and cancer. Finally, novel mechanisms of regulation of mitochondrial function are discussed, which open new scenarios for mitochondria targeting.
C1 [Sorriento, Daniela; Carillo, Anna Lisa; Annunziata, Roberto; Trimarco, Bruno] Univ Naples Federico II, Dipartimento Sci Biomed Avanzate, I-80131 Naples, Italy.
   [Pascale, Antonietta Valeria; Finelli, Rosa; Iaccarino, Guido] Univ Salerno, Dipartimento Med & Chirurg, I-84081 Baronissi, Italy.
   [Iaccarino, Guido] IRCCS Multimed, I-20138 Milan, Italy.
C3 University of Naples Federico II; University of Salerno; IRCCS Multimedica
RP Sorriento, D (corresponding author), Univ Naples Federico II, Dipartimento Sci Biomed Avanzate, Via Pansini 5, I-80131 Naples, Italy.
EM danisor@libero.it
CR Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com
   Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010
   Amelio I, 2012, CELL CYCLE, V11, P4530, DOI 10.4161/cc.22820
   Ames BN, 2004, ANN NY ACAD SCI, V1019, P406, DOI 10.1196/annals.1297.073
   Ames Bruce N, 2005, MOLECULAR ASPECTS OF MEDICINE, V26, P363, DOI 10.1016/j.mam.2005.07.007
   Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795
   Atamna H, 2004, AGEING RES REV, V3, P303, DOI 10.1016/j.arr.2004.02.002
   Atamna H, 2007, J NUTR, V137, P25, DOI 10.1093/jn/137.1.25
   Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200
   Balliet RM, 2011, CELL CYCLE, V10, P4065, DOI 10.4161/cc.10.23.18254
   Bauer G, 2012, ANTICANCER RES, V32, P2599
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bertozzi D, 2011, CELL CYCLE, V10, P3189, DOI 10.4161/cc.10.18.17183
   Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020
   Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143
   Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360
   Briston T, 2011, CELL CYCLE, V10, P4170, DOI 10.4161/cc.10.23.18565
   Bugger H, 2008, CLIN SCI, V114, P195, DOI 10.1042/CS20070166
   Cantó C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4
   Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043
   Carreras Maria C, 2004, MOLECULAR ASPECTS OF MEDICINE, V25, P125, DOI 10.1016/j.mam.2004.02.014
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007
   Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242
   Compton S, 2011, J BIOL CHEM, V286, P20297, DOI 10.1074/jbc.M110.163063
   Cooper SA, 2007, AM J PHYSIOL-HEART C, V293, PH2009, DOI 10.1152/ajpheart.00522.2007
   Cuezva JM, 2002, CANCER RES, V62, P6674
   De Pauw A, 2009, AM J PATHOL, V175, P927, DOI 10.2353/ajpath.2009.081155
   Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200
   Duchen Michael R, 2004, MOLECULAR ASPECTS OF MEDICINE, V25, P365, DOI 10.1016/j.mam.2004.03.001
   Dumas JF, 2009, DIABETES METAB, V35, P159, DOI 10.1016/j.diabet.2009.02.002
   Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039
   Fink BD, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0004250
   FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   FOSTER CS, 1978, ACTA NEUROCHIR, V43, P229, DOI 10.1007/BF01587958
   FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6
   Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, PE867, DOI 10.1152/ajpendo.00207.2006
   Fulda S, 2010, MITOCHONDRION, V10, P598, DOI 10.1016/j.mito.2010.05.001
   Galluzzi L, 2010, MOL ASPECTS MED, V31, P1, DOI 10.1016/j.mam.2009.08.002
   Gastaldi G, 2008, REV MED SUISSE, V4, P1387
   Green K, 2004, DIABETES, V53, PS110, DOI 10.2337/diabetes.53.2007.S110
   Hagland H, 2007, EXPERT OPIN THER TAR, V11, P1055, DOI 10.1517/14728222.11.8.1055
   Harper ME, 2004, ACTA PHYSIOL SCAND, V182, P321, DOI 10.1111/j.1365-201X.2004.01370.x
   He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004
   Heiser D, 2004, EXP GERONTOL, V39, P1125, DOI 10.1016/j.exger.2004.04.011
   Henriksen EJ, 2002, J APPL PHYSIOL, V93, P788, DOI 10.1152/japplphysiol.01219.2001
   Henze AT, 2010, CELL CYCLE, V9, P2749, DOI 10.4161/cc.9.14.12249
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Höckel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266
   Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006
   Holinger EP, 1999, J BIOL CHEM, V274, P13298, DOI 10.1074/jbc.274.19.13298
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Hu F, 2011, CELL SIGNAL, V23, P1528, DOI 10.1016/j.cellsig.2011.05.008
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   James AM, 2002, J BIOMED SCI, V9, P475, DOI 10.1159/000064721
   Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje
   John AP, 2001, MED HYPOTHESES, V57, P429, DOI 10.1054/mehy.2001.1335
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   Knowler William C, 2002, N ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
   Kong XX, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011707
   Kostis JB, 2005, AM J HYPERTENS, V18, P731, DOI 10.1016/j.amjhyper.2004.11.038
   Krebs M, 2005, DIABETES OBES METAB, V7, P621, DOI 10.1111/j.1463-1326.2004.00439.x
   Kwong JQ, 2007, J CELL BIOL, V179, P1163, DOI 10.1083/jcb.200704059
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Li M, 2007, ANTIOXID REDOX SIGN, V9, P855, DOI 10.1089/ars.2007.1568
   Liu JK, 2002, P NATL ACAD SCI USA, V99, P1876, DOI 10.1073/pnas.261709098
   Liu VWS, 2001, CANCER RES, V61, P5998
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Ma JW, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064047
   Maassen JA, 2006, BIOCHEM SOC T, V34, P819, DOI 10.1042/BST0340819
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   MAGUIRE JJ, 1989, J BIOL CHEM, V264, P21462
   Maxwell PH, 2004, CELL CYCLE, V3, P156
   Mayers RM, 2005, BIOCHEM SOC T, V33, P367, DOI 10.1042/BST0330367
   Mehta K, 2002, NUTR REV, V60, P289, DOI 10.1301/002966402320387224
   Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159
   Mensink M, 2007, INT J OBESITY, V31, P1302, DOI 10.1038/sj.ijo.0803567
   Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261
   Mitchell C, 2009, AM J PATHOL, V175, P1929, DOI 10.2353/ajpath.2009.090332
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Moreno-Sánchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x
   Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151
   Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794
   Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121
   Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200
   Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597
   Pelicano H, 2009, CANCER RES, V69, P2375, DOI 10.1158/0008-5472.CAN-08-3359
   Pérez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398
   Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Rapisarda A, 2009, CELL CYCLE, V8, P4040, DOI 10.4161/cc.8.24.10145
   Rasmussen AK, 2003, NUCLEIC ACIDS RES, V31, P3909, DOI 10.1093/nar/gkg446
   Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155
   Reaven GM, 1996, CIRCULATION, V93, P1780, DOI 10.1161/01.CIR.93.10.1780
   Reed JC, 1998, SEMIN ONCOL, V25, P11
   Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512
   Röckl KSC, 2008, IUBMB LIFE, V60, P145, DOI 10.1002/iub.21
   Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135
   Rossmeisl M, 2000, FASEB J, V14, P1793, DOI 10.1096/fj.99-0965com
   Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849
   Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227
   Salem AF, 2012, CELL CYCLE, V11, P2545, DOI 10.4161/cc.20920
   Sanchez-Cespedes M, 2001, CANCER RES, V61, P7015
   Saretzki G, 2003, AGING CELL, V2, P141, DOI 10.1046/j.1474-9728.2003.00040.x
   Schäfer M, 2003, CIRC RES, V92, P1010, DOI 10.1161/01.RES.0000070882.81508.FC
   Schulz TJ, 2006, J BIOL CHEM, V281, P977, DOI 10.1074/jbc.M511064200
   Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6
   Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846
   Seyfried TN, 2010, NUTR METAB, V7, P0, DOI 10.1186/1743-7075-7-7
   Sharief MK, 2002, J NEUROIMMUNOL, V125, P155, DOI 10.1016/S0165-5728(02)00024-3
   Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x
   Smith SC, 2007, AM J MED, V120, PS3, DOI 10.1016/j.amjmed.2007.01.002
   Sowers JR, 2004, AM J PHYSIOL-HEART C, V286, PH1597, DOI 10.1152/ajpheart.00026.2004
   Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F
   SZATROWSKI TP, 1991, CANCER RES, V51, P794
   Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372
   Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102
   Tan DJ, 2002, CANCER RES, V62, P972
   Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7
   Walder K, 2005, DIABETOLOGIA, V48, P459, DOI 10.1007/s00125-005-1675-9
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x
   Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057
   Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219
   Wu YT, 2010, ANN NY ACAD SCI, V1201, P147, DOI 10.1111/j.1749-6632.2010.05631.x
   Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200
   Yi XW, 2006, DIABETES, V55, P2238, DOI 10.2337/db06-0251
   Yorek MA, 2003, FREE RADICAL RES, V37, P471, DOI 10.1080/1071576031000083161
   Zhu XY, 2009, ACTA BIOCH BIOPH SIN, V41, P179, DOI 10.1093/abbs/gmn021
NR 139
TC 21
Z9 23
U1 0
U2 20
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1537-744X
EI 
J9 SCI WORLD J
JI Sci. World J.
PD JUN 15
PY 2014
VL 0
IS 
BP 
EP 
DI 10.1155/2014/604685
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD5KP
UT WOS:000333291800001
DA 2024-11-01
ER

PT J
AU Gonzalez, AS
   Elguero, ME
   Finocchietto, P
   Holod, S
   Romorini, L
   Miriuka, SG
   Peralta, JG
   Poderoso, JJ
   Carreras, MC
AF Gonzalez, A. S.
   Elguero, M. E.
   Finocchietto, P.
   Holod, S.
   Romorini, L.
   Miriuka, S. G.
   Peralta, J. G.
   Poderoso, J. J.
   Carreras, M. C.
TI Abnormal mitochondrial fusion-fission balance contributes to the progression of experimental sepsis
SO FREE RADICAL RESEARCH
LA English
DT Article
DE nitric oxide; mitochondria; lipopolysaccharide; reactive oxygen species; iNOS
ID nitric-oxide synthase; complex-i; oxidative stress; s-nitrosylation; peroxynitrite; dysfunction; inhibition; biogenesis; dynamics; muscle
AB Sepsis-associated multiple organ failure is a major cause of mortality characterized by a massive increase of reactive oxygen and nitrogen species (ROS/RNS) and mitochondrial dysfunction. Despite intensive research, determining events in the progression or reversal of the disease are incompletely understood. Herein, we studied two prototype sepsis models: endotoxemia and cecal ligation and puncture (CLP)-which showed very diff erent lethality rates (2.5% and 67%, respectively)-, evaluated iNOS, ROS and respiratory chain activity, and investigated mitochondrial biogenesis and dynamics, as possible processes involved in sepsis outcome. Endotoxemia and CLP showed diff erent iNOS, ROS/RNS, and complex activities time-courses. Moreover, these alterations reverted after 24-h endotoxemia but not after CLP. Mitochondrial biogenesis was not elicited during the fi rst 24 h in either model but instead, 50% mtDNA depletion was observed. Mitochondrial fusion and fi ssion were evaluated using real-time PCR of mitofusin-2 (Mfn2), dynamin-related protein-1 (Drp1), and using electron microscopy. During endotoxemia, we observed a decrease of Mfn2-mRNA levels at 4-6 h, and an increase of mitochondrial fragmentation at 6 h. These parameters reverted at 24 h. In contrast, CLP showed not only decreased Mfn2-mRNA levels at 12-18 h but also increased Drp1-mRNA levels at 4 h, and enhanced and sustained mitochondrial fragmentation. The in vivo pretreatment with mdivi-1 (Drp1 inhibitor) signifi cantly attenuated mitochondrial dysfunction and apoptosis in CLP. Therefore, abnormal fusion-to-fi ssion balance, probably evoked by ROS/RNS secondary to iNOS induction, contributes to the progression of sepsis. Pharmacological targeting of Drp1 may be a potential novel therapeutic tool for sepsis.
C1 [Gonzalez, A. S.; Elguero, M. E.; Finocchietto, P.; Peralta, J. G.; Poderoso, J. J.; Carreras, M. C.] Univ Buenos Aires, Lab Oxygen Metab, INIGEM CONICET, Buenos Aires, DF, Argentina.
   [Gonzalez, A. S.; Holod, S.; Carreras, M. C.] Univ Buenos Aires, INFIBIOC, Sch Pharm & Biochem, Dept Clin Biochem, Buenos Aires, DF, Argentina.
   [Romorini, L.; Miriuka, S. G.] FLENI, LIAN, Lab Biol Desarrollo Celular, Buenos Aires, DF, Argentina.
C3 University of Buenos Aires; University of Buenos Aires
RP Carreras, MC (corresponding author), Univ Buenos Aires, Lab Oxygen Metab, INIGEM CONICET, Cordoba 2351,C1120AAR, Buenos Aires, DF, Argentina.
EM carreras@ffyb.uba.ar
FU Agencia Nacional de Promocion Cientfica y Tecnologica (FONCyT) [PICT 01625]; University of Buenos Aires [UBACyT M058, W443]; CONICET [PIP 0422]; Fundacion Perez Companc, Buenos Aires, Argentina
CR Alvarez S, 2004, FREE RADICAL BIO MED, V37, P1472, DOI 10.1016/j.freeradbiomed.2004.06.034
   Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085
   Beal AL, 1991, JAMA-J AM MED ASSOC, V271, P226
   Beltrán B, 2000, BRIT J PHARMACOL, V129, P953, DOI 10.1038/sj.bjp.0703147
   BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   Bhatia M, 2009, FRONT BIOSCI-LANDMRK, V14, P4703, DOI 10.2741/3561
   Boczkowski J, 1999, FASEB J, V13, P1637, DOI 10.1096/fasebj.13.12.1637
   Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X
   Brealey D, 2004, AM J PHYSIOL-REG I, V286, PR491, DOI 10.1152/ajpregu.00432.2003
   Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829
   Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016
   Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115
   Cardoso SM, 1999, FREE RADICAL BIO MED, V26, P3, DOI 10.1016/S0891-5849(98)00205-6
   Carreras Maria C, 2004, MOLECULAR ASPECTS OF MEDICINE, V25, P125, DOI 10.1016/j.mam.2004.02.014
   Carreras MC, 2007, AM J PHYSIOL-CELL PH, V292, PC1569, DOI 10.1152/ajpcell.00248.2006
   Carreras MC, 2004, HEPATOLOGY, V40, P157, DOI 10.1002/hep.20255
   Cauwels A, 2007, KIDNEY INT, V72, P557, DOI 10.1038/sj.ki.5002340
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chen HC, 2005, HUM MOL GENET, V14, PR283, DOI 10.1093/hmg/ddi270
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091
   Choumar A, 2011, ANTIOXID REDOX SIGN, V15, P2837, DOI 10.1089/ars.2010.3713
   Crouser ED, 2006, CRIT CARE MED, V34, P2439, DOI 10.1097/01.CCM.0000230240.02216.21
   Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x
   DELLINGER RP, 2013, INTENS CARE MED, V39, P165, DOI 10.1007/s00134-012-2769-8
   Dyson A, 2009, CRIT CARE MED, V37, PS30, DOI 10.1097/CCM.0b013e3181922bd3
   Escames G, 2003, FASEB J, V17, P932, DOI 10.1096/fj.02-0692fje
   Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007
   Franco MC, 2006, J BIOL CHEM, V281, P4779, DOI 10.1074/jbc.M512080200
   Fredriksson K, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003686
   Hauser B, 2005, ANESTH ANALG, V101, P488, DOI 10.1213/01.ANE.0000177117.80058.4D
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e
   Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, PC1024, DOI 10.1152/ajpcell.00162.2005
   Kurose I, 1996, HEPATOLOGY, V24, P1185
   Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010
   Lisdero CL, 2004, METHOD ENZYMOL, V382, P67
   López LC, 2006, INT J BIOCHEM CELL B, V38, P267, DOI 10.1016/j.biocel.2005.09.008
   López-Figueroa MO, 2000, BIOCHEM BIOPH RES CO, V272, P129, DOI 10.1006/bbrc.2000.2748
   Muster B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011910
   Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006
   Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021
   Piantadosi CA, 2012, FREE RADICAL BIO MED, V53, P2043, DOI 10.1016/j.freeradbiomed.2012.09.014
   Poderoso JJ, 1999, J BIOL CHEM, V274, P37709, DOI 10.1074/jbc.274.53.37709
   Protti A, 2007, CRIT CARE MED, V35, P2150, DOI 10.1097/01.ccm.0000281448.00095.4d
   Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200
   Remick DG, 2005, SHOCK, V24, P7, DOI 10.1097/01.shk.0000191384.34066.85
   Riobó NA, 2001, BIOCHEM J, V359, P139, DOI 10.1042/0264-6021:3590139
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x
NR 52
TC 80
Z9 92
U1 0
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-5762
EI 1029-2470
J9 FREE RADICAL RES
JI Free Radic. Res.
PD JUL 15
PY 2014
VL 48
IS 7
BP 769
EP 783
DI 10.3109/10715762.2014.906592
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AI7AP
UT WOS:000337031900005
PM 24720571
DA 2024-11-01
ER

PT J
AU Fujioka, H
   Tandler, B
   Rosca, M
   McCandless, SE
   Katirji, B
   Cohen, ML
   Rapisuwon, S
   Hoppel, CL
AF Fujioka, Hisashi
   Tandler, Bernard
   Rosca, Mariana
   McCandless, Shawn E.
   Katirji, Bashar
   Cohen, Mark L.
   Rapisuwon, Suthee
   Hoppel, Charles L.
TI Multiple Muscle Cell Alterations in a Case of Encephalomyopathy
SO ULTRASTRUCTURAL PATHOLOGY
LA English
DT Article
DE Encephalomyopathy; mitochondrial DNA; mitochondrial function; mitochondrial structure; myopathy
ID sarcoplasmic-reticulum origin; skeletal-muscle; electron-microscopy; oxidative-phosphorylation; mitochondrial myopathy; crystalloid inclusions; complex-iii; mutation; liver; heart
AB Skeletal muscle from an encephalomyopathy was examined by morphological and biochemical modalities. Mitochondria displayed variability in size, numbers per myocyte, and morphology. Certain organelles had stacks of dense cristae, others contained variable numbers of crystalloids or several lipid droplets. In isolated skeletal muscle mitochondria, oxidative phosphorylation was reduced, but activities of the electron transport chain components were unaffected. This is the second case of adult onset encephalomyopathy with a phenotype overlapping MERRF and Kearns-Sayre syndrome associated with a heteroplasmic mtDNA 3255G>A mutation in the tRNA(UUR(LEU)). This study emphasizes the desirability of a multidisciplinary approach in the diagnosis of complex myopathies.
C1 [Fujioka, Hisashi] Case Western Reserve Univ, Electron Microscopy Facil, Cleveland, OH 44106 USA.
   [Fujioka, Hisashi; Tandler, Bernard; Rosca, Mariana; Rapisuwon, Suthee; Hoppel, Charles L.] Case Western Reserve Univ, Sch Med, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA.
   [Tandler, Bernard] Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA.
   [Rosca, Mariana; Rapisuwon, Suthee; Hoppel, Charles L.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.
   [McCandless, Shawn E.] Case Western Reserve Univ, Case Med Ctr, Univ Hosp, Dept Human Genet, Cleveland, OH 44106 USA.
   [Katirji, Bashar; Cohen, Mark L.; Rapisuwon, Suthee] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.
   [Katirji, Bashar] Case Western Reserve Univ, Case Med Ctr, Univ Hosp, Dept Neurol, Cleveland, OH 44106 USA.
   [Cohen, Mark L.] Case Western Reserve Univ, Case Med Ctr, Univ Hosp, Dept Pathol, Cleveland, OH 44106 USA.
   [Hoppel, Charles L.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.
C3 University System of Ohio; Case Western Reserve University; University System of Ohio; Case Western Reserve University; University System of Ohio; Case Western Reserve University; University System of Ohio; Case Western Reserve University; University System of Ohio; Case Western Reserve University; University Hospitals of Cleveland; University System of Ohio; Case Western Reserve University; University System of Ohio; Case Western Reserve University; University Hospitals of Cleveland; University Hospitals of Cleveland; University System of Ohio; Case Western Reserve University; University System of Ohio; Case Western Reserve University
RP Hoppel, CL (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM charles.hoppel@case.edu
FU Center for Inherited Diseases of Energy Metabolism (CIDEM), University Hospital, Case Medical Center, Cleveland, Ohio, USA; Fraternal Order of Eagles 2436, Chagrin Falls, Ohio
CR Bereiter-Hahn Juergen, 2008, BIOTECHNOLOGY JOURNAL, V3, P765, DOI 10.1002/biot.200800024
   BONILLA E, 1980, ACTA NEUROPATHOL, V52, P35, DOI 10.1007/BF00687226
   BOUDIN G, 1976, J NEUROL SCI, V30, P313, DOI 10.1016/0022-510X(76)90137-4
   Chevessier F, 2005, J PATHOL, V207, P313, DOI 10.1002/path.1832
   Chevessier F, 2004, NEUROMUSCULAR DISORD, V14, P208, DOI 10.1016/j.nmd.2003.11.007
   CHOU SM, 1969, ACTA NEUROPATHOL, V12, P68, DOI 10.1007/BF00685312
   Claeys KG, 2010, NEUROMUSCULAR DISORD, V20, P701, DOI 10.1016/j.nmd.2010.06.006
   DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N
   ENGEL AG, 1968, MAYO CLIN PROC, V43, P233
   Fackenthal DL, 2005, METH MOL B, V311, P73
   FISHER ER, 1969, AM J CLIN PATHOL, V51, P619
   FRANKE WW, 1971, PROTOPLASMA, V73, P35, DOI 10.1007/BF01286409
   HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304
   HOPPEL CL, 1973, BIOCHEM PHARMACOL, V22, P2311, DOI 10.1016/0006-2952(73)90012-9
   HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   KALT MR, 1971, J ULTRA MOL STRUCT R, V36, P633, DOI 10.1016/S0022-5320(71)90020-7
   Karnovsky MJ, 1971, PROC 11TH ANNU MTG AM SOC CELL BIOL, V0, P146
   KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998
   KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4
   Kyriacou K, 2005, ULTRASTRUCT PATHOL, V29, P169, DOI 10.1080/01913120590951158
   Miles L, 2006, HUM PATHOL, V37, P173, DOI 10.1016/j.humpath.2005.10.008
   MORRE DJ, 1971, PROTOPLASMA, V73, P43, DOI 10.1007/BF01286410
   Müller HD, 2001, ACTA NEUROPATHOL, V102, P27
   Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034
   NIAKAN E, 1985, J NEUROL NEUROSUR PS, V48, P882, DOI 10.1136/jnnp.48.9.882
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Oldfors A, 2008, ADV EXP MED BIOL, V642, P78
   Pavlovicová M, 2003, GEN PHYSIOL BIOPHYS, V22, P425
   PRICE HM, 1967, J NEUROPATH EXP NEUR, V26, P475, DOI 10.1097/00005072-196707000-00009
   Prince FP, 2004, ANAT REC PART A, V278A, P454, DOI 10.1002/ar.a.20019
   Puchowicz MA, 2004, MITOCHONDRION, V4, P377, DOI 10.1016/j.mito.2004.07.004
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Riva A, 2010, ARCH HISTOL CYTOL, V73, P37, DOI 10.1679/aohc.73.37
   Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184
   ROSENBERG NL, 1985, ARCH NEUROL-CHICAGO, V42, P973, DOI 10.1001/archneur.1985.04060090055014
   SALVIATI G, 1985, MUSCLE NERVE, V8, P299, DOI 10.1002/mus.880080406
   SCHELLENS JP, 1969, VIRCHOWS ARCH B, V4, P21
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   TANDLER B, 1964, J ULTRA MOL STRUCT R, V11, P292, DOI 10.1016/S0022-5320(64)90034-6
   Tandler B, 2004, ENCY BIOL CHEM, V2, P186
   TASSIN S, 1980, NEUROPATH APPL NEURO, V6, P337, DOI 10.1111/j.1365-2990.1980.tb00670.x
   Tomonaga M, 1974, J CLIN ELECT MICROSC, V6, P107
   Voets AM, 2011, MITOCHONDRION, V11, P964, DOI 10.1016/j.mito.2011.09.003
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
NR 45
TC 7
Z9 7
U1 0
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0191-3123
EI 1521-0758
J9 ULTRASTRUCT PATHOL
JI Ultrastruct. Pathol.
PD FEB 15
PY 2014
VL 38
IS 1
BP 13
EP 25
DI 10.3109/01913123.2013.831158
PG 13
WC Microscopy; Pathology
SC Microscopy; Pathology
GA AC7TQ
UT WOS:000332735200003
PM 24134831
DA 2024-11-01
ER

PT J
AU Busch, KB
   Kowald, A
   Spelbrink, JN
AF Busch, Karin B.
   Kowald, Axel
   Spelbrink, Johannes N.
TI Quality matters: how does mitochondrial network dynamics and quality control impact on mtDNA integrity?
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Review
DE mitochondrial dynamics; mtDNA; mitophagy; nucleoids; TFAM; OXPHOS
ID dna deletion mutations; aged muscle-fibers; oxidative stress; skeletal-muscle; superresolution fluorescence; functional-organization; clonal expansion; optic atrophy; fission; fusion
AB Mammalian mtDNA encodes for 13 core proteins of oxidative phosphorylation. Mitochondrial DNA mutations and deletions cause severe myopathies and neuromuscular diseases. Thus, the integrity of mtDNA is pivotal for cell survival and health of the organism. We here discuss the possible impact of mitochondrial fusion and fission on mtDNA maintenance as well as positive and negative selection processes. Our focus is centred on the important question of how the quality of mtDNA nucleoids can be assured when selection and mitochondrial quality control works on functional and physiological phenotypes constituted by oxidative phosphorylation proteins. The organelle control theory suggests a link between phenotype and nucleoid genotype. This is discussed in the light of new results presented here showing that mitochondrial transcription factor A/nucleoids are restricted in their intramitochondrial mobility and probably have a limited sphere of influence. Together with recent published work on mitochondrial and mtDNA heteroplasmy dynamics, these data suggest first, that single mitochondria might well be internally heterogeneous and second, that nucleoid genotypes might be linked to local phenotypes (although the link might often be leaky). We discuss how random or site-specific mitochondrial fission can isolate dysfunctional parts and enable their elimination by mitophagy, stressing the importance of fission in the process of mtDNA quality control. The role of fusion is more multifaceted and less understood in this context, but the mixing and equilibration of matrix content might be one of its important functions.
C1 [Busch, Karin B.] Univ Osnabruck, Sch Biol & Chem, Div Mitochondrial Dynam, D-49069 Osnabruck, Germany.
   [Kowald, Axel] Newcastle Univ, Inst Ageing & Hlth, Ctr Integrated Syst Biol Ageing & Nutr, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Spelbrink, Johannes N.] Radboud Univ Nijmegen, Nijmegen Ctr Mitochondrial Disorders, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
   [Spelbrink, Johannes N.] FinMIT Ctr Excellence, Inst Biomed Technol, Tampere 33014, Finland.
   [Spelbrink, Johannes N.] Tampere Univ Hosp, Pirkanmaa Hosp Dist, Tampere 33014, Finland.
C3 University Osnabruck; Newcastle University - UK; Radboud University Nijmegen; Pirkanmaa Hospital District; Tampere University; Tampere University Hospital
RP Spelbrink, JN (corresponding author), Radboud Univ Nijmegen, Nijmegen Ctr Mitochondrial Disorders, Med Ctr, Dept Pediat, Geert Grootepl 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM hans.spelbrink@radboudumc.nl
FU Academy of Finland; Netherlands Organization for Scientific Research (NWO: VICI) [865.10.004]; DFG [Bu2288/1-1];  [SFB 944]
CR ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Appelhans T, 2012, NANO LETT, V12, P610, DOI 10.1021/nl203343a
   Arakaki N, 2006, BIOL PHARM BULL, V29, P1962, DOI 10.1248/bpb.29.1962
   Arimura S, 2004, P NATL ACAD SCI USA, V101, P7805, DOI 10.1073/pnas.0401077101
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Bereiter-Hahn J, 1997, EXPERIMENTAL BIOLOGY ONLINE, V1, P1
   BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303
   BEREITHERHAHN J, 1998, EXP BIOL ONLINE, V3, P12
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11
   Busch KB, 2006, MOL MEMBR BIOL, V23, P509, DOI 10.1080/09687860600877292
   Busch KB, 2013, BIOL CHEM, V394, P163, DOI 10.1515/hsz-2012-0254
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616
   COMFORT A, 1974, MECH AGEING DEV, V3, P1, DOI 10.1016/0047-6374(74)90002-5
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   de Vries RLA, 2012, AUTOPHAGY, V8, P699, DOI 10.4161/auto.19470
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   Dieteren CEJ, 2011, P NATL ACAD SCI USA, V108, P8657, DOI 10.1073/pnas.1017581108
   Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   HAYASHI JI, 1994, J CELL BIOL, V125, P43, DOI 10.1083/jcb.125.1.43
   Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Holt IJ, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0451
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Iborra FJ, 2004, BMC BIOL, V2, P0, DOI 10.1186/1741-7007-2-9
   Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0
   Jensen RE, 2000, MICROSC RES TECHNIQ, V51, P573, DOI 10.1002/1097-0029(20001215)51:6<573::AID-JEMT7>3.0.CO;2-2
   Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849
   Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768
   Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030
   Kopek BG, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0077209
   Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kowald A, 2014, J THEOR BIOL, V340, P111, DOI 10.1016/j.jtbi.2013.09.009
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488
   Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5
   McDonald SAC, 2006, CELL CYCLE, V5, P808, DOI 10.4161/cc.5.8.2641
   Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612
   MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x
   Molina AJA, 2009, METHOD ENZYMOL, V457, P289, DOI 10.1016/S0076-6879(09)05016-2
   Muster B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011910
   Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799
   NASS MMK, 1969, J MOL BIOL, V42, P521, DOI 10.1016/0022-2836(69)90240-X
   Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233
   Oettinghaus B, 2012, ACTA NEUROPATHOL, V123, P189, DOI 10.1007/s00401-011-0930-z
   Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613
   Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005
   Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988
   Rube DA, 2004, MOL CELL BIOCHEM, V256, P331, DOI 10.1023/B:MCBI.0000009879.01256.f6
   Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38
   SCHWARTZ RM, 1978, SCIENCE, V199, P395, DOI 10.1126/science.202030
   Scorrano L, 2003, CELL DEATH DIFFER, V10, P1287, DOI 10.1038/sj.cdd.4401310
   Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2
   Sheahan MB, 2005, PLANT J, V44, P744, DOI 10.1111/j.1365-313X.2005.02561.x
   Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Twig G, 2006, AM J PHYSIOL-CELL PH, V291, PC176, DOI 10.1152/ajpcell.00348.2005
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wilkens V, 2013, J CELL SCI, V126, P103, DOI 10.1242/jcs.108852
   Woldringh CL, 2002, MOL MICROBIOL, V45, P17, DOI 10.1046/j.1365-2958.2002.02993.x
   Yaffe MP, 1999, NAT CELL BIOL, V1, PE149, DOI 10.1038/14101
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Zunino R, 2009, J BIOL CHEM, V284, P17783, DOI 10.1074/jbc.M901902200
NR 97
TC 59
Z9 67
U1 1
U2 30
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
EI 1471-2970
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD JUL 5
PY 2014
VL 369
IS 1646
BP 
EP 
DI 10.1098/rstb.2013.0442
PG 12
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA AJ0SV
UT WOS:000337367200004
PM 24864312
DA 2024-11-01
ER

PT J
AU Melchionda, L
   Damseh, NS
   Abu Libdeh, B
   Nasca, A
   Elpeleg, O
   Zanolini, A
   Ghezzi, D
AF Melchionda, Laura
   Damseh, Nadirah S.
   Abu Libdeh, BassamY.
   Nasca, Alessia
   Elpeleg, Orly
   Zanolini, Alice
   Ghezzi, Daniele
TI A novel mutation in <i>TTC19</i> associated with isolated complex III deficiency, cerebellar hypoplasia, and bilateral basal ganglia lesions
SO FRONTIERS IN GENETICS
LA English
DT Article
ID encephalopathy; impairment; reveals
AB Isolated complex III (cIII) deficiency is a rare biochemical finding in mitochondrial disorders, mainly associated with mutations in mitochondrial DNA MTCYB gene, encoding cytochrome b, or in assembly factor genes (BCS1L, TTC19, UQCC2, and LYRM7), whereas mutations in nuclear genes encoding cIII structural subunits are extremely infrequent. We report here a patient, a 9 year old female born from first cousin related parents, with normal development till 18 months when she showed unsteady gait with frequent falling down, cognitive, and speech worsening. Her course deteriorated progressively. Brain MRI showed cerebellar vermis hypoplasia and bilateral lentiform nucleus high signal lesions. Now she is bed ridden with tetraparesis and severely impaired cognitive and language functions. Biochemical analysis revealed isolated cIII deficiency in muscle, and impaired respiration in fibroblasts. We identified a novel homozygous rearrangement in TTC19 (c.213_229dup), resulting in frameshift with creation of a premature termination codon (p.G1n77Argfs*30). Western blot analysis demonstrated the absence of TTC19 protein in patient's fibroblasts, while Blue-Native Gel Electrophoresis analysis revealed the presence of cIII-specific assembly intermediates. Mutations in TTC19 have been rarely associated with mitochondrial disease to date, being described in about ten patients with heterogeneous clinical presentations, ranging from early onset encephalomyopathy to adult forms with cerebellar ataxia. Contrariwise, the biochemical defect was a common hallmark in TTC19 mutant patients, confirming the importance of TTC19 in cIII assembly/stability. Therefore, we suggest extending the TTC19 mutational screening to all patients with cIII deficiency, independently from their phenotypes.
C1 [Melchionda, Laura; Nasca, Alessia; Zanolini, Alice; Ghezzi, Daniele] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
   [Damseh, Nadirah S.; Abu Libdeh, BassamY.] Al Makassed Islamic Charitable Hosp, Genet Unit, Jerusalem, Israel.
   [Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Monique & Jacques Roboh Dept Genet Res, Jerusalem, Israel.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; Hebrew University of Jerusalem; Hadassah University Medical Center
RP Ghezzi, D (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, Via Temolo 4, I-20126 Milan, Italy.
EM dghezzi@istituto-besta.it
CR Atwal PS, 2013, JIMD REP, V14, P43, DOI 10.1007/8904_2013_282
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2003, AM J MED GENET A, V121A, P126, DOI 10.1002/ajmg.a.20171
   Edvardson S, 2013, J MED GENET, V50, P733, DOI 10.1136/jmedgenet-2013-101753
   Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Gil Borlado MC, 2010, PLOS ONE, V5, Pe125, DOI 10.1371/journal.pone.0012801
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   Invernizzi F, 2013, HUM MUTAT, V34, P1619, DOI 10.1002/humu.22441
   Iwata K, 1998, BIOCHEM BIOPH RES CO, V253, P648, DOI 10.1006/bbrc.1998.9769
   Morino H, 2014, BMC NEUROL, V14, P0, DOI 10.1186/1471-2377-14-5
   Nogueira C, 2013, NEUROGENETICS, V14, P153, DOI 10.1007/s10048-013-0361-1
   Tucker EJ, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1004034
NR 14
TC 15
Z9 15
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND
SN 1664-8021
EI 
J9 FRONT GENET
JI Front. Genet.
PD NOV 14
PY 2014
VL 5
IS 
BP 
EP 
DI 10.3389/fgene.2014.00397
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA AZ0ND
UT WOS:000347941100001
PM 25452764
DA 2024-11-01
ER

